data_1xoa_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1xoa _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp . . . . . 0 C--O 1.232 0.152 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm -114.6 109.79 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.004 2.522 . . . . 0.0 108.983 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.2 mm -88.55 119.47 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.916 0.865 . . . . 0.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -84.95 75.26 10.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.79 162.59 10.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.649 1.18 . . . . 0.0 112.667 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 p -131.88 162.77 29.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -52.96 -44.03 66.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 110.025 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.31 -45.17 95.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.041 1.337 . . . . 0.0 112.057 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.44 -27.95 46.56 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.172 -0.33 . . . . 0.0 111.356 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -36.22 -51.74 0.78 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.653 1.581 . . . . 0.0 114.031 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.54 -64.86 0.73 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.651 0.738 . . . . 0.0 111.275 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.38 -37.93 82.29 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.263 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -55.54 4.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.305 -0.247 . . . . 0.0 111.537 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 -57.38 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 112.518 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.04 -36.75 80.41 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.384 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 122.463 0.305 . . . . 0.0 111.19 175.895 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mt -117.62 119.0 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.511 1.124 . . . . 0.0 108.734 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -93.0 102.98 15.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.1 t -87.29 113.84 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -93.54 117.68 30.39 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.36 121.68 32.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -134.01 179.49 6.22 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.639 1.176 . . . . 0.0 110.752 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.4 39.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.459 1.104 . . . . 0.0 108.907 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -53.12 -36.29 60.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.129 0.972 . . . . 0.0 111.53 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -86.8 -4.68 59.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.857 1.263 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.8 t -79.99 80.22 6.42 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.92 -1.113 . . . . 0.0 112.656 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.51 -58.51 4.0 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 123.456 0.551 . . . . 0.0 112.344 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.23 -37.01 69.54 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.219 2.613 . . . . 0.0 113.634 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.31 -44.21 97.6 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -63.99 -47.64 79.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.8 mtm -53.48 -39.52 64.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.166 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 pt -82.64 -13.21 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.227 0.921 . . . . 0.0 112.818 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -50.86 54.75 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 0.0 113.405 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.57 -44.52 46.8 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.357 2.038 . . . . 0.0 111.631 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.43 -51.24 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.85 -43.2 76.83 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.227 -0.296 . . . . 0.0 110.93 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -59.86 -52.83 63.77 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 0.0 109.888 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -55.59 -50.31 70.45 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.82 0.848 . . . . 0.0 109.938 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 mm -56.25 -50.88 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.711 0.805 . . . . 0.0 109.758 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.04 -43.41 66.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.206 0.603 . . . . 0.0 110.239 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.81 -57.63 6.66 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.588 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -47.19 -49.82 21.99 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.876 1.27 . . . . 0.0 112.973 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -91.28 14.16 15.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.253 0.621 . . . . 0.0 112.258 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 134.18 23.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.865 1.211 . . . . 0.0 111.178 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -29.26 6.95 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.494 -0.615 . . . . 0.0 111.797 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -98.98 -40.33 8.11 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.117 0.959 . . . . 0.0 109.013 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.0 tp -133.11 149.29 52.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.574 1.55 . . . . 0.0 109.072 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.6 m -124.17 147.24 48.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -121.73 152.34 25.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 119.458 1.026 . . . . 0.0 108.534 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.81 151.02 45.41 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.79 100.45 5.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.94 121.72 40.2 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.376 -0.827 . . . . 0.0 110.682 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.68 108.45 16.06 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.488 0.715 . . . . 0.0 109.759 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -65.1 -25.13 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.008 0.523 . . . . 0.0 112.288 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.42 -44.11 92.25 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.274 0.943 . . . . 0.0 108.896 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.88 -35.64 62.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.954 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -120.74 68.14 15.31 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 124.089 0.956 . . . . 0.0 111.815 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.29 -42.23 36.39 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.884 1.722 . . . . 0.0 110.22 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -37.59 6.07 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.623 1.106 . . . . 0.0 114.184 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -22.45 56.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.38 1.09 . . . . 0.0 112.965 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.64 -59.22 14.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.663 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.09 -46.6 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.584 2.189 . . . . 0.0 112.88 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.2 mttp . . . . . 0 C--N 1.341 0.201 0 C-N-CA 123.987 0.915 . . . . 0.0 112.501 -178.351 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 132.14 17.68 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.659 1.271 . . . . 0.0 111.011 -0.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.67 145.89 31.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -129.72 100.39 5.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.87 119.87 40.51 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.37 107.5 19.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.322 0.649 . . . . 0.0 109.936 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 124.832 1.253 . . . . 0.0 109.395 179.87 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 81.1 t -62.94 102.55 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.01 -42.43 26.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.637 0.775 . . . . 0.0 110.387 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.16 153.67 28.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.3 p -132.68 114.88 14.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.155 1.382 . . . . 0.0 109.176 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -110.0 144.0 39.17 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.34 127.63 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 167.36 35.61 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.972 0.796 . . . . 0.0 111.465 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 166.43 21.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.118 0.567 . . . . 0.0 110.624 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.41 165.03 31.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.294 1.438 . . . . 0.0 107.787 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -72.38 159.24 34.34 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.006 0.431 . . . . 0.0 110.494 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.94 -42.5 80.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.25 -54.74 33.61 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -55.36 -47.1 76.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.106 0.453 . . . . 0.0 110.36 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -59.21 -50.56 73.54 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -55.21 -48.2 74.21 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.971 -0.455 . . . . 0.0 110.737 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -58.82 -53.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.205 0.602 . . . . 0.0 109.84 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.6 -53.21 40.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.145 0.978 . . . . 0.0 110.127 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.49 -51.87 68.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.521 0.328 . . . . 0.0 110.757 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -54.44 -51.9 63.5 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.78 0.264 . . . . 0.0 110.565 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.42 72.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.381 1.072 . . . . 0.0 111.942 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -78.34 -43.95 26.44 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.987 0.358 . . . . 0.0 110.63 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -62.62 -47.17 84.94 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.905 0.482 . . . . 0.0 109.781 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.203 0 C-N-CA 124.564 1.146 . . . . 0.0 111.467 179.403 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.4 mt -112.3 143.28 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 125.476 1.51 . . . . 0.0 110.269 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.21 110.89 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.452 0.644 . . . . 0.0 110.773 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.18 97.32 8.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.534 1.134 . . . . 0.0 108.519 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.7 mt -80.73 169.94 16.96 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.731 0.776 . . . . 0.0 111.676 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.3 p -137.62 161.51 36.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.45 -43.31 67.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.5 -46.61 89.27 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.265 1.426 . . . . 0.0 112.009 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.8 p -78.23 -27.45 47.71 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.086 -0.384 . . . . 0.0 111.736 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -36.71 -54.74 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.425 1.49 . . . . 0.0 113.599 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -54.83 -63.57 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.424 0.63 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.85 -37.97 69.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.965 0.906 . . . . 0.0 113.022 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.53 -61.2 1.82 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.806 0.336 . . . . 0.0 111.485 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.72 -49.42 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.484 1.114 . . . . 0.0 112.538 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.252 45.1 mt -65.18 -29.9 70.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.862 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 122.578 0.351 . . . . 0.0 110.827 173.309 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.11 124.56 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.781 1.232 . . . . 0.0 108.523 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -102.78 104.3 14.58 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.33 113.49 26.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 122.761 0.425 . . . . 0.0 110.076 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.56 107.86 19.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 108.643 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -79.96 124.49 28.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -143.14 -179.72 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 111.452 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.2 150.78 33.18 Favored 'General case' 0 C--N 1.337 0.051 0 C-N-CA 125.848 1.659 . . . . 0.0 108.54 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -52.81 -42.86 65.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.465 0.706 . . . . 0.0 111.471 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -79.38 -6.53 57.01 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.292 1.037 . . . . 0.0 112.77 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.4 t -79.72 80.86 6.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 120.918 -1.114 . . . . 0.0 111.158 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.4 -59.08 3.7 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.65 -33.31 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.422 2.748 . . . . 0.0 113.653 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.92 -50.82 38.32 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -55.34 -43.99 75.51 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 -30.85 57.78 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.495 -0.764 . . . . 0.0 112.242 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 pt -92.97 -3.03 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.604 1.093 . . . . 0.0 112.204 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 88.49 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 119.785 1.175 . . . . 0.0 110.993 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.99 -47.35 28.04 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 111.352 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.4 mt -55.13 -52.87 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.49 -40.81 83.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 122.642 0.377 . . . . 0.0 110.77 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.55 -50.31 74.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.719 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.63 -50.34 72.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.289 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.0 mm -55.21 -48.61 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.6 -47.24 70.36 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.152 0.433 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.21 -49.11 75.5 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 111.462 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.71 -49.19 76.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -91.4 27.44 1.95 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.167 0.987 . . . . 0.0 113.259 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -53.86 128.36 29.72 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -17.05 14.31 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.274 -0.737 . . . . 0.0 113.195 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -99.7 -41.85 7.11 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.648 1.224 . . . . 0.0 110.171 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -140.05 133.2 29.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.781 0.832 . . . . 0.0 109.251 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.7 m -98.71 107.95 20.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.35 134.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.53 51.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.884 0.873 . . . . 0.0 108.776 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -127.55 145.13 50.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.974 1.31 . . . . 0.0 107.959 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -134.71 118.92 17.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.41 101.51 14.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -52.0 -37.65 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.29 -47.53 85.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.883 0.765 . . . . 0.0 110.423 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -81.92 -20.3 39.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.395 1.078 . . . . 0.0 111.561 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -129.25 63.76 68.6 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.424 1.49 . . . . 0.0 108.846 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.56 -45.14 7.3 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.581 2.188 . . . . 0.0 113.746 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.49 -45.67 1.94 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.356 1.455 . . . . 0.0 115.581 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -73.09 -28.13 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.82 -57.69 15.04 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.76 -43.47 16.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.478 1.452 . . . . 0.0 111.048 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mttp . . . . . 0 C--N 1.342 0.243 0 C-N-CA 123.043 0.537 . . . . 0.0 111.503 -179.345 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 pt . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.67 143.55 71.7 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.706 1.288 . . . . 0.0 109.854 -0.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.0 m -137.59 122.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -108.43 115.96 31.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.058 1.343 . . . . 0.0 109.218 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.54 121.73 46.03 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp -97.99 110.04 22.69 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.456 -0.13 0 C-N-CA 125.828 1.651 . . . . 0.0 111.329 -178.323 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.9 115.42 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -46.39 17.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.665 0.786 . . . . 0.0 109.212 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.74 163.3 26.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.567 0.747 . . . . 0.0 109.252 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 71.9 p -136.81 134.56 37.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.481 1.112 . . . . 0.0 109.125 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -124.6 117.59 24.64 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.59 133.11 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.2 161.5 37.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.986 0.803 . . . . 0.0 111.554 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.31 167.89 13.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.114 0.566 . . . . 0.0 110.549 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.57 163.6 27.2 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.807 1.243 . . . . 0.0 108.121 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -72.68 162.74 29.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.334 0.588 . . . . 0.0 111.282 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -54.16 -46.63 72.36 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.85 22.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -53.81 -45.45 70.78 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 117.455 0.627 . . . . 0.0 110.37 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.9 tp -59.16 -51.09 71.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.35 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -53.34 -49.78 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.559 0.618 . . . . 0.0 110.46 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -57.36 -50.63 72.35 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 117.772 0.26 . . . . 0.0 110.693 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -54.39 -53.21 57.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 0.0 110.516 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -58.04 -53.02 62.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.837 0.455 . . . . 0.0 110.328 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.35 -51.49 62.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.493 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.29 68.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.696 0.798 . . . . 0.0 111.863 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -78.04 -47.53 18.2 Favored 'General case' 0 CA--C 1.526 0.039 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.29 -44.76 88.65 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.196 0.598 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 122.996 0.518 . . . . 0.0 109.612 177.647 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.5 mt -91.85 140.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.951 0.9 . . . . 0.0 109.686 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.3 mm -90.38 122.48 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 122.019 0.914 . . . . 0.0 111.188 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -95.57 83.32 3.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.17 166.01 17.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.007 1.323 . . . . 0.0 112.715 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.0 p -128.41 161.2 30.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.85 -45.02 78.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.66 -47.23 86.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.883 1.273 . . . . 0.0 111.458 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -78.2 -24.78 46.96 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.126 -0.359 . . . . 0.0 111.846 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -36.45 -50.24 0.76 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.017 1.727 . . . . 0.0 113.548 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.21 -63.76 1.06 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 110.374 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -59.47 -34.52 72.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.439 0.696 . . . . 0.0 112.072 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -83.29 -65.9 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.94 -45.49 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 112.603 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.261 46.9 mt -64.89 -30.26 71.24 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.245 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 110.726 172.639 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 110.71 -0.107 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mt -119.78 128.48 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.957 1.303 . . . . 0.0 107.802 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.53 103.11 13.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.89 110.13 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 122.663 0.385 . . . . 0.0 110.454 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.69 108.31 19.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 118.0 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -133.0 178.32 6.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.472 1.109 . . . . 0.0 112.184 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.17 154.57 35.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.127 1.371 . . . . 0.0 108.57 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.89 -26.04 58.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -92.03 -4.32 54.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.468 1.107 . . . . 0.0 112.254 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.5 t -79.66 83.37 5.64 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.93 -1.106 . . . . 0.0 112.105 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.03 -58.91 4.14 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 123.582 0.61 . . . . 0.0 112.518 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.06 -30.82 61.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.074 2.516 . . . . 0.0 113.347 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.2 m -65.47 -42.81 91.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.49 -43.08 98.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 51.5 ttp -54.27 -47.96 71.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.636 0.374 . . . . 0.0 110.675 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.2 pt -77.54 -26.56 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.848 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.92 -57.08 1.06 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.94 -36.41 96.9 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 112.003 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.93 -49.63 78.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -55.04 -42.82 73.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.77 0.428 . . . . 0.0 110.376 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.87 -48.75 80.44 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.87 -49.71 74.68 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mm -54.39 -46.27 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.979 0.912 . . . . 0.0 109.79 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.37 55.41 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.965 0.506 . . . . 0.0 111.459 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.21 -58.84 2.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -48.51 -44.55 36.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.677 1.191 . . . . 0.0 113.232 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -104.92 23.09 14.1 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.468 1.107 . . . . 0.0 111.024 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -55.32 130.1 41.07 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.027 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -19.15 21.84 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.887 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -99.37 -45.22 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.606 1.203 . . . . 0.0 109.34 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 tp -131.57 116.73 17.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.658 1.183 . . . . 0.0 108.64 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 m -87.41 109.07 19.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.24 140.5 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.29 149.07 46.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.934 0.894 . . . . 0.0 109.767 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -130.44 103.92 6.95 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -98.37 119.52 37.2 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 122.98 0.512 . . . . 0.0 109.836 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -81.21 106.64 13.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.199 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.0 -32.32 55.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 123.74 0.816 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.27 -44.62 95.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.183 0.901 . . . . 0.0 109.145 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -77.33 -35.05 55.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.261 0.624 . . . . 0.0 110.762 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.3 67.78 7.01 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.13 0.972 . . . . 0.0 111.22 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.14 -40.33 26.94 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.16 1.907 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.46 3.52 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.219 1.39 . . . . 0.0 114.459 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.59 60.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.429 1.115 . . . . 0.0 112.971 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.45 -57.39 26.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -62.92 -35.72 65.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.24 1.96 . . . . 0.0 112.441 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.1 mttp . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 118.898 0.772 . . . . 0.0 112.051 -179.411 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.9 pt . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 118.723 -0.656 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.38 129.79 16.98 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 CA-C-N 120.189 1.103 . . . . 0.0 111.34 -0.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.3 112.16 23.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.92 94.49 6.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.17 115.11 27.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.04 105.99 18.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 CA--C 1.529 0.142 0 C-N-CA 125.351 1.46 . . . . 0.0 111.609 -177.821 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.25 109.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.23 -43.36 23.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.926 0.891 . . . . 0.0 110.314 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.87 160.08 35.75 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.176 0.59 . . . . 0.0 109.482 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.6 p -135.64 103.87 5.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 109.152 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -90.55 120.84 31.97 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.95 103.35 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.34 161.62 13.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.486 0.565 . . . . 0.0 112.015 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 166.0 23.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.852 0.861 . . . . 0.0 111.669 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -163.84 164.35 23.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.262 1.825 . . . . 0.0 107.36 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 p -93.31 170.86 9.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.987 1.315 . . . . 0.0 113.051 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -61.87 156.28 21.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.68 -62.64 4.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -59.61 -54.69 43.55 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.81 -48.99 74.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.141 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -55.18 -47.08 75.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.558 0.343 . . . . 0.0 111.829 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.43 -47.84 80.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.059 0.544 . . . . 0.0 109.796 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -53.47 -52.49 59.33 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.22 -51.16 71.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.586 0.355 . . . . 0.0 110.648 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.04 -50.91 65.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.704 0.401 . . . . 0.0 110.774 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.84 69.47 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.237 1.015 . . . . 0.0 111.434 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -77.55 -48.15 17.69 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.0 mt -54.95 -48.4 73.23 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.307 0 C-N-CA 123.096 0.559 . . . . 0.0 109.51 176.905 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.97 136.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.949 -0.469 . . . . 0.0 111.054 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.43 115.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-O 121.545 0.688 . . . . 0.0 111.587 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -82.69 96.69 8.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.018 0.927 . . . . 0.0 108.679 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.35 158.86 21.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.125 0.964 . . . . 0.0 113.188 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -125.1 160.46 29.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.904 2.082 . . . . 0.0 106.699 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -55.95 -44.31 78.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.44 -46.97 73.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.875 1.27 . . . . 0.0 111.019 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.4 p -78.1 -28.04 48.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.229 -0.295 . . . . 0.0 111.681 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -38.08 -53.67 1.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.51 1.524 . . . . 0.0 113.673 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -54.93 -62.83 1.4 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -36.69 71.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.179 0.992 . . . . 0.0 113.319 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.25 -62.04 1.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.771 0.32 . . . . 0.0 111.294 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.65 -49.07 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.487 1.115 . . . . 0.0 112.636 -172.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.67 -30.36 71.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.619 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mttm . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 119.443 -0.313 . . . . 0.0 110.848 173.877 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mt -112.67 125.91 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.518 1.127 . . . . 0.0 108.652 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.35 104.2 14.05 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 t -91.74 114.97 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.756 0.422 . . . . 0.0 110.344 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.83 106.83 19.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.693 1.197 . . . . 0.0 107.91 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.35 121.82 25.6 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -135.21 179.28 6.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.679 1.192 . . . . 0.0 110.852 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.34 155.64 40.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.799 1.24 . . . . 0.0 108.727 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -57.5 -27.9 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.589 0.632 . . . . 0.0 112.232 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -90.07 -3.96 57.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.614 1.166 . . . . 0.0 112.452 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.2 t -79.67 80.11 6.1 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 120.936 -1.102 . . . . 0.0 112.581 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.62 -58.86 4.52 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.151 0.405 . . . . 0.0 112.156 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.72 -32.52 55.61 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.369 2.713 . . . . 0.0 113.697 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.6 m -63.34 -44.36 95.09 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.97 -43.57 98.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtt -55.62 -42.51 75.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.149 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.68 -23.26 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 112.89 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.49 -51.74 6.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.57 -43.09 60.7 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.449 2.099 . . . . 0.0 111.964 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.58 -48.65 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -56.74 -41.62 77.86 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 122.419 -0.176 . . . . 0.0 110.551 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.41 -49.65 74.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.43 -50.45 69.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 mm -56.22 -49.02 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.411 0.684 . . . . 0.0 109.733 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -43.2 67.92 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.126 0.57 . . . . 0.0 110.358 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.73 -57.19 6.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.289 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.5 -44.07 55.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.18 . . . . 0.0 112.758 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.17 21.53 12.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 111.973 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -54.67 128.14 31.25 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.566 1.075 . . . . 0.0 110.189 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -19.18 28.58 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.213 -0.771 . . . . 0.0 113.049 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -99.09 -45.39 5.94 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.668 1.234 . . . . 0.0 109.452 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -129.6 131.22 46.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.447 1.099 . . . . 0.0 108.46 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.1 m -99.4 104.07 15.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.29 138.84 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.63 47.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.863 0.865 . . . . 0.0 109.241 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -125.81 135.31 51.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -125.92 122.0 34.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -86.71 110.97 20.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.32 -29.29 45.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -63.23 -47.66 81.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -70.34 -31.17 68.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.495 1.118 . . . . 0.0 110.253 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.04 73.41 76.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 0.0 111.834 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.37 -56.05 3.06 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.616 2.211 . . . . 0.0 112.688 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.58 -48.26 1.25 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.216 1.865 . . . . 0.0 115.57 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -28.52 69.54 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.756 -0.85 . . . . 0.0 113.023 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.89 -64.41 2.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.49 -42.74 45.39 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.734 1.623 . . . . 0.0 111.22 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt . . . . . 0 C--N 1.341 0.21 0 CA-C-N 118.229 0.468 . . . . 0.0 111.765 179.812 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.46 142.19 61.77 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 CA-C-N 120.586 1.245 . . . . 0.0 110.154 -1.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 m -134.9 119.98 18.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.0 mt -105.19 116.16 31.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.543 1.537 . . . . 0.0 109.156 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.7 mp -111.22 122.26 47.4 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp -98.17 104.88 16.95 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.455 -0.196 0 C-N-CA 125.276 1.43 . . . . 0.0 110.392 -179.839 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.45 110.13 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.02 -42.42 26.55 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.798 0.839 . . . . 0.0 109.836 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.68 162.6 35.11 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 62.1 p -137.36 138.81 40.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.446 1.098 . . . . 0.0 109.345 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -130.47 122.26 27.35 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.73 131.14 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.34 165.46 37.7 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.066 0.841 . . . . 0.0 111.934 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.72 165.96 22.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.257 0.623 . . . . 0.0 110.443 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.18 167.92 26.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.816 1.246 . . . . 0.0 108.55 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -75.46 159.91 30.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.99 0.424 . . . . 0.0 110.55 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.61 -42.88 75.52 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.24 -56.53 24.72 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -56.41 -42.43 77.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.804 0.802 . . . . 0.0 110.721 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.6 -51.36 70.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.82 -47.69 73.75 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.726 0.694 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -55.43 -53.33 57.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.041 0.382 . . . . 0.0 110.052 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -54.17 -53.01 59.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.778 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.05 -53.39 58.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.894 0.478 . . . . 0.0 110.526 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.37 -51.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.321 0.649 . . . . 0.0 110.29 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.73 -37.35 68.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.209 0.604 . . . . 0.0 111.693 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -78.13 -46.23 21.21 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.134 -0.354 . . . . 0.0 110.665 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.46 -47.08 85.2 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 C-N-CA 123.005 0.522 . . . . 0.0 109.614 177.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 mt -102.38 139.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.876 0.87 . . . . 0.0 109.895 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mm -88.68 114.25 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.244 1.021 . . . . 0.0 111.175 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -87.02 76.4 9.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.183 0.993 . . . . 0.0 108.95 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.48 160.17 25.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.997 1.319 . . . . 0.0 113.632 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 p -125.18 160.45 29.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.473 1.909 . . . . 0.0 107.638 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.61 -49.88 66.87 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.74 -45.87 67.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.993 1.317 . . . . 0.0 111.591 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 p -78.33 -28.57 47.34 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -35.82 -55.23 0.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.64 1.576 . . . . 0.0 115.001 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.65 -62.29 1.75 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.715 0.769 . . . . 0.0 111.347 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -61.99 -41.77 98.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.212 0.605 . . . . 0.0 112.193 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.31 -40.47 51.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.8 t -101.15 -63.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.841 0.856 . . . . 0.0 112.151 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.62 -33.48 71.55 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.4 mttt . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.696 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mt -114.45 123.05 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.16 1.384 . . . . 0.0 108.649 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.05 103.6 13.69 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.46 113.13 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.79 109.27 20.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -79.68 126.89 31.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -134.72 177.14 8.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.392 1.077 . . . . 0.0 110.005 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.45 156.45 43.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -59.51 -27.73 66.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.347 0.521 . . . . 0.0 110.723 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -91.22 -1.77 57.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -79.85 79.03 6.41 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.864 -1.147 . . . . 0.0 111.868 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.8 -56.98 6.3 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 119.823 -0.432 . . . . 0.0 112.12 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -52.89 -34.32 65.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.254 2.636 . . . . 0.0 113.722 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.78 -41.99 99.49 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -67.86 -45.62 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.8 ttm -50.66 -44.03 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.837 0.455 . . . . 0.0 111.265 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.02 -5.77 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.67 78.29 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 112.336 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.55 -46.11 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.364 2.043 . . . . 0.0 111.361 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.05 -52.8 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.44 -39.92 73.92 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.143 -0.348 . . . . 0.0 110.986 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.22 -50.99 69.56 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.91 -49.46 73.39 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.16 -49.25 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.387 0.675 . . . . 0.0 109.821 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.73 64.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.999 0.363 . . . . 0.0 110.595 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.74 -55.81 8.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.849 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -49.02 -49.15 42.42 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.447 1.099 . . . . 0.0 112.329 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -97.45 23.59 7.47 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.927 0.891 . . . . 0.0 111.5 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.95 130.0 28.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.35 0.977 . . . . 0.0 110.937 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.09 -17.61 9.34 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.435 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.18 -41.79 7.34 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.708 1.254 . . . . 0.0 109.107 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -131.63 134.88 46.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.216 1.407 . . . . 0.0 108.071 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -107.52 104.2 13.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -79.83 140.69 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.47 150.32 49.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.002 . . . . 0.0 109.203 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -132.91 99.31 4.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.709 1.204 . . . . 0.0 108.575 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tt -98.22 127.01 43.94 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 110.559 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.72 112.56 22.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.6 pt -67.18 -30.38 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.522 0.729 . . . . 0.0 112.832 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -65.98 -45.76 80.49 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.98 -36.51 83.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.76 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -124.78 74.77 64.77 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 123.91 0.884 . . . . 0.0 112.612 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.67 -61.23 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.389 2.726 . . . . 0.0 113.672 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.36 -48.94 1.66 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.039 1.78 . . . . 0.0 114.684 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -34.13 59.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.37 -68.88 0.68 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-O 117.598 -1.192 . . . . 0.0 110.193 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.49 -48.18 16.05 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.107 1.871 . . . . 0.0 112.715 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 C--N 1.345 0.409 0 CA-C-N 118.653 0.66 . . . . 0.0 111.916 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 pp . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.057 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.06 143.89 75.71 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 CA-C-N 120.362 1.165 . . . . 0.0 110.8 -0.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.9 m -140.78 123.04 15.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.1 mt -104.12 126.19 51.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.64 1.576 . . . . 0.0 109.362 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.61 119.25 33.2 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.82 102.05 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 125.301 1.44 . . . . 0.0 108.998 179.222 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 110.878 -0.045 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.08 105.49 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.03 -43.73 17.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.455 0.702 . . . . 0.0 110.556 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.04 33.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.9 p -145.21 169.1 18.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.16 0.584 . . . . 0.0 109.655 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -150.03 151.34 33.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.4 140.29 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.86 40.74 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 173.17 10.2 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.277 -0.543 . . . . 0.0 110.224 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.86 162.05 32.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.173 1.389 . . . . 0.0 107.366 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.31 151.64 29.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.428 0.691 . . . . 0.0 110.894 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -50.07 -47.54 53.57 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.463 1.105 . . . . 0.0 112.139 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.55 -56.52 23.2 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -53.62 -45.08 69.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.796 0.838 . . . . 0.0 110.259 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.75 -53.25 60.47 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -54.52 -47.28 73.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.117 0.417 . . . . 0.0 111.345 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.68 -52.28 66.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.07 -53.48 52.59 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.87 0.868 . . . . 0.0 110.076 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.57 -51.75 68.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.429 0.292 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.56 -51.69 64.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.832 0.453 . . . . 0.0 110.493 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.02 -39.06 71.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.916 0.887 . . . . 0.0 111.7 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -77.87 -42.73 32.46 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.315 -0.24 . . . . 0.0 110.413 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.6 mt -60.35 -45.54 93.09 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 123.152 0.581 . . . . 0.0 109.659 177.686 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 mt -91.12 141.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.004 0.922 . . . . 0.0 110.75 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -90.91 113.53 26.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.465 0.65 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -84.33 97.89 9.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.271 1.028 . . . . 0.0 109.261 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.07 160.25 18.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.2 1.0 . . . . 0.0 112.837 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.8 p -127.31 160.31 31.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.399 1.88 . . . . 0.0 106.951 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -53.33 -48.74 68.2 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.99 -45.52 71.47 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.926 1.29 . . . . 0.0 111.423 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.5 p -78.67 -28.78 45.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -33.35 -65.61 0.17 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 126.059 1.743 . . . . 0.0 115.268 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.4 -56.49 14.63 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.607 -0.683 . . . . 0.0 111.43 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.95 -45.63 92.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.331 0.652 . . . . 0.0 112.758 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.56 -39.64 52.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.35 -65.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.679 1.192 . . . . 0.0 112.116 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.39 -31.35 70.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 mttm . . . . . 0 CA--C 1.538 0.507 0 CA-C-N 118.524 0.602 . . . . 0.0 112.567 177.854 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.8 129.2 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 125.012 1.325 . . . . 0.0 108.843 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -109.91 103.73 12.55 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.5 t -90.9 117.68 34.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 118.326 0.512 . . . . 0.0 110.468 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.78 110.91 23.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.849 1.259 . . . . 0.0 108.918 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -83.66 121.32 27.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -137.34 176.57 8.59 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.15 149.17 31.51 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.842 1.657 . . . . 0.0 109.243 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.36 -34.8 64.6 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.532 0.733 . . . . 0.0 112.388 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -84.6 -10.27 57.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.94 0.896 . . . . 0.0 112.084 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.75 79.99 6.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.076 -1.015 . . . . 0.0 110.906 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.78 -58.58 2.6 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.153 0.882 . . . . 0.0 112.074 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -36.51 84.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.344 2.696 . . . . 0.0 113.598 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.7 m -63.59 -46.08 87.45 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -64.65 -42.17 95.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.9 ttp -52.69 -44.35 66.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.4 pt -78.78 -10.05 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.34 -57.21 12.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 120.052 1.297 . . . . 0.0 113.116 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.69 -41.06 77.08 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.056 1.837 . . . . 0.0 111.435 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 mt -59.84 -51.93 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.4 mt -55.65 -41.22 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.833 0.453 . . . . 0.0 110.55 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.11 -52.69 63.84 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.45 -48.63 68.66 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.829 -0.545 . . . . 0.0 109.984 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.56 -49.43 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 122.997 0.519 . . . . 0.0 109.668 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.0 -45.94 68.1 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.39 -57.41 8.42 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.818 0.342 . . . . 0.0 110.476 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.21 -50.57 37.73 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.919 1.288 . . . . 0.0 112.548 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -94.04 20.49 7.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.71 0.804 . . . . 0.0 111.995 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.53 99.83 0.05 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.687 1.13 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.7 -23.48 8.34 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.617 1.103 . . . . 0.0 111.284 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -99.43 -36.79 9.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.664 1.186 . . . . 0.0 109.706 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -138.33 139.03 38.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.062 0.945 . . . . 0.0 108.522 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.6 m -106.89 102.38 11.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.21 138.31 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.21 154.12 51.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.086 0.955 . . . . 0.0 108.662 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.0 145.42 51.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.022 1.329 . . . . 0.0 108.208 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -137.6 121.32 17.45 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -84.35 110.34 18.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.89 -31.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.88 -45.57 91.94 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.231 0.923 . . . . 0.0 109.058 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -71.93 -36.8 70.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.068 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -122.63 69.9 35.24 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.246 1.018 . . . . 0.0 111.612 -175.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.05 -47.27 6.74 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.972 1.781 . . . . 0.0 111.083 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -37.85 2.15 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.529 1.538 . . . . 0.0 114.895 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.4 -22.84 61.06 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.346 1.073 . . . . 0.0 113.677 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.92 -55.74 5.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.62 -37.02 42.52 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.327 2.684 . . . . 0.0 113.577 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 CA--C 1.531 0.218 0 C-N-CA 124.103 0.961 . . . . 0.0 112.107 179.796 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.7 pt . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.19 145.15 75.07 Favored 'Cis proline' 0 N--CA 1.456 -0.733 0 CA-C-N 120.725 1.295 . . . . 0.0 110.006 -0.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 m -138.79 124.51 19.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.06 115.74 30.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.616 1.566 . . . . 0.0 108.913 -175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.95 116.41 31.9 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 tp -96.72 104.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 125.576 1.55 . . . . 0.0 109.206 178.822 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.2 107.98 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -45.02 19.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.25 159.92 34.7 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.4 p -136.53 129.87 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.335 1.054 . . . . 0.0 108.53 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -119.31 119.22 33.38 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.52 132.32 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.51 163.89 34.37 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.147 0.879 . . . . 0.0 111.435 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.2 167.26 22.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.044 0.537 . . . . 0.0 110.221 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -160.93 162.99 32.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.782 1.233 . . . . 0.0 108.147 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.88 162.91 28.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.206 0.527 . . . . 0.0 110.98 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -55.8 -45.07 78.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.65 -54.41 36.57 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -56.43 -46.13 80.42 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 110.447 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.29 -52.34 66.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -55.93 -48.11 76.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 110.535 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -56.99 -53.41 58.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.777 0.431 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.98 -54.09 40.25 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.093 0.957 . . . . 0.0 110.312 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.54 -53.24 60.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.57 -52.31 60.15 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.918 0.327 . . . . 0.0 110.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.83 73.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.899 0.88 . . . . 0.0 112.004 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -77.68 -42.61 33.96 Favored 'General case' 0 C--O 1.23 0.029 0 O-C-N 122.095 -0.378 . . . . 0.0 110.319 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.49 -48.24 82.41 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 123.139 0.576 . . . . 0.0 109.525 177.077 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.4 138.51 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.318 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.6 mm -86.5 110.91 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.218 1.009 . . . . 0.0 111.01 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -82.41 76.11 9.29 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.771 0.828 . . . . 0.0 108.9 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.76 159.19 22.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.715 1.206 . . . . 0.0 113.659 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 p -125.74 160.53 29.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.8 2.04 . . . . 0.0 106.755 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -54.68 -45.46 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.67 -46.13 74.01 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.3 1.44 . . . . 0.0 111.432 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 p -78.67 -27.45 45.18 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -37.8 -54.51 1.24 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.327 1.451 . . . . 0.0 114.113 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.09 -50.25 73.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 111.664 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -66.24 -40.94 90.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.237 1.015 . . . . 0.0 111.339 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.01 -58.49 2.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.72 -51.52 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.038 0.935 . . . . 0.0 112.4 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 mt -64.87 -32.78 74.64 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.299 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttm . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 122.499 0.319 . . . . 0.0 111.201 174.552 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mt -120.25 119.44 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.179 1.392 . . . . 0.0 108.096 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.8 tp -94.61 104.8 16.73 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.68 109.66 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 122.829 0.452 . . . . 0.0 110.014 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -90.19 119.35 30.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.74 125.62 34.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -138.43 176.31 8.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.486 0.715 . . . . 0.0 111.157 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.45 151.77 32.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.056 1.342 . . . . 0.0 107.563 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -56.08 -36.87 68.59 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.615 0.766 . . . . 0.0 111.55 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -79.71 -11.03 59.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.241 1.017 . . . . 0.0 112.813 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -79.56 81.3 5.84 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.046 -1.034 . . . . 0.0 111.855 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.07 -57.62 3.51 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.013 0.816 . . . . 0.0 112.369 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.91 -33.58 82.72 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.862 2.375 . . . . 0.0 113.261 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -65.04 -43.55 91.98 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.49 -47.6 84.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -50.38 -41.89 52.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.888 0.875 . . . . 0.0 111.953 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -83.69 -8.82 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.91 -51.17 73.32 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.9 1.227 . . . . 0.0 112.721 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.94 -40.96 78.8 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.508 2.139 . . . . 0.0 112.078 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.08 -52.5 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.24 -42.84 77.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.826 0.45 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.28 -53.43 58.28 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.827 0.822 . . . . 0.0 109.327 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.87 -47.14 77.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.007 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 mm -56.11 -50.4 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.116 0.566 . . . . 0.0 109.806 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.61 67.65 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.982 0.513 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.24 -50.3 54.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.299 -0.251 . . . . 0.0 110.966 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.62 -49.32 77.92 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.33 0.652 . . . . 0.0 112.731 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -87.11 30.14 0.79 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.745 0.818 . . . . 0.0 112.592 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -52.27 125.0 14.57 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.561 -0.712 . . . . 0.0 110.213 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.65 -15.35 14.36 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.484 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.7 -36.23 9.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.431 1.116 . . . . 0.0 110.568 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -146.67 142.23 27.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.199 0.6 . . . . 0.0 109.479 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.8 m -108.36 139.79 42.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.96 143.19 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.83 151.08 51.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.943 0.897 . . . . 0.0 108.599 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -133.27 101.93 5.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -98.01 123.28 41.96 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.729 -0.607 . . . . 0.0 110.791 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -82.34 108.44 15.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.238 0.615 . . . . 0.0 110.077 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.66 -23.9 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.744 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -62.18 -46.17 90.15 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.3 -32.54 58.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.478 0.711 . . . . 0.0 110.558 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -128.53 70.19 79.73 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.574 0.75 . . . . 0.0 112.411 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.64 -59.35 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.505 2.137 . . . . 0.0 112.923 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.18 -42.22 1.62 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.345 1.926 . . . . 0.0 115.296 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -28.15 65.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.871 0.835 . . . . 0.0 112.854 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.01 -65.21 1.17 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.196 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -47.25 -40.18 27.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.247 2.631 . . . . 0.0 113.192 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 118.937 0.789 . . . . 0.0 112.242 178.011 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 CA--C 1.537 0.481 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.68 142.48 67.64 Favored 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.541 1.229 . . . . 0.0 110.523 -0.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -142.85 127.51 18.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.72 118.57 37.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.466 1.506 . . . . 0.0 109.234 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -110.66 118.31 35.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.44 107.36 19.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.456 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 111.465 -178.316 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.67 111.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -44.42 22.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.366 0.666 . . . . 0.0 109.639 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.13 161.33 31.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 78.4 p -135.23 132.28 37.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.395 1.078 . . . . 0.0 109.166 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -120.54 117.99 29.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -93.71 132.75 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.09 163.64 39.39 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.635 0.636 . . . . 0.0 111.778 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.35 167.94 15.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.14 0.576 . . . . 0.0 110.416 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.54 166.61 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.972 1.309 . . . . 0.0 107.723 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 76.8 p -82.42 161.49 22.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.225 0.536 . . . . 0.0 110.799 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -48.82 -51.88 27.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.019 . . . . 0.0 109.813 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.55 -54.78 28.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -55.28 -46.39 76.18 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.089 0.445 . . . . 0.0 110.337 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.06 -48.39 81.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.543 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -55.93 -50.13 71.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.319 0.509 . . . . 0.0 110.026 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -56.99 -50.79 71.62 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.836 0.289 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.32 -53.79 45.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 0.0 110.364 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.85 -54.93 41.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.562 0.345 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -52.2 -51.7 56.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.262 0.625 . . . . 0.0 110.674 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -38.04 69.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.669 0.788 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -78.07 -48.64 15.61 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.16 -0.338 . . . . 0.0 110.36 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -58.55 -44.77 89.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.161 0.584 . . . . 0.0 109.911 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 122.837 0.455 . . . . 0.0 109.775 177.768 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 mt -96.31 139.37 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 110.344 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -86.44 110.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.178 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -81.12 94.04 6.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.106 0.962 . . . . 0.0 108.799 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.78 163.82 22.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.986 0.914 . . . . 0.0 112.614 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.1 p -133.56 163.55 29.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.457 1.903 . . . . 0.0 106.226 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.07 -43.38 73.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.13 -46.31 90.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.962 1.305 . . . . 0.0 111.877 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -78.31 -27.54 47.24 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.096 -0.377 . . . . 0.0 111.385 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -36.65 -54.62 0.88 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 113.426 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.9 -63.73 1.06 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 110.902 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -56.1 -41.74 75.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.845 0.858 . . . . 0.0 112.787 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -58.42 2.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.11 -52.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.881 0.872 . . . . 0.0 112.712 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.24 -29.99 71.06 Favored 'General case' 0 C--O 1.228 -0.047 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 172.574 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -116.42 125.58 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 C-N-CA 124.619 1.168 . . . . 0.0 108.354 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 tp -103.28 103.34 13.35 Favored 'General case' 0 CA--C 1.524 -0.051 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -89.8 114.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 122.745 0.418 . . . . 0.0 110.103 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.36 114.3 26.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -82.86 128.1 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -142.43 174.61 10.47 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.446 0.698 . . . . 0.0 111.787 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.46 153.89 41.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.41 1.484 . . . . 0.0 107.789 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -52.32 -43.67 64.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.663 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -80.08 -2.45 44.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.952 1.301 . . . . 0.0 112.957 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -79.4 78.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.896 -1.128 . . . . 0.0 111.004 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.78 -57.36 3.43 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 123.74 0.686 . . . . 0.0 112.185 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.81 -32.46 77.08 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.071 2.514 . . . . 0.0 113.413 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.18 -47.64 76.27 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.62 -40.4 87.44 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -58.59 -46.11 87.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.96 0.504 . . . . 0.0 110.876 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 pt -76.27 -26.82 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 118.746 0.703 . . . . 0.0 112.555 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.91 -56.66 1.11 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.97 -38.89 94.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.217 1.944 . . . . 0.0 112.09 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 mt -62.11 -48.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -56.5 -42.55 78.54 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.24 -0.288 . . . . 0.0 110.261 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.05 -48.83 80.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.188 0.595 . . . . 0.0 109.703 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -59.35 -49.6 77.21 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.795 -0.565 . . . . 0.0 109.832 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.6 mm -52.04 -45.95 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.631 0.773 . . . . 0.0 110.047 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.82 -33.42 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.691 0.397 . . . . 0.0 111.38 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.47 -54.86 5.71 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.88 -44.53 49.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.909 . . . . 0.0 112.516 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -103.77 22.1 15.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.962 0.905 . . . . 0.0 112.189 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -51.17 135.97 24.89 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.876 0.762 . . . . 0.0 111.17 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 -23.51 3.61 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.97 -0.906 . . . . 0.0 113.531 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.38 -45.3 5.89 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.015 1.408 . . . . 0.0 110.251 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.02 121.69 40.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 m -93.54 103.67 15.84 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.94 137.96 20.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.08 48.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.053 0.941 . . . . 0.0 109.434 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -128.92 136.48 50.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -127.33 122.08 32.78 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.194 0.597 . . . . 0.0 110.19 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -83.07 106.34 14.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.047 0.539 . . . . 0.0 110.077 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.84 -26.22 36.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -58.51 -51.02 71.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.327 0.967 . . . . 0.0 109.298 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -78.83 -31.06 45.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.795 0.838 . . . . 0.0 111.089 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.82 66.46 20.79 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.446 0.698 . . . . 0.0 111.479 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.8 -54.24 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.379 2.053 . . . . 0.0 112.156 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.41 -46.44 1.45 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.881 1.705 . . . . 0.0 114.3 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -38.86 60.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.938 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.4 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.691 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.87 -45.32 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.167 1.911 . . . . 0.0 112.695 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? . . . . . 0 C--N 1.344 0.34 0 CA-C-N 119.095 0.861 . . . . 0.0 111.858 -179.618 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.3 pt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.1 147.6 89.03 Favored 'Cis proline' 0 N--CA 1.454 -0.795 0 CA-C-N 119.555 0.877 . . . . 0.0 110.296 -1.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -145.76 127.12 14.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt -102.51 126.0 49.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.669 1.588 . . . . 0.0 108.558 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.33 120.25 38.28 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -96.64 102.06 13.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.363 0.665 . . . . 0.0 109.444 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 N--CA 1.454 -0.261 0 C-N-CA 125.704 1.602 . . . . 0.0 110.116 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 N--CA 1.455 -0.221 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.87 106.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -43.29 22.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.444 0.698 . . . . 0.0 110.297 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.82 168.75 25.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 p -144.72 163.2 34.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -142.14 121.63 13.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.14 132.44 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.457 1.103 . . . . 0.0 108.783 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.49 167.19 42.38 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.598 0.555 . . . . 0.0 111.963 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.48 169.07 14.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.15 0.58 . . . . 0.0 110.266 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.69 165.64 27.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.037 1.335 . . . . 0.0 107.66 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.9 p -75.69 159.24 31.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.171 0.51 . . . . 0.0 110.417 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -52.77 -46.88 67.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.578 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.46 -57.01 19.09 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -54.05 -46.06 71.83 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.311 0.555 . . . . 0.0 111.199 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.39 -51.25 70.28 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.239 -0.288 . . . . 0.0 110.683 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.46 -48.53 74.36 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 122.18 -0.325 . . . . 0.0 110.621 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.83 -51.71 68.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.938 0.895 . . . . 0.0 110.036 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.36 -54.02 46.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.872 0.869 . . . . 0.0 109.962 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.86 -50.03 74.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.209 -0.307 . . . . 0.0 110.758 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.72 -52.23 63.13 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.543 0.337 . . . . 0.0 110.156 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -36.06 71.76 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.047 0.939 . . . . 0.0 111.947 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.32 -50.88 10.98 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 117.918 0.326 . . . . 0.0 110.46 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.05 -42.3 97.09 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.107 -0.371 . . . . 0.0 110.575 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 124.717 1.207 . . . . 0.0 111.727 179.292 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.8 mttp . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 mt -103.47 134.83 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.479 0.712 . . . . 0.0 110.94 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.5 mm -89.12 117.36 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 122.207 1.003 . . . . 0.0 110.6 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -89.07 78.26 7.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.81 163.87 18.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.747 1.219 . . . . 0.0 112.937 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.1 p -132.67 163.56 28.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.259 1.824 . . . . 0.0 106.707 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.74 -42.7 71.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.267 0.485 . . . . 0.0 109.743 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.57 -45.69 92.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.898 1.279 . . . . 0.0 111.709 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 p -78.71 -26.24 44.82 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.161 -0.337 . . . . 0.0 111.321 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -37.81 -57.06 1.04 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.532 1.533 . . . . 0.0 113.581 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -54.79 -61.69 2.15 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.703 0.763 . . . . 0.0 110.394 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -52.26 -42.58 63.78 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.201 1.4 . . . . 0.0 113.326 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -57.48 2.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.961 0.504 . . . . 0.0 112.068 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.92 -51.01 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.061 0.944 . . . . 0.0 112.536 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.7 -36.11 82.69 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.215 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.826 173.524 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mt -111.98 125.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.444 1.097 . . . . 0.0 108.299 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -104.16 100.48 10.22 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.94 112.7 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.44 0.296 . . . . 0.0 110.424 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -89.35 108.06 19.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -79.93 120.23 23.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -137.25 173.19 11.95 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.38 151.27 50.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.675 1.19 . . . . 0.0 108.357 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -55.04 -38.39 67.92 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.281 0.491 . . . . 0.0 111.357 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -83.81 -2.48 56.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.679 1.192 . . . . 0.0 112.488 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.47 80.79 5.81 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.948 -1.095 . . . . 0.0 110.685 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.89 -58.51 2.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.184 0.897 . . . . 0.0 111.919 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -54.0 -39.58 84.57 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.428 2.752 . . . . 0.0 113.543 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -62.28 -48.7 78.72 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.76 -44.24 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.4 ttm -52.53 -41.46 63.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.08 0.952 . . . . 0.0 111.135 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -82.58 -11.97 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.775 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.75 -49.85 54.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.321 1.419 . . . . 0.0 113.423 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.31 -37.96 94.14 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.315 2.01 . . . . 0.0 111.764 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.56 -48.98 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.52 -41.78 73.61 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.271 0.487 . . . . 0.0 110.236 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.47 -52.54 64.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.158 0.583 . . . . 0.0 109.92 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -54.06 -47.68 71.38 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.951 0.5 . . . . 0.0 109.698 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.1 -49.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.73 0.812 . . . . 0.0 109.539 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.7 67.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.073 0.397 . . . . 0.0 110.064 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.3 -50.83 64.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.197 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -60.39 -44.24 95.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.722 1.209 . . . . 0.0 113.62 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.52 29.19 3.38 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.713 1.205 . . . . 0.0 112.131 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.82 132.28 18.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.83 -0.543 . . . . 0.0 111.418 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.13 -19.04 2.34 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.123 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -98.84 -41.75 7.49 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.429 1.614 . . . . 0.0 109.859 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -129.97 119.74 23.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.542 0.737 . . . . 0.0 109.415 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -95.41 103.73 15.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.24 144.06 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.317 -0.864 . . . . 0.0 109.8 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.12 151.75 45.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.113 0.965 . . . . 0.0 109.134 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -133.15 103.86 6.22 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.69 119.57 37.66 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.754 0.421 . . . . 0.0 110.606 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -80.15 106.35 12.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.83 -27.46 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.753 0.821 . . . . 0.0 112.519 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.05 -51.3 70.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.215 0.916 . . . . 0.0 109.385 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -74.63 -32.15 62.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.71 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -118.85 67.49 7.99 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 111.661 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.92 -44.72 9.48 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 110.714 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.18 -37.7 4.59 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.291 1.424 . . . . 0.0 114.325 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.22 -24.34 64.01 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.255 1.027 . . . . 0.0 113.087 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -59.32 14.21 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -62.14 -33.8 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.216 1.944 . . . . 0.0 112.377 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 119.082 0.856 . . . . 0.0 111.922 179.778 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.4 pt . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.97 134.43 31.75 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.991 1.033 . . . . 0.0 110.739 -0.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.79 115.76 28.28 Favored 'General case' 0 C--N 1.338 0.074 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.51 94.06 6.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mp -91.91 114.92 27.59 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -94.09 100.12 12.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.564 0.746 . . . . 0.0 109.511 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 N--CA 1.456 -0.16 0 C-N-CA 125.231 1.412 . . . . 0.0 110.672 -179.691 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.0 107.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.26 24.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.64 0.776 . . . . 0.0 109.959 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.27 159.92 31.97 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.458 0.703 . . . . 0.0 109.243 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.6 p -134.11 103.77 5.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.439 1.096 . . . . 0.0 108.461 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -87.59 114.95 24.67 Favored 'General case' 0 C--N 1.338 0.087 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.84 119.22 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.05 166.38 26.92 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 121.579 0.544 . . . . 0.0 112.436 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.64 165.19 25.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.463 0.705 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -163.89 168.62 19.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.214 1.806 . . . . 0.0 106.994 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.3 p -97.1 178.44 5.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.11 0.957 . . . . 0.0 112.235 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -64.67 161.77 17.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.7 4.69 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.31 -56.23 22.85 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 tp -56.9 -46.02 82.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.056 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.14 -49.76 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.335 -0.228 . . . . 0.0 111.072 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.86 -50.31 73.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.269 0.628 . . . . 0.0 109.831 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -52.97 -52.24 58.8 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -58.96 -47.1 86.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.694 0.397 . . . . 0.0 110.957 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.9 -54.15 48.21 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.075 0.95 . . . . 0.0 111.983 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -77.89 -50.86 11.39 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 122.209 -0.307 . . . . 0.0 110.739 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 72.5 mt -59.73 -42.87 94.12 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.137 0.575 . . . . 0.0 109.956 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.525 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 110.529 -0.175 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.7 mt -83.26 136.21 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 122.07 -0.394 . . . . 0.0 111.303 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 mm -90.28 120.66 39.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.958 0.885 . . . . 0.0 111.121 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -92.86 80.93 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.1 0.96 . . . . 0.0 108.871 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.55 164.97 15.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.879 1.272 . . . . 0.0 112.784 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.6 p -132.9 163.04 30.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.71 -44.24 69.65 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.157 0.503 . . . . 0.0 109.659 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.9 -45.85 92.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.997 1.319 . . . . 0.0 111.963 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.35 -26.76 46.86 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.109 -0.37 . . . . 0.0 111.487 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -36.93 -54.76 0.93 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.737 1.615 . . . . 0.0 113.391 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.7 -62.85 1.39 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.447 0.641 . . . . 0.0 110.999 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -38.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.685 0.794 . . . . 0.0 113.108 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -59.21 2.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 -52.89 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.532 1.133 . . . . 0.0 112.439 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.31 -28.61 69.83 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.329 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.4 mttp . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 122.813 0.445 . . . . 0.0 110.112 174.036 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -117.51 127.31 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.505 1.122 . . . . 0.0 108.792 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -104.83 102.83 12.36 Favored 'General case' 0 C--N 1.337 0.055 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 t -89.76 113.23 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -93.46 111.5 23.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -80.91 124.9 29.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -139.69 -179.57 6.0 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.861 0.864 . . . . 0.0 111.191 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.871 1.268 . . . . 0.0 108.935 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.43 -22.55 54.74 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.502 1.121 . . . . 0.0 113.226 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -99.44 -2.04 37.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.712 1.205 . . . . 0.0 111.727 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.9 t -79.96 83.92 5.8 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.021 -1.049 . . . . 0.0 112.29 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.83 -59.88 3.12 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 123.828 0.728 . . . . 0.0 112.437 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -32.79 67.64 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 0.0 113.337 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.13 -45.88 83.24 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.57 -42.25 96.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -57.51 -44.79 85.3 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.964 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 pt -77.5 -21.19 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.922 0.783 . . . . 0.0 112.734 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.52 -57.31 2.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.702 1.137 . . . . 0.0 114.024 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -56.09 -40.08 87.16 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.161 1.907 . . . . 0.0 112.055 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.73 -50.61 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.2 -44.13 83.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.132 0.573 . . . . 0.0 110.682 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.94 -51.85 67.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.636 0.775 . . . . 0.0 110.002 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.56 -51.43 65.27 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.536 0.734 . . . . 0.0 109.221 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.51 -47.67 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.34 75.42 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.198 0.453 . . . . 0.0 110.946 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.61 -43.15 81.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.82 -54.89 15.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.342 1.057 . . . . 0.0 112.476 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -82.57 23.46 0.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.401 1.08 . . . . 0.0 111.038 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.23 101.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.823 1.649 . . . . 0.0 110.276 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.45 -21.53 16.87 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.629 1.109 . . . . 0.0 111.446 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -99.6 -35.67 9.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.707 1.203 . . . . 0.0 110.236 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -142.09 139.43 32.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.22 1.008 . . . . 0.0 109.447 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -109.51 105.33 14.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -80.09 140.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.6 150.35 49.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.69 0.796 . . . . 0.0 109.459 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -131.19 103.06 6.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.884 1.274 . . . . 0.0 108.101 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -98.32 119.78 37.6 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 121.815 -0.553 . . . . 0.0 110.407 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -81.89 108.82 15.71 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.04 -25.01 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.32 0.648 . . . . 0.0 111.894 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.1 -47.68 81.8 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.294 0.952 . . . . 0.0 108.542 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -71.99 -32.82 67.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -124.32 69.52 51.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.506 0.722 . . . . 0.0 112.638 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.21 -50.78 12.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.332 2.021 . . . . 0.0 111.897 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.54 -42.45 3.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.705 1.621 . . . . 0.0 114.989 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.63 64.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.289 1.045 . . . . 0.0 112.85 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.37 -62.37 6.07 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.65 -42.34 47.8 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.799 1.666 . . . . 0.0 111.376 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt . . . . . 0 CA--C 1.531 0.247 0 C-N-CA 123.276 0.63 . . . . 0.0 111.866 179.821 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.53 142.66 68.0 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 CA-C-N 120.651 1.268 . . . . 0.0 110.029 -0.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -137.31 114.96 11.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.9 mt -95.24 127.8 41.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.089 1.356 . . . . 0.0 108.941 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.73 119.02 32.42 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.0 tp -97.16 104.02 16.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.037 0.535 . . . . 0.0 109.655 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 . . . . . 0 N--CA 1.452 -0.339 0 C-N-CA 125.799 1.639 . . . . 0.0 109.823 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.78 106.3 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.29 -43.47 23.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.635 0.774 . . . . 0.0 109.755 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.41 169.12 23.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.4 p -139.46 164.93 28.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.28 116.72 6.13 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.76 133.73 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.16 163.94 39.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.57 0.605 . . . . 0.0 111.674 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 167.57 16.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.277 0.631 . . . . 0.0 110.815 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.01 167.61 24.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.989 1.316 . . . . 0.0 108.074 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.4 p -79.5 165.97 22.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.318 0.58 . . . . 0.0 111.29 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -56.19 -45.24 79.88 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.46 -57.66 18.67 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.854 0.74 . . . . 0.0 111.432 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -57.68 -40.95 80.58 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.684 0.742 . . . . 0.0 110.701 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.64 -50.8 71.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.978 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -53.16 -51.3 62.48 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.482 0.583 . . . . 0.0 110.19 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.72 -53.28 54.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.572 0.749 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -54.29 -52.48 61.31 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.711 0.804 . . . . 0.0 110.491 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.7 mt -58.12 -52.47 65.42 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.61 0.364 . . . . 0.0 110.584 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -54.12 -52.86 59.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.668 0.787 . . . . 0.0 109.68 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.54 -40.72 68.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.585 0.754 . . . . 0.0 111.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -78.23 -48.12 16.47 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 122.326 -0.234 . . . . 0.0 111.168 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.6 mt -57.22 -46.24 83.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.515 0.726 . . . . 0.0 109.3 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.123 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mt -84.58 138.32 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.127 0.571 . . . . 0.0 111.088 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.79 113.6 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.378 0.671 . . . . 0.0 110.808 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -84.36 99.43 10.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.396 1.078 . . . . 0.0 109.28 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.73 171.19 11.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.202 1.001 . . . . 0.0 111.481 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.7 p -137.37 166.43 23.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -52.81 -41.95 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.287 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.63 -47.93 79.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.642 1.177 . . . . 0.0 111.904 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.37 -26.41 46.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -35.14 -54.16 0.61 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.368 1.467 . . . . 0.0 113.898 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.02 -65.47 0.57 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.523 0.677 . . . . 0.0 111.013 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -56.46 -37.5 70.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.166 0.987 . . . . 0.0 112.746 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.39 -60.72 1.95 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.87 -50.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 112.479 -173.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.07 -32.5 74.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.078 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.4 mttt . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 122.512 0.325 . . . . 0.0 110.872 174.834 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mt -116.85 124.24 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.09 1.356 . . . . 0.0 108.14 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.1 tp -100.95 102.68 13.75 Favored 'General case' 0 C--O 1.228 -0.051 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.57 113.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 122.657 0.383 . . . . 0.0 110.426 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.48 109.54 21.73 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.528 1.131 . . . . 0.0 108.634 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -79.97 122.04 26.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -136.81 178.65 6.91 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.583 1.153 . . . . 0.0 111.063 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.02 154.26 36.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.858 1.663 . . . . 0.0 108.004 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -54.56 -40.51 68.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.295 0.952 . . . . 0.0 112.035 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -79.34 -2.43 41.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 112.968 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -79.41 78.58 5.91 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.901 -1.124 . . . . 0.0 111.55 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.61 3.63 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.772 0.701 . . . . 0.0 112.206 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.26 -34.42 79.56 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.902 2.401 . . . . 0.0 113.239 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -63.67 -46.34 86.02 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.07 -46.75 87.47 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.8 mtp -55.07 -43.83 74.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.569 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.37 -20.71 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.916 0.78 . . . . 0.0 112.97 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.15 -52.65 9.4 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.977 1.262 . . . . 0.0 114.238 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -52.9 -41.14 72.87 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.493 2.129 . . . . 0.0 112.143 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -62.92 -49.58 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.96 -42.28 72.16 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -62.5 -45.82 91.25 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 110.176 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -59.24 -46.92 87.19 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.717 -0.614 . . . . 0.0 109.775 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.67 -48.4 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -43.39 64.7 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.381 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.82 -63.46 1.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.448 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -45.41 -47.11 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.956 1.302 . . . . 0.0 113.618 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -95.09 21.54 7.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.023 0.929 . . . . 0.0 112.295 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.59 130.92 17.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.435 1.016 . . . . 0.0 110.302 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.09 -18.18 4.3 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.209 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -99.29 -39.39 8.45 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.821 1.31 . . . . 0.0 109.768 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.74 136.62 32.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.232 1.013 . . . . 0.0 108.361 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.4 m -102.23 107.46 18.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.0 135.89 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.23 154.3 51.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.534 0.733 . . . . 0.0 109.323 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.36 144.77 51.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.206 1.402 . . . . 0.0 108.707 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.9 tt -134.37 129.42 35.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.38 100.89 12.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -57.09 -30.1 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -61.77 -46.1 91.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.27 0.941 . . . . 0.0 109.966 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -88.58 -19.33 26.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.365 1.466 . . . . 0.0 111.771 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -127.24 55.52 15.61 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.413 1.485 . . . . 0.0 109.946 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.25 -42.67 21.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.722 2.281 . . . . 0.0 112.295 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.47 -33.68 4.52 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.578 1.085 . . . . 0.0 113.827 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.4 -55.66 28.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 119.286 0.948 . . . . 0.0 112.407 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.52 -41.83 58.57 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 113.496 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mttp . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 123.511 0.724 . . . . 0.0 112.574 -178.185 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.95 143.36 74.0 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.328 1.153 . . . . 0.0 110.204 -0.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 m -139.69 126.01 20.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.57 116.14 31.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 108.948 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.13 119.33 38.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.3 tp -94.55 106.3 18.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 . . . . . 0 N--CA 1.457 -0.098 0 C-N-CA 125.352 1.461 . . . . 0.0 111.707 -178.283 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.04 111.32 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.71 23.61 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.429 0.692 . . . . 0.0 109.746 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.24 161.13 33.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.5 p -135.59 135.41 40.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.401 1.08 . . . . 0.0 109.157 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 127.97 49.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.74 129.19 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.17 173.72 44.98 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.053 0.835 . . . . 0.0 111.43 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.02 171.35 13.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.34 -0.506 . . . . 0.0 110.221 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -164.3 164.46 22.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.528 1.531 . . . . 0.0 107.617 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.2 p -73.9 161.17 30.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.124 0.488 . . . . 0.0 110.764 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.43 -42.93 78.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.89 -58.65 13.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.33 -45.49 69.09 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.265 0.532 . . . . 0.0 110.872 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.5 tp -59.8 -52.06 67.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -55.83 -46.94 78.02 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.111 -0.368 . . . . 0.0 110.893 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.95 -52.86 63.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.901 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -53.79 -53.14 56.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.223 1.009 . . . . 0.0 110.219 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.96 -50.32 74.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.402 0.281 . . . . 0.0 110.685 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.36 -49.83 71.26 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.491 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.551 0.741 . . . . 0.0 111.521 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -77.65 -46.38 22.17 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 122.151 -0.343 . . . . 0.0 110.923 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.6 mt -62.3 -43.77 98.06 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 125.606 1.562 . . . . 0.0 108.501 178.089 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 mt -100.82 138.19 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 111.507 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -92.83 118.55 38.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 110.542 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -87.74 101.3 13.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.24 1.016 . . . . 0.0 109.292 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.94 168.34 12.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.549 1.14 . . . . 0.0 112.593 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -135.43 162.12 33.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.83 -43.83 69.74 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.78 -46.24 91.25 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.968 1.307 . . . . 0.0 112.014 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.27 -26.46 47.17 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.028 -0.42 . . . . 0.0 111.467 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -35.97 -54.12 0.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.745 1.618 . . . . 0.0 113.633 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -55.34 -62.3 1.76 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.939 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -59.03 -40.3 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.281 0.632 . . . . 0.0 112.44 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.19 -58.38 3.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -80.74 -52.35 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.885 0.874 . . . . 0.0 112.349 -173.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -63.36 -26.13 68.61 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.635 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 123.078 0.551 . . . . 0.0 109.859 172.781 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.68 132.03 69.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 C-N-CA 124.316 1.046 . . . . 0.0 108.531 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.84 100.92 9.3 Favored 'General case' 0 C--O 1.229 -0.025 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.16 117.64 33.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 122.661 0.385 . . . . 0.0 110.75 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -97.43 109.39 22.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.882 1.273 . . . . 0.0 108.882 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -82.43 124.18 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -142.38 172.83 12.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 147.98 40.23 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.293 1.437 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -54.92 -35.87 64.64 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.177 0.591 . . . . 0.0 112.033 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -84.81 -5.67 59.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.954 0.902 . . . . 0.0 112.358 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.85 82.01 6.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.063 -1.023 . . . . 0.0 110.728 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.76 -57.51 3.37 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 123.941 0.782 . . . . 0.0 111.983 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.51 -34.36 81.81 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.148 2.565 . . . . 0.0 113.435 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.76 -49.57 67.91 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -58.98 -39.98 83.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.5 ttp -58.52 -47.69 83.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.203 0.601 . . . . 0.0 110.426 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.2 pt -75.83 -25.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.626 -0.702 . . . . 0.0 112.659 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -58.02 1.16 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.13 -40.63 83.63 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.192 1.928 . . . . 0.0 111.521 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.0 mt -58.97 -49.97 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.77 -42.52 75.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.889 0.313 . . . . 0.0 110.46 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -59.9 -53.66 55.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -45.89 75.47 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.62 -0.675 . . . . 0.0 110.392 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -57.07 -48.62 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.017 0.527 . . . . 0.0 109.648 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.63 76.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.557 0.743 . . . . 0.0 110.27 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.52 -56.73 13.71 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.57 -51.0 40.02 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.992 1.317 . . . . 0.0 112.028 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -96.98 23.7 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.797 0.839 . . . . 0.0 112.525 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -54.89 128.93 35.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.028 . . . . 0.0 110.461 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.51 -16.99 21.94 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.298 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.52 -42.72 6.8 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.674 1.237 . . . . 0.0 109.365 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -134.11 119.25 18.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.807 1.243 . . . . 0.0 107.648 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.8 m -86.24 102.78 14.25 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.63 139.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.55 154.59 49.8 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.19 145.17 51.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.136 1.374 . . . . 0.0 108.489 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.19 123.39 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -84.53 109.38 17.89 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -62.8 -31.54 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.38 -52.72 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.998 0.817 . . . . 0.0 110.069 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.82 -30.82 65.9 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.826 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -117.64 71.14 7.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.935 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.94 -53.98 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.716 2.277 . . . . 0.0 112.597 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.71 -45.81 2.08 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.38 1.467 . . . . 0.0 114.358 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.55 65.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.4 1.08 . . . . 0.0 113.356 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.41 -66.34 1.07 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.842 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -58.88 -42.9 48.01 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 121.228 1.474 . . . . 0.0 111.106 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 118.452 0.569 . . . . 0.0 111.692 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.19 146.27 80.5 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.365 1.166 . . . . 0.0 110.042 -1.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.0 m -137.82 123.54 19.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.6 mt -108.58 112.64 25.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.727 1.611 . . . . 0.0 109.173 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.86 122.28 45.43 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -96.55 99.75 11.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.787 0.835 . . . . 0.0 109.278 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 N--CA 1.452 -0.345 0 C-N-CA 125.862 1.665 . . . . 0.0 109.708 179.533 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -62.89 102.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.0 -41.76 25.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.867 0.867 . . . . 0.0 110.976 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.11 159.16 42.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.2 p -138.54 131.13 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.262 1.025 . . . . 0.0 109.299 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -120.27 117.68 28.46 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.35 134.06 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 163.65 39.46 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.663 0.649 . . . . 0.0 111.864 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.34 169.12 14.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.395 0.678 . . . . 0.0 110.488 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.61 168.66 21.41 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.627 1.171 . . . . 0.0 108.531 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 149.47 33.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.747 1.219 . . . . 0.0 110.609 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.47 -49.18 65.18 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.173 0.589 . . . . 0.0 111.252 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.77 42.14 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -58.67 -43.17 89.8 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.97 0.508 . . . . 0.0 110.418 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.3 -50.55 73.19 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -54.63 -49.94 69.33 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 122.045 -0.409 . . . . 0.0 110.503 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.46 -52.79 63.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.08 0.952 . . . . 0.0 110.095 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.27 -53.76 49.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.671 0.788 . . . . 0.0 110.19 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.12 -49.95 75.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.624 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.97 -51.36 64.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 117.968 0.349 . . . . 0.0 110.138 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.31 -36.41 71.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.791 0.837 . . . . 0.0 111.894 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -77.7 -46.01 23.16 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 121.988 -0.445 . . . . 0.0 109.855 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.26 -46.48 88.41 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 123.062 0.545 . . . . 0.0 109.624 177.571 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.5 mttt . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.3 mt -85.58 138.31 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.136 0.574 . . . . 0.0 111.166 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.57 119.99 41.1 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.283 0.563 . . . . 0.0 110.365 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -88.94 103.55 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.444 1.097 . . . . 0.0 109.34 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.22 164.99 14.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.612 1.165 . . . . 0.0 113.206 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.4 p -136.07 162.21 33.53 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.65 -44.14 69.38 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.331 0.514 . . . . 0.0 109.939 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.23 -46.24 90.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.925 1.29 . . . . 0.0 112.096 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.6 p -78.56 -26.17 45.56 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.085 -0.385 . . . . 0.0 111.482 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -36.98 -54.43 0.95 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.015 1.726 . . . . 0.0 114.125 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -52.69 -60.2 3.55 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.521 -0.737 . . . . 0.0 111.159 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.53 97.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.592 0.757 . . . . 0.0 112.335 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -27.01 50.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.8 -62.55 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 124.017 0.927 . . . . 0.0 111.746 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.86 -35.81 77.56 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 121.949 -0.47 . . . . 0.0 111.444 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 119.222 -0.418 . . . . 0.0 112.124 177.444 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.46 139.25 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 126.147 1.779 . . . . 0.0 107.793 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.97 99.35 6.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 t -90.92 114.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -91.59 107.58 19.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.159 0.983 . . . . 0.0 108.404 174.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -79.72 120.41 23.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -136.49 179.46 6.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.968 0.907 . . . . 0.0 110.868 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.69 36.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.275 1.03 . . . . 0.0 109.652 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -56.25 -26.33 51.14 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.775 1.23 . . . . 0.0 112.333 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -93.75 -8.22 41.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.526 1.131 . . . . 0.0 112.483 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.74 82.88 5.77 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.992 -1.067 . . . . 0.0 112.903 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.42 -58.23 4.69 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.571 0.605 . . . . 0.0 112.469 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -53.16 -32.28 58.98 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.2 2.6 . . . . 0.0 113.236 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.7 m -65.45 -43.85 89.08 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -63.24 -41.78 99.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 50.9 ttp -55.11 -47.73 74.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.618 0.367 . . . . 0.0 110.83 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.54 -26.92 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.14 -56.66 1.18 Allowed Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -57.44 -35.94 98.81 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.183 1.922 . . . . 0.0 111.953 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.0 mt -64.73 -49.45 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.5 mt -54.51 -42.22 70.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.799 0.272 . . . . 0.0 110.473 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -61.83 -51.46 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -52.69 -47.96 66.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.934 -0.478 . . . . 0.0 109.863 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.12 -48.58 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.39 0.676 . . . . 0.0 109.421 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 -43.21 65.44 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.182 0.593 . . . . 0.0 110.05 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.12 -61.65 1.82 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.751 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -53.14 -48.4 67.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.113 0.965 . . . . 0.0 112.397 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -88.7 13.52 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 0.0 112.248 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -55.08 116.5 2.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.906 1.23 . . . . 0.0 109.729 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.66 -26.79 18.61 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.798 0.713 . . . . 0.0 111.585 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -99.19 -42.15 7.17 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.681 0.793 . . . . 0.0 109.765 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -129.08 141.34 51.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.296 1.038 . . . . 0.0 109.956 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -108.59 96.81 6.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -78.92 136.42 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.213 -0.929 . . . . 0.0 108.534 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 157.44 46.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.937 0.895 . . . . 0.0 109.249 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -131.97 146.52 52.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.279 1.432 . . . . 0.0 108.789 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -138.45 124.98 20.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -86.97 108.55 18.87 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 pt -65.43 -23.56 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.16 -45.36 93.75 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.132 0.878 . . . . 0.0 108.794 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -77.49 -35.18 53.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.371 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -123.03 69.13 37.3 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.986 0.914 . . . . 0.0 111.51 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.24 -55.86 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.102 1.868 . . . . 0.0 112.19 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.3 -40.65 2.68 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.782 1.658 . . . . 0.0 114.691 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.55 -33.7 68.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.092 -0.652 . . . . 0.0 112.494 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.58 -65.07 2.17 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.581 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.21 -42.99 32.6 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.783 2.322 . . . . 0.0 112.786 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? . . . . . 0 C--N 1.343 0.325 0 CA-C-N 118.942 0.792 . . . . 0.0 112.027 179.082 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 117.998 -1.001 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.44 141.37 57.48 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 120.727 1.295 . . . . 0.0 110.308 -0.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 m -141.07 125.72 17.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.51 107.37 17.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.274 1.43 . . . . 0.0 109.516 -174.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -95.79 116.13 28.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.5 99.9 12.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 N--CA 1.454 -0.236 0 C-N-CA 125.225 1.41 . . . . 0.0 108.949 179.069 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.0 t -61.34 104.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.32 22.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.674 0.79 . . . . 0.0 110.067 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.67 156.45 34.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.09 0.556 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.0 p -132.07 112.45 12.35 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.673 1.189 . . . . 0.0 109.025 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -98.73 110.85 23.39 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.59 131.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.29 162.69 38.46 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.744 0.688 . . . . 0.0 111.996 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.43 170.06 12.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.223 0.609 . . . . 0.0 110.442 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -164.54 163.75 21.89 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.027 1.331 . . . . 0.0 108.002 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.9 p -73.79 163.08 28.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.124 0.487 . . . . 0.0 110.817 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.41 -44.63 76.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.36 -54.52 36.49 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -56.65 -44.47 81.34 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.272 0.536 . . . . 0.0 110.404 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.79 -53.87 52.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -54.82 -46.28 74.52 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.142 0.428 . . . . 0.0 110.835 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.03 -53.72 54.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.528 0.731 . . . . 0.0 110.057 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.64 -53.09 59.33 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.148 0.979 . . . . 0.0 110.421 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.21 -50.62 72.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.674 0.389 . . . . 0.0 110.305 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.3 -51.71 65.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.612 0.365 . . . . 0.0 110.288 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.91 -37.79 69.39 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.658 0.783 . . . . 0.0 111.928 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -77.88 -46.89 20.07 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.0 mt -58.77 -44.64 90.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.066 0.546 . . . . 0.0 109.719 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 122.998 0.519 . . . . 0.0 109.636 177.556 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.6 mttm . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 mt -105.86 133.02 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.023 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mt -86.94 146.03 6.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -115.52 100.1 7.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.1 163.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.636 1.174 . . . . 0.0 113.209 -173.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.2 p -135.57 163.89 29.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.512 1.925 . . . . 0.0 106.288 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -54.39 -45.91 72.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 109.89 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.21 -44.56 92.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.184 1.394 . . . . 0.0 112.049 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -78.61 -31.61 47.11 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.203 -0.311 . . . . 0.0 111.227 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -32.66 -55.07 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.215 1.806 . . . . 0.0 115.048 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -54.67 -62.55 1.58 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.455 -0.778 . . . . 0.0 111.438 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -63.52 -42.48 98.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.969 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.13 -37.85 66.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.505 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.46 -65.21 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.749 0.82 . . . . 0.0 112.382 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.09 -36.2 72.51 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 118.5 -0.762 . . . . 0.0 113.018 179.167 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mt -111.36 129.9 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.99 1.316 . . . . 0.0 107.724 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.06 102.46 10.67 Favored 'General case' 0 C--O 1.228 -0.057 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.92 115.69 32.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.521 0.329 . . . . 0.0 110.692 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.45 110.55 22.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.527 1.131 . . . . 0.0 109.073 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -82.14 123.9 29.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -138.07 173.8 11.24 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.421 0.688 . . . . 0.0 111.55 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.96 151.42 38.59 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 125.207 1.403 . . . . 0.0 107.734 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.75 -38.12 66.78 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.777 0.717 . . . . 0.0 112.354 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -80.05 -4.7 53.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.128 0.971 . . . . 0.0 112.911 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.0 t -79.46 82.03 5.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 120.906 -1.121 . . . . 0.0 111.193 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.92 -57.95 4.5 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.429 0.538 . . . . 0.0 112.269 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.21 -32.23 49.41 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.386 2.724 . . . . 0.0 113.481 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.39 -41.01 98.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -63.61 -41.63 98.29 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 92.5 mmm -60.35 -45.06 94.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.535 -0.269 . . . . 0.0 110.981 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.21 -27.66 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.605 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -57.38 1.26 Allowed Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.26 -37.45 95.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.069 1.846 . . . . 0.0 111.66 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mt -62.11 -48.95 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.64 -43.92 76.68 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -60.51 -51.91 67.43 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.113 -0.367 . . . . 0.0 110.732 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -54.45 -50.99 66.38 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.92 -46.95 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.747 0.819 . . . . 0.0 109.937 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -43.44 71.61 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.12 -55.95 12.03 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.378 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.66 -45.45 63.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.285 1.034 . . . . 0.0 112.858 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -98.15 22.38 9.57 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.216 1.007 . . . . 0.0 111.426 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -52.9 131.34 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.514 1.052 . . . . 0.0 110.512 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.13 -20.75 11.87 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.081 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.18 -48.47 4.83 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.735 1.267 . . . . 0.0 109.268 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.59 122.51 39.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.495 1.118 . . . . 0.0 109.156 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.9 m -92.78 101.58 13.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -78.91 139.57 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.97 157.94 44.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.867 0.867 . . . . 0.0 108.918 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.67 147.81 51.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.155 1.782 . . . . 0.0 108.085 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -139.11 125.61 20.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -87.37 109.04 19.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.2 -24.88 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.74 -50.22 74.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.452 1.024 . . . . 0.0 108.847 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -75.53 -26.71 58.29 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.001 0.92 . . . . 0.0 111.185 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -127.47 69.35 75.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.405 0.682 . . . . 0.0 111.939 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.55 -59.57 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.428 2.085 . . . . 0.0 112.94 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.93 -41.0 2.46 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.064 1.792 . . . . 0.0 115.233 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -26.9 66.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.026 -0.69 . . . . 0.0 112.717 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.31 -64.94 1.02 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.083 0.856 . . . . 0.0 110.463 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.44 -39.07 28.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.283 2.656 . . . . 0.0 112.971 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 118.602 0.637 . . . . 0.0 112.59 177.644 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.12 145.2 75.04 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 120.573 1.24 . . . . 0.0 109.927 -1.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.3 m -139.96 127.58 21.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -110.4 108.18 18.12 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.126 1.37 . . . . 0.0 109.686 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.45 118.16 32.38 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -97.0 99.51 11.04 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.426 0.69 . . . . 0.0 109.379 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 . . . . . 0 N--CA 1.452 -0.34 0 C-N-CA 125.734 1.613 . . . . 0.0 109.991 179.783 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.12 106.25 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.64 22.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.632 0.773 . . . . 0.0 109.824 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.84 158.51 35.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.249 0.62 . . . . 0.0 109.657 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.7 p -131.97 112.17 12.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.869 1.267 . . . . 0.0 108.653 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -98.79 111.51 23.87 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -91.0 130.51 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.24 163.78 34.71 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.084 0.85 . . . . 0.0 111.896 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.62 167.22 22.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 110.246 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.06 166.81 27.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.566 1.146 . . . . 0.0 108.544 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.0 p -83.21 161.71 21.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.022 0.439 . . . . 0.0 110.526 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -52.98 -42.85 65.92 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.524 0.73 . . . . 0.0 110.519 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.79 -54.39 37.94 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -55.36 -46.05 76.48 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.348 -0.501 . . . . 0.0 109.979 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.5 tp -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -53.63 -49.88 66.91 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.607 0.639 . . . . 0.0 111.107 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -57.76 -50.96 71.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.94 -52.6 60.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.506 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.69 -52.11 66.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.037 0.535 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.11 -52.7 60.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.646 0.379 . . . . 0.0 110.292 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.74 -39.5 71.23 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.767 0.827 . . . . 0.0 112.003 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.85 -47.08 19.66 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.218 -0.301 . . . . 0.0 110.554 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -57.98 -47.6 82.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.176 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.9 mt -87.0 140.06 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.424 0.69 . . . . 0.0 111.215 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -90.97 114.53 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.326 0.65 . . . . 0.0 110.422 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -85.59 102.4 13.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 0.0 109.946 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.96 163.16 14.1 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.035 1.334 . . . . 0.0 113.19 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.0 p -130.74 159.74 36.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.189 2.196 . . . . 0.0 106.228 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.24 -45.6 68.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.35 -47.46 75.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.92 1.288 . . . . 0.0 111.626 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -78.23 -26.07 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -37.24 -51.87 1.04 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 114.092 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.87 -62.95 1.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.574 0.702 . . . . 0.0 111.019 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -57.65 -39.21 76.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.918 0.887 . . . . 0.0 112.32 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -55.58 4.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.91 -53.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.235 1.014 . . . . 0.0 112.959 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.01 -37.74 86.02 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.991 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.109 174.934 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.87 125.33 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.543 1.137 . . . . 0.0 108.219 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 tp -102.31 101.91 12.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.4 t -86.57 118.62 33.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -97.73 116.5 30.07 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.575 0.75 . . . . 0.0 109.053 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -90.81 121.35 32.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -135.39 178.65 6.87 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.936 0.895 . . . . 0.0 111.584 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.72 150.6 33.44 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 125.413 1.485 . . . . 0.0 108.327 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -55.75 -37.27 68.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.891 0.876 . . . . 0.0 112.386 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -83.33 -5.43 59.14 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.139 0.976 . . . . 0.0 112.54 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.59 81.69 5.81 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 120.958 -1.089 . . . . 0.0 111.684 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.81 -57.49 3.41 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.811 0.72 . . . . 0.0 112.362 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -52.59 -36.96 73.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.999 2.466 . . . . 0.0 113.31 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.0 m -64.01 -47.75 79.05 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -57.85 -43.22 85.75 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.2 mtm -61.0 -44.89 96.76 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.598 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -74.67 -27.51 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.359 0.981 . . . . 0.0 112.507 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.43 -58.16 1.03 Allowed Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.99 -37.42 96.14 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.495 2.13 . . . . 0.0 112.324 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.8 mt -62.4 -51.13 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.4 mt -55.09 -42.05 72.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.17 0.188 . . . . 0.0 110.598 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.67 -51.74 68.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 109.727 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.22 -44.75 84.01 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.866 -0.521 . . . . 0.0 110.274 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.4 mm -58.33 -46.78 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.548 0.739 . . . . 0.0 109.287 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -45.46 66.9 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.79 -59.12 5.31 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -48.81 -48.04 41.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -94.02 15.09 17.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.243 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.47 1.032 . . . . 0.0 111.491 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.25 -28.47 2.58 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.819 1.199 . . . . 0.0 110.242 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -99.47 -38.2 8.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.28 1.032 . . . . 0.0 109.987 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 tp -135.11 141.32 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.8 m -108.03 104.82 14.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -79.11 137.74 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.7 156.17 48.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.863 0.865 . . . . 0.0 108.786 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -132.64 146.21 51.7 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.476 1.51 . . . . 0.0 109.908 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.42 126.17 19.29 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.421 0.688 . . . . 0.0 109.394 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -87.17 109.31 19.37 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.88 -24.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.99 0.516 . . . . 0.0 111.719 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.51 -46.39 90.29 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.261 0.937 . . . . 0.0 108.898 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -77.66 -35.72 52.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -121.79 69.15 25.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.28 1.032 . . . . 0.0 111.139 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.32 -56.33 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.473 2.115 . . . . 0.0 112.787 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.62 -45.6 1.02 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.092 1.806 . . . . 0.0 114.597 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -37.23 31.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.307 1.043 . . . . 0.0 113.078 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.04 -66.44 1.49 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.396 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.63 -36.84 91.21 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.72 1.613 . . . . 0.0 111.22 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 C--N 1.345 0.373 0 CA-C-N 119.349 0.977 . . . . 0.0 110.71 177.303 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 pt . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.67 142.0 65.22 Favored 'Cis proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.219 1.114 . . . . 0.0 110.562 -0.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 144.46 47.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.0 mt -128.64 101.46 6.16 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 mp -104.97 120.71 42.12 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -95.47 105.01 16.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.842 0.857 . . . . 0.0 109.495 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 125.835 1.654 . . . . 0.0 110.057 179.709 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.49 102.79 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.68 -43.28 23.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.047 0.939 . . . . 0.0 110.956 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.57 154.36 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.142 0.577 . . . . 0.0 109.524 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.8 p -136.75 116.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.473 1.109 . . . . 0.0 109.453 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -108.46 136.26 48.38 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.62 128.16 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.57 168.15 35.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.789 0.709 . . . . 0.0 111.394 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.39 168.05 20.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.198 0.599 . . . . 0.0 110.552 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -162.24 164.07 27.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 107.779 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.67 161.26 30.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -56.72 -43.67 80.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.1 -58.33 14.23 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -53.13 -45.93 68.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 110.945 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.75 -51.38 70.0 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.388 -0.195 . . . . 0.0 110.73 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -56.64 -47.66 79.24 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.132 0.424 . . . . 0.0 110.688 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.73 -52.37 65.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.661 0.784 . . . . 0.0 109.757 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -54.87 -55.4 30.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.997 0.919 . . . . 0.0 110.319 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -57.3 -48.61 78.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.136 -0.352 . . . . 0.0 110.792 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.57 -51.48 68.43 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.577 0.351 . . . . 0.0 110.243 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.26 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.975 0.91 . . . . 0.0 111.972 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -78.17 -50.06 12.66 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 117.847 0.294 . . . . 0.0 110.367 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.9 mt -63.38 -42.97 98.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.444 . . . . 0.0 110.514 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.136 0 C-N-CA 124.703 1.201 . . . . 0.0 111.703 179.359 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.1 mt -108.17 137.42 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.922 1.289 . . . . 0.0 108.809 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 mt -85.73 146.92 5.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -117.29 99.38 6.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.81 164.36 14.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.476 1.111 . . . . 0.0 113.306 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.1 p -134.98 162.69 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.228 1.811 . . . . 0.0 106.417 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.64 -44.59 77.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.403 0.547 . . . . 0.0 109.615 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.53 -44.71 89.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.976 1.31 . . . . 0.0 111.893 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.58 -32.71 47.82 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.159 -0.338 . . . . 0.0 111.222 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -32.15 -53.32 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.028 2.131 . . . . 0.0 115.315 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.99 -61.61 2.19 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 110.983 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -43.54 98.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.736 0.815 . . . . 0.0 112.307 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -31.07 53.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.261 -0.876 . . . . 0.0 113.273 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.35 -61.63 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.975 0.91 . . . . 0.0 111.382 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.22 -36.13 74.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.22 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.29 127.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.926 1.29 . . . . 0.0 108.714 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.39 103.0 12.36 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.8 t -90.49 118.48 35.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.46 108.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.913 1.285 . . . . 0.0 108.442 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.72 121.81 25.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -137.54 179.48 6.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.919 0.887 . . . . 0.0 111.696 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.6 30.22 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.325 1.45 . . . . 0.0 109.55 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -51.74 -37.12 49.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.84 0.745 . . . . 0.0 112.203 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -85.63 -4.56 59.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.053 0.941 . . . . 0.0 113.03 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -79.42 79.86 5.83 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.934 -1.104 . . . . 0.0 111.111 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.28 -59.91 2.1 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 123.904 0.764 . . . . 0.0 112.693 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.87 -29.07 51.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.402 2.735 . . . . 0.0 113.937 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.75 -42.47 99.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.408 -0.807 . . . . 0.0 109.227 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -66.12 -35.58 80.88 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.8 mtt -62.27 -44.64 96.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.26 -25.54 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 118.772 -0.632 . . . . 0.0 112.435 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.31 -57.88 1.31 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.03 -38.17 96.58 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.812 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mt -60.84 -50.32 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -55.71 -43.95 76.99 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.808 0.443 . . . . 0.0 110.303 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.92 -51.58 68.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.477 0.656 . . . . 0.0 110.354 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -54.73 -48.72 72.18 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.68 -47.61 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 122.827 0.451 . . . . 0.0 109.824 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.71 -44.94 66.66 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.4 0.545 . . . . 0.0 110.495 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -68.13 -57.77 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.755 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -52.19 -43.06 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 113.515 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.07 16.85 19.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.244 1.018 . . . . 0.0 111.674 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.26 134.33 33.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.353 0.979 . . . . 0.0 110.25 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -25.5 6.7 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.705 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -98.84 -41.1 7.79 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.782 1.291 . . . . 0.0 109.689 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -131.19 140.03 49.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.541 1.137 . . . . 0.0 109.743 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -109.56 106.1 15.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.87 135.66 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.67 156.75 47.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.739 0.816 . . . . 0.0 109.115 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.897 1.679 . . . . 0.0 107.403 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.6 123.83 19.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -86.79 108.48 18.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.22 -25.81 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 111.933 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -62.41 -45.86 91.22 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.584 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.8 70.12 72.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.26 -56.22 2.94 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.425 2.083 . . . . 0.0 112.857 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.98 -40.85 2.44 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.059 1.79 . . . . 0.0 115.625 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 -22.01 66.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.836 0.818 . . . . 0.0 112.98 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.6 -61.98 1.03 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.452 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.42 -39.85 36.2 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.132 2.555 . . . . 0.0 112.274 175.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp . . . . . 0 C--N 1.344 0.336 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.345 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 pt . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.03 141.11 54.59 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 121.027 1.403 . . . . 0.0 109.99 -0.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.6 m -139.45 121.86 16.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 mt -100.75 127.62 47.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.393 1.477 . . . . 0.0 108.943 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.2 119.36 34.46 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.31 102.87 14.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.454 -0.265 0 C-N-CA 125.685 1.594 . . . . 0.0 110.018 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.68 107.26 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.58 -44.14 21.64 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.366 0.667 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.36 167.84 25.0 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.7 p -142.65 165.99 25.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -150.67 120.59 7.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.83 131.64 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.22 164.86 36.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.947 0.784 . . . . 0.0 111.598 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.96 167.11 22.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.157 0.583 . . . . 0.0 110.256 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -161.38 162.85 30.86 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.911 1.284 . . . . 0.0 108.254 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.8 p -73.95 164.14 27.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.363 0.601 . . . . 0.0 111.487 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -53.29 -49.28 67.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.17 -55.21 30.55 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.69 -47.61 73.44 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 117.542 0.671 . . . . 0.0 110.671 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 tp -59.8 -49.58 77.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -53.29 -50.85 64.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.64 0.376 . . . . 0.0 110.875 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -60.14 -50.19 74.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.798 0.439 . . . . 0.0 110.47 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.37 -54.25 39.37 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.141 0.576 . . . . 0.0 109.946 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.6 mt -59.18 -49.91 76.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.269 -0.269 . . . . 0.0 110.884 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.86 -53.51 54.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 117.784 0.266 . . . . 0.0 110.306 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.98 74.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.234 1.014 . . . . 0.0 111.916 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -77.74 -42.53 33.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.258 -0.276 . . . . 0.0 110.727 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.13 -44.87 94.38 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.559 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.37 132.21 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.16 123.87 48.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 123.502 0.721 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -90.67 108.51 19.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.143 0.977 . . . . 0.0 109.469 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.6 mt -94.04 166.36 12.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.072 0.949 . . . . 0.0 112.943 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -132.5 162.24 31.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.14 -47.65 74.81 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.65 -47.62 83.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.095 1.358 . . . . 0.0 111.534 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -78.45 -25.25 45.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -35.9 -51.27 0.7 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.443 1.897 . . . . 0.0 114.91 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.53 -62.32 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.93 0.787 . . . . 0.0 110.739 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -60.36 -42.36 95.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.529 0.731 . . . . 0.0 111.643 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.59 -41.41 69.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.3 t -107.98 -63.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.487 1.115 . . . . 0.0 113.133 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.11 -37.28 74.25 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.062 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.31 124.48 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 108.643 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 tp -105.39 99.48 9.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -89.37 114.66 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -89.56 105.57 17.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.52 119.96 23.23 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -134.33 -177.94 4.82 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.563 1.145 . . . . 0.0 111.2 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.59 35.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.737 1.215 . . . . 0.0 109.306 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -54.88 -28.53 51.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.519 1.128 . . . . 0.0 112.758 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -94.96 -4.63 46.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 112.387 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.1 t -79.99 83.7 5.85 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.007 -1.058 . . . . 0.0 111.583 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.7 -61.38 3.37 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.24 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.38 -36.71 31.14 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.7 2.933 . . . . 0.0 113.779 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.5 -37.99 85.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -70.27 -46.5 64.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -40.91 60.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 119.184 -0.436 . . . . 0.0 111.461 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -81.82 -10.88 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.5 -51.45 69.25 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 119.995 1.27 . . . . 0.0 113.295 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.73 -41.7 72.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.314 2.01 . . . . 0.0 111.537 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.11 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -54.31 -44.61 72.14 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -60.13 -57.27 13.54 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.007 0.523 . . . . 0.0 111.321 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -60.0 -40.81 90.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.627 -0.671 . . . . 0.0 110.719 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.81 -46.5 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.92 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.725 0.41 . . . . 0.0 110.259 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.09 -54.7 25.96 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -51.16 -46.71 62.12 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.391 1.076 . . . . 0.0 112.593 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -96.07 18.84 12.66 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.642 0.777 . . . . 0.0 111.903 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -50.67 137.02 20.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.335 0.971 . . . . 0.0 111.334 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 -26.23 5.11 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.554 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -99.1 -51.27 3.88 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.772 1.286 . . . . 0.0 109.189 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.39 132.09 56.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.663 1.185 . . . . 0.0 108.995 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -106.65 102.47 11.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.34 160.8 39.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -136.04 147.46 47.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.949 1.3 . . . . 0.0 108.351 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -140.76 125.6 18.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -87.97 108.58 19.27 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.88 -25.71 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.711 0.804 . . . . 0.0 112.178 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.41 -46.48 89.95 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.105 0.866 . . . . 0.0 108.976 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.98 -35.44 57.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.344 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -120.92 68.82 16.82 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.126 0.97 . . . . 0.0 111.313 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.59 -51.97 2.17 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.381 2.054 . . . . 0.0 112.335 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.0 -38.08 4.53 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.873 1.225 . . . . 0.0 114.305 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -31.8 71.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.954 -0.733 . . . . 0.0 112.341 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.86 -65.26 2.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.434 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.52 -45.76 29.63 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.558 2.172 . . . . 0.0 112.438 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp . . . . . 0 C--N 1.344 0.362 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.433 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.6 pt . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.22 147.44 87.55 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.834 0.976 . . . . 0.0 110.435 -0.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 m -133.19 122.79 24.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.85 100.05 10.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.99 113.37 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -93.28 97.55 10.69 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.631 0.772 . . . . 0.0 109.646 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 N--CA 1.451 -0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 108.895 178.288 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 106.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.52 -43.18 23.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.611 0.764 . . . . 0.0 109.887 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.99 156.51 31.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.706 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.9 p -127.8 99.93 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.226 1.41 . . . . 0.0 108.389 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.07 105.53 16.56 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.33 132.7 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.83 164.89 40.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.163 0.887 . . . . 0.0 112.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.4 171.14 13.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.143 0.577 . . . . 0.0 110.235 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.33 168.07 17.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.474 1.51 . . . . 0.0 107.774 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -77.94 164.57 24.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.918 0.389 . . . . 0.0 110.467 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.45 -46.85 80.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.54 -56.34 24.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.44 -39.73 80.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.617 0.708 . . . . 0.0 110.514 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.06 -48.61 80.94 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.147 0.431 . . . . 0.0 110.127 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -56.17 -47.96 77.26 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.595 0.634 . . . . 0.0 110.665 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -57.19 -52.01 67.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.649 0.379 . . . . 0.0 110.153 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -53.66 -53.26 54.43 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 110.154 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -56.6 -52.39 65.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.761 0.424 . . . . 0.0 110.303 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.19 -52.07 62.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.916 0.325 . . . . 0.0 110.615 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.7 75.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.871 0.868 . . . . 0.0 112.287 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -78.45 -46.05 20.68 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 117.899 0.318 . . . . 0.0 110.872 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -61.23 -47.28 86.81 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.407 0.683 . . . . 0.0 109.744 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 124.606 1.162 . . . . 0.0 111.492 179.391 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.56 142.36 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.385 0.674 . . . . 0.0 110.874 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -91.86 116.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-O 121.473 0.654 . . . . 0.0 110.875 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.23 101.87 11.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.524 1.129 . . . . 0.0 108.921 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.1 164.71 20.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 112.933 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.5 p -132.49 160.65 35.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 170.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -55.71 -44.24 77.27 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.742 0.701 . . . . 0.0 109.475 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.21 -47.98 83.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.848 1.259 . . . . 0.0 111.549 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.8 p -78.64 -21.79 47.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.007 -0.433 . . . . 0.0 112.105 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.95 -51.89 1.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.161 1.784 . . . . 0.0 113.729 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -51.65 -61.51 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.468 0.652 . . . . 0.0 110.681 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -60.92 -46.86 88.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.716 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -69.88 -32.21 70.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.7 -64.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.267 1.027 . . . . 0.0 111.833 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.3 -37.45 77.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.46 -0.15 . . . . 0.0 111.358 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 mttm . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.967 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.75 138.26 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 C-N-CA 125.577 1.551 . . . . 0.0 108.622 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.2 tp -118.08 102.47 9.05 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -94.5 106.41 18.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.879 1.272 . . . . 0.0 107.923 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.22 123.94 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -138.09 177.62 7.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.606 0.762 . . . . 0.0 112.061 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.64 151.15 35.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.807 1.643 . . . . 0.0 108.126 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -54.69 -36.93 65.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.309 0.644 . . . . 0.0 111.897 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -85.12 -2.47 58.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.524 1.13 . . . . 0.0 112.745 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.2 t -79.58 80.3 5.97 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.9 -1.125 . . . . 0.0 111.411 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.61 -57.86 3.73 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 123.785 0.707 . . . . 0.0 112.001 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -53.1 -34.46 68.4 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.097 2.531 . . . . 0.0 113.484 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -64.01 -46.55 83.99 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -61.41 -41.86 97.81 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -57.43 -43.76 84.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.198 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -78.76 -26.25 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.822 0.737 . . . . 0.0 112.81 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.2 -55.09 3.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.37 -43.17 39.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.948 2.432 . . . . 0.0 112.904 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.8 -49.82 82.7 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 mt -55.74 -44.06 77.19 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -58.63 -57.68 11.89 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.524 0.73 . . . . 0.0 110.377 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -59.74 -43.08 94.38 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.773 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 mm -54.59 -44.66 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.912 0.485 . . . . 0.0 109.996 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -35.17 65.73 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.074 0.397 . . . . 0.0 111.126 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -76.48 -52.44 9.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.0 -45.12 64.42 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.953 0.901 . . . . 0.0 111.682 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -98.06 24.72 6.75 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.266 1.027 . . . . 0.0 111.522 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -54.04 129.73 35.4 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.462 1.028 . . . . 0.0 110.421 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.77 -17.47 15.6 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.305 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -99.38 -44.79 6.07 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.692 1.246 . . . . 0.0 109.56 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.4 tp -127.22 128.53 46.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.166 0.986 . . . . 0.0 109.724 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -94.94 96.03 9.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.21 136.1 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.67 150.31 49.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.17 0.988 . . . . 0.0 109.524 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -124.61 138.65 54.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.508 1.523 . . . . 0.0 107.38 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -131.06 120.4 23.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.49 110.77 18.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.9 -36.72 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.42 -46.63 89.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.0 0.818 . . . . 0.0 109.688 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.33 -30.05 65.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.244 1.017 . . . . 0.0 110.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -127.92 72.4 78.88 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.857 0.863 . . . . 0.0 111.341 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -52.79 -59.04 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.896 2.397 . . . . 0.0 113.192 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.68 -47.32 2.29 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.765 1.65 . . . . 0.0 115.171 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -28.63 68.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.03 -67.68 0.98 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.302 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.22 -45.11 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.194 1.929 . . . . 0.0 112.558 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 C--N 1.345 0.379 0 CA-C-N 118.359 0.527 . . . . 0.0 112.2 179.042 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.36 145.15 75.42 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 120.575 1.241 . . . . 0.0 109.624 -1.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.9 m -139.38 127.87 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.02 113.03 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.302 1.441 . . . . 0.0 109.233 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.87 120.18 41.09 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.66 103.83 15.82 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 126.352 1.861 . . . . 0.0 109.538 -179.757 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.41 105.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.73 -45.26 19.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.733 0.813 . . . . 0.0 109.949 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.66 158.56 35.67 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 p -134.26 124.99 26.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.531 1.133 . . . . 0.0 108.756 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -113.77 117.88 32.74 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -95.37 129.72 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.18 164.71 35.04 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.007 0.813 . . . . 0.0 111.554 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 164.51 25.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.948 0.499 . . . . 0.0 110.116 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.86 161.51 39.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.296 1.038 . . . . 0.0 108.81 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.4 p -72.84 162.26 29.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.316 0.579 . . . . 0.0 110.589 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -56.73 -40.12 75.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.6 -54.69 35.61 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -56.77 -43.53 80.9 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.201 0.501 . . . . 0.0 110.299 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.22 -53.63 56.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -53.82 -48.15 70.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.469 0.577 . . . . 0.0 110.731 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.76 -53.16 58.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.187 0.595 . . . . 0.0 110.04 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -55.17 -52.31 63.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.598 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -57.0 -54.01 51.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.847 0.459 . . . . 0.0 110.221 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.58 -50.55 67.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.923 0.489 . . . . 0.0 110.653 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.17 76.94 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.197 0.599 . . . . 0.0 111.691 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -77.96 -49.38 14.23 Favored 'General case' 0 N--CA 1.46 0.074 0 O-C-N 122.19 -0.319 . . . . 0.0 111.048 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.4 mt -60.07 -46.03 90.93 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.214 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 177.941 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.4 mttm . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.6 mt -86.44 136.11 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.898 0.479 . . . . 0.0 111.111 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -91.93 116.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.388 0.675 . . . . 0.0 110.6 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -86.29 99.95 11.94 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.291 1.037 . . . . 0.0 109.204 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.24 166.1 16.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.139 0.976 . . . . 0.0 112.24 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p -131.09 163.37 27.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -53.97 -49.78 68.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.92 -46.19 90.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.03 1.332 . . . . 0.0 111.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.9 p -78.46 -24.75 45.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -34.57 -61.3 0.4 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 126.034 1.734 . . . . 0.0 114.052 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.68 -59.32 4.75 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.714 -0.616 . . . . 0.0 110.916 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.36 -38.15 71.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.424 0.69 . . . . 0.0 112.698 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -81.86 -57.93 3.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.405 0.622 . . . . 0.0 112.086 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.39 -55.29 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.18 1.792 . . . . 0.0 113.075 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.13 -28.67 69.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.581 -0.699 . . . . 0.0 111.898 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 CA--C 1.54 0.582 0 O-C-N 122.079 -0.388 . . . . 0.0 111.468 174.824 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.9 127.99 69.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.297 1.039 . . . . 0.0 108.931 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.32 101.86 11.31 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -89.86 112.14 24.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 118.099 0.409 . . . . 0.0 110.718 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.23 106.22 18.27 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.223 1.009 . . . . 0.0 108.659 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -79.69 121.56 25.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -139.24 -178.41 5.35 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.493 0.717 . . . . 0.0 111.169 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.8 151.86 34.24 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 108.495 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -53.69 -39.5 65.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.074 0.95 . . . . 0.0 111.876 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -82.23 -6.23 59.07 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.078 0.951 . . . . 0.0 112.573 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.3 t -79.43 80.61 5.78 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.059 -1.026 . . . . 0.0 111.115 -177.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.45 -58.48 2.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.29 0.948 . . . . 0.0 112.149 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.48 -38.66 89.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.331 2.687 . . . . 0.0 113.18 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -62.6 -47.58 83.18 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.83 -44.46 96.79 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.6 ttm -52.04 -41.56 62.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.919 0.888 . . . . 0.0 111.315 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -83.49 -8.71 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.57 -50.79 74.96 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.058 1.299 . . . . 0.0 113.032 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.68 -41.83 70.95 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.445 2.097 . . . . 0.0 111.516 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.96 -51.15 76.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -54.85 -43.85 73.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.112 0.414 . . . . 0.0 110.78 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.01 -53.15 60.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.272 0.558 . . . . 0.0 109.872 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.49 -47.04 73.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.895 0.478 . . . . 0.0 110.083 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.9 mm -59.12 -47.19 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.157 0.983 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.36 -42.43 66.82 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.753 0.421 . . . . 0.0 109.875 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.38 -56.64 8.86 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -50.67 -45.23 57.95 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.738 0.815 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -97.33 21.36 10.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.91 128.71 31.27 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.408 1.004 . . . . 0.0 110.109 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.55 -19.55 23.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.224 -0.765 . . . . 0.0 113.058 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -99.14 -44.29 6.33 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.658 1.229 . . . . 0.0 109.381 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -132.71 133.97 44.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.369 1.068 . . . . 0.0 108.796 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.4 m -101.44 105.74 16.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.04 139.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.99 154.89 50.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.897 0.879 . . . . 0.0 109.074 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.95 147.56 52.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.719 1.207 . . . . 0.0 108.433 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 tt -138.89 120.32 14.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -85.29 107.51 17.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.29 -24.19 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.651 0.781 . . . . 0.0 112.116 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -61.77 -46.56 89.06 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.122 0.874 . . . . 0.0 108.885 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -76.05 -35.44 59.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.277 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.42 70.13 11.87 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.377 1.071 . . . . 0.0 111.073 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.12 -54.36 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.385 2.057 . . . . 0.0 112.418 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.12 -41.42 3.75 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.941 1.258 . . . . 0.0 114.594 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.23 71.12 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.016 -0.696 . . . . 0.0 112.32 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.02 -66.81 1.33 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.641 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.31 -48.49 18.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.166 1.911 . . . . 0.0 112.173 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp . . . . . 0 C--N 1.344 0.355 0 CA-C-N 118.079 0.399 . . . . 0.0 111.845 -179.736 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.7 144.51 76.71 Favored 'Cis proline' 0 N--CA 1.456 -0.719 0 CA-C-N 120.543 1.23 . . . . 0.0 110.053 -0.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.5 m -136.81 123.4 20.97 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -107.21 104.27 13.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 109.704 -173.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.09 115.77 28.12 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.5 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.956 1.302 . . . . 0.0 109.306 178.504 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.92 107.13 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.67 -43.96 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.62 0.768 . . . . 0.0 110.046 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.53 156.28 34.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.078 0.551 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.7 p -129.26 110.81 12.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.856 1.262 . . . . 0.0 109.348 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -98.49 110.46 23.05 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -91.29 129.68 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.34 163.9 34.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.191 0.901 . . . . 0.0 112.177 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 167.77 20.18 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 110.129 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.81 169.55 21.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.332 1.053 . . . . 0.0 109.258 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.6 p -77.54 160.16 28.8 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.782 0.433 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.11 -45.52 75.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.98 -54.05 38.04 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.02 -39.19 88.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.923 0.862 . . . . 0.0 111.148 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.98 -52.36 65.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -55.33 -45.51 76.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.898 -0.501 . . . . 0.0 111.283 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.48 -55.35 34.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 109.885 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -53.4 -51.88 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.041 0.936 . . . . 0.0 110.727 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.64 -51.73 68.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.811 0.444 . . . . 0.0 110.238 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -54.42 -51.68 64.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.807 0.443 . . . . 0.0 110.214 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.48 70.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.503 0.721 . . . . 0.0 111.843 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -78.06 -40.32 38.98 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.121 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.2 mt -62.01 -47.45 84.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.262 0 C-N-CA 123.17 0.588 . . . . 0.0 109.734 177.592 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -95.56 142.76 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.895 0.878 . . . . 0.0 110.611 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.97 115.35 29.97 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-O 121.572 0.701 . . . . 0.0 111.456 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -84.56 95.77 8.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.777 1.231 . . . . 0.0 109.408 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.44 163.24 16.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.072 0.949 . . . . 0.0 113.121 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.1 p -128.17 160.67 31.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.547 1.939 . . . . 0.0 107.701 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.1 -51.55 57.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.037 0.935 . . . . 0.0 109.197 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.23 -45.15 72.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.343 1.457 . . . . 0.0 111.836 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.61 -26.69 45.4 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -34.03 -69.43 0.09 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.608 1.563 . . . . 0.0 114.968 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.74 -59.75 3.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.58 0.752 . . . . 0.0 110.295 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -51.58 -42.53 61.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.96 1.304 . . . . 0.0 113.377 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.28 -53.15 5.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.747 0.419 . . . . 0.0 111.538 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -79.66 -58.78 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.791 1.236 . . . . 0.0 113.204 -173.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.34 -32.8 73.63 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.055 -0.403 . . . . 0.0 111.579 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.727 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.08 134.19 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.05 101.78 9.32 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.57 114.93 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.84 107.35 19.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.847 1.259 . . . . 0.0 108.294 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -79.8 126.11 30.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -136.12 178.26 7.19 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.654 0.781 . . . . 0.0 111.734 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.8 37.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.556 1.542 . . . . 0.0 108.245 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -53.15 -35.82 60.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.998 0.919 . . . . 0.0 112.121 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -89.2 -2.37 58.47 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.999 1.319 . . . . 0.0 112.79 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.4 t -79.52 78.04 6.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.948 -1.095 . . . . 0.0 111.711 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.88 -57.78 3.36 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.659 0.647 . . . . 0.0 112.341 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -52.51 -35.7 67.47 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.227 2.618 . . . . 0.0 113.241 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.39 -45.48 92.97 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -60.76 -42.74 98.06 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 93.5 mmm -59.02 -45.84 89.68 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.164 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -76.6 -26.23 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.612 0.642 . . . . 0.0 112.592 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.57 -57.69 0.91 Allowed Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.36 -40.09 87.45 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.298 1.998 . . . . 0.0 111.835 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.2 -49.14 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 mt -56.27 -42.85 78.14 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.88 -47.5 86.09 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.12 -48.47 80.11 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.833 -0.542 . . . . 0.0 109.73 177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.8 mm -55.66 -46.79 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.976 0.51 . . . . 0.0 109.9 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.06 -35.97 62.6 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.238 0.615 . . . . 0.0 110.768 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.4 -59.15 2.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -49.63 -44.19 47.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.53 1.132 . . . . 0.0 113.174 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -102.21 20.75 16.16 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.108 0.963 . . . . 0.0 111.502 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.41 125.71 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.386 0.994 . . . . 0.0 109.496 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.42 -20.09 39.81 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.58 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -99.2 -46.69 5.46 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.492 1.146 . . . . 0.0 109.362 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -127.11 124.17 38.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.715 1.206 . . . . 0.0 108.553 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.7 m -92.45 101.02 13.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -78.82 139.97 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.75 154.76 50.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.438 1.095 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -130.28 145.99 51.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.043 1.737 . . . . 0.0 107.35 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -143.94 126.79 16.27 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -86.7 106.72 17.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 109.256 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.15 -24.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.996 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -62.23 -44.41 96.62 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.419 1.009 . . . . 0.0 108.903 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -78.68 -34.47 46.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.425 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -123.4 66.37 33.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.678 1.191 . . . . 0.0 111.922 -173.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.15 -52.06 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.686 2.257 . . . . 0.0 112.94 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.07 -41.74 1.44 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.82 1.676 . . . . 0.0 114.268 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -37.21 54.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.195 0.998 . . . . 0.0 113.239 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.43 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.768 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.9 -48.1 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.795 2.33 . . . . 0.0 113.131 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt . . . . . 0 C--N 1.346 0.442 0 CA-C-N 118.912 0.778 . . . . 0.0 112.572 -179.546 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.8 pt . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.4 141.94 71.51 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.936 1.013 . . . . 0.0 109.582 -2.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -139.32 130.38 26.5 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.45 103.64 12.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.047 1.339 . . . . 0.0 109.35 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.83 115.53 28.14 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.57 12.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.468 1.507 . . . . 0.0 108.205 178.415 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 110.7 -0.111 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.77 105.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.92 -43.61 21.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.171 0.588 . . . . 0.0 110.462 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.11 154.35 32.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.087 0.555 . . . . 0.0 109.681 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -128.19 99.12 5.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.787 1.235 . . . . 0.0 107.776 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -86.0 110.12 19.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 130.18 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.53 163.39 38.43 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.83 0.729 . . . . 0.0 112.382 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 168.95 17.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.271 0.629 . . . . 0.0 110.309 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -163.64 164.22 24.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.088 1.355 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.1 p -72.32 161.95 30.13 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.37 -43.27 79.04 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.86 22.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -53.54 -44.86 69.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.269 0.534 . . . . 0.0 110.572 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.3 tp -58.74 -52.51 65.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -56.09 -46.77 78.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.571 0.623 . . . . 0.0 110.799 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.27 -52.89 62.83 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.501 0.32 . . . . 0.0 110.256 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -54.36 -53.19 57.34 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.859 0.864 . . . . 0.0 110.476 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.5 mt -56.69 -52.95 62.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.877 0.471 . . . . 0.0 110.29 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.35 -51.84 61.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.718 0.407 . . . . 0.0 110.318 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.38 74.75 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.313 0.645 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.02 -38.25 45.16 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.147 -0.346 . . . . 0.0 110.797 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -62.56 -48.54 79.05 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 123.156 0.582 . . . . 0.0 109.643 177.401 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -158.57 -137.21 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.414 1.086 . . . . 0.0 108.877 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -95.27 53.75 1.55 Allowed 'General case' 0 C--O 1.232 0.152 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm -114.6 109.79 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.004 2.522 . . . . 0.0 108.983 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.2 mm -88.55 119.47 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.916 0.865 . . . . 0.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -84.95 75.26 10.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.79 162.59 10.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.649 1.18 . . . . 0.0 112.667 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 p -131.88 162.77 29.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -52.96 -44.03 66.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 110.025 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.31 -45.17 95.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.041 1.337 . . . . 0.0 112.057 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.44 -27.95 46.56 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.172 -0.33 . . . . 0.0 111.356 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -36.22 -51.74 0.78 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.653 1.581 . . . . 0.0 114.031 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.54 -64.86 0.73 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.651 0.738 . . . . 0.0 111.275 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.38 -37.93 82.29 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.263 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -55.54 4.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.305 -0.247 . . . . 0.0 111.537 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 -57.38 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 112.518 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.04 -36.75 80.41 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.384 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -102.02 29.64 4.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.463 0.305 . . . . 0.0 111.19 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.56 121.71 9.68 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.778 0.717 . . . . 0.0 112.057 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -80.27 53.36 1.76 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.453 0.701 . . . . 0.0 109.236 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.06 -149.8 21.29 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.63 122.63 47.09 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.264 1.026 . . . . 0.0 108.489 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mt -117.62 119.0 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.511 1.124 . . . . 0.0 108.734 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -93.0 102.98 15.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.1 t -87.29 113.84 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -93.54 117.68 30.39 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.36 121.68 32.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -134.01 179.49 6.22 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.639 1.176 . . . . 0.0 110.752 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.4 39.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.459 1.104 . . . . 0.0 108.907 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -53.12 -36.29 60.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.129 0.972 . . . . 0.0 111.53 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -86.8 -4.68 59.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.857 1.263 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.8 t -79.99 80.22 6.42 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.92 -1.113 . . . . 0.0 112.656 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.51 -58.51 4.0 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 123.456 0.551 . . . . 0.0 112.344 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.23 -37.01 69.54 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.219 2.613 . . . . 0.0 113.634 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.31 -44.21 97.6 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -63.99 -47.64 79.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.8 mtm -53.48 -39.52 64.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.166 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 pt -82.64 -13.21 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.227 0.921 . . . . 0.0 112.818 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -50.86 54.75 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 0.0 113.405 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.57 -44.52 46.8 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.357 2.038 . . . . 0.0 111.631 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.43 -51.24 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.85 -43.2 76.83 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.227 -0.296 . . . . 0.0 110.93 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -59.86 -52.83 63.77 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 0.0 109.888 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -55.59 -50.31 70.45 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.82 0.848 . . . . 0.0 109.938 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 mm -56.25 -50.88 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.711 0.805 . . . . 0.0 109.758 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.04 -43.41 66.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.206 0.603 . . . . 0.0 110.239 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.81 -57.63 6.66 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.588 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -47.19 -49.82 21.99 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.876 1.27 . . . . 0.0 112.973 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -91.28 14.16 15.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.253 0.621 . . . . 0.0 112.258 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 134.18 23.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.865 1.211 . . . . 0.0 111.178 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -29.26 6.95 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.494 -0.615 . . . . 0.0 111.797 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -98.98 -40.33 8.11 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.117 0.959 . . . . 0.0 109.013 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.0 tp -133.11 149.29 52.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.574 1.55 . . . . 0.0 109.072 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.6 m -124.17 147.24 48.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -121.73 152.34 25.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 119.458 1.026 . . . . 0.0 108.534 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.81 151.02 45.41 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.79 100.45 5.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.94 121.72 40.2 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.376 -0.827 . . . . 0.0 110.682 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.68 108.45 16.06 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.488 0.715 . . . . 0.0 109.759 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -65.1 -25.13 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.008 0.523 . . . . 0.0 112.288 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.42 -44.11 92.25 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.274 0.943 . . . . 0.0 108.896 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.88 -35.64 62.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.954 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -120.74 68.14 15.31 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 124.089 0.956 . . . . 0.0 111.815 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.29 -42.23 36.39 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.884 1.722 . . . . 0.0 110.22 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -37.59 6.07 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.623 1.106 . . . . 0.0 114.184 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -22.45 56.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.38 1.09 . . . . 0.0 112.965 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.64 -59.22 14.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.663 -178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -51.09 -46.6 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.584 2.189 . . . . 0.0 112.88 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -45.16 -46.44 12.03 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.987 0.915 . . . . 0.0 112.501 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -108.1 25.26 11.82 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.001 0.521 . . . . 0.0 111.962 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.19 46.39 21.16 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.031 0.824 . . . . 0.0 112.37 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.8 mm -75.62 77.84 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.13 -4.26 57.41 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.78 0.832 . . . . 0.0 110.504 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.48 146.76 12.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt -133.48 154.71 80.96 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.611 1.565 . . . . 0.0 108.346 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 132.14 17.68 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.659 1.271 . . . . 0.0 111.011 -0.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.67 145.89 31.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -129.72 100.39 5.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.87 119.87 40.51 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.37 107.5 19.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.322 0.649 . . . . 0.0 109.936 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -97.59 103.96 15.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.832 1.253 . . . . 0.0 109.395 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -86.98 104.38 16.24 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 48.07 50.94 15.37 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.662 0.744 . . . . 0.0 110.764 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.73 -19.98 6.82 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.928 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -80.44 112.37 17.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.195 1.497 . . . . 0.0 109.627 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 81.1 t -62.94 102.55 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.01 -42.43 26.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.637 0.775 . . . . 0.0 110.387 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.16 153.67 28.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.3 p -132.68 114.88 14.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.155 1.382 . . . . 0.0 109.176 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -110.0 144.0 39.17 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.34 127.63 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 167.36 35.61 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.972 0.796 . . . . 0.0 111.465 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 166.43 21.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.118 0.567 . . . . 0.0 110.624 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.41 165.03 31.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.294 1.438 . . . . 0.0 107.787 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -72.38 159.24 34.34 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.006 0.431 . . . . 0.0 110.494 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.94 -42.5 80.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.25 -54.74 33.61 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -55.36 -47.1 76.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.106 0.453 . . . . 0.0 110.36 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -59.21 -50.56 73.54 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -55.21 -48.2 74.21 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.971 -0.455 . . . . 0.0 110.737 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -58.82 -53.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.205 0.602 . . . . 0.0 109.84 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.6 -53.21 40.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.145 0.978 . . . . 0.0 110.127 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.49 -51.87 68.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.521 0.328 . . . . 0.0 110.757 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -54.44 -51.9 63.5 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.78 0.264 . . . . 0.0 110.565 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.42 72.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.381 1.072 . . . . 0.0 111.942 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -78.34 -43.95 26.44 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.987 0.358 . . . . 0.0 110.63 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -62.62 -47.17 84.94 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.905 0.482 . . . . 0.0 109.781 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.203 0 C-N-CA 124.564 1.146 . . . . 0.0 111.467 179.403 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.75 72.35 0.37 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.137 0.975 . . . . 0.0 110.28 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -103.43 50.28 0.81 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.4 mt -112.3 143.28 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 125.476 1.51 . . . . 0.0 110.269 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.21 110.89 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.452 0.644 . . . . 0.0 110.773 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.18 97.32 8.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.534 1.134 . . . . 0.0 108.519 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.7 mt -80.73 169.94 16.96 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.731 0.776 . . . . 0.0 111.676 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.3 p -137.62 161.51 36.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.45 -43.31 67.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.5 -46.61 89.27 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.265 1.426 . . . . 0.0 112.009 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.8 p -78.23 -27.45 47.71 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.086 -0.384 . . . . 0.0 111.736 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -36.71 -54.74 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.425 1.49 . . . . 0.0 113.599 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -54.83 -63.57 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.424 0.63 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.85 -37.97 69.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.965 0.906 . . . . 0.0 113.022 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.53 -61.2 1.82 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.806 0.336 . . . . 0.0 111.485 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.72 -49.42 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.484 1.114 . . . . 0.0 112.538 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.252 45.1 mt -65.18 -29.9 70.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.862 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -100.18 35.3 2.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.578 0.351 . . . . 0.0 110.827 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.08 73.42 0.07 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.727 0.811 . . . . 0.0 112.058 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -70.24 72.37 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.277 1.031 . . . . 0.0 109.802 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.96 -117.7 0.79 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.362 -2.695 . . . . 0.0 106.362 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.09 118.54 6.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.11 124.56 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.781 1.232 . . . . 0.0 108.523 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -102.78 104.3 14.58 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.33 113.49 26.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 122.761 0.425 . . . . 0.0 110.076 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.56 107.86 19.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 108.643 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -79.96 124.49 28.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -143.14 -179.72 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 111.452 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.2 150.78 33.18 Favored 'General case' 0 C--N 1.337 0.051 0 C-N-CA 125.848 1.659 . . . . 0.0 108.54 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -52.81 -42.86 65.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.465 0.706 . . . . 0.0 111.471 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -79.38 -6.53 57.01 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.292 1.037 . . . . 0.0 112.77 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.4 t -79.72 80.86 6.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 120.918 -1.114 . . . . 0.0 111.158 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.4 -59.08 3.7 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.65 -33.31 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.422 2.748 . . . . 0.0 113.653 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.92 -50.82 38.32 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -55.34 -43.99 75.51 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 -30.85 57.78 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.495 -0.764 . . . . 0.0 112.242 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 pt -92.97 -3.03 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.604 1.093 . . . . 0.0 112.204 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 88.49 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 119.785 1.175 . . . . 0.0 110.993 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.99 -47.35 28.04 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 111.352 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.4 mt -55.13 -52.87 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.49 -40.81 83.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 122.642 0.377 . . . . 0.0 110.77 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.55 -50.31 74.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.719 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.63 -50.34 72.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.289 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.0 mm -55.21 -48.61 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.6 -47.24 70.36 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.152 0.433 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.21 -49.11 75.5 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 111.462 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.71 -49.19 76.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -91.4 27.44 1.95 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.167 0.987 . . . . 0.0 113.259 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -53.86 128.36 29.72 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -17.05 14.31 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.274 -0.737 . . . . 0.0 113.195 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -99.7 -41.85 7.11 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.648 1.224 . . . . 0.0 110.171 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -140.05 133.2 29.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.781 0.832 . . . . 0.0 109.251 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.7 m -98.71 107.95 20.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.35 134.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.53 51.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.884 0.873 . . . . 0.0 108.776 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -127.55 145.13 50.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.974 1.31 . . . . 0.0 107.959 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -134.71 118.92 17.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.41 101.51 14.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -52.0 -37.65 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.29 -47.53 85.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.883 0.765 . . . . 0.0 110.423 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -81.92 -20.3 39.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.395 1.078 . . . . 0.0 111.561 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -129.25 63.76 68.6 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.424 1.49 . . . . 0.0 108.846 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.56 -45.14 7.3 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.581 2.188 . . . . 0.0 113.746 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.49 -45.67 1.94 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.356 1.455 . . . . 0.0 115.581 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -73.09 -28.13 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.82 -57.69 15.04 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.76 -43.47 16.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.478 1.452 . . . . 0.0 111.048 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -48.44 -49.13 36.55 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.043 0.537 . . . . 0.0 111.503 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -99.15 24.09 8.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.49 48.95 7.11 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.57 1.081 . . . . 0.0 113.274 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mm -76.32 74.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -79.97 -4.66 53.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.354 0.662 . . . . 0.0 111.798 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.33 165.41 34.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 pt -149.58 153.53 36.88 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.593 1.557 . . . . 0.0 107.286 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.67 143.55 71.7 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.706 1.288 . . . . 0.0 109.854 -0.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.0 m -137.59 122.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -108.43 115.96 31.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.058 1.343 . . . . 0.0 109.218 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.54 121.73 46.03 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp -97.99 110.04 22.69 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -103.67 130.45 51.14 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.828 1.651 . . . . 0.0 111.329 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -122.3 113.2 19.09 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.5 t30 51.99 42.1 30.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.915 0.779 . . . . 0.0 110.177 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.62 -14.31 3.46 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.561 -0.712 . . . . 0.0 114.095 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -80.55 120.9 25.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.918 1.359 . . . . 0.0 107.342 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.9 115.42 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -46.39 17.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.665 0.786 . . . . 0.0 109.212 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.74 163.3 26.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.567 0.747 . . . . 0.0 109.252 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 71.9 p -136.81 134.56 37.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.481 1.112 . . . . 0.0 109.125 -179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -124.6 117.59 24.64 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.59 133.11 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.2 161.5 37.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.986 0.803 . . . . 0.0 111.554 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.31 167.89 13.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.114 0.566 . . . . 0.0 110.549 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.57 163.6 27.2 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.807 1.243 . . . . 0.0 108.121 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -72.68 162.74 29.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.334 0.588 . . . . 0.0 111.282 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -54.16 -46.63 72.36 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.85 22.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -53.81 -45.45 70.78 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 117.455 0.627 . . . . 0.0 110.37 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.9 tp -59.16 -51.09 71.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.35 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -53.34 -49.78 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.559 0.618 . . . . 0.0 110.46 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -57.36 -50.63 72.35 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 117.772 0.26 . . . . 0.0 110.693 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -54.39 -53.21 57.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 0.0 110.516 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -58.04 -53.02 62.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.837 0.455 . . . . 0.0 110.328 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.35 -51.49 62.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.493 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.29 68.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.696 0.798 . . . . 0.0 111.863 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -78.04 -47.53 18.2 Favored 'General case' 0 CA--C 1.526 0.039 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.29 -44.76 88.65 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.196 0.598 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 122.996 0.518 . . . . 0.0 109.612 177.647 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.8 t70 39.59 -100.75 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.984 1.714 . . . . 0.0 112.777 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -133.84 37.3 3.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.424 1.089 . . . . 0.0 108.892 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.5 mt -91.85 140.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.951 0.9 . . . . 0.0 109.686 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.3 mm -90.38 122.48 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 122.019 0.914 . . . . 0.0 111.188 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -95.57 83.32 3.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.17 166.01 17.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.007 1.323 . . . . 0.0 112.715 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.0 p -128.41 161.2 30.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.85 -45.02 78.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.66 -47.23 86.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.883 1.273 . . . . 0.0 111.458 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -78.2 -24.78 46.96 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.126 -0.359 . . . . 0.0 111.846 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -36.45 -50.24 0.76 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.017 1.727 . . . . 0.0 113.548 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.21 -63.76 1.06 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 110.374 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -59.47 -34.52 72.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.439 0.696 . . . . 0.0 112.072 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -83.29 -65.9 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.94 -45.49 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 112.603 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.261 46.9 mt -64.89 -30.26 71.24 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.245 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -96.22 30.43 2.49 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 110.726 172.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 74.78 0.05 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -56.54 135.52 54.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.58 -95.68 1.23 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.899 -2.081 . . . . 0.0 107.899 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.19 136.32 2.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.954 0.877 . . . . 0.0 110.71 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mt -119.78 128.48 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.957 1.303 . . . . 0.0 107.802 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.53 103.11 13.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.89 110.13 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 122.663 0.385 . . . . 0.0 110.454 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.69 108.31 19.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 118.0 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -133.0 178.32 6.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.472 1.109 . . . . 0.0 112.184 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.17 154.57 35.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.127 1.371 . . . . 0.0 108.57 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.89 -26.04 58.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -92.03 -4.32 54.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.468 1.107 . . . . 0.0 112.254 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.5 t -79.66 83.37 5.64 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.93 -1.106 . . . . 0.0 112.105 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.03 -58.91 4.14 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 123.582 0.61 . . . . 0.0 112.518 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.06 -30.82 61.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.074 2.516 . . . . 0.0 113.347 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.2 m -65.47 -42.81 91.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.49 -43.08 98.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 51.5 ttp -54.27 -47.96 71.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.636 0.374 . . . . 0.0 110.675 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.2 pt -77.54 -26.56 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.848 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.92 -57.08 1.06 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.94 -36.41 96.9 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 112.003 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.93 -49.63 78.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -55.04 -42.82 73.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.77 0.428 . . . . 0.0 110.376 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.87 -48.75 80.44 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.87 -49.71 74.68 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mm -54.39 -46.27 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.979 0.912 . . . . 0.0 109.79 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.37 55.41 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.965 0.506 . . . . 0.0 111.459 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.21 -58.84 2.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -48.51 -44.55 36.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.677 1.191 . . . . 0.0 113.232 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -104.92 23.09 14.1 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.468 1.107 . . . . 0.0 111.024 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -55.32 130.1 41.07 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.027 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -19.15 21.84 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.887 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -99.37 -45.22 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.606 1.203 . . . . 0.0 109.34 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 tp -131.57 116.73 17.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.658 1.183 . . . . 0.0 108.64 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 m -87.41 109.07 19.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.24 140.5 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.29 149.07 46.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.934 0.894 . . . . 0.0 109.767 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -130.44 103.92 6.95 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -98.37 119.52 37.2 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 122.98 0.512 . . . . 0.0 109.836 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -81.21 106.64 13.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.199 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.0 -32.32 55.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 123.74 0.816 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.27 -44.62 95.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.183 0.901 . . . . 0.0 109.145 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -77.33 -35.05 55.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.261 0.624 . . . . 0.0 110.762 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.3 67.78 7.01 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.13 0.972 . . . . 0.0 111.22 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.14 -40.33 26.94 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.16 1.907 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.46 3.52 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.219 1.39 . . . . 0.0 114.459 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.59 60.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.429 1.115 . . . . 0.0 112.971 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.45 -57.39 26.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -62.92 -35.72 65.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.24 1.96 . . . . 0.0 112.441 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -47.14 -44.37 21.63 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.898 0.772 . . . . 0.0 112.051 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -113.87 24.96 11.59 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.342 0.657 . . . . 0.0 110.693 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 36.97 50.96 1.54 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 126.627 2.061 . . . . 0.0 113.405 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -45.02 118.21 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.094 0.957 . . . . 0.0 110.919 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -79.72 -45.33 19.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.03 0.932 . . . . 0.0 111.335 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.19 142.62 6.97 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.9 pt -90.95 145.95 32.79 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.899 0.88 . . . . 0.0 110.37 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.38 129.79 16.98 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 CA-C-N 120.189 1.103 . . . . 0.0 111.34 -0.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.3 112.16 23.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.92 94.49 6.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.1 mp -93.17 115.11 27.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.04 105.99 18.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -101.88 122.87 44.82 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.351 1.46 . . . . 0.0 111.609 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -105.47 102.88 12.32 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.74 58.8 2.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.937 1.295 . . . . 0.0 111.819 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.13 -25.35 5.51 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.902 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -79.96 109.59 14.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.659 1.23 . . . . 0.0 110.186 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.25 109.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.23 -43.36 23.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.926 0.891 . . . . 0.0 110.314 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.87 160.08 35.75 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.176 0.59 . . . . 0.0 109.482 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.6 p -135.64 103.87 5.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 109.152 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -90.55 120.84 31.97 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.95 103.35 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.34 161.62 13.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.486 0.565 . . . . 0.0 112.015 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 166.0 23.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.852 0.861 . . . . 0.0 111.669 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -163.84 164.35 23.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.262 1.825 . . . . 0.0 107.36 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 p -93.31 170.86 9.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.987 1.315 . . . . 0.0 113.051 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -61.87 156.28 21.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.68 -62.64 4.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -59.61 -54.69 43.55 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.81 -48.99 74.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.141 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -55.18 -47.08 75.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.558 0.343 . . . . 0.0 111.829 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.43 -47.84 80.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.059 0.544 . . . . 0.0 109.796 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -53.47 -52.49 59.33 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.22 -51.16 71.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.586 0.355 . . . . 0.0 110.648 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.04 -50.91 65.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.704 0.401 . . . . 0.0 110.774 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.84 69.47 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.237 1.015 . . . . 0.0 111.434 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -77.55 -48.15 17.69 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.0 mt -54.95 -48.4 73.23 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.307 0 C-N-CA 123.096 0.559 . . . . 0.0 109.51 176.905 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.226 -0.136 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.6 t70 34.55 -95.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.76 2.024 . . . . 0.0 114.553 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -132.37 25.94 4.47 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.673 1.189 . . . . 0.0 109.701 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.97 136.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.949 -0.469 . . . . 0.0 111.054 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.43 115.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-O 121.545 0.688 . . . . 0.0 111.587 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -82.69 96.69 8.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.018 0.927 . . . . 0.0 108.679 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.35 158.86 21.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.125 0.964 . . . . 0.0 113.188 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -125.1 160.46 29.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.904 2.082 . . . . 0.0 106.699 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -55.95 -44.31 78.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.44 -46.97 73.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.875 1.27 . . . . 0.0 111.019 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.4 p -78.1 -28.04 48.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.229 -0.295 . . . . 0.0 111.681 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -38.08 -53.67 1.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.51 1.524 . . . . 0.0 113.673 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -54.93 -62.83 1.4 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -36.69 71.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.179 0.992 . . . . 0.0 113.319 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.25 -62.04 1.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.771 0.32 . . . . 0.0 111.294 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.65 -49.07 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.487 1.115 . . . . 0.0 112.636 -172.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.67 -30.36 71.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.619 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -96.48 32.48 2.01 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.443 -0.313 . . . . 0.0 110.848 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.4 66.86 0.19 Allowed 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.839 0.856 . . . . 0.0 111.629 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -72.75 70.58 0.97 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.728 1.211 . . . . 0.0 109.297 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.07 -117.82 0.77 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 104.993 -3.243 . . . . 0.0 104.993 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.79 115.21 5.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.13 0.965 . . . . 0.0 108.74 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mt -112.67 125.91 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.518 1.127 . . . . 0.0 108.652 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.35 104.2 14.05 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 t -91.74 114.97 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.756 0.422 . . . . 0.0 110.344 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.83 106.83 19.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.693 1.197 . . . . 0.0 107.91 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.35 121.82 25.6 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -135.21 179.28 6.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.679 1.192 . . . . 0.0 110.852 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.34 155.64 40.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.799 1.24 . . . . 0.0 108.727 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -57.5 -27.9 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.589 0.632 . . . . 0.0 112.232 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -90.07 -3.96 57.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.614 1.166 . . . . 0.0 112.452 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.2 t -79.67 80.11 6.1 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 120.936 -1.102 . . . . 0.0 112.581 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.62 -58.86 4.52 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.151 0.405 . . . . 0.0 112.156 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.72 -32.52 55.61 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.369 2.713 . . . . 0.0 113.697 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.6 m -63.34 -44.36 95.09 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.97 -43.57 98.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtt -55.62 -42.51 75.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.149 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.68 -23.26 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 112.89 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.49 -51.74 6.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.57 -43.09 60.7 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.449 2.099 . . . . 0.0 111.964 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.58 -48.65 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -56.74 -41.62 77.86 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 122.419 -0.176 . . . . 0.0 110.551 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.41 -49.65 74.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.43 -50.45 69.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 mm -56.22 -49.02 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.411 0.684 . . . . 0.0 109.733 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -43.2 67.92 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.126 0.57 . . . . 0.0 110.358 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.73 -57.19 6.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.289 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.5 -44.07 55.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.18 . . . . 0.0 112.758 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.17 21.53 12.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 111.973 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -54.67 128.14 31.25 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.566 1.075 . . . . 0.0 110.189 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -19.18 28.58 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.213 -0.771 . . . . 0.0 113.049 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -99.09 -45.39 5.94 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.668 1.234 . . . . 0.0 109.452 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -129.6 131.22 46.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.447 1.099 . . . . 0.0 108.46 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.1 m -99.4 104.07 15.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.29 138.84 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.63 47.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.863 0.865 . . . . 0.0 109.241 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -125.81 135.31 51.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -125.92 122.0 34.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -86.71 110.97 20.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.32 -29.29 45.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -63.23 -47.66 81.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -70.34 -31.17 68.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.495 1.118 . . . . 0.0 110.253 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.04 73.41 76.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 0.0 111.834 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.37 -56.05 3.06 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.616 2.211 . . . . 0.0 112.688 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.58 -48.26 1.25 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.216 1.865 . . . . 0.0 115.57 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -28.52 69.54 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.756 -0.85 . . . . 0.0 113.023 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.89 -64.41 2.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.49 -42.74 45.39 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.734 1.623 . . . . 0.0 111.22 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -49.24 -44.58 43.65 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 118.229 0.468 . . . . 0.0 111.765 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -104.07 25.9 9.42 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.3 44.97 10.71 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.537 1.065 . . . . 0.0 113.477 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 mm -75.71 75.77 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.606 0.717 . . . . 0.0 109.177 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -79.43 -4.93 53.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.013 0.925 . . . . 0.0 111.545 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.25 170.74 40.34 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.384 -2.287 . . . . 0.0 107.384 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt -150.73 153.16 33.39 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.092 1.357 . . . . 0.0 107.711 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.46 142.19 61.77 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 CA-C-N 120.586 1.245 . . . . 0.0 110.154 -1.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 m -134.9 119.98 18.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.0 mt -105.19 116.16 31.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.543 1.537 . . . . 0.0 109.156 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.7 mp -111.22 122.26 47.4 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp -98.17 104.88 16.95 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -95.0 122.56 37.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.276 1.43 . . . . 0.0 110.392 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -117.33 113.75 22.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 175.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.44 44.2 29.12 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.359 1.064 . . . . 0.0 110.056 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.96 -17.31 7.28 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.229 -0.761 . . . . 0.0 114.172 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.55 123.73 32.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.059 1.429 . . . . 0.0 109.938 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.45 110.13 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.02 -42.42 26.55 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.798 0.839 . . . . 0.0 109.836 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.68 162.6 35.11 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 62.1 p -137.36 138.81 40.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.446 1.098 . . . . 0.0 109.345 -178.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -130.47 122.26 27.35 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.73 131.14 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.34 165.46 37.7 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.066 0.841 . . . . 0.0 111.934 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.72 165.96 22.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.257 0.623 . . . . 0.0 110.443 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.18 167.92 26.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.816 1.246 . . . . 0.0 108.55 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -75.46 159.91 30.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.99 0.424 . . . . 0.0 110.55 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.61 -42.88 75.52 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.24 -56.53 24.72 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -56.41 -42.43 77.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.804 0.802 . . . . 0.0 110.721 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.6 -51.36 70.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.82 -47.69 73.75 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.726 0.694 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -55.43 -53.33 57.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.041 0.382 . . . . 0.0 110.052 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -54.17 -53.01 59.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.778 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.05 -53.39 58.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.894 0.478 . . . . 0.0 110.526 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.37 -51.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.321 0.649 . . . . 0.0 110.29 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.73 -37.35 68.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.209 0.604 . . . . 0.0 111.693 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -78.13 -46.23 21.21 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.134 -0.354 . . . . 0.0 110.665 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.46 -47.08 85.2 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 C-N-CA 123.005 0.522 . . . . 0.0 109.614 177.258 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -163.4 173.92 12.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.898 1.279 . . . . 0.0 108.336 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -134.82 48.65 2.28 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 mt -102.38 139.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.876 0.87 . . . . 0.0 109.895 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mm -88.68 114.25 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.244 1.021 . . . . 0.0 111.175 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -87.02 76.4 9.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.183 0.993 . . . . 0.0 108.95 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.48 160.17 25.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.997 1.319 . . . . 0.0 113.632 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 p -125.18 160.45 29.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.473 1.909 . . . . 0.0 107.638 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.61 -49.88 66.87 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.74 -45.87 67.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.993 1.317 . . . . 0.0 111.591 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 p -78.33 -28.57 47.34 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -35.82 -55.23 0.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.64 1.576 . . . . 0.0 115.001 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.65 -62.29 1.75 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.715 0.769 . . . . 0.0 111.347 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -61.99 -41.77 98.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.212 0.605 . . . . 0.0 112.193 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.31 -40.47 51.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.8 t -101.15 -63.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.841 0.856 . . . . 0.0 112.151 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.62 -33.48 71.55 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.78 4.98 50.16 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.37 105.71 11.84 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 120.384 1.447 . . . . 0.0 111.978 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -77.26 67.25 3.18 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 173.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.69 -157.72 10.62 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.88 110.53 19.15 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.778 1.231 . . . . 0.0 108.378 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mt -114.45 123.05 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.16 1.384 . . . . 0.0 108.649 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.05 103.6 13.69 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.46 113.13 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.79 109.27 20.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -79.68 126.89 31.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -134.72 177.14 8.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.392 1.077 . . . . 0.0 110.005 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.45 156.45 43.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -59.51 -27.73 66.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.347 0.521 . . . . 0.0 110.723 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -91.22 -1.77 57.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 178.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -79.85 79.03 6.41 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.864 -1.147 . . . . 0.0 111.868 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.8 -56.98 6.3 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 119.823 -0.432 . . . . 0.0 112.12 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -52.89 -34.32 65.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.254 2.636 . . . . 0.0 113.722 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.78 -41.99 99.49 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -67.86 -45.62 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.8 ttm -50.66 -44.03 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.837 0.455 . . . . 0.0 111.265 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.02 -5.77 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.67 78.29 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 112.336 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.55 -46.11 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.364 2.043 . . . . 0.0 111.361 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.05 -52.8 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.44 -39.92 73.92 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.143 -0.348 . . . . 0.0 110.986 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.22 -50.99 69.56 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.91 -49.46 73.39 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.16 -49.25 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.387 0.675 . . . . 0.0 109.821 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.73 64.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.999 0.363 . . . . 0.0 110.595 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.74 -55.81 8.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.849 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -49.02 -49.15 42.42 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.447 1.099 . . . . 0.0 112.329 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -97.45 23.59 7.47 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.927 0.891 . . . . 0.0 111.5 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.95 130.0 28.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.35 0.977 . . . . 0.0 110.937 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.09 -17.61 9.34 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.435 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.18 -41.79 7.34 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.708 1.254 . . . . 0.0 109.107 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -131.63 134.88 46.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.216 1.407 . . . . 0.0 108.071 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -107.52 104.2 13.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -79.83 140.69 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.47 150.32 49.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.002 . . . . 0.0 109.203 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -132.91 99.31 4.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.709 1.204 . . . . 0.0 108.575 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tt -98.22 127.01 43.94 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 110.559 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.72 112.56 22.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.6 pt -67.18 -30.38 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.522 0.729 . . . . 0.0 112.832 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -65.98 -45.76 80.49 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.98 -36.51 83.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.76 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -124.78 74.77 64.77 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 123.91 0.884 . . . . 0.0 112.612 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.67 -61.23 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.389 2.726 . . . . 0.0 113.672 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.36 -48.94 1.66 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.039 1.78 . . . . 0.0 114.684 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -34.13 59.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.37 -68.88 0.68 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-O 117.598 -1.192 . . . . 0.0 110.193 178.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -47.49 -48.18 16.05 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.107 1.871 . . . . 0.0 112.715 174.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -48.1 -47.65 34.15 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.653 0.66 . . . . 0.0 111.916 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -101.49 25.16 8.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.26 39.33 20.55 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.345 0.974 . . . . 0.0 113.095 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -78.1 91.21 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -83.28 -8.5 59.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.402 0.281 . . . . 0.0 111.183 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.69 167.93 40.67 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 107.149 -2.381 . . . . 0.0 107.149 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 1.3 pp -132.77 157.94 77.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.349 1.46 . . . . 0.0 109.057 -179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.06 143.89 75.71 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 CA-C-N 120.362 1.165 . . . . 0.0 110.8 -0.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.9 m -140.78 123.04 15.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.1 mt -104.12 126.19 51.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.64 1.576 . . . . 0.0 109.362 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.61 119.25 33.2 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.82 102.05 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -89.44 117.4 28.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.301 1.44 . . . . 0.0 108.998 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -111.91 124.87 53.29 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 51.99 42.91 30.63 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.461 0.648 . . . . 0.0 109.857 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.44 -8.43 13.77 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.49 -1.172 . . . . 0.0 115.377 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -104.96 133.0 50.49 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.708 1.754 . . . . 0.0 110.878 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.08 105.49 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.03 -43.73 17.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.455 0.702 . . . . 0.0 110.556 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.04 33.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.9 p -145.21 169.1 18.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.16 0.584 . . . . 0.0 109.655 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -150.03 151.34 33.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.4 140.29 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.86 40.74 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 173.17 10.2 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.277 -0.543 . . . . 0.0 110.224 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.86 162.05 32.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.173 1.389 . . . . 0.0 107.366 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.31 151.64 29.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.428 0.691 . . . . 0.0 110.894 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -50.07 -47.54 53.57 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.463 1.105 . . . . 0.0 112.139 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.55 -56.52 23.2 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -53.62 -45.08 69.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.796 0.838 . . . . 0.0 110.259 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.75 -53.25 60.47 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -54.52 -47.28 73.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.117 0.417 . . . . 0.0 111.345 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.68 -52.28 66.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.07 -53.48 52.59 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.87 0.868 . . . . 0.0 110.076 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.57 -51.75 68.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.429 0.292 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.56 -51.69 64.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.832 0.453 . . . . 0.0 110.493 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.02 -39.06 71.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.916 0.887 . . . . 0.0 111.7 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -77.87 -42.73 32.46 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.315 -0.24 . . . . 0.0 110.413 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.6 mt -60.35 -45.54 93.09 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 123.152 0.581 . . . . 0.0 109.659 177.686 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -72.88 97.65 2.31 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -122.75 40.86 3.59 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 mt -91.12 141.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.004 0.922 . . . . 0.0 110.75 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -90.91 113.53 26.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.465 0.65 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -84.33 97.89 9.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.271 1.028 . . . . 0.0 109.261 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.07 160.25 18.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.2 1.0 . . . . 0.0 112.837 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.8 p -127.31 160.31 31.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.399 1.88 . . . . 0.0 106.951 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -53.33 -48.74 68.2 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.99 -45.52 71.47 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.926 1.29 . . . . 0.0 111.423 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.5 p -78.67 -28.78 45.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -33.35 -65.61 0.17 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 126.059 1.743 . . . . 0.0 115.268 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.4 -56.49 14.63 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.607 -0.683 . . . . 0.0 111.43 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.95 -45.63 92.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.331 0.652 . . . . 0.0 112.758 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.56 -39.64 52.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.35 -65.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.679 1.192 . . . . 0.0 112.116 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.39 -31.35 70.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -91.46 3.84 53.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.524 0.602 . . . . 0.0 112.567 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -77.57 106.3 9.27 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.106 1.321 . . . . 0.0 112.104 -178.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.37 67.31 3.29 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 173.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -170.27 -159.03 15.17 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -114.82 111.85 21.87 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.917 0.887 . . . . 0.0 109.07 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.8 129.2 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 125.012 1.325 . . . . 0.0 108.843 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -109.91 103.73 12.55 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.5 t -90.9 117.68 34.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 118.326 0.512 . . . . 0.0 110.468 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.78 110.91 23.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.849 1.259 . . . . 0.0 108.918 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -83.66 121.32 27.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -137.34 176.57 8.59 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.15 149.17 31.51 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.842 1.657 . . . . 0.0 109.243 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.36 -34.8 64.6 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.532 0.733 . . . . 0.0 112.388 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -84.6 -10.27 57.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.94 0.896 . . . . 0.0 112.084 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.75 79.99 6.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.076 -1.015 . . . . 0.0 110.906 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.78 -58.58 2.6 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.153 0.882 . . . . 0.0 112.074 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -36.51 84.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.344 2.696 . . . . 0.0 113.598 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.7 m -63.59 -46.08 87.45 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -64.65 -42.17 95.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.9 ttp -52.69 -44.35 66.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.4 pt -78.78 -10.05 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.34 -57.21 12.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 120.052 1.297 . . . . 0.0 113.116 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.69 -41.06 77.08 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.056 1.837 . . . . 0.0 111.435 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 mt -59.84 -51.93 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.4 mt -55.65 -41.22 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.833 0.453 . . . . 0.0 110.55 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.11 -52.69 63.84 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.45 -48.63 68.66 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.829 -0.545 . . . . 0.0 109.984 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.56 -49.43 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 122.997 0.519 . . . . 0.0 109.668 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.0 -45.94 68.1 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.39 -57.41 8.42 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.818 0.342 . . . . 0.0 110.476 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.21 -50.57 37.73 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.919 1.288 . . . . 0.0 112.548 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -94.04 20.49 7.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.71 0.804 . . . . 0.0 111.995 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.53 99.83 0.05 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.687 1.13 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.7 -23.48 8.34 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.617 1.103 . . . . 0.0 111.284 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -99.43 -36.79 9.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.664 1.186 . . . . 0.0 109.706 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -138.33 139.03 38.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.062 0.945 . . . . 0.0 108.522 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.6 m -106.89 102.38 11.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.21 138.31 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.21 154.12 51.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.086 0.955 . . . . 0.0 108.662 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.0 145.42 51.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.022 1.329 . . . . 0.0 108.208 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -137.6 121.32 17.45 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -84.35 110.34 18.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.89 -31.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.88 -45.57 91.94 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.231 0.923 . . . . 0.0 109.058 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -71.93 -36.8 70.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.068 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -122.63 69.9 35.24 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.246 1.018 . . . . 0.0 111.612 -175.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.05 -47.27 6.74 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.972 1.781 . . . . 0.0 111.083 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -37.85 2.15 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.529 1.538 . . . . 0.0 114.895 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.4 -22.84 61.06 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.346 1.073 . . . . 0.0 113.677 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.92 -55.74 5.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.62 -37.02 42.52 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.327 2.684 . . . . 0.0 113.577 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -43.78 -43.25 6.01 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.103 0.961 . . . . 0.0 112.107 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -117.82 29.93 7.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.403 0.681 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.89 40.77 27.38 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.693 1.14 . . . . 0.0 112.823 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.6 mt -78.99 79.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -88.68 -4.66 58.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.886 0.874 . . . . 0.0 111.541 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.27 160.91 27.28 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.7 pt -147.59 156.35 45.27 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.586 1.554 . . . . 0.0 107.745 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.19 145.15 75.07 Favored 'Cis proline' 0 N--CA 1.456 -0.733 0 CA-C-N 120.725 1.295 . . . . 0.0 110.006 -0.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 m -138.79 124.51 19.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.06 115.74 30.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.616 1.566 . . . . 0.0 108.913 -175.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.95 116.41 31.9 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 tp -96.72 104.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -94.94 118.81 32.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.576 1.55 . . . . 0.0 109.206 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -111.46 122.48 47.96 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.39 42.69 31.19 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.253 0.621 . . . . 0.0 109.912 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.77 -14.73 5.52 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.71 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -94.19 134.77 36.29 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.215 1.508 . . . . 0.0 110.535 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.2 107.98 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -45.02 19.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.25 159.92 34.7 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.4 p -136.53 129.87 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.335 1.054 . . . . 0.0 108.53 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -119.31 119.22 33.38 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.52 132.32 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.51 163.89 34.37 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.147 0.879 . . . . 0.0 111.435 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.2 167.26 22.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.044 0.537 . . . . 0.0 110.221 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -160.93 162.99 32.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.782 1.233 . . . . 0.0 108.147 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.88 162.91 28.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.206 0.527 . . . . 0.0 110.98 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -55.8 -45.07 78.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.65 -54.41 36.57 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -56.43 -46.13 80.42 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 110.447 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.29 -52.34 66.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -55.93 -48.11 76.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 110.535 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -56.99 -53.41 58.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.777 0.431 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.98 -54.09 40.25 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.093 0.957 . . . . 0.0 110.312 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.54 -53.24 60.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.57 -52.31 60.15 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.918 0.327 . . . . 0.0 110.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.83 73.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.899 0.88 . . . . 0.0 112.004 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -77.68 -42.61 33.96 Favored 'General case' 0 C--O 1.23 0.029 0 O-C-N 122.095 -0.378 . . . . 0.0 110.319 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.49 -48.24 82.41 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 123.139 0.576 . . . . 0.0 109.525 177.077 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -73.67 70.94 1.39 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.528 0.731 . . . . 0.0 109.894 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -103.82 47.74 0.87 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.4 138.51 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.318 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.6 mm -86.5 110.91 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.218 1.009 . . . . 0.0 111.01 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -82.41 76.11 9.29 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.771 0.828 . . . . 0.0 108.9 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.76 159.19 22.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.715 1.206 . . . . 0.0 113.659 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 p -125.74 160.53 29.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.8 2.04 . . . . 0.0 106.755 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -54.68 -45.46 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.67 -46.13 74.01 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.3 1.44 . . . . 0.0 111.432 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 p -78.67 -27.45 45.18 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -37.8 -54.51 1.24 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.327 1.451 . . . . 0.0 114.113 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.09 -50.25 73.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 111.664 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -66.24 -40.94 90.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.237 1.015 . . . . 0.0 111.339 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.01 -58.49 2.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.72 -51.52 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.038 0.935 . . . . 0.0 112.4 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 mt -64.87 -32.78 74.64 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.299 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -96.8 26.07 4.81 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.499 0.319 . . . . 0.0 111.201 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.32 72.93 0.32 Allowed 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.338 -0.851 . . . . 0.0 111.664 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -67.56 73.58 0.15 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.706 1.203 . . . . 0.0 110.211 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.51 -112.75 0.53 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 106.303 -2.719 . . . . 0.0 106.303 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.63 122.69 5.41 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.813 0.807 . . . . 0.0 109.132 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mt -120.25 119.44 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.179 1.392 . . . . 0.0 108.096 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.8 tp -94.61 104.8 16.73 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.68 109.66 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 122.829 0.452 . . . . 0.0 110.014 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -90.19 119.35 30.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.74 125.62 34.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -138.43 176.31 8.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.486 0.715 . . . . 0.0 111.157 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.45 151.77 32.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.056 1.342 . . . . 0.0 107.563 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -56.08 -36.87 68.59 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.615 0.766 . . . . 0.0 111.55 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -79.71 -11.03 59.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.241 1.017 . . . . 0.0 112.813 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -79.56 81.3 5.84 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.046 -1.034 . . . . 0.0 111.855 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.07 -57.62 3.51 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.013 0.816 . . . . 0.0 112.369 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.91 -33.58 82.72 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.862 2.375 . . . . 0.0 113.261 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -65.04 -43.55 91.98 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.49 -47.6 84.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -50.38 -41.89 52.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.888 0.875 . . . . 0.0 111.953 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -83.69 -8.82 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.91 -51.17 73.32 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.9 1.227 . . . . 0.0 112.721 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.94 -40.96 78.8 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.508 2.139 . . . . 0.0 112.078 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.08 -52.5 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.24 -42.84 77.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.826 0.45 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.28 -53.43 58.28 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.827 0.822 . . . . 0.0 109.327 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.87 -47.14 77.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.007 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 mm -56.11 -50.4 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.116 0.566 . . . . 0.0 109.806 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.61 67.65 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.982 0.513 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.24 -50.3 54.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.299 -0.251 . . . . 0.0 110.966 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.62 -49.32 77.92 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.33 0.652 . . . . 0.0 112.731 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -87.11 30.14 0.79 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.745 0.818 . . . . 0.0 112.592 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -52.27 125.0 14.57 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.561 -0.712 . . . . 0.0 110.213 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.65 -15.35 14.36 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.484 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.7 -36.23 9.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.431 1.116 . . . . 0.0 110.568 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -146.67 142.23 27.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.199 0.6 . . . . 0.0 109.479 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.8 m -108.36 139.79 42.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.96 143.19 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.83 151.08 51.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.943 0.897 . . . . 0.0 108.599 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -133.27 101.93 5.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -98.01 123.28 41.96 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.729 -0.607 . . . . 0.0 110.791 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -82.34 108.44 15.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.238 0.615 . . . . 0.0 110.077 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.66 -23.9 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.744 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -62.18 -46.17 90.15 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.3 -32.54 58.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.478 0.711 . . . . 0.0 110.558 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -128.53 70.19 79.73 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.574 0.75 . . . . 0.0 112.411 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.64 -59.35 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.505 2.137 . . . . 0.0 112.923 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.18 -42.22 1.62 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.345 1.926 . . . . 0.0 115.296 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -28.15 65.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.871 0.835 . . . . 0.0 112.854 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -70.01 -65.21 1.17 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.196 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -47.25 -40.18 27.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.247 2.631 . . . . 0.0 113.192 175.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -49.42 -38.3 28.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.937 0.789 . . . . 0.0 112.242 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -111.3 26.24 10.88 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.347 0.659 . . . . 0.0 110.68 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.4 37.65 25.75 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.14 1.352 . . . . 0.0 113.336 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.4 mt -78.84 99.71 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 117.808 0.804 . . . . 0.0 109.087 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -79.8 -19.16 49.22 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.837 1.255 . . . . 0.0 112.897 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.78 174.35 35.14 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.31 157.5 59.73 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 125.474 1.51 . . . . 0.0 108.122 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.68 142.48 67.64 Favored 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.541 1.229 . . . . 0.0 110.523 -0.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -142.85 127.51 18.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.72 118.57 37.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.466 1.506 . . . . 0.0 109.234 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -110.66 118.31 35.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.44 107.36 19.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -102.17 126.95 49.27 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 111.465 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.49 102.02 10.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.48 57.45 3.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.758 1.223 . . . . 0.0 111.712 -177.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.81 -23.65 4.93 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.44 -0.645 . . . . 0.0 113.836 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -79.76 108.93 13.71 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.759 1.279 . . . . 0.0 109.005 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.67 111.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -44.42 22.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.366 0.666 . . . . 0.0 109.639 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.13 161.33 31.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 78.4 p -135.23 132.28 37.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.395 1.078 . . . . 0.0 109.166 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -120.54 117.99 29.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -93.71 132.75 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.09 163.64 39.39 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.635 0.636 . . . . 0.0 111.778 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.35 167.94 15.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.14 0.576 . . . . 0.0 110.416 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.54 166.61 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.972 1.309 . . . . 0.0 107.723 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 76.8 p -82.42 161.49 22.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.225 0.536 . . . . 0.0 110.799 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -48.82 -51.88 27.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.019 . . . . 0.0 109.813 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.55 -54.78 28.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -55.28 -46.39 76.18 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.089 0.445 . . . . 0.0 110.337 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.06 -48.39 81.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.543 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -55.93 -50.13 71.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.319 0.509 . . . . 0.0 110.026 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -56.99 -50.79 71.62 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.836 0.289 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.32 -53.79 45.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 0.0 110.364 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.85 -54.93 41.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.562 0.345 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -52.2 -51.7 56.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.262 0.625 . . . . 0.0 110.674 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -38.04 69.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.669 0.788 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -78.07 -48.64 15.61 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.16 -0.338 . . . . 0.0 110.36 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -58.55 -44.77 89.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.161 0.584 . . . . 0.0 109.911 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 122.837 0.455 . . . . 0.0 109.775 177.768 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -74.02 74.07 1.69 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.175 0.512 . . . . 0.0 111.236 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -108.64 39.53 1.98 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 mt -96.31 139.37 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 110.344 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -86.44 110.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.178 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -81.12 94.04 6.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.106 0.962 . . . . 0.0 108.799 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.78 163.82 22.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.986 0.914 . . . . 0.0 112.614 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.1 p -133.56 163.55 29.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.457 1.903 . . . . 0.0 106.226 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.07 -43.38 73.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.13 -46.31 90.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.962 1.305 . . . . 0.0 111.877 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -78.31 -27.54 47.24 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.096 -0.377 . . . . 0.0 111.385 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -36.65 -54.62 0.88 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 113.426 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.9 -63.73 1.06 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 110.902 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -56.1 -41.74 75.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.845 0.858 . . . . 0.0 112.787 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -58.42 2.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.11 -52.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.881 0.872 . . . . 0.0 112.712 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.24 -29.99 71.06 Favored 'General case' 0 C--O 1.228 -0.047 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -105.52 40.54 1.53 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.52 123.99 8.64 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.551 0.74 . . . . 0.0 112.425 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -76.9 61.43 1.93 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.632 1.173 . . . . 0.0 109.306 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.19 -116.97 3.86 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.28 122.17 45.11 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.196 0.998 . . . . 0.0 109.052 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -116.42 125.58 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 C-N-CA 124.619 1.168 . . . . 0.0 108.354 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 tp -103.28 103.34 13.35 Favored 'General case' 0 CA--C 1.524 -0.051 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -89.8 114.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 122.745 0.418 . . . . 0.0 110.103 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.36 114.3 26.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -82.86 128.1 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -142.43 174.61 10.47 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.446 0.698 . . . . 0.0 111.787 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.46 153.89 41.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.41 1.484 . . . . 0.0 107.789 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -52.32 -43.67 64.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.663 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -80.08 -2.45 44.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.952 1.301 . . . . 0.0 112.957 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -79.4 78.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.896 -1.128 . . . . 0.0 111.004 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.78 -57.36 3.43 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 123.74 0.686 . . . . 0.0 112.185 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.81 -32.46 77.08 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.071 2.514 . . . . 0.0 113.413 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.18 -47.64 76.27 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.62 -40.4 87.44 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -58.59 -46.11 87.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.96 0.504 . . . . 0.0 110.876 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 pt -76.27 -26.82 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 118.746 0.703 . . . . 0.0 112.555 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.91 -56.66 1.11 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.97 -38.89 94.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.217 1.944 . . . . 0.0 112.09 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 mt -62.11 -48.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -56.5 -42.55 78.54 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.24 -0.288 . . . . 0.0 110.261 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.05 -48.83 80.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.188 0.595 . . . . 0.0 109.703 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -59.35 -49.6 77.21 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.795 -0.565 . . . . 0.0 109.832 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.6 mm -52.04 -45.95 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.631 0.773 . . . . 0.0 110.047 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.82 -33.42 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.691 0.397 . . . . 0.0 111.38 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.47 -54.86 5.71 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.88 -44.53 49.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.909 . . . . 0.0 112.516 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -103.77 22.1 15.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.962 0.905 . . . . 0.0 112.189 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -51.17 135.97 24.89 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.876 0.762 . . . . 0.0 111.17 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 -23.51 3.61 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.97 -0.906 . . . . 0.0 113.531 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.38 -45.3 5.89 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.015 1.408 . . . . 0.0 110.251 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.02 121.69 40.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 m -93.54 103.67 15.84 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.94 137.96 20.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.08 48.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.053 0.941 . . . . 0.0 109.434 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -128.92 136.48 50.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -127.33 122.08 32.78 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.194 0.597 . . . . 0.0 110.19 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -83.07 106.34 14.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.047 0.539 . . . . 0.0 110.077 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.84 -26.22 36.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -58.51 -51.02 71.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.327 0.967 . . . . 0.0 109.298 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -78.83 -31.06 45.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.795 0.838 . . . . 0.0 111.089 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.82 66.46 20.79 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.446 0.698 . . . . 0.0 111.479 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.8 -54.24 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.379 2.053 . . . . 0.0 112.156 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.41 -46.44 1.45 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.881 1.705 . . . . 0.0 114.3 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -38.86 60.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.938 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.4 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.691 179.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -50.87 -45.32 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.167 1.911 . . . . 0.0 112.695 174.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -52.51 -46.49 66.69 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.095 0.861 . . . . 0.0 111.858 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -95.03 19.15 10.82 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.316 0.507 . . . . 0.0 111.648 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.95 46.07 14.39 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 125.741 1.639 . . . . 0.0 112.996 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.19 135.66 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 117.999 0.899 . . . . 0.0 110.372 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -37.77 37.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.952 0.901 . . . . 0.0 111.164 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.9 -161.07 25.92 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.3 pt -139.32 141.22 28.37 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 119.055 1.427 . . . . 0.0 108.943 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.1 147.6 89.03 Favored 'Cis proline' 0 N--CA 1.454 -0.795 0 CA-C-N 119.555 0.877 . . . . 0.0 110.296 -1.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -145.76 127.12 14.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt -102.51 126.0 49.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.669 1.588 . . . . 0.0 108.558 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.33 120.25 38.28 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -96.64 102.06 13.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.363 0.665 . . . . 0.0 109.444 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -92.86 112.04 23.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.704 1.602 . . . . 0.0 110.116 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -96.73 112.32 24.12 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.82 39.07 13.27 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.572 0.749 . . . . 0.0 111.462 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.05 -16.92 55.94 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.514 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -90.23 121.02 31.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 119.342 1.571 . . . . 0.0 109.631 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.87 106.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -43.29 22.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.444 0.698 . . . . 0.0 110.297 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.82 168.75 25.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 p -144.72 163.2 34.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -142.14 121.63 13.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.14 132.44 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.457 1.103 . . . . 0.0 108.783 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.49 167.19 42.38 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.598 0.555 . . . . 0.0 111.963 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.48 169.07 14.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.15 0.58 . . . . 0.0 110.266 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.69 165.64 27.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.037 1.335 . . . . 0.0 107.66 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.9 p -75.69 159.24 31.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.171 0.51 . . . . 0.0 110.417 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -52.77 -46.88 67.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.578 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.46 -57.01 19.09 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -54.05 -46.06 71.83 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.311 0.555 . . . . 0.0 111.199 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.39 -51.25 70.28 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.239 -0.288 . . . . 0.0 110.683 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.46 -48.53 74.36 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 122.18 -0.325 . . . . 0.0 110.621 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.83 -51.71 68.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.938 0.895 . . . . 0.0 110.036 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.36 -54.02 46.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.872 0.869 . . . . 0.0 109.962 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.86 -50.03 74.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.209 -0.307 . . . . 0.0 110.758 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.72 -52.23 63.13 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.543 0.337 . . . . 0.0 110.156 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -36.06 71.76 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.047 0.939 . . . . 0.0 111.947 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.32 -50.88 10.98 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 117.918 0.326 . . . . 0.0 110.46 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.05 -42.3 97.09 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.107 -0.371 . . . . 0.0 110.575 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 124.717 1.207 . . . . 0.0 111.727 179.292 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.1 p . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t70 5.21 -85.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 129.158 2.983 . . . . 0.0 114.725 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -133.5 44.62 2.77 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.803 1.241 . . . . 0.0 107.696 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 mt -103.47 134.83 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.479 0.712 . . . . 0.0 110.94 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.5 mm -89.12 117.36 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 122.207 1.003 . . . . 0.0 110.6 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -89.07 78.26 7.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.81 163.87 18.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.747 1.219 . . . . 0.0 112.937 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.1 p -132.67 163.56 28.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.259 1.824 . . . . 0.0 106.707 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.74 -42.7 71.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.267 0.485 . . . . 0.0 109.743 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.57 -45.69 92.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.898 1.279 . . . . 0.0 111.709 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 p -78.71 -26.24 44.82 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.161 -0.337 . . . . 0.0 111.321 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -37.81 -57.06 1.04 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.532 1.533 . . . . 0.0 113.581 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -54.79 -61.69 2.15 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.703 0.763 . . . . 0.0 110.394 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -52.26 -42.58 63.78 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.201 1.4 . . . . 0.0 113.326 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -57.48 2.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.961 0.504 . . . . 0.0 112.068 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.92 -51.01 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.061 0.944 . . . . 0.0 112.536 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.7 -36.11 82.69 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.215 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -96.79 32.64 2.04 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.826 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.67 114.74 1.65 Allowed 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.178 0.899 . . . . 0.0 111.601 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -79.09 62.59 3.54 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.99 -136.43 8.32 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.68 120.25 40.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.647 1.179 . . . . 0.0 108.722 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mt -111.98 125.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.444 1.097 . . . . 0.0 108.299 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -104.16 100.48 10.22 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.94 112.7 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.44 0.296 . . . . 0.0 110.424 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -89.35 108.06 19.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -79.93 120.23 23.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -137.25 173.19 11.95 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.38 151.27 50.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.675 1.19 . . . . 0.0 108.357 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -55.04 -38.39 67.92 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.281 0.491 . . . . 0.0 111.357 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -83.81 -2.48 56.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.679 1.192 . . . . 0.0 112.488 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.47 80.79 5.81 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.948 -1.095 . . . . 0.0 110.685 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.89 -58.51 2.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.184 0.897 . . . . 0.0 111.919 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -54.0 -39.58 84.57 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.428 2.752 . . . . 0.0 113.543 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -62.28 -48.7 78.72 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.76 -44.24 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.4 ttm -52.53 -41.46 63.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.08 0.952 . . . . 0.0 111.135 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -82.58 -11.97 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.775 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.75 -49.85 54.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.321 1.419 . . . . 0.0 113.423 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.31 -37.96 94.14 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.315 2.01 . . . . 0.0 111.764 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.56 -48.98 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.52 -41.78 73.61 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.271 0.487 . . . . 0.0 110.236 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.47 -52.54 64.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.158 0.583 . . . . 0.0 109.92 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -54.06 -47.68 71.38 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.951 0.5 . . . . 0.0 109.698 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.1 -49.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.73 0.812 . . . . 0.0 109.539 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.7 67.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.073 0.397 . . . . 0.0 110.064 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.3 -50.83 64.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.197 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -60.39 -44.24 95.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.722 1.209 . . . . 0.0 113.62 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.52 29.19 3.38 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.713 1.205 . . . . 0.0 112.131 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.82 132.28 18.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.83 -0.543 . . . . 0.0 111.418 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.13 -19.04 2.34 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.123 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -98.84 -41.75 7.49 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.429 1.614 . . . . 0.0 109.859 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -129.97 119.74 23.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.542 0.737 . . . . 0.0 109.415 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -95.41 103.73 15.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.24 144.06 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.317 -0.864 . . . . 0.0 109.8 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.12 151.75 45.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.113 0.965 . . . . 0.0 109.134 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -133.15 103.86 6.22 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.69 119.57 37.66 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.754 0.421 . . . . 0.0 110.606 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -80.15 106.35 12.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.83 -27.46 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.753 0.821 . . . . 0.0 112.519 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.05 -51.3 70.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.215 0.916 . . . . 0.0 109.385 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -74.63 -32.15 62.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.71 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -118.85 67.49 7.99 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 111.661 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.92 -44.72 9.48 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 110.714 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.18 -37.7 4.59 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.291 1.424 . . . . 0.0 114.325 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.22 -24.34 64.01 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.255 1.027 . . . . 0.0 113.087 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -59.32 14.21 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -62.14 -33.8 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.216 1.944 . . . . 0.0 112.377 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -48.44 -42.87 33.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.082 0.856 . . . . 0.0 111.922 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -113.19 26.48 10.42 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.365 0.666 . . . . 0.0 110.715 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 36.82 52.64 1.49 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 126.035 1.778 . . . . 0.0 112.9 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.44 115.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 118.039 0.919 . . . . 0.0 109.297 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.58 -43.99 21.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.962 0.505 . . . . 0.0 111.027 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.91 142.85 7.95 Favored Glycine 0 C--N 1.335 0.524 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.4 pt -94.45 148.13 34.45 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.183 0.993 . . . . 0.0 110.288 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.97 134.43 31.75 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.991 1.033 . . . . 0.0 110.739 -0.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.79 115.76 28.28 Favored 'General case' 0 C--N 1.338 0.074 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.51 94.06 6.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 9.4 mp -91.91 114.92 27.59 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.067 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -94.09 100.12 12.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.564 0.746 . . . . 0.0 109.511 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -94.22 111.0 22.7 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.231 1.412 . . . . 0.0 110.672 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -93.86 106.94 18.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 44.22 52.72 7.0 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.282 0.633 . . . . 0.0 111.875 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.94 -19.91 8.99 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.314 -0.714 . . . . 0.0 114.426 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -84.35 114.37 21.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.1 1.45 . . . . 0.0 110.022 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.0 107.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.26 24.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.64 0.776 . . . . 0.0 109.959 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.27 159.92 31.97 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.458 0.703 . . . . 0.0 109.243 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.6 p -134.11 103.77 5.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.439 1.096 . . . . 0.0 108.461 -179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -87.59 114.95 24.67 Favored 'General case' 0 C--N 1.338 0.087 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.84 119.22 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.05 166.38 26.92 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 121.579 0.544 . . . . 0.0 112.436 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.64 165.19 25.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.463 0.705 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -163.89 168.62 19.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.214 1.806 . . . . 0.0 106.994 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.3 p -97.1 178.44 5.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.11 0.957 . . . . 0.0 112.235 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -64.67 161.77 17.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.7 4.69 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.31 -56.23 22.85 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 tp -56.9 -46.02 82.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.056 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.14 -49.76 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.335 -0.228 . . . . 0.0 111.072 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.86 -50.31 73.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.269 0.628 . . . . 0.0 109.831 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -52.97 -52.24 58.8 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -58.96 -47.1 86.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.694 0.397 . . . . 0.0 110.957 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.9 -54.15 48.21 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.075 0.95 . . . . 0.0 111.983 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -77.89 -50.86 11.39 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 122.209 -0.307 . . . . 0.0 110.739 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 72.5 mt -59.73 -42.87 94.12 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.137 0.575 . . . . 0.0 109.956 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.525 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.659 0.266 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 35.13 -92.28 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.682 2.393 . . . . 0.0 113.406 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -139.71 33.37 2.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.632 0.773 . . . . 0.0 110.529 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.7 mt -83.26 136.21 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 122.07 -0.394 . . . . 0.0 111.303 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 mm -90.28 120.66 39.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.958 0.885 . . . . 0.0 111.121 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -92.86 80.93 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.1 0.96 . . . . 0.0 108.871 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.55 164.97 15.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.879 1.272 . . . . 0.0 112.784 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.6 p -132.9 163.04 30.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.71 -44.24 69.65 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.157 0.503 . . . . 0.0 109.659 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.9 -45.85 92.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.997 1.319 . . . . 0.0 111.963 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.35 -26.76 46.86 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.109 -0.37 . . . . 0.0 111.487 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -36.93 -54.76 0.93 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.737 1.615 . . . . 0.0 113.391 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.7 -62.85 1.39 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.447 0.641 . . . . 0.0 110.999 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -38.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.685 0.794 . . . . 0.0 113.108 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -59.21 2.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 -52.89 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.532 1.133 . . . . 0.0 112.439 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.31 -28.61 69.83 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.329 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -103.26 35.2 2.63 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.813 0.445 . . . . 0.0 110.112 174.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.84 115.63 1.34 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.83 69.79 2.52 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.63 -107.63 1.55 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.902 1.239 . . . . 0.0 110.051 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.35 125.79 29.93 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.625 0.77 . . . . 0.0 110.079 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -117.51 127.31 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.505 1.122 . . . . 0.0 108.792 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -104.83 102.83 12.36 Favored 'General case' 0 C--N 1.337 0.055 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 t -89.76 113.23 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -93.46 111.5 23.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -80.91 124.9 29.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -139.69 -179.57 6.0 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.861 0.864 . . . . 0.0 111.191 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.871 1.268 . . . . 0.0 108.935 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.43 -22.55 54.74 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.502 1.121 . . . . 0.0 113.226 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -99.44 -2.04 37.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.712 1.205 . . . . 0.0 111.727 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.9 t -79.96 83.92 5.8 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.021 -1.049 . . . . 0.0 112.29 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.83 -59.88 3.12 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 123.828 0.728 . . . . 0.0 112.437 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -32.79 67.64 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 0.0 113.337 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.13 -45.88 83.24 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.57 -42.25 96.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -57.51 -44.79 85.3 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.964 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 pt -77.5 -21.19 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.922 0.783 . . . . 0.0 112.734 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.52 -57.31 2.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.702 1.137 . . . . 0.0 114.024 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -56.09 -40.08 87.16 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.161 1.907 . . . . 0.0 112.055 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.73 -50.61 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.2 -44.13 83.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.132 0.573 . . . . 0.0 110.682 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.94 -51.85 67.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.636 0.775 . . . . 0.0 110.002 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.56 -51.43 65.27 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.536 0.734 . . . . 0.0 109.221 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.51 -47.67 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.34 75.42 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.198 0.453 . . . . 0.0 110.946 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.61 -43.15 81.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.82 -54.89 15.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.342 1.057 . . . . 0.0 112.476 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -82.57 23.46 0.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.401 1.08 . . . . 0.0 111.038 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.23 101.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.823 1.649 . . . . 0.0 110.276 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.45 -21.53 16.87 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.629 1.109 . . . . 0.0 111.446 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -99.6 -35.67 9.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.707 1.203 . . . . 0.0 110.236 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -142.09 139.43 32.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.22 1.008 . . . . 0.0 109.447 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -109.51 105.33 14.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -80.09 140.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.6 150.35 49.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.69 0.796 . . . . 0.0 109.459 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -131.19 103.06 6.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.884 1.274 . . . . 0.0 108.101 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -98.32 119.78 37.6 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 121.815 -0.553 . . . . 0.0 110.407 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -81.89 108.82 15.71 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.04 -25.01 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.32 0.648 . . . . 0.0 111.894 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.1 -47.68 81.8 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.294 0.952 . . . . 0.0 108.542 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -71.99 -32.82 67.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -124.32 69.52 51.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.506 0.722 . . . . 0.0 112.638 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.21 -50.78 12.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.332 2.021 . . . . 0.0 111.897 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.54 -42.45 3.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.705 1.621 . . . . 0.0 114.989 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.63 64.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.289 1.045 . . . . 0.0 112.85 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.37 -62.37 6.07 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.65 -42.34 47.8 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.799 1.666 . . . . 0.0 111.376 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -47.03 -44.74 20.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.276 0.63 . . . . 0.0 111.866 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -106.52 24.86 11.92 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.96 47.04 26.14 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.892 0.758 . . . . 0.0 113.045 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.1 mm -80.23 77.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -79.16 -5.29 53.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.543 0.737 . . . . 0.0 111.583 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.6 171.34 40.04 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.572 -2.211 . . . . 0.0 107.572 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.6 pt -148.83 152.69 37.69 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.235 1.414 . . . . 0.0 107.421 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.53 142.66 68.0 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 CA-C-N 120.651 1.268 . . . . 0.0 110.029 -0.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -137.31 114.96 11.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.9 mt -95.24 127.8 41.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.089 1.356 . . . . 0.0 108.941 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.73 119.02 32.42 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.0 tp -97.16 104.02 16.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.037 0.535 . . . . 0.0 109.655 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -93.33 106.43 18.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.799 1.639 . . . . 0.0 109.823 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -93.17 114.55 27.07 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.39 47.11 17.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.098 0.959 . . . . 0.0 110.972 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.64 -14.49 30.09 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.092 -0.838 . . . . 0.0 114.723 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -94.92 122.5 37.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.218 1.509 . . . . 0.0 110.157 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.78 106.3 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.29 -43.47 23.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.635 0.774 . . . . 0.0 109.755 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.41 169.12 23.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.4 p -139.46 164.93 28.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.28 116.72 6.13 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.76 133.73 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.16 163.94 39.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.57 0.605 . . . . 0.0 111.674 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 167.57 16.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.277 0.631 . . . . 0.0 110.815 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.01 167.61 24.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.989 1.316 . . . . 0.0 108.074 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.4 p -79.5 165.97 22.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.318 0.58 . . . . 0.0 111.29 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -56.19 -45.24 79.88 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.46 -57.66 18.67 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.854 0.74 . . . . 0.0 111.432 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -57.68 -40.95 80.58 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.684 0.742 . . . . 0.0 110.701 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.64 -50.8 71.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.978 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -53.16 -51.3 62.48 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.482 0.583 . . . . 0.0 110.19 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.72 -53.28 54.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.572 0.749 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -54.29 -52.48 61.31 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.711 0.804 . . . . 0.0 110.491 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.7 mt -58.12 -52.47 65.42 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.61 0.364 . . . . 0.0 110.584 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -54.12 -52.86 59.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.668 0.787 . . . . 0.0 109.68 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.54 -40.72 68.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.585 0.754 . . . . 0.0 111.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -78.23 -48.12 16.47 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 122.326 -0.234 . . . . 0.0 111.168 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.6 mt -57.22 -46.24 83.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.515 0.726 . . . . 0.0 109.3 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.123 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 111.3 0.111 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -67.13 103.62 1.24 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.625 0.37 . . . . 0.0 110.881 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -122.78 35.43 4.88 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mt -84.58 138.32 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.127 0.571 . . . . 0.0 111.088 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.79 113.6 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.378 0.671 . . . . 0.0 110.808 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -84.36 99.43 10.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.396 1.078 . . . . 0.0 109.28 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.73 171.19 11.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.202 1.001 . . . . 0.0 111.481 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.7 p -137.37 166.43 23.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -52.81 -41.95 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.287 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.63 -47.93 79.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.642 1.177 . . . . 0.0 111.904 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.37 -26.41 46.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -35.14 -54.16 0.61 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.368 1.467 . . . . 0.0 113.898 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.02 -65.47 0.57 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.523 0.677 . . . . 0.0 111.013 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -56.46 -37.5 70.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.166 0.987 . . . . 0.0 112.746 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.39 -60.72 1.95 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.87 -50.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 112.479 -173.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.07 -32.5 74.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.078 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -98.8 27.59 4.83 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.512 0.325 . . . . 0.0 110.872 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.89 73.22 0.26 Allowed 'General case' 0 C--N 1.343 0.291 0 O-C-N 121.522 -0.736 . . . . 0.0 111.863 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -68.09 73.49 0.2 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.373 1.069 . . . . 0.0 109.991 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.24 -121.05 0.99 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.66 120.0 7.87 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mt -116.85 124.24 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.09 1.356 . . . . 0.0 108.14 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.1 tp -100.95 102.68 13.75 Favored 'General case' 0 C--O 1.228 -0.051 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.57 113.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 122.657 0.383 . . . . 0.0 110.426 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.48 109.54 21.73 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.528 1.131 . . . . 0.0 108.634 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -79.97 122.04 26.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -136.81 178.65 6.91 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.583 1.153 . . . . 0.0 111.063 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.02 154.26 36.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.858 1.663 . . . . 0.0 108.004 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -54.56 -40.51 68.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.295 0.952 . . . . 0.0 112.035 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -79.34 -2.43 41.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 112.968 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -79.41 78.58 5.91 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.901 -1.124 . . . . 0.0 111.55 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.61 3.63 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.772 0.701 . . . . 0.0 112.206 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.26 -34.42 79.56 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.902 2.401 . . . . 0.0 113.239 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -63.67 -46.34 86.02 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.07 -46.75 87.47 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.8 mtp -55.07 -43.83 74.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.569 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.37 -20.71 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.916 0.78 . . . . 0.0 112.97 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.15 -52.65 9.4 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.977 1.262 . . . . 0.0 114.238 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -52.9 -41.14 72.87 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.493 2.129 . . . . 0.0 112.143 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -62.92 -49.58 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.96 -42.28 72.16 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -62.5 -45.82 91.25 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 110.176 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -59.24 -46.92 87.19 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.717 -0.614 . . . . 0.0 109.775 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.67 -48.4 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -43.39 64.7 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.381 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.82 -63.46 1.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.448 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -45.41 -47.11 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.956 1.302 . . . . 0.0 113.618 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -95.09 21.54 7.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.023 0.929 . . . . 0.0 112.295 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.59 130.92 17.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.435 1.016 . . . . 0.0 110.302 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.09 -18.18 4.3 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.209 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -99.29 -39.39 8.45 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.821 1.31 . . . . 0.0 109.768 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.74 136.62 32.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.232 1.013 . . . . 0.0 108.361 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.4 m -102.23 107.46 18.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.0 135.89 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.23 154.3 51.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.534 0.733 . . . . 0.0 109.323 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.36 144.77 51.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.206 1.402 . . . . 0.0 108.707 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.9 tt -134.37 129.42 35.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.38 100.89 12.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -57.09 -30.1 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -61.77 -46.1 91.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.27 0.941 . . . . 0.0 109.966 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -88.58 -19.33 26.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.365 1.466 . . . . 0.0 111.771 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -127.24 55.52 15.61 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.413 1.485 . . . . 0.0 109.946 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.25 -42.67 21.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.722 2.281 . . . . 0.0 112.295 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.47 -33.68 4.52 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.578 1.085 . . . . 0.0 113.827 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.4 -55.66 28.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 119.286 0.948 . . . . 0.0 112.407 -179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -51.52 -41.83 58.57 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 113.496 177.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -45.65 -46.55 14.68 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.511 0.724 . . . . 0.0 112.574 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -108.03 16.53 23.31 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.2 0.6 . . . . 0.0 111.197 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 46.46 47.22 17.21 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 125.195 1.379 . . . . 0.0 111.216 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.3 mm -51.61 115.78 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 117.5 0.65 . . . . 0.0 109.838 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.02 -28.54 43.32 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.279 1.032 . . . . 0.0 112.07 -173.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.14 -167.78 35.42 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt -146.76 151.02 41.36 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.95 143.36 74.0 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.328 1.153 . . . . 0.0 110.204 -0.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 m -139.69 126.01 20.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.57 116.14 31.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 108.948 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -110.13 119.33 38.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.3 tp -94.55 106.3 18.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -101.23 128.94 47.13 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 125.352 1.461 . . . . 0.0 111.707 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -113.11 102.04 10.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.34 58.38 3.04 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.056 1.342 . . . . 0.0 111.738 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.84 -24.13 4.69 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.504 -0.609 . . . . 0.0 113.784 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -79.78 109.12 13.89 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.664 1.232 . . . . 0.0 109.239 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.04 111.32 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.71 23.61 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.429 0.692 . . . . 0.0 109.746 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.24 161.13 33.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.5 p -135.59 135.41 40.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.401 1.08 . . . . 0.0 109.157 -179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 127.97 49.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.74 129.19 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.17 173.72 44.98 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.053 0.835 . . . . 0.0 111.43 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.02 171.35 13.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.34 -0.506 . . . . 0.0 110.221 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -164.3 164.46 22.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.528 1.531 . . . . 0.0 107.617 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.2 p -73.9 161.17 30.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.124 0.488 . . . . 0.0 110.764 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.43 -42.93 78.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.89 -58.65 13.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.33 -45.49 69.09 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.265 0.532 . . . . 0.0 110.872 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.5 tp -59.8 -52.06 67.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -55.83 -46.94 78.02 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.111 -0.368 . . . . 0.0 110.893 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.95 -52.86 63.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.901 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -53.79 -53.14 56.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.223 1.009 . . . . 0.0 110.219 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.96 -50.32 74.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.402 0.281 . . . . 0.0 110.685 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.36 -49.83 71.26 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.491 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.551 0.741 . . . . 0.0 111.521 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -77.65 -46.38 22.17 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 122.151 -0.343 . . . . 0.0 110.923 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.6 mt -62.3 -43.77 98.06 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 125.606 1.562 . . . . 0.0 108.501 178.089 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -73.88 90.33 1.91 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -113.61 36.89 3.42 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 mt -100.82 138.19 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 111.507 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -92.83 118.55 38.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 110.542 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -87.74 101.3 13.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.24 1.016 . . . . 0.0 109.292 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.94 168.34 12.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.549 1.14 . . . . 0.0 112.593 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -135.43 162.12 33.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.83 -43.83 69.74 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.78 -46.24 91.25 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.968 1.307 . . . . 0.0 112.014 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.27 -26.46 47.17 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.028 -0.42 . . . . 0.0 111.467 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -35.97 -54.12 0.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.745 1.618 . . . . 0.0 113.633 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -55.34 -62.3 1.76 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.939 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -59.03 -40.3 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.281 0.632 . . . . 0.0 112.44 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.19 -58.38 3.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -80.74 -52.35 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.885 0.874 . . . . 0.0 112.349 -173.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -63.36 -26.13 68.61 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.635 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -103.09 36.12 2.33 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.078 0.551 . . . . 0.0 109.859 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.4 136.36 4.17 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -72.74 75.62 1.12 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.208 1.003 . . . . 0.0 108.74 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.89 -74.64 1.57 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -136.12 121.46 19.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.888 0.844 . . . . 0.0 109.857 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.68 132.03 69.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 C-N-CA 124.316 1.046 . . . . 0.0 108.531 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.84 100.92 9.3 Favored 'General case' 0 C--O 1.229 -0.025 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.16 117.64 33.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 122.661 0.385 . . . . 0.0 110.75 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -97.43 109.39 22.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.882 1.273 . . . . 0.0 108.882 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -82.43 124.18 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -142.38 172.83 12.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 147.98 40.23 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.293 1.437 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -54.92 -35.87 64.64 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.177 0.591 . . . . 0.0 112.033 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -84.81 -5.67 59.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.954 0.902 . . . . 0.0 112.358 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.85 82.01 6.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.063 -1.023 . . . . 0.0 110.728 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.76 -57.51 3.37 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 123.941 0.782 . . . . 0.0 111.983 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.51 -34.36 81.81 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.148 2.565 . . . . 0.0 113.435 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.76 -49.57 67.91 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -58.98 -39.98 83.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.5 ttp -58.52 -47.69 83.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.203 0.601 . . . . 0.0 110.426 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.2 pt -75.83 -25.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.626 -0.702 . . . . 0.0 112.659 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -58.02 1.16 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.13 -40.63 83.63 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.192 1.928 . . . . 0.0 111.521 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.0 mt -58.97 -49.97 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.77 -42.52 75.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.889 0.313 . . . . 0.0 110.46 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -59.9 -53.66 55.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -45.89 75.47 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.62 -0.675 . . . . 0.0 110.392 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -57.07 -48.62 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.017 0.527 . . . . 0.0 109.648 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.63 76.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.557 0.743 . . . . 0.0 110.27 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.52 -56.73 13.71 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.57 -51.0 40.02 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.992 1.317 . . . . 0.0 112.028 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -96.98 23.7 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.797 0.839 . . . . 0.0 112.525 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -54.89 128.93 35.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.028 . . . . 0.0 110.461 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.51 -16.99 21.94 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.298 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.52 -42.72 6.8 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.674 1.237 . . . . 0.0 109.365 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -134.11 119.25 18.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.807 1.243 . . . . 0.0 107.648 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.8 m -86.24 102.78 14.25 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.63 139.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.55 154.59 49.8 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.19 145.17 51.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.136 1.374 . . . . 0.0 108.489 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.19 123.39 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -84.53 109.38 17.89 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -62.8 -31.54 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.38 -52.72 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.998 0.817 . . . . 0.0 110.069 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.82 -30.82 65.9 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.826 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -117.64 71.14 7.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.935 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.94 -53.98 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.716 2.277 . . . . 0.0 112.597 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.71 -45.81 2.08 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.38 1.467 . . . . 0.0 114.358 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.55 65.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.4 1.08 . . . . 0.0 113.356 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.41 -66.34 1.07 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.842 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -58.88 -42.9 48.01 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 121.228 1.474 . . . . 0.0 111.106 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -50.35 -46.09 55.5 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.452 0.569 . . . . 0.0 111.692 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -100.32 24.62 8.55 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.38 41.8 24.97 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.07 0.843 . . . . 0.0 113.584 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.5 mm -76.82 76.36 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.18 -4.48 50.71 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.34 0.656 . . . . 0.0 111.451 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.45 171.44 40.72 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt -147.99 152.15 39.59 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.93 1.292 . . . . 0.0 107.54 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.19 146.27 80.5 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.365 1.166 . . . . 0.0 110.042 -1.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.0 m -137.82 123.54 19.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.6 mt -108.58 112.64 25.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.727 1.611 . . . . 0.0 109.173 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.1 mp -104.86 122.28 45.43 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -96.55 99.75 11.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.787 0.835 . . . . 0.0 109.278 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -89.55 107.36 19.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.862 1.665 . . . . 0.0 109.708 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -92.49 112.2 24.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 174.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.23 45.7 9.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.297 1.039 . . . . 0.0 111.083 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.2 -13.58 56.89 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.125 -0.82 . . . . 0.0 115.077 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -95.44 121.38 37.06 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.151 1.476 . . . . 0.0 109.967 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -62.89 102.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.0 -41.76 25.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.867 0.867 . . . . 0.0 110.976 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.11 159.16 42.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.2 p -138.54 131.13 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.262 1.025 . . . . 0.0 109.299 -178.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -120.27 117.68 28.46 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.35 134.06 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 163.65 39.46 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.663 0.649 . . . . 0.0 111.864 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.34 169.12 14.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.395 0.678 . . . . 0.0 110.488 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.61 168.66 21.41 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.627 1.171 . . . . 0.0 108.531 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 149.47 33.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.747 1.219 . . . . 0.0 110.609 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.47 -49.18 65.18 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.173 0.589 . . . . 0.0 111.252 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.77 42.14 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -58.67 -43.17 89.8 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.97 0.508 . . . . 0.0 110.418 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.3 -50.55 73.19 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -54.63 -49.94 69.33 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 122.045 -0.409 . . . . 0.0 110.503 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.46 -52.79 63.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.08 0.952 . . . . 0.0 110.095 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.27 -53.76 49.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.671 0.788 . . . . 0.0 110.19 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.12 -49.95 75.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.624 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.97 -51.36 64.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 117.968 0.349 . . . . 0.0 110.138 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.31 -36.41 71.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.791 0.837 . . . . 0.0 111.894 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -77.7 -46.01 23.16 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 121.988 -0.445 . . . . 0.0 109.855 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.26 -46.48 88.41 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 123.062 0.545 . . . . 0.0 109.624 177.571 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.5 p . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -73.94 100.51 3.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.11 -0.369 . . . . 0.0 110.172 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -120.43 33.36 5.62 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.3 mt -85.58 138.31 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.136 0.574 . . . . 0.0 111.166 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.57 119.99 41.1 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.283 0.563 . . . . 0.0 110.365 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -88.94 103.55 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.444 1.097 . . . . 0.0 109.34 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.22 164.99 14.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.612 1.165 . . . . 0.0 113.206 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.4 p -136.07 162.21 33.53 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.65 -44.14 69.38 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.331 0.514 . . . . 0.0 109.939 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.23 -46.24 90.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.925 1.29 . . . . 0.0 112.096 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.6 p -78.56 -26.17 45.56 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.085 -0.385 . . . . 0.0 111.482 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -36.98 -54.43 0.95 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.015 1.726 . . . . 0.0 114.125 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -52.69 -60.2 3.55 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.521 -0.737 . . . . 0.0 111.159 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.53 97.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.592 0.757 . . . . 0.0 112.335 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -27.01 50.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.8 -62.55 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 124.017 0.927 . . . . 0.0 111.746 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.86 -35.81 77.56 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 121.949 -0.47 . . . . 0.0 111.444 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -91.11 5.72 47.85 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 119.222 -0.418 . . . . 0.0 112.124 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.49 98.0 3.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.755 1.161 . . . . 0.0 111.13 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -73.6 69.48 1.26 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.13 -160.44 27.43 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.15 119.16 38.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.805 0.802 . . . . 0.0 109.124 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.46 139.25 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 126.147 1.779 . . . . 0.0 107.793 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.97 99.35 6.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 t -90.92 114.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -91.59 107.58 19.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.159 0.983 . . . . 0.0 108.404 174.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -79.72 120.41 23.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -136.49 179.46 6.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.968 0.907 . . . . 0.0 110.868 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.69 36.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.275 1.03 . . . . 0.0 109.652 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -56.25 -26.33 51.14 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.775 1.23 . . . . 0.0 112.333 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -93.75 -8.22 41.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.526 1.131 . . . . 0.0 112.483 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.74 82.88 5.77 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.992 -1.067 . . . . 0.0 112.903 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.42 -58.23 4.69 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.571 0.605 . . . . 0.0 112.469 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -53.16 -32.28 58.98 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.2 2.6 . . . . 0.0 113.236 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.7 m -65.45 -43.85 89.08 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -63.24 -41.78 99.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 50.9 ttp -55.11 -47.73 74.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.618 0.367 . . . . 0.0 110.83 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.54 -26.92 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.14 -56.66 1.18 Allowed Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -57.44 -35.94 98.81 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.183 1.922 . . . . 0.0 111.953 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.0 mt -64.73 -49.45 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.5 mt -54.51 -42.22 70.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.799 0.272 . . . . 0.0 110.473 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -61.83 -51.46 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -52.69 -47.96 66.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.934 -0.478 . . . . 0.0 109.863 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.12 -48.58 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.39 0.676 . . . . 0.0 109.421 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 -43.21 65.44 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.182 0.593 . . . . 0.0 110.05 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.12 -61.65 1.82 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.751 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -53.14 -48.4 67.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.113 0.965 . . . . 0.0 112.397 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -88.7 13.52 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 0.0 112.248 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -55.08 116.5 2.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.906 1.23 . . . . 0.0 109.729 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.66 -26.79 18.61 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.798 0.713 . . . . 0.0 111.585 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -99.19 -42.15 7.17 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.681 0.793 . . . . 0.0 109.765 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -129.08 141.34 51.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.296 1.038 . . . . 0.0 109.956 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -108.59 96.81 6.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -78.92 136.42 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.213 -0.929 . . . . 0.0 108.534 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 157.44 46.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.937 0.895 . . . . 0.0 109.249 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -131.97 146.52 52.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.279 1.432 . . . . 0.0 108.789 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -138.45 124.98 20.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -86.97 108.55 18.87 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 pt -65.43 -23.56 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.16 -45.36 93.75 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.132 0.878 . . . . 0.0 108.794 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -77.49 -35.18 53.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.371 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -123.03 69.13 37.3 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.986 0.914 . . . . 0.0 111.51 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.24 -55.86 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.102 1.868 . . . . 0.0 112.19 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.3 -40.65 2.68 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.782 1.658 . . . . 0.0 114.691 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.55 -33.7 68.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.092 -0.652 . . . . 0.0 112.494 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -64.58 -65.07 2.17 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.581 178.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -48.21 -42.99 32.6 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.783 2.322 . . . . 0.0 112.786 174.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? -49.84 -42.38 47.22 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.942 0.792 . . . . 0.0 112.027 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -103.82 25.3 10.01 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.043 0.383 . . . . 0.0 111.502 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.77 46.32 48.27 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.432 1.015 . . . . 0.0 113.172 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.8 mt -94.27 105.96 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -30.04 40.84 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.659 0.784 . . . . 0.0 112.431 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.97 -179.14 26.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 pt -143.02 159.31 56.68 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.63 1.572 . . . . 0.0 108.347 -178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.44 141.37 57.48 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 120.727 1.295 . . . . 0.0 110.308 -0.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 m -141.07 125.72 17.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.51 107.37 17.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.274 1.43 . . . . 0.0 109.516 -174.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -95.79 116.13 28.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.5 99.9 12.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -92.91 112.33 24.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.225 1.41 . . . . 0.0 108.949 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.29 118.2 36.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 43.38 31.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.607 0.763 . . . . 0.0 109.524 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.88 -0.98 33.95 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.816 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -102.5 125.1 49.1 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.602 1.701 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.0 t -61.34 104.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.32 22.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.674 0.79 . . . . 0.0 110.067 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.67 156.45 34.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.09 0.556 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 77.0 p -132.07 112.45 12.35 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.673 1.189 . . . . 0.0 109.025 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -98.73 110.85 23.39 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.59 131.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.29 162.69 38.46 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.744 0.688 . . . . 0.0 111.996 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.43 170.06 12.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.223 0.609 . . . . 0.0 110.442 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -164.54 163.75 21.89 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.027 1.331 . . . . 0.0 108.002 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.9 p -73.79 163.08 28.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.124 0.487 . . . . 0.0 110.817 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.41 -44.63 76.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.36 -54.52 36.49 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -56.65 -44.47 81.34 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.272 0.536 . . . . 0.0 110.404 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.79 -53.87 52.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -54.82 -46.28 74.52 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.142 0.428 . . . . 0.0 110.835 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.03 -53.72 54.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.528 0.731 . . . . 0.0 110.057 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.64 -53.09 59.33 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.148 0.979 . . . . 0.0 110.421 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.21 -50.62 72.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.674 0.389 . . . . 0.0 110.305 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.3 -51.71 65.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.612 0.365 . . . . 0.0 110.288 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.91 -37.79 69.39 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.658 0.783 . . . . 0.0 111.928 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -77.88 -46.89 20.07 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.0 mt -58.77 -44.64 90.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.066 0.546 . . . . 0.0 109.719 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 122.998 0.519 . . . . 0.0 109.636 177.556 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.2 t70 3.54 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 129.173 2.989 . . . . 0.0 114.501 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -135.8 45.12 2.44 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 mt -105.86 133.02 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.023 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mt -86.94 146.03 6.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -115.52 100.1 7.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.1 163.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.636 1.174 . . . . 0.0 113.209 -173.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.2 p -135.57 163.89 29.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.512 1.925 . . . . 0.0 106.288 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -54.39 -45.91 72.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 109.89 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.21 -44.56 92.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.184 1.394 . . . . 0.0 112.049 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -78.61 -31.61 47.11 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.203 -0.311 . . . . 0.0 111.227 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -32.66 -55.07 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.215 1.806 . . . . 0.0 115.048 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -54.67 -62.55 1.58 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.455 -0.778 . . . . 0.0 111.438 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -63.52 -42.48 98.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.969 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.13 -37.85 66.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.505 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.46 -65.21 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.749 0.82 . . . . 0.0 112.382 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.09 -36.2 72.51 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -92.63 8.49 38.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.5 -0.762 . . . . 0.0 113.018 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.08 169.36 18.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 120.595 1.543 . . . . 0.0 112.08 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -119.02 166.45 12.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.49 -139.77 25.21 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.3 123.82 30.92 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.661 0.73 . . . . 0.0 110.208 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mt -111.36 129.9 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.99 1.316 . . . . 0.0 107.724 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.06 102.46 10.67 Favored 'General case' 0 C--O 1.228 -0.057 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.92 115.69 32.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.521 0.329 . . . . 0.0 110.692 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.45 110.55 22.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.527 1.131 . . . . 0.0 109.073 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -82.14 123.9 29.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -138.07 173.8 11.24 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.421 0.688 . . . . 0.0 111.55 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.96 151.42 38.59 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 125.207 1.403 . . . . 0.0 107.734 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.75 -38.12 66.78 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.777 0.717 . . . . 0.0 112.354 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -80.05 -4.7 53.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.128 0.971 . . . . 0.0 112.911 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.0 t -79.46 82.03 5.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 120.906 -1.121 . . . . 0.0 111.193 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.92 -57.95 4.5 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.429 0.538 . . . . 0.0 112.269 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.21 -32.23 49.41 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.386 2.724 . . . . 0.0 113.481 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.39 -41.01 98.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -63.61 -41.63 98.29 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 92.5 mmm -60.35 -45.06 94.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.535 -0.269 . . . . 0.0 110.981 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.21 -27.66 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.605 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -57.38 1.26 Allowed Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.26 -37.45 95.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.069 1.846 . . . . 0.0 111.66 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mt -62.11 -48.95 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.64 -43.92 76.68 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -60.51 -51.91 67.43 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.113 -0.367 . . . . 0.0 110.732 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -54.45 -50.99 66.38 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.92 -46.95 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.747 0.819 . . . . 0.0 109.937 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -43.44 71.61 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.12 -55.95 12.03 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.378 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.66 -45.45 63.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.285 1.034 . . . . 0.0 112.858 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -98.15 22.38 9.57 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.216 1.007 . . . . 0.0 111.426 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -52.9 131.34 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.514 1.052 . . . . 0.0 110.512 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.13 -20.75 11.87 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.081 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.18 -48.47 4.83 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.735 1.267 . . . . 0.0 109.268 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.59 122.51 39.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.495 1.118 . . . . 0.0 109.156 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.9 m -92.78 101.58 13.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -78.91 139.57 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.97 157.94 44.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.867 0.867 . . . . 0.0 108.918 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.67 147.81 51.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.155 1.782 . . . . 0.0 108.085 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -139.11 125.61 20.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -87.37 109.04 19.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.2 -24.88 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.74 -50.22 74.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.452 1.024 . . . . 0.0 108.847 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -75.53 -26.71 58.29 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.001 0.92 . . . . 0.0 111.185 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -127.47 69.35 75.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.405 0.682 . . . . 0.0 111.939 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.55 -59.57 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.428 2.085 . . . . 0.0 112.94 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.93 -41.0 2.46 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.064 1.792 . . . . 0.0 115.233 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -26.9 66.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.026 -0.69 . . . . 0.0 112.717 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.31 -64.94 1.02 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.083 0.856 . . . . 0.0 110.463 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_exo -47.44 -39.07 28.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.283 2.656 . . . . 0.0 112.971 175.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -47.7 -36.18 10.86 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.602 0.637 . . . . 0.0 112.59 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -117.42 28.66 8.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.073 0.549 . . . . 0.0 110.667 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.43 35.48 44.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.734 1.159 . . . . 0.0 113.467 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.51 82.45 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.655 -0.909 . . . . 0.0 109.265 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -79.46 -5.57 55.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.6 0.76 . . . . 0.0 112.771 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.05 166.4 31.48 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt -144.83 156.61 55.6 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.507 1.523 . . . . 0.0 107.854 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.12 145.2 75.04 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 120.573 1.24 . . . . 0.0 109.927 -1.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.3 m -139.96 127.58 21.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -110.4 108.18 18.12 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.126 1.37 . . . . 0.0 109.686 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -96.45 118.16 32.38 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -97.0 99.51 11.04 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.426 0.69 . . . . 0.0 109.379 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -91.23 105.34 17.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.734 1.613 . . . . 0.0 109.991 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -89.73 113.81 25.39 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 173.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 44.87 52.7 7.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.424 1.089 . . . . 0.0 110.864 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.3 -12.75 12.35 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.915 -0.936 . . . . 0.0 115.035 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -94.73 121.74 36.62 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.571 1.685 . . . . 0.0 110.254 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.12 106.25 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.64 22.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.632 0.773 . . . . 0.0 109.824 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.84 158.51 35.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.249 0.62 . . . . 0.0 109.657 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.7 p -131.97 112.17 12.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.869 1.267 . . . . 0.0 108.653 -179.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -98.79 111.51 23.87 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -91.0 130.51 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.24 163.78 34.71 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.084 0.85 . . . . 0.0 111.896 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.62 167.22 22.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 110.246 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.06 166.81 27.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.566 1.146 . . . . 0.0 108.544 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.0 p -83.21 161.71 21.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.022 0.439 . . . . 0.0 110.526 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -52.98 -42.85 65.92 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.524 0.73 . . . . 0.0 110.519 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.79 -54.39 37.94 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -55.36 -46.05 76.48 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.348 -0.501 . . . . 0.0 109.979 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.5 tp -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -53.63 -49.88 66.91 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.607 0.639 . . . . 0.0 111.107 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -57.76 -50.96 71.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.94 -52.6 60.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.506 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.69 -52.11 66.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.037 0.535 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.11 -52.7 60.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.646 0.379 . . . . 0.0 110.292 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.74 -39.5 71.23 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.767 0.827 . . . . 0.0 112.003 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.85 -47.08 19.66 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.218 -0.301 . . . . 0.0 110.554 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -57.98 -47.6 82.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.176 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -63.74 104.84 0.72 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.526 0.73 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -124.56 36.11 4.67 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.9 mt -87.0 140.06 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.424 0.69 . . . . 0.0 111.215 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -90.97 114.53 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.326 0.65 . . . . 0.0 110.422 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -85.59 102.4 13.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 0.0 109.946 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.96 163.16 14.1 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.035 1.334 . . . . 0.0 113.19 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.0 p -130.74 159.74 36.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.189 2.196 . . . . 0.0 106.228 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.24 -45.6 68.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.35 -47.46 75.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.92 1.288 . . . . 0.0 111.626 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -78.23 -26.07 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -37.24 -51.87 1.04 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 114.092 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.87 -62.95 1.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.574 0.702 . . . . 0.0 111.019 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -57.65 -39.21 76.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.918 0.887 . . . . 0.0 112.32 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -55.58 4.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.91 -53.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.235 1.014 . . . . 0.0 112.959 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.01 -37.74 86.02 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.991 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -97.61 29.62 3.25 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.109 174.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.81 119.54 5.1 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.221 0.919 . . . . 0.0 111.985 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -79.85 60.18 3.38 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.55 -143.86 13.65 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.24 117.24 33.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.349 1.46 . . . . 0.0 108.767 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.87 125.33 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.543 1.137 . . . . 0.0 108.219 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 tp -102.31 101.91 12.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.4 t -86.57 118.62 33.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -97.73 116.5 30.07 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.575 0.75 . . . . 0.0 109.053 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -90.81 121.35 32.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -135.39 178.65 6.87 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.936 0.895 . . . . 0.0 111.584 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.72 150.6 33.44 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 125.413 1.485 . . . . 0.0 108.327 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -55.75 -37.27 68.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.891 0.876 . . . . 0.0 112.386 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -83.33 -5.43 59.14 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.139 0.976 . . . . 0.0 112.54 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.59 81.69 5.81 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 120.958 -1.089 . . . . 0.0 111.684 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.81 -57.49 3.41 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.811 0.72 . . . . 0.0 112.362 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -52.59 -36.96 73.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.999 2.466 . . . . 0.0 113.31 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.0 m -64.01 -47.75 79.05 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -57.85 -43.22 85.75 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.2 mtm -61.0 -44.89 96.76 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.598 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -74.67 -27.51 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.359 0.981 . . . . 0.0 112.507 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.43 -58.16 1.03 Allowed Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.99 -37.42 96.14 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.495 2.13 . . . . 0.0 112.324 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.8 mt -62.4 -51.13 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.4 mt -55.09 -42.05 72.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.17 0.188 . . . . 0.0 110.598 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.67 -51.74 68.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 109.727 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.22 -44.75 84.01 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.866 -0.521 . . . . 0.0 110.274 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.4 mm -58.33 -46.78 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.548 0.739 . . . . 0.0 109.287 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -45.46 66.9 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.79 -59.12 5.31 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -48.81 -48.04 41.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -94.02 15.09 17.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.243 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.47 1.032 . . . . 0.0 111.491 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.25 -28.47 2.58 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.819 1.199 . . . . 0.0 110.242 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -99.47 -38.2 8.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.28 1.032 . . . . 0.0 109.987 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 tp -135.11 141.32 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.8 m -108.03 104.82 14.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -79.11 137.74 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.7 156.17 48.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.863 0.865 . . . . 0.0 108.786 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -132.64 146.21 51.7 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.476 1.51 . . . . 0.0 109.908 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.42 126.17 19.29 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.421 0.688 . . . . 0.0 109.394 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -87.17 109.31 19.37 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.88 -24.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.99 0.516 . . . . 0.0 111.719 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.51 -46.39 90.29 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.261 0.937 . . . . 0.0 108.898 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -77.66 -35.72 52.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -121.79 69.15 25.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.28 1.032 . . . . 0.0 111.139 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.32 -56.33 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.473 2.115 . . . . 0.0 112.787 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.62 -45.6 1.02 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.092 1.806 . . . . 0.0 114.597 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -37.23 31.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.307 1.043 . . . . 0.0 113.078 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.04 -66.44 1.49 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.396 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.63 -36.84 91.21 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.72 1.613 . . . . 0.0 111.22 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -51.56 -45.99 63.24 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.349 0.977 . . . . 0.0 110.71 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -98.68 28.65 4.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.35 0.26 . . . . 0.0 111.683 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.15 46.87 3.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.769 1.652 . . . . 0.0 114.052 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.59 135.75 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.663 -0.904 . . . . 0.0 110.439 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -46.37 9.38 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.889 1.276 . . . . 0.0 109.818 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.99 167.16 37.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.55 152.64 44.8 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 125.376 1.47 . . . . 0.0 109.376 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.67 142.0 65.22 Favored 'Cis proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.219 1.114 . . . . 0.0 110.562 -0.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 144.46 47.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.0 mt -128.64 101.46 6.16 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 mp -104.97 120.71 42.12 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -95.47 105.01 16.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.842 0.857 . . . . 0.0 109.495 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -97.62 110.54 23.08 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.835 1.654 . . . . 0.0 110.057 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -93.88 105.18 17.21 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 173.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 46.29 51.83 11.06 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.669 0.747 . . . . 0.0 111.272 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.9 -19.96 7.03 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.247 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.59 111.22 16.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.061 1.43 . . . . 0.0 109.623 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.49 102.79 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.68 -43.28 23.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.047 0.939 . . . . 0.0 110.956 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.57 154.36 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.142 0.577 . . . . 0.0 109.524 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.8 p -136.75 116.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.473 1.109 . . . . 0.0 109.453 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -108.46 136.26 48.38 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.62 128.16 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.57 168.15 35.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.789 0.709 . . . . 0.0 111.394 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.39 168.05 20.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.198 0.599 . . . . 0.0 110.552 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -162.24 164.07 27.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 107.779 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.67 161.26 30.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -56.72 -43.67 80.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.1 -58.33 14.23 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -53.13 -45.93 68.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 110.945 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.75 -51.38 70.0 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.388 -0.195 . . . . 0.0 110.73 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -56.64 -47.66 79.24 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.132 0.424 . . . . 0.0 110.688 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.73 -52.37 65.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.661 0.784 . . . . 0.0 109.757 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -54.87 -55.4 30.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.997 0.919 . . . . 0.0 110.319 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -57.3 -48.61 78.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.136 -0.352 . . . . 0.0 110.792 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.57 -51.48 68.43 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.577 0.351 . . . . 0.0 110.243 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.26 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.975 0.91 . . . . 0.0 111.972 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -78.17 -50.06 12.66 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 117.847 0.294 . . . . 0.0 110.367 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.9 mt -63.38 -42.97 98.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.444 . . . . 0.0 110.514 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.136 0 C-N-CA 124.703 1.201 . . . . 0.0 111.703 179.359 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.624 0.726 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.85 68.68 1.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.106 0.962 . . . . 0.0 109.354 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -123.6 50.42 1.6 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.1 mt -108.17 137.42 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.922 1.289 . . . . 0.0 108.809 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 mt -85.73 146.92 5.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -117.29 99.38 6.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.81 164.36 14.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.476 1.111 . . . . 0.0 113.306 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.1 p -134.98 162.69 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.228 1.811 . . . . 0.0 106.417 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.64 -44.59 77.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.403 0.547 . . . . 0.0 109.615 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.53 -44.71 89.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.976 1.31 . . . . 0.0 111.893 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.58 -32.71 47.82 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.159 -0.338 . . . . 0.0 111.222 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -32.15 -53.32 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.028 2.131 . . . . 0.0 115.315 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.99 -61.61 2.19 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 110.983 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -43.54 98.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.736 0.815 . . . . 0.0 112.307 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -31.07 53.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.261 -0.876 . . . . 0.0 113.273 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.35 -61.63 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.975 0.91 . . . . 0.0 111.382 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.22 -36.13 74.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -92.54 6.17 48.17 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.99 99.85 9.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 120.427 1.467 . . . . 0.0 111.618 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -71.85 74.46 0.87 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.29 -165.5 32.11 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.53 110.06 21.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.326 1.05 . . . . 0.0 108.325 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.29 127.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.926 1.29 . . . . 0.0 108.714 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.39 103.0 12.36 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.8 t -90.49 118.48 35.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.46 108.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.913 1.285 . . . . 0.0 108.442 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.72 121.81 25.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -137.54 179.48 6.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.919 0.887 . . . . 0.0 111.696 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.6 30.22 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.325 1.45 . . . . 0.0 109.55 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -51.74 -37.12 49.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.84 0.745 . . . . 0.0 112.203 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -85.63 -4.56 59.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.053 0.941 . . . . 0.0 113.03 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -79.42 79.86 5.83 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.934 -1.104 . . . . 0.0 111.111 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.28 -59.91 2.1 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 123.904 0.764 . . . . 0.0 112.693 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.87 -29.07 51.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.402 2.735 . . . . 0.0 113.937 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.75 -42.47 99.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.408 -0.807 . . . . 0.0 109.227 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -66.12 -35.58 80.88 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.8 mtt -62.27 -44.64 96.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.26 -25.54 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 118.772 -0.632 . . . . 0.0 112.435 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.31 -57.88 1.31 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.03 -38.17 96.58 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.812 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mt -60.84 -50.32 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -55.71 -43.95 76.99 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.808 0.443 . . . . 0.0 110.303 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.92 -51.58 68.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.477 0.656 . . . . 0.0 110.354 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -54.73 -48.72 72.18 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.68 -47.61 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 122.827 0.451 . . . . 0.0 109.824 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.71 -44.94 66.66 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.4 0.545 . . . . 0.0 110.495 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -68.13 -57.77 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.755 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -52.19 -43.06 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 113.515 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.07 16.85 19.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.244 1.018 . . . . 0.0 111.674 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.26 134.33 33.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.353 0.979 . . . . 0.0 110.25 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -25.5 6.7 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.705 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -98.84 -41.1 7.79 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.782 1.291 . . . . 0.0 109.689 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -131.19 140.03 49.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.541 1.137 . . . . 0.0 109.743 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -109.56 106.1 15.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.87 135.66 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.67 156.75 47.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.739 0.816 . . . . 0.0 109.115 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.897 1.679 . . . . 0.0 107.403 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.6 123.83 19.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -86.79 108.48 18.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.22 -25.81 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 111.933 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -62.41 -45.86 91.22 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.584 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.8 70.12 72.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.26 -56.22 2.94 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.425 2.083 . . . . 0.0 112.857 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.98 -40.85 2.44 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.059 1.79 . . . . 0.0 115.625 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 -22.01 66.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.836 0.818 . . . . 0.0 112.98 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.6 -61.98 1.03 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.452 178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -48.42 -39.85 36.2 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.132 2.555 . . . . 0.0 112.274 175.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -45.78 -34.1 3.48 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -124.28 29.71 6.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.883 0.473 . . . . 0.0 110.602 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.17 37.94 31.71 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.867 1.222 . . . . 0.0 113.26 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.9 mt -80.53 85.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -86.13 -4.91 59.27 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.517 0.727 . . . . 0.0 112.224 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.26 166.74 30.09 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 pt -146.71 156.88 48.31 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.902 1.681 . . . . 0.0 107.285 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.03 141.11 54.59 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 121.027 1.403 . . . . 0.0 109.99 -0.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.6 m -139.45 121.86 16.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 mt -100.75 127.62 47.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.393 1.477 . . . . 0.0 108.943 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.2 119.36 34.46 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.31 102.87 14.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -94.84 120.7 35.5 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.685 1.594 . . . . 0.0 110.018 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -106.33 116.03 31.22 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.0 47.54 23.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.519 0.676 . . . . 0.0 109.927 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.24 -7.22 8.44 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.774 -1.014 . . . . 0.0 115.454 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -96.17 126.83 41.66 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 119.592 1.696 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.68 107.26 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.58 -44.14 21.64 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.366 0.667 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.36 167.84 25.0 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.7 p -142.65 165.99 25.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -150.67 120.59 7.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.83 131.64 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.22 164.86 36.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.947 0.784 . . . . 0.0 111.598 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.96 167.11 22.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.157 0.583 . . . . 0.0 110.256 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -161.38 162.85 30.86 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.911 1.284 . . . . 0.0 108.254 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.8 p -73.95 164.14 27.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.363 0.601 . . . . 0.0 111.487 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -53.29 -49.28 67.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.17 -55.21 30.55 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.69 -47.61 73.44 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 117.542 0.671 . . . . 0.0 110.671 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 tp -59.8 -49.58 77.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -53.29 -50.85 64.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.64 0.376 . . . . 0.0 110.875 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -60.14 -50.19 74.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.798 0.439 . . . . 0.0 110.47 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.37 -54.25 39.37 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.141 0.576 . . . . 0.0 109.946 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.6 mt -59.18 -49.91 76.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.269 -0.269 . . . . 0.0 110.884 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.86 -53.51 54.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 117.784 0.266 . . . . 0.0 110.306 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.98 74.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.234 1.014 . . . . 0.0 111.916 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -77.74 -42.53 33.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.258 -0.276 . . . . 0.0 110.727 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.13 -44.87 94.38 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.559 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.8 p . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.2 t70 59.06 -91.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.476 1.111 . . . . 0.0 110.614 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -139.57 20.03 2.54 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.647 1.179 . . . . 0.0 110.223 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.37 132.21 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.16 123.87 48.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 123.502 0.721 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -90.67 108.51 19.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.143 0.977 . . . . 0.0 109.469 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.6 mt -94.04 166.36 12.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.072 0.949 . . . . 0.0 112.943 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -132.5 162.24 31.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.14 -47.65 74.81 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.65 -47.62 83.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.095 1.358 . . . . 0.0 111.534 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -78.45 -25.25 45.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -35.9 -51.27 0.7 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.443 1.897 . . . . 0.0 114.91 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.53 -62.32 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.93 0.787 . . . . 0.0 110.739 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -60.36 -42.36 95.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.529 0.731 . . . . 0.0 111.643 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.59 -41.41 69.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.3 t -107.98 -63.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.487 1.115 . . . . 0.0 113.133 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.11 -37.28 74.25 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -88.36 2.29 52.87 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.52 106.82 14.7 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.638 1.563 . . . . 0.0 110.723 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -76.5 62.36 1.87 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.786 0.835 . . . . 0.0 109.345 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.75 -167.65 24.55 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.57 108.96 20.45 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.31 124.48 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 108.643 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 tp -105.39 99.48 9.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -89.37 114.66 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -89.56 105.57 17.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.52 119.96 23.23 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -134.33 -177.94 4.82 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.563 1.145 . . . . 0.0 111.2 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.59 35.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.737 1.215 . . . . 0.0 109.306 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -54.88 -28.53 51.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.519 1.128 . . . . 0.0 112.758 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -94.96 -4.63 46.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 112.387 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.1 t -79.99 83.7 5.85 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.007 -1.058 . . . . 0.0 111.583 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.7 -61.38 3.37 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.24 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.38 -36.71 31.14 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.7 2.933 . . . . 0.0 113.779 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.5 -37.99 85.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -70.27 -46.5 64.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -40.91 60.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 119.184 -0.436 . . . . 0.0 111.461 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -81.82 -10.88 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.5 -51.45 69.25 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 119.995 1.27 . . . . 0.0 113.295 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.73 -41.7 72.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.314 2.01 . . . . 0.0 111.537 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.11 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -54.31 -44.61 72.14 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -60.13 -57.27 13.54 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.007 0.523 . . . . 0.0 111.321 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -60.0 -40.81 90.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.627 -0.671 . . . . 0.0 110.719 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.81 -46.5 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.92 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.725 0.41 . . . . 0.0 110.259 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.09 -54.7 25.96 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -51.16 -46.71 62.12 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.391 1.076 . . . . 0.0 112.593 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -96.07 18.84 12.66 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.642 0.777 . . . . 0.0 111.903 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -50.67 137.02 20.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.335 0.971 . . . . 0.0 111.334 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 -26.23 5.11 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.554 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -99.1 -51.27 3.88 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.772 1.286 . . . . 0.0 109.189 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.39 132.09 56.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.663 1.185 . . . . 0.0 108.995 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -106.65 102.47 11.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.34 160.8 39.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -136.04 147.46 47.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.949 1.3 . . . . 0.0 108.351 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -140.76 125.6 18.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -87.97 108.58 19.27 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.88 -25.71 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.711 0.804 . . . . 0.0 112.178 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.41 -46.48 89.95 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.105 0.866 . . . . 0.0 108.976 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.98 -35.44 57.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.344 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -120.92 68.82 16.82 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.126 0.97 . . . . 0.0 111.313 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.59 -51.97 2.17 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.381 2.054 . . . . 0.0 112.335 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.0 -38.08 4.53 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.873 1.225 . . . . 0.0 114.305 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -31.8 71.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.954 -0.733 . . . . 0.0 112.341 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.86 -65.26 2.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.434 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_exo -49.52 -45.76 29.63 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.558 2.172 . . . . 0.0 112.438 174.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -47.61 -42.48 24.18 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -108.23 22.71 15.56 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.325 0.511 . . . . 0.0 111.673 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.44 46.19 45.42 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.366 0.984 . . . . 0.0 113.361 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.06 132.4 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.0 mtm-85 -104.86 -10.89 17.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.523 1.129 . . . . 0.0 113.108 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.47 -172.08 44.44 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.6 pt -144.24 144.91 27.5 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.604 1.202 . . . . 0.0 108.316 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.22 147.44 87.55 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.834 0.976 . . . . 0.0 110.435 -0.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 m -133.19 122.79 24.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.85 100.05 10.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.99 113.37 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -93.28 97.55 10.69 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.631 0.772 . . . . 0.0 109.646 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -86.35 106.12 17.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 108.895 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -94.45 114.16 26.13 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.97 45.65 27.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.109 0.964 . . . . 0.0 109.935 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.72 -3.19 44.76 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.629 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -101.5 122.36 43.67 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.669 1.735 . . . . 0.0 109.796 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 106.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.52 -43.18 23.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.611 0.764 . . . . 0.0 109.887 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.99 156.51 31.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.706 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.9 p -127.8 99.93 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.226 1.41 . . . . 0.0 108.389 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.07 105.53 16.56 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.33 132.7 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.83 164.89 40.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.163 0.887 . . . . 0.0 112.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.4 171.14 13.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.143 0.577 . . . . 0.0 110.235 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.33 168.07 17.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.474 1.51 . . . . 0.0 107.774 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -77.94 164.57 24.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.918 0.389 . . . . 0.0 110.467 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.45 -46.85 80.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.54 -56.34 24.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.44 -39.73 80.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.617 0.708 . . . . 0.0 110.514 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.06 -48.61 80.94 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.147 0.431 . . . . 0.0 110.127 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -56.17 -47.96 77.26 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.595 0.634 . . . . 0.0 110.665 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -57.19 -52.01 67.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.649 0.379 . . . . 0.0 110.153 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -53.66 -53.26 54.43 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 110.154 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -56.6 -52.39 65.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.761 0.424 . . . . 0.0 110.303 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.19 -52.07 62.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.916 0.325 . . . . 0.0 110.615 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.7 75.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.871 0.868 . . . . 0.0 112.287 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -78.45 -46.05 20.68 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 117.899 0.318 . . . . 0.0 110.872 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -61.23 -47.28 86.81 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.407 0.683 . . . . 0.0 109.744 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 124.606 1.162 . . . . 0.0 111.492 179.391 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.637 0.256 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -66.32 98.58 0.48 Allowed 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.298 -0.251 . . . . 0.0 110.532 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -113.28 38.58 2.83 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.56 142.36 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.385 0.674 . . . . 0.0 110.874 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -91.86 116.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-O 121.473 0.654 . . . . 0.0 110.875 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.23 101.87 11.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.524 1.129 . . . . 0.0 108.921 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.1 164.71 20.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 112.933 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.5 p -132.49 160.65 35.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 170.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -55.71 -44.24 77.27 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.742 0.701 . . . . 0.0 109.475 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.21 -47.98 83.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.848 1.259 . . . . 0.0 111.549 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.8 p -78.64 -21.79 47.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.007 -0.433 . . . . 0.0 112.105 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.95 -51.89 1.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.161 1.784 . . . . 0.0 113.729 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -51.65 -61.51 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.468 0.652 . . . . 0.0 110.681 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -60.92 -46.86 88.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.716 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -69.88 -32.21 70.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.7 -64.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.267 1.027 . . . . 0.0 111.833 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.3 -37.45 77.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.46 -0.15 . . . . 0.0 111.358 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -99.89 14.82 29.12 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.62 120.97 14.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.417 1.008 . . . . 0.0 110.528 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -78.47 56.47 1.78 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.525 0.73 . . . . 0.0 110.241 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.22 -162.03 35.66 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.67 129.98 38.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.75 138.26 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 C-N-CA 125.577 1.551 . . . . 0.0 108.622 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.2 tp -118.08 102.47 9.05 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -94.5 106.41 18.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.879 1.272 . . . . 0.0 107.923 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.22 123.94 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -138.09 177.62 7.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.606 0.762 . . . . 0.0 112.061 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.64 151.15 35.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.807 1.643 . . . . 0.0 108.126 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -54.69 -36.93 65.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.309 0.644 . . . . 0.0 111.897 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -85.12 -2.47 58.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.524 1.13 . . . . 0.0 112.745 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.2 t -79.58 80.3 5.97 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.9 -1.125 . . . . 0.0 111.411 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.61 -57.86 3.73 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 123.785 0.707 . . . . 0.0 112.001 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -53.1 -34.46 68.4 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.097 2.531 . . . . 0.0 113.484 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -64.01 -46.55 83.99 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -61.41 -41.86 97.81 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -57.43 -43.76 84.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.198 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -78.76 -26.25 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.822 0.737 . . . . 0.0 112.81 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.2 -55.09 3.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.37 -43.17 39.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.948 2.432 . . . . 0.0 112.904 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.8 -49.82 82.7 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 mt -55.74 -44.06 77.19 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -58.63 -57.68 11.89 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.524 0.73 . . . . 0.0 110.377 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -59.74 -43.08 94.38 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.773 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 mm -54.59 -44.66 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.912 0.485 . . . . 0.0 109.996 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -35.17 65.73 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.074 0.397 . . . . 0.0 111.126 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -76.48 -52.44 9.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.0 -45.12 64.42 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.953 0.901 . . . . 0.0 111.682 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -98.06 24.72 6.75 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.266 1.027 . . . . 0.0 111.522 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -54.04 129.73 35.4 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.462 1.028 . . . . 0.0 110.421 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.77 -17.47 15.6 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.305 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -99.38 -44.79 6.07 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.692 1.246 . . . . 0.0 109.56 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.4 tp -127.22 128.53 46.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.166 0.986 . . . . 0.0 109.724 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -94.94 96.03 9.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.21 136.1 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.67 150.31 49.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.17 0.988 . . . . 0.0 109.524 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -124.61 138.65 54.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.508 1.523 . . . . 0.0 107.38 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -131.06 120.4 23.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.49 110.77 18.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.9 -36.72 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.42 -46.63 89.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.0 0.818 . . . . 0.0 109.688 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.33 -30.05 65.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.244 1.017 . . . . 0.0 110.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -127.92 72.4 78.88 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.857 0.863 . . . . 0.0 111.341 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -52.79 -59.04 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.896 2.397 . . . . 0.0 113.192 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.68 -47.32 2.29 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.765 1.65 . . . . 0.0 115.171 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -28.63 68.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.03 -67.68 0.98 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.302 178.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -49.22 -45.11 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.194 1.929 . . . . 0.0 112.558 175.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -47.77 -40.86 21.86 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.359 0.527 . . . . 0.0 112.2 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -110.66 25.93 11.24 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.102 0.561 . . . . 0.0 111.847 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.82 38.78 23.74 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.237 0.922 . . . . 0.0 113.107 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.6 mm -78.35 79.86 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -85.6 -2.72 58.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.225 0.61 . . . . 0.0 111.099 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.74 165.91 33.72 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt -147.86 154.21 43.39 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 125.514 1.525 . . . . 0.0 107.729 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.36 145.15 75.42 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 120.575 1.241 . . . . 0.0 109.624 -1.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.9 m -139.38 127.87 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.02 113.03 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.302 1.441 . . . . 0.0 109.233 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.0 mp -105.87 120.18 41.09 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.66 103.83 15.82 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.13 104.98 16.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.352 1.861 . . . . 0.0 109.538 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -83.71 102.48 12.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 47.9 54.49 9.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.805 0.812 . . . . 0.0 110.925 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.59 -18.61 8.43 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-O 119.19 -0.783 . . . . 0.0 113.804 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -84.97 109.93 18.53 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.443 1.621 . . . . 0.0 109.973 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.41 105.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.73 -45.26 19.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.733 0.813 . . . . 0.0 109.949 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.66 158.56 35.67 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 53.3 p -134.26 124.99 26.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.531 1.133 . . . . 0.0 108.756 -178.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -113.77 117.88 32.74 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -95.37 129.72 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.18 164.71 35.04 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.007 0.813 . . . . 0.0 111.554 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 164.51 25.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.948 0.499 . . . . 0.0 110.116 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.86 161.51 39.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.296 1.038 . . . . 0.0 108.81 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.4 p -72.84 162.26 29.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.316 0.579 . . . . 0.0 110.589 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -56.73 -40.12 75.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.6 -54.69 35.61 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -56.77 -43.53 80.9 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.201 0.501 . . . . 0.0 110.299 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.22 -53.63 56.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -53.82 -48.15 70.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.469 0.577 . . . . 0.0 110.731 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.76 -53.16 58.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.187 0.595 . . . . 0.0 110.04 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -55.17 -52.31 63.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.598 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -57.0 -54.01 51.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.847 0.459 . . . . 0.0 110.221 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.58 -50.55 67.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.923 0.489 . . . . 0.0 110.653 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.17 76.94 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.197 0.599 . . . . 0.0 111.691 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -77.96 -49.38 14.23 Favored 'General case' 0 N--CA 1.46 0.074 0 O-C-N 122.19 -0.319 . . . . 0.0 111.048 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.4 mt -60.07 -46.03 90.93 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.214 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 177.941 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -69.72 104.79 2.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -121.39 34.14 5.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.6 mt -86.44 136.11 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.898 0.479 . . . . 0.0 111.111 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -91.93 116.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.388 0.675 . . . . 0.0 110.6 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -86.29 99.95 11.94 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.291 1.037 . . . . 0.0 109.204 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.24 166.1 16.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.139 0.976 . . . . 0.0 112.24 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p -131.09 163.37 27.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -53.97 -49.78 68.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.92 -46.19 90.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.03 1.332 . . . . 0.0 111.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.9 p -78.46 -24.75 45.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -34.57 -61.3 0.4 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 126.034 1.734 . . . . 0.0 114.052 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.68 -59.32 4.75 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.714 -0.616 . . . . 0.0 110.916 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.36 -38.15 71.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.424 0.69 . . . . 0.0 112.698 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -81.86 -57.93 3.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.405 0.622 . . . . 0.0 112.086 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.39 -55.29 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.18 1.792 . . . . 0.0 113.075 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.13 -28.67 69.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.581 -0.699 . . . . 0.0 111.898 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -88.84 8.64 28.09 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 122.079 -0.388 . . . . 0.0 111.468 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.1 81.69 0.69 Allowed 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.12 -0.987 . . . . 0.0 111.846 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -71.6 70.15 0.66 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.97 -134.35 2.93 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 106.953 -2.459 . . . . 0.0 106.953 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.61 114.66 13.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.92 0.86 . . . . 0.0 110.106 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.9 127.99 69.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.297 1.039 . . . . 0.0 108.931 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.32 101.86 11.31 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -89.86 112.14 24.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 118.099 0.409 . . . . 0.0 110.718 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.23 106.22 18.27 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.223 1.009 . . . . 0.0 108.659 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -79.69 121.56 25.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -139.24 -178.41 5.35 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.493 0.717 . . . . 0.0 111.169 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.8 151.86 34.24 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 108.495 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -53.69 -39.5 65.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.074 0.95 . . . . 0.0 111.876 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -82.23 -6.23 59.07 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.078 0.951 . . . . 0.0 112.573 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.3 t -79.43 80.61 5.78 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.059 -1.026 . . . . 0.0 111.115 -177.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.45 -58.48 2.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.29 0.948 . . . . 0.0 112.149 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.48 -38.66 89.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.331 2.687 . . . . 0.0 113.18 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -62.6 -47.58 83.18 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.83 -44.46 96.79 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.6 ttm -52.04 -41.56 62.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.919 0.888 . . . . 0.0 111.315 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -83.49 -8.71 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.57 -50.79 74.96 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.058 1.299 . . . . 0.0 113.032 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.68 -41.83 70.95 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.445 2.097 . . . . 0.0 111.516 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.96 -51.15 76.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -54.85 -43.85 73.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.112 0.414 . . . . 0.0 110.78 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.01 -53.15 60.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.272 0.558 . . . . 0.0 109.872 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.49 -47.04 73.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.895 0.478 . . . . 0.0 110.083 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.9 mm -59.12 -47.19 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.157 0.983 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.36 -42.43 66.82 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.753 0.421 . . . . 0.0 109.875 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.38 -56.64 8.86 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -50.67 -45.23 57.95 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.738 0.815 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -97.33 21.36 10.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.91 128.71 31.27 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.408 1.004 . . . . 0.0 110.109 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.55 -19.55 23.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.224 -0.765 . . . . 0.0 113.058 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -99.14 -44.29 6.33 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.658 1.229 . . . . 0.0 109.381 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -132.71 133.97 44.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.369 1.068 . . . . 0.0 108.796 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.4 m -101.44 105.74 16.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.04 139.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.99 154.89 50.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.897 0.879 . . . . 0.0 109.074 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.95 147.56 52.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.719 1.207 . . . . 0.0 108.433 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 tt -138.89 120.32 14.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -85.29 107.51 17.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.29 -24.19 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.651 0.781 . . . . 0.0 112.116 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -61.77 -46.56 89.06 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.122 0.874 . . . . 0.0 108.885 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -76.05 -35.44 59.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.277 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.42 70.13 11.87 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.377 1.071 . . . . 0.0 111.073 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.12 -54.36 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.385 2.057 . . . . 0.0 112.418 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.12 -41.42 3.75 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.941 1.258 . . . . 0.0 114.594 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.23 71.12 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.016 -0.696 . . . . 0.0 112.32 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.02 -66.81 1.33 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.641 179.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_exo -49.31 -48.49 18.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.166 1.911 . . . . 0.0 112.173 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -48.67 -48.67 39.76 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.079 0.399 . . . . 0.0 111.845 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -97.55 24.74 6.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.25 40.64 29.96 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.197 0.904 . . . . 0.0 113.184 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 mm -77.4 86.26 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -78.89 -6.09 55.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.169 0.588 . . . . 0.0 112.386 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.64 175.01 43.32 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt -146.6 152.56 45.57 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.667 1.187 . . . . 0.0 107.997 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.7 144.51 76.71 Favored 'Cis proline' 0 N--CA 1.456 -0.719 0 CA-C-N 120.543 1.23 . . . . 0.0 110.053 -0.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.5 m -136.81 123.4 20.97 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -107.21 104.27 13.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 109.704 -173.275 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.1 mp -94.09 115.77 28.12 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.5 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -87.18 109.28 19.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.956 1.302 . . . . 0.0 109.306 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -100.61 120.45 40.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.61 47.44 22.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.242 0.617 . . . . 0.0 110.274 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.81 -5.61 11.76 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.528 -1.151 . . . . 0.0 115.225 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -105.28 129.43 53.64 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.825 1.813 . . . . 0.0 110.481 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.92 107.13 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.67 -43.96 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.62 0.768 . . . . 0.0 110.046 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.53 156.28 34.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.078 0.551 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 73.7 p -129.26 110.81 12.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.856 1.262 . . . . 0.0 109.348 -178.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -98.49 110.46 23.05 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -91.29 129.68 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.34 163.9 34.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.191 0.901 . . . . 0.0 112.177 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 167.77 20.18 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 110.129 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.81 169.55 21.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.332 1.053 . . . . 0.0 109.258 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.6 p -77.54 160.16 28.8 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.782 0.433 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.11 -45.52 75.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.98 -54.05 38.04 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.02 -39.19 88.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.923 0.862 . . . . 0.0 111.148 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.98 -52.36 65.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -55.33 -45.51 76.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.898 -0.501 . . . . 0.0 111.283 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.48 -55.35 34.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 109.885 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -53.4 -51.88 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.041 0.936 . . . . 0.0 110.727 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.64 -51.73 68.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.811 0.444 . . . . 0.0 110.238 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -54.42 -51.68 64.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.807 0.443 . . . . 0.0 110.214 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.48 70.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.503 0.721 . . . . 0.0 111.843 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -78.06 -40.32 38.98 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.121 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.2 mt -62.01 -47.45 84.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.262 0 C-N-CA 123.17 0.588 . . . . 0.0 109.734 177.592 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -58.78 98.92 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.902 0.881 . . . . 0.0 112.397 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -125.03 45.12 2.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -95.56 142.76 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.895 0.878 . . . . 0.0 110.611 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.97 115.35 29.97 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-O 121.572 0.701 . . . . 0.0 111.456 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -84.56 95.77 8.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.777 1.231 . . . . 0.0 109.408 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.44 163.24 16.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.072 0.949 . . . . 0.0 113.121 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.1 p -128.17 160.67 31.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.547 1.939 . . . . 0.0 107.701 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.1 -51.55 57.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.037 0.935 . . . . 0.0 109.197 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.23 -45.15 72.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.343 1.457 . . . . 0.0 111.836 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.61 -26.69 45.4 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -34.03 -69.43 0.09 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.608 1.563 . . . . 0.0 114.968 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.74 -59.75 3.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.58 0.752 . . . . 0.0 110.295 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -51.58 -42.53 61.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.96 1.304 . . . . 0.0 113.377 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.28 -53.15 5.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.747 0.419 . . . . 0.0 111.538 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -79.66 -58.78 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.791 1.236 . . . . 0.0 113.204 -173.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.34 -32.8 73.63 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.055 -0.403 . . . . 0.0 111.579 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -81.06 -5.52 57.73 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.77 95.0 2.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 119.725 1.148 . . . . 0.0 111.763 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.02 64.87 1.97 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.9 -154.35 9.25 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.61 116.03 27.44 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.604 1.702 . . . . 0.0 109.137 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.08 134.19 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.05 101.78 9.32 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.57 114.93 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.84 107.35 19.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.847 1.259 . . . . 0.0 108.294 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -79.8 126.11 30.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -136.12 178.26 7.19 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.654 0.781 . . . . 0.0 111.734 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.8 37.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.556 1.542 . . . . 0.0 108.245 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -53.15 -35.82 60.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.998 0.919 . . . . 0.0 112.121 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -89.2 -2.37 58.47 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.999 1.319 . . . . 0.0 112.79 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.4 t -79.52 78.04 6.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.948 -1.095 . . . . 0.0 111.711 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.88 -57.78 3.36 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.659 0.647 . . . . 0.0 112.341 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -52.51 -35.7 67.47 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.227 2.618 . . . . 0.0 113.241 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.39 -45.48 92.97 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -60.76 -42.74 98.06 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 93.5 mmm -59.02 -45.84 89.68 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.164 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -76.6 -26.23 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.612 0.642 . . . . 0.0 112.592 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.57 -57.69 0.91 Allowed Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.36 -40.09 87.45 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.298 1.998 . . . . 0.0 111.835 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.2 -49.14 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 mt -56.27 -42.85 78.14 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.88 -47.5 86.09 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.12 -48.47 80.11 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.833 -0.542 . . . . 0.0 109.73 177.002 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.8 mm -55.66 -46.79 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.976 0.51 . . . . 0.0 109.9 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.06 -35.97 62.6 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.238 0.615 . . . . 0.0 110.768 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.4 -59.15 2.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -49.63 -44.19 47.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.53 1.132 . . . . 0.0 113.174 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -102.21 20.75 16.16 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.108 0.963 . . . . 0.0 111.502 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.41 125.71 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.386 0.994 . . . . 0.0 109.496 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.42 -20.09 39.81 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.58 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -99.2 -46.69 5.46 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.492 1.146 . . . . 0.0 109.362 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -127.11 124.17 38.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.715 1.206 . . . . 0.0 108.553 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.7 m -92.45 101.02 13.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -78.82 139.97 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.75 154.76 50.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.438 1.095 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -130.28 145.99 51.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.043 1.737 . . . . 0.0 107.35 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -143.94 126.79 16.27 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -86.7 106.72 17.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 109.256 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.15 -24.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.996 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -62.23 -44.41 96.62 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.419 1.009 . . . . 0.0 108.903 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -78.68 -34.47 46.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.425 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -123.4 66.37 33.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.678 1.191 . . . . 0.0 111.922 -173.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.15 -52.06 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.686 2.257 . . . . 0.0 112.94 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.07 -41.74 1.44 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.82 1.676 . . . . 0.0 114.268 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -37.21 54.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.195 0.998 . . . . 0.0 113.239 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.43 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.768 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 99.8 Cg_exo -44.9 -48.1 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.795 2.33 . . . . 0.0 113.131 173.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -48.16 -43.75 31.82 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 118.912 0.778 . . . . 0.0 112.572 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.01 25.82 11.12 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.973 0.351 . . . . 0.0 111.521 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 41.75 47.71 5.0 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.239 1.399 . . . . 0.0 112.299 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.6 mt -74.81 130.15 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -36.52 40.82 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -175.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.53 -156.74 12.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.8 pt -144.98 151.35 48.71 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 124.377 1.071 . . . . 0.0 108.343 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.4 141.94 71.51 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.936 1.013 . . . . 0.0 109.582 -2.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -139.32 130.38 26.5 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.45 103.64 12.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.047 1.339 . . . . 0.0 109.35 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.6 mp -91.83 115.53 28.14 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.57 12.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -87.11 104.3 16.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.468 1.507 . . . . 0.0 108.205 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -94.84 113.52 25.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.4 43.31 29.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.503 1.521 . . . . 0.0 111.335 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.06 -12.67 53.12 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.992 -0.893 . . . . 0.0 113.77 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -99.46 128.73 45.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.459 1.629 . . . . 0.0 110.7 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.77 105.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.92 -43.61 21.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.171 0.588 . . . . 0.0 110.462 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.11 154.35 32.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.087 0.555 . . . . 0.0 109.681 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 32.7 p -128.19 99.12 5.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.787 1.235 . . . . 0.0 107.776 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -86.0 110.12 19.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 130.18 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.53 163.39 38.43 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.83 0.729 . . . . 0.0 112.382 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 168.95 17.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.271 0.629 . . . . 0.0 110.309 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -163.64 164.22 24.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.088 1.355 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.1 p -72.32 161.95 30.13 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.37 -43.27 79.04 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.86 22.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -53.54 -44.86 69.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.269 0.534 . . . . 0.0 110.572 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.3 tp -58.74 -52.51 65.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -56.09 -46.77 78.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.571 0.623 . . . . 0.0 110.799 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.27 -52.89 62.83 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.501 0.32 . . . . 0.0 110.256 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -54.36 -53.19 57.34 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.859 0.864 . . . . 0.0 110.476 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.5 mt -56.69 -52.95 62.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.877 0.471 . . . . 0.0 110.29 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.35 -51.84 61.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.718 0.407 . . . . 0.0 110.318 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.38 74.75 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.313 0.645 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.02 -38.25 45.16 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.147 -0.346 . . . . 0.0 110.797 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -62.56 -48.54 79.05 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 123.156 0.582 . . . . 0.0 109.643 177.401 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp . . . . . 0 C--O 1.232 0.152 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm -114.6 109.79 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.004 2.522 . . . . 0.0 108.983 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.2 mm -88.55 119.47 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.916 0.865 . . . . 0.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -84.95 75.26 10.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.79 162.59 10.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.649 1.18 . . . . 0.0 112.667 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 p -131.88 162.77 29.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -52.96 -44.03 66.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 110.025 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.31 -45.17 95.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.041 1.337 . . . . 0.0 112.057 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.44 -27.95 46.56 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.172 -0.33 . . . . 0.0 111.356 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -36.22 -51.74 0.78 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.653 1.581 . . . . 0.0 114.031 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.54 -64.86 0.73 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.651 0.738 . . . . 0.0 111.275 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.38 -37.93 82.29 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.263 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -55.54 4.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.305 -0.247 . . . . 0.0 111.537 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 -57.38 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 112.518 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.04 -36.75 80.41 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.384 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 122.463 0.305 . . . . 0.0 111.19 175.895 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mt -117.62 119.0 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.511 1.124 . . . . 0.0 108.734 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -93.0 102.98 15.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.1 t -87.29 113.84 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -93.54 117.68 30.39 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.36 121.68 32.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -134.01 179.49 6.22 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.639 1.176 . . . . 0.0 110.752 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.4 39.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.459 1.104 . . . . 0.0 108.907 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -53.12 -36.29 60.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.129 0.972 . . . . 0.0 111.53 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -86.8 -4.68 59.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.857 1.263 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.8 t -79.99 80.22 6.42 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.92 -1.113 . . . . 0.0 112.656 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.51 -58.51 4.0 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 123.456 0.551 . . . . 0.0 112.344 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.23 -37.01 69.54 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.219 2.613 . . . . 0.0 113.634 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.31 -44.21 97.6 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -63.99 -47.64 79.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.8 mtm -53.48 -39.52 64.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.166 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 pt -82.64 -13.21 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.227 0.921 . . . . 0.0 112.818 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -50.86 54.75 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 0.0 113.405 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.57 -44.52 46.8 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.357 2.038 . . . . 0.0 111.631 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.43 -51.24 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.85 -43.2 76.83 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.227 -0.296 . . . . 0.0 110.93 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -59.86 -52.83 63.77 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 0.0 109.888 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -55.59 -50.31 70.45 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.82 0.848 . . . . 0.0 109.938 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 mm -56.25 -50.88 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.711 0.805 . . . . 0.0 109.758 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.04 -43.41 66.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.206 0.603 . . . . 0.0 110.239 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.81 -57.63 6.66 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.588 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -47.19 -49.82 21.99 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.876 1.27 . . . . 0.0 112.973 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -91.28 14.16 15.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.253 0.621 . . . . 0.0 112.258 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 134.18 23.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.865 1.211 . . . . 0.0 111.178 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -29.26 6.95 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.494 -0.615 . . . . 0.0 111.797 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -98.98 -40.33 8.11 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.117 0.959 . . . . 0.0 109.013 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.0 tp -133.11 149.29 52.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.574 1.55 . . . . 0.0 109.072 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.6 m -124.17 147.24 48.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -121.73 152.34 25.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 119.458 1.026 . . . . 0.0 108.534 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.81 151.02 45.41 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.79 100.45 5.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.94 121.72 40.2 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.376 -0.827 . . . . 0.0 110.682 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.68 108.45 16.06 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.488 0.715 . . . . 0.0 109.759 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -65.1 -25.13 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.008 0.523 . . . . 0.0 112.288 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.42 -44.11 92.25 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.274 0.943 . . . . 0.0 108.896 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.88 -35.64 62.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.954 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -120.74 68.14 15.31 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 124.089 0.956 . . . . 0.0 111.815 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.29 -42.23 36.39 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.884 1.722 . . . . 0.0 110.22 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -37.59 6.07 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.623 1.106 . . . . 0.0 114.184 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -22.45 56.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.38 1.09 . . . . 0.0 112.965 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.64 -59.22 14.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.663 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 75.4 Cg_exo -51.09 -46.6 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.584 2.189 . . . . 0.0 112.88 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.2 mttp . . . . . 0 C--N 1.341 0.201 0 C-N-CA 123.987 0.915 . . . . 0.0 112.501 -178.351 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 132.14 17.68 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.659 1.271 . . . . 0.0 111.011 -0.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.67 145.89 31.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -129.72 100.39 5.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.87 119.87 40.51 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.37 107.5 19.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.322 0.649 . . . . 0.0 109.936 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 124.832 1.253 . . . . 0.0 109.395 179.87 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 81.1 t -62.94 102.55 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.01 -42.43 26.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.637 0.775 . . . . 0.0 110.387 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.16 153.67 28.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.3 p -132.68 114.88 14.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.155 1.382 . . . . 0.0 109.176 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -110.0 144.0 39.17 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.34 127.63 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 167.36 35.61 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.972 0.796 . . . . 0.0 111.465 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 166.43 21.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.118 0.567 . . . . 0.0 110.624 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.41 165.03 31.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.294 1.438 . . . . 0.0 107.787 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -72.38 159.24 34.34 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.006 0.431 . . . . 0.0 110.494 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.94 -42.5 80.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.25 -54.74 33.61 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -55.36 -47.1 76.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.106 0.453 . . . . 0.0 110.36 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -59.21 -50.56 73.54 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -55.21 -48.2 74.21 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.971 -0.455 . . . . 0.0 110.737 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -58.82 -53.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.205 0.602 . . . . 0.0 109.84 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.6 -53.21 40.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.145 0.978 . . . . 0.0 110.127 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.49 -51.87 68.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.521 0.328 . . . . 0.0 110.757 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -54.44 -51.9 63.5 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.78 0.264 . . . . 0.0 110.565 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.42 72.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.381 1.072 . . . . 0.0 111.942 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -78.34 -43.95 26.44 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.987 0.358 . . . . 0.0 110.63 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -62.62 -47.17 84.94 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.905 0.482 . . . . 0.0 109.781 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.203 0 C-N-CA 124.564 1.146 . . . . 0.0 111.467 179.403 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.4 mt -112.3 143.28 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 125.476 1.51 . . . . 0.0 110.269 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.21 110.89 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.452 0.644 . . . . 0.0 110.773 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.18 97.32 8.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.534 1.134 . . . . 0.0 108.519 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.7 mt -80.73 169.94 16.96 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.731 0.776 . . . . 0.0 111.676 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.3 p -137.62 161.51 36.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.45 -43.31 67.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.5 -46.61 89.27 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.265 1.426 . . . . 0.0 112.009 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.8 p -78.23 -27.45 47.71 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.086 -0.384 . . . . 0.0 111.736 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -36.71 -54.74 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.425 1.49 . . . . 0.0 113.599 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -54.83 -63.57 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.424 0.63 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.85 -37.97 69.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.965 0.906 . . . . 0.0 113.022 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.53 -61.2 1.82 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.806 0.336 . . . . 0.0 111.485 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.72 -49.42 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.484 1.114 . . . . 0.0 112.538 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.252 45.1 mt -65.18 -29.9 70.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.862 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 122.578 0.351 . . . . 0.0 110.827 173.309 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.11 124.56 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.781 1.232 . . . . 0.0 108.523 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -102.78 104.3 14.58 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.33 113.49 26.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 122.761 0.425 . . . . 0.0 110.076 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.56 107.86 19.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 108.643 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -79.96 124.49 28.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -143.14 -179.72 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 111.452 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.2 150.78 33.18 Favored 'General case' 0 C--N 1.337 0.051 0 C-N-CA 125.848 1.659 . . . . 0.0 108.54 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -52.81 -42.86 65.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.465 0.706 . . . . 0.0 111.471 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -79.38 -6.53 57.01 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.292 1.037 . . . . 0.0 112.77 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.4 t -79.72 80.86 6.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 120.918 -1.114 . . . . 0.0 111.158 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.4 -59.08 3.7 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.65 -33.31 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.422 2.748 . . . . 0.0 113.653 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.92 -50.82 38.32 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -55.34 -43.99 75.51 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 -30.85 57.78 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.495 -0.764 . . . . 0.0 112.242 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 pt -92.97 -3.03 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.604 1.093 . . . . 0.0 112.204 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 88.49 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 119.785 1.175 . . . . 0.0 110.993 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.99 -47.35 28.04 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 111.352 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.4 mt -55.13 -52.87 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.49 -40.81 83.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 122.642 0.377 . . . . 0.0 110.77 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.55 -50.31 74.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.719 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.63 -50.34 72.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.289 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.0 mm -55.21 -48.61 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.6 -47.24 70.36 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.152 0.433 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.21 -49.11 75.5 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 111.462 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.71 -49.19 76.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -91.4 27.44 1.95 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.167 0.987 . . . . 0.0 113.259 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -53.86 128.36 29.72 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -17.05 14.31 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.274 -0.737 . . . . 0.0 113.195 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -99.7 -41.85 7.11 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.648 1.224 . . . . 0.0 110.171 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -140.05 133.2 29.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.781 0.832 . . . . 0.0 109.251 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.7 m -98.71 107.95 20.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.35 134.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.53 51.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.884 0.873 . . . . 0.0 108.776 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -127.55 145.13 50.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.974 1.31 . . . . 0.0 107.959 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -134.71 118.92 17.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.41 101.51 14.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -52.0 -37.65 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.29 -47.53 85.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.883 0.765 . . . . 0.0 110.423 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -81.92 -20.3 39.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.395 1.078 . . . . 0.0 111.561 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -129.25 63.76 68.6 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.424 1.49 . . . . 0.0 108.846 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.56 -45.14 7.3 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.581 2.188 . . . . 0.0 113.746 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.49 -45.67 1.94 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.356 1.455 . . . . 0.0 115.581 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -73.09 -28.13 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.82 -57.69 15.04 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.76 -43.47 16.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.478 1.452 . . . . 0.0 111.048 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mttp . . . . . 0 C--N 1.342 0.243 0 C-N-CA 123.043 0.537 . . . . 0.0 111.503 -179.345 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 pt . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.67 143.55 71.7 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.706 1.288 . . . . 0.0 109.854 -0.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.0 m -137.59 122.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -108.43 115.96 31.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.058 1.343 . . . . 0.0 109.218 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -110.54 121.73 46.03 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp -97.99 110.04 22.69 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.456 -0.13 0 C-N-CA 125.828 1.651 . . . . 0.0 111.329 -178.323 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.9 115.42 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -46.39 17.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.665 0.786 . . . . 0.0 109.212 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.74 163.3 26.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.567 0.747 . . . . 0.0 109.252 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.447 HG22 ' HG ' ' A' ' 79' ' ' LEU . 71.9 p -136.81 134.56 37.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.481 1.112 . . . . 0.0 109.125 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -124.6 117.59 24.64 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.59 133.11 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.2 161.5 37.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.986 0.803 . . . . 0.0 111.554 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.31 167.89 13.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.114 0.566 . . . . 0.0 110.549 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.57 163.6 27.2 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.807 1.243 . . . . 0.0 108.121 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -72.68 162.74 29.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.334 0.588 . . . . 0.0 111.282 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -54.16 -46.63 72.36 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.85 22.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -53.81 -45.45 70.78 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 117.455 0.627 . . . . 0.0 110.37 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.9 tp -59.16 -51.09 71.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.35 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -53.34 -49.78 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.559 0.618 . . . . 0.0 110.46 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -57.36 -50.63 72.35 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 117.772 0.26 . . . . 0.0 110.693 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -54.39 -53.21 57.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 0.0 110.516 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -58.04 -53.02 62.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.837 0.455 . . . . 0.0 110.328 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.35 -51.49 62.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.493 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.29 68.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.696 0.798 . . . . 0.0 111.863 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -78.04 -47.53 18.2 Favored 'General case' 0 CA--C 1.526 0.039 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.29 -44.76 88.65 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.196 0.598 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 122.996 0.518 . . . . 0.0 109.612 177.647 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.5 mt -91.85 140.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.951 0.9 . . . . 0.0 109.686 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.3 mm -90.38 122.48 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 122.019 0.914 . . . . 0.0 111.188 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -95.57 83.32 3.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.17 166.01 17.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.007 1.323 . . . . 0.0 112.715 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.0 p -128.41 161.2 30.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.85 -45.02 78.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.66 -47.23 86.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.883 1.273 . . . . 0.0 111.458 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -78.2 -24.78 46.96 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.126 -0.359 . . . . 0.0 111.846 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -36.45 -50.24 0.76 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.017 1.727 . . . . 0.0 113.548 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.21 -63.76 1.06 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 110.374 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -59.47 -34.52 72.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.439 0.696 . . . . 0.0 112.072 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -83.29 -65.9 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.94 -45.49 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 112.603 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.261 46.9 mt -64.89 -30.26 71.24 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.245 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 110.726 172.639 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 110.71 -0.107 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mt -119.78 128.48 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.957 1.303 . . . . 0.0 107.802 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.53 103.11 13.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.89 110.13 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 122.663 0.385 . . . . 0.0 110.454 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.69 108.31 19.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 118.0 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -133.0 178.32 6.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.472 1.109 . . . . 0.0 112.184 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.17 154.57 35.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.127 1.371 . . . . 0.0 108.57 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.89 -26.04 58.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -92.03 -4.32 54.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.468 1.107 . . . . 0.0 112.254 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.5 t -79.66 83.37 5.64 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.93 -1.106 . . . . 0.0 112.105 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.03 -58.91 4.14 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 123.582 0.61 . . . . 0.0 112.518 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.06 -30.82 61.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.074 2.516 . . . . 0.0 113.347 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.2 m -65.47 -42.81 91.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.49 -43.08 98.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 51.5 ttp -54.27 -47.96 71.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.636 0.374 . . . . 0.0 110.675 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.2 pt -77.54 -26.56 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.848 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.92 -57.08 1.06 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.94 -36.41 96.9 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 112.003 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.93 -49.63 78.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -55.04 -42.82 73.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.77 0.428 . . . . 0.0 110.376 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.87 -48.75 80.44 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.87 -49.71 74.68 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mm -54.39 -46.27 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.979 0.912 . . . . 0.0 109.79 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.37 55.41 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.965 0.506 . . . . 0.0 111.459 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.21 -58.84 2.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -48.51 -44.55 36.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.677 1.191 . . . . 0.0 113.232 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -104.92 23.09 14.1 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.468 1.107 . . . . 0.0 111.024 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -55.32 130.1 41.07 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.027 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -19.15 21.84 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.887 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -99.37 -45.22 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.606 1.203 . . . . 0.0 109.34 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 tp -131.57 116.73 17.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.658 1.183 . . . . 0.0 108.64 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 m -87.41 109.07 19.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.24 140.5 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.29 149.07 46.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.934 0.894 . . . . 0.0 109.767 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -130.44 103.92 6.95 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -98.37 119.52 37.2 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 122.98 0.512 . . . . 0.0 109.836 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -81.21 106.64 13.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.199 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.0 -32.32 55.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 123.74 0.816 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.27 -44.62 95.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.183 0.901 . . . . 0.0 109.145 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -77.33 -35.05 55.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.261 0.624 . . . . 0.0 110.762 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.3 67.78 7.01 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.13 0.972 . . . . 0.0 111.22 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.14 -40.33 26.94 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.16 1.907 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.46 3.52 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.219 1.39 . . . . 0.0 114.459 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.59 60.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.429 1.115 . . . . 0.0 112.971 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.45 -57.39 26.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -62.92 -35.72 65.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.24 1.96 . . . . 0.0 112.441 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.1 mttp . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 118.898 0.772 . . . . 0.0 112.051 -179.411 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.9 pt . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 118.723 -0.656 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.38 129.79 16.98 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 CA-C-N 120.189 1.103 . . . . 0.0 111.34 -0.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.3 112.16 23.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.92 94.49 6.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.404 ' HG ' HG22 ' A' ' 89' ' ' THR . 9.1 mp -93.17 115.11 27.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.04 105.99 18.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 CA--C 1.529 0.142 0 C-N-CA 125.351 1.46 . . . . 0.0 111.609 -177.821 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.25 109.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.23 -43.36 23.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.926 0.891 . . . . 0.0 110.314 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.87 160.08 35.75 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.176 0.59 . . . . 0.0 109.482 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.404 HG22 ' HG ' ' A' ' 79' ' ' LEU . 61.6 p -135.64 103.87 5.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 109.152 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -90.55 120.84 31.97 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.95 103.35 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.34 161.62 13.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.486 0.565 . . . . 0.0 112.015 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 166.0 23.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.852 0.861 . . . . 0.0 111.669 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -163.84 164.35 23.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.262 1.825 . . . . 0.0 107.36 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 p -93.31 170.86 9.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.987 1.315 . . . . 0.0 113.051 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -61.87 156.28 21.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.68 -62.64 4.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -59.61 -54.69 43.55 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.81 -48.99 74.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.141 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -55.18 -47.08 75.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.558 0.343 . . . . 0.0 111.829 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.43 -47.84 80.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.059 0.544 . . . . 0.0 109.796 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -53.47 -52.49 59.33 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.22 -51.16 71.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.586 0.355 . . . . 0.0 110.648 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.04 -50.91 65.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.704 0.401 . . . . 0.0 110.774 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.84 69.47 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.237 1.015 . . . . 0.0 111.434 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -77.55 -48.15 17.69 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.0 mt -54.95 -48.4 73.23 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.307 0 C-N-CA 123.096 0.559 . . . . 0.0 109.51 176.905 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.97 136.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.949 -0.469 . . . . 0.0 111.054 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.43 115.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-O 121.545 0.688 . . . . 0.0 111.587 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -82.69 96.69 8.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.018 0.927 . . . . 0.0 108.679 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.35 158.86 21.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.125 0.964 . . . . 0.0 113.188 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -125.1 160.46 29.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.904 2.082 . . . . 0.0 106.699 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -55.95 -44.31 78.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.44 -46.97 73.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.875 1.27 . . . . 0.0 111.019 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.4 p -78.1 -28.04 48.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.229 -0.295 . . . . 0.0 111.681 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -38.08 -53.67 1.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.51 1.524 . . . . 0.0 113.673 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -54.93 -62.83 1.4 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -36.69 71.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.179 0.992 . . . . 0.0 113.319 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.25 -62.04 1.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.771 0.32 . . . . 0.0 111.294 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.65 -49.07 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.487 1.115 . . . . 0.0 112.636 -172.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.67 -30.36 71.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.619 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mttm . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 119.443 -0.313 . . . . 0.0 110.848 173.877 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mt -112.67 125.91 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.518 1.127 . . . . 0.0 108.652 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.35 104.2 14.05 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 t -91.74 114.97 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.756 0.422 . . . . 0.0 110.344 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.83 106.83 19.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.693 1.197 . . . . 0.0 107.91 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.35 121.82 25.6 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -135.21 179.28 6.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.679 1.192 . . . . 0.0 110.852 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.34 155.64 40.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.799 1.24 . . . . 0.0 108.727 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -57.5 -27.9 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.589 0.632 . . . . 0.0 112.232 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -90.07 -3.96 57.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.614 1.166 . . . . 0.0 112.452 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.2 t -79.67 80.11 6.1 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 120.936 -1.102 . . . . 0.0 112.581 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.62 -58.86 4.52 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.151 0.405 . . . . 0.0 112.156 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.72 -32.52 55.61 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.369 2.713 . . . . 0.0 113.697 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.6 m -63.34 -44.36 95.09 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.97 -43.57 98.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtt -55.62 -42.51 75.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.149 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.68 -23.26 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 112.89 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.49 -51.74 6.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.57 -43.09 60.7 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.449 2.099 . . . . 0.0 111.964 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.58 -48.65 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -56.74 -41.62 77.86 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 122.419 -0.176 . . . . 0.0 110.551 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.41 -49.65 74.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.43 -50.45 69.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 mm -56.22 -49.02 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.411 0.684 . . . . 0.0 109.733 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -43.2 67.92 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.126 0.57 . . . . 0.0 110.358 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.73 -57.19 6.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.289 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.5 -44.07 55.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.18 . . . . 0.0 112.758 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.17 21.53 12.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 111.973 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -54.67 128.14 31.25 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.566 1.075 . . . . 0.0 110.189 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -19.18 28.58 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.213 -0.771 . . . . 0.0 113.049 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -99.09 -45.39 5.94 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.668 1.234 . . . . 0.0 109.452 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -129.6 131.22 46.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.447 1.099 . . . . 0.0 108.46 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.1 m -99.4 104.07 15.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.29 138.84 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.63 47.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.863 0.865 . . . . 0.0 109.241 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -125.81 135.31 51.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -125.92 122.0 34.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -86.71 110.97 20.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.32 -29.29 45.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -63.23 -47.66 81.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -70.34 -31.17 68.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.495 1.118 . . . . 0.0 110.253 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.04 73.41 76.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 0.0 111.834 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.37 -56.05 3.06 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.616 2.211 . . . . 0.0 112.688 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.58 -48.26 1.25 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.216 1.865 . . . . 0.0 115.57 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -28.52 69.54 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.756 -0.85 . . . . 0.0 113.023 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.89 -64.41 2.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.49 -42.74 45.39 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.734 1.623 . . . . 0.0 111.22 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt . . . . . 0 C--N 1.341 0.21 0 CA-C-N 118.229 0.468 . . . . 0.0 111.765 179.812 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.46 142.19 61.77 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 CA-C-N 120.586 1.245 . . . . 0.0 110.154 -1.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 m -134.9 119.98 18.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.0 mt -105.19 116.16 31.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.543 1.537 . . . . 0.0 109.156 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.7 mp -111.22 122.26 47.4 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp -98.17 104.88 16.95 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.455 -0.196 0 C-N-CA 125.276 1.43 . . . . 0.0 110.392 -179.839 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.45 110.13 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.02 -42.42 26.55 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.798 0.839 . . . . 0.0 109.836 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.68 162.6 35.11 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.472 HG22 ' HG ' ' A' ' 79' ' ' LEU . 62.1 p -137.36 138.81 40.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.446 1.098 . . . . 0.0 109.345 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -130.47 122.26 27.35 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.73 131.14 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.34 165.46 37.7 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.066 0.841 . . . . 0.0 111.934 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.72 165.96 22.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.257 0.623 . . . . 0.0 110.443 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.18 167.92 26.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.816 1.246 . . . . 0.0 108.55 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -75.46 159.91 30.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.99 0.424 . . . . 0.0 110.55 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.61 -42.88 75.52 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.24 -56.53 24.72 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -56.41 -42.43 77.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.804 0.802 . . . . 0.0 110.721 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.6 -51.36 70.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.82 -47.69 73.75 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.726 0.694 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -55.43 -53.33 57.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.041 0.382 . . . . 0.0 110.052 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -54.17 -53.01 59.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.778 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.05 -53.39 58.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.894 0.478 . . . . 0.0 110.526 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.37 -51.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.321 0.649 . . . . 0.0 110.29 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.73 -37.35 68.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.209 0.604 . . . . 0.0 111.693 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -78.13 -46.23 21.21 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.134 -0.354 . . . . 0.0 110.665 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.46 -47.08 85.2 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 C-N-CA 123.005 0.522 . . . . 0.0 109.614 177.258 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 mt -102.38 139.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.876 0.87 . . . . 0.0 109.895 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mm -88.68 114.25 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.244 1.021 . . . . 0.0 111.175 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -87.02 76.4 9.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.183 0.993 . . . . 0.0 108.95 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.48 160.17 25.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.997 1.319 . . . . 0.0 113.632 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 p -125.18 160.45 29.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.473 1.909 . . . . 0.0 107.638 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.61 -49.88 66.87 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.74 -45.87 67.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.993 1.317 . . . . 0.0 111.591 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 p -78.33 -28.57 47.34 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -35.82 -55.23 0.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.64 1.576 . . . . 0.0 115.001 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.65 -62.29 1.75 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.715 0.769 . . . . 0.0 111.347 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -61.99 -41.77 98.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.212 0.605 . . . . 0.0 112.193 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.31 -40.47 51.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.8 t -101.15 -63.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.841 0.856 . . . . 0.0 112.151 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.62 -33.48 71.55 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.4 mttt . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.696 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mt -114.45 123.05 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.16 1.384 . . . . 0.0 108.649 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.05 103.6 13.69 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.46 113.13 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.79 109.27 20.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -79.68 126.89 31.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -134.72 177.14 8.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.392 1.077 . . . . 0.0 110.005 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.45 156.45 43.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -59.51 -27.73 66.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.347 0.521 . . . . 0.0 110.723 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.436 ' CZ3' HD11 ' A' ' 75' ' ' ILE . 52.5 p-90 -91.22 -1.77 57.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -79.85 79.03 6.41 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.864 -1.147 . . . . 0.0 111.868 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.8 -56.98 6.3 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 119.823 -0.432 . . . . 0.0 112.12 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -52.89 -34.32 65.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.254 2.636 . . . . 0.0 113.722 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.78 -41.99 99.49 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -67.86 -45.62 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.8 ttm -50.66 -44.03 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.837 0.455 . . . . 0.0 111.265 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.02 -5.77 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.67 78.29 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 112.336 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.55 -46.11 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.364 2.043 . . . . 0.0 111.361 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.05 -52.8 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.44 -39.92 73.92 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.143 -0.348 . . . . 0.0 110.986 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.22 -50.99 69.56 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.91 -49.46 73.39 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.16 -49.25 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.387 0.675 . . . . 0.0 109.821 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.73 64.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.999 0.363 . . . . 0.0 110.595 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.74 -55.81 8.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.849 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -49.02 -49.15 42.42 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.447 1.099 . . . . 0.0 112.329 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -97.45 23.59 7.47 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.927 0.891 . . . . 0.0 111.5 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.95 130.0 28.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.35 0.977 . . . . 0.0 110.937 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.09 -17.61 9.34 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.435 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.18 -41.79 7.34 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.708 1.254 . . . . 0.0 109.107 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -131.63 134.88 46.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.216 1.407 . . . . 0.0 108.071 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -107.52 104.2 13.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -79.83 140.69 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.47 150.32 49.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.002 . . . . 0.0 109.203 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -132.91 99.31 4.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.709 1.204 . . . . 0.0 108.575 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tt -98.22 127.01 43.94 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 110.559 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.72 112.56 22.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.6 pt -67.18 -30.38 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.522 0.729 . . . . 0.0 112.832 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -65.98 -45.76 80.49 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.98 -36.51 83.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.76 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -124.78 74.77 64.77 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 123.91 0.884 . . . . 0.0 112.612 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.67 -61.23 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.389 2.726 . . . . 0.0 113.672 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.36 -48.94 1.66 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.039 1.78 . . . . 0.0 114.684 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -34.13 59.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.37 -68.88 0.68 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-O 117.598 -1.192 . . . . 0.0 110.193 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 84.8 Cg_exo -47.49 -48.18 16.05 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.107 1.871 . . . . 0.0 112.715 174.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 C--N 1.345 0.409 0 CA-C-N 118.653 0.66 . . . . 0.0 111.916 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.436 HD11 ' CZ3' ' A' ' 31' ' ' TRP . 1.3 pp . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.057 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.06 143.89 75.71 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 CA-C-N 120.362 1.165 . . . . 0.0 110.8 -0.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.9 m -140.78 123.04 15.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.1 mt -104.12 126.19 51.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.64 1.576 . . . . 0.0 109.362 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.61 119.25 33.2 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.82 102.05 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 125.301 1.44 . . . . 0.0 108.998 179.222 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 110.878 -0.045 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.08 105.49 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.03 -43.73 17.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.455 0.702 . . . . 0.0 110.556 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.04 33.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.9 p -145.21 169.1 18.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.16 0.584 . . . . 0.0 109.655 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -150.03 151.34 33.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.4 140.29 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.86 40.74 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 173.17 10.2 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.277 -0.543 . . . . 0.0 110.224 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.86 162.05 32.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.173 1.389 . . . . 0.0 107.366 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.31 151.64 29.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.428 0.691 . . . . 0.0 110.894 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -50.07 -47.54 53.57 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.463 1.105 . . . . 0.0 112.139 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.55 -56.52 23.2 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -53.62 -45.08 69.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.796 0.838 . . . . 0.0 110.259 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.75 -53.25 60.47 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -54.52 -47.28 73.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.117 0.417 . . . . 0.0 111.345 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.68 -52.28 66.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.07 -53.48 52.59 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.87 0.868 . . . . 0.0 110.076 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.57 -51.75 68.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.429 0.292 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.56 -51.69 64.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.832 0.453 . . . . 0.0 110.493 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.02 -39.06 71.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.916 0.887 . . . . 0.0 111.7 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -77.87 -42.73 32.46 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.315 -0.24 . . . . 0.0 110.413 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.6 mt -60.35 -45.54 93.09 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 123.152 0.581 . . . . 0.0 109.659 177.686 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 mt -91.12 141.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.004 0.922 . . . . 0.0 110.75 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -90.91 113.53 26.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.465 0.65 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -84.33 97.89 9.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.271 1.028 . . . . 0.0 109.261 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.07 160.25 18.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.2 1.0 . . . . 0.0 112.837 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.8 p -127.31 160.31 31.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.399 1.88 . . . . 0.0 106.951 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -53.33 -48.74 68.2 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.99 -45.52 71.47 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.926 1.29 . . . . 0.0 111.423 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.5 p -78.67 -28.78 45.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -33.35 -65.61 0.17 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 126.059 1.743 . . . . 0.0 115.268 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.4 -56.49 14.63 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.607 -0.683 . . . . 0.0 111.43 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.95 -45.63 92.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.331 0.652 . . . . 0.0 112.758 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.56 -39.64 52.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.35 -65.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.679 1.192 . . . . 0.0 112.116 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.39 -31.35 70.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 mttm . . . . . 0 CA--C 1.538 0.507 0 CA-C-N 118.524 0.602 . . . . 0.0 112.567 177.854 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.8 129.2 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 125.012 1.325 . . . . 0.0 108.843 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -109.91 103.73 12.55 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.5 t -90.9 117.68 34.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 118.326 0.512 . . . . 0.0 110.468 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.78 110.91 23.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.849 1.259 . . . . 0.0 108.918 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -83.66 121.32 27.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -137.34 176.57 8.59 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.15 149.17 31.51 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.842 1.657 . . . . 0.0 109.243 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.36 -34.8 64.6 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.532 0.733 . . . . 0.0 112.388 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -84.6 -10.27 57.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.94 0.896 . . . . 0.0 112.084 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.75 79.99 6.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.076 -1.015 . . . . 0.0 110.906 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.78 -58.58 2.6 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.153 0.882 . . . . 0.0 112.074 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -36.51 84.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.344 2.696 . . . . 0.0 113.598 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.7 m -63.59 -46.08 87.45 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -64.65 -42.17 95.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.9 ttp -52.69 -44.35 66.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.4 pt -78.78 -10.05 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.34 -57.21 12.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 120.052 1.297 . . . . 0.0 113.116 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.69 -41.06 77.08 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.056 1.837 . . . . 0.0 111.435 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 mt -59.84 -51.93 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.4 mt -55.65 -41.22 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.833 0.453 . . . . 0.0 110.55 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.11 -52.69 63.84 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.45 -48.63 68.66 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.829 -0.545 . . . . 0.0 109.984 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.56 -49.43 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 122.997 0.519 . . . . 0.0 109.668 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.0 -45.94 68.1 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.39 -57.41 8.42 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.818 0.342 . . . . 0.0 110.476 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.21 -50.57 37.73 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.919 1.288 . . . . 0.0 112.548 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -94.04 20.49 7.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.71 0.804 . . . . 0.0 111.995 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.53 99.83 0.05 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.687 1.13 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.7 -23.48 8.34 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.617 1.103 . . . . 0.0 111.284 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -99.43 -36.79 9.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.664 1.186 . . . . 0.0 109.706 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -138.33 139.03 38.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.062 0.945 . . . . 0.0 108.522 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.6 m -106.89 102.38 11.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.21 138.31 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.21 154.12 51.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.086 0.955 . . . . 0.0 108.662 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.0 145.42 51.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.022 1.329 . . . . 0.0 108.208 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -137.6 121.32 17.45 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -84.35 110.34 18.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.89 -31.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.88 -45.57 91.94 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.231 0.923 . . . . 0.0 109.058 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -71.93 -36.8 70.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.068 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -122.63 69.9 35.24 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.246 1.018 . . . . 0.0 111.612 -175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.05 -47.27 6.74 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.972 1.781 . . . . 0.0 111.083 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -37.85 2.15 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.529 1.538 . . . . 0.0 114.895 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.4 -22.84 61.06 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.346 1.073 . . . . 0.0 113.677 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.92 -55.74 5.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.62 -37.02 42.52 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.327 2.684 . . . . 0.0 113.577 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 CA--C 1.531 0.218 0 C-N-CA 124.103 0.961 . . . . 0.0 112.107 179.796 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.7 pt . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.19 145.15 75.07 Favored 'Cis proline' 0 N--CA 1.456 -0.733 0 CA-C-N 120.725 1.295 . . . . 0.0 110.006 -0.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 m -138.79 124.51 19.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.06 115.74 30.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.616 1.566 . . . . 0.0 108.913 -175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.95 116.41 31.9 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 tp -96.72 104.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 125.576 1.55 . . . . 0.0 109.206 178.822 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.2 107.98 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -45.02 19.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.25 159.92 34.7 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.4 p -136.53 129.87 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.335 1.054 . . . . 0.0 108.53 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -119.31 119.22 33.38 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.52 132.32 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.51 163.89 34.37 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.147 0.879 . . . . 0.0 111.435 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.2 167.26 22.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.044 0.537 . . . . 0.0 110.221 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -160.93 162.99 32.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.782 1.233 . . . . 0.0 108.147 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.88 162.91 28.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.206 0.527 . . . . 0.0 110.98 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -55.8 -45.07 78.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.65 -54.41 36.57 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -56.43 -46.13 80.42 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 110.447 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.29 -52.34 66.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -55.93 -48.11 76.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 110.535 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -56.99 -53.41 58.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.777 0.431 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.98 -54.09 40.25 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.093 0.957 . . . . 0.0 110.312 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.54 -53.24 60.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.57 -52.31 60.15 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.918 0.327 . . . . 0.0 110.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.83 73.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.899 0.88 . . . . 0.0 112.004 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -77.68 -42.61 33.96 Favored 'General case' 0 C--O 1.23 0.029 0 O-C-N 122.095 -0.378 . . . . 0.0 110.319 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.49 -48.24 82.41 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 123.139 0.576 . . . . 0.0 109.525 177.077 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.4 138.51 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.318 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.6 mm -86.5 110.91 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.218 1.009 . . . . 0.0 111.01 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -82.41 76.11 9.29 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.771 0.828 . . . . 0.0 108.9 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.76 159.19 22.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.715 1.206 . . . . 0.0 113.659 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 p -125.74 160.53 29.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.8 2.04 . . . . 0.0 106.755 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -54.68 -45.46 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.67 -46.13 74.01 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.3 1.44 . . . . 0.0 111.432 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 p -78.67 -27.45 45.18 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -37.8 -54.51 1.24 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.327 1.451 . . . . 0.0 114.113 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.09 -50.25 73.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 111.664 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -66.24 -40.94 90.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.237 1.015 . . . . 0.0 111.339 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.01 -58.49 2.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.72 -51.52 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.038 0.935 . . . . 0.0 112.4 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 mt -64.87 -32.78 74.64 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.299 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttm . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 122.499 0.319 . . . . 0.0 111.201 174.552 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mt -120.25 119.44 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.179 1.392 . . . . 0.0 108.096 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.8 tp -94.61 104.8 16.73 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.68 109.66 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 122.829 0.452 . . . . 0.0 110.014 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -90.19 119.35 30.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.74 125.62 34.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -138.43 176.31 8.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.486 0.715 . . . . 0.0 111.157 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.45 151.77 32.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.056 1.342 . . . . 0.0 107.563 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -56.08 -36.87 68.59 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.615 0.766 . . . . 0.0 111.55 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -79.71 -11.03 59.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.241 1.017 . . . . 0.0 112.813 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -79.56 81.3 5.84 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.046 -1.034 . . . . 0.0 111.855 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.07 -57.62 3.51 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.013 0.816 . . . . 0.0 112.369 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.91 -33.58 82.72 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.862 2.375 . . . . 0.0 113.261 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -65.04 -43.55 91.98 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.49 -47.6 84.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -50.38 -41.89 52.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.888 0.875 . . . . 0.0 111.953 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -83.69 -8.82 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.91 -51.17 73.32 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.9 1.227 . . . . 0.0 112.721 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.94 -40.96 78.8 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.508 2.139 . . . . 0.0 112.078 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.08 -52.5 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.24 -42.84 77.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.826 0.45 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.28 -53.43 58.28 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.827 0.822 . . . . 0.0 109.327 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.87 -47.14 77.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.007 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 mm -56.11 -50.4 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.116 0.566 . . . . 0.0 109.806 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.61 67.65 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.982 0.513 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.24 -50.3 54.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.299 -0.251 . . . . 0.0 110.966 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.62 -49.32 77.92 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.33 0.652 . . . . 0.0 112.731 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -87.11 30.14 0.79 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.745 0.818 . . . . 0.0 112.592 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -52.27 125.0 14.57 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.561 -0.712 . . . . 0.0 110.213 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.65 -15.35 14.36 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.484 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.7 -36.23 9.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.431 1.116 . . . . 0.0 110.568 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -146.67 142.23 27.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.199 0.6 . . . . 0.0 109.479 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.8 m -108.36 139.79 42.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.96 143.19 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.83 151.08 51.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.943 0.897 . . . . 0.0 108.599 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -133.27 101.93 5.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -98.01 123.28 41.96 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.729 -0.607 . . . . 0.0 110.791 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -82.34 108.44 15.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.238 0.615 . . . . 0.0 110.077 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.66 -23.9 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.744 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -62.18 -46.17 90.15 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.3 -32.54 58.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.478 0.711 . . . . 0.0 110.558 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -128.53 70.19 79.73 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.574 0.75 . . . . 0.0 112.411 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.64 -59.35 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.505 2.137 . . . . 0.0 112.923 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.18 -42.22 1.62 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.345 1.926 . . . . 0.0 115.296 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -28.15 65.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.871 0.835 . . . . 0.0 112.854 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -70.01 -65.21 1.17 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.196 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 94.4 Cg_exo -47.25 -40.18 27.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.247 2.631 . . . . 0.0 113.192 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 118.937 0.789 . . . . 0.0 112.242 178.011 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 CA--C 1.537 0.481 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.68 142.48 67.64 Favored 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.541 1.229 . . . . 0.0 110.523 -0.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -142.85 127.51 18.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.72 118.57 37.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.466 1.506 . . . . 0.0 109.234 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -110.66 118.31 35.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.44 107.36 19.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.456 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 111.465 -178.316 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.67 111.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -44.42 22.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.366 0.666 . . . . 0.0 109.639 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.13 161.33 31.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 78.4 p -135.23 132.28 37.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.395 1.078 . . . . 0.0 109.166 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -120.54 117.99 29.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -93.71 132.75 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.09 163.64 39.39 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.635 0.636 . . . . 0.0 111.778 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.35 167.94 15.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.14 0.576 . . . . 0.0 110.416 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.54 166.61 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.972 1.309 . . . . 0.0 107.723 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 76.8 p -82.42 161.49 22.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.225 0.536 . . . . 0.0 110.799 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -48.82 -51.88 27.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.019 . . . . 0.0 109.813 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.55 -54.78 28.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -55.28 -46.39 76.18 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.089 0.445 . . . . 0.0 110.337 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.06 -48.39 81.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.543 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -55.93 -50.13 71.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.319 0.509 . . . . 0.0 110.026 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -56.99 -50.79 71.62 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.836 0.289 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.32 -53.79 45.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 0.0 110.364 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.85 -54.93 41.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.562 0.345 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -52.2 -51.7 56.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.262 0.625 . . . . 0.0 110.674 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -38.04 69.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.669 0.788 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -78.07 -48.64 15.61 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.16 -0.338 . . . . 0.0 110.36 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -58.55 -44.77 89.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.161 0.584 . . . . 0.0 109.911 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 122.837 0.455 . . . . 0.0 109.775 177.768 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 mt -96.31 139.37 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 110.344 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -86.44 110.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.178 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -81.12 94.04 6.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.106 0.962 . . . . 0.0 108.799 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.78 163.82 22.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.986 0.914 . . . . 0.0 112.614 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.1 p -133.56 163.55 29.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.457 1.903 . . . . 0.0 106.226 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.07 -43.38 73.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.13 -46.31 90.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.962 1.305 . . . . 0.0 111.877 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -78.31 -27.54 47.24 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.096 -0.377 . . . . 0.0 111.385 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -36.65 -54.62 0.88 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 113.426 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.9 -63.73 1.06 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 110.902 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -56.1 -41.74 75.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.845 0.858 . . . . 0.0 112.787 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -58.42 2.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.11 -52.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.881 0.872 . . . . 0.0 112.712 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.24 -29.99 71.06 Favored 'General case' 0 C--O 1.228 -0.047 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 172.574 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -116.42 125.58 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 C-N-CA 124.619 1.168 . . . . 0.0 108.354 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 tp -103.28 103.34 13.35 Favored 'General case' 0 CA--C 1.524 -0.051 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -89.8 114.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 122.745 0.418 . . . . 0.0 110.103 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.36 114.3 26.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -82.86 128.1 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -142.43 174.61 10.47 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.446 0.698 . . . . 0.0 111.787 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.46 153.89 41.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.41 1.484 . . . . 0.0 107.789 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -52.32 -43.67 64.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.663 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -80.08 -2.45 44.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.952 1.301 . . . . 0.0 112.957 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -79.4 78.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.896 -1.128 . . . . 0.0 111.004 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.78 -57.36 3.43 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 123.74 0.686 . . . . 0.0 112.185 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.81 -32.46 77.08 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.071 2.514 . . . . 0.0 113.413 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.18 -47.64 76.27 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.62 -40.4 87.44 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -58.59 -46.11 87.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.96 0.504 . . . . 0.0 110.876 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 pt -76.27 -26.82 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 118.746 0.703 . . . . 0.0 112.555 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.91 -56.66 1.11 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.97 -38.89 94.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.217 1.944 . . . . 0.0 112.09 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 mt -62.11 -48.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -56.5 -42.55 78.54 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.24 -0.288 . . . . 0.0 110.261 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.05 -48.83 80.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.188 0.595 . . . . 0.0 109.703 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -59.35 -49.6 77.21 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.795 -0.565 . . . . 0.0 109.832 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.6 mm -52.04 -45.95 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.631 0.773 . . . . 0.0 110.047 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.82 -33.42 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.691 0.397 . . . . 0.0 111.38 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.47 -54.86 5.71 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.88 -44.53 49.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.909 . . . . 0.0 112.516 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -103.77 22.1 15.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.962 0.905 . . . . 0.0 112.189 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -51.17 135.97 24.89 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.876 0.762 . . . . 0.0 111.17 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 -23.51 3.61 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.97 -0.906 . . . . 0.0 113.531 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.38 -45.3 5.89 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.015 1.408 . . . . 0.0 110.251 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.02 121.69 40.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 m -93.54 103.67 15.84 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.94 137.96 20.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.08 48.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.053 0.941 . . . . 0.0 109.434 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -128.92 136.48 50.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -127.33 122.08 32.78 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.194 0.597 . . . . 0.0 110.19 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -83.07 106.34 14.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.047 0.539 . . . . 0.0 110.077 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.84 -26.22 36.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -58.51 -51.02 71.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.327 0.967 . . . . 0.0 109.298 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -78.83 -31.06 45.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.795 0.838 . . . . 0.0 111.089 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.82 66.46 20.79 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.446 0.698 . . . . 0.0 111.479 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.8 -54.24 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.379 2.053 . . . . 0.0 112.156 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.41 -46.44 1.45 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.881 1.705 . . . . 0.0 114.3 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -38.86 60.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.938 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.55 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.4 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.691 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 78.5 Cg_exo -50.87 -45.32 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.167 1.911 . . . . 0.0 112.695 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? . . . . . 0 C--N 1.344 0.34 0 CA-C-N 119.095 0.861 . . . . 0.0 111.858 -179.618 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.3 pt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.1 147.6 89.03 Favored 'Cis proline' 0 N--CA 1.454 -0.795 0 CA-C-N 119.555 0.877 . . . . 0.0 110.296 -1.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -145.76 127.12 14.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt -102.51 126.0 49.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.669 1.588 . . . . 0.0 108.558 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.33 120.25 38.28 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -96.64 102.06 13.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.363 0.665 . . . . 0.0 109.444 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 N--CA 1.454 -0.261 0 C-N-CA 125.704 1.602 . . . . 0.0 110.116 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 N--CA 1.455 -0.221 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.87 106.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -43.29 22.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.444 0.698 . . . . 0.0 110.297 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.82 168.75 25.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 p -144.72 163.2 34.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -142.14 121.63 13.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.14 132.44 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.457 1.103 . . . . 0.0 108.783 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.49 167.19 42.38 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.598 0.555 . . . . 0.0 111.963 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.48 169.07 14.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.15 0.58 . . . . 0.0 110.266 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.69 165.64 27.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.037 1.335 . . . . 0.0 107.66 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.9 p -75.69 159.24 31.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.171 0.51 . . . . 0.0 110.417 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -52.77 -46.88 67.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.578 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.46 -57.01 19.09 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -54.05 -46.06 71.83 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.311 0.555 . . . . 0.0 111.199 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.39 -51.25 70.28 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.239 -0.288 . . . . 0.0 110.683 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.46 -48.53 74.36 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 122.18 -0.325 . . . . 0.0 110.621 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.83 -51.71 68.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.938 0.895 . . . . 0.0 110.036 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.36 -54.02 46.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.872 0.869 . . . . 0.0 109.962 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.86 -50.03 74.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.209 -0.307 . . . . 0.0 110.758 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.72 -52.23 63.13 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.543 0.337 . . . . 0.0 110.156 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -36.06 71.76 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.047 0.939 . . . . 0.0 111.947 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.32 -50.88 10.98 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 117.918 0.326 . . . . 0.0 110.46 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.05 -42.3 97.09 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.107 -0.371 . . . . 0.0 110.575 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 124.717 1.207 . . . . 0.0 111.727 179.292 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.8 mttp . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 mt -103.47 134.83 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.479 0.712 . . . . 0.0 110.94 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.5 mm -89.12 117.36 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 122.207 1.003 . . . . 0.0 110.6 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -89.07 78.26 7.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.81 163.87 18.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.747 1.219 . . . . 0.0 112.937 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.1 p -132.67 163.56 28.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.259 1.824 . . . . 0.0 106.707 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.74 -42.7 71.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.267 0.485 . . . . 0.0 109.743 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.57 -45.69 92.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.898 1.279 . . . . 0.0 111.709 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 p -78.71 -26.24 44.82 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.161 -0.337 . . . . 0.0 111.321 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -37.81 -57.06 1.04 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.532 1.533 . . . . 0.0 113.581 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -54.79 -61.69 2.15 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.703 0.763 . . . . 0.0 110.394 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -52.26 -42.58 63.78 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.201 1.4 . . . . 0.0 113.326 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -57.48 2.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.961 0.504 . . . . 0.0 112.068 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.92 -51.01 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.061 0.944 . . . . 0.0 112.536 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.7 -36.11 82.69 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.215 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.826 173.524 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mt -111.98 125.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.444 1.097 . . . . 0.0 108.299 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -104.16 100.48 10.22 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.94 112.7 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.44 0.296 . . . . 0.0 110.424 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -89.35 108.06 19.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -79.93 120.23 23.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -137.25 173.19 11.95 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.38 151.27 50.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.675 1.19 . . . . 0.0 108.357 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -55.04 -38.39 67.92 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.281 0.491 . . . . 0.0 111.357 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -83.81 -2.48 56.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.679 1.192 . . . . 0.0 112.488 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.47 80.79 5.81 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.948 -1.095 . . . . 0.0 110.685 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.89 -58.51 2.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.184 0.897 . . . . 0.0 111.919 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -54.0 -39.58 84.57 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.428 2.752 . . . . 0.0 113.543 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -62.28 -48.7 78.72 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.76 -44.24 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.4 ttm -52.53 -41.46 63.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.08 0.952 . . . . 0.0 111.135 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -82.58 -11.97 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.775 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.75 -49.85 54.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.321 1.419 . . . . 0.0 113.423 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.31 -37.96 94.14 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.315 2.01 . . . . 0.0 111.764 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.56 -48.98 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.52 -41.78 73.61 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.271 0.487 . . . . 0.0 110.236 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.47 -52.54 64.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.158 0.583 . . . . 0.0 109.92 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -54.06 -47.68 71.38 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.951 0.5 . . . . 0.0 109.698 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.1 -49.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.73 0.812 . . . . 0.0 109.539 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.7 67.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.073 0.397 . . . . 0.0 110.064 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.3 -50.83 64.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.197 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -60.39 -44.24 95.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.722 1.209 . . . . 0.0 113.62 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.52 29.19 3.38 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.713 1.205 . . . . 0.0 112.131 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.82 132.28 18.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.83 -0.543 . . . . 0.0 111.418 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.13 -19.04 2.34 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.123 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -98.84 -41.75 7.49 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.429 1.614 . . . . 0.0 109.859 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -129.97 119.74 23.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.542 0.737 . . . . 0.0 109.415 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -95.41 103.73 15.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.24 144.06 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.317 -0.864 . . . . 0.0 109.8 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.12 151.75 45.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.113 0.965 . . . . 0.0 109.134 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -133.15 103.86 6.22 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.69 119.57 37.66 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.754 0.421 . . . . 0.0 110.606 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -80.15 106.35 12.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.83 -27.46 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.753 0.821 . . . . 0.0 112.519 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.05 -51.3 70.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.215 0.916 . . . . 0.0 109.385 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -74.63 -32.15 62.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.71 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -118.85 67.49 7.99 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 111.661 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.92 -44.72 9.48 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 110.714 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.18 -37.7 4.59 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.291 1.424 . . . . 0.0 114.325 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.22 -24.34 64.01 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.255 1.027 . . . . 0.0 113.087 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -59.32 14.21 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -62.14 -33.8 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.216 1.944 . . . . 0.0 112.377 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 119.082 0.856 . . . . 0.0 111.922 179.778 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.4 pt . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.97 134.43 31.75 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.991 1.033 . . . . 0.0 110.739 -0.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.79 115.76 28.28 Favored 'General case' 0 C--N 1.338 0.074 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.51 94.06 6.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 89' ' ' THR . 9.4 mp -91.91 114.92 27.59 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -94.09 100.12 12.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.564 0.746 . . . . 0.0 109.511 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 N--CA 1.456 -0.16 0 C-N-CA 125.231 1.412 . . . . 0.0 110.672 -179.691 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.0 107.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.26 24.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.64 0.776 . . . . 0.0 109.959 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.27 159.92 31.97 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.458 0.703 . . . . 0.0 109.243 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.418 HG22 ' HG ' ' A' ' 79' ' ' LEU . 45.6 p -134.11 103.77 5.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.439 1.096 . . . . 0.0 108.461 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -87.59 114.95 24.67 Favored 'General case' 0 C--N 1.338 0.087 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.84 119.22 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.05 166.38 26.92 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 121.579 0.544 . . . . 0.0 112.436 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.64 165.19 25.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.463 0.705 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -163.89 168.62 19.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.214 1.806 . . . . 0.0 106.994 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.3 p -97.1 178.44 5.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.11 0.957 . . . . 0.0 112.235 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -64.67 161.77 17.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.7 4.69 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.31 -56.23 22.85 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 tp -56.9 -46.02 82.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.056 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.14 -49.76 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.335 -0.228 . . . . 0.0 111.072 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.86 -50.31 73.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.269 0.628 . . . . 0.0 109.831 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -52.97 -52.24 58.8 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -58.96 -47.1 86.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.694 0.397 . . . . 0.0 110.957 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.9 -54.15 48.21 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.075 0.95 . . . . 0.0 111.983 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -77.89 -50.86 11.39 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 122.209 -0.307 . . . . 0.0 110.739 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 72.5 mt -59.73 -42.87 94.12 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.137 0.575 . . . . 0.0 109.956 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.525 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 110.529 -0.175 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.7 mt -83.26 136.21 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 122.07 -0.394 . . . . 0.0 111.303 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 mm -90.28 120.66 39.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.958 0.885 . . . . 0.0 111.121 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -92.86 80.93 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.1 0.96 . . . . 0.0 108.871 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.55 164.97 15.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.879 1.272 . . . . 0.0 112.784 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.6 p -132.9 163.04 30.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.71 -44.24 69.65 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.157 0.503 . . . . 0.0 109.659 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.9 -45.85 92.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.997 1.319 . . . . 0.0 111.963 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.35 -26.76 46.86 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.109 -0.37 . . . . 0.0 111.487 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -36.93 -54.76 0.93 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.737 1.615 . . . . 0.0 113.391 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.7 -62.85 1.39 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.447 0.641 . . . . 0.0 110.999 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -38.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.685 0.794 . . . . 0.0 113.108 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -59.21 2.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 -52.89 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.532 1.133 . . . . 0.0 112.439 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.31 -28.61 69.83 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.329 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.4 mttp . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 122.813 0.445 . . . . 0.0 110.112 174.036 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -117.51 127.31 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.505 1.122 . . . . 0.0 108.792 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -104.83 102.83 12.36 Favored 'General case' 0 C--N 1.337 0.055 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 t -89.76 113.23 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -93.46 111.5 23.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -80.91 124.9 29.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -139.69 -179.57 6.0 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.861 0.864 . . . . 0.0 111.191 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.871 1.268 . . . . 0.0 108.935 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.43 -22.55 54.74 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.502 1.121 . . . . 0.0 113.226 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -99.44 -2.04 37.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.712 1.205 . . . . 0.0 111.727 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.9 t -79.96 83.92 5.8 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.021 -1.049 . . . . 0.0 112.29 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.83 -59.88 3.12 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 123.828 0.728 . . . . 0.0 112.437 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -32.79 67.64 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 0.0 113.337 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.13 -45.88 83.24 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.57 -42.25 96.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -57.51 -44.79 85.3 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.964 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 pt -77.5 -21.19 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.922 0.783 . . . . 0.0 112.734 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.52 -57.31 2.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.702 1.137 . . . . 0.0 114.024 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -56.09 -40.08 87.16 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.161 1.907 . . . . 0.0 112.055 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.73 -50.61 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.2 -44.13 83.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.132 0.573 . . . . 0.0 110.682 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.94 -51.85 67.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.636 0.775 . . . . 0.0 110.002 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.56 -51.43 65.27 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.536 0.734 . . . . 0.0 109.221 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.51 -47.67 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.34 75.42 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.198 0.453 . . . . 0.0 110.946 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.61 -43.15 81.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.82 -54.89 15.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.342 1.057 . . . . 0.0 112.476 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -82.57 23.46 0.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.401 1.08 . . . . 0.0 111.038 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.23 101.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.823 1.649 . . . . 0.0 110.276 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.45 -21.53 16.87 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.629 1.109 . . . . 0.0 111.446 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -99.6 -35.67 9.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.707 1.203 . . . . 0.0 110.236 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -142.09 139.43 32.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.22 1.008 . . . . 0.0 109.447 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -109.51 105.33 14.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -80.09 140.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.6 150.35 49.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.69 0.796 . . . . 0.0 109.459 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -131.19 103.06 6.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.884 1.274 . . . . 0.0 108.101 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -98.32 119.78 37.6 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 121.815 -0.553 . . . . 0.0 110.407 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -81.89 108.82 15.71 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.04 -25.01 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.32 0.648 . . . . 0.0 111.894 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.1 -47.68 81.8 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.294 0.952 . . . . 0.0 108.542 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -71.99 -32.82 67.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -124.32 69.52 51.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.506 0.722 . . . . 0.0 112.638 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.21 -50.78 12.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.332 2.021 . . . . 0.0 111.897 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.54 -42.45 3.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.705 1.621 . . . . 0.0 114.989 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.63 64.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.289 1.045 . . . . 0.0 112.85 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.37 -62.37 6.07 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.65 -42.34 47.8 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.799 1.666 . . . . 0.0 111.376 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt . . . . . 0 CA--C 1.531 0.247 0 C-N-CA 123.276 0.63 . . . . 0.0 111.866 179.821 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.53 142.66 68.0 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 CA-C-N 120.651 1.268 . . . . 0.0 110.029 -0.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -137.31 114.96 11.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.9 mt -95.24 127.8 41.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.089 1.356 . . . . 0.0 108.941 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.73 119.02 32.42 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.0 tp -97.16 104.02 16.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.037 0.535 . . . . 0.0 109.655 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 . . . . . 0 N--CA 1.452 -0.339 0 C-N-CA 125.799 1.639 . . . . 0.0 109.823 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.78 106.3 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.29 -43.47 23.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.635 0.774 . . . . 0.0 109.755 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.41 169.12 23.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.4 p -139.46 164.93 28.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.28 116.72 6.13 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.76 133.73 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.16 163.94 39.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.57 0.605 . . . . 0.0 111.674 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 167.57 16.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.277 0.631 . . . . 0.0 110.815 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.01 167.61 24.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.989 1.316 . . . . 0.0 108.074 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.4 p -79.5 165.97 22.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.318 0.58 . . . . 0.0 111.29 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -56.19 -45.24 79.88 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.46 -57.66 18.67 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.854 0.74 . . . . 0.0 111.432 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -57.68 -40.95 80.58 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.684 0.742 . . . . 0.0 110.701 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.64 -50.8 71.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.978 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -53.16 -51.3 62.48 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.482 0.583 . . . . 0.0 110.19 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.72 -53.28 54.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.572 0.749 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -54.29 -52.48 61.31 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.711 0.804 . . . . 0.0 110.491 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.7 mt -58.12 -52.47 65.42 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.61 0.364 . . . . 0.0 110.584 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -54.12 -52.86 59.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.668 0.787 . . . . 0.0 109.68 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.54 -40.72 68.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.585 0.754 . . . . 0.0 111.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -78.23 -48.12 16.47 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 122.326 -0.234 . . . . 0.0 111.168 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.6 mt -57.22 -46.24 83.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.515 0.726 . . . . 0.0 109.3 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.123 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mt -84.58 138.32 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.127 0.571 . . . . 0.0 111.088 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.79 113.6 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.378 0.671 . . . . 0.0 110.808 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -84.36 99.43 10.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.396 1.078 . . . . 0.0 109.28 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.73 171.19 11.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.202 1.001 . . . . 0.0 111.481 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.7 p -137.37 166.43 23.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -52.81 -41.95 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.287 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.63 -47.93 79.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.642 1.177 . . . . 0.0 111.904 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.37 -26.41 46.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -35.14 -54.16 0.61 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.368 1.467 . . . . 0.0 113.898 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.02 -65.47 0.57 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.523 0.677 . . . . 0.0 111.013 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -56.46 -37.5 70.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.166 0.987 . . . . 0.0 112.746 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.39 -60.72 1.95 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.87 -50.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 112.479 -173.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.07 -32.5 74.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.078 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.4 mttt . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 122.512 0.325 . . . . 0.0 110.872 174.834 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mt -116.85 124.24 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.09 1.356 . . . . 0.0 108.14 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.1 tp -100.95 102.68 13.75 Favored 'General case' 0 C--O 1.228 -0.051 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.57 113.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 122.657 0.383 . . . . 0.0 110.426 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.48 109.54 21.73 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.528 1.131 . . . . 0.0 108.634 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -79.97 122.04 26.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -136.81 178.65 6.91 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.583 1.153 . . . . 0.0 111.063 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.02 154.26 36.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.858 1.663 . . . . 0.0 108.004 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -54.56 -40.51 68.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.295 0.952 . . . . 0.0 112.035 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -79.34 -2.43 41.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 112.968 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -79.41 78.58 5.91 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.901 -1.124 . . . . 0.0 111.55 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.61 3.63 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.772 0.701 . . . . 0.0 112.206 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.26 -34.42 79.56 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.902 2.401 . . . . 0.0 113.239 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -63.67 -46.34 86.02 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.07 -46.75 87.47 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.8 mtp -55.07 -43.83 74.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.569 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.37 -20.71 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.916 0.78 . . . . 0.0 112.97 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.15 -52.65 9.4 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.977 1.262 . . . . 0.0 114.238 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -52.9 -41.14 72.87 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.493 2.129 . . . . 0.0 112.143 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -62.92 -49.58 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.96 -42.28 72.16 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -62.5 -45.82 91.25 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 110.176 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -59.24 -46.92 87.19 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.717 -0.614 . . . . 0.0 109.775 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.67 -48.4 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -43.39 64.7 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.381 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.82 -63.46 1.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.448 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -45.41 -47.11 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.956 1.302 . . . . 0.0 113.618 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -95.09 21.54 7.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.023 0.929 . . . . 0.0 112.295 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.59 130.92 17.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.435 1.016 . . . . 0.0 110.302 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.09 -18.18 4.3 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.209 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -99.29 -39.39 8.45 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.821 1.31 . . . . 0.0 109.768 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.74 136.62 32.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.232 1.013 . . . . 0.0 108.361 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.4 m -102.23 107.46 18.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.0 135.89 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.23 154.3 51.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.534 0.733 . . . . 0.0 109.323 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.36 144.77 51.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.206 1.402 . . . . 0.0 108.707 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.9 tt -134.37 129.42 35.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.38 100.89 12.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -57.09 -30.1 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -61.77 -46.1 91.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.27 0.941 . . . . 0.0 109.966 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -88.58 -19.33 26.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.365 1.466 . . . . 0.0 111.771 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -127.24 55.52 15.61 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.413 1.485 . . . . 0.0 109.946 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.25 -42.67 21.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.722 2.281 . . . . 0.0 112.295 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.47 -33.68 4.52 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.578 1.085 . . . . 0.0 113.827 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -64.4 -55.66 28.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 119.286 0.948 . . . . 0.0 112.407 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 72.2 Cg_exo -51.52 -41.83 58.57 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 113.496 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mttp . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 123.511 0.724 . . . . 0.0 112.574 -178.185 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.95 143.36 74.0 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.328 1.153 . . . . 0.0 110.204 -0.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 m -139.69 126.01 20.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.57 116.14 31.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 108.948 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.2 mp -110.13 119.33 38.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.3 tp -94.55 106.3 18.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 . . . . . 0 N--CA 1.457 -0.098 0 C-N-CA 125.352 1.461 . . . . 0.0 111.707 -178.283 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.04 111.32 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.71 23.61 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.429 0.692 . . . . 0.0 109.746 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.24 161.13 33.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.405 HG22 ' HG ' ' A' ' 79' ' ' LEU . 80.5 p -135.59 135.41 40.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.401 1.08 . . . . 0.0 109.157 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 127.97 49.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.74 129.19 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.17 173.72 44.98 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.053 0.835 . . . . 0.0 111.43 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.02 171.35 13.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.34 -0.506 . . . . 0.0 110.221 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -164.3 164.46 22.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.528 1.531 . . . . 0.0 107.617 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.2 p -73.9 161.17 30.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.124 0.488 . . . . 0.0 110.764 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.43 -42.93 78.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.89 -58.65 13.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.33 -45.49 69.09 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.265 0.532 . . . . 0.0 110.872 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.5 tp -59.8 -52.06 67.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -55.83 -46.94 78.02 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.111 -0.368 . . . . 0.0 110.893 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.95 -52.86 63.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.901 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -53.79 -53.14 56.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.223 1.009 . . . . 0.0 110.219 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.96 -50.32 74.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.402 0.281 . . . . 0.0 110.685 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.36 -49.83 71.26 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.491 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.551 0.741 . . . . 0.0 111.521 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -77.65 -46.38 22.17 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 122.151 -0.343 . . . . 0.0 110.923 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.6 mt -62.3 -43.77 98.06 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 125.606 1.562 . . . . 0.0 108.501 178.089 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 mt -100.82 138.19 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 111.507 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -92.83 118.55 38.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 110.542 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -87.74 101.3 13.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.24 1.016 . . . . 0.0 109.292 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.94 168.34 12.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.549 1.14 . . . . 0.0 112.593 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -135.43 162.12 33.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.83 -43.83 69.74 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.78 -46.24 91.25 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.968 1.307 . . . . 0.0 112.014 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.27 -26.46 47.17 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.028 -0.42 . . . . 0.0 111.467 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -35.97 -54.12 0.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.745 1.618 . . . . 0.0 113.633 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -55.34 -62.3 1.76 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.939 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -59.03 -40.3 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.281 0.632 . . . . 0.0 112.44 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.19 -58.38 3.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -80.74 -52.35 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.885 0.874 . . . . 0.0 112.349 -173.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -63.36 -26.13 68.61 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.635 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 123.078 0.551 . . . . 0.0 109.859 172.781 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.68 132.03 69.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 C-N-CA 124.316 1.046 . . . . 0.0 108.531 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.84 100.92 9.3 Favored 'General case' 0 C--O 1.229 -0.025 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.16 117.64 33.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 122.661 0.385 . . . . 0.0 110.75 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -97.43 109.39 22.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.882 1.273 . . . . 0.0 108.882 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -82.43 124.18 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -142.38 172.83 12.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 147.98 40.23 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.293 1.437 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -54.92 -35.87 64.64 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.177 0.591 . . . . 0.0 112.033 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -84.81 -5.67 59.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.954 0.902 . . . . 0.0 112.358 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.85 82.01 6.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.063 -1.023 . . . . 0.0 110.728 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.76 -57.51 3.37 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 123.941 0.782 . . . . 0.0 111.983 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.51 -34.36 81.81 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.148 2.565 . . . . 0.0 113.435 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.76 -49.57 67.91 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -58.98 -39.98 83.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.5 ttp -58.52 -47.69 83.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.203 0.601 . . . . 0.0 110.426 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.2 pt -75.83 -25.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.626 -0.702 . . . . 0.0 112.659 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -58.02 1.16 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.13 -40.63 83.63 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.192 1.928 . . . . 0.0 111.521 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.0 mt -58.97 -49.97 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.77 -42.52 75.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.889 0.313 . . . . 0.0 110.46 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -59.9 -53.66 55.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -45.89 75.47 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.62 -0.675 . . . . 0.0 110.392 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -57.07 -48.62 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.017 0.527 . . . . 0.0 109.648 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.63 76.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.557 0.743 . . . . 0.0 110.27 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.52 -56.73 13.71 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.57 -51.0 40.02 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.992 1.317 . . . . 0.0 112.028 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -96.98 23.7 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.797 0.839 . . . . 0.0 112.525 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -54.89 128.93 35.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.028 . . . . 0.0 110.461 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.51 -16.99 21.94 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.298 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.52 -42.72 6.8 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.674 1.237 . . . . 0.0 109.365 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -134.11 119.25 18.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.807 1.243 . . . . 0.0 107.648 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.8 m -86.24 102.78 14.25 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.63 139.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.55 154.59 49.8 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.19 145.17 51.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.136 1.374 . . . . 0.0 108.489 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.19 123.39 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -84.53 109.38 17.89 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -62.8 -31.54 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.38 -52.72 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.998 0.817 . . . . 0.0 110.069 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.82 -30.82 65.9 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.826 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -117.64 71.14 7.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.935 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.94 -53.98 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.716 2.277 . . . . 0.0 112.597 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.71 -45.81 2.08 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.38 1.467 . . . . 0.0 114.358 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.55 65.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.4 1.08 . . . . 0.0 113.356 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.41 -66.34 1.07 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.842 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -58.88 -42.9 48.01 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 121.228 1.474 . . . . 0.0 111.106 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 118.452 0.569 . . . . 0.0 111.692 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.19 146.27 80.5 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.365 1.166 . . . . 0.0 110.042 -1.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.0 m -137.82 123.54 19.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.6 mt -108.58 112.64 25.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.727 1.611 . . . . 0.0 109.173 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.1 mp -104.86 122.28 45.43 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -96.55 99.75 11.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.787 0.835 . . . . 0.0 109.278 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 N--CA 1.452 -0.345 0 C-N-CA 125.862 1.665 . . . . 0.0 109.708 179.533 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -62.89 102.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.0 -41.76 25.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.867 0.867 . . . . 0.0 110.976 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.11 159.16 42.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.418 HG22 ' HG ' ' A' ' 79' ' ' LEU . 82.2 p -138.54 131.13 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.262 1.025 . . . . 0.0 109.299 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -120.27 117.68 28.46 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.35 134.06 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 163.65 39.46 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.663 0.649 . . . . 0.0 111.864 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.34 169.12 14.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.395 0.678 . . . . 0.0 110.488 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.61 168.66 21.41 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.627 1.171 . . . . 0.0 108.531 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 149.47 33.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.747 1.219 . . . . 0.0 110.609 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.47 -49.18 65.18 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.173 0.589 . . . . 0.0 111.252 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.77 42.14 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -58.67 -43.17 89.8 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.97 0.508 . . . . 0.0 110.418 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.3 -50.55 73.19 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -54.63 -49.94 69.33 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 122.045 -0.409 . . . . 0.0 110.503 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.46 -52.79 63.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.08 0.952 . . . . 0.0 110.095 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.27 -53.76 49.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.671 0.788 . . . . 0.0 110.19 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.12 -49.95 75.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.624 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.97 -51.36 64.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 117.968 0.349 . . . . 0.0 110.138 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.31 -36.41 71.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.791 0.837 . . . . 0.0 111.894 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -77.7 -46.01 23.16 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 121.988 -0.445 . . . . 0.0 109.855 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.26 -46.48 88.41 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 123.062 0.545 . . . . 0.0 109.624 177.571 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.5 mttt . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.3 mt -85.58 138.31 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.136 0.574 . . . . 0.0 111.166 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.57 119.99 41.1 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.283 0.563 . . . . 0.0 110.365 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -88.94 103.55 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.444 1.097 . . . . 0.0 109.34 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.22 164.99 14.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.612 1.165 . . . . 0.0 113.206 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.4 p -136.07 162.21 33.53 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.65 -44.14 69.38 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.331 0.514 . . . . 0.0 109.939 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.23 -46.24 90.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.925 1.29 . . . . 0.0 112.096 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.6 p -78.56 -26.17 45.56 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.085 -0.385 . . . . 0.0 111.482 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -36.98 -54.43 0.95 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.015 1.726 . . . . 0.0 114.125 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -52.69 -60.2 3.55 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.521 -0.737 . . . . 0.0 111.159 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.53 97.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.592 0.757 . . . . 0.0 112.335 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -27.01 50.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.8 -62.55 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 124.017 0.927 . . . . 0.0 111.746 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.86 -35.81 77.56 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 121.949 -0.47 . . . . 0.0 111.444 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 119.222 -0.418 . . . . 0.0 112.124 177.444 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.46 139.25 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 126.147 1.779 . . . . 0.0 107.793 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.97 99.35 6.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 t -90.92 114.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -91.59 107.58 19.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.159 0.983 . . . . 0.0 108.404 174.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -79.72 120.41 23.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -136.49 179.46 6.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.968 0.907 . . . . 0.0 110.868 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.69 36.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.275 1.03 . . . . 0.0 109.652 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -56.25 -26.33 51.14 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.775 1.23 . . . . 0.0 112.333 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -93.75 -8.22 41.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.526 1.131 . . . . 0.0 112.483 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.74 82.88 5.77 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.992 -1.067 . . . . 0.0 112.903 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.42 -58.23 4.69 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.571 0.605 . . . . 0.0 112.469 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -53.16 -32.28 58.98 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.2 2.6 . . . . 0.0 113.236 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.7 m -65.45 -43.85 89.08 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -63.24 -41.78 99.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 50.9 ttp -55.11 -47.73 74.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.618 0.367 . . . . 0.0 110.83 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.54 -26.92 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.14 -56.66 1.18 Allowed Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -57.44 -35.94 98.81 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.183 1.922 . . . . 0.0 111.953 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.0 mt -64.73 -49.45 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.5 mt -54.51 -42.22 70.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.799 0.272 . . . . 0.0 110.473 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -61.83 -51.46 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -52.69 -47.96 66.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.934 -0.478 . . . . 0.0 109.863 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.12 -48.58 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.39 0.676 . . . . 0.0 109.421 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 -43.21 65.44 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.182 0.593 . . . . 0.0 110.05 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.12 -61.65 1.82 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.751 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -53.14 -48.4 67.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.113 0.965 . . . . 0.0 112.397 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -88.7 13.52 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 0.0 112.248 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -55.08 116.5 2.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.906 1.23 . . . . 0.0 109.729 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.66 -26.79 18.61 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.798 0.713 . . . . 0.0 111.585 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -99.19 -42.15 7.17 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.681 0.793 . . . . 0.0 109.765 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -129.08 141.34 51.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.296 1.038 . . . . 0.0 109.956 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -108.59 96.81 6.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -78.92 136.42 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.213 -0.929 . . . . 0.0 108.534 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 157.44 46.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.937 0.895 . . . . 0.0 109.249 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -131.97 146.52 52.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.279 1.432 . . . . 0.0 108.789 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -138.45 124.98 20.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -86.97 108.55 18.87 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 pt -65.43 -23.56 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.16 -45.36 93.75 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.132 0.878 . . . . 0.0 108.794 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -77.49 -35.18 53.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.371 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -123.03 69.13 37.3 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.986 0.914 . . . . 0.0 111.51 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.24 -55.86 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.102 1.868 . . . . 0.0 112.19 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.3 -40.65 2.68 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.782 1.658 . . . . 0.0 114.691 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.55 -33.7 68.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.092 -0.652 . . . . 0.0 112.494 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -64.58 -65.07 2.17 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.581 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 80.5 Cg_exo -48.21 -42.99 32.6 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.783 2.322 . . . . 0.0 112.786 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? . . . . . 0 C--N 1.343 0.325 0 CA-C-N 118.942 0.792 . . . . 0.0 112.027 179.082 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 117.998 -1.001 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.44 141.37 57.48 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 120.727 1.295 . . . . 0.0 110.308 -0.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 m -141.07 125.72 17.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.51 107.37 17.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.274 1.43 . . . . 0.0 109.516 -174.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -95.79 116.13 28.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.5 99.9 12.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 N--CA 1.454 -0.236 0 C-N-CA 125.225 1.41 . . . . 0.0 108.949 179.069 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.0 t -61.34 104.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.32 22.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.674 0.79 . . . . 0.0 110.067 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.67 156.45 34.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.09 0.556 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.447 HG22 ' HG ' ' A' ' 79' ' ' LEU . 77.0 p -132.07 112.45 12.35 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.673 1.189 . . . . 0.0 109.025 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -98.73 110.85 23.39 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.59 131.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.29 162.69 38.46 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.744 0.688 . . . . 0.0 111.996 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.43 170.06 12.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.223 0.609 . . . . 0.0 110.442 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -164.54 163.75 21.89 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.027 1.331 . . . . 0.0 108.002 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.9 p -73.79 163.08 28.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.124 0.487 . . . . 0.0 110.817 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.41 -44.63 76.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.36 -54.52 36.49 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -56.65 -44.47 81.34 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.272 0.536 . . . . 0.0 110.404 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.79 -53.87 52.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -54.82 -46.28 74.52 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.142 0.428 . . . . 0.0 110.835 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.03 -53.72 54.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.528 0.731 . . . . 0.0 110.057 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.64 -53.09 59.33 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.148 0.979 . . . . 0.0 110.421 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.21 -50.62 72.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.674 0.389 . . . . 0.0 110.305 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.3 -51.71 65.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.612 0.365 . . . . 0.0 110.288 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.91 -37.79 69.39 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.658 0.783 . . . . 0.0 111.928 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -77.88 -46.89 20.07 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.0 mt -58.77 -44.64 90.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.066 0.546 . . . . 0.0 109.719 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 122.998 0.519 . . . . 0.0 109.636 177.556 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.6 mttm . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 mt -105.86 133.02 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.023 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mt -86.94 146.03 6.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -115.52 100.1 7.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.1 163.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.636 1.174 . . . . 0.0 113.209 -173.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.2 p -135.57 163.89 29.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.512 1.925 . . . . 0.0 106.288 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -54.39 -45.91 72.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 109.89 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.21 -44.56 92.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.184 1.394 . . . . 0.0 112.049 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -78.61 -31.61 47.11 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.203 -0.311 . . . . 0.0 111.227 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -32.66 -55.07 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.215 1.806 . . . . 0.0 115.048 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -54.67 -62.55 1.58 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.455 -0.778 . . . . 0.0 111.438 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -63.52 -42.48 98.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.969 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.13 -37.85 66.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.505 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.46 -65.21 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.749 0.82 . . . . 0.0 112.382 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.09 -36.2 72.51 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 118.5 -0.762 . . . . 0.0 113.018 179.167 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mt -111.36 129.9 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.99 1.316 . . . . 0.0 107.724 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.06 102.46 10.67 Favored 'General case' 0 C--O 1.228 -0.057 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.92 115.69 32.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.521 0.329 . . . . 0.0 110.692 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.45 110.55 22.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.527 1.131 . . . . 0.0 109.073 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -82.14 123.9 29.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -138.07 173.8 11.24 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.421 0.688 . . . . 0.0 111.55 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.96 151.42 38.59 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 125.207 1.403 . . . . 0.0 107.734 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.75 -38.12 66.78 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.777 0.717 . . . . 0.0 112.354 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -80.05 -4.7 53.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.128 0.971 . . . . 0.0 112.911 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.0 t -79.46 82.03 5.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 120.906 -1.121 . . . . 0.0 111.193 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.92 -57.95 4.5 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.429 0.538 . . . . 0.0 112.269 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.21 -32.23 49.41 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.386 2.724 . . . . 0.0 113.481 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.39 -41.01 98.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -63.61 -41.63 98.29 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 92.5 mmm -60.35 -45.06 94.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.535 -0.269 . . . . 0.0 110.981 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.21 -27.66 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.605 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -57.38 1.26 Allowed Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.26 -37.45 95.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.069 1.846 . . . . 0.0 111.66 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mt -62.11 -48.95 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.64 -43.92 76.68 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -60.51 -51.91 67.43 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.113 -0.367 . . . . 0.0 110.732 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -54.45 -50.99 66.38 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.92 -46.95 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.747 0.819 . . . . 0.0 109.937 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -43.44 71.61 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.12 -55.95 12.03 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.378 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.66 -45.45 63.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.285 1.034 . . . . 0.0 112.858 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -98.15 22.38 9.57 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.216 1.007 . . . . 0.0 111.426 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -52.9 131.34 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.514 1.052 . . . . 0.0 110.512 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.13 -20.75 11.87 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.081 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.18 -48.47 4.83 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.735 1.267 . . . . 0.0 109.268 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.59 122.51 39.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.495 1.118 . . . . 0.0 109.156 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.9 m -92.78 101.58 13.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -78.91 139.57 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.97 157.94 44.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.867 0.867 . . . . 0.0 108.918 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.67 147.81 51.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.155 1.782 . . . . 0.0 108.085 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -139.11 125.61 20.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -87.37 109.04 19.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.2 -24.88 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.74 -50.22 74.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.452 1.024 . . . . 0.0 108.847 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -75.53 -26.71 58.29 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.001 0.92 . . . . 0.0 111.185 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -127.47 69.35 75.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.405 0.682 . . . . 0.0 111.939 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.55 -59.57 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.428 2.085 . . . . 0.0 112.94 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.93 -41.0 2.46 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.064 1.792 . . . . 0.0 115.233 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -26.9 66.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.026 -0.69 . . . . 0.0 112.717 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.572 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -71.31 -64.94 1.02 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.083 0.856 . . . . 0.0 110.463 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 88.7 Cg_exo -47.44 -39.07 28.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.283 2.656 . . . . 0.0 112.971 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 118.602 0.637 . . . . 0.0 112.59 177.644 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.12 145.2 75.04 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 120.573 1.24 . . . . 0.0 109.927 -1.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.3 m -139.96 127.58 21.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -110.4 108.18 18.12 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.126 1.37 . . . . 0.0 109.686 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -96.45 118.16 32.38 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -97.0 99.51 11.04 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.426 0.69 . . . . 0.0 109.379 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 . . . . . 0 N--CA 1.452 -0.34 0 C-N-CA 125.734 1.613 . . . . 0.0 109.991 179.783 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.12 106.25 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.64 22.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.632 0.773 . . . . 0.0 109.824 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.84 158.51 35.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.249 0.62 . . . . 0.0 109.657 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.451 HG22 ' HG ' ' A' ' 79' ' ' LEU . 80.7 p -131.97 112.17 12.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.869 1.267 . . . . 0.0 108.653 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -98.79 111.51 23.87 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -91.0 130.51 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.24 163.78 34.71 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.084 0.85 . . . . 0.0 111.896 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.62 167.22 22.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 110.246 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.06 166.81 27.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.566 1.146 . . . . 0.0 108.544 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.0 p -83.21 161.71 21.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.022 0.439 . . . . 0.0 110.526 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -52.98 -42.85 65.92 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.524 0.73 . . . . 0.0 110.519 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.79 -54.39 37.94 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -55.36 -46.05 76.48 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.348 -0.501 . . . . 0.0 109.979 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.5 tp -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -53.63 -49.88 66.91 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.607 0.639 . . . . 0.0 111.107 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -57.76 -50.96 71.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.94 -52.6 60.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.506 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.69 -52.11 66.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.037 0.535 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.11 -52.7 60.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.646 0.379 . . . . 0.0 110.292 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.74 -39.5 71.23 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.767 0.827 . . . . 0.0 112.003 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.85 -47.08 19.66 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.218 -0.301 . . . . 0.0 110.554 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -57.98 -47.6 82.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.176 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.9 mt -87.0 140.06 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.424 0.69 . . . . 0.0 111.215 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -90.97 114.53 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.326 0.65 . . . . 0.0 110.422 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -85.59 102.4 13.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 0.0 109.946 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.96 163.16 14.1 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.035 1.334 . . . . 0.0 113.19 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.0 p -130.74 159.74 36.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.189 2.196 . . . . 0.0 106.228 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.24 -45.6 68.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.35 -47.46 75.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.92 1.288 . . . . 0.0 111.626 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -78.23 -26.07 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -37.24 -51.87 1.04 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 114.092 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.87 -62.95 1.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.574 0.702 . . . . 0.0 111.019 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -57.65 -39.21 76.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.918 0.887 . . . . 0.0 112.32 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -55.58 4.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.91 -53.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.235 1.014 . . . . 0.0 112.959 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.01 -37.74 86.02 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.991 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.109 174.934 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.87 125.33 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.543 1.137 . . . . 0.0 108.219 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 tp -102.31 101.91 12.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.4 t -86.57 118.62 33.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -97.73 116.5 30.07 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.575 0.75 . . . . 0.0 109.053 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -90.81 121.35 32.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -135.39 178.65 6.87 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.936 0.895 . . . . 0.0 111.584 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.72 150.6 33.44 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 125.413 1.485 . . . . 0.0 108.327 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -55.75 -37.27 68.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.891 0.876 . . . . 0.0 112.386 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -83.33 -5.43 59.14 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.139 0.976 . . . . 0.0 112.54 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.59 81.69 5.81 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 120.958 -1.089 . . . . 0.0 111.684 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.81 -57.49 3.41 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.811 0.72 . . . . 0.0 112.362 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -52.59 -36.96 73.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.999 2.466 . . . . 0.0 113.31 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.0 m -64.01 -47.75 79.05 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -57.85 -43.22 85.75 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.2 mtm -61.0 -44.89 96.76 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.598 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -74.67 -27.51 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.359 0.981 . . . . 0.0 112.507 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.43 -58.16 1.03 Allowed Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.99 -37.42 96.14 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.495 2.13 . . . . 0.0 112.324 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.8 mt -62.4 -51.13 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.4 mt -55.09 -42.05 72.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.17 0.188 . . . . 0.0 110.598 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.67 -51.74 68.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 109.727 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.22 -44.75 84.01 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.866 -0.521 . . . . 0.0 110.274 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.4 mm -58.33 -46.78 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.548 0.739 . . . . 0.0 109.287 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -45.46 66.9 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.79 -59.12 5.31 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -48.81 -48.04 41.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -94.02 15.09 17.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.243 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.47 1.032 . . . . 0.0 111.491 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.25 -28.47 2.58 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.819 1.199 . . . . 0.0 110.242 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -99.47 -38.2 8.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.28 1.032 . . . . 0.0 109.987 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 tp -135.11 141.32 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.8 m -108.03 104.82 14.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -79.11 137.74 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.7 156.17 48.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.863 0.865 . . . . 0.0 108.786 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -132.64 146.21 51.7 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.476 1.51 . . . . 0.0 109.908 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.42 126.17 19.29 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.421 0.688 . . . . 0.0 109.394 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -87.17 109.31 19.37 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.88 -24.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.99 0.516 . . . . 0.0 111.719 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.51 -46.39 90.29 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.261 0.937 . . . . 0.0 108.898 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -77.66 -35.72 52.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -121.79 69.15 25.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.28 1.032 . . . . 0.0 111.139 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.32 -56.33 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.473 2.115 . . . . 0.0 112.787 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.62 -45.6 1.02 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.092 1.806 . . . . 0.0 114.597 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -37.23 31.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.307 1.043 . . . . 0.0 113.078 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.04 -66.44 1.49 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.396 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.63 -36.84 91.21 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.72 1.613 . . . . 0.0 111.22 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 C--N 1.345 0.373 0 CA-C-N 119.349 0.977 . . . . 0.0 110.71 177.303 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 pt . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.67 142.0 65.22 Favored 'Cis proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.219 1.114 . . . . 0.0 110.562 -0.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 144.46 47.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.0 mt -128.64 101.46 6.16 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 mp -104.97 120.71 42.12 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -95.47 105.01 16.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.842 0.857 . . . . 0.0 109.495 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 125.835 1.654 . . . . 0.0 110.057 179.709 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.49 102.79 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.68 -43.28 23.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.047 0.939 . . . . 0.0 110.956 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.57 154.36 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.142 0.577 . . . . 0.0 109.524 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.8 p -136.75 116.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.473 1.109 . . . . 0.0 109.453 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -108.46 136.26 48.38 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.62 128.16 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.57 168.15 35.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.789 0.709 . . . . 0.0 111.394 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.39 168.05 20.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.198 0.599 . . . . 0.0 110.552 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -162.24 164.07 27.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 107.779 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.67 161.26 30.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -56.72 -43.67 80.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.1 -58.33 14.23 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -53.13 -45.93 68.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 110.945 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.75 -51.38 70.0 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.388 -0.195 . . . . 0.0 110.73 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -56.64 -47.66 79.24 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.132 0.424 . . . . 0.0 110.688 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.73 -52.37 65.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.661 0.784 . . . . 0.0 109.757 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -54.87 -55.4 30.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.997 0.919 . . . . 0.0 110.319 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -57.3 -48.61 78.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.136 -0.352 . . . . 0.0 110.792 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.57 -51.48 68.43 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.577 0.351 . . . . 0.0 110.243 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.26 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.975 0.91 . . . . 0.0 111.972 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -78.17 -50.06 12.66 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 117.847 0.294 . . . . 0.0 110.367 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.9 mt -63.38 -42.97 98.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.444 . . . . 0.0 110.514 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.136 0 C-N-CA 124.703 1.201 . . . . 0.0 111.703 179.359 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.1 mt -108.17 137.42 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.922 1.289 . . . . 0.0 108.809 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 mt -85.73 146.92 5.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -117.29 99.38 6.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.81 164.36 14.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.476 1.111 . . . . 0.0 113.306 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.1 p -134.98 162.69 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.228 1.811 . . . . 0.0 106.417 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.64 -44.59 77.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.403 0.547 . . . . 0.0 109.615 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.53 -44.71 89.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.976 1.31 . . . . 0.0 111.893 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.58 -32.71 47.82 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.159 -0.338 . . . . 0.0 111.222 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -32.15 -53.32 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.028 2.131 . . . . 0.0 115.315 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.99 -61.61 2.19 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 110.983 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -43.54 98.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.736 0.815 . . . . 0.0 112.307 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -31.07 53.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.261 -0.876 . . . . 0.0 113.273 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.35 -61.63 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.975 0.91 . . . . 0.0 111.382 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.22 -36.13 74.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.22 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.29 127.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.926 1.29 . . . . 0.0 108.714 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.39 103.0 12.36 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.8 t -90.49 118.48 35.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.46 108.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.913 1.285 . . . . 0.0 108.442 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.72 121.81 25.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -137.54 179.48 6.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.919 0.887 . . . . 0.0 111.696 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.6 30.22 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.325 1.45 . . . . 0.0 109.55 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -51.74 -37.12 49.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.84 0.745 . . . . 0.0 112.203 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -85.63 -4.56 59.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.053 0.941 . . . . 0.0 113.03 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -79.42 79.86 5.83 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.934 -1.104 . . . . 0.0 111.111 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.28 -59.91 2.1 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 123.904 0.764 . . . . 0.0 112.693 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.87 -29.07 51.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.402 2.735 . . . . 0.0 113.937 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.75 -42.47 99.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.408 -0.807 . . . . 0.0 109.227 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -66.12 -35.58 80.88 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.8 mtt -62.27 -44.64 96.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.26 -25.54 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 118.772 -0.632 . . . . 0.0 112.435 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.31 -57.88 1.31 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.03 -38.17 96.58 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.812 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mt -60.84 -50.32 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -55.71 -43.95 76.99 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.808 0.443 . . . . 0.0 110.303 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.92 -51.58 68.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.477 0.656 . . . . 0.0 110.354 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -54.73 -48.72 72.18 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.68 -47.61 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 122.827 0.451 . . . . 0.0 109.824 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.71 -44.94 66.66 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.4 0.545 . . . . 0.0 110.495 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -68.13 -57.77 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.755 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -52.19 -43.06 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 113.515 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.07 16.85 19.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.244 1.018 . . . . 0.0 111.674 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.26 134.33 33.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.353 0.979 . . . . 0.0 110.25 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -25.5 6.7 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.705 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -98.84 -41.1 7.79 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.782 1.291 . . . . 0.0 109.689 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -131.19 140.03 49.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.541 1.137 . . . . 0.0 109.743 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -109.56 106.1 15.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.87 135.66 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.67 156.75 47.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.739 0.816 . . . . 0.0 109.115 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.897 1.679 . . . . 0.0 107.403 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.6 123.83 19.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -86.79 108.48 18.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.22 -25.81 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 111.933 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -62.41 -45.86 91.22 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.584 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.8 70.12 72.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.26 -56.22 2.94 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.425 2.083 . . . . 0.0 112.857 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.98 -40.85 2.44 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.059 1.79 . . . . 0.0 115.625 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 -22.01 66.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.836 0.818 . . . . 0.0 112.98 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -74.6 -61.98 1.03 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.452 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 87.8 Cg_exo -48.42 -39.85 36.2 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.132 2.555 . . . . 0.0 112.274 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp . . . . . 0 C--N 1.344 0.336 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.345 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 pt . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.03 141.11 54.59 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 121.027 1.403 . . . . 0.0 109.99 -0.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.6 m -139.45 121.86 16.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 mt -100.75 127.62 47.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.393 1.477 . . . . 0.0 108.943 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.2 119.36 34.46 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.31 102.87 14.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.454 -0.265 0 C-N-CA 125.685 1.594 . . . . 0.0 110.018 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.68 107.26 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.58 -44.14 21.64 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.366 0.667 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.36 167.84 25.0 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.7 p -142.65 165.99 25.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -150.67 120.59 7.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.83 131.64 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.22 164.86 36.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.947 0.784 . . . . 0.0 111.598 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.96 167.11 22.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.157 0.583 . . . . 0.0 110.256 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -161.38 162.85 30.86 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.911 1.284 . . . . 0.0 108.254 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.8 p -73.95 164.14 27.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.363 0.601 . . . . 0.0 111.487 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -53.29 -49.28 67.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.17 -55.21 30.55 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.69 -47.61 73.44 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 117.542 0.671 . . . . 0.0 110.671 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 tp -59.8 -49.58 77.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -53.29 -50.85 64.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.64 0.376 . . . . 0.0 110.875 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -60.14 -50.19 74.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.798 0.439 . . . . 0.0 110.47 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.37 -54.25 39.37 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.141 0.576 . . . . 0.0 109.946 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.6 mt -59.18 -49.91 76.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.269 -0.269 . . . . 0.0 110.884 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.86 -53.51 54.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 117.784 0.266 . . . . 0.0 110.306 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.98 74.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.234 1.014 . . . . 0.0 111.916 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -77.74 -42.53 33.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.258 -0.276 . . . . 0.0 110.727 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.13 -44.87 94.38 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.559 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.37 132.21 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.16 123.87 48.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 123.502 0.721 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -90.67 108.51 19.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.143 0.977 . . . . 0.0 109.469 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.6 mt -94.04 166.36 12.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.072 0.949 . . . . 0.0 112.943 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -132.5 162.24 31.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.14 -47.65 74.81 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.65 -47.62 83.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.095 1.358 . . . . 0.0 111.534 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -78.45 -25.25 45.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -35.9 -51.27 0.7 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.443 1.897 . . . . 0.0 114.91 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.53 -62.32 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.93 0.787 . . . . 0.0 110.739 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -60.36 -42.36 95.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.529 0.731 . . . . 0.0 111.643 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.59 -41.41 69.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.3 t -107.98 -63.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.487 1.115 . . . . 0.0 113.133 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.11 -37.28 74.25 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.062 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.31 124.48 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 108.643 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 tp -105.39 99.48 9.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -89.37 114.66 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -89.56 105.57 17.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.52 119.96 23.23 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -134.33 -177.94 4.82 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.563 1.145 . . . . 0.0 111.2 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.59 35.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.737 1.215 . . . . 0.0 109.306 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -54.88 -28.53 51.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.519 1.128 . . . . 0.0 112.758 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -94.96 -4.63 46.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 112.387 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.1 t -79.99 83.7 5.85 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.007 -1.058 . . . . 0.0 111.583 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.7 -61.38 3.37 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.24 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.38 -36.71 31.14 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.7 2.933 . . . . 0.0 113.779 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.5 -37.99 85.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -70.27 -46.5 64.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -40.91 60.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 119.184 -0.436 . . . . 0.0 111.461 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -81.82 -10.88 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.5 -51.45 69.25 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 119.995 1.27 . . . . 0.0 113.295 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.73 -41.7 72.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.314 2.01 . . . . 0.0 111.537 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.11 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -54.31 -44.61 72.14 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -60.13 -57.27 13.54 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.007 0.523 . . . . 0.0 111.321 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -60.0 -40.81 90.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.627 -0.671 . . . . 0.0 110.719 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.81 -46.5 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.92 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.725 0.41 . . . . 0.0 110.259 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.09 -54.7 25.96 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -51.16 -46.71 62.12 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.391 1.076 . . . . 0.0 112.593 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -96.07 18.84 12.66 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.642 0.777 . . . . 0.0 111.903 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -50.67 137.02 20.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.335 0.971 . . . . 0.0 111.334 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 -26.23 5.11 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.554 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -99.1 -51.27 3.88 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.772 1.286 . . . . 0.0 109.189 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.39 132.09 56.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.663 1.185 . . . . 0.0 108.995 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -106.65 102.47 11.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.34 160.8 39.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -136.04 147.46 47.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.949 1.3 . . . . 0.0 108.351 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -140.76 125.6 18.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -87.97 108.58 19.27 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.88 -25.71 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.711 0.804 . . . . 0.0 112.178 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.41 -46.48 89.95 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.105 0.866 . . . . 0.0 108.976 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.98 -35.44 57.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.344 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -120.92 68.82 16.82 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.126 0.97 . . . . 0.0 111.313 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.59 -51.97 2.17 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.381 2.054 . . . . 0.0 112.335 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.0 -38.08 4.53 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.873 1.225 . . . . 0.0 114.305 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -31.8 71.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.954 -0.733 . . . . 0.0 112.341 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.86 -65.26 2.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.434 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 83.3 Cg_exo -49.52 -45.76 29.63 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.558 2.172 . . . . 0.0 112.438 174.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp . . . . . 0 C--N 1.344 0.362 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.433 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.6 pt . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.22 147.44 87.55 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.834 0.976 . . . . 0.0 110.435 -0.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 m -133.19 122.79 24.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.85 100.05 10.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.99 113.37 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -93.28 97.55 10.69 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.631 0.772 . . . . 0.0 109.646 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 N--CA 1.451 -0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 108.895 178.288 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 106.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.52 -43.18 23.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.611 0.764 . . . . 0.0 109.887 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.99 156.51 31.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.706 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.9 p -127.8 99.93 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.226 1.41 . . . . 0.0 108.389 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.07 105.53 16.56 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.33 132.7 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.83 164.89 40.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.163 0.887 . . . . 0.0 112.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.4 171.14 13.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.143 0.577 . . . . 0.0 110.235 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.33 168.07 17.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.474 1.51 . . . . 0.0 107.774 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -77.94 164.57 24.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.918 0.389 . . . . 0.0 110.467 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.45 -46.85 80.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.54 -56.34 24.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.44 -39.73 80.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.617 0.708 . . . . 0.0 110.514 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.06 -48.61 80.94 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.147 0.431 . . . . 0.0 110.127 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -56.17 -47.96 77.26 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.595 0.634 . . . . 0.0 110.665 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -57.19 -52.01 67.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.649 0.379 . . . . 0.0 110.153 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -53.66 -53.26 54.43 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 110.154 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -56.6 -52.39 65.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.761 0.424 . . . . 0.0 110.303 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.19 -52.07 62.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.916 0.325 . . . . 0.0 110.615 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.7 75.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.871 0.868 . . . . 0.0 112.287 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -78.45 -46.05 20.68 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 117.899 0.318 . . . . 0.0 110.872 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -61.23 -47.28 86.81 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.407 0.683 . . . . 0.0 109.744 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 124.606 1.162 . . . . 0.0 111.492 179.391 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.56 142.36 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.385 0.674 . . . . 0.0 110.874 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -91.86 116.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-O 121.473 0.654 . . . . 0.0 110.875 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.23 101.87 11.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.524 1.129 . . . . 0.0 108.921 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.1 164.71 20.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 112.933 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.5 p -132.49 160.65 35.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 170.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -55.71 -44.24 77.27 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.742 0.701 . . . . 0.0 109.475 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.21 -47.98 83.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.848 1.259 . . . . 0.0 111.549 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.8 p -78.64 -21.79 47.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.007 -0.433 . . . . 0.0 112.105 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.95 -51.89 1.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.161 1.784 . . . . 0.0 113.729 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -51.65 -61.51 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.468 0.652 . . . . 0.0 110.681 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -60.92 -46.86 88.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.716 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -69.88 -32.21 70.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.7 -64.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.267 1.027 . . . . 0.0 111.833 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.3 -37.45 77.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.46 -0.15 . . . . 0.0 111.358 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 mttm . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.967 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.75 138.26 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 C-N-CA 125.577 1.551 . . . . 0.0 108.622 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.2 tp -118.08 102.47 9.05 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -94.5 106.41 18.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.879 1.272 . . . . 0.0 107.923 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.22 123.94 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -138.09 177.62 7.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.606 0.762 . . . . 0.0 112.061 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.64 151.15 35.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.807 1.643 . . . . 0.0 108.126 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -54.69 -36.93 65.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.309 0.644 . . . . 0.0 111.897 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -85.12 -2.47 58.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.524 1.13 . . . . 0.0 112.745 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.2 t -79.58 80.3 5.97 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.9 -1.125 . . . . 0.0 111.411 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.61 -57.86 3.73 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 123.785 0.707 . . . . 0.0 112.001 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -53.1 -34.46 68.4 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.097 2.531 . . . . 0.0 113.484 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -64.01 -46.55 83.99 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -61.41 -41.86 97.81 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -57.43 -43.76 84.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.198 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -78.76 -26.25 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.822 0.737 . . . . 0.0 112.81 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.2 -55.09 3.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.37 -43.17 39.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.948 2.432 . . . . 0.0 112.904 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.8 -49.82 82.7 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 mt -55.74 -44.06 77.19 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -58.63 -57.68 11.89 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.524 0.73 . . . . 0.0 110.377 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -59.74 -43.08 94.38 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.773 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 mm -54.59 -44.66 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.912 0.485 . . . . 0.0 109.996 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -35.17 65.73 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.074 0.397 . . . . 0.0 111.126 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -76.48 -52.44 9.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.0 -45.12 64.42 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.953 0.901 . . . . 0.0 111.682 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -98.06 24.72 6.75 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.266 1.027 . . . . 0.0 111.522 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -54.04 129.73 35.4 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.462 1.028 . . . . 0.0 110.421 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.77 -17.47 15.6 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.305 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -99.38 -44.79 6.07 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.692 1.246 . . . . 0.0 109.56 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.4 tp -127.22 128.53 46.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.166 0.986 . . . . 0.0 109.724 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -94.94 96.03 9.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.21 136.1 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.67 150.31 49.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.17 0.988 . . . . 0.0 109.524 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -124.61 138.65 54.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.508 1.523 . . . . 0.0 107.38 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -131.06 120.4 23.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.49 110.77 18.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.9 -36.72 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.42 -46.63 89.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.0 0.818 . . . . 0.0 109.688 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.33 -30.05 65.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.244 1.017 . . . . 0.0 110.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -127.92 72.4 78.88 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.857 0.863 . . . . 0.0 111.341 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -52.79 -59.04 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.896 2.397 . . . . 0.0 113.192 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.68 -47.32 2.29 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.765 1.65 . . . . 0.0 115.171 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -28.63 68.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -65.03 -67.68 0.98 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.302 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 89.0 Cg_exo -49.22 -45.11 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.194 1.929 . . . . 0.0 112.558 175.542 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 C--N 1.345 0.379 0 CA-C-N 118.359 0.527 . . . . 0.0 112.2 179.042 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.36 145.15 75.42 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 120.575 1.241 . . . . 0.0 109.624 -1.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.9 m -139.38 127.87 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.02 113.03 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.302 1.441 . . . . 0.0 109.233 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -105.87 120.18 41.09 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.66 103.83 15.82 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 126.352 1.861 . . . . 0.0 109.538 -179.757 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.41 105.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.73 -45.26 19.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.733 0.813 . . . . 0.0 109.949 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.66 158.56 35.67 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.525 HG22 ' HG ' ' A' ' 79' ' ' LEU . 53.3 p -134.26 124.99 26.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.531 1.133 . . . . 0.0 108.756 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -113.77 117.88 32.74 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -95.37 129.72 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.18 164.71 35.04 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.007 0.813 . . . . 0.0 111.554 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 164.51 25.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.948 0.499 . . . . 0.0 110.116 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.86 161.51 39.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.296 1.038 . . . . 0.0 108.81 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.4 p -72.84 162.26 29.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.316 0.579 . . . . 0.0 110.589 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -56.73 -40.12 75.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.6 -54.69 35.61 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -56.77 -43.53 80.9 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.201 0.501 . . . . 0.0 110.299 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.22 -53.63 56.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -53.82 -48.15 70.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.469 0.577 . . . . 0.0 110.731 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.76 -53.16 58.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.187 0.595 . . . . 0.0 110.04 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -55.17 -52.31 63.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.598 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -57.0 -54.01 51.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.847 0.459 . . . . 0.0 110.221 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.58 -50.55 67.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.923 0.489 . . . . 0.0 110.653 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.17 76.94 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.197 0.599 . . . . 0.0 111.691 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -77.96 -49.38 14.23 Favored 'General case' 0 N--CA 1.46 0.074 0 O-C-N 122.19 -0.319 . . . . 0.0 111.048 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.4 mt -60.07 -46.03 90.93 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.214 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 177.941 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.4 mttm . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.6 mt -86.44 136.11 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.898 0.479 . . . . 0.0 111.111 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -91.93 116.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.388 0.675 . . . . 0.0 110.6 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -86.29 99.95 11.94 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.291 1.037 . . . . 0.0 109.204 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.24 166.1 16.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.139 0.976 . . . . 0.0 112.24 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p -131.09 163.37 27.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -53.97 -49.78 68.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.92 -46.19 90.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.03 1.332 . . . . 0.0 111.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.9 p -78.46 -24.75 45.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -34.57 -61.3 0.4 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 126.034 1.734 . . . . 0.0 114.052 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.68 -59.32 4.75 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.714 -0.616 . . . . 0.0 110.916 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.36 -38.15 71.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.424 0.69 . . . . 0.0 112.698 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -81.86 -57.93 3.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.405 0.622 . . . . 0.0 112.086 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.39 -55.29 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.18 1.792 . . . . 0.0 113.075 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.13 -28.67 69.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.581 -0.699 . . . . 0.0 111.898 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 CA--C 1.54 0.582 0 O-C-N 122.079 -0.388 . . . . 0.0 111.468 174.824 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.9 127.99 69.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.297 1.039 . . . . 0.0 108.931 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.32 101.86 11.31 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -89.86 112.14 24.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 118.099 0.409 . . . . 0.0 110.718 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.23 106.22 18.27 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.223 1.009 . . . . 0.0 108.659 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -79.69 121.56 25.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -139.24 -178.41 5.35 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.493 0.717 . . . . 0.0 111.169 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.8 151.86 34.24 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 108.495 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -53.69 -39.5 65.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.074 0.95 . . . . 0.0 111.876 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -82.23 -6.23 59.07 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.078 0.951 . . . . 0.0 112.573 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.3 t -79.43 80.61 5.78 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.059 -1.026 . . . . 0.0 111.115 -177.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.45 -58.48 2.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.29 0.948 . . . . 0.0 112.149 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.48 -38.66 89.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.331 2.687 . . . . 0.0 113.18 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -62.6 -47.58 83.18 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.83 -44.46 96.79 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.6 ttm -52.04 -41.56 62.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.919 0.888 . . . . 0.0 111.315 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -83.49 -8.71 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.57 -50.79 74.96 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.058 1.299 . . . . 0.0 113.032 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.68 -41.83 70.95 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.445 2.097 . . . . 0.0 111.516 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.96 -51.15 76.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -54.85 -43.85 73.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.112 0.414 . . . . 0.0 110.78 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.01 -53.15 60.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.272 0.558 . . . . 0.0 109.872 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.49 -47.04 73.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.895 0.478 . . . . 0.0 110.083 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.9 mm -59.12 -47.19 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.157 0.983 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.36 -42.43 66.82 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.753 0.421 . . . . 0.0 109.875 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.38 -56.64 8.86 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -50.67 -45.23 57.95 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.738 0.815 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -97.33 21.36 10.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.91 128.71 31.27 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.408 1.004 . . . . 0.0 110.109 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.55 -19.55 23.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.224 -0.765 . . . . 0.0 113.058 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -99.14 -44.29 6.33 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.658 1.229 . . . . 0.0 109.381 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -132.71 133.97 44.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.369 1.068 . . . . 0.0 108.796 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.4 m -101.44 105.74 16.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.04 139.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.99 154.89 50.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.897 0.879 . . . . 0.0 109.074 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.95 147.56 52.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.719 1.207 . . . . 0.0 108.433 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 tt -138.89 120.32 14.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -85.29 107.51 17.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.29 -24.19 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.651 0.781 . . . . 0.0 112.116 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -61.77 -46.56 89.06 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.122 0.874 . . . . 0.0 108.885 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -76.05 -35.44 59.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.277 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.42 70.13 11.87 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.377 1.071 . . . . 0.0 111.073 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.12 -54.36 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.385 2.057 . . . . 0.0 112.418 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.12 -41.42 3.75 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.941 1.258 . . . . 0.0 114.594 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.23 71.12 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.016 -0.696 . . . . 0.0 112.32 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.02 -66.81 1.33 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.641 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 81.0 Cg_exo -49.31 -48.49 18.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.166 1.911 . . . . 0.0 112.173 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp . . . . . 0 C--N 1.344 0.355 0 CA-C-N 118.079 0.399 . . . . 0.0 111.845 -179.736 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.7 144.51 76.71 Favored 'Cis proline' 0 N--CA 1.456 -0.719 0 CA-C-N 120.543 1.23 . . . . 0.0 110.053 -0.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.5 m -136.81 123.4 20.97 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -107.21 104.27 13.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 109.704 -173.275 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.512 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.1 mp -94.09 115.77 28.12 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.5 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.956 1.302 . . . . 0.0 109.306 178.504 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.92 107.13 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.67 -43.96 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.62 0.768 . . . . 0.0 110.046 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.53 156.28 34.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.078 0.551 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.512 HG22 ' HG ' ' A' ' 79' ' ' LEU . 73.7 p -129.26 110.81 12.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.856 1.262 . . . . 0.0 109.348 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -98.49 110.46 23.05 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -91.29 129.68 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.34 163.9 34.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.191 0.901 . . . . 0.0 112.177 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 167.77 20.18 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 110.129 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.81 169.55 21.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.332 1.053 . . . . 0.0 109.258 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.6 p -77.54 160.16 28.8 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.782 0.433 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.11 -45.52 75.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.98 -54.05 38.04 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.02 -39.19 88.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.923 0.862 . . . . 0.0 111.148 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.98 -52.36 65.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -55.33 -45.51 76.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.898 -0.501 . . . . 0.0 111.283 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.48 -55.35 34.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 109.885 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -53.4 -51.88 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.041 0.936 . . . . 0.0 110.727 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.64 -51.73 68.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.811 0.444 . . . . 0.0 110.238 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -54.42 -51.68 64.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.807 0.443 . . . . 0.0 110.214 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.48 70.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.503 0.721 . . . . 0.0 111.843 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -78.06 -40.32 38.98 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.121 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.2 mt -62.01 -47.45 84.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.262 0 C-N-CA 123.17 0.588 . . . . 0.0 109.734 177.592 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -95.56 142.76 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.895 0.878 . . . . 0.0 110.611 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.97 115.35 29.97 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-O 121.572 0.701 . . . . 0.0 111.456 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -84.56 95.77 8.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.777 1.231 . . . . 0.0 109.408 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.44 163.24 16.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.072 0.949 . . . . 0.0 113.121 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.1 p -128.17 160.67 31.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.547 1.939 . . . . 0.0 107.701 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.1 -51.55 57.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.037 0.935 . . . . 0.0 109.197 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.23 -45.15 72.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.343 1.457 . . . . 0.0 111.836 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.61 -26.69 45.4 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -34.03 -69.43 0.09 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.608 1.563 . . . . 0.0 114.968 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.74 -59.75 3.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.58 0.752 . . . . 0.0 110.295 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -51.58 -42.53 61.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.96 1.304 . . . . 0.0 113.377 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.28 -53.15 5.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.747 0.419 . . . . 0.0 111.538 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -79.66 -58.78 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.791 1.236 . . . . 0.0 113.204 -173.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.34 -32.8 73.63 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.055 -0.403 . . . . 0.0 111.579 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.727 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.08 134.19 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.05 101.78 9.32 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.57 114.93 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.84 107.35 19.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.847 1.259 . . . . 0.0 108.294 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -79.8 126.11 30.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -136.12 178.26 7.19 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.654 0.781 . . . . 0.0 111.734 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.8 37.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.556 1.542 . . . . 0.0 108.245 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -53.15 -35.82 60.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.998 0.919 . . . . 0.0 112.121 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -89.2 -2.37 58.47 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.999 1.319 . . . . 0.0 112.79 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.4 t -79.52 78.04 6.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.948 -1.095 . . . . 0.0 111.711 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.88 -57.78 3.36 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.659 0.647 . . . . 0.0 112.341 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -52.51 -35.7 67.47 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.227 2.618 . . . . 0.0 113.241 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.39 -45.48 92.97 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -60.76 -42.74 98.06 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 93.5 mmm -59.02 -45.84 89.68 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.164 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -76.6 -26.23 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.612 0.642 . . . . 0.0 112.592 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.57 -57.69 0.91 Allowed Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.36 -40.09 87.45 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.298 1.998 . . . . 0.0 111.835 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.2 -49.14 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 mt -56.27 -42.85 78.14 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.88 -47.5 86.09 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.12 -48.47 80.11 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.833 -0.542 . . . . 0.0 109.73 177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.8 mm -55.66 -46.79 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.976 0.51 . . . . 0.0 109.9 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.06 -35.97 62.6 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.238 0.615 . . . . 0.0 110.768 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.4 -59.15 2.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -49.63 -44.19 47.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.53 1.132 . . . . 0.0 113.174 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -102.21 20.75 16.16 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.108 0.963 . . . . 0.0 111.502 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.41 125.71 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.386 0.994 . . . . 0.0 109.496 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.42 -20.09 39.81 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.58 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -99.2 -46.69 5.46 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.492 1.146 . . . . 0.0 109.362 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -127.11 124.17 38.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.715 1.206 . . . . 0.0 108.553 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.7 m -92.45 101.02 13.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -78.82 139.97 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.75 154.76 50.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.438 1.095 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -130.28 145.99 51.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.043 1.737 . . . . 0.0 107.35 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -143.94 126.79 16.27 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -86.7 106.72 17.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 109.256 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.15 -24.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.996 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -62.23 -44.41 96.62 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.419 1.009 . . . . 0.0 108.903 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -78.68 -34.47 46.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.425 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -123.4 66.37 33.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.678 1.191 . . . . 0.0 111.922 -173.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.15 -52.06 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.686 2.257 . . . . 0.0 112.94 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.07 -41.74 1.44 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.82 1.676 . . . . 0.0 114.268 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -37.21 54.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.195 0.998 . . . . 0.0 113.239 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.43 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.768 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 99.8 Cg_exo -44.9 -48.1 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.795 2.33 . . . . 0.0 113.131 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt . . . . . 0 C--N 1.346 0.442 0 CA-C-N 118.912 0.778 . . . . 0.0 112.572 -179.546 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.8 pt . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.4 141.94 71.51 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.936 1.013 . . . . 0.0 109.582 -2.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -139.32 130.38 26.5 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.45 103.64 12.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.047 1.339 . . . . 0.0 109.35 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.497 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.6 mp -91.83 115.53 28.14 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.57 12.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.468 1.507 . . . . 0.0 108.205 178.415 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 110.7 -0.111 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.77 105.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.92 -43.61 21.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.171 0.588 . . . . 0.0 110.462 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.11 154.35 32.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.087 0.555 . . . . 0.0 109.681 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.497 HG22 ' HG ' ' A' ' 79' ' ' LEU . 32.7 p -128.19 99.12 5.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.787 1.235 . . . . 0.0 107.776 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -86.0 110.12 19.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 130.18 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.53 163.39 38.43 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.83 0.729 . . . . 0.0 112.382 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 168.95 17.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.271 0.629 . . . . 0.0 110.309 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -163.64 164.22 24.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.088 1.355 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.1 p -72.32 161.95 30.13 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.37 -43.27 79.04 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.86 22.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -53.54 -44.86 69.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.269 0.534 . . . . 0.0 110.572 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.3 tp -58.74 -52.51 65.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -56.09 -46.77 78.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.571 0.623 . . . . 0.0 110.799 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.27 -52.89 62.83 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.501 0.32 . . . . 0.0 110.256 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -54.36 -53.19 57.34 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.859 0.864 . . . . 0.0 110.476 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.5 mt -56.69 -52.95 62.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.877 0.471 . . . . 0.0 110.29 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.35 -51.84 61.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.718 0.407 . . . . 0.0 110.318 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.38 74.75 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.313 0.645 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.02 -38.25 45.16 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.147 -0.346 . . . . 0.0 110.797 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -62.56 -48.54 79.05 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 123.156 0.582 . . . . 0.0 109.643 177.401 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -158.57 -137.21 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.414 1.086 . . . . 0.0 108.877 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -95.27 53.75 1.55 Allowed 'General case' 0 C--O 1.232 0.152 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm -114.6 109.79 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.004 2.522 . . . . 0.0 108.983 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.2 mm -88.55 119.47 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.916 0.865 . . . . 0.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -84.95 75.26 10.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.79 162.59 10.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.649 1.18 . . . . 0.0 112.667 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 p -131.88 162.77 29.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -52.96 -44.03 66.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 110.025 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.31 -45.17 95.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.041 1.337 . . . . 0.0 112.057 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.44 -27.95 46.56 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.172 -0.33 . . . . 0.0 111.356 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -36.22 -51.74 0.78 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.653 1.581 . . . . 0.0 114.031 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.54 -64.86 0.73 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.651 0.738 . . . . 0.0 111.275 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.38 -37.93 82.29 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.263 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -55.54 4.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.305 -0.247 . . . . 0.0 111.537 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 -57.38 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 112.518 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.04 -36.75 80.41 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.384 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -102.02 29.64 4.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.463 0.305 . . . . 0.0 111.19 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.56 121.71 9.68 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.778 0.717 . . . . 0.0 112.057 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -80.27 53.36 1.76 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.453 0.701 . . . . 0.0 109.236 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.06 -149.8 21.29 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.63 122.63 47.09 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.264 1.026 . . . . 0.0 108.489 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mt -117.62 119.0 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.511 1.124 . . . . 0.0 108.734 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -93.0 102.98 15.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.1 t -87.29 113.84 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -93.54 117.68 30.39 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.36 121.68 32.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -134.01 179.49 6.22 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.639 1.176 . . . . 0.0 110.752 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.4 39.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.459 1.104 . . . . 0.0 108.907 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -53.12 -36.29 60.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.129 0.972 . . . . 0.0 111.53 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -86.8 -4.68 59.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.857 1.263 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.8 t -79.99 80.22 6.42 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.92 -1.113 . . . . 0.0 112.656 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.51 -58.51 4.0 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 123.456 0.551 . . . . 0.0 112.344 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.23 -37.01 69.54 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.219 2.613 . . . . 0.0 113.634 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.31 -44.21 97.6 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -63.99 -47.64 79.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.8 mtm -53.48 -39.52 64.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.166 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 pt -82.64 -13.21 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.227 0.921 . . . . 0.0 112.818 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -50.86 54.75 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 0.0 113.405 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.57 -44.52 46.8 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.357 2.038 . . . . 0.0 111.631 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.43 -51.24 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.85 -43.2 76.83 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.227 -0.296 . . . . 0.0 110.93 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -59.86 -52.83 63.77 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 0.0 109.888 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -55.59 -50.31 70.45 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.82 0.848 . . . . 0.0 109.938 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 mm -56.25 -50.88 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.711 0.805 . . . . 0.0 109.758 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.04 -43.41 66.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.206 0.603 . . . . 0.0 110.239 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.81 -57.63 6.66 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.588 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -47.19 -49.82 21.99 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.876 1.27 . . . . 0.0 112.973 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -91.28 14.16 15.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.253 0.621 . . . . 0.0 112.258 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 134.18 23.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.865 1.211 . . . . 0.0 111.178 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -29.26 6.95 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.494 -0.615 . . . . 0.0 111.797 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -98.98 -40.33 8.11 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.117 0.959 . . . . 0.0 109.013 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.0 tp -133.11 149.29 52.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.574 1.55 . . . . 0.0 109.072 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.6 m -124.17 147.24 48.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -121.73 152.34 25.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 119.458 1.026 . . . . 0.0 108.534 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.81 151.02 45.41 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.79 100.45 5.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.94 121.72 40.2 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.376 -0.827 . . . . 0.0 110.682 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.68 108.45 16.06 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.488 0.715 . . . . 0.0 109.759 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -65.1 -25.13 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.008 0.523 . . . . 0.0 112.288 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.42 -44.11 92.25 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.274 0.943 . . . . 0.0 108.896 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.88 -35.64 62.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.954 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -120.74 68.14 15.31 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 124.089 0.956 . . . . 0.0 111.815 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.29 -42.23 36.39 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.884 1.722 . . . . 0.0 110.22 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -37.59 6.07 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.623 1.106 . . . . 0.0 114.184 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -22.45 56.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.38 1.09 . . . . 0.0 112.965 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.64 -59.22 14.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.663 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 75.4 Cg_exo -51.09 -46.6 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.584 2.189 . . . . 0.0 112.88 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -45.16 -46.44 12.03 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.987 0.915 . . . . 0.0 112.501 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -108.1 25.26 11.82 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.001 0.521 . . . . 0.0 111.962 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.19 46.39 21.16 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.031 0.824 . . . . 0.0 112.37 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.8 mm -75.62 77.84 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.13 -4.26 57.41 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.78 0.832 . . . . 0.0 110.504 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.48 146.76 12.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt -133.48 154.71 80.96 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.611 1.565 . . . . 0.0 108.346 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 132.14 17.68 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.659 1.271 . . . . 0.0 111.011 -0.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.67 145.89 31.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -129.72 100.39 5.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.87 119.87 40.51 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.37 107.5 19.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.322 0.649 . . . . 0.0 109.936 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -97.59 103.96 15.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.832 1.253 . . . . 0.0 109.395 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -86.98 104.38 16.24 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 48.07 50.94 15.37 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.662 0.744 . . . . 0.0 110.764 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.73 -19.98 6.82 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.928 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -80.44 112.37 17.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.195 1.497 . . . . 0.0 109.627 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 81.1 t -62.94 102.55 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.01 -42.43 26.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.637 0.775 . . . . 0.0 110.387 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.16 153.67 28.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.3 p -132.68 114.88 14.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.155 1.382 . . . . 0.0 109.176 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -110.0 144.0 39.17 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.34 127.63 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 167.36 35.61 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.972 0.796 . . . . 0.0 111.465 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 166.43 21.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.118 0.567 . . . . 0.0 110.624 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.41 165.03 31.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.294 1.438 . . . . 0.0 107.787 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -72.38 159.24 34.34 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.006 0.431 . . . . 0.0 110.494 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.94 -42.5 80.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.25 -54.74 33.61 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -55.36 -47.1 76.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.106 0.453 . . . . 0.0 110.36 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -59.21 -50.56 73.54 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -55.21 -48.2 74.21 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.971 -0.455 . . . . 0.0 110.737 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -58.82 -53.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.205 0.602 . . . . 0.0 109.84 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.6 -53.21 40.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.145 0.978 . . . . 0.0 110.127 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.49 -51.87 68.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.521 0.328 . . . . 0.0 110.757 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -54.44 -51.9 63.5 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.78 0.264 . . . . 0.0 110.565 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.42 72.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.381 1.072 . . . . 0.0 111.942 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -78.34 -43.95 26.44 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.987 0.358 . . . . 0.0 110.63 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -62.62 -47.17 84.94 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.905 0.482 . . . . 0.0 109.781 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.203 0 C-N-CA 124.564 1.146 . . . . 0.0 111.467 179.403 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.75 72.35 0.37 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.137 0.975 . . . . 0.0 110.28 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -103.43 50.28 0.81 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.4 mt -112.3 143.28 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 125.476 1.51 . . . . 0.0 110.269 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.21 110.89 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.452 0.644 . . . . 0.0 110.773 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.18 97.32 8.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.534 1.134 . . . . 0.0 108.519 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.7 mt -80.73 169.94 16.96 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.731 0.776 . . . . 0.0 111.676 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.3 p -137.62 161.51 36.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.45 -43.31 67.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.5 -46.61 89.27 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.265 1.426 . . . . 0.0 112.009 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.8 p -78.23 -27.45 47.71 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.086 -0.384 . . . . 0.0 111.736 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -36.71 -54.74 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.425 1.49 . . . . 0.0 113.599 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -54.83 -63.57 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.424 0.63 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.85 -37.97 69.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.965 0.906 . . . . 0.0 113.022 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.53 -61.2 1.82 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.806 0.336 . . . . 0.0 111.485 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.72 -49.42 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.484 1.114 . . . . 0.0 112.538 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.252 45.1 mt -65.18 -29.9 70.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.862 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -100.18 35.3 2.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.578 0.351 . . . . 0.0 110.827 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.08 73.42 0.07 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.727 0.811 . . . . 0.0 112.058 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -70.24 72.37 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.277 1.031 . . . . 0.0 109.802 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.96 -117.7 0.79 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.362 -2.695 . . . . 0.0 106.362 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.09 118.54 6.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.11 124.56 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.781 1.232 . . . . 0.0 108.523 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -102.78 104.3 14.58 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.33 113.49 26.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 122.761 0.425 . . . . 0.0 110.076 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.56 107.86 19.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 108.643 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -79.96 124.49 28.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -143.14 -179.72 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 111.452 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.2 150.78 33.18 Favored 'General case' 0 C--N 1.337 0.051 0 C-N-CA 125.848 1.659 . . . . 0.0 108.54 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -52.81 -42.86 65.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.465 0.706 . . . . 0.0 111.471 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -79.38 -6.53 57.01 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.292 1.037 . . . . 0.0 112.77 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.4 t -79.72 80.86 6.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 120.918 -1.114 . . . . 0.0 111.158 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.4 -59.08 3.7 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.65 -33.31 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.422 2.748 . . . . 0.0 113.653 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.92 -50.82 38.32 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -55.34 -43.99 75.51 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 -30.85 57.78 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.495 -0.764 . . . . 0.0 112.242 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 pt -92.97 -3.03 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.604 1.093 . . . . 0.0 112.204 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 88.49 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 119.785 1.175 . . . . 0.0 110.993 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.99 -47.35 28.04 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 111.352 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.4 mt -55.13 -52.87 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.49 -40.81 83.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 122.642 0.377 . . . . 0.0 110.77 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.55 -50.31 74.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.719 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.63 -50.34 72.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.289 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.0 mm -55.21 -48.61 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.6 -47.24 70.36 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.152 0.433 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.21 -49.11 75.5 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 111.462 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.71 -49.19 76.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -91.4 27.44 1.95 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.167 0.987 . . . . 0.0 113.259 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -53.86 128.36 29.72 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -17.05 14.31 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.274 -0.737 . . . . 0.0 113.195 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -99.7 -41.85 7.11 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.648 1.224 . . . . 0.0 110.171 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -140.05 133.2 29.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.781 0.832 . . . . 0.0 109.251 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.7 m -98.71 107.95 20.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.35 134.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.53 51.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.884 0.873 . . . . 0.0 108.776 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -127.55 145.13 50.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.974 1.31 . . . . 0.0 107.959 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -134.71 118.92 17.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.41 101.51 14.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -52.0 -37.65 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.29 -47.53 85.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.883 0.765 . . . . 0.0 110.423 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -81.92 -20.3 39.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.395 1.078 . . . . 0.0 111.561 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -129.25 63.76 68.6 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.424 1.49 . . . . 0.0 108.846 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.56 -45.14 7.3 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.581 2.188 . . . . 0.0 113.746 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.49 -45.67 1.94 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.356 1.455 . . . . 0.0 115.581 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -73.09 -28.13 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.82 -57.69 15.04 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.76 -43.47 16.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.478 1.452 . . . . 0.0 111.048 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -48.44 -49.13 36.55 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.043 0.537 . . . . 0.0 111.503 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -99.15 24.09 8.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.49 48.95 7.11 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.57 1.081 . . . . 0.0 113.274 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mm -76.32 74.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -79.97 -4.66 53.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.354 0.662 . . . . 0.0 111.798 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.33 165.41 34.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 pt -149.58 153.53 36.88 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.593 1.557 . . . . 0.0 107.286 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.67 143.55 71.7 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.706 1.288 . . . . 0.0 109.854 -0.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.0 m -137.59 122.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -108.43 115.96 31.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.058 1.343 . . . . 0.0 109.218 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -110.54 121.73 46.03 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp -97.99 110.04 22.69 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -103.67 130.45 51.14 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.828 1.651 . . . . 0.0 111.329 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -122.3 113.2 19.09 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.5 t30 51.99 42.1 30.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.915 0.779 . . . . 0.0 110.177 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.62 -14.31 3.46 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.561 -0.712 . . . . 0.0 114.095 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -80.55 120.9 25.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.918 1.359 . . . . 0.0 107.342 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.9 115.42 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -46.39 17.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.665 0.786 . . . . 0.0 109.212 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.74 163.3 26.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.567 0.747 . . . . 0.0 109.252 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.447 HG22 ' HG ' ' A' ' 79' ' ' LEU . 71.9 p -136.81 134.56 37.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.481 1.112 . . . . 0.0 109.125 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -124.6 117.59 24.64 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.59 133.11 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.2 161.5 37.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.986 0.803 . . . . 0.0 111.554 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.31 167.89 13.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.114 0.566 . . . . 0.0 110.549 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.57 163.6 27.2 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.807 1.243 . . . . 0.0 108.121 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -72.68 162.74 29.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.334 0.588 . . . . 0.0 111.282 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -54.16 -46.63 72.36 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.85 22.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -53.81 -45.45 70.78 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 117.455 0.627 . . . . 0.0 110.37 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.9 tp -59.16 -51.09 71.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.35 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -53.34 -49.78 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.559 0.618 . . . . 0.0 110.46 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -57.36 -50.63 72.35 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 117.772 0.26 . . . . 0.0 110.693 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -54.39 -53.21 57.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 0.0 110.516 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -58.04 -53.02 62.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.837 0.455 . . . . 0.0 110.328 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.35 -51.49 62.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.493 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.29 68.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.696 0.798 . . . . 0.0 111.863 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -78.04 -47.53 18.2 Favored 'General case' 0 CA--C 1.526 0.039 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.29 -44.76 88.65 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.196 0.598 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 122.996 0.518 . . . . 0.0 109.612 177.647 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.8 t70 39.59 -100.75 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.984 1.714 . . . . 0.0 112.777 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -133.84 37.3 3.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.424 1.089 . . . . 0.0 108.892 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.5 mt -91.85 140.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.951 0.9 . . . . 0.0 109.686 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.3 mm -90.38 122.48 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 122.019 0.914 . . . . 0.0 111.188 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -95.57 83.32 3.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.17 166.01 17.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.007 1.323 . . . . 0.0 112.715 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.0 p -128.41 161.2 30.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.85 -45.02 78.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.66 -47.23 86.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.883 1.273 . . . . 0.0 111.458 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -78.2 -24.78 46.96 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.126 -0.359 . . . . 0.0 111.846 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -36.45 -50.24 0.76 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.017 1.727 . . . . 0.0 113.548 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.21 -63.76 1.06 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 110.374 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -59.47 -34.52 72.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.439 0.696 . . . . 0.0 112.072 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -83.29 -65.9 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.94 -45.49 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 112.603 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.261 46.9 mt -64.89 -30.26 71.24 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.245 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -96.22 30.43 2.49 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 110.726 172.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 74.78 0.05 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -56.54 135.52 54.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.58 -95.68 1.23 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.899 -2.081 . . . . 0.0 107.899 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.19 136.32 2.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.954 0.877 . . . . 0.0 110.71 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mt -119.78 128.48 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.957 1.303 . . . . 0.0 107.802 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.53 103.11 13.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.89 110.13 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 122.663 0.385 . . . . 0.0 110.454 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.69 108.31 19.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 118.0 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -133.0 178.32 6.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.472 1.109 . . . . 0.0 112.184 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.17 154.57 35.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.127 1.371 . . . . 0.0 108.57 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.89 -26.04 58.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -92.03 -4.32 54.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.468 1.107 . . . . 0.0 112.254 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.5 t -79.66 83.37 5.64 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.93 -1.106 . . . . 0.0 112.105 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.03 -58.91 4.14 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 123.582 0.61 . . . . 0.0 112.518 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.06 -30.82 61.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.074 2.516 . . . . 0.0 113.347 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.2 m -65.47 -42.81 91.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.49 -43.08 98.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 51.5 ttp -54.27 -47.96 71.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.636 0.374 . . . . 0.0 110.675 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.2 pt -77.54 -26.56 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.848 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.92 -57.08 1.06 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.94 -36.41 96.9 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 112.003 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.93 -49.63 78.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -55.04 -42.82 73.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.77 0.428 . . . . 0.0 110.376 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.87 -48.75 80.44 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.87 -49.71 74.68 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mm -54.39 -46.27 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.979 0.912 . . . . 0.0 109.79 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.37 55.41 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.965 0.506 . . . . 0.0 111.459 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.21 -58.84 2.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -48.51 -44.55 36.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.677 1.191 . . . . 0.0 113.232 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -104.92 23.09 14.1 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.468 1.107 . . . . 0.0 111.024 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -55.32 130.1 41.07 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.027 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -19.15 21.84 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.887 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -99.37 -45.22 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.606 1.203 . . . . 0.0 109.34 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 tp -131.57 116.73 17.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.658 1.183 . . . . 0.0 108.64 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 m -87.41 109.07 19.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.24 140.5 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.29 149.07 46.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.934 0.894 . . . . 0.0 109.767 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -130.44 103.92 6.95 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -98.37 119.52 37.2 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 122.98 0.512 . . . . 0.0 109.836 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -81.21 106.64 13.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.199 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.0 -32.32 55.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 123.74 0.816 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.27 -44.62 95.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.183 0.901 . . . . 0.0 109.145 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -77.33 -35.05 55.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.261 0.624 . . . . 0.0 110.762 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.3 67.78 7.01 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.13 0.972 . . . . 0.0 111.22 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.14 -40.33 26.94 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.16 1.907 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.46 3.52 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.219 1.39 . . . . 0.0 114.459 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.59 60.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.429 1.115 . . . . 0.0 112.971 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.45 -57.39 26.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -62.92 -35.72 65.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.24 1.96 . . . . 0.0 112.441 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -47.14 -44.37 21.63 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.898 0.772 . . . . 0.0 112.051 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -113.87 24.96 11.59 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.342 0.657 . . . . 0.0 110.693 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 36.97 50.96 1.54 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 126.627 2.061 . . . . 0.0 113.405 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -45.02 118.21 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.094 0.957 . . . . 0.0 110.919 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -79.72 -45.33 19.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.03 0.932 . . . . 0.0 111.335 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.19 142.62 6.97 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.9 pt -90.95 145.95 32.79 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.899 0.88 . . . . 0.0 110.37 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.38 129.79 16.98 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 CA-C-N 120.189 1.103 . . . . 0.0 111.34 -0.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.3 112.16 23.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.92 94.49 6.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.404 ' HG ' HG22 ' A' ' 89' ' ' THR . 9.1 mp -93.17 115.11 27.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.04 105.99 18.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -101.88 122.87 44.82 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.351 1.46 . . . . 0.0 111.609 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -105.47 102.88 12.32 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.74 58.8 2.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.937 1.295 . . . . 0.0 111.819 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.13 -25.35 5.51 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.902 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -79.96 109.59 14.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.659 1.23 . . . . 0.0 110.186 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.25 109.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.23 -43.36 23.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.926 0.891 . . . . 0.0 110.314 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.87 160.08 35.75 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.176 0.59 . . . . 0.0 109.482 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.404 HG22 ' HG ' ' A' ' 79' ' ' LEU . 61.6 p -135.64 103.87 5.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 109.152 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -90.55 120.84 31.97 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.95 103.35 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.34 161.62 13.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.486 0.565 . . . . 0.0 112.015 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 166.0 23.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.852 0.861 . . . . 0.0 111.669 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -163.84 164.35 23.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.262 1.825 . . . . 0.0 107.36 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 p -93.31 170.86 9.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.987 1.315 . . . . 0.0 113.051 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -61.87 156.28 21.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.68 -62.64 4.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -59.61 -54.69 43.55 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.81 -48.99 74.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.141 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -55.18 -47.08 75.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.558 0.343 . . . . 0.0 111.829 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.43 -47.84 80.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.059 0.544 . . . . 0.0 109.796 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -53.47 -52.49 59.33 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.22 -51.16 71.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.586 0.355 . . . . 0.0 110.648 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.04 -50.91 65.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.704 0.401 . . . . 0.0 110.774 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.84 69.47 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.237 1.015 . . . . 0.0 111.434 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -77.55 -48.15 17.69 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.0 mt -54.95 -48.4 73.23 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.307 0 C-N-CA 123.096 0.559 . . . . 0.0 109.51 176.905 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.226 -0.136 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.6 t70 34.55 -95.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.76 2.024 . . . . 0.0 114.553 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -132.37 25.94 4.47 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.673 1.189 . . . . 0.0 109.701 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.97 136.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.949 -0.469 . . . . 0.0 111.054 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.43 115.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-O 121.545 0.688 . . . . 0.0 111.587 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -82.69 96.69 8.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.018 0.927 . . . . 0.0 108.679 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.35 158.86 21.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.125 0.964 . . . . 0.0 113.188 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -125.1 160.46 29.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.904 2.082 . . . . 0.0 106.699 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -55.95 -44.31 78.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.44 -46.97 73.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.875 1.27 . . . . 0.0 111.019 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.4 p -78.1 -28.04 48.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.229 -0.295 . . . . 0.0 111.681 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -38.08 -53.67 1.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.51 1.524 . . . . 0.0 113.673 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -54.93 -62.83 1.4 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -36.69 71.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.179 0.992 . . . . 0.0 113.319 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.25 -62.04 1.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.771 0.32 . . . . 0.0 111.294 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.65 -49.07 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.487 1.115 . . . . 0.0 112.636 -172.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.67 -30.36 71.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.619 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -96.48 32.48 2.01 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.443 -0.313 . . . . 0.0 110.848 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.4 66.86 0.19 Allowed 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.839 0.856 . . . . 0.0 111.629 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -72.75 70.58 0.97 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.728 1.211 . . . . 0.0 109.297 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.07 -117.82 0.77 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 104.993 -3.243 . . . . 0.0 104.993 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.79 115.21 5.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.13 0.965 . . . . 0.0 108.74 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mt -112.67 125.91 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.518 1.127 . . . . 0.0 108.652 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.35 104.2 14.05 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 t -91.74 114.97 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.756 0.422 . . . . 0.0 110.344 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.83 106.83 19.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.693 1.197 . . . . 0.0 107.91 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.35 121.82 25.6 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -135.21 179.28 6.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.679 1.192 . . . . 0.0 110.852 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.34 155.64 40.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.799 1.24 . . . . 0.0 108.727 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -57.5 -27.9 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.589 0.632 . . . . 0.0 112.232 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -90.07 -3.96 57.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.614 1.166 . . . . 0.0 112.452 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.2 t -79.67 80.11 6.1 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 120.936 -1.102 . . . . 0.0 112.581 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.62 -58.86 4.52 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.151 0.405 . . . . 0.0 112.156 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.72 -32.52 55.61 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.369 2.713 . . . . 0.0 113.697 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.6 m -63.34 -44.36 95.09 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.97 -43.57 98.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtt -55.62 -42.51 75.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.149 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.68 -23.26 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 112.89 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.49 -51.74 6.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.57 -43.09 60.7 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.449 2.099 . . . . 0.0 111.964 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.58 -48.65 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -56.74 -41.62 77.86 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 122.419 -0.176 . . . . 0.0 110.551 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.41 -49.65 74.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.43 -50.45 69.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 mm -56.22 -49.02 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.411 0.684 . . . . 0.0 109.733 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -43.2 67.92 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.126 0.57 . . . . 0.0 110.358 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.73 -57.19 6.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.289 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.5 -44.07 55.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.18 . . . . 0.0 112.758 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.17 21.53 12.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 111.973 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -54.67 128.14 31.25 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.566 1.075 . . . . 0.0 110.189 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -19.18 28.58 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.213 -0.771 . . . . 0.0 113.049 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -99.09 -45.39 5.94 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.668 1.234 . . . . 0.0 109.452 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -129.6 131.22 46.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.447 1.099 . . . . 0.0 108.46 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.1 m -99.4 104.07 15.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.29 138.84 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.63 47.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.863 0.865 . . . . 0.0 109.241 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -125.81 135.31 51.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -125.92 122.0 34.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -86.71 110.97 20.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.32 -29.29 45.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -63.23 -47.66 81.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -70.34 -31.17 68.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.495 1.118 . . . . 0.0 110.253 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.04 73.41 76.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 0.0 111.834 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.37 -56.05 3.06 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.616 2.211 . . . . 0.0 112.688 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.58 -48.26 1.25 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.216 1.865 . . . . 0.0 115.57 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -28.52 69.54 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.756 -0.85 . . . . 0.0 113.023 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.89 -64.41 2.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.49 -42.74 45.39 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.734 1.623 . . . . 0.0 111.22 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -49.24 -44.58 43.65 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 118.229 0.468 . . . . 0.0 111.765 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -104.07 25.9 9.42 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.3 44.97 10.71 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.537 1.065 . . . . 0.0 113.477 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 mm -75.71 75.77 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.606 0.717 . . . . 0.0 109.177 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -79.43 -4.93 53.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.013 0.925 . . . . 0.0 111.545 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.25 170.74 40.34 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.384 -2.287 . . . . 0.0 107.384 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt -150.73 153.16 33.39 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.092 1.357 . . . . 0.0 107.711 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.46 142.19 61.77 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 CA-C-N 120.586 1.245 . . . . 0.0 110.154 -1.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 m -134.9 119.98 18.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.0 mt -105.19 116.16 31.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.543 1.537 . . . . 0.0 109.156 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.7 mp -111.22 122.26 47.4 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp -98.17 104.88 16.95 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -95.0 122.56 37.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.276 1.43 . . . . 0.0 110.392 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -117.33 113.75 22.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 175.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.44 44.2 29.12 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.359 1.064 . . . . 0.0 110.056 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.96 -17.31 7.28 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.229 -0.761 . . . . 0.0 114.172 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.55 123.73 32.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.059 1.429 . . . . 0.0 109.938 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.45 110.13 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.02 -42.42 26.55 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.798 0.839 . . . . 0.0 109.836 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.68 162.6 35.11 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.472 HG22 ' HG ' ' A' ' 79' ' ' LEU . 62.1 p -137.36 138.81 40.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.446 1.098 . . . . 0.0 109.345 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -130.47 122.26 27.35 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.73 131.14 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.34 165.46 37.7 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.066 0.841 . . . . 0.0 111.934 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.72 165.96 22.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.257 0.623 . . . . 0.0 110.443 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.18 167.92 26.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.816 1.246 . . . . 0.0 108.55 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -75.46 159.91 30.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.99 0.424 . . . . 0.0 110.55 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.61 -42.88 75.52 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.24 -56.53 24.72 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -56.41 -42.43 77.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.804 0.802 . . . . 0.0 110.721 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.6 -51.36 70.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.82 -47.69 73.75 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.726 0.694 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -55.43 -53.33 57.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.041 0.382 . . . . 0.0 110.052 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -54.17 -53.01 59.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.778 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.05 -53.39 58.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.894 0.478 . . . . 0.0 110.526 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.37 -51.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.321 0.649 . . . . 0.0 110.29 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.73 -37.35 68.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.209 0.604 . . . . 0.0 111.693 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -78.13 -46.23 21.21 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.134 -0.354 . . . . 0.0 110.665 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.46 -47.08 85.2 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 C-N-CA 123.005 0.522 . . . . 0.0 109.614 177.258 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -163.4 173.92 12.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.898 1.279 . . . . 0.0 108.336 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -134.82 48.65 2.28 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 mt -102.38 139.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.876 0.87 . . . . 0.0 109.895 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mm -88.68 114.25 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.244 1.021 . . . . 0.0 111.175 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -87.02 76.4 9.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.183 0.993 . . . . 0.0 108.95 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.48 160.17 25.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.997 1.319 . . . . 0.0 113.632 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 p -125.18 160.45 29.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.473 1.909 . . . . 0.0 107.638 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.61 -49.88 66.87 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.74 -45.87 67.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.993 1.317 . . . . 0.0 111.591 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 p -78.33 -28.57 47.34 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -35.82 -55.23 0.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.64 1.576 . . . . 0.0 115.001 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.65 -62.29 1.75 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.715 0.769 . . . . 0.0 111.347 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -61.99 -41.77 98.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.212 0.605 . . . . 0.0 112.193 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.31 -40.47 51.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.8 t -101.15 -63.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.841 0.856 . . . . 0.0 112.151 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.62 -33.48 71.55 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.78 4.98 50.16 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.37 105.71 11.84 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 120.384 1.447 . . . . 0.0 111.978 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -77.26 67.25 3.18 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 173.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.69 -157.72 10.62 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.88 110.53 19.15 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.778 1.231 . . . . 0.0 108.378 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mt -114.45 123.05 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.16 1.384 . . . . 0.0 108.649 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.05 103.6 13.69 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.46 113.13 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.79 109.27 20.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -79.68 126.89 31.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -134.72 177.14 8.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.392 1.077 . . . . 0.0 110.005 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.45 156.45 43.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -59.51 -27.73 66.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.347 0.521 . . . . 0.0 110.723 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.436 ' CZ3' HD11 ' A' ' 75' ' ' ILE . 52.5 p-90 -91.22 -1.77 57.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -79.85 79.03 6.41 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.864 -1.147 . . . . 0.0 111.868 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.8 -56.98 6.3 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 119.823 -0.432 . . . . 0.0 112.12 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -52.89 -34.32 65.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.254 2.636 . . . . 0.0 113.722 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.78 -41.99 99.49 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -67.86 -45.62 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.8 ttm -50.66 -44.03 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.837 0.455 . . . . 0.0 111.265 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.02 -5.77 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.67 78.29 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 112.336 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.55 -46.11 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.364 2.043 . . . . 0.0 111.361 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.05 -52.8 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.44 -39.92 73.92 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.143 -0.348 . . . . 0.0 110.986 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.22 -50.99 69.56 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.91 -49.46 73.39 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.16 -49.25 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.387 0.675 . . . . 0.0 109.821 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.73 64.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.999 0.363 . . . . 0.0 110.595 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.74 -55.81 8.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.849 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -49.02 -49.15 42.42 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.447 1.099 . . . . 0.0 112.329 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -97.45 23.59 7.47 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.927 0.891 . . . . 0.0 111.5 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.95 130.0 28.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.35 0.977 . . . . 0.0 110.937 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.09 -17.61 9.34 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.435 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.18 -41.79 7.34 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.708 1.254 . . . . 0.0 109.107 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -131.63 134.88 46.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.216 1.407 . . . . 0.0 108.071 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -107.52 104.2 13.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -79.83 140.69 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.47 150.32 49.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.002 . . . . 0.0 109.203 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -132.91 99.31 4.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.709 1.204 . . . . 0.0 108.575 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tt -98.22 127.01 43.94 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 110.559 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.72 112.56 22.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.6 pt -67.18 -30.38 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.522 0.729 . . . . 0.0 112.832 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -65.98 -45.76 80.49 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.98 -36.51 83.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.76 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -124.78 74.77 64.77 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 123.91 0.884 . . . . 0.0 112.612 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.67 -61.23 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.389 2.726 . . . . 0.0 113.672 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.36 -48.94 1.66 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.039 1.78 . . . . 0.0 114.684 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -34.13 59.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.37 -68.88 0.68 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-O 117.598 -1.192 . . . . 0.0 110.193 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 84.8 Cg_exo -47.49 -48.18 16.05 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.107 1.871 . . . . 0.0 112.715 174.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -48.1 -47.65 34.15 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.653 0.66 . . . . 0.0 111.916 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -101.49 25.16 8.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.26 39.33 20.55 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.345 0.974 . . . . 0.0 113.095 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -78.1 91.21 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -83.28 -8.5 59.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.402 0.281 . . . . 0.0 111.183 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.69 167.93 40.67 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 107.149 -2.381 . . . . 0.0 107.149 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.436 HD11 ' CZ3' ' A' ' 31' ' ' TRP . 1.3 pp -132.77 157.94 77.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.349 1.46 . . . . 0.0 109.057 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.06 143.89 75.71 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 CA-C-N 120.362 1.165 . . . . 0.0 110.8 -0.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.9 m -140.78 123.04 15.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.1 mt -104.12 126.19 51.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.64 1.576 . . . . 0.0 109.362 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.61 119.25 33.2 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.82 102.05 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -89.44 117.4 28.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.301 1.44 . . . . 0.0 108.998 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -111.91 124.87 53.29 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 51.99 42.91 30.63 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.461 0.648 . . . . 0.0 109.857 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.44 -8.43 13.77 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.49 -1.172 . . . . 0.0 115.377 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -104.96 133.0 50.49 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.708 1.754 . . . . 0.0 110.878 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.08 105.49 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.03 -43.73 17.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.455 0.702 . . . . 0.0 110.556 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.04 33.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.9 p -145.21 169.1 18.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.16 0.584 . . . . 0.0 109.655 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -150.03 151.34 33.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.4 140.29 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.86 40.74 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 173.17 10.2 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.277 -0.543 . . . . 0.0 110.224 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.86 162.05 32.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.173 1.389 . . . . 0.0 107.366 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.31 151.64 29.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.428 0.691 . . . . 0.0 110.894 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -50.07 -47.54 53.57 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.463 1.105 . . . . 0.0 112.139 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.55 -56.52 23.2 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -53.62 -45.08 69.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.796 0.838 . . . . 0.0 110.259 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.75 -53.25 60.47 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -54.52 -47.28 73.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.117 0.417 . . . . 0.0 111.345 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.68 -52.28 66.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.07 -53.48 52.59 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.87 0.868 . . . . 0.0 110.076 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.57 -51.75 68.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.429 0.292 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.56 -51.69 64.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.832 0.453 . . . . 0.0 110.493 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.02 -39.06 71.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.916 0.887 . . . . 0.0 111.7 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -77.87 -42.73 32.46 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.315 -0.24 . . . . 0.0 110.413 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.6 mt -60.35 -45.54 93.09 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 123.152 0.581 . . . . 0.0 109.659 177.686 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -72.88 97.65 2.31 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -122.75 40.86 3.59 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 mt -91.12 141.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.004 0.922 . . . . 0.0 110.75 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -90.91 113.53 26.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.465 0.65 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -84.33 97.89 9.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.271 1.028 . . . . 0.0 109.261 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.07 160.25 18.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.2 1.0 . . . . 0.0 112.837 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.8 p -127.31 160.31 31.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.399 1.88 . . . . 0.0 106.951 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -53.33 -48.74 68.2 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.99 -45.52 71.47 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.926 1.29 . . . . 0.0 111.423 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.5 p -78.67 -28.78 45.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -33.35 -65.61 0.17 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 126.059 1.743 . . . . 0.0 115.268 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.4 -56.49 14.63 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.607 -0.683 . . . . 0.0 111.43 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.95 -45.63 92.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.331 0.652 . . . . 0.0 112.758 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.56 -39.64 52.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.35 -65.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.679 1.192 . . . . 0.0 112.116 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.39 -31.35 70.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -91.46 3.84 53.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.524 0.602 . . . . 0.0 112.567 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.413 ' CB ' HD12 ' A' ' 23' ' ' ILE . . . -77.57 106.3 9.27 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.106 1.321 . . . . 0.0 112.104 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.37 67.31 3.29 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 173.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -170.27 -159.03 15.17 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -114.82 111.85 21.87 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.917 0.887 . . . . 0.0 109.07 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.413 HD12 ' CB ' ' A' ' 19' ' ' ALA . 7.7 mt -113.8 129.2 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 125.012 1.325 . . . . 0.0 108.843 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -109.91 103.73 12.55 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.5 t -90.9 117.68 34.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 118.326 0.512 . . . . 0.0 110.468 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.78 110.91 23.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.849 1.259 . . . . 0.0 108.918 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -83.66 121.32 27.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -137.34 176.57 8.59 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.15 149.17 31.51 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.842 1.657 . . . . 0.0 109.243 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.36 -34.8 64.6 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.532 0.733 . . . . 0.0 112.388 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -84.6 -10.27 57.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.94 0.896 . . . . 0.0 112.084 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.75 79.99 6.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.076 -1.015 . . . . 0.0 110.906 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.78 -58.58 2.6 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.153 0.882 . . . . 0.0 112.074 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -36.51 84.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.344 2.696 . . . . 0.0 113.598 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.7 m -63.59 -46.08 87.45 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -64.65 -42.17 95.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.9 ttp -52.69 -44.35 66.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.4 pt -78.78 -10.05 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.34 -57.21 12.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 120.052 1.297 . . . . 0.0 113.116 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.69 -41.06 77.08 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.056 1.837 . . . . 0.0 111.435 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 mt -59.84 -51.93 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.4 mt -55.65 -41.22 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.833 0.453 . . . . 0.0 110.55 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.11 -52.69 63.84 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.45 -48.63 68.66 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.829 -0.545 . . . . 0.0 109.984 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.56 -49.43 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 122.997 0.519 . . . . 0.0 109.668 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.0 -45.94 68.1 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.39 -57.41 8.42 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.818 0.342 . . . . 0.0 110.476 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.21 -50.57 37.73 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.919 1.288 . . . . 0.0 112.548 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -94.04 20.49 7.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.71 0.804 . . . . 0.0 111.995 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.53 99.83 0.05 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.687 1.13 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.7 -23.48 8.34 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.617 1.103 . . . . 0.0 111.284 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -99.43 -36.79 9.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.664 1.186 . . . . 0.0 109.706 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -138.33 139.03 38.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.062 0.945 . . . . 0.0 108.522 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.6 m -106.89 102.38 11.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.21 138.31 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.21 154.12 51.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.086 0.955 . . . . 0.0 108.662 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.0 145.42 51.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.022 1.329 . . . . 0.0 108.208 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -137.6 121.32 17.45 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -84.35 110.34 18.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.89 -31.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.88 -45.57 91.94 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.231 0.923 . . . . 0.0 109.058 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -71.93 -36.8 70.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.068 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -122.63 69.9 35.24 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.246 1.018 . . . . 0.0 111.612 -175.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.05 -47.27 6.74 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.972 1.781 . . . . 0.0 111.083 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -37.85 2.15 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.529 1.538 . . . . 0.0 114.895 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.4 -22.84 61.06 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.346 1.073 . . . . 0.0 113.677 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.92 -55.74 5.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.62 -37.02 42.52 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.327 2.684 . . . . 0.0 113.577 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -43.78 -43.25 6.01 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.103 0.961 . . . . 0.0 112.107 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -117.82 29.93 7.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.403 0.681 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.89 40.77 27.38 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.693 1.14 . . . . 0.0 112.823 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.6 mt -78.99 79.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -88.68 -4.66 58.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.886 0.874 . . . . 0.0 111.541 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.27 160.91 27.28 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.7 pt -147.59 156.35 45.27 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.586 1.554 . . . . 0.0 107.745 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.19 145.15 75.07 Favored 'Cis proline' 0 N--CA 1.456 -0.733 0 CA-C-N 120.725 1.295 . . . . 0.0 110.006 -0.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 m -138.79 124.51 19.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.06 115.74 30.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.616 1.566 . . . . 0.0 108.913 -175.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.95 116.41 31.9 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 tp -96.72 104.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -94.94 118.81 32.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.576 1.55 . . . . 0.0 109.206 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -111.46 122.48 47.96 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.39 42.69 31.19 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.253 0.621 . . . . 0.0 109.912 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.77 -14.73 5.52 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.71 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -94.19 134.77 36.29 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.215 1.508 . . . . 0.0 110.535 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.2 107.98 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -45.02 19.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.25 159.92 34.7 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.4 p -136.53 129.87 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.335 1.054 . . . . 0.0 108.53 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -119.31 119.22 33.38 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.52 132.32 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.51 163.89 34.37 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.147 0.879 . . . . 0.0 111.435 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.2 167.26 22.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.044 0.537 . . . . 0.0 110.221 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -160.93 162.99 32.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.782 1.233 . . . . 0.0 108.147 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.88 162.91 28.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.206 0.527 . . . . 0.0 110.98 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -55.8 -45.07 78.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.65 -54.41 36.57 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -56.43 -46.13 80.42 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 110.447 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.29 -52.34 66.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -55.93 -48.11 76.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 110.535 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -56.99 -53.41 58.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.777 0.431 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.98 -54.09 40.25 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.093 0.957 . . . . 0.0 110.312 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.54 -53.24 60.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.57 -52.31 60.15 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.918 0.327 . . . . 0.0 110.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.83 73.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.899 0.88 . . . . 0.0 112.004 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -77.68 -42.61 33.96 Favored 'General case' 0 C--O 1.23 0.029 0 O-C-N 122.095 -0.378 . . . . 0.0 110.319 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.49 -48.24 82.41 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 123.139 0.576 . . . . 0.0 109.525 177.077 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -73.67 70.94 1.39 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.528 0.731 . . . . 0.0 109.894 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -103.82 47.74 0.87 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.4 138.51 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.318 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.6 mm -86.5 110.91 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.218 1.009 . . . . 0.0 111.01 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -82.41 76.11 9.29 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.771 0.828 . . . . 0.0 108.9 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.76 159.19 22.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.715 1.206 . . . . 0.0 113.659 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 p -125.74 160.53 29.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.8 2.04 . . . . 0.0 106.755 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -54.68 -45.46 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.67 -46.13 74.01 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.3 1.44 . . . . 0.0 111.432 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 p -78.67 -27.45 45.18 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -37.8 -54.51 1.24 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.327 1.451 . . . . 0.0 114.113 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.09 -50.25 73.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 111.664 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -66.24 -40.94 90.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.237 1.015 . . . . 0.0 111.339 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.01 -58.49 2.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.72 -51.52 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.038 0.935 . . . . 0.0 112.4 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 mt -64.87 -32.78 74.64 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.299 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -96.8 26.07 4.81 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.499 0.319 . . . . 0.0 111.201 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.32 72.93 0.32 Allowed 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.338 -0.851 . . . . 0.0 111.664 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -67.56 73.58 0.15 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.706 1.203 . . . . 0.0 110.211 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.51 -112.75 0.53 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 106.303 -2.719 . . . . 0.0 106.303 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.63 122.69 5.41 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.813 0.807 . . . . 0.0 109.132 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mt -120.25 119.44 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.179 1.392 . . . . 0.0 108.096 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.8 tp -94.61 104.8 16.73 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.68 109.66 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 122.829 0.452 . . . . 0.0 110.014 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -90.19 119.35 30.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.74 125.62 34.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -138.43 176.31 8.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.486 0.715 . . . . 0.0 111.157 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.45 151.77 32.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.056 1.342 . . . . 0.0 107.563 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -56.08 -36.87 68.59 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.615 0.766 . . . . 0.0 111.55 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -79.71 -11.03 59.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.241 1.017 . . . . 0.0 112.813 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -79.56 81.3 5.84 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.046 -1.034 . . . . 0.0 111.855 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.07 -57.62 3.51 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.013 0.816 . . . . 0.0 112.369 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.91 -33.58 82.72 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.862 2.375 . . . . 0.0 113.261 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -65.04 -43.55 91.98 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.49 -47.6 84.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -50.38 -41.89 52.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.888 0.875 . . . . 0.0 111.953 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -83.69 -8.82 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.91 -51.17 73.32 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.9 1.227 . . . . 0.0 112.721 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.94 -40.96 78.8 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.508 2.139 . . . . 0.0 112.078 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.08 -52.5 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.24 -42.84 77.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.826 0.45 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.28 -53.43 58.28 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.827 0.822 . . . . 0.0 109.327 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.87 -47.14 77.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.007 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 mm -56.11 -50.4 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.116 0.566 . . . . 0.0 109.806 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.61 67.65 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.982 0.513 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.24 -50.3 54.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.299 -0.251 . . . . 0.0 110.966 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.62 -49.32 77.92 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.33 0.652 . . . . 0.0 112.731 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -87.11 30.14 0.79 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.745 0.818 . . . . 0.0 112.592 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -52.27 125.0 14.57 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.561 -0.712 . . . . 0.0 110.213 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.65 -15.35 14.36 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.484 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.7 -36.23 9.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.431 1.116 . . . . 0.0 110.568 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -146.67 142.23 27.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.199 0.6 . . . . 0.0 109.479 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.8 m -108.36 139.79 42.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.96 143.19 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.83 151.08 51.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.943 0.897 . . . . 0.0 108.599 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -133.27 101.93 5.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -98.01 123.28 41.96 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.729 -0.607 . . . . 0.0 110.791 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -82.34 108.44 15.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.238 0.615 . . . . 0.0 110.077 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.66 -23.9 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.744 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -62.18 -46.17 90.15 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.3 -32.54 58.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.478 0.711 . . . . 0.0 110.558 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -128.53 70.19 79.73 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.574 0.75 . . . . 0.0 112.411 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.64 -59.35 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.505 2.137 . . . . 0.0 112.923 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.18 -42.22 1.62 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.345 1.926 . . . . 0.0 115.296 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -28.15 65.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.871 0.835 . . . . 0.0 112.854 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -70.01 -65.21 1.17 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.196 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 94.4 Cg_exo -47.25 -40.18 27.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.247 2.631 . . . . 0.0 113.192 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -49.42 -38.3 28.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.937 0.789 . . . . 0.0 112.242 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -111.3 26.24 10.88 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.347 0.659 . . . . 0.0 110.68 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.4 37.65 25.75 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.14 1.352 . . . . 0.0 113.336 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.4 mt -78.84 99.71 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 117.808 0.804 . . . . 0.0 109.087 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -79.8 -19.16 49.22 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.837 1.255 . . . . 0.0 112.897 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.78 174.35 35.14 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.31 157.5 59.73 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 125.474 1.51 . . . . 0.0 108.122 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.68 142.48 67.64 Favored 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.541 1.229 . . . . 0.0 110.523 -0.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -142.85 127.51 18.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.72 118.57 37.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.466 1.506 . . . . 0.0 109.234 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -110.66 118.31 35.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.44 107.36 19.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -102.17 126.95 49.27 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 111.465 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.49 102.02 10.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.48 57.45 3.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.758 1.223 . . . . 0.0 111.712 -177.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.81 -23.65 4.93 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.44 -0.645 . . . . 0.0 113.836 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -79.76 108.93 13.71 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.759 1.279 . . . . 0.0 109.005 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.67 111.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -44.42 22.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.366 0.666 . . . . 0.0 109.639 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.13 161.33 31.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 78.4 p -135.23 132.28 37.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.395 1.078 . . . . 0.0 109.166 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -120.54 117.99 29.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -93.71 132.75 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.09 163.64 39.39 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.635 0.636 . . . . 0.0 111.778 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.35 167.94 15.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.14 0.576 . . . . 0.0 110.416 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.54 166.61 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.972 1.309 . . . . 0.0 107.723 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 76.8 p -82.42 161.49 22.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.225 0.536 . . . . 0.0 110.799 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -48.82 -51.88 27.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.019 . . . . 0.0 109.813 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.55 -54.78 28.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -55.28 -46.39 76.18 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.089 0.445 . . . . 0.0 110.337 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.06 -48.39 81.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.543 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -55.93 -50.13 71.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.319 0.509 . . . . 0.0 110.026 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -56.99 -50.79 71.62 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.836 0.289 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.32 -53.79 45.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 0.0 110.364 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.85 -54.93 41.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.562 0.345 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -52.2 -51.7 56.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.262 0.625 . . . . 0.0 110.674 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -38.04 69.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.669 0.788 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -78.07 -48.64 15.61 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.16 -0.338 . . . . 0.0 110.36 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -58.55 -44.77 89.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.161 0.584 . . . . 0.0 109.911 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 122.837 0.455 . . . . 0.0 109.775 177.768 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -74.02 74.07 1.69 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.175 0.512 . . . . 0.0 111.236 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -108.64 39.53 1.98 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 mt -96.31 139.37 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 110.344 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -86.44 110.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.178 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -81.12 94.04 6.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.106 0.962 . . . . 0.0 108.799 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.78 163.82 22.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.986 0.914 . . . . 0.0 112.614 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.1 p -133.56 163.55 29.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.457 1.903 . . . . 0.0 106.226 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.07 -43.38 73.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.13 -46.31 90.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.962 1.305 . . . . 0.0 111.877 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -78.31 -27.54 47.24 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.096 -0.377 . . . . 0.0 111.385 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -36.65 -54.62 0.88 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 113.426 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.9 -63.73 1.06 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 110.902 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -56.1 -41.74 75.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.845 0.858 . . . . 0.0 112.787 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -58.42 2.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.11 -52.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.881 0.872 . . . . 0.0 112.712 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.24 -29.99 71.06 Favored 'General case' 0 C--O 1.228 -0.047 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -105.52 40.54 1.53 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.52 123.99 8.64 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.551 0.74 . . . . 0.0 112.425 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -76.9 61.43 1.93 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.632 1.173 . . . . 0.0 109.306 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.19 -116.97 3.86 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.28 122.17 45.11 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.196 0.998 . . . . 0.0 109.052 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -116.42 125.58 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 C-N-CA 124.619 1.168 . . . . 0.0 108.354 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 tp -103.28 103.34 13.35 Favored 'General case' 0 CA--C 1.524 -0.051 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -89.8 114.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 122.745 0.418 . . . . 0.0 110.103 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.36 114.3 26.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -82.86 128.1 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -142.43 174.61 10.47 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.446 0.698 . . . . 0.0 111.787 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.46 153.89 41.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.41 1.484 . . . . 0.0 107.789 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -52.32 -43.67 64.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.663 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -80.08 -2.45 44.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.952 1.301 . . . . 0.0 112.957 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -79.4 78.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.896 -1.128 . . . . 0.0 111.004 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.78 -57.36 3.43 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 123.74 0.686 . . . . 0.0 112.185 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.81 -32.46 77.08 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.071 2.514 . . . . 0.0 113.413 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.18 -47.64 76.27 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.62 -40.4 87.44 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -58.59 -46.11 87.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.96 0.504 . . . . 0.0 110.876 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 pt -76.27 -26.82 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 118.746 0.703 . . . . 0.0 112.555 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.91 -56.66 1.11 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.97 -38.89 94.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.217 1.944 . . . . 0.0 112.09 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 mt -62.11 -48.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -56.5 -42.55 78.54 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.24 -0.288 . . . . 0.0 110.261 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.05 -48.83 80.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.188 0.595 . . . . 0.0 109.703 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -59.35 -49.6 77.21 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.795 -0.565 . . . . 0.0 109.832 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.6 mm -52.04 -45.95 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.631 0.773 . . . . 0.0 110.047 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.82 -33.42 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.691 0.397 . . . . 0.0 111.38 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.47 -54.86 5.71 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.88 -44.53 49.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.909 . . . . 0.0 112.516 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -103.77 22.1 15.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.962 0.905 . . . . 0.0 112.189 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -51.17 135.97 24.89 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.876 0.762 . . . . 0.0 111.17 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 -23.51 3.61 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.97 -0.906 . . . . 0.0 113.531 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.38 -45.3 5.89 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.015 1.408 . . . . 0.0 110.251 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.02 121.69 40.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 m -93.54 103.67 15.84 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.94 137.96 20.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.08 48.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.053 0.941 . . . . 0.0 109.434 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -128.92 136.48 50.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -127.33 122.08 32.78 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.194 0.597 . . . . 0.0 110.19 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -83.07 106.34 14.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.047 0.539 . . . . 0.0 110.077 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.84 -26.22 36.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -58.51 -51.02 71.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.327 0.967 . . . . 0.0 109.298 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -78.83 -31.06 45.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.795 0.838 . . . . 0.0 111.089 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.82 66.46 20.79 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.446 0.698 . . . . 0.0 111.479 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.8 -54.24 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.379 2.053 . . . . 0.0 112.156 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.41 -46.44 1.45 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.881 1.705 . . . . 0.0 114.3 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -38.86 60.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.938 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.55 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.4 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.691 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 78.5 Cg_exo -50.87 -45.32 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.167 1.911 . . . . 0.0 112.695 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -52.51 -46.49 66.69 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.095 0.861 . . . . 0.0 111.858 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -95.03 19.15 10.82 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.316 0.507 . . . . 0.0 111.648 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.95 46.07 14.39 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 125.741 1.639 . . . . 0.0 112.996 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.19 135.66 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 117.999 0.899 . . . . 0.0 110.372 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -37.77 37.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.952 0.901 . . . . 0.0 111.164 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.9 -161.07 25.92 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.3 pt -139.32 141.22 28.37 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 119.055 1.427 . . . . 0.0 108.943 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.1 147.6 89.03 Favored 'Cis proline' 0 N--CA 1.454 -0.795 0 CA-C-N 119.555 0.877 . . . . 0.0 110.296 -1.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -145.76 127.12 14.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt -102.51 126.0 49.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.669 1.588 . . . . 0.0 108.558 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.33 120.25 38.28 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -96.64 102.06 13.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.363 0.665 . . . . 0.0 109.444 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -92.86 112.04 23.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.704 1.602 . . . . 0.0 110.116 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -96.73 112.32 24.12 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.82 39.07 13.27 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.572 0.749 . . . . 0.0 111.462 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.05 -16.92 55.94 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.514 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -90.23 121.02 31.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 119.342 1.571 . . . . 0.0 109.631 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.87 106.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -43.29 22.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.444 0.698 . . . . 0.0 110.297 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.82 168.75 25.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 p -144.72 163.2 34.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -142.14 121.63 13.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.14 132.44 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.457 1.103 . . . . 0.0 108.783 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.49 167.19 42.38 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.598 0.555 . . . . 0.0 111.963 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.48 169.07 14.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.15 0.58 . . . . 0.0 110.266 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.69 165.64 27.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.037 1.335 . . . . 0.0 107.66 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.9 p -75.69 159.24 31.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.171 0.51 . . . . 0.0 110.417 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -52.77 -46.88 67.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.578 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.46 -57.01 19.09 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -54.05 -46.06 71.83 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.311 0.555 . . . . 0.0 111.199 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.39 -51.25 70.28 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.239 -0.288 . . . . 0.0 110.683 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.46 -48.53 74.36 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 122.18 -0.325 . . . . 0.0 110.621 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.83 -51.71 68.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.938 0.895 . . . . 0.0 110.036 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.36 -54.02 46.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.872 0.869 . . . . 0.0 109.962 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.86 -50.03 74.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.209 -0.307 . . . . 0.0 110.758 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.72 -52.23 63.13 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.543 0.337 . . . . 0.0 110.156 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -36.06 71.76 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.047 0.939 . . . . 0.0 111.947 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.32 -50.88 10.98 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 117.918 0.326 . . . . 0.0 110.46 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.05 -42.3 97.09 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.107 -0.371 . . . . 0.0 110.575 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 124.717 1.207 . . . . 0.0 111.727 179.292 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.1 p . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t70 5.21 -85.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 129.158 2.983 . . . . 0.0 114.725 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -133.5 44.62 2.77 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.803 1.241 . . . . 0.0 107.696 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 mt -103.47 134.83 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.479 0.712 . . . . 0.0 110.94 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.5 mm -89.12 117.36 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 122.207 1.003 . . . . 0.0 110.6 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -89.07 78.26 7.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.81 163.87 18.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.747 1.219 . . . . 0.0 112.937 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.1 p -132.67 163.56 28.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.259 1.824 . . . . 0.0 106.707 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.74 -42.7 71.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.267 0.485 . . . . 0.0 109.743 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.57 -45.69 92.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.898 1.279 . . . . 0.0 111.709 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 p -78.71 -26.24 44.82 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.161 -0.337 . . . . 0.0 111.321 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -37.81 -57.06 1.04 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.532 1.533 . . . . 0.0 113.581 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -54.79 -61.69 2.15 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.703 0.763 . . . . 0.0 110.394 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -52.26 -42.58 63.78 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.201 1.4 . . . . 0.0 113.326 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -57.48 2.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.961 0.504 . . . . 0.0 112.068 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.92 -51.01 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.061 0.944 . . . . 0.0 112.536 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.7 -36.11 82.69 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.215 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -96.79 32.64 2.04 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.826 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.67 114.74 1.65 Allowed 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.178 0.899 . . . . 0.0 111.601 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -79.09 62.59 3.54 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.99 -136.43 8.32 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.68 120.25 40.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.647 1.179 . . . . 0.0 108.722 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mt -111.98 125.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.444 1.097 . . . . 0.0 108.299 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -104.16 100.48 10.22 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.94 112.7 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.44 0.296 . . . . 0.0 110.424 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -89.35 108.06 19.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -79.93 120.23 23.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -137.25 173.19 11.95 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.38 151.27 50.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.675 1.19 . . . . 0.0 108.357 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -55.04 -38.39 67.92 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.281 0.491 . . . . 0.0 111.357 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -83.81 -2.48 56.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.679 1.192 . . . . 0.0 112.488 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.47 80.79 5.81 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.948 -1.095 . . . . 0.0 110.685 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.89 -58.51 2.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.184 0.897 . . . . 0.0 111.919 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -54.0 -39.58 84.57 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.428 2.752 . . . . 0.0 113.543 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -62.28 -48.7 78.72 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.76 -44.24 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.4 ttm -52.53 -41.46 63.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.08 0.952 . . . . 0.0 111.135 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -82.58 -11.97 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.775 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.75 -49.85 54.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.321 1.419 . . . . 0.0 113.423 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.31 -37.96 94.14 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.315 2.01 . . . . 0.0 111.764 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.56 -48.98 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.52 -41.78 73.61 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.271 0.487 . . . . 0.0 110.236 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.47 -52.54 64.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.158 0.583 . . . . 0.0 109.92 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -54.06 -47.68 71.38 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.951 0.5 . . . . 0.0 109.698 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.1 -49.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.73 0.812 . . . . 0.0 109.539 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.7 67.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.073 0.397 . . . . 0.0 110.064 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.3 -50.83 64.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.197 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -60.39 -44.24 95.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.722 1.209 . . . . 0.0 113.62 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.52 29.19 3.38 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.713 1.205 . . . . 0.0 112.131 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.82 132.28 18.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.83 -0.543 . . . . 0.0 111.418 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.13 -19.04 2.34 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.123 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -98.84 -41.75 7.49 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.429 1.614 . . . . 0.0 109.859 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -129.97 119.74 23.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.542 0.737 . . . . 0.0 109.415 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -95.41 103.73 15.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.24 144.06 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.317 -0.864 . . . . 0.0 109.8 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.12 151.75 45.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.113 0.965 . . . . 0.0 109.134 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -133.15 103.86 6.22 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.69 119.57 37.66 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.754 0.421 . . . . 0.0 110.606 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -80.15 106.35 12.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.83 -27.46 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.753 0.821 . . . . 0.0 112.519 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.05 -51.3 70.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.215 0.916 . . . . 0.0 109.385 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -74.63 -32.15 62.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.71 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -118.85 67.49 7.99 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 111.661 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.92 -44.72 9.48 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 110.714 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.18 -37.7 4.59 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.291 1.424 . . . . 0.0 114.325 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.22 -24.34 64.01 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.255 1.027 . . . . 0.0 113.087 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -59.32 14.21 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -62.14 -33.8 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.216 1.944 . . . . 0.0 112.377 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -48.44 -42.87 33.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.082 0.856 . . . . 0.0 111.922 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -113.19 26.48 10.42 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.365 0.666 . . . . 0.0 110.715 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 36.82 52.64 1.49 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 126.035 1.778 . . . . 0.0 112.9 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.44 115.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 118.039 0.919 . . . . 0.0 109.297 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.58 -43.99 21.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.962 0.505 . . . . 0.0 111.027 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.91 142.85 7.95 Favored Glycine 0 C--N 1.335 0.524 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.4 pt -94.45 148.13 34.45 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.183 0.993 . . . . 0.0 110.288 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.97 134.43 31.75 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.991 1.033 . . . . 0.0 110.739 -0.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.79 115.76 28.28 Favored 'General case' 0 C--N 1.338 0.074 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.51 94.06 6.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 89' ' ' THR . 9.4 mp -91.91 114.92 27.59 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -94.09 100.12 12.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.564 0.746 . . . . 0.0 109.511 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -94.22 111.0 22.7 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.231 1.412 . . . . 0.0 110.672 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -93.86 106.94 18.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 44.22 52.72 7.0 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.282 0.633 . . . . 0.0 111.875 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.94 -19.91 8.99 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.314 -0.714 . . . . 0.0 114.426 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -84.35 114.37 21.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.1 1.45 . . . . 0.0 110.022 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.0 107.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.26 24.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.64 0.776 . . . . 0.0 109.959 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.27 159.92 31.97 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.458 0.703 . . . . 0.0 109.243 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.418 HG22 ' HG ' ' A' ' 79' ' ' LEU . 45.6 p -134.11 103.77 5.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.439 1.096 . . . . 0.0 108.461 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -87.59 114.95 24.67 Favored 'General case' 0 C--N 1.338 0.087 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.84 119.22 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.05 166.38 26.92 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 121.579 0.544 . . . . 0.0 112.436 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.64 165.19 25.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.463 0.705 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -163.89 168.62 19.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.214 1.806 . . . . 0.0 106.994 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.3 p -97.1 178.44 5.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.11 0.957 . . . . 0.0 112.235 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -64.67 161.77 17.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.7 4.69 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.31 -56.23 22.85 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 tp -56.9 -46.02 82.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.056 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.14 -49.76 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.335 -0.228 . . . . 0.0 111.072 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.86 -50.31 73.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.269 0.628 . . . . 0.0 109.831 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -52.97 -52.24 58.8 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -58.96 -47.1 86.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.694 0.397 . . . . 0.0 110.957 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.9 -54.15 48.21 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.075 0.95 . . . . 0.0 111.983 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -77.89 -50.86 11.39 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 122.209 -0.307 . . . . 0.0 110.739 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 72.5 mt -59.73 -42.87 94.12 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.137 0.575 . . . . 0.0 109.956 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.525 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.659 0.266 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 35.13 -92.28 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.682 2.393 . . . . 0.0 113.406 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -139.71 33.37 2.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.632 0.773 . . . . 0.0 110.529 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.7 mt -83.26 136.21 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 122.07 -0.394 . . . . 0.0 111.303 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 mm -90.28 120.66 39.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.958 0.885 . . . . 0.0 111.121 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -92.86 80.93 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.1 0.96 . . . . 0.0 108.871 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.55 164.97 15.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.879 1.272 . . . . 0.0 112.784 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.6 p -132.9 163.04 30.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.71 -44.24 69.65 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.157 0.503 . . . . 0.0 109.659 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.9 -45.85 92.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.997 1.319 . . . . 0.0 111.963 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.35 -26.76 46.86 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.109 -0.37 . . . . 0.0 111.487 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -36.93 -54.76 0.93 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.737 1.615 . . . . 0.0 113.391 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.7 -62.85 1.39 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.447 0.641 . . . . 0.0 110.999 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -38.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.685 0.794 . . . . 0.0 113.108 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -59.21 2.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 -52.89 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.532 1.133 . . . . 0.0 112.439 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.31 -28.61 69.83 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.329 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -103.26 35.2 2.63 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.813 0.445 . . . . 0.0 110.112 174.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.84 115.63 1.34 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.83 69.79 2.52 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.63 -107.63 1.55 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.902 1.239 . . . . 0.0 110.051 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.35 125.79 29.93 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.625 0.77 . . . . 0.0 110.079 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -117.51 127.31 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.505 1.122 . . . . 0.0 108.792 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -104.83 102.83 12.36 Favored 'General case' 0 C--N 1.337 0.055 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 t -89.76 113.23 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -93.46 111.5 23.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -80.91 124.9 29.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -139.69 -179.57 6.0 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.861 0.864 . . . . 0.0 111.191 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.871 1.268 . . . . 0.0 108.935 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.43 -22.55 54.74 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.502 1.121 . . . . 0.0 113.226 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -99.44 -2.04 37.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.712 1.205 . . . . 0.0 111.727 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.9 t -79.96 83.92 5.8 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.021 -1.049 . . . . 0.0 112.29 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.83 -59.88 3.12 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 123.828 0.728 . . . . 0.0 112.437 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -32.79 67.64 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 0.0 113.337 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.13 -45.88 83.24 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.57 -42.25 96.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -57.51 -44.79 85.3 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.964 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 pt -77.5 -21.19 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.922 0.783 . . . . 0.0 112.734 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.52 -57.31 2.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.702 1.137 . . . . 0.0 114.024 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -56.09 -40.08 87.16 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.161 1.907 . . . . 0.0 112.055 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.73 -50.61 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.2 -44.13 83.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.132 0.573 . . . . 0.0 110.682 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.94 -51.85 67.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.636 0.775 . . . . 0.0 110.002 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.56 -51.43 65.27 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.536 0.734 . . . . 0.0 109.221 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.51 -47.67 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.34 75.42 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.198 0.453 . . . . 0.0 110.946 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.61 -43.15 81.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.82 -54.89 15.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.342 1.057 . . . . 0.0 112.476 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -82.57 23.46 0.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.401 1.08 . . . . 0.0 111.038 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.23 101.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.823 1.649 . . . . 0.0 110.276 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.45 -21.53 16.87 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.629 1.109 . . . . 0.0 111.446 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -99.6 -35.67 9.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.707 1.203 . . . . 0.0 110.236 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -142.09 139.43 32.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.22 1.008 . . . . 0.0 109.447 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -109.51 105.33 14.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -80.09 140.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.6 150.35 49.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.69 0.796 . . . . 0.0 109.459 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -131.19 103.06 6.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.884 1.274 . . . . 0.0 108.101 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -98.32 119.78 37.6 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 121.815 -0.553 . . . . 0.0 110.407 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -81.89 108.82 15.71 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.04 -25.01 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.32 0.648 . . . . 0.0 111.894 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.1 -47.68 81.8 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.294 0.952 . . . . 0.0 108.542 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -71.99 -32.82 67.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -124.32 69.52 51.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.506 0.722 . . . . 0.0 112.638 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.21 -50.78 12.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.332 2.021 . . . . 0.0 111.897 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.54 -42.45 3.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.705 1.621 . . . . 0.0 114.989 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.63 64.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.289 1.045 . . . . 0.0 112.85 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.37 -62.37 6.07 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.65 -42.34 47.8 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.799 1.666 . . . . 0.0 111.376 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -47.03 -44.74 20.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.276 0.63 . . . . 0.0 111.866 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -106.52 24.86 11.92 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.96 47.04 26.14 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.892 0.758 . . . . 0.0 113.045 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.1 mm -80.23 77.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -79.16 -5.29 53.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.543 0.737 . . . . 0.0 111.583 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.6 171.34 40.04 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.572 -2.211 . . . . 0.0 107.572 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.6 pt -148.83 152.69 37.69 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.235 1.414 . . . . 0.0 107.421 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.53 142.66 68.0 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 CA-C-N 120.651 1.268 . . . . 0.0 110.029 -0.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -137.31 114.96 11.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.9 mt -95.24 127.8 41.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.089 1.356 . . . . 0.0 108.941 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.73 119.02 32.42 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.0 tp -97.16 104.02 16.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.037 0.535 . . . . 0.0 109.655 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -93.33 106.43 18.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.799 1.639 . . . . 0.0 109.823 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -93.17 114.55 27.07 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.39 47.11 17.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.098 0.959 . . . . 0.0 110.972 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.64 -14.49 30.09 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.092 -0.838 . . . . 0.0 114.723 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -94.92 122.5 37.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.218 1.509 . . . . 0.0 110.157 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.78 106.3 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.29 -43.47 23.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.635 0.774 . . . . 0.0 109.755 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.41 169.12 23.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.4 p -139.46 164.93 28.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.28 116.72 6.13 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.76 133.73 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.16 163.94 39.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.57 0.605 . . . . 0.0 111.674 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 167.57 16.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.277 0.631 . . . . 0.0 110.815 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.01 167.61 24.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.989 1.316 . . . . 0.0 108.074 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.4 p -79.5 165.97 22.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.318 0.58 . . . . 0.0 111.29 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -56.19 -45.24 79.88 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.46 -57.66 18.67 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.854 0.74 . . . . 0.0 111.432 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -57.68 -40.95 80.58 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.684 0.742 . . . . 0.0 110.701 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.64 -50.8 71.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.978 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -53.16 -51.3 62.48 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.482 0.583 . . . . 0.0 110.19 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.72 -53.28 54.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.572 0.749 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -54.29 -52.48 61.31 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.711 0.804 . . . . 0.0 110.491 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.7 mt -58.12 -52.47 65.42 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.61 0.364 . . . . 0.0 110.584 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -54.12 -52.86 59.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.668 0.787 . . . . 0.0 109.68 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.54 -40.72 68.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.585 0.754 . . . . 0.0 111.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -78.23 -48.12 16.47 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 122.326 -0.234 . . . . 0.0 111.168 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.6 mt -57.22 -46.24 83.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.515 0.726 . . . . 0.0 109.3 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.123 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 111.3 0.111 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -67.13 103.62 1.24 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.625 0.37 . . . . 0.0 110.881 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -122.78 35.43 4.88 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mt -84.58 138.32 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.127 0.571 . . . . 0.0 111.088 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.79 113.6 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.378 0.671 . . . . 0.0 110.808 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -84.36 99.43 10.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.396 1.078 . . . . 0.0 109.28 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.73 171.19 11.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.202 1.001 . . . . 0.0 111.481 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.7 p -137.37 166.43 23.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -52.81 -41.95 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.287 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.63 -47.93 79.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.642 1.177 . . . . 0.0 111.904 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.37 -26.41 46.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -35.14 -54.16 0.61 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.368 1.467 . . . . 0.0 113.898 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.02 -65.47 0.57 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.523 0.677 . . . . 0.0 111.013 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -56.46 -37.5 70.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.166 0.987 . . . . 0.0 112.746 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.39 -60.72 1.95 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.87 -50.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 112.479 -173.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.07 -32.5 74.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.078 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -98.8 27.59 4.83 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.512 0.325 . . . . 0.0 110.872 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.89 73.22 0.26 Allowed 'General case' 0 C--N 1.343 0.291 0 O-C-N 121.522 -0.736 . . . . 0.0 111.863 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -68.09 73.49 0.2 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.373 1.069 . . . . 0.0 109.991 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.24 -121.05 0.99 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.66 120.0 7.87 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mt -116.85 124.24 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.09 1.356 . . . . 0.0 108.14 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.1 tp -100.95 102.68 13.75 Favored 'General case' 0 C--O 1.228 -0.051 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.57 113.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 122.657 0.383 . . . . 0.0 110.426 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.48 109.54 21.73 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.528 1.131 . . . . 0.0 108.634 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -79.97 122.04 26.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -136.81 178.65 6.91 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.583 1.153 . . . . 0.0 111.063 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.02 154.26 36.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.858 1.663 . . . . 0.0 108.004 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -54.56 -40.51 68.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.295 0.952 . . . . 0.0 112.035 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -79.34 -2.43 41.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 112.968 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -79.41 78.58 5.91 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.901 -1.124 . . . . 0.0 111.55 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.61 3.63 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.772 0.701 . . . . 0.0 112.206 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.26 -34.42 79.56 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.902 2.401 . . . . 0.0 113.239 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -63.67 -46.34 86.02 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.07 -46.75 87.47 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.8 mtp -55.07 -43.83 74.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.569 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.37 -20.71 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.916 0.78 . . . . 0.0 112.97 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.15 -52.65 9.4 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.977 1.262 . . . . 0.0 114.238 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -52.9 -41.14 72.87 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.493 2.129 . . . . 0.0 112.143 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -62.92 -49.58 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.96 -42.28 72.16 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -62.5 -45.82 91.25 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 110.176 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -59.24 -46.92 87.19 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.717 -0.614 . . . . 0.0 109.775 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.67 -48.4 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -43.39 64.7 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.381 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.82 -63.46 1.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.448 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -45.41 -47.11 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.956 1.302 . . . . 0.0 113.618 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -95.09 21.54 7.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.023 0.929 . . . . 0.0 112.295 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.59 130.92 17.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.435 1.016 . . . . 0.0 110.302 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.09 -18.18 4.3 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.209 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -99.29 -39.39 8.45 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.821 1.31 . . . . 0.0 109.768 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.74 136.62 32.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.232 1.013 . . . . 0.0 108.361 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.4 m -102.23 107.46 18.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.0 135.89 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.23 154.3 51.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.534 0.733 . . . . 0.0 109.323 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.36 144.77 51.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.206 1.402 . . . . 0.0 108.707 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.9 tt -134.37 129.42 35.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.38 100.89 12.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -57.09 -30.1 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -61.77 -46.1 91.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.27 0.941 . . . . 0.0 109.966 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -88.58 -19.33 26.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.365 1.466 . . . . 0.0 111.771 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -127.24 55.52 15.61 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.413 1.485 . . . . 0.0 109.946 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.25 -42.67 21.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.722 2.281 . . . . 0.0 112.295 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.47 -33.68 4.52 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.578 1.085 . . . . 0.0 113.827 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -64.4 -55.66 28.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 119.286 0.948 . . . . 0.0 112.407 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 72.2 Cg_exo -51.52 -41.83 58.57 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 113.496 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -45.65 -46.55 14.68 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.511 0.724 . . . . 0.0 112.574 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -108.03 16.53 23.31 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.2 0.6 . . . . 0.0 111.197 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 46.46 47.22 17.21 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 125.195 1.379 . . . . 0.0 111.216 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.3 mm -51.61 115.78 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 117.5 0.65 . . . . 0.0 109.838 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.02 -28.54 43.32 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.279 1.032 . . . . 0.0 112.07 -173.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.14 -167.78 35.42 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt -146.76 151.02 41.36 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.95 143.36 74.0 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.328 1.153 . . . . 0.0 110.204 -0.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 m -139.69 126.01 20.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.57 116.14 31.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 108.948 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.2 mp -110.13 119.33 38.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.3 tp -94.55 106.3 18.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -101.23 128.94 47.13 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 125.352 1.461 . . . . 0.0 111.707 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -113.11 102.04 10.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.34 58.38 3.04 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.056 1.342 . . . . 0.0 111.738 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.84 -24.13 4.69 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.504 -0.609 . . . . 0.0 113.784 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -79.78 109.12 13.89 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.664 1.232 . . . . 0.0 109.239 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.04 111.32 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.71 23.61 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.429 0.692 . . . . 0.0 109.746 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.24 161.13 33.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.405 HG22 ' HG ' ' A' ' 79' ' ' LEU . 80.5 p -135.59 135.41 40.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.401 1.08 . . . . 0.0 109.157 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 127.97 49.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.74 129.19 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.17 173.72 44.98 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.053 0.835 . . . . 0.0 111.43 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.02 171.35 13.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.34 -0.506 . . . . 0.0 110.221 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -164.3 164.46 22.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.528 1.531 . . . . 0.0 107.617 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.2 p -73.9 161.17 30.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.124 0.488 . . . . 0.0 110.764 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.43 -42.93 78.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.89 -58.65 13.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.33 -45.49 69.09 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.265 0.532 . . . . 0.0 110.872 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.5 tp -59.8 -52.06 67.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -55.83 -46.94 78.02 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.111 -0.368 . . . . 0.0 110.893 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.95 -52.86 63.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.901 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -53.79 -53.14 56.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.223 1.009 . . . . 0.0 110.219 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.96 -50.32 74.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.402 0.281 . . . . 0.0 110.685 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.36 -49.83 71.26 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.491 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.551 0.741 . . . . 0.0 111.521 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -77.65 -46.38 22.17 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 122.151 -0.343 . . . . 0.0 110.923 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.6 mt -62.3 -43.77 98.06 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 125.606 1.562 . . . . 0.0 108.501 178.089 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -73.88 90.33 1.91 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -113.61 36.89 3.42 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 mt -100.82 138.19 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 111.507 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -92.83 118.55 38.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 110.542 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -87.74 101.3 13.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.24 1.016 . . . . 0.0 109.292 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.94 168.34 12.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.549 1.14 . . . . 0.0 112.593 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -135.43 162.12 33.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.83 -43.83 69.74 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.78 -46.24 91.25 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.968 1.307 . . . . 0.0 112.014 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.27 -26.46 47.17 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.028 -0.42 . . . . 0.0 111.467 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -35.97 -54.12 0.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.745 1.618 . . . . 0.0 113.633 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -55.34 -62.3 1.76 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.939 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -59.03 -40.3 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.281 0.632 . . . . 0.0 112.44 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.19 -58.38 3.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -80.74 -52.35 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.885 0.874 . . . . 0.0 112.349 -173.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -63.36 -26.13 68.61 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.635 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -103.09 36.12 2.33 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.078 0.551 . . . . 0.0 109.859 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.4 136.36 4.17 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -72.74 75.62 1.12 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.208 1.003 . . . . 0.0 108.74 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.89 -74.64 1.57 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -136.12 121.46 19.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.888 0.844 . . . . 0.0 109.857 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.68 132.03 69.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 C-N-CA 124.316 1.046 . . . . 0.0 108.531 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.84 100.92 9.3 Favored 'General case' 0 C--O 1.229 -0.025 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.16 117.64 33.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 122.661 0.385 . . . . 0.0 110.75 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -97.43 109.39 22.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.882 1.273 . . . . 0.0 108.882 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -82.43 124.18 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -142.38 172.83 12.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 147.98 40.23 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.293 1.437 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -54.92 -35.87 64.64 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.177 0.591 . . . . 0.0 112.033 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -84.81 -5.67 59.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.954 0.902 . . . . 0.0 112.358 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.85 82.01 6.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.063 -1.023 . . . . 0.0 110.728 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.76 -57.51 3.37 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 123.941 0.782 . . . . 0.0 111.983 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.51 -34.36 81.81 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.148 2.565 . . . . 0.0 113.435 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.76 -49.57 67.91 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -58.98 -39.98 83.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.5 ttp -58.52 -47.69 83.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.203 0.601 . . . . 0.0 110.426 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.2 pt -75.83 -25.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.626 -0.702 . . . . 0.0 112.659 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -58.02 1.16 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.13 -40.63 83.63 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.192 1.928 . . . . 0.0 111.521 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.0 mt -58.97 -49.97 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.77 -42.52 75.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.889 0.313 . . . . 0.0 110.46 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -59.9 -53.66 55.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -45.89 75.47 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.62 -0.675 . . . . 0.0 110.392 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -57.07 -48.62 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.017 0.527 . . . . 0.0 109.648 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.63 76.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.557 0.743 . . . . 0.0 110.27 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.52 -56.73 13.71 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.57 -51.0 40.02 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.992 1.317 . . . . 0.0 112.028 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -96.98 23.7 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.797 0.839 . . . . 0.0 112.525 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -54.89 128.93 35.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.028 . . . . 0.0 110.461 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.51 -16.99 21.94 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.298 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.52 -42.72 6.8 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.674 1.237 . . . . 0.0 109.365 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -134.11 119.25 18.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.807 1.243 . . . . 0.0 107.648 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.8 m -86.24 102.78 14.25 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.63 139.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.55 154.59 49.8 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.19 145.17 51.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.136 1.374 . . . . 0.0 108.489 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.19 123.39 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -84.53 109.38 17.89 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -62.8 -31.54 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.38 -52.72 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.998 0.817 . . . . 0.0 110.069 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.82 -30.82 65.9 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.826 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -117.64 71.14 7.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.935 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.94 -53.98 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.716 2.277 . . . . 0.0 112.597 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.71 -45.81 2.08 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.38 1.467 . . . . 0.0 114.358 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.55 65.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.4 1.08 . . . . 0.0 113.356 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.41 -66.34 1.07 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.842 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -58.88 -42.9 48.01 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 121.228 1.474 . . . . 0.0 111.106 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -50.35 -46.09 55.5 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.452 0.569 . . . . 0.0 111.692 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -100.32 24.62 8.55 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.38 41.8 24.97 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.07 0.843 . . . . 0.0 113.584 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.5 mm -76.82 76.36 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.18 -4.48 50.71 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.34 0.656 . . . . 0.0 111.451 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.45 171.44 40.72 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt -147.99 152.15 39.59 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.93 1.292 . . . . 0.0 107.54 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.19 146.27 80.5 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.365 1.166 . . . . 0.0 110.042 -1.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.0 m -137.82 123.54 19.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.6 mt -108.58 112.64 25.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.727 1.611 . . . . 0.0 109.173 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.1 mp -104.86 122.28 45.43 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -96.55 99.75 11.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.787 0.835 . . . . 0.0 109.278 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -89.55 107.36 19.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.862 1.665 . . . . 0.0 109.708 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -92.49 112.2 24.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 174.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.23 45.7 9.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.297 1.039 . . . . 0.0 111.083 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.2 -13.58 56.89 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.125 -0.82 . . . . 0.0 115.077 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -95.44 121.38 37.06 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.151 1.476 . . . . 0.0 109.967 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -62.89 102.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.0 -41.76 25.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.867 0.867 . . . . 0.0 110.976 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.11 159.16 42.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.418 HG22 ' HG ' ' A' ' 79' ' ' LEU . 82.2 p -138.54 131.13 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.262 1.025 . . . . 0.0 109.299 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -120.27 117.68 28.46 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.35 134.06 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 163.65 39.46 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.663 0.649 . . . . 0.0 111.864 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.34 169.12 14.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.395 0.678 . . . . 0.0 110.488 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.61 168.66 21.41 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.627 1.171 . . . . 0.0 108.531 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 149.47 33.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.747 1.219 . . . . 0.0 110.609 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.47 -49.18 65.18 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.173 0.589 . . . . 0.0 111.252 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.77 42.14 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -58.67 -43.17 89.8 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.97 0.508 . . . . 0.0 110.418 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.3 -50.55 73.19 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -54.63 -49.94 69.33 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 122.045 -0.409 . . . . 0.0 110.503 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.46 -52.79 63.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.08 0.952 . . . . 0.0 110.095 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.27 -53.76 49.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.671 0.788 . . . . 0.0 110.19 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.12 -49.95 75.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.624 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.97 -51.36 64.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 117.968 0.349 . . . . 0.0 110.138 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.31 -36.41 71.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.791 0.837 . . . . 0.0 111.894 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -77.7 -46.01 23.16 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 121.988 -0.445 . . . . 0.0 109.855 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.26 -46.48 88.41 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 123.062 0.545 . . . . 0.0 109.624 177.571 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.5 p . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -73.94 100.51 3.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.11 -0.369 . . . . 0.0 110.172 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -120.43 33.36 5.62 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.3 mt -85.58 138.31 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.136 0.574 . . . . 0.0 111.166 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.57 119.99 41.1 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.283 0.563 . . . . 0.0 110.365 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -88.94 103.55 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.444 1.097 . . . . 0.0 109.34 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.22 164.99 14.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.612 1.165 . . . . 0.0 113.206 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.4 p -136.07 162.21 33.53 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.65 -44.14 69.38 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.331 0.514 . . . . 0.0 109.939 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.23 -46.24 90.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.925 1.29 . . . . 0.0 112.096 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.6 p -78.56 -26.17 45.56 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.085 -0.385 . . . . 0.0 111.482 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -36.98 -54.43 0.95 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.015 1.726 . . . . 0.0 114.125 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -52.69 -60.2 3.55 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.521 -0.737 . . . . 0.0 111.159 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.53 97.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.592 0.757 . . . . 0.0 112.335 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -27.01 50.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.8 -62.55 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 124.017 0.927 . . . . 0.0 111.746 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.86 -35.81 77.56 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 121.949 -0.47 . . . . 0.0 111.444 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -91.11 5.72 47.85 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 119.222 -0.418 . . . . 0.0 112.124 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.49 98.0 3.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.755 1.161 . . . . 0.0 111.13 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -73.6 69.48 1.26 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.13 -160.44 27.43 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.15 119.16 38.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.805 0.802 . . . . 0.0 109.124 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.46 139.25 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 126.147 1.779 . . . . 0.0 107.793 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.97 99.35 6.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 t -90.92 114.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -91.59 107.58 19.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.159 0.983 . . . . 0.0 108.404 174.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -79.72 120.41 23.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -136.49 179.46 6.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.968 0.907 . . . . 0.0 110.868 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.69 36.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.275 1.03 . . . . 0.0 109.652 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -56.25 -26.33 51.14 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.775 1.23 . . . . 0.0 112.333 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -93.75 -8.22 41.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.526 1.131 . . . . 0.0 112.483 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.74 82.88 5.77 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.992 -1.067 . . . . 0.0 112.903 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.42 -58.23 4.69 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.571 0.605 . . . . 0.0 112.469 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -53.16 -32.28 58.98 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.2 2.6 . . . . 0.0 113.236 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.7 m -65.45 -43.85 89.08 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -63.24 -41.78 99.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 50.9 ttp -55.11 -47.73 74.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.618 0.367 . . . . 0.0 110.83 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.54 -26.92 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.14 -56.66 1.18 Allowed Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -57.44 -35.94 98.81 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.183 1.922 . . . . 0.0 111.953 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.0 mt -64.73 -49.45 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.5 mt -54.51 -42.22 70.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.799 0.272 . . . . 0.0 110.473 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -61.83 -51.46 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -52.69 -47.96 66.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.934 -0.478 . . . . 0.0 109.863 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.12 -48.58 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.39 0.676 . . . . 0.0 109.421 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 -43.21 65.44 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.182 0.593 . . . . 0.0 110.05 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.12 -61.65 1.82 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.751 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -53.14 -48.4 67.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.113 0.965 . . . . 0.0 112.397 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -88.7 13.52 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 0.0 112.248 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -55.08 116.5 2.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.906 1.23 . . . . 0.0 109.729 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.66 -26.79 18.61 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.798 0.713 . . . . 0.0 111.585 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -99.19 -42.15 7.17 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.681 0.793 . . . . 0.0 109.765 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -129.08 141.34 51.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.296 1.038 . . . . 0.0 109.956 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -108.59 96.81 6.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -78.92 136.42 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.213 -0.929 . . . . 0.0 108.534 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 157.44 46.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.937 0.895 . . . . 0.0 109.249 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -131.97 146.52 52.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.279 1.432 . . . . 0.0 108.789 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -138.45 124.98 20.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -86.97 108.55 18.87 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 pt -65.43 -23.56 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.16 -45.36 93.75 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.132 0.878 . . . . 0.0 108.794 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -77.49 -35.18 53.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.371 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -123.03 69.13 37.3 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.986 0.914 . . . . 0.0 111.51 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.24 -55.86 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.102 1.868 . . . . 0.0 112.19 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.3 -40.65 2.68 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.782 1.658 . . . . 0.0 114.691 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.55 -33.7 68.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.092 -0.652 . . . . 0.0 112.494 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -64.58 -65.07 2.17 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.581 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 80.5 Cg_exo -48.21 -42.99 32.6 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.783 2.322 . . . . 0.0 112.786 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? -49.84 -42.38 47.22 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.942 0.792 . . . . 0.0 112.027 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -103.82 25.3 10.01 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.043 0.383 . . . . 0.0 111.502 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.77 46.32 48.27 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.432 1.015 . . . . 0.0 113.172 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.8 mt -94.27 105.96 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -30.04 40.84 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.659 0.784 . . . . 0.0 112.431 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.97 -179.14 26.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 pt -143.02 159.31 56.68 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.63 1.572 . . . . 0.0 108.347 -178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.44 141.37 57.48 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 120.727 1.295 . . . . 0.0 110.308 -0.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 m -141.07 125.72 17.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.51 107.37 17.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.274 1.43 . . . . 0.0 109.516 -174.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -95.79 116.13 28.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.5 99.9 12.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -92.91 112.33 24.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.225 1.41 . . . . 0.0 108.949 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.29 118.2 36.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 43.38 31.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.607 0.763 . . . . 0.0 109.524 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.88 -0.98 33.95 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.816 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -102.5 125.1 49.1 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.602 1.701 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.0 t -61.34 104.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.32 22.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.674 0.79 . . . . 0.0 110.067 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.67 156.45 34.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.09 0.556 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.447 HG22 ' HG ' ' A' ' 79' ' ' LEU . 77.0 p -132.07 112.45 12.35 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.673 1.189 . . . . 0.0 109.025 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -98.73 110.85 23.39 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.59 131.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.29 162.69 38.46 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.744 0.688 . . . . 0.0 111.996 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.43 170.06 12.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.223 0.609 . . . . 0.0 110.442 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -164.54 163.75 21.89 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.027 1.331 . . . . 0.0 108.002 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.9 p -73.79 163.08 28.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.124 0.487 . . . . 0.0 110.817 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.41 -44.63 76.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.36 -54.52 36.49 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -56.65 -44.47 81.34 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.272 0.536 . . . . 0.0 110.404 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.79 -53.87 52.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -54.82 -46.28 74.52 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.142 0.428 . . . . 0.0 110.835 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.03 -53.72 54.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.528 0.731 . . . . 0.0 110.057 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.64 -53.09 59.33 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.148 0.979 . . . . 0.0 110.421 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.21 -50.62 72.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.674 0.389 . . . . 0.0 110.305 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.3 -51.71 65.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.612 0.365 . . . . 0.0 110.288 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.91 -37.79 69.39 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.658 0.783 . . . . 0.0 111.928 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -77.88 -46.89 20.07 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.0 mt -58.77 -44.64 90.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.066 0.546 . . . . 0.0 109.719 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 122.998 0.519 . . . . 0.0 109.636 177.556 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.2 t70 3.54 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 129.173 2.989 . . . . 0.0 114.501 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -135.8 45.12 2.44 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 mt -105.86 133.02 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.023 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mt -86.94 146.03 6.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -115.52 100.1 7.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.1 163.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.636 1.174 . . . . 0.0 113.209 -173.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.2 p -135.57 163.89 29.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.512 1.925 . . . . 0.0 106.288 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -54.39 -45.91 72.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 109.89 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.21 -44.56 92.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.184 1.394 . . . . 0.0 112.049 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -78.61 -31.61 47.11 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.203 -0.311 . . . . 0.0 111.227 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -32.66 -55.07 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.215 1.806 . . . . 0.0 115.048 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -54.67 -62.55 1.58 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.455 -0.778 . . . . 0.0 111.438 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -63.52 -42.48 98.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.969 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.13 -37.85 66.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.505 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.46 -65.21 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.749 0.82 . . . . 0.0 112.382 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.09 -36.2 72.51 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -92.63 8.49 38.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.5 -0.762 . . . . 0.0 113.018 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.08 169.36 18.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 120.595 1.543 . . . . 0.0 112.08 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -119.02 166.45 12.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.49 -139.77 25.21 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.3 123.82 30.92 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.661 0.73 . . . . 0.0 110.208 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mt -111.36 129.9 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.99 1.316 . . . . 0.0 107.724 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.06 102.46 10.67 Favored 'General case' 0 C--O 1.228 -0.057 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.92 115.69 32.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.521 0.329 . . . . 0.0 110.692 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.45 110.55 22.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.527 1.131 . . . . 0.0 109.073 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -82.14 123.9 29.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -138.07 173.8 11.24 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.421 0.688 . . . . 0.0 111.55 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.96 151.42 38.59 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 125.207 1.403 . . . . 0.0 107.734 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.75 -38.12 66.78 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.777 0.717 . . . . 0.0 112.354 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -80.05 -4.7 53.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.128 0.971 . . . . 0.0 112.911 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.0 t -79.46 82.03 5.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 120.906 -1.121 . . . . 0.0 111.193 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.92 -57.95 4.5 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.429 0.538 . . . . 0.0 112.269 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.21 -32.23 49.41 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.386 2.724 . . . . 0.0 113.481 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.39 -41.01 98.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -63.61 -41.63 98.29 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 92.5 mmm -60.35 -45.06 94.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.535 -0.269 . . . . 0.0 110.981 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.21 -27.66 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.605 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -57.38 1.26 Allowed Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.26 -37.45 95.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.069 1.846 . . . . 0.0 111.66 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mt -62.11 -48.95 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.64 -43.92 76.68 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -60.51 -51.91 67.43 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.113 -0.367 . . . . 0.0 110.732 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -54.45 -50.99 66.38 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.92 -46.95 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.747 0.819 . . . . 0.0 109.937 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -43.44 71.61 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.12 -55.95 12.03 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.378 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.66 -45.45 63.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.285 1.034 . . . . 0.0 112.858 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -98.15 22.38 9.57 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.216 1.007 . . . . 0.0 111.426 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -52.9 131.34 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.514 1.052 . . . . 0.0 110.512 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.13 -20.75 11.87 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.081 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.18 -48.47 4.83 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.735 1.267 . . . . 0.0 109.268 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.59 122.51 39.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.495 1.118 . . . . 0.0 109.156 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.9 m -92.78 101.58 13.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -78.91 139.57 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.97 157.94 44.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.867 0.867 . . . . 0.0 108.918 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.67 147.81 51.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.155 1.782 . . . . 0.0 108.085 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -139.11 125.61 20.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -87.37 109.04 19.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.2 -24.88 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.74 -50.22 74.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.452 1.024 . . . . 0.0 108.847 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -75.53 -26.71 58.29 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.001 0.92 . . . . 0.0 111.185 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -127.47 69.35 75.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.405 0.682 . . . . 0.0 111.939 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.55 -59.57 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.428 2.085 . . . . 0.0 112.94 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.93 -41.0 2.46 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.064 1.792 . . . . 0.0 115.233 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -26.9 66.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.026 -0.69 . . . . 0.0 112.717 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.572 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -71.31 -64.94 1.02 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.083 0.856 . . . . 0.0 110.463 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 88.7 Cg_exo -47.44 -39.07 28.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.283 2.656 . . . . 0.0 112.971 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -47.7 -36.18 10.86 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.602 0.637 . . . . 0.0 112.59 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -117.42 28.66 8.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.073 0.549 . . . . 0.0 110.667 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.43 35.48 44.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.734 1.159 . . . . 0.0 113.467 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.51 82.45 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.655 -0.909 . . . . 0.0 109.265 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -79.46 -5.57 55.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.6 0.76 . . . . 0.0 112.771 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.05 166.4 31.48 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt -144.83 156.61 55.6 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.507 1.523 . . . . 0.0 107.854 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.12 145.2 75.04 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 120.573 1.24 . . . . 0.0 109.927 -1.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.3 m -139.96 127.58 21.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -110.4 108.18 18.12 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.126 1.37 . . . . 0.0 109.686 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -96.45 118.16 32.38 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -97.0 99.51 11.04 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.426 0.69 . . . . 0.0 109.379 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -91.23 105.34 17.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.734 1.613 . . . . 0.0 109.991 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -89.73 113.81 25.39 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 173.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 44.87 52.7 7.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.424 1.089 . . . . 0.0 110.864 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.3 -12.75 12.35 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.915 -0.936 . . . . 0.0 115.035 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -94.73 121.74 36.62 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.571 1.685 . . . . 0.0 110.254 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.12 106.25 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.64 22.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.632 0.773 . . . . 0.0 109.824 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.84 158.51 35.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.249 0.62 . . . . 0.0 109.657 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.451 HG22 ' HG ' ' A' ' 79' ' ' LEU . 80.7 p -131.97 112.17 12.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.869 1.267 . . . . 0.0 108.653 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -98.79 111.51 23.87 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -91.0 130.51 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.24 163.78 34.71 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.084 0.85 . . . . 0.0 111.896 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.62 167.22 22.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 110.246 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.06 166.81 27.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.566 1.146 . . . . 0.0 108.544 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.0 p -83.21 161.71 21.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.022 0.439 . . . . 0.0 110.526 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -52.98 -42.85 65.92 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.524 0.73 . . . . 0.0 110.519 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.79 -54.39 37.94 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -55.36 -46.05 76.48 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.348 -0.501 . . . . 0.0 109.979 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.5 tp -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -53.63 -49.88 66.91 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.607 0.639 . . . . 0.0 111.107 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -57.76 -50.96 71.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.94 -52.6 60.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.506 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.69 -52.11 66.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.037 0.535 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.11 -52.7 60.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.646 0.379 . . . . 0.0 110.292 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.74 -39.5 71.23 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.767 0.827 . . . . 0.0 112.003 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.85 -47.08 19.66 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.218 -0.301 . . . . 0.0 110.554 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -57.98 -47.6 82.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.176 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -63.74 104.84 0.72 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.526 0.73 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -124.56 36.11 4.67 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.9 mt -87.0 140.06 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.424 0.69 . . . . 0.0 111.215 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -90.97 114.53 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.326 0.65 . . . . 0.0 110.422 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -85.59 102.4 13.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 0.0 109.946 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.96 163.16 14.1 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.035 1.334 . . . . 0.0 113.19 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.0 p -130.74 159.74 36.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.189 2.196 . . . . 0.0 106.228 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.24 -45.6 68.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.35 -47.46 75.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.92 1.288 . . . . 0.0 111.626 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -78.23 -26.07 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -37.24 -51.87 1.04 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 114.092 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.87 -62.95 1.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.574 0.702 . . . . 0.0 111.019 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -57.65 -39.21 76.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.918 0.887 . . . . 0.0 112.32 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -55.58 4.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.91 -53.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.235 1.014 . . . . 0.0 112.959 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.01 -37.74 86.02 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.991 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -97.61 29.62 3.25 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.109 174.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.81 119.54 5.1 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.221 0.919 . . . . 0.0 111.985 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -79.85 60.18 3.38 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.55 -143.86 13.65 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.24 117.24 33.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.349 1.46 . . . . 0.0 108.767 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.87 125.33 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.543 1.137 . . . . 0.0 108.219 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 tp -102.31 101.91 12.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.4 t -86.57 118.62 33.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -97.73 116.5 30.07 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.575 0.75 . . . . 0.0 109.053 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -90.81 121.35 32.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -135.39 178.65 6.87 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.936 0.895 . . . . 0.0 111.584 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.72 150.6 33.44 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 125.413 1.485 . . . . 0.0 108.327 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -55.75 -37.27 68.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.891 0.876 . . . . 0.0 112.386 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -83.33 -5.43 59.14 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.139 0.976 . . . . 0.0 112.54 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.59 81.69 5.81 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 120.958 -1.089 . . . . 0.0 111.684 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.81 -57.49 3.41 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.811 0.72 . . . . 0.0 112.362 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -52.59 -36.96 73.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.999 2.466 . . . . 0.0 113.31 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.0 m -64.01 -47.75 79.05 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -57.85 -43.22 85.75 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.2 mtm -61.0 -44.89 96.76 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.598 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -74.67 -27.51 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.359 0.981 . . . . 0.0 112.507 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.43 -58.16 1.03 Allowed Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.99 -37.42 96.14 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.495 2.13 . . . . 0.0 112.324 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.8 mt -62.4 -51.13 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.4 mt -55.09 -42.05 72.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.17 0.188 . . . . 0.0 110.598 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.67 -51.74 68.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 109.727 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.22 -44.75 84.01 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.866 -0.521 . . . . 0.0 110.274 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.4 mm -58.33 -46.78 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.548 0.739 . . . . 0.0 109.287 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -45.46 66.9 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.79 -59.12 5.31 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -48.81 -48.04 41.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -94.02 15.09 17.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.243 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.47 1.032 . . . . 0.0 111.491 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.25 -28.47 2.58 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.819 1.199 . . . . 0.0 110.242 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -99.47 -38.2 8.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.28 1.032 . . . . 0.0 109.987 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 tp -135.11 141.32 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.8 m -108.03 104.82 14.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -79.11 137.74 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.7 156.17 48.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.863 0.865 . . . . 0.0 108.786 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -132.64 146.21 51.7 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.476 1.51 . . . . 0.0 109.908 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.42 126.17 19.29 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.421 0.688 . . . . 0.0 109.394 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -87.17 109.31 19.37 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.88 -24.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.99 0.516 . . . . 0.0 111.719 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.51 -46.39 90.29 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.261 0.937 . . . . 0.0 108.898 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -77.66 -35.72 52.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -121.79 69.15 25.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.28 1.032 . . . . 0.0 111.139 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.32 -56.33 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.473 2.115 . . . . 0.0 112.787 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.62 -45.6 1.02 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.092 1.806 . . . . 0.0 114.597 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -37.23 31.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.307 1.043 . . . . 0.0 113.078 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.04 -66.44 1.49 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.396 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.63 -36.84 91.21 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.72 1.613 . . . . 0.0 111.22 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -51.56 -45.99 63.24 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.349 0.977 . . . . 0.0 110.71 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -98.68 28.65 4.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.35 0.26 . . . . 0.0 111.683 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.15 46.87 3.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.769 1.652 . . . . 0.0 114.052 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.59 135.75 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.663 -0.904 . . . . 0.0 110.439 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -46.37 9.38 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.889 1.276 . . . . 0.0 109.818 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.99 167.16 37.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.55 152.64 44.8 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 125.376 1.47 . . . . 0.0 109.376 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.67 142.0 65.22 Favored 'Cis proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.219 1.114 . . . . 0.0 110.562 -0.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 144.46 47.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.0 mt -128.64 101.46 6.16 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 mp -104.97 120.71 42.12 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -95.47 105.01 16.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.842 0.857 . . . . 0.0 109.495 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -97.62 110.54 23.08 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.835 1.654 . . . . 0.0 110.057 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -93.88 105.18 17.21 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 173.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 46.29 51.83 11.06 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.669 0.747 . . . . 0.0 111.272 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.9 -19.96 7.03 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.247 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.59 111.22 16.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.061 1.43 . . . . 0.0 109.623 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.49 102.79 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.68 -43.28 23.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.047 0.939 . . . . 0.0 110.956 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.57 154.36 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.142 0.577 . . . . 0.0 109.524 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.8 p -136.75 116.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.473 1.109 . . . . 0.0 109.453 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -108.46 136.26 48.38 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.62 128.16 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.57 168.15 35.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.789 0.709 . . . . 0.0 111.394 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.39 168.05 20.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.198 0.599 . . . . 0.0 110.552 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -162.24 164.07 27.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 107.779 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.67 161.26 30.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -56.72 -43.67 80.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.1 -58.33 14.23 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -53.13 -45.93 68.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 110.945 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.75 -51.38 70.0 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.388 -0.195 . . . . 0.0 110.73 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -56.64 -47.66 79.24 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.132 0.424 . . . . 0.0 110.688 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.73 -52.37 65.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.661 0.784 . . . . 0.0 109.757 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -54.87 -55.4 30.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.997 0.919 . . . . 0.0 110.319 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -57.3 -48.61 78.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.136 -0.352 . . . . 0.0 110.792 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.57 -51.48 68.43 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.577 0.351 . . . . 0.0 110.243 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.26 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.975 0.91 . . . . 0.0 111.972 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -78.17 -50.06 12.66 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 117.847 0.294 . . . . 0.0 110.367 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.9 mt -63.38 -42.97 98.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.444 . . . . 0.0 110.514 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.136 0 C-N-CA 124.703 1.201 . . . . 0.0 111.703 179.359 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.624 0.726 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.85 68.68 1.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.106 0.962 . . . . 0.0 109.354 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -123.6 50.42 1.6 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.1 mt -108.17 137.42 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.922 1.289 . . . . 0.0 108.809 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 mt -85.73 146.92 5.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -117.29 99.38 6.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.81 164.36 14.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.476 1.111 . . . . 0.0 113.306 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.1 p -134.98 162.69 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.228 1.811 . . . . 0.0 106.417 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.64 -44.59 77.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.403 0.547 . . . . 0.0 109.615 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.53 -44.71 89.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.976 1.31 . . . . 0.0 111.893 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.58 -32.71 47.82 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.159 -0.338 . . . . 0.0 111.222 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -32.15 -53.32 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.028 2.131 . . . . 0.0 115.315 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.99 -61.61 2.19 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 110.983 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -43.54 98.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.736 0.815 . . . . 0.0 112.307 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -31.07 53.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.261 -0.876 . . . . 0.0 113.273 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.35 -61.63 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.975 0.91 . . . . 0.0 111.382 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.22 -36.13 74.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -92.54 6.17 48.17 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.99 99.85 9.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 120.427 1.467 . . . . 0.0 111.618 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -71.85 74.46 0.87 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.29 -165.5 32.11 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.53 110.06 21.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.326 1.05 . . . . 0.0 108.325 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.29 127.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.926 1.29 . . . . 0.0 108.714 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.39 103.0 12.36 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.8 t -90.49 118.48 35.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.46 108.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.913 1.285 . . . . 0.0 108.442 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.72 121.81 25.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -137.54 179.48 6.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.919 0.887 . . . . 0.0 111.696 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.6 30.22 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.325 1.45 . . . . 0.0 109.55 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -51.74 -37.12 49.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.84 0.745 . . . . 0.0 112.203 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -85.63 -4.56 59.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.053 0.941 . . . . 0.0 113.03 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -79.42 79.86 5.83 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.934 -1.104 . . . . 0.0 111.111 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.28 -59.91 2.1 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 123.904 0.764 . . . . 0.0 112.693 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.87 -29.07 51.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.402 2.735 . . . . 0.0 113.937 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.75 -42.47 99.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.408 -0.807 . . . . 0.0 109.227 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -66.12 -35.58 80.88 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.8 mtt -62.27 -44.64 96.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.26 -25.54 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 118.772 -0.632 . . . . 0.0 112.435 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.31 -57.88 1.31 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.03 -38.17 96.58 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.812 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mt -60.84 -50.32 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -55.71 -43.95 76.99 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.808 0.443 . . . . 0.0 110.303 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.92 -51.58 68.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.477 0.656 . . . . 0.0 110.354 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -54.73 -48.72 72.18 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.68 -47.61 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 122.827 0.451 . . . . 0.0 109.824 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.71 -44.94 66.66 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.4 0.545 . . . . 0.0 110.495 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -68.13 -57.77 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.755 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -52.19 -43.06 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 113.515 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.07 16.85 19.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.244 1.018 . . . . 0.0 111.674 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.26 134.33 33.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.353 0.979 . . . . 0.0 110.25 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -25.5 6.7 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.705 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -98.84 -41.1 7.79 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.782 1.291 . . . . 0.0 109.689 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -131.19 140.03 49.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.541 1.137 . . . . 0.0 109.743 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -109.56 106.1 15.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.87 135.66 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.67 156.75 47.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.739 0.816 . . . . 0.0 109.115 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.897 1.679 . . . . 0.0 107.403 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.6 123.83 19.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -86.79 108.48 18.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.22 -25.81 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 111.933 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -62.41 -45.86 91.22 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.584 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.8 70.12 72.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.26 -56.22 2.94 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.425 2.083 . . . . 0.0 112.857 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.98 -40.85 2.44 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.059 1.79 . . . . 0.0 115.625 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 -22.01 66.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.836 0.818 . . . . 0.0 112.98 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -74.6 -61.98 1.03 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.452 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 87.8 Cg_exo -48.42 -39.85 36.2 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.132 2.555 . . . . 0.0 112.274 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -45.78 -34.1 3.48 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -124.28 29.71 6.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.883 0.473 . . . . 0.0 110.602 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.17 37.94 31.71 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.867 1.222 . . . . 0.0 113.26 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.9 mt -80.53 85.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -86.13 -4.91 59.27 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.517 0.727 . . . . 0.0 112.224 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.26 166.74 30.09 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 pt -146.71 156.88 48.31 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.902 1.681 . . . . 0.0 107.285 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.03 141.11 54.59 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 121.027 1.403 . . . . 0.0 109.99 -0.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.6 m -139.45 121.86 16.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 mt -100.75 127.62 47.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.393 1.477 . . . . 0.0 108.943 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.2 119.36 34.46 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.31 102.87 14.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -94.84 120.7 35.5 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.685 1.594 . . . . 0.0 110.018 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -106.33 116.03 31.22 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.0 47.54 23.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.519 0.676 . . . . 0.0 109.927 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.24 -7.22 8.44 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.774 -1.014 . . . . 0.0 115.454 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -96.17 126.83 41.66 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 119.592 1.696 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.68 107.26 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.58 -44.14 21.64 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.366 0.667 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.36 167.84 25.0 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.7 p -142.65 165.99 25.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -150.67 120.59 7.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.83 131.64 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.22 164.86 36.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.947 0.784 . . . . 0.0 111.598 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.96 167.11 22.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.157 0.583 . . . . 0.0 110.256 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -161.38 162.85 30.86 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.911 1.284 . . . . 0.0 108.254 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.8 p -73.95 164.14 27.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.363 0.601 . . . . 0.0 111.487 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -53.29 -49.28 67.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.17 -55.21 30.55 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.69 -47.61 73.44 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 117.542 0.671 . . . . 0.0 110.671 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 tp -59.8 -49.58 77.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -53.29 -50.85 64.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.64 0.376 . . . . 0.0 110.875 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -60.14 -50.19 74.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.798 0.439 . . . . 0.0 110.47 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.37 -54.25 39.37 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.141 0.576 . . . . 0.0 109.946 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.6 mt -59.18 -49.91 76.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.269 -0.269 . . . . 0.0 110.884 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.86 -53.51 54.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 117.784 0.266 . . . . 0.0 110.306 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.98 74.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.234 1.014 . . . . 0.0 111.916 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -77.74 -42.53 33.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.258 -0.276 . . . . 0.0 110.727 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.13 -44.87 94.38 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.559 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.8 p . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.2 t70 59.06 -91.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.476 1.111 . . . . 0.0 110.614 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -139.57 20.03 2.54 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.647 1.179 . . . . 0.0 110.223 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.37 132.21 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.16 123.87 48.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 123.502 0.721 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -90.67 108.51 19.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.143 0.977 . . . . 0.0 109.469 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.6 mt -94.04 166.36 12.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.072 0.949 . . . . 0.0 112.943 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -132.5 162.24 31.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.14 -47.65 74.81 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.65 -47.62 83.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.095 1.358 . . . . 0.0 111.534 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -78.45 -25.25 45.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -35.9 -51.27 0.7 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.443 1.897 . . . . 0.0 114.91 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.53 -62.32 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.93 0.787 . . . . 0.0 110.739 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -60.36 -42.36 95.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.529 0.731 . . . . 0.0 111.643 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.59 -41.41 69.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.3 t -107.98 -63.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.487 1.115 . . . . 0.0 113.133 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.11 -37.28 74.25 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -88.36 2.29 52.87 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.52 106.82 14.7 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.638 1.563 . . . . 0.0 110.723 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -76.5 62.36 1.87 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.786 0.835 . . . . 0.0 109.345 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.75 -167.65 24.55 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.57 108.96 20.45 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.31 124.48 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 108.643 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 tp -105.39 99.48 9.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -89.37 114.66 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -89.56 105.57 17.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.52 119.96 23.23 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -134.33 -177.94 4.82 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.563 1.145 . . . . 0.0 111.2 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.59 35.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.737 1.215 . . . . 0.0 109.306 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -54.88 -28.53 51.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.519 1.128 . . . . 0.0 112.758 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -94.96 -4.63 46.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 112.387 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.1 t -79.99 83.7 5.85 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.007 -1.058 . . . . 0.0 111.583 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.7 -61.38 3.37 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.24 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.38 -36.71 31.14 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.7 2.933 . . . . 0.0 113.779 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.5 -37.99 85.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -70.27 -46.5 64.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -40.91 60.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 119.184 -0.436 . . . . 0.0 111.461 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -81.82 -10.88 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.5 -51.45 69.25 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 119.995 1.27 . . . . 0.0 113.295 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.73 -41.7 72.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.314 2.01 . . . . 0.0 111.537 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.11 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -54.31 -44.61 72.14 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -60.13 -57.27 13.54 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.007 0.523 . . . . 0.0 111.321 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -60.0 -40.81 90.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.627 -0.671 . . . . 0.0 110.719 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.81 -46.5 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.92 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.725 0.41 . . . . 0.0 110.259 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.09 -54.7 25.96 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -51.16 -46.71 62.12 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.391 1.076 . . . . 0.0 112.593 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -96.07 18.84 12.66 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.642 0.777 . . . . 0.0 111.903 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -50.67 137.02 20.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.335 0.971 . . . . 0.0 111.334 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 -26.23 5.11 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.554 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -99.1 -51.27 3.88 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.772 1.286 . . . . 0.0 109.189 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.39 132.09 56.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.663 1.185 . . . . 0.0 108.995 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -106.65 102.47 11.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.34 160.8 39.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -136.04 147.46 47.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.949 1.3 . . . . 0.0 108.351 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -140.76 125.6 18.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -87.97 108.58 19.27 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.88 -25.71 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.711 0.804 . . . . 0.0 112.178 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.41 -46.48 89.95 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.105 0.866 . . . . 0.0 108.976 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.98 -35.44 57.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.344 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -120.92 68.82 16.82 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.126 0.97 . . . . 0.0 111.313 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.59 -51.97 2.17 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.381 2.054 . . . . 0.0 112.335 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.0 -38.08 4.53 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.873 1.225 . . . . 0.0 114.305 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -31.8 71.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.954 -0.733 . . . . 0.0 112.341 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.86 -65.26 2.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.434 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 83.3 Cg_exo -49.52 -45.76 29.63 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.558 2.172 . . . . 0.0 112.438 174.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -47.61 -42.48 24.18 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -108.23 22.71 15.56 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.325 0.511 . . . . 0.0 111.673 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.44 46.19 45.42 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.366 0.984 . . . . 0.0 113.361 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.06 132.4 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.0 mtm-85 -104.86 -10.89 17.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.523 1.129 . . . . 0.0 113.108 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.47 -172.08 44.44 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.6 pt -144.24 144.91 27.5 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.604 1.202 . . . . 0.0 108.316 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.22 147.44 87.55 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.834 0.976 . . . . 0.0 110.435 -0.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 m -133.19 122.79 24.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.85 100.05 10.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.99 113.37 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -93.28 97.55 10.69 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.631 0.772 . . . . 0.0 109.646 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -86.35 106.12 17.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 108.895 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -94.45 114.16 26.13 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.97 45.65 27.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.109 0.964 . . . . 0.0 109.935 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.72 -3.19 44.76 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.629 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -101.5 122.36 43.67 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.669 1.735 . . . . 0.0 109.796 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 106.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.52 -43.18 23.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.611 0.764 . . . . 0.0 109.887 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.99 156.51 31.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.706 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.9 p -127.8 99.93 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.226 1.41 . . . . 0.0 108.389 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.07 105.53 16.56 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.33 132.7 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.83 164.89 40.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.163 0.887 . . . . 0.0 112.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.4 171.14 13.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.143 0.577 . . . . 0.0 110.235 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.33 168.07 17.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.474 1.51 . . . . 0.0 107.774 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -77.94 164.57 24.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.918 0.389 . . . . 0.0 110.467 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.45 -46.85 80.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.54 -56.34 24.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.44 -39.73 80.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.617 0.708 . . . . 0.0 110.514 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.06 -48.61 80.94 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.147 0.431 . . . . 0.0 110.127 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -56.17 -47.96 77.26 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.595 0.634 . . . . 0.0 110.665 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -57.19 -52.01 67.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.649 0.379 . . . . 0.0 110.153 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -53.66 -53.26 54.43 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 110.154 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -56.6 -52.39 65.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.761 0.424 . . . . 0.0 110.303 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.19 -52.07 62.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.916 0.325 . . . . 0.0 110.615 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.7 75.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.871 0.868 . . . . 0.0 112.287 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -78.45 -46.05 20.68 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 117.899 0.318 . . . . 0.0 110.872 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -61.23 -47.28 86.81 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.407 0.683 . . . . 0.0 109.744 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 124.606 1.162 . . . . 0.0 111.492 179.391 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.637 0.256 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -66.32 98.58 0.48 Allowed 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.298 -0.251 . . . . 0.0 110.532 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -113.28 38.58 2.83 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.56 142.36 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.385 0.674 . . . . 0.0 110.874 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -91.86 116.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-O 121.473 0.654 . . . . 0.0 110.875 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.23 101.87 11.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.524 1.129 . . . . 0.0 108.921 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.1 164.71 20.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 112.933 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.5 p -132.49 160.65 35.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 170.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -55.71 -44.24 77.27 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.742 0.701 . . . . 0.0 109.475 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.21 -47.98 83.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.848 1.259 . . . . 0.0 111.549 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.8 p -78.64 -21.79 47.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.007 -0.433 . . . . 0.0 112.105 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.95 -51.89 1.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.161 1.784 . . . . 0.0 113.729 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -51.65 -61.51 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.468 0.652 . . . . 0.0 110.681 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -60.92 -46.86 88.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.716 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -69.88 -32.21 70.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.7 -64.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.267 1.027 . . . . 0.0 111.833 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.3 -37.45 77.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.46 -0.15 . . . . 0.0 111.358 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -99.89 14.82 29.12 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.62 120.97 14.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.417 1.008 . . . . 0.0 110.528 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -78.47 56.47 1.78 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.525 0.73 . . . . 0.0 110.241 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.22 -162.03 35.66 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.67 129.98 38.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.75 138.26 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 C-N-CA 125.577 1.551 . . . . 0.0 108.622 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.2 tp -118.08 102.47 9.05 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -94.5 106.41 18.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.879 1.272 . . . . 0.0 107.923 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.22 123.94 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -138.09 177.62 7.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.606 0.762 . . . . 0.0 112.061 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.64 151.15 35.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.807 1.643 . . . . 0.0 108.126 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -54.69 -36.93 65.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.309 0.644 . . . . 0.0 111.897 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -85.12 -2.47 58.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.524 1.13 . . . . 0.0 112.745 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.2 t -79.58 80.3 5.97 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.9 -1.125 . . . . 0.0 111.411 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.61 -57.86 3.73 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 123.785 0.707 . . . . 0.0 112.001 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -53.1 -34.46 68.4 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.097 2.531 . . . . 0.0 113.484 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -64.01 -46.55 83.99 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -61.41 -41.86 97.81 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -57.43 -43.76 84.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.198 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -78.76 -26.25 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.822 0.737 . . . . 0.0 112.81 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.2 -55.09 3.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.37 -43.17 39.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.948 2.432 . . . . 0.0 112.904 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.8 -49.82 82.7 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 mt -55.74 -44.06 77.19 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -58.63 -57.68 11.89 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.524 0.73 . . . . 0.0 110.377 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -59.74 -43.08 94.38 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.773 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 mm -54.59 -44.66 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.912 0.485 . . . . 0.0 109.996 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -35.17 65.73 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.074 0.397 . . . . 0.0 111.126 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -76.48 -52.44 9.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.0 -45.12 64.42 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.953 0.901 . . . . 0.0 111.682 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -98.06 24.72 6.75 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.266 1.027 . . . . 0.0 111.522 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -54.04 129.73 35.4 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.462 1.028 . . . . 0.0 110.421 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.77 -17.47 15.6 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.305 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -99.38 -44.79 6.07 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.692 1.246 . . . . 0.0 109.56 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.4 tp -127.22 128.53 46.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.166 0.986 . . . . 0.0 109.724 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -94.94 96.03 9.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.21 136.1 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.67 150.31 49.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.17 0.988 . . . . 0.0 109.524 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -124.61 138.65 54.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.508 1.523 . . . . 0.0 107.38 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -131.06 120.4 23.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.49 110.77 18.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.9 -36.72 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.42 -46.63 89.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.0 0.818 . . . . 0.0 109.688 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.33 -30.05 65.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.244 1.017 . . . . 0.0 110.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -127.92 72.4 78.88 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.857 0.863 . . . . 0.0 111.341 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -52.79 -59.04 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.896 2.397 . . . . 0.0 113.192 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.68 -47.32 2.29 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.765 1.65 . . . . 0.0 115.171 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -28.63 68.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -65.03 -67.68 0.98 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.302 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 89.0 Cg_exo -49.22 -45.11 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.194 1.929 . . . . 0.0 112.558 175.542 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -47.77 -40.86 21.86 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.359 0.527 . . . . 0.0 112.2 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -110.66 25.93 11.24 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.102 0.561 . . . . 0.0 111.847 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.82 38.78 23.74 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.237 0.922 . . . . 0.0 113.107 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.6 mm -78.35 79.86 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -85.6 -2.72 58.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.225 0.61 . . . . 0.0 111.099 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.74 165.91 33.72 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt -147.86 154.21 43.39 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 125.514 1.525 . . . . 0.0 107.729 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.36 145.15 75.42 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 120.575 1.241 . . . . 0.0 109.624 -1.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.9 m -139.38 127.87 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.02 113.03 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.302 1.441 . . . . 0.0 109.233 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -105.87 120.18 41.09 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.66 103.83 15.82 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.13 104.98 16.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.352 1.861 . . . . 0.0 109.538 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -83.71 102.48 12.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 47.9 54.49 9.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.805 0.812 . . . . 0.0 110.925 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.59 -18.61 8.43 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-O 119.19 -0.783 . . . . 0.0 113.804 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -84.97 109.93 18.53 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.443 1.621 . . . . 0.0 109.973 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.41 105.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.73 -45.26 19.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.733 0.813 . . . . 0.0 109.949 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.66 158.56 35.67 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.525 HG22 ' HG ' ' A' ' 79' ' ' LEU . 53.3 p -134.26 124.99 26.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.531 1.133 . . . . 0.0 108.756 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -113.77 117.88 32.74 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -95.37 129.72 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.18 164.71 35.04 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.007 0.813 . . . . 0.0 111.554 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 164.51 25.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.948 0.499 . . . . 0.0 110.116 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.86 161.51 39.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.296 1.038 . . . . 0.0 108.81 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.4 p -72.84 162.26 29.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.316 0.579 . . . . 0.0 110.589 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -56.73 -40.12 75.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.6 -54.69 35.61 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -56.77 -43.53 80.9 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.201 0.501 . . . . 0.0 110.299 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.22 -53.63 56.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -53.82 -48.15 70.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.469 0.577 . . . . 0.0 110.731 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.76 -53.16 58.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.187 0.595 . . . . 0.0 110.04 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -55.17 -52.31 63.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.598 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -57.0 -54.01 51.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.847 0.459 . . . . 0.0 110.221 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.58 -50.55 67.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.923 0.489 . . . . 0.0 110.653 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.17 76.94 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.197 0.599 . . . . 0.0 111.691 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -77.96 -49.38 14.23 Favored 'General case' 0 N--CA 1.46 0.074 0 O-C-N 122.19 -0.319 . . . . 0.0 111.048 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.4 mt -60.07 -46.03 90.93 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.214 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 177.941 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -69.72 104.79 2.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -121.39 34.14 5.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.6 mt -86.44 136.11 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.898 0.479 . . . . 0.0 111.111 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -91.93 116.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.388 0.675 . . . . 0.0 110.6 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -86.29 99.95 11.94 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.291 1.037 . . . . 0.0 109.204 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.24 166.1 16.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.139 0.976 . . . . 0.0 112.24 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p -131.09 163.37 27.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -53.97 -49.78 68.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.92 -46.19 90.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.03 1.332 . . . . 0.0 111.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.9 p -78.46 -24.75 45.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -34.57 -61.3 0.4 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 126.034 1.734 . . . . 0.0 114.052 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.68 -59.32 4.75 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.714 -0.616 . . . . 0.0 110.916 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.36 -38.15 71.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.424 0.69 . . . . 0.0 112.698 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -81.86 -57.93 3.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.405 0.622 . . . . 0.0 112.086 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.39 -55.29 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.18 1.792 . . . . 0.0 113.075 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.13 -28.67 69.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.581 -0.699 . . . . 0.0 111.898 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -88.84 8.64 28.09 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 122.079 -0.388 . . . . 0.0 111.468 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.1 81.69 0.69 Allowed 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.12 -0.987 . . . . 0.0 111.846 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -71.6 70.15 0.66 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.97 -134.35 2.93 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 106.953 -2.459 . . . . 0.0 106.953 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.61 114.66 13.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.92 0.86 . . . . 0.0 110.106 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.9 127.99 69.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.297 1.039 . . . . 0.0 108.931 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.32 101.86 11.31 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -89.86 112.14 24.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 118.099 0.409 . . . . 0.0 110.718 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.23 106.22 18.27 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.223 1.009 . . . . 0.0 108.659 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -79.69 121.56 25.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -139.24 -178.41 5.35 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.493 0.717 . . . . 0.0 111.169 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.8 151.86 34.24 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 108.495 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -53.69 -39.5 65.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.074 0.95 . . . . 0.0 111.876 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -82.23 -6.23 59.07 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.078 0.951 . . . . 0.0 112.573 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.3 t -79.43 80.61 5.78 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.059 -1.026 . . . . 0.0 111.115 -177.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.45 -58.48 2.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.29 0.948 . . . . 0.0 112.149 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.48 -38.66 89.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.331 2.687 . . . . 0.0 113.18 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -62.6 -47.58 83.18 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.83 -44.46 96.79 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.6 ttm -52.04 -41.56 62.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.919 0.888 . . . . 0.0 111.315 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -83.49 -8.71 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.57 -50.79 74.96 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.058 1.299 . . . . 0.0 113.032 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.68 -41.83 70.95 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.445 2.097 . . . . 0.0 111.516 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.96 -51.15 76.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -54.85 -43.85 73.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.112 0.414 . . . . 0.0 110.78 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.01 -53.15 60.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.272 0.558 . . . . 0.0 109.872 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.49 -47.04 73.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.895 0.478 . . . . 0.0 110.083 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.9 mm -59.12 -47.19 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.157 0.983 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.36 -42.43 66.82 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.753 0.421 . . . . 0.0 109.875 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.38 -56.64 8.86 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -50.67 -45.23 57.95 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.738 0.815 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -97.33 21.36 10.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.91 128.71 31.27 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.408 1.004 . . . . 0.0 110.109 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.55 -19.55 23.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.224 -0.765 . . . . 0.0 113.058 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -99.14 -44.29 6.33 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.658 1.229 . . . . 0.0 109.381 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -132.71 133.97 44.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.369 1.068 . . . . 0.0 108.796 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.4 m -101.44 105.74 16.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.04 139.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.99 154.89 50.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.897 0.879 . . . . 0.0 109.074 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.95 147.56 52.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.719 1.207 . . . . 0.0 108.433 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 tt -138.89 120.32 14.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -85.29 107.51 17.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.29 -24.19 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.651 0.781 . . . . 0.0 112.116 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -61.77 -46.56 89.06 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.122 0.874 . . . . 0.0 108.885 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -76.05 -35.44 59.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.277 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.42 70.13 11.87 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.377 1.071 . . . . 0.0 111.073 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.12 -54.36 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.385 2.057 . . . . 0.0 112.418 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.12 -41.42 3.75 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.941 1.258 . . . . 0.0 114.594 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.23 71.12 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.016 -0.696 . . . . 0.0 112.32 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.02 -66.81 1.33 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.641 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 81.0 Cg_exo -49.31 -48.49 18.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.166 1.911 . . . . 0.0 112.173 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -48.67 -48.67 39.76 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.079 0.399 . . . . 0.0 111.845 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -97.55 24.74 6.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.25 40.64 29.96 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.197 0.904 . . . . 0.0 113.184 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 mm -77.4 86.26 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -78.89 -6.09 55.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.169 0.588 . . . . 0.0 112.386 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.64 175.01 43.32 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt -146.6 152.56 45.57 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.667 1.187 . . . . 0.0 107.997 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.7 144.51 76.71 Favored 'Cis proline' 0 N--CA 1.456 -0.719 0 CA-C-N 120.543 1.23 . . . . 0.0 110.053 -0.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.5 m -136.81 123.4 20.97 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -107.21 104.27 13.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 109.704 -173.275 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.512 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.1 mp -94.09 115.77 28.12 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.5 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -87.18 109.28 19.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.956 1.302 . . . . 0.0 109.306 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -100.61 120.45 40.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.61 47.44 22.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.242 0.617 . . . . 0.0 110.274 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.81 -5.61 11.76 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.528 -1.151 . . . . 0.0 115.225 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -105.28 129.43 53.64 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.825 1.813 . . . . 0.0 110.481 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.92 107.13 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.67 -43.96 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.62 0.768 . . . . 0.0 110.046 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.53 156.28 34.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.078 0.551 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.512 HG22 ' HG ' ' A' ' 79' ' ' LEU . 73.7 p -129.26 110.81 12.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.856 1.262 . . . . 0.0 109.348 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -98.49 110.46 23.05 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -91.29 129.68 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.34 163.9 34.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.191 0.901 . . . . 0.0 112.177 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 167.77 20.18 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 110.129 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.81 169.55 21.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.332 1.053 . . . . 0.0 109.258 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.6 p -77.54 160.16 28.8 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.782 0.433 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.11 -45.52 75.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.98 -54.05 38.04 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.02 -39.19 88.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.923 0.862 . . . . 0.0 111.148 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.98 -52.36 65.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -55.33 -45.51 76.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.898 -0.501 . . . . 0.0 111.283 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.48 -55.35 34.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 109.885 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -53.4 -51.88 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.041 0.936 . . . . 0.0 110.727 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.64 -51.73 68.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.811 0.444 . . . . 0.0 110.238 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -54.42 -51.68 64.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.807 0.443 . . . . 0.0 110.214 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.48 70.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.503 0.721 . . . . 0.0 111.843 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -78.06 -40.32 38.98 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.121 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.2 mt -62.01 -47.45 84.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.262 0 C-N-CA 123.17 0.588 . . . . 0.0 109.734 177.592 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -58.78 98.92 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.902 0.881 . . . . 0.0 112.397 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -125.03 45.12 2.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -95.56 142.76 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.895 0.878 . . . . 0.0 110.611 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.97 115.35 29.97 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-O 121.572 0.701 . . . . 0.0 111.456 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -84.56 95.77 8.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.777 1.231 . . . . 0.0 109.408 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.44 163.24 16.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.072 0.949 . . . . 0.0 113.121 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.1 p -128.17 160.67 31.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.547 1.939 . . . . 0.0 107.701 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.1 -51.55 57.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.037 0.935 . . . . 0.0 109.197 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.23 -45.15 72.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.343 1.457 . . . . 0.0 111.836 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.61 -26.69 45.4 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -34.03 -69.43 0.09 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.608 1.563 . . . . 0.0 114.968 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.74 -59.75 3.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.58 0.752 . . . . 0.0 110.295 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -51.58 -42.53 61.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.96 1.304 . . . . 0.0 113.377 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.28 -53.15 5.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.747 0.419 . . . . 0.0 111.538 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -79.66 -58.78 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.791 1.236 . . . . 0.0 113.204 -173.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.34 -32.8 73.63 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.055 -0.403 . . . . 0.0 111.579 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -81.06 -5.52 57.73 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 23' ' ' ILE . . . -73.77 95.0 2.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 119.725 1.148 . . . . 0.0 111.763 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.02 64.87 1.97 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.9 -154.35 9.25 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.61 116.03 27.44 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.604 1.702 . . . . 0.0 109.137 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 19' ' ' ALA . 2.7 mt -113.08 134.19 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.05 101.78 9.32 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.57 114.93 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.84 107.35 19.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.847 1.259 . . . . 0.0 108.294 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -79.8 126.11 30.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -136.12 178.26 7.19 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.654 0.781 . . . . 0.0 111.734 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.8 37.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.556 1.542 . . . . 0.0 108.245 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -53.15 -35.82 60.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.998 0.919 . . . . 0.0 112.121 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -89.2 -2.37 58.47 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.999 1.319 . . . . 0.0 112.79 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.4 t -79.52 78.04 6.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.948 -1.095 . . . . 0.0 111.711 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.88 -57.78 3.36 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.659 0.647 . . . . 0.0 112.341 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -52.51 -35.7 67.47 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.227 2.618 . . . . 0.0 113.241 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.39 -45.48 92.97 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -60.76 -42.74 98.06 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 93.5 mmm -59.02 -45.84 89.68 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.164 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -76.6 -26.23 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.612 0.642 . . . . 0.0 112.592 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.57 -57.69 0.91 Allowed Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.36 -40.09 87.45 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.298 1.998 . . . . 0.0 111.835 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.2 -49.14 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 mt -56.27 -42.85 78.14 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.88 -47.5 86.09 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.12 -48.47 80.11 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.833 -0.542 . . . . 0.0 109.73 177.002 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.8 mm -55.66 -46.79 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.976 0.51 . . . . 0.0 109.9 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.06 -35.97 62.6 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.238 0.615 . . . . 0.0 110.768 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.4 -59.15 2.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -49.63 -44.19 47.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.53 1.132 . . . . 0.0 113.174 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -102.21 20.75 16.16 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.108 0.963 . . . . 0.0 111.502 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.41 125.71 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.386 0.994 . . . . 0.0 109.496 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.42 -20.09 39.81 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.58 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -99.2 -46.69 5.46 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.492 1.146 . . . . 0.0 109.362 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -127.11 124.17 38.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.715 1.206 . . . . 0.0 108.553 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.7 m -92.45 101.02 13.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -78.82 139.97 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.75 154.76 50.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.438 1.095 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -130.28 145.99 51.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.043 1.737 . . . . 0.0 107.35 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -143.94 126.79 16.27 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -86.7 106.72 17.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 109.256 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.15 -24.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.996 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -62.23 -44.41 96.62 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.419 1.009 . . . . 0.0 108.903 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -78.68 -34.47 46.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.425 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -123.4 66.37 33.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.678 1.191 . . . . 0.0 111.922 -173.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.15 -52.06 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.686 2.257 . . . . 0.0 112.94 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.07 -41.74 1.44 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.82 1.676 . . . . 0.0 114.268 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -37.21 54.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.195 0.998 . . . . 0.0 113.239 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.43 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.768 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 99.8 Cg_exo -44.9 -48.1 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.795 2.33 . . . . 0.0 113.131 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -48.16 -43.75 31.82 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 118.912 0.778 . . . . 0.0 112.572 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.01 25.82 11.12 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.973 0.351 . . . . 0.0 111.521 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 41.75 47.71 5.0 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.239 1.399 . . . . 0.0 112.299 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.6 mt -74.81 130.15 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -36.52 40.82 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -175.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.53 -156.74 12.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.8 pt -144.98 151.35 48.71 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 124.377 1.071 . . . . 0.0 108.343 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.4 141.94 71.51 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.936 1.013 . . . . 0.0 109.582 -2.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -139.32 130.38 26.5 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.45 103.64 12.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.047 1.339 . . . . 0.0 109.35 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.497 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.6 mp -91.83 115.53 28.14 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.57 12.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -87.11 104.3 16.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.468 1.507 . . . . 0.0 108.205 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -94.84 113.52 25.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.4 43.31 29.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.503 1.521 . . . . 0.0 111.335 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.06 -12.67 53.12 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.992 -0.893 . . . . 0.0 113.77 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -99.46 128.73 45.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.459 1.629 . . . . 0.0 110.7 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.77 105.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.92 -43.61 21.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.171 0.588 . . . . 0.0 110.462 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.11 154.35 32.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.087 0.555 . . . . 0.0 109.681 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.497 HG22 ' HG ' ' A' ' 79' ' ' LEU . 32.7 p -128.19 99.12 5.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.787 1.235 . . . . 0.0 107.776 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -86.0 110.12 19.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 130.18 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.53 163.39 38.43 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.83 0.729 . . . . 0.0 112.382 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 168.95 17.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.271 0.629 . . . . 0.0 110.309 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -163.64 164.22 24.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.088 1.355 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.1 p -72.32 161.95 30.13 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.37 -43.27 79.04 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.86 22.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -53.54 -44.86 69.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.269 0.534 . . . . 0.0 110.572 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.3 tp -58.74 -52.51 65.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -56.09 -46.77 78.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.571 0.623 . . . . 0.0 110.799 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.27 -52.89 62.83 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.501 0.32 . . . . 0.0 110.256 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -54.36 -53.19 57.34 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.859 0.864 . . . . 0.0 110.476 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.5 mt -56.69 -52.95 62.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.877 0.471 . . . . 0.0 110.29 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.35 -51.84 61.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.718 0.407 . . . . 0.0 110.318 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.38 74.75 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.313 0.645 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.02 -38.25 45.16 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.147 -0.346 . . . . 0.0 110.797 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -62.56 -48.54 79.05 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 123.156 0.582 . . . . 0.0 109.643 177.401 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp . . . . . 0 C--O 1.232 0.152 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm -114.6 109.79 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.004 2.522 . . . . 0.0 108.983 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.2 mm -88.55 119.47 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.916 0.865 . . . . 0.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -84.95 75.26 10.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.79 162.59 10.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.649 1.18 . . . . 0.0 112.667 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 p -131.88 162.77 29.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -52.96 -44.03 66.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 110.025 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.31 -45.17 95.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.041 1.337 . . . . 0.0 112.057 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.44 -27.95 46.56 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.172 -0.33 . . . . 0.0 111.356 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -36.22 -51.74 0.78 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.653 1.581 . . . . 0.0 114.031 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.54 -64.86 0.73 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.651 0.738 . . . . 0.0 111.275 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.38 -37.93 82.29 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.263 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -55.54 4.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.305 -0.247 . . . . 0.0 111.537 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 -57.38 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 112.518 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.04 -36.75 80.41 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.384 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 122.463 0.305 . . . . 0.0 111.19 175.895 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.228 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mt -117.62 119.0 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.511 1.124 . . . . 0.0 108.734 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -93.0 102.98 15.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.1 t -87.29 113.84 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -93.54 117.68 30.39 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.36 121.68 32.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -134.01 179.49 6.22 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.639 1.176 . . . . 0.0 110.752 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.4 39.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.459 1.104 . . . . 0.0 108.907 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -53.12 -36.29 60.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.129 0.972 . . . . 0.0 111.53 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -86.8 -4.68 59.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.857 1.263 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.8 t -79.99 80.22 6.42 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.92 -1.113 . . . . 0.0 112.656 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.51 -58.51 4.0 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 123.456 0.551 . . . . 0.0 112.344 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.23 -37.01 69.54 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.219 2.613 . . . . 0.0 113.634 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.31 -44.21 97.6 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -63.99 -47.64 79.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.8 mtm -53.48 -39.52 64.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.166 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 pt -82.64 -13.21 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.227 0.921 . . . . 0.0 112.818 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -50.86 54.75 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 0.0 113.405 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.57 -44.52 46.8 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.357 2.038 . . . . 0.0 111.631 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.43 -51.24 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.85 -43.2 76.83 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.227 -0.296 . . . . 0.0 110.93 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -59.86 -52.83 63.77 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 0.0 109.888 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -55.59 -50.31 70.45 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.82 0.848 . . . . 0.0 109.938 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 mm -56.25 -50.88 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.711 0.805 . . . . 0.0 109.758 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.04 -43.41 66.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.206 0.603 . . . . 0.0 110.239 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.81 -57.63 6.66 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.588 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -47.19 -49.82 21.99 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.876 1.27 . . . . 0.0 112.973 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -91.28 14.16 15.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.253 0.621 . . . . 0.0 112.258 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 134.18 23.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.865 1.211 . . . . 0.0 111.178 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -29.26 6.95 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.494 -0.615 . . . . 0.0 111.797 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -98.98 -40.33 8.11 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.117 0.959 . . . . 0.0 109.013 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.0 tp -133.11 149.29 52.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.574 1.55 . . . . 0.0 109.072 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.6 m -124.17 147.24 48.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -121.73 152.34 25.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 119.458 1.026 . . . . 0.0 108.534 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.81 151.02 45.41 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.79 100.45 5.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.94 121.72 40.2 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.376 -0.827 . . . . 0.0 110.682 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.68 108.45 16.06 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.488 0.715 . . . . 0.0 109.759 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -65.1 -25.13 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.008 0.523 . . . . 0.0 112.288 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.42 -44.11 92.25 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.274 0.943 . . . . 0.0 108.896 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.88 -35.64 62.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.954 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -120.74 68.14 15.31 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 124.089 0.956 . . . . 0.0 111.815 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.29 -42.23 36.39 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.884 1.722 . . . . 0.0 110.22 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -37.59 6.07 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.623 1.106 . . . . 0.0 114.184 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -22.45 56.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.38 1.09 . . . . 0.0 112.965 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.64 -59.22 14.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.663 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 75.4 Cg_exo -51.09 -46.6 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.584 2.189 . . . . 0.0 112.88 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.2 mttp . . . . . 0 C--N 1.341 0.201 0 C-N-CA 123.987 0.915 . . . . 0.0 112.501 -178.351 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt . . . . . 0 CA--C 1.537 0.453 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 132.14 17.68 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.659 1.271 . . . . 0.0 111.011 -0.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.67 145.89 31.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -129.72 100.39 5.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.87 119.87 40.51 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.37 107.5 19.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.322 0.649 . . . . 0.0 109.936 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 . . . . . 0 N--CA 1.453 -0.281 0 C-N-CA 124.832 1.253 . . . . 0.0 109.395 179.87 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 81.1 t -62.94 102.55 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.01 -42.43 26.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.637 0.775 . . . . 0.0 110.387 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.16 153.67 28.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.3 p -132.68 114.88 14.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.155 1.382 . . . . 0.0 109.176 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -110.0 144.0 39.17 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.34 127.63 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 167.36 35.61 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.972 0.796 . . . . 0.0 111.465 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 166.43 21.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.118 0.567 . . . . 0.0 110.624 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.41 165.03 31.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.294 1.438 . . . . 0.0 107.787 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -72.38 159.24 34.34 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.006 0.431 . . . . 0.0 110.494 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.94 -42.5 80.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.25 -54.74 33.61 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -55.36 -47.1 76.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.106 0.453 . . . . 0.0 110.36 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -59.21 -50.56 73.54 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -55.21 -48.2 74.21 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.971 -0.455 . . . . 0.0 110.737 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -58.82 -53.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.205 0.602 . . . . 0.0 109.84 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.6 -53.21 40.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.145 0.978 . . . . 0.0 110.127 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.49 -51.87 68.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.521 0.328 . . . . 0.0 110.757 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -54.44 -51.9 63.5 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.78 0.264 . . . . 0.0 110.565 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.42 72.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.381 1.072 . . . . 0.0 111.942 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -78.34 -43.95 26.44 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.987 0.358 . . . . 0.0 110.63 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -62.62 -47.17 84.94 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.905 0.482 . . . . 0.0 109.781 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.203 0 C-N-CA 124.564 1.146 . . . . 0.0 111.467 179.403 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.4 mt -112.3 143.28 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 125.476 1.51 . . . . 0.0 110.269 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.21 110.89 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.452 0.644 . . . . 0.0 110.773 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.18 97.32 8.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.534 1.134 . . . . 0.0 108.519 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.7 mt -80.73 169.94 16.96 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.731 0.776 . . . . 0.0 111.676 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.3 p -137.62 161.51 36.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.45 -43.31 67.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.5 -46.61 89.27 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.265 1.426 . . . . 0.0 112.009 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.8 p -78.23 -27.45 47.71 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.086 -0.384 . . . . 0.0 111.736 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -36.71 -54.74 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.425 1.49 . . . . 0.0 113.599 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -54.83 -63.57 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.424 0.63 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.85 -37.97 69.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.965 0.906 . . . . 0.0 113.022 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.53 -61.2 1.82 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.806 0.336 . . . . 0.0 111.485 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.72 -49.42 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.484 1.114 . . . . 0.0 112.538 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.252 45.1 mt -65.18 -29.9 70.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.862 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt . . . . . 0 CA--C 1.54 0.565 0 C-N-CA 122.578 0.351 . . . . 0.0 110.827 173.309 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.11 124.56 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.781 1.232 . . . . 0.0 108.523 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -102.78 104.3 14.58 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.33 113.49 26.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 122.761 0.425 . . . . 0.0 110.076 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.56 107.86 19.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 108.643 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -79.96 124.49 28.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -143.14 -179.72 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 111.452 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.2 150.78 33.18 Favored 'General case' 0 C--N 1.337 0.051 0 C-N-CA 125.848 1.659 . . . . 0.0 108.54 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -52.81 -42.86 65.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.465 0.706 . . . . 0.0 111.471 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -79.38 -6.53 57.01 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.292 1.037 . . . . 0.0 112.77 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.4 t -79.72 80.86 6.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 120.918 -1.114 . . . . 0.0 111.158 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.4 -59.08 3.7 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.65 -33.31 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.422 2.748 . . . . 0.0 113.653 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.92 -50.82 38.32 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -55.34 -43.99 75.51 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 -30.85 57.78 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.495 -0.764 . . . . 0.0 112.242 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 pt -92.97 -3.03 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.604 1.093 . . . . 0.0 112.204 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 88.49 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 119.785 1.175 . . . . 0.0 110.993 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.99 -47.35 28.04 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 111.352 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.4 mt -55.13 -52.87 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.49 -40.81 83.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 122.642 0.377 . . . . 0.0 110.77 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.55 -50.31 74.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.719 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.63 -50.34 72.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.289 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.0 mm -55.21 -48.61 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.6 -47.24 70.36 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.152 0.433 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.21 -49.11 75.5 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 111.462 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.71 -49.19 76.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -91.4 27.44 1.95 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.167 0.987 . . . . 0.0 113.259 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -53.86 128.36 29.72 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -17.05 14.31 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.274 -0.737 . . . . 0.0 113.195 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -99.7 -41.85 7.11 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.648 1.224 . . . . 0.0 110.171 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -140.05 133.2 29.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.781 0.832 . . . . 0.0 109.251 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.7 m -98.71 107.95 20.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.35 134.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.53 51.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.884 0.873 . . . . 0.0 108.776 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -127.55 145.13 50.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.974 1.31 . . . . 0.0 107.959 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -134.71 118.92 17.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.41 101.51 14.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -52.0 -37.65 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.29 -47.53 85.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.883 0.765 . . . . 0.0 110.423 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -81.92 -20.3 39.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.395 1.078 . . . . 0.0 111.561 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -129.25 63.76 68.6 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.424 1.49 . . . . 0.0 108.846 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.56 -45.14 7.3 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.581 2.188 . . . . 0.0 113.746 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.49 -45.67 1.94 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.356 1.455 . . . . 0.0 115.581 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -73.09 -28.13 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.82 -57.69 15.04 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.76 -43.47 16.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.478 1.452 . . . . 0.0 111.048 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mttp . . . . . 0 C--N 1.342 0.243 0 C-N-CA 123.043 0.537 . . . . 0.0 111.503 -179.345 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 pt . . . . . 0 CA--C 1.541 0.603 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.67 143.55 71.7 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.706 1.288 . . . . 0.0 109.854 -0.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.0 m -137.59 122.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -108.43 115.96 31.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.058 1.343 . . . . 0.0 109.218 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -110.54 121.73 46.03 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp -97.99 110.04 22.69 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 . . . . . 0 N--CA 1.456 -0.13 0 C-N-CA 125.828 1.651 . . . . 0.0 111.329 -178.323 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 . . . . . 0 N--CA 1.449 -0.503 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.9 115.42 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -46.39 17.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.665 0.786 . . . . 0.0 109.212 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.74 163.3 26.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.567 0.747 . . . . 0.0 109.252 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.447 HG22 ' HG ' ' A' ' 79' ' ' LEU . 71.9 p -136.81 134.56 37.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.481 1.112 . . . . 0.0 109.125 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -124.6 117.59 24.64 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.59 133.11 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.2 161.5 37.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.986 0.803 . . . . 0.0 111.554 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.31 167.89 13.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.114 0.566 . . . . 0.0 110.549 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.57 163.6 27.2 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.807 1.243 . . . . 0.0 108.121 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -72.68 162.74 29.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.334 0.588 . . . . 0.0 111.282 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -54.16 -46.63 72.36 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.85 22.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -53.81 -45.45 70.78 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 117.455 0.627 . . . . 0.0 110.37 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.9 tp -59.16 -51.09 71.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.35 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -53.34 -49.78 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.559 0.618 . . . . 0.0 110.46 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -57.36 -50.63 72.35 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 117.772 0.26 . . . . 0.0 110.693 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -54.39 -53.21 57.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 0.0 110.516 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -58.04 -53.02 62.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.837 0.455 . . . . 0.0 110.328 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.35 -51.49 62.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.493 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.29 68.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.696 0.798 . . . . 0.0 111.863 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -78.04 -47.53 18.2 Favored 'General case' 0 CA--C 1.526 0.039 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.29 -44.76 88.65 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.196 0.598 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 122.996 0.518 . . . . 0.0 109.612 177.647 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.5 mt -91.85 140.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.951 0.9 . . . . 0.0 109.686 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.3 mm -90.38 122.48 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 122.019 0.914 . . . . 0.0 111.188 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -95.57 83.32 3.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.17 166.01 17.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.007 1.323 . . . . 0.0 112.715 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.0 p -128.41 161.2 30.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.85 -45.02 78.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.66 -47.23 86.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.883 1.273 . . . . 0.0 111.458 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -78.2 -24.78 46.96 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.126 -0.359 . . . . 0.0 111.846 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -36.45 -50.24 0.76 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.017 1.727 . . . . 0.0 113.548 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.21 -63.76 1.06 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 110.374 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -59.47 -34.52 72.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.439 0.696 . . . . 0.0 112.072 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -83.29 -65.9 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.94 -45.49 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 112.603 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.261 46.9 mt -64.89 -30.26 71.24 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.245 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm . . . . . 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 110.726 172.639 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.256 0 N-CA-C 110.71 -0.107 . . . . 0.0 110.71 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mt -119.78 128.48 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.957 1.303 . . . . 0.0 107.802 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.53 103.11 13.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.89 110.13 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 122.663 0.385 . . . . 0.0 110.454 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.69 108.31 19.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 118.0 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -133.0 178.32 6.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.472 1.109 . . . . 0.0 112.184 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.17 154.57 35.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.127 1.371 . . . . 0.0 108.57 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.89 -26.04 58.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -92.03 -4.32 54.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.468 1.107 . . . . 0.0 112.254 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.5 t -79.66 83.37 5.64 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.93 -1.106 . . . . 0.0 112.105 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.03 -58.91 4.14 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 123.582 0.61 . . . . 0.0 112.518 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.06 -30.82 61.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.074 2.516 . . . . 0.0 113.347 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.2 m -65.47 -42.81 91.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.49 -43.08 98.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 51.5 ttp -54.27 -47.96 71.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.636 0.374 . . . . 0.0 110.675 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.2 pt -77.54 -26.56 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.848 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.92 -57.08 1.06 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.94 -36.41 96.9 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 112.003 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.93 -49.63 78.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -55.04 -42.82 73.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.77 0.428 . . . . 0.0 110.376 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.87 -48.75 80.44 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.87 -49.71 74.68 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mm -54.39 -46.27 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.979 0.912 . . . . 0.0 109.79 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.37 55.41 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.965 0.506 . . . . 0.0 111.459 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.21 -58.84 2.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -48.51 -44.55 36.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.677 1.191 . . . . 0.0 113.232 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -104.92 23.09 14.1 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.468 1.107 . . . . 0.0 111.024 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -55.32 130.1 41.07 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.027 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -19.15 21.84 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.887 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -99.37 -45.22 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.606 1.203 . . . . 0.0 109.34 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 tp -131.57 116.73 17.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.658 1.183 . . . . 0.0 108.64 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 m -87.41 109.07 19.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.24 140.5 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.29 149.07 46.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.934 0.894 . . . . 0.0 109.767 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -130.44 103.92 6.95 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -98.37 119.52 37.2 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 122.98 0.512 . . . . 0.0 109.836 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -81.21 106.64 13.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.199 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.0 -32.32 55.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 123.74 0.816 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.27 -44.62 95.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.183 0.901 . . . . 0.0 109.145 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -77.33 -35.05 55.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.261 0.624 . . . . 0.0 110.762 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.3 67.78 7.01 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.13 0.972 . . . . 0.0 111.22 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.14 -40.33 26.94 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.16 1.907 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.46 3.52 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.219 1.39 . . . . 0.0 114.459 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.59 60.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.429 1.115 . . . . 0.0 112.971 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.45 -57.39 26.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -62.92 -35.72 65.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.24 1.96 . . . . 0.0 112.441 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.1 mttp . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 118.898 0.772 . . . . 0.0 112.051 -179.411 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.9 pt . . . . . 0 CA--C 1.536 0.431 0 CA-C-O 118.723 -0.656 . . . . 0.0 110.37 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.38 129.79 16.98 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 CA-C-N 120.189 1.103 . . . . 0.0 111.34 -0.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.3 112.16 23.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.92 94.49 6.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.404 ' HG ' HG22 ' A' ' 89' ' ' THR . 9.1 mp -93.17 115.11 27.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.04 105.99 18.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 . . . . . 0 CA--C 1.529 0.142 0 C-N-CA 125.351 1.46 . . . . 0.0 111.609 -177.821 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 . . . . . 0 N--CA 1.451 -0.396 0 N-CA-C 110.186 -0.301 . . . . 0.0 110.186 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.25 109.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.23 -43.36 23.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.926 0.891 . . . . 0.0 110.314 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.87 160.08 35.75 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.176 0.59 . . . . 0.0 109.482 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.404 HG22 ' HG ' ' A' ' 79' ' ' LEU . 61.6 p -135.64 103.87 5.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 109.152 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -90.55 120.84 31.97 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.95 103.35 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.34 161.62 13.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.486 0.565 . . . . 0.0 112.015 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 166.0 23.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.852 0.861 . . . . 0.0 111.669 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -163.84 164.35 23.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.262 1.825 . . . . 0.0 107.36 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 p -93.31 170.86 9.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.987 1.315 . . . . 0.0 113.051 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -61.87 156.28 21.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.68 -62.64 4.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -59.61 -54.69 43.55 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.81 -48.99 74.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.141 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -55.18 -47.08 75.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.558 0.343 . . . . 0.0 111.829 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.43 -47.84 80.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.059 0.544 . . . . 0.0 109.796 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -53.47 -52.49 59.33 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.22 -51.16 71.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.586 0.355 . . . . 0.0 110.648 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.04 -50.91 65.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.704 0.401 . . . . 0.0 110.774 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.84 69.47 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.237 1.015 . . . . 0.0 111.434 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -77.55 -48.15 17.69 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.0 mt -54.95 -48.4 73.23 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.307 0 C-N-CA 123.096 0.559 . . . . 0.0 109.51 176.905 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttp . . . . . 0 CA--C 1.533 0.313 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.97 136.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.949 -0.469 . . . . 0.0 111.054 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.43 115.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-O 121.545 0.688 . . . . 0.0 111.587 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -82.69 96.69 8.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.018 0.927 . . . . 0.0 108.679 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.35 158.86 21.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.125 0.964 . . . . 0.0 113.188 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -125.1 160.46 29.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.904 2.082 . . . . 0.0 106.699 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -55.95 -44.31 78.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.44 -46.97 73.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.875 1.27 . . . . 0.0 111.019 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.4 p -78.1 -28.04 48.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.229 -0.295 . . . . 0.0 111.681 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -38.08 -53.67 1.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.51 1.524 . . . . 0.0 113.673 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -54.93 -62.83 1.4 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -36.69 71.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.179 0.992 . . . . 0.0 113.319 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.25 -62.04 1.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.771 0.32 . . . . 0.0 111.294 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.65 -49.07 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.487 1.115 . . . . 0.0 112.636 -172.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.67 -30.36 71.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.619 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mttm . . . . . 0 CA--C 1.541 0.612 0 CA-C-O 119.443 -0.313 . . . . 0.0 110.848 173.877 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.297 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mt -112.67 125.91 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.518 1.127 . . . . 0.0 108.652 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.35 104.2 14.05 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 t -91.74 114.97 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.756 0.422 . . . . 0.0 110.344 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.83 106.83 19.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.693 1.197 . . . . 0.0 107.91 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.35 121.82 25.6 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -135.21 179.28 6.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.679 1.192 . . . . 0.0 110.852 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.34 155.64 40.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.799 1.24 . . . . 0.0 108.727 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -57.5 -27.9 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.589 0.632 . . . . 0.0 112.232 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -90.07 -3.96 57.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.614 1.166 . . . . 0.0 112.452 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.2 t -79.67 80.11 6.1 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 120.936 -1.102 . . . . 0.0 112.581 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.62 -58.86 4.52 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.151 0.405 . . . . 0.0 112.156 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.72 -32.52 55.61 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.369 2.713 . . . . 0.0 113.697 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.6 m -63.34 -44.36 95.09 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.97 -43.57 98.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtt -55.62 -42.51 75.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.149 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.68 -23.26 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 112.89 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.49 -51.74 6.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.57 -43.09 60.7 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.449 2.099 . . . . 0.0 111.964 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.58 -48.65 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -56.74 -41.62 77.86 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 122.419 -0.176 . . . . 0.0 110.551 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.41 -49.65 74.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.43 -50.45 69.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 mm -56.22 -49.02 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.411 0.684 . . . . 0.0 109.733 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -43.2 67.92 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.126 0.57 . . . . 0.0 110.358 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.73 -57.19 6.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.289 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.5 -44.07 55.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.18 . . . . 0.0 112.758 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.17 21.53 12.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 111.973 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -54.67 128.14 31.25 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.566 1.075 . . . . 0.0 110.189 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -19.18 28.58 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.213 -0.771 . . . . 0.0 113.049 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -99.09 -45.39 5.94 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.668 1.234 . . . . 0.0 109.452 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -129.6 131.22 46.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.447 1.099 . . . . 0.0 108.46 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.1 m -99.4 104.07 15.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.29 138.84 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.63 47.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.863 0.865 . . . . 0.0 109.241 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -125.81 135.31 51.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -125.92 122.0 34.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -86.71 110.97 20.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.32 -29.29 45.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -63.23 -47.66 81.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -70.34 -31.17 68.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.495 1.118 . . . . 0.0 110.253 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.04 73.41 76.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 0.0 111.834 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.37 -56.05 3.06 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.616 2.211 . . . . 0.0 112.688 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.58 -48.26 1.25 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.216 1.865 . . . . 0.0 115.57 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -28.52 69.54 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.756 -0.85 . . . . 0.0 113.023 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.89 -64.41 2.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.49 -42.74 45.39 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.734 1.623 . . . . 0.0 111.22 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt . . . . . 0 C--N 1.341 0.21 0 CA-C-N 118.229 0.468 . . . . 0.0 111.765 179.812 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt . . . . . 0 CA--C 1.537 0.478 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.46 142.19 61.77 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 CA-C-N 120.586 1.245 . . . . 0.0 110.154 -1.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 m -134.9 119.98 18.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.0 mt -105.19 116.16 31.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.543 1.537 . . . . 0.0 109.156 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.7 mp -111.22 122.26 47.4 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp -98.17 104.88 16.95 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 . . . . . 0 N--CA 1.455 -0.196 0 C-N-CA 125.276 1.43 . . . . 0.0 110.392 -179.839 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 . . . . . 0 N--CA 1.452 -0.366 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.45 110.13 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.02 -42.42 26.55 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.798 0.839 . . . . 0.0 109.836 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.68 162.6 35.11 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.472 HG22 ' HG ' ' A' ' 79' ' ' LEU . 62.1 p -137.36 138.81 40.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.446 1.098 . . . . 0.0 109.345 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -130.47 122.26 27.35 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.73 131.14 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.34 165.46 37.7 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.066 0.841 . . . . 0.0 111.934 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.72 165.96 22.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.257 0.623 . . . . 0.0 110.443 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.18 167.92 26.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.816 1.246 . . . . 0.0 108.55 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -75.46 159.91 30.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.99 0.424 . . . . 0.0 110.55 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.61 -42.88 75.52 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.24 -56.53 24.72 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -56.41 -42.43 77.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.804 0.802 . . . . 0.0 110.721 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.6 -51.36 70.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.82 -47.69 73.75 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.726 0.694 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -55.43 -53.33 57.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.041 0.382 . . . . 0.0 110.052 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -54.17 -53.01 59.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.778 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.05 -53.39 58.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.894 0.478 . . . . 0.0 110.526 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.37 -51.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.321 0.649 . . . . 0.0 110.29 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.73 -37.35 68.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.209 0.604 . . . . 0.0 111.693 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -78.13 -46.23 21.21 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.134 -0.354 . . . . 0.0 110.665 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.46 -47.08 85.2 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 C-N-CA 123.005 0.522 . . . . 0.0 109.614 177.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 mt -102.38 139.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.876 0.87 . . . . 0.0 109.895 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mm -88.68 114.25 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.244 1.021 . . . . 0.0 111.175 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -87.02 76.4 9.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.183 0.993 . . . . 0.0 108.95 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.48 160.17 25.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.997 1.319 . . . . 0.0 113.632 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 p -125.18 160.45 29.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.473 1.909 . . . . 0.0 107.638 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.61 -49.88 66.87 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.74 -45.87 67.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.993 1.317 . . . . 0.0 111.591 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 p -78.33 -28.57 47.34 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -35.82 -55.23 0.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.64 1.576 . . . . 0.0 115.001 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.65 -62.29 1.75 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.715 0.769 . . . . 0.0 111.347 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -61.99 -41.77 98.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.212 0.605 . . . . 0.0 112.193 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.31 -40.47 51.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.8 t -101.15 -63.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.841 0.856 . . . . 0.0 112.151 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.62 -33.48 71.55 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.4 mttt . . . . . 0 CA--C 1.538 0.486 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.696 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.184 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mt -114.45 123.05 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.16 1.384 . . . . 0.0 108.649 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.05 103.6 13.69 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.46 113.13 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.79 109.27 20.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -79.68 126.89 31.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -134.72 177.14 8.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.392 1.077 . . . . 0.0 110.005 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.45 156.45 43.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -59.51 -27.73 66.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.347 0.521 . . . . 0.0 110.723 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.436 ' CZ3' HD11 ' A' ' 75' ' ' ILE . 52.5 p-90 -91.22 -1.77 57.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -79.85 79.03 6.41 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.864 -1.147 . . . . 0.0 111.868 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.8 -56.98 6.3 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 119.823 -0.432 . . . . 0.0 112.12 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -52.89 -34.32 65.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.254 2.636 . . . . 0.0 113.722 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.78 -41.99 99.49 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -67.86 -45.62 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.8 ttm -50.66 -44.03 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.837 0.455 . . . . 0.0 111.265 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.02 -5.77 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.67 78.29 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 112.336 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.55 -46.11 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.364 2.043 . . . . 0.0 111.361 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.05 -52.8 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.44 -39.92 73.92 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.143 -0.348 . . . . 0.0 110.986 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.22 -50.99 69.56 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.91 -49.46 73.39 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.16 -49.25 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.387 0.675 . . . . 0.0 109.821 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.73 64.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.999 0.363 . . . . 0.0 110.595 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.74 -55.81 8.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.849 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -49.02 -49.15 42.42 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.447 1.099 . . . . 0.0 112.329 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -97.45 23.59 7.47 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.927 0.891 . . . . 0.0 111.5 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.95 130.0 28.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.35 0.977 . . . . 0.0 110.937 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.09 -17.61 9.34 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.435 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.18 -41.79 7.34 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.708 1.254 . . . . 0.0 109.107 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -131.63 134.88 46.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.216 1.407 . . . . 0.0 108.071 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -107.52 104.2 13.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -79.83 140.69 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.47 150.32 49.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.002 . . . . 0.0 109.203 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -132.91 99.31 4.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.709 1.204 . . . . 0.0 108.575 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tt -98.22 127.01 43.94 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 110.559 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.72 112.56 22.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.6 pt -67.18 -30.38 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.522 0.729 . . . . 0.0 112.832 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -65.98 -45.76 80.49 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.98 -36.51 83.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.76 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -124.78 74.77 64.77 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 123.91 0.884 . . . . 0.0 112.612 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.67 -61.23 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.389 2.726 . . . . 0.0 113.672 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.36 -48.94 1.66 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.039 1.78 . . . . 0.0 114.684 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -34.13 59.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.37 -68.88 0.68 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-O 117.598 -1.192 . . . . 0.0 110.193 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 84.8 Cg_exo -47.49 -48.18 16.05 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.107 1.871 . . . . 0.0 112.715 174.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttp . . . . . 0 C--N 1.345 0.409 0 CA-C-N 118.653 0.66 . . . . 0.0 111.916 -179.852 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.436 HD11 ' CZ3' ' A' ' 31' ' ' TRP . 1.3 pp . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 118.496 -0.764 . . . . 0.0 109.057 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.06 143.89 75.71 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 CA-C-N 120.362 1.165 . . . . 0.0 110.8 -0.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.9 m -140.78 123.04 15.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.1 mt -104.12 126.19 51.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.64 1.576 . . . . 0.0 109.362 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.61 119.25 33.2 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.82 102.05 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 . . . . . 0 N--CA 1.45 -0.444 0 C-N-CA 125.301 1.44 . . . . 0.0 108.998 179.222 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 . . . . . 0 CA--C 1.529 0.136 0 N-CA-C 110.878 -0.045 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.08 105.49 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.03 -43.73 17.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.455 0.702 . . . . 0.0 110.556 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.04 33.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.9 p -145.21 169.1 18.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.16 0.584 . . . . 0.0 109.655 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -150.03 151.34 33.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.4 140.29 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.86 40.74 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 173.17 10.2 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.277 -0.543 . . . . 0.0 110.224 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.86 162.05 32.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.173 1.389 . . . . 0.0 107.366 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.31 151.64 29.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.428 0.691 . . . . 0.0 110.894 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -50.07 -47.54 53.57 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.463 1.105 . . . . 0.0 112.139 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.55 -56.52 23.2 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -53.62 -45.08 69.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.796 0.838 . . . . 0.0 110.259 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.75 -53.25 60.47 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -54.52 -47.28 73.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.117 0.417 . . . . 0.0 111.345 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.68 -52.28 66.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.07 -53.48 52.59 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.87 0.868 . . . . 0.0 110.076 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.57 -51.75 68.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.429 0.292 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.56 -51.69 64.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.832 0.453 . . . . 0.0 110.493 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.02 -39.06 71.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.916 0.887 . . . . 0.0 111.7 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -77.87 -42.73 32.46 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.315 -0.24 . . . . 0.0 110.413 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.6 mt -60.35 -45.54 93.09 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 123.152 0.581 . . . . 0.0 109.659 177.686 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 mt -91.12 141.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.004 0.922 . . . . 0.0 110.75 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -90.91 113.53 26.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.465 0.65 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -84.33 97.89 9.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.271 1.028 . . . . 0.0 109.261 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.07 160.25 18.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.2 1.0 . . . . 0.0 112.837 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.8 p -127.31 160.31 31.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.399 1.88 . . . . 0.0 106.951 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -53.33 -48.74 68.2 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.99 -45.52 71.47 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.926 1.29 . . . . 0.0 111.423 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.5 p -78.67 -28.78 45.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -33.35 -65.61 0.17 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 126.059 1.743 . . . . 0.0 115.268 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.4 -56.49 14.63 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.607 -0.683 . . . . 0.0 111.43 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.95 -45.63 92.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.331 0.652 . . . . 0.0 112.758 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.56 -39.64 52.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.35 -65.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.679 1.192 . . . . 0.0 112.116 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.39 -31.35 70.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 mttm . . . . . 0 CA--C 1.538 0.507 0 CA-C-N 118.524 0.602 . . . . 0.0 112.567 177.854 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.174 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.7 mt -113.8 129.2 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 125.012 1.325 . . . . 0.0 108.843 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -109.91 103.73 12.55 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.5 t -90.9 117.68 34.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 118.326 0.512 . . . . 0.0 110.468 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.78 110.91 23.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.849 1.259 . . . . 0.0 108.918 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -83.66 121.32 27.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -137.34 176.57 8.59 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.15 149.17 31.51 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.842 1.657 . . . . 0.0 109.243 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.36 -34.8 64.6 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.532 0.733 . . . . 0.0 112.388 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -84.6 -10.27 57.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.94 0.896 . . . . 0.0 112.084 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.75 79.99 6.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.076 -1.015 . . . . 0.0 110.906 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.78 -58.58 2.6 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.153 0.882 . . . . 0.0 112.074 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -36.51 84.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.344 2.696 . . . . 0.0 113.598 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.7 m -63.59 -46.08 87.45 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -64.65 -42.17 95.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.9 ttp -52.69 -44.35 66.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.4 pt -78.78 -10.05 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.34 -57.21 12.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 120.052 1.297 . . . . 0.0 113.116 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.69 -41.06 77.08 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.056 1.837 . . . . 0.0 111.435 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 mt -59.84 -51.93 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.4 mt -55.65 -41.22 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.833 0.453 . . . . 0.0 110.55 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.11 -52.69 63.84 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.45 -48.63 68.66 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.829 -0.545 . . . . 0.0 109.984 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.56 -49.43 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 122.997 0.519 . . . . 0.0 109.668 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.0 -45.94 68.1 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.39 -57.41 8.42 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.818 0.342 . . . . 0.0 110.476 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.21 -50.57 37.73 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.919 1.288 . . . . 0.0 112.548 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -94.04 20.49 7.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.71 0.804 . . . . 0.0 111.995 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.53 99.83 0.05 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.687 1.13 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.7 -23.48 8.34 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.617 1.103 . . . . 0.0 111.284 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -99.43 -36.79 9.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.664 1.186 . . . . 0.0 109.706 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -138.33 139.03 38.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.062 0.945 . . . . 0.0 108.522 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.6 m -106.89 102.38 11.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.21 138.31 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.21 154.12 51.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.086 0.955 . . . . 0.0 108.662 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.0 145.42 51.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.022 1.329 . . . . 0.0 108.208 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -137.6 121.32 17.45 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -84.35 110.34 18.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.89 -31.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.88 -45.57 91.94 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.231 0.923 . . . . 0.0 109.058 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -71.93 -36.8 70.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.068 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -122.63 69.9 35.24 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.246 1.018 . . . . 0.0 111.612 -175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.05 -47.27 6.74 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.972 1.781 . . . . 0.0 111.083 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -37.85 2.15 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.529 1.538 . . . . 0.0 114.895 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.4 -22.84 61.06 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.346 1.073 . . . . 0.0 113.677 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.92 -55.74 5.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.62 -37.02 42.52 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.327 2.684 . . . . 0.0 113.577 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 CA--C 1.531 0.218 0 C-N-CA 124.103 0.961 . . . . 0.0 112.107 179.796 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.7 pt . . . . . 0 CA--C 1.54 0.586 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.19 145.15 75.07 Favored 'Cis proline' 0 N--CA 1.456 -0.733 0 CA-C-N 120.725 1.295 . . . . 0.0 110.006 -0.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 m -138.79 124.51 19.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.06 115.74 30.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.616 1.566 . . . . 0.0 108.913 -175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.95 116.41 31.9 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 tp -96.72 104.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 125.576 1.55 . . . . 0.0 109.206 178.822 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 110.535 -0.172 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.2 107.98 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -45.02 19.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.25 159.92 34.7 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.4 p -136.53 129.87 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.335 1.054 . . . . 0.0 108.53 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -119.31 119.22 33.38 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.52 132.32 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.51 163.89 34.37 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.147 0.879 . . . . 0.0 111.435 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.2 167.26 22.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.044 0.537 . . . . 0.0 110.221 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -160.93 162.99 32.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.782 1.233 . . . . 0.0 108.147 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.88 162.91 28.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.206 0.527 . . . . 0.0 110.98 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -55.8 -45.07 78.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.65 -54.41 36.57 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -56.43 -46.13 80.42 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 110.447 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.29 -52.34 66.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -55.93 -48.11 76.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 110.535 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -56.99 -53.41 58.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.777 0.431 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.98 -54.09 40.25 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.093 0.957 . . . . 0.0 110.312 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.54 -53.24 60.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.57 -52.31 60.15 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.918 0.327 . . . . 0.0 110.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.83 73.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.899 0.88 . . . . 0.0 112.004 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -77.68 -42.61 33.96 Favored 'General case' 0 C--O 1.23 0.029 0 O-C-N 122.095 -0.378 . . . . 0.0 110.319 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.49 -48.24 82.41 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 123.139 0.576 . . . . 0.0 109.525 177.077 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.4 138.51 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.318 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.6 mm -86.5 110.91 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.218 1.009 . . . . 0.0 111.01 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -82.41 76.11 9.29 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.771 0.828 . . . . 0.0 108.9 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.76 159.19 22.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.715 1.206 . . . . 0.0 113.659 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 p -125.74 160.53 29.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.8 2.04 . . . . 0.0 106.755 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -54.68 -45.46 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.67 -46.13 74.01 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.3 1.44 . . . . 0.0 111.432 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 p -78.67 -27.45 45.18 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -37.8 -54.51 1.24 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.327 1.451 . . . . 0.0 114.113 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.09 -50.25 73.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 111.664 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -66.24 -40.94 90.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.237 1.015 . . . . 0.0 111.339 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.01 -58.49 2.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.72 -51.52 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.038 0.935 . . . . 0.0 112.4 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 mt -64.87 -32.78 74.64 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.299 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttm . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 122.499 0.319 . . . . 0.0 111.201 174.552 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mt -120.25 119.44 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.179 1.392 . . . . 0.0 108.096 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.8 tp -94.61 104.8 16.73 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.68 109.66 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 122.829 0.452 . . . . 0.0 110.014 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -90.19 119.35 30.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.74 125.62 34.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -138.43 176.31 8.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.486 0.715 . . . . 0.0 111.157 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.45 151.77 32.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.056 1.342 . . . . 0.0 107.563 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -56.08 -36.87 68.59 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.615 0.766 . . . . 0.0 111.55 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -79.71 -11.03 59.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.241 1.017 . . . . 0.0 112.813 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -79.56 81.3 5.84 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.046 -1.034 . . . . 0.0 111.855 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.07 -57.62 3.51 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.013 0.816 . . . . 0.0 112.369 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.91 -33.58 82.72 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.862 2.375 . . . . 0.0 113.261 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -65.04 -43.55 91.98 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.49 -47.6 84.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -50.38 -41.89 52.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.888 0.875 . . . . 0.0 111.953 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -83.69 -8.82 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.91 -51.17 73.32 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.9 1.227 . . . . 0.0 112.721 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.94 -40.96 78.8 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.508 2.139 . . . . 0.0 112.078 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.08 -52.5 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.24 -42.84 77.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.826 0.45 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.28 -53.43 58.28 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.827 0.822 . . . . 0.0 109.327 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.87 -47.14 77.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.007 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 mm -56.11 -50.4 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.116 0.566 . . . . 0.0 109.806 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.61 67.65 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.982 0.513 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.24 -50.3 54.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.299 -0.251 . . . . 0.0 110.966 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.62 -49.32 77.92 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.33 0.652 . . . . 0.0 112.731 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -87.11 30.14 0.79 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.745 0.818 . . . . 0.0 112.592 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -52.27 125.0 14.57 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.561 -0.712 . . . . 0.0 110.213 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.65 -15.35 14.36 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.484 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.7 -36.23 9.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.431 1.116 . . . . 0.0 110.568 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -146.67 142.23 27.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.199 0.6 . . . . 0.0 109.479 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.8 m -108.36 139.79 42.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.96 143.19 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.83 151.08 51.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.943 0.897 . . . . 0.0 108.599 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -133.27 101.93 5.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -98.01 123.28 41.96 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.729 -0.607 . . . . 0.0 110.791 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -82.34 108.44 15.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.238 0.615 . . . . 0.0 110.077 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.66 -23.9 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.744 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -62.18 -46.17 90.15 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.3 -32.54 58.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.478 0.711 . . . . 0.0 110.558 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -128.53 70.19 79.73 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.574 0.75 . . . . 0.0 112.411 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.64 -59.35 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.505 2.137 . . . . 0.0 112.923 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.18 -42.22 1.62 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.345 1.926 . . . . 0.0 115.296 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -28.15 65.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.871 0.835 . . . . 0.0 112.854 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -70.01 -65.21 1.17 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.196 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 94.4 Cg_exo -47.25 -40.18 27.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.247 2.631 . . . . 0.0 113.192 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 CA--C 1.536 0.418 0 CA-C-N 118.937 0.789 . . . . 0.0 112.242 178.011 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.7 pt . . . . . 0 CA--C 1.537 0.481 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.68 142.48 67.64 Favored 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.541 1.229 . . . . 0.0 110.523 -0.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -142.85 127.51 18.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.72 118.57 37.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.466 1.506 . . . . 0.0 109.234 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -110.66 118.31 35.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.44 107.36 19.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 N--CA 1.456 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 111.465 -178.316 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.67 111.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -44.42 22.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.366 0.666 . . . . 0.0 109.639 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.13 161.33 31.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 78.4 p -135.23 132.28 37.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.395 1.078 . . . . 0.0 109.166 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -120.54 117.99 29.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -93.71 132.75 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.09 163.64 39.39 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.635 0.636 . . . . 0.0 111.778 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.35 167.94 15.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.14 0.576 . . . . 0.0 110.416 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.54 166.61 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.972 1.309 . . . . 0.0 107.723 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 76.8 p -82.42 161.49 22.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.225 0.536 . . . . 0.0 110.799 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -48.82 -51.88 27.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.019 . . . . 0.0 109.813 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.55 -54.78 28.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -55.28 -46.39 76.18 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.089 0.445 . . . . 0.0 110.337 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.06 -48.39 81.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.543 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -55.93 -50.13 71.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.319 0.509 . . . . 0.0 110.026 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -56.99 -50.79 71.62 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.836 0.289 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.32 -53.79 45.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 0.0 110.364 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.85 -54.93 41.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.562 0.345 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -52.2 -51.7 56.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.262 0.625 . . . . 0.0 110.674 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -38.04 69.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.669 0.788 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -78.07 -48.64 15.61 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.16 -0.338 . . . . 0.0 110.36 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -58.55 -44.77 89.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.161 0.584 . . . . 0.0 109.911 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 122.837 0.455 . . . . 0.0 109.775 177.768 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm . . . . . 0 N--CA 1.456 -0.144 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 mt -96.31 139.37 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 110.344 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -86.44 110.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.178 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -81.12 94.04 6.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.106 0.962 . . . . 0.0 108.799 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.78 163.82 22.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.986 0.914 . . . . 0.0 112.614 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.1 p -133.56 163.55 29.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.457 1.903 . . . . 0.0 106.226 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.07 -43.38 73.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.13 -46.31 90.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.962 1.305 . . . . 0.0 111.877 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -78.31 -27.54 47.24 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.096 -0.377 . . . . 0.0 111.385 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -36.65 -54.62 0.88 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 113.426 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.9 -63.73 1.06 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 110.902 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -56.1 -41.74 75.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.845 0.858 . . . . 0.0 112.787 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -58.42 2.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.11 -52.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.881 0.872 . . . . 0.0 112.712 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.24 -29.99 71.06 Favored 'General case' 0 C--O 1.228 -0.047 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 172.574 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -116.42 125.58 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 C-N-CA 124.619 1.168 . . . . 0.0 108.354 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 tp -103.28 103.34 13.35 Favored 'General case' 0 CA--C 1.524 -0.051 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -89.8 114.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 122.745 0.418 . . . . 0.0 110.103 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.36 114.3 26.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -82.86 128.1 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -142.43 174.61 10.47 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.446 0.698 . . . . 0.0 111.787 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.46 153.89 41.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.41 1.484 . . . . 0.0 107.789 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -52.32 -43.67 64.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.663 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -80.08 -2.45 44.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.952 1.301 . . . . 0.0 112.957 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -79.4 78.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.896 -1.128 . . . . 0.0 111.004 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.78 -57.36 3.43 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 123.74 0.686 . . . . 0.0 112.185 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.81 -32.46 77.08 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.071 2.514 . . . . 0.0 113.413 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.18 -47.64 76.27 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.62 -40.4 87.44 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -58.59 -46.11 87.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.96 0.504 . . . . 0.0 110.876 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 pt -76.27 -26.82 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 118.746 0.703 . . . . 0.0 112.555 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.91 -56.66 1.11 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.97 -38.89 94.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.217 1.944 . . . . 0.0 112.09 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 mt -62.11 -48.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -56.5 -42.55 78.54 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.24 -0.288 . . . . 0.0 110.261 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.05 -48.83 80.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.188 0.595 . . . . 0.0 109.703 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -59.35 -49.6 77.21 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.795 -0.565 . . . . 0.0 109.832 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.6 mm -52.04 -45.95 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.631 0.773 . . . . 0.0 110.047 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.82 -33.42 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.691 0.397 . . . . 0.0 111.38 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.47 -54.86 5.71 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.88 -44.53 49.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.909 . . . . 0.0 112.516 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -103.77 22.1 15.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.962 0.905 . . . . 0.0 112.189 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -51.17 135.97 24.89 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.876 0.762 . . . . 0.0 111.17 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 -23.51 3.61 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.97 -0.906 . . . . 0.0 113.531 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.38 -45.3 5.89 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.015 1.408 . . . . 0.0 110.251 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.02 121.69 40.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 m -93.54 103.67 15.84 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.94 137.96 20.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.08 48.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.053 0.941 . . . . 0.0 109.434 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -128.92 136.48 50.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -127.33 122.08 32.78 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.194 0.597 . . . . 0.0 110.19 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -83.07 106.34 14.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.047 0.539 . . . . 0.0 110.077 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.84 -26.22 36.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -58.51 -51.02 71.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.327 0.967 . . . . 0.0 109.298 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -78.83 -31.06 45.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.795 0.838 . . . . 0.0 111.089 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.82 66.46 20.79 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.446 0.698 . . . . 0.0 111.479 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.8 -54.24 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.379 2.053 . . . . 0.0 112.156 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.41 -46.44 1.45 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.881 1.705 . . . . 0.0 114.3 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -38.86 60.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.938 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.55 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.4 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.691 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 78.5 Cg_exo -50.87 -45.32 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.167 1.911 . . . . 0.0 112.695 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? . . . . . 0 C--N 1.344 0.34 0 CA-C-N 119.095 0.861 . . . . 0.0 111.858 -179.618 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.3 pt . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.1 147.6 89.03 Favored 'Cis proline' 0 N--CA 1.454 -0.795 0 CA-C-N 119.555 0.877 . . . . 0.0 110.296 -1.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -145.76 127.12 14.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt -102.51 126.0 49.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.669 1.588 . . . . 0.0 108.558 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.33 120.25 38.28 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -96.64 102.06 13.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.363 0.665 . . . . 0.0 109.444 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 . . . . . 0 N--CA 1.454 -0.261 0 C-N-CA 125.704 1.602 . . . . 0.0 110.116 -179.97 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 . . . . . 0 N--CA 1.455 -0.221 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.87 106.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -43.29 22.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.444 0.698 . . . . 0.0 110.297 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.82 168.75 25.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 p -144.72 163.2 34.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -142.14 121.63 13.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.14 132.44 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.457 1.103 . . . . 0.0 108.783 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.49 167.19 42.38 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.598 0.555 . . . . 0.0 111.963 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.48 169.07 14.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.15 0.58 . . . . 0.0 110.266 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.69 165.64 27.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.037 1.335 . . . . 0.0 107.66 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.9 p -75.69 159.24 31.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.171 0.51 . . . . 0.0 110.417 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -52.77 -46.88 67.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.578 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.46 -57.01 19.09 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -54.05 -46.06 71.83 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.311 0.555 . . . . 0.0 111.199 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.39 -51.25 70.28 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.239 -0.288 . . . . 0.0 110.683 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.46 -48.53 74.36 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 122.18 -0.325 . . . . 0.0 110.621 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.83 -51.71 68.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.938 0.895 . . . . 0.0 110.036 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.36 -54.02 46.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.872 0.869 . . . . 0.0 109.962 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.86 -50.03 74.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.209 -0.307 . . . . 0.0 110.758 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.72 -52.23 63.13 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.543 0.337 . . . . 0.0 110.156 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -36.06 71.76 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.047 0.939 . . . . 0.0 111.947 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.32 -50.88 10.98 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 117.918 0.326 . . . . 0.0 110.46 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.05 -42.3 97.09 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.107 -0.371 . . . . 0.0 110.575 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 124.717 1.207 . . . . 0.0 111.727 179.292 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.8 mttp . . . . . 0 N--CA 1.456 -0.169 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 mt -103.47 134.83 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.479 0.712 . . . . 0.0 110.94 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.5 mm -89.12 117.36 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 122.207 1.003 . . . . 0.0 110.6 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -89.07 78.26 7.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.81 163.87 18.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.747 1.219 . . . . 0.0 112.937 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.1 p -132.67 163.56 28.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.259 1.824 . . . . 0.0 106.707 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.74 -42.7 71.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.267 0.485 . . . . 0.0 109.743 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.57 -45.69 92.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.898 1.279 . . . . 0.0 111.709 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 p -78.71 -26.24 44.82 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.161 -0.337 . . . . 0.0 111.321 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -37.81 -57.06 1.04 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.532 1.533 . . . . 0.0 113.581 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -54.79 -61.69 2.15 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.703 0.763 . . . . 0.0 110.394 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -52.26 -42.58 63.78 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.201 1.4 . . . . 0.0 113.326 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -57.48 2.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.961 0.504 . . . . 0.0 112.068 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.92 -51.01 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.061 0.944 . . . . 0.0 112.536 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.7 -36.11 82.69 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.215 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? . . . . . 0 CA--C 1.538 0.512 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.826 173.524 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.33 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mt -111.98 125.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.444 1.097 . . . . 0.0 108.299 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -104.16 100.48 10.22 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.94 112.7 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.44 0.296 . . . . 0.0 110.424 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -89.35 108.06 19.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -79.93 120.23 23.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -137.25 173.19 11.95 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.38 151.27 50.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.675 1.19 . . . . 0.0 108.357 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -55.04 -38.39 67.92 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.281 0.491 . . . . 0.0 111.357 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -83.81 -2.48 56.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.679 1.192 . . . . 0.0 112.488 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.47 80.79 5.81 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.948 -1.095 . . . . 0.0 110.685 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.89 -58.51 2.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.184 0.897 . . . . 0.0 111.919 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -54.0 -39.58 84.57 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.428 2.752 . . . . 0.0 113.543 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -62.28 -48.7 78.72 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.76 -44.24 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.4 ttm -52.53 -41.46 63.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.08 0.952 . . . . 0.0 111.135 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -82.58 -11.97 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.775 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.75 -49.85 54.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.321 1.419 . . . . 0.0 113.423 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.31 -37.96 94.14 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.315 2.01 . . . . 0.0 111.764 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.56 -48.98 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.52 -41.78 73.61 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.271 0.487 . . . . 0.0 110.236 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.47 -52.54 64.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.158 0.583 . . . . 0.0 109.92 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -54.06 -47.68 71.38 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.951 0.5 . . . . 0.0 109.698 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.1 -49.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.73 0.812 . . . . 0.0 109.539 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.7 67.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.073 0.397 . . . . 0.0 110.064 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.3 -50.83 64.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.197 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -60.39 -44.24 95.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.722 1.209 . . . . 0.0 113.62 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.52 29.19 3.38 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.713 1.205 . . . . 0.0 112.131 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.82 132.28 18.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.83 -0.543 . . . . 0.0 111.418 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.13 -19.04 2.34 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.123 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -98.84 -41.75 7.49 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.429 1.614 . . . . 0.0 109.859 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -129.97 119.74 23.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.542 0.737 . . . . 0.0 109.415 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -95.41 103.73 15.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.24 144.06 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.317 -0.864 . . . . 0.0 109.8 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.12 151.75 45.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.113 0.965 . . . . 0.0 109.134 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -133.15 103.86 6.22 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.69 119.57 37.66 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.754 0.421 . . . . 0.0 110.606 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -80.15 106.35 12.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.83 -27.46 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.753 0.821 . . . . 0.0 112.519 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.05 -51.3 70.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.215 0.916 . . . . 0.0 109.385 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -74.63 -32.15 62.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.71 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -118.85 67.49 7.99 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 111.661 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.92 -44.72 9.48 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 110.714 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.18 -37.7 4.59 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.291 1.424 . . . . 0.0 114.325 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.22 -24.34 64.01 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.255 1.027 . . . . 0.0 113.087 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -59.32 14.21 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -62.14 -33.8 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.216 1.944 . . . . 0.0 112.377 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm . . . . . 0 N--CA 1.465 0.317 0 CA-C-N 119.082 0.856 . . . . 0.0 111.922 179.778 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.4 pt . . . . . 0 CA--C 1.538 0.511 0 CA-C-O 118.836 -0.602 . . . . 0.0 110.288 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.97 134.43 31.75 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.991 1.033 . . . . 0.0 110.739 -0.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.79 115.76 28.28 Favored 'General case' 0 C--N 1.338 0.074 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.51 94.06 6.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 89' ' ' THR . 9.4 mp -91.91 114.92 27.59 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -94.09 100.12 12.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.564 0.746 . . . . 0.0 109.511 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 . . . . . 0 N--CA 1.456 -0.16 0 C-N-CA 125.231 1.412 . . . . 0.0 110.672 -179.691 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.0 107.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.26 24.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.64 0.776 . . . . 0.0 109.959 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.27 159.92 31.97 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.458 0.703 . . . . 0.0 109.243 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.418 HG22 ' HG ' ' A' ' 79' ' ' LEU . 45.6 p -134.11 103.77 5.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.439 1.096 . . . . 0.0 108.461 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -87.59 114.95 24.67 Favored 'General case' 0 C--N 1.338 0.087 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.84 119.22 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.05 166.38 26.92 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 121.579 0.544 . . . . 0.0 112.436 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.64 165.19 25.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.463 0.705 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -163.89 168.62 19.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.214 1.806 . . . . 0.0 106.994 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.3 p -97.1 178.44 5.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.11 0.957 . . . . 0.0 112.235 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -64.67 161.77 17.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.7 4.69 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.31 -56.23 22.85 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 tp -56.9 -46.02 82.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.056 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.14 -49.76 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.335 -0.228 . . . . 0.0 111.072 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.86 -50.31 73.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.269 0.628 . . . . 0.0 109.831 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -52.97 -52.24 58.8 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -58.96 -47.1 86.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.694 0.397 . . . . 0.0 110.957 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.9 -54.15 48.21 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.075 0.95 . . . . 0.0 111.983 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -77.89 -50.86 11.39 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 122.209 -0.307 . . . . 0.0 110.739 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 72.5 mt -59.73 -42.87 94.12 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.137 0.575 . . . . 0.0 109.956 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.525 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp . . . . . 0 CA--C 1.531 0.22 0 N-CA-C 110.529 -0.175 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.7 mt -83.26 136.21 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 122.07 -0.394 . . . . 0.0 111.303 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 mm -90.28 120.66 39.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.958 0.885 . . . . 0.0 111.121 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -92.86 80.93 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.1 0.96 . . . . 0.0 108.871 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.55 164.97 15.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.879 1.272 . . . . 0.0 112.784 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.6 p -132.9 163.04 30.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.71 -44.24 69.65 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.157 0.503 . . . . 0.0 109.659 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.9 -45.85 92.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.997 1.319 . . . . 0.0 111.963 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.35 -26.76 46.86 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.109 -0.37 . . . . 0.0 111.487 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -36.93 -54.76 0.93 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.737 1.615 . . . . 0.0 113.391 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.7 -62.85 1.39 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.447 0.641 . . . . 0.0 110.999 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -38.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.685 0.794 . . . . 0.0 113.108 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -59.21 2.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 -52.89 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.532 1.133 . . . . 0.0 112.439 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.31 -28.61 69.83 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.329 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.4 mttp . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 122.813 0.445 . . . . 0.0 110.112 174.036 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.163 0 N-CA-C 110.079 -0.341 . . . . 0.0 110.079 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -117.51 127.31 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.505 1.122 . . . . 0.0 108.792 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -104.83 102.83 12.36 Favored 'General case' 0 C--N 1.337 0.055 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 t -89.76 113.23 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -93.46 111.5 23.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -80.91 124.9 29.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -139.69 -179.57 6.0 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.861 0.864 . . . . 0.0 111.191 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.871 1.268 . . . . 0.0 108.935 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.43 -22.55 54.74 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.502 1.121 . . . . 0.0 113.226 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -99.44 -2.04 37.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.712 1.205 . . . . 0.0 111.727 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.9 t -79.96 83.92 5.8 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.021 -1.049 . . . . 0.0 112.29 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.83 -59.88 3.12 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 123.828 0.728 . . . . 0.0 112.437 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -32.79 67.64 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 0.0 113.337 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.13 -45.88 83.24 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.57 -42.25 96.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -57.51 -44.79 85.3 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.964 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 pt -77.5 -21.19 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.922 0.783 . . . . 0.0 112.734 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.52 -57.31 2.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.702 1.137 . . . . 0.0 114.024 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -56.09 -40.08 87.16 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.161 1.907 . . . . 0.0 112.055 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.73 -50.61 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.2 -44.13 83.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.132 0.573 . . . . 0.0 110.682 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.94 -51.85 67.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.636 0.775 . . . . 0.0 110.002 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.56 -51.43 65.27 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.536 0.734 . . . . 0.0 109.221 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.51 -47.67 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.34 75.42 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.198 0.453 . . . . 0.0 110.946 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.61 -43.15 81.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.82 -54.89 15.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.342 1.057 . . . . 0.0 112.476 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -82.57 23.46 0.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.401 1.08 . . . . 0.0 111.038 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.23 101.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.823 1.649 . . . . 0.0 110.276 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.45 -21.53 16.87 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.629 1.109 . . . . 0.0 111.446 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -99.6 -35.67 9.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.707 1.203 . . . . 0.0 110.236 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -142.09 139.43 32.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.22 1.008 . . . . 0.0 109.447 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -109.51 105.33 14.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -80.09 140.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.6 150.35 49.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.69 0.796 . . . . 0.0 109.459 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -131.19 103.06 6.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.884 1.274 . . . . 0.0 108.101 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -98.32 119.78 37.6 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 121.815 -0.553 . . . . 0.0 110.407 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -81.89 108.82 15.71 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.04 -25.01 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.32 0.648 . . . . 0.0 111.894 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.1 -47.68 81.8 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.294 0.952 . . . . 0.0 108.542 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -71.99 -32.82 67.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -124.32 69.52 51.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.506 0.722 . . . . 0.0 112.638 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.21 -50.78 12.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.332 2.021 . . . . 0.0 111.897 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.54 -42.45 3.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.705 1.621 . . . . 0.0 114.989 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.63 64.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.289 1.045 . . . . 0.0 112.85 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.37 -62.37 6.07 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.65 -42.34 47.8 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.799 1.666 . . . . 0.0 111.376 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt . . . . . 0 CA--C 1.531 0.247 0 C-N-CA 123.276 0.63 . . . . 0.0 111.866 179.821 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.6 pt . . . . . 0 CA--C 1.538 0.494 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.53 142.66 68.0 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 CA-C-N 120.651 1.268 . . . . 0.0 110.029 -0.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -137.31 114.96 11.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.9 mt -95.24 127.8 41.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.089 1.356 . . . . 0.0 108.941 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.73 119.02 32.42 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.0 tp -97.16 104.02 16.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.037 0.535 . . . . 0.0 109.655 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 . . . . . 0 N--CA 1.452 -0.339 0 C-N-CA 125.799 1.639 . . . . 0.0 109.823 -179.916 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 . . . . . 0 N--CA 1.453 -0.313 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.78 106.3 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.29 -43.47 23.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.635 0.774 . . . . 0.0 109.755 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.41 169.12 23.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.4 p -139.46 164.93 28.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.28 116.72 6.13 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.76 133.73 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.16 163.94 39.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.57 0.605 . . . . 0.0 111.674 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 167.57 16.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.277 0.631 . . . . 0.0 110.815 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.01 167.61 24.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.989 1.316 . . . . 0.0 108.074 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.4 p -79.5 165.97 22.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.318 0.58 . . . . 0.0 111.29 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -56.19 -45.24 79.88 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.46 -57.66 18.67 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.854 0.74 . . . . 0.0 111.432 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -57.68 -40.95 80.58 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.684 0.742 . . . . 0.0 110.701 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.64 -50.8 71.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.978 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -53.16 -51.3 62.48 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.482 0.583 . . . . 0.0 110.19 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.72 -53.28 54.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.572 0.749 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -54.29 -52.48 61.31 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.711 0.804 . . . . 0.0 110.491 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.7 mt -58.12 -52.47 65.42 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.61 0.364 . . . . 0.0 110.584 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -54.12 -52.86 59.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.668 0.787 . . . . 0.0 109.68 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.54 -40.72 68.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.585 0.754 . . . . 0.0 111.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -78.23 -48.12 16.47 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 122.326 -0.234 . . . . 0.0 111.168 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.6 mt -57.22 -46.24 83.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.515 0.726 . . . . 0.0 109.3 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.123 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp . . . . . 0 CA--C 1.534 0.336 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mt -84.58 138.32 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.127 0.571 . . . . 0.0 111.088 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.79 113.6 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.378 0.671 . . . . 0.0 110.808 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -84.36 99.43 10.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.396 1.078 . . . . 0.0 109.28 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.73 171.19 11.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.202 1.001 . . . . 0.0 111.481 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.7 p -137.37 166.43 23.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -52.81 -41.95 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.287 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.63 -47.93 79.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.642 1.177 . . . . 0.0 111.904 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.37 -26.41 46.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -35.14 -54.16 0.61 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.368 1.467 . . . . 0.0 113.898 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.02 -65.47 0.57 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.523 0.677 . . . . 0.0 111.013 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -56.46 -37.5 70.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.166 0.987 . . . . 0.0 112.746 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.39 -60.72 1.95 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.87 -50.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 112.479 -173.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.07 -32.5 74.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.078 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.4 mttt . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 122.512 0.325 . . . . 0.0 110.872 174.834 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mt -116.85 124.24 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.09 1.356 . . . . 0.0 108.14 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.1 tp -100.95 102.68 13.75 Favored 'General case' 0 C--O 1.228 -0.051 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.57 113.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 122.657 0.383 . . . . 0.0 110.426 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.48 109.54 21.73 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.528 1.131 . . . . 0.0 108.634 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -79.97 122.04 26.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -136.81 178.65 6.91 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.583 1.153 . . . . 0.0 111.063 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.02 154.26 36.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.858 1.663 . . . . 0.0 108.004 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -54.56 -40.51 68.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.295 0.952 . . . . 0.0 112.035 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -79.34 -2.43 41.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 112.968 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -79.41 78.58 5.91 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.901 -1.124 . . . . 0.0 111.55 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.61 3.63 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.772 0.701 . . . . 0.0 112.206 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.26 -34.42 79.56 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.902 2.401 . . . . 0.0 113.239 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -63.67 -46.34 86.02 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.07 -46.75 87.47 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.8 mtp -55.07 -43.83 74.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.569 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.37 -20.71 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.916 0.78 . . . . 0.0 112.97 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.15 -52.65 9.4 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.977 1.262 . . . . 0.0 114.238 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -52.9 -41.14 72.87 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.493 2.129 . . . . 0.0 112.143 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -62.92 -49.58 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.96 -42.28 72.16 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -62.5 -45.82 91.25 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 110.176 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -59.24 -46.92 87.19 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.717 -0.614 . . . . 0.0 109.775 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.67 -48.4 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -43.39 64.7 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.381 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.82 -63.46 1.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.448 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -45.41 -47.11 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.956 1.302 . . . . 0.0 113.618 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -95.09 21.54 7.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.023 0.929 . . . . 0.0 112.295 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.59 130.92 17.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.435 1.016 . . . . 0.0 110.302 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.09 -18.18 4.3 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.209 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -99.29 -39.39 8.45 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.821 1.31 . . . . 0.0 109.768 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.74 136.62 32.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.232 1.013 . . . . 0.0 108.361 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.4 m -102.23 107.46 18.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.0 135.89 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.23 154.3 51.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.534 0.733 . . . . 0.0 109.323 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.36 144.77 51.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.206 1.402 . . . . 0.0 108.707 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.9 tt -134.37 129.42 35.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.38 100.89 12.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -57.09 -30.1 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -61.77 -46.1 91.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.27 0.941 . . . . 0.0 109.966 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -88.58 -19.33 26.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.365 1.466 . . . . 0.0 111.771 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -127.24 55.52 15.61 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.413 1.485 . . . . 0.0 109.946 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.25 -42.67 21.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.722 2.281 . . . . 0.0 112.295 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.47 -33.68 4.52 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.578 1.085 . . . . 0.0 113.827 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -64.4 -55.66 28.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 119.286 0.948 . . . . 0.0 112.407 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 72.2 Cg_exo -51.52 -41.83 58.57 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 113.496 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mttp . . . . . 0 N--CA 1.463 0.212 0 C-N-CA 123.511 0.724 . . . . 0.0 112.574 -178.185 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt . . . . . 0 CA--C 1.535 0.38 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.95 143.36 74.0 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.328 1.153 . . . . 0.0 110.204 -0.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 m -139.69 126.01 20.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.57 116.14 31.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 108.948 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.2 mp -110.13 119.33 38.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.3 tp -94.55 106.3 18.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 . . . . . 0 N--CA 1.457 -0.098 0 C-N-CA 125.352 1.461 . . . . 0.0 111.707 -178.283 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 . . . . . 0 N--CA 1.451 -0.4 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.04 111.32 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.71 23.61 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.429 0.692 . . . . 0.0 109.746 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.24 161.13 33.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.405 HG22 ' HG ' ' A' ' 79' ' ' LEU . 80.5 p -135.59 135.41 40.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.401 1.08 . . . . 0.0 109.157 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 127.97 49.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.74 129.19 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.17 173.72 44.98 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.053 0.835 . . . . 0.0 111.43 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.02 171.35 13.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.34 -0.506 . . . . 0.0 110.221 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -164.3 164.46 22.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.528 1.531 . . . . 0.0 107.617 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.2 p -73.9 161.17 30.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.124 0.488 . . . . 0.0 110.764 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.43 -42.93 78.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.89 -58.65 13.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.33 -45.49 69.09 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.265 0.532 . . . . 0.0 110.872 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.5 tp -59.8 -52.06 67.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -55.83 -46.94 78.02 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.111 -0.368 . . . . 0.0 110.893 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.95 -52.86 63.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.901 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -53.79 -53.14 56.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.223 1.009 . . . . 0.0 110.219 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.96 -50.32 74.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.402 0.281 . . . . 0.0 110.685 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.36 -49.83 71.26 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.491 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.551 0.741 . . . . 0.0 111.521 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -77.65 -46.38 22.17 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 122.151 -0.343 . . . . 0.0 110.923 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.6 mt -62.3 -43.77 98.06 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 125.606 1.562 . . . . 0.0 108.501 178.089 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm . . . . . 0 CA--C 1.532 0.252 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 mt -100.82 138.19 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 111.507 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -92.83 118.55 38.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 110.542 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -87.74 101.3 13.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.24 1.016 . . . . 0.0 109.292 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.94 168.34 12.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.549 1.14 . . . . 0.0 112.593 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -135.43 162.12 33.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.83 -43.83 69.74 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.78 -46.24 91.25 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.968 1.307 . . . . 0.0 112.014 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.27 -26.46 47.17 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.028 -0.42 . . . . 0.0 111.467 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -35.97 -54.12 0.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.745 1.618 . . . . 0.0 113.633 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -55.34 -62.3 1.76 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.939 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -59.03 -40.3 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.281 0.632 . . . . 0.0 112.44 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.19 -58.38 3.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -80.74 -52.35 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.885 0.874 . . . . 0.0 112.349 -173.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -63.36 -26.13 68.61 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.635 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm . . . . . 0 CA--C 1.542 0.669 0 C-N-CA 123.078 0.551 . . . . 0.0 109.859 172.781 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.186 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.68 132.03 69.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 C-N-CA 124.316 1.046 . . . . 0.0 108.531 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.84 100.92 9.3 Favored 'General case' 0 C--O 1.229 -0.025 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.16 117.64 33.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 122.661 0.385 . . . . 0.0 110.75 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -97.43 109.39 22.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.882 1.273 . . . . 0.0 108.882 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -82.43 124.18 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -142.38 172.83 12.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 147.98 40.23 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.293 1.437 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -54.92 -35.87 64.64 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.177 0.591 . . . . 0.0 112.033 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -84.81 -5.67 59.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.954 0.902 . . . . 0.0 112.358 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.85 82.01 6.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.063 -1.023 . . . . 0.0 110.728 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.76 -57.51 3.37 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 123.941 0.782 . . . . 0.0 111.983 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.51 -34.36 81.81 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.148 2.565 . . . . 0.0 113.435 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.76 -49.57 67.91 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -58.98 -39.98 83.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.5 ttp -58.52 -47.69 83.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.203 0.601 . . . . 0.0 110.426 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.2 pt -75.83 -25.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.626 -0.702 . . . . 0.0 112.659 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -58.02 1.16 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.13 -40.63 83.63 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.192 1.928 . . . . 0.0 111.521 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.0 mt -58.97 -49.97 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.77 -42.52 75.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.889 0.313 . . . . 0.0 110.46 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -59.9 -53.66 55.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -45.89 75.47 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.62 -0.675 . . . . 0.0 110.392 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -57.07 -48.62 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.017 0.527 . . . . 0.0 109.648 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.63 76.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.557 0.743 . . . . 0.0 110.27 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.52 -56.73 13.71 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.57 -51.0 40.02 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.992 1.317 . . . . 0.0 112.028 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -96.98 23.7 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.797 0.839 . . . . 0.0 112.525 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -54.89 128.93 35.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.028 . . . . 0.0 110.461 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.51 -16.99 21.94 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.298 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.52 -42.72 6.8 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.674 1.237 . . . . 0.0 109.365 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -134.11 119.25 18.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.807 1.243 . . . . 0.0 107.648 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.8 m -86.24 102.78 14.25 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.63 139.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.55 154.59 49.8 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.19 145.17 51.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.136 1.374 . . . . 0.0 108.489 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.19 123.39 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -84.53 109.38 17.89 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -62.8 -31.54 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.38 -52.72 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.998 0.817 . . . . 0.0 110.069 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.82 -30.82 65.9 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.826 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -117.64 71.14 7.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.935 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.94 -53.98 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.716 2.277 . . . . 0.0 112.597 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.71 -45.81 2.08 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.38 1.467 . . . . 0.0 114.358 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.55 65.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.4 1.08 . . . . 0.0 113.356 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.41 -66.34 1.07 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.842 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -58.88 -42.9 48.01 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 121.228 1.474 . . . . 0.0 111.106 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? . . . . . 0 CA--C 1.531 0.248 0 CA-C-N 118.452 0.569 . . . . 0.0 111.692 179.924 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt . . . . . 0 CA--C 1.538 0.513 0 N-CA-C 107.54 -1.281 . . . . 0.0 107.54 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.19 146.27 80.5 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.365 1.166 . . . . 0.0 110.042 -1.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.0 m -137.82 123.54 19.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.6 mt -108.58 112.64 25.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.727 1.611 . . . . 0.0 109.173 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.1 mp -104.86 122.28 45.43 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -96.55 99.75 11.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.787 0.835 . . . . 0.0 109.278 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 N--CA 1.452 -0.345 0 C-N-CA 125.862 1.665 . . . . 0.0 109.708 179.533 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 . . . . . 0 CA--C 1.531 0.218 0 N-CA-C 109.967 -0.382 . . . . 0.0 109.967 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -62.89 102.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.0 -41.76 25.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.867 0.867 . . . . 0.0 110.976 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.11 159.16 42.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.418 HG22 ' HG ' ' A' ' 79' ' ' LEU . 82.2 p -138.54 131.13 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.262 1.025 . . . . 0.0 109.299 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -120.27 117.68 28.46 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.35 134.06 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 163.65 39.46 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.663 0.649 . . . . 0.0 111.864 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.34 169.12 14.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.395 0.678 . . . . 0.0 110.488 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.61 168.66 21.41 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.627 1.171 . . . . 0.0 108.531 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 149.47 33.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.747 1.219 . . . . 0.0 110.609 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.47 -49.18 65.18 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.173 0.589 . . . . 0.0 111.252 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.77 42.14 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -58.67 -43.17 89.8 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.97 0.508 . . . . 0.0 110.418 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.3 -50.55 73.19 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -54.63 -49.94 69.33 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 122.045 -0.409 . . . . 0.0 110.503 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.46 -52.79 63.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.08 0.952 . . . . 0.0 110.095 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.27 -53.76 49.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.671 0.788 . . . . 0.0 110.19 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.12 -49.95 75.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.624 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.97 -51.36 64.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 117.968 0.349 . . . . 0.0 110.138 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.31 -36.41 71.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.791 0.837 . . . . 0.0 111.894 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -77.7 -46.01 23.16 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 121.988 -0.445 . . . . 0.0 109.855 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.26 -46.48 88.41 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 123.062 0.545 . . . . 0.0 109.624 177.571 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.5 mttt . . . . . 0 CA--C 1.531 0.223 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.3 mt -85.58 138.31 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.136 0.574 . . . . 0.0 111.166 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.57 119.99 41.1 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.283 0.563 . . . . 0.0 110.365 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -88.94 103.55 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.444 1.097 . . . . 0.0 109.34 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.22 164.99 14.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.612 1.165 . . . . 0.0 113.206 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.4 p -136.07 162.21 33.53 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.65 -44.14 69.38 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.331 0.514 . . . . 0.0 109.939 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.23 -46.24 90.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.925 1.29 . . . . 0.0 112.096 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.6 p -78.56 -26.17 45.56 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.085 -0.385 . . . . 0.0 111.482 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -36.98 -54.43 0.95 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.015 1.726 . . . . 0.0 114.125 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -52.69 -60.2 3.55 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.521 -0.737 . . . . 0.0 111.159 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.53 97.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.592 0.757 . . . . 0.0 112.335 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -27.01 50.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.8 -62.55 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 124.017 0.927 . . . . 0.0 111.746 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.86 -35.81 77.56 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 121.949 -0.47 . . . . 0.0 111.444 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? . . . . . 0 CA--C 1.538 0.489 0 CA-C-O 119.222 -0.418 . . . . 0.0 112.124 177.444 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.258 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.46 139.25 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 126.147 1.779 . . . . 0.0 107.793 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.97 99.35 6.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 t -90.92 114.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -91.59 107.58 19.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.159 0.983 . . . . 0.0 108.404 174.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -79.72 120.41 23.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -136.49 179.46 6.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.968 0.907 . . . . 0.0 110.868 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.69 36.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.275 1.03 . . . . 0.0 109.652 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -56.25 -26.33 51.14 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.775 1.23 . . . . 0.0 112.333 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -93.75 -8.22 41.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.526 1.131 . . . . 0.0 112.483 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.74 82.88 5.77 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.992 -1.067 . . . . 0.0 112.903 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.42 -58.23 4.69 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.571 0.605 . . . . 0.0 112.469 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -53.16 -32.28 58.98 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.2 2.6 . . . . 0.0 113.236 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.7 m -65.45 -43.85 89.08 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -63.24 -41.78 99.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 50.9 ttp -55.11 -47.73 74.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.618 0.367 . . . . 0.0 110.83 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.54 -26.92 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.14 -56.66 1.18 Allowed Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -57.44 -35.94 98.81 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.183 1.922 . . . . 0.0 111.953 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.0 mt -64.73 -49.45 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.5 mt -54.51 -42.22 70.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.799 0.272 . . . . 0.0 110.473 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -61.83 -51.46 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -52.69 -47.96 66.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.934 -0.478 . . . . 0.0 109.863 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.12 -48.58 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.39 0.676 . . . . 0.0 109.421 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 -43.21 65.44 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.182 0.593 . . . . 0.0 110.05 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.12 -61.65 1.82 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.751 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -53.14 -48.4 67.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.113 0.965 . . . . 0.0 112.397 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -88.7 13.52 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 0.0 112.248 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -55.08 116.5 2.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.906 1.23 . . . . 0.0 109.729 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.66 -26.79 18.61 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.798 0.713 . . . . 0.0 111.585 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -99.19 -42.15 7.17 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.681 0.793 . . . . 0.0 109.765 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -129.08 141.34 51.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.296 1.038 . . . . 0.0 109.956 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -108.59 96.81 6.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -78.92 136.42 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.213 -0.929 . . . . 0.0 108.534 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 157.44 46.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.937 0.895 . . . . 0.0 109.249 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -131.97 146.52 52.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.279 1.432 . . . . 0.0 108.789 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -138.45 124.98 20.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -86.97 108.55 18.87 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 pt -65.43 -23.56 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.16 -45.36 93.75 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.132 0.878 . . . . 0.0 108.794 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -77.49 -35.18 53.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.371 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -123.03 69.13 37.3 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.986 0.914 . . . . 0.0 111.51 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.24 -55.86 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.102 1.868 . . . . 0.0 112.19 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.3 -40.65 2.68 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.782 1.658 . . . . 0.0 114.691 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.55 -33.7 68.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.092 -0.652 . . . . 0.0 112.494 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -64.58 -65.07 2.17 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.581 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 80.5 Cg_exo -48.21 -42.99 32.6 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.783 2.322 . . . . 0.0 112.786 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? . . . . . 0 C--N 1.343 0.325 0 CA-C-N 118.942 0.792 . . . . 0.0 112.027 179.082 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 pt . . . . . 0 CA--C 1.538 0.485 0 CA-C-O 117.998 -1.001 . . . . 0.0 108.347 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.44 141.37 57.48 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 120.727 1.295 . . . . 0.0 110.308 -0.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 m -141.07 125.72 17.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.51 107.37 17.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.274 1.43 . . . . 0.0 109.516 -174.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -95.79 116.13 28.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.5 99.9 12.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 N--CA 1.454 -0.236 0 C-N-CA 125.225 1.41 . . . . 0.0 108.949 179.069 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 . . . . . 0 CA--C 1.528 0.11 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.0 t -61.34 104.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.32 22.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.674 0.79 . . . . 0.0 110.067 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.67 156.45 34.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.09 0.556 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.447 HG22 ' HG ' ' A' ' 79' ' ' LEU . 77.0 p -132.07 112.45 12.35 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.673 1.189 . . . . 0.0 109.025 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -98.73 110.85 23.39 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.59 131.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.29 162.69 38.46 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.744 0.688 . . . . 0.0 111.996 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.43 170.06 12.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.223 0.609 . . . . 0.0 110.442 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -164.54 163.75 21.89 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.027 1.331 . . . . 0.0 108.002 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.9 p -73.79 163.08 28.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.124 0.487 . . . . 0.0 110.817 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.41 -44.63 76.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.36 -54.52 36.49 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -56.65 -44.47 81.34 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.272 0.536 . . . . 0.0 110.404 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.79 -53.87 52.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -54.82 -46.28 74.52 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.142 0.428 . . . . 0.0 110.835 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.03 -53.72 54.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.528 0.731 . . . . 0.0 110.057 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.64 -53.09 59.33 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.148 0.979 . . . . 0.0 110.421 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.21 -50.62 72.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.674 0.389 . . . . 0.0 110.305 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.3 -51.71 65.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.612 0.365 . . . . 0.0 110.288 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.91 -37.79 69.39 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.658 0.783 . . . . 0.0 111.928 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -77.88 -46.89 20.07 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.0 mt -58.77 -44.64 90.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.066 0.546 . . . . 0.0 109.719 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 122.998 0.519 . . . . 0.0 109.636 177.556 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.6 mttm . . . . . 0 CA--C 1.531 0.214 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 mt -105.86 133.02 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.023 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mt -86.94 146.03 6.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -115.52 100.1 7.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.1 163.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.636 1.174 . . . . 0.0 113.209 -173.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.2 p -135.57 163.89 29.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.512 1.925 . . . . 0.0 106.288 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -54.39 -45.91 72.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 109.89 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.21 -44.56 92.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.184 1.394 . . . . 0.0 112.049 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -78.61 -31.61 47.11 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.203 -0.311 . . . . 0.0 111.227 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -32.66 -55.07 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.215 1.806 . . . . 0.0 115.048 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -54.67 -62.55 1.58 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.455 -0.778 . . . . 0.0 111.438 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -63.52 -42.48 98.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.969 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.13 -37.85 66.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.505 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.46 -65.21 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.749 0.82 . . . . 0.0 112.382 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.09 -36.2 72.51 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt . . . . . 0 CA--C 1.537 0.464 0 CA-C-O 118.5 -0.762 . . . . 0.0 113.018 179.167 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.283 0 N-CA-C 110.208 -0.293 . . . . 0.0 110.208 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mt -111.36 129.9 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.99 1.316 . . . . 0.0 107.724 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.06 102.46 10.67 Favored 'General case' 0 C--O 1.228 -0.057 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.92 115.69 32.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.521 0.329 . . . . 0.0 110.692 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.45 110.55 22.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.527 1.131 . . . . 0.0 109.073 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -82.14 123.9 29.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -138.07 173.8 11.24 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.421 0.688 . . . . 0.0 111.55 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.96 151.42 38.59 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 125.207 1.403 . . . . 0.0 107.734 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.75 -38.12 66.78 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.777 0.717 . . . . 0.0 112.354 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -80.05 -4.7 53.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.128 0.971 . . . . 0.0 112.911 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.0 t -79.46 82.03 5.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 120.906 -1.121 . . . . 0.0 111.193 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.92 -57.95 4.5 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.429 0.538 . . . . 0.0 112.269 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.21 -32.23 49.41 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.386 2.724 . . . . 0.0 113.481 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.39 -41.01 98.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -63.61 -41.63 98.29 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 92.5 mmm -60.35 -45.06 94.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.535 -0.269 . . . . 0.0 110.981 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.21 -27.66 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.605 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -57.38 1.26 Allowed Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.26 -37.45 95.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.069 1.846 . . . . 0.0 111.66 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mt -62.11 -48.95 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.64 -43.92 76.68 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -60.51 -51.91 67.43 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.113 -0.367 . . . . 0.0 110.732 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -54.45 -50.99 66.38 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.92 -46.95 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.747 0.819 . . . . 0.0 109.937 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -43.44 71.61 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.12 -55.95 12.03 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.378 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.66 -45.45 63.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.285 1.034 . . . . 0.0 112.858 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -98.15 22.38 9.57 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.216 1.007 . . . . 0.0 111.426 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -52.9 131.34 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.514 1.052 . . . . 0.0 110.512 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.13 -20.75 11.87 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.081 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.18 -48.47 4.83 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.735 1.267 . . . . 0.0 109.268 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.59 122.51 39.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.495 1.118 . . . . 0.0 109.156 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.9 m -92.78 101.58 13.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -78.91 139.57 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.97 157.94 44.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.867 0.867 . . . . 0.0 108.918 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.67 147.81 51.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.155 1.782 . . . . 0.0 108.085 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -139.11 125.61 20.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -87.37 109.04 19.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.2 -24.88 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.74 -50.22 74.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.452 1.024 . . . . 0.0 108.847 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -75.53 -26.71 58.29 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.001 0.92 . . . . 0.0 111.185 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -127.47 69.35 75.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.405 0.682 . . . . 0.0 111.939 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.55 -59.57 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.428 2.085 . . . . 0.0 112.94 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.93 -41.0 2.46 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.064 1.792 . . . . 0.0 115.233 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -26.9 66.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.026 -0.69 . . . . 0.0 112.717 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.572 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -71.31 -64.94 1.02 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.083 0.856 . . . . 0.0 110.463 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 88.7 Cg_exo -47.44 -39.07 28.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.283 2.656 . . . . 0.0 112.971 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp . . . . . 0 CA--C 1.535 0.372 0 CA-C-N 118.602 0.637 . . . . 0.0 112.59 177.644 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 CA--C 1.539 0.53 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.12 145.2 75.04 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 120.573 1.24 . . . . 0.0 109.927 -1.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.3 m -139.96 127.58 21.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -110.4 108.18 18.12 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.126 1.37 . . . . 0.0 109.686 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -96.45 118.16 32.38 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -97.0 99.51 11.04 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.426 0.69 . . . . 0.0 109.379 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 . . . . . 0 N--CA 1.452 -0.34 0 C-N-CA 125.734 1.613 . . . . 0.0 109.991 179.783 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 . . . . . 0 CA--C 1.53 0.176 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.12 106.25 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.64 22.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.632 0.773 . . . . 0.0 109.824 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.84 158.51 35.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.249 0.62 . . . . 0.0 109.657 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.451 HG22 ' HG ' ' A' ' 79' ' ' LEU . 80.7 p -131.97 112.17 12.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.869 1.267 . . . . 0.0 108.653 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -98.79 111.51 23.87 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -91.0 130.51 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.24 163.78 34.71 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.084 0.85 . . . . 0.0 111.896 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.62 167.22 22.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 110.246 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.06 166.81 27.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.566 1.146 . . . . 0.0 108.544 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.0 p -83.21 161.71 21.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.022 0.439 . . . . 0.0 110.526 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -52.98 -42.85 65.92 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.524 0.73 . . . . 0.0 110.519 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.79 -54.39 37.94 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -55.36 -46.05 76.48 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.348 -0.501 . . . . 0.0 109.979 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.5 tp -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -53.63 -49.88 66.91 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.607 0.639 . . . . 0.0 111.107 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -57.76 -50.96 71.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.94 -52.6 60.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.506 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.69 -52.11 66.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.037 0.535 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.11 -52.7 60.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.646 0.379 . . . . 0.0 110.292 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.74 -39.5 71.23 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.767 0.827 . . . . 0.0 112.003 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.85 -47.08 19.66 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.218 -0.301 . . . . 0.0 110.554 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -57.98 -47.6 82.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.176 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.4 mttt . . . . . 0 CA--C 1.532 0.257 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.9 mt -87.0 140.06 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.424 0.69 . . . . 0.0 111.215 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -90.97 114.53 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.326 0.65 . . . . 0.0 110.422 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -85.59 102.4 13.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 0.0 109.946 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.96 163.16 14.1 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.035 1.334 . . . . 0.0 113.19 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.0 p -130.74 159.74 36.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.189 2.196 . . . . 0.0 106.228 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.24 -45.6 68.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.35 -47.46 75.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.92 1.288 . . . . 0.0 111.626 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -78.23 -26.07 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -37.24 -51.87 1.04 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 114.092 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.87 -62.95 1.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.574 0.702 . . . . 0.0 111.019 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -57.65 -39.21 76.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.918 0.887 . . . . 0.0 112.32 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -55.58 4.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.91 -53.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.235 1.014 . . . . 0.0 112.959 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.01 -37.74 86.02 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.991 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.109 174.934 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.293 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.87 125.33 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.543 1.137 . . . . 0.0 108.219 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 tp -102.31 101.91 12.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.4 t -86.57 118.62 33.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -97.73 116.5 30.07 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.575 0.75 . . . . 0.0 109.053 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -90.81 121.35 32.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -135.39 178.65 6.87 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.936 0.895 . . . . 0.0 111.584 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.72 150.6 33.44 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 125.413 1.485 . . . . 0.0 108.327 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -55.75 -37.27 68.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.891 0.876 . . . . 0.0 112.386 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -83.33 -5.43 59.14 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.139 0.976 . . . . 0.0 112.54 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.59 81.69 5.81 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 120.958 -1.089 . . . . 0.0 111.684 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.81 -57.49 3.41 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.811 0.72 . . . . 0.0 112.362 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -52.59 -36.96 73.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.999 2.466 . . . . 0.0 113.31 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.0 m -64.01 -47.75 79.05 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -57.85 -43.22 85.75 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.2 mtm -61.0 -44.89 96.76 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.598 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -74.67 -27.51 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.359 0.981 . . . . 0.0 112.507 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.43 -58.16 1.03 Allowed Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.99 -37.42 96.14 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.495 2.13 . . . . 0.0 112.324 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.8 mt -62.4 -51.13 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.4 mt -55.09 -42.05 72.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.17 0.188 . . . . 0.0 110.598 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.67 -51.74 68.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 109.727 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.22 -44.75 84.01 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.866 -0.521 . . . . 0.0 110.274 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.4 mm -58.33 -46.78 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.548 0.739 . . . . 0.0 109.287 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -45.46 66.9 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.79 -59.12 5.31 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -48.81 -48.04 41.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -94.02 15.09 17.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.243 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.47 1.032 . . . . 0.0 111.491 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.25 -28.47 2.58 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.819 1.199 . . . . 0.0 110.242 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -99.47 -38.2 8.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.28 1.032 . . . . 0.0 109.987 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 tp -135.11 141.32 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.8 m -108.03 104.82 14.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -79.11 137.74 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.7 156.17 48.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.863 0.865 . . . . 0.0 108.786 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -132.64 146.21 51.7 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.476 1.51 . . . . 0.0 109.908 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.42 126.17 19.29 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.421 0.688 . . . . 0.0 109.394 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -87.17 109.31 19.37 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.88 -24.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.99 0.516 . . . . 0.0 111.719 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.51 -46.39 90.29 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.261 0.937 . . . . 0.0 108.898 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -77.66 -35.72 52.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -121.79 69.15 25.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.28 1.032 . . . . 0.0 111.139 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.32 -56.33 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.473 2.115 . . . . 0.0 112.787 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.62 -45.6 1.02 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.092 1.806 . . . . 0.0 114.597 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -37.23 31.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.307 1.043 . . . . 0.0 113.078 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.04 -66.44 1.49 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.396 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.63 -36.84 91.21 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.72 1.613 . . . . 0.0 111.22 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt . . . . . 0 C--N 1.345 0.373 0 CA-C-N 119.349 0.977 . . . . 0.0 110.71 177.303 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 pt . . . . . 0 CA--C 1.538 0.492 0 CA-C-O 118.617 -0.706 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.67 142.0 65.22 Favored 'Cis proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.219 1.114 . . . . 0.0 110.562 -0.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 144.46 47.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.0 mt -128.64 101.46 6.16 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 mp -104.97 120.71 42.12 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -95.47 105.01 16.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.842 0.857 . . . . 0.0 109.495 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 . . . . . 0 N--CA 1.453 -0.287 0 C-N-CA 125.835 1.654 . . . . 0.0 110.057 179.709 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 . . . . . 0 N--CA 1.452 -0.362 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.49 102.79 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.68 -43.28 23.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.047 0.939 . . . . 0.0 110.956 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.57 154.36 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.142 0.577 . . . . 0.0 109.524 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.8 p -136.75 116.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.473 1.109 . . . . 0.0 109.453 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -108.46 136.26 48.38 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.62 128.16 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.57 168.15 35.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.789 0.709 . . . . 0.0 111.394 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.39 168.05 20.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.198 0.599 . . . . 0.0 110.552 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -162.24 164.07 27.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 107.779 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.67 161.26 30.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -56.72 -43.67 80.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.1 -58.33 14.23 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -53.13 -45.93 68.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 110.945 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.75 -51.38 70.0 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.388 -0.195 . . . . 0.0 110.73 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -56.64 -47.66 79.24 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.132 0.424 . . . . 0.0 110.688 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.73 -52.37 65.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.661 0.784 . . . . 0.0 109.757 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -54.87 -55.4 30.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.997 0.919 . . . . 0.0 110.319 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -57.3 -48.61 78.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.136 -0.352 . . . . 0.0 110.792 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.57 -51.48 68.43 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.577 0.351 . . . . 0.0 110.243 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.26 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.975 0.91 . . . . 0.0 111.972 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -78.17 -50.06 12.66 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 117.847 0.294 . . . . 0.0 110.367 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.9 mt -63.38 -42.97 98.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.444 . . . . 0.0 110.514 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.136 0 C-N-CA 124.703 1.201 . . . . 0.0 111.703 179.359 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt . . . . . 0 N--CA 1.454 -0.234 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.1 mt -108.17 137.42 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.922 1.289 . . . . 0.0 108.809 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 mt -85.73 146.92 5.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -117.29 99.38 6.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.81 164.36 14.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.476 1.111 . . . . 0.0 113.306 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.1 p -134.98 162.69 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.228 1.811 . . . . 0.0 106.417 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.64 -44.59 77.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.403 0.547 . . . . 0.0 109.615 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.53 -44.71 89.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.976 1.31 . . . . 0.0 111.893 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.58 -32.71 47.82 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.159 -0.338 . . . . 0.0 111.222 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -32.15 -53.32 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.028 2.131 . . . . 0.0 115.315 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.99 -61.61 2.19 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 110.983 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -43.54 98.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.736 0.815 . . . . 0.0 112.307 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -31.07 53.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.261 -0.876 . . . . 0.0 113.273 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.35 -61.63 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.975 0.91 . . . . 0.0 111.382 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.22 -36.13 74.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.22 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.152 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.29 127.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.926 1.29 . . . . 0.0 108.714 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.39 103.0 12.36 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.8 t -90.49 118.48 35.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.46 108.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.913 1.285 . . . . 0.0 108.442 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.72 121.81 25.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -137.54 179.48 6.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.919 0.887 . . . . 0.0 111.696 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.6 30.22 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.325 1.45 . . . . 0.0 109.55 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -51.74 -37.12 49.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.84 0.745 . . . . 0.0 112.203 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -85.63 -4.56 59.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.053 0.941 . . . . 0.0 113.03 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -79.42 79.86 5.83 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.934 -1.104 . . . . 0.0 111.111 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.28 -59.91 2.1 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 123.904 0.764 . . . . 0.0 112.693 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.87 -29.07 51.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.402 2.735 . . . . 0.0 113.937 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.75 -42.47 99.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.408 -0.807 . . . . 0.0 109.227 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -66.12 -35.58 80.88 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.8 mtt -62.27 -44.64 96.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.26 -25.54 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 118.772 -0.632 . . . . 0.0 112.435 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.31 -57.88 1.31 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.03 -38.17 96.58 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.812 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mt -60.84 -50.32 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -55.71 -43.95 76.99 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.808 0.443 . . . . 0.0 110.303 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.92 -51.58 68.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.477 0.656 . . . . 0.0 110.354 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -54.73 -48.72 72.18 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.68 -47.61 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 122.827 0.451 . . . . 0.0 109.824 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.71 -44.94 66.66 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.4 0.545 . . . . 0.0 110.495 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -68.13 -57.77 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.755 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -52.19 -43.06 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 113.515 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.07 16.85 19.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.244 1.018 . . . . 0.0 111.674 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.26 134.33 33.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.353 0.979 . . . . 0.0 110.25 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -25.5 6.7 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.705 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -98.84 -41.1 7.79 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.782 1.291 . . . . 0.0 109.689 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -131.19 140.03 49.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.541 1.137 . . . . 0.0 109.743 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -109.56 106.1 15.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.87 135.66 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.67 156.75 47.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.739 0.816 . . . . 0.0 109.115 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.897 1.679 . . . . 0.0 107.403 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.6 123.83 19.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -86.79 108.48 18.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.22 -25.81 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 111.933 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -62.41 -45.86 91.22 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.584 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.8 70.12 72.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.26 -56.22 2.94 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.425 2.083 . . . . 0.0 112.857 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.98 -40.85 2.44 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.059 1.79 . . . . 0.0 115.625 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 -22.01 66.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.836 0.818 . . . . 0.0 112.98 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -74.6 -61.98 1.03 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.452 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 87.8 Cg_exo -48.42 -39.85 36.2 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.132 2.555 . . . . 0.0 112.274 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp . . . . . 0 C--N 1.344 0.336 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.345 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 pt . . . . . 0 CA--C 1.539 0.547 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.03 141.11 54.59 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 121.027 1.403 . . . . 0.0 109.99 -0.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.6 m -139.45 121.86 16.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 mt -100.75 127.62 47.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.393 1.477 . . . . 0.0 108.943 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.2 119.36 34.46 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.31 102.87 14.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 . . . . . 0 N--CA 1.454 -0.265 0 C-N-CA 125.685 1.594 . . . . 0.0 110.018 179.953 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 . . . . . 0 N--CA 1.455 -0.177 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.68 107.26 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.58 -44.14 21.64 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.366 0.667 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.36 167.84 25.0 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.7 p -142.65 165.99 25.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -150.67 120.59 7.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.83 131.64 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.22 164.86 36.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.947 0.784 . . . . 0.0 111.598 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.96 167.11 22.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.157 0.583 . . . . 0.0 110.256 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -161.38 162.85 30.86 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.911 1.284 . . . . 0.0 108.254 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.8 p -73.95 164.14 27.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.363 0.601 . . . . 0.0 111.487 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -53.29 -49.28 67.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.17 -55.21 30.55 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.69 -47.61 73.44 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 117.542 0.671 . . . . 0.0 110.671 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 tp -59.8 -49.58 77.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -53.29 -50.85 64.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.64 0.376 . . . . 0.0 110.875 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -60.14 -50.19 74.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.798 0.439 . . . . 0.0 110.47 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.37 -54.25 39.37 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.141 0.576 . . . . 0.0 109.946 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.6 mt -59.18 -49.91 76.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.269 -0.269 . . . . 0.0 110.884 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.86 -53.51 54.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 117.784 0.266 . . . . 0.0 110.306 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.98 74.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.234 1.014 . . . . 0.0 111.916 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -77.74 -42.53 33.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.258 -0.276 . . . . 0.0 110.727 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.13 -44.87 94.38 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.559 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mttm . . . . . 0 CA--C 1.536 0.419 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.37 132.21 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.16 123.87 48.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 123.502 0.721 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -90.67 108.51 19.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.143 0.977 . . . . 0.0 109.469 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.6 mt -94.04 166.36 12.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.072 0.949 . . . . 0.0 112.943 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -132.5 162.24 31.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.14 -47.65 74.81 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.65 -47.62 83.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.095 1.358 . . . . 0.0 111.534 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -78.45 -25.25 45.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -35.9 -51.27 0.7 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.443 1.897 . . . . 0.0 114.91 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.53 -62.32 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.93 0.787 . . . . 0.0 110.739 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -60.36 -42.36 95.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.529 0.731 . . . . 0.0 111.643 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.59 -41.41 69.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.3 t -107.98 -63.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.487 1.115 . . . . 0.0 113.133 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.11 -37.28 74.25 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt . . . . . 0 CA--C 1.538 0.481 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.062 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.159 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.31 124.48 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 108.643 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 tp -105.39 99.48 9.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -89.37 114.66 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -89.56 105.57 17.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.52 119.96 23.23 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -134.33 -177.94 4.82 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.563 1.145 . . . . 0.0 111.2 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.59 35.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.737 1.215 . . . . 0.0 109.306 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -54.88 -28.53 51.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.519 1.128 . . . . 0.0 112.758 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -94.96 -4.63 46.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 112.387 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.1 t -79.99 83.7 5.85 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.007 -1.058 . . . . 0.0 111.583 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.7 -61.38 3.37 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.24 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.38 -36.71 31.14 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.7 2.933 . . . . 0.0 113.779 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.5 -37.99 85.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -70.27 -46.5 64.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -40.91 60.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 119.184 -0.436 . . . . 0.0 111.461 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -81.82 -10.88 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.5 -51.45 69.25 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 119.995 1.27 . . . . 0.0 113.295 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.73 -41.7 72.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.314 2.01 . . . . 0.0 111.537 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.11 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -54.31 -44.61 72.14 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -60.13 -57.27 13.54 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.007 0.523 . . . . 0.0 111.321 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -60.0 -40.81 90.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.627 -0.671 . . . . 0.0 110.719 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.81 -46.5 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.92 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.725 0.41 . . . . 0.0 110.259 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.09 -54.7 25.96 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -51.16 -46.71 62.12 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.391 1.076 . . . . 0.0 112.593 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -96.07 18.84 12.66 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.642 0.777 . . . . 0.0 111.903 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -50.67 137.02 20.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.335 0.971 . . . . 0.0 111.334 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 -26.23 5.11 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.554 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -99.1 -51.27 3.88 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.772 1.286 . . . . 0.0 109.189 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.39 132.09 56.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.663 1.185 . . . . 0.0 108.995 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -106.65 102.47 11.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.34 160.8 39.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -136.04 147.46 47.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.949 1.3 . . . . 0.0 108.351 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -140.76 125.6 18.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -87.97 108.58 19.27 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.88 -25.71 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.711 0.804 . . . . 0.0 112.178 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.41 -46.48 89.95 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.105 0.866 . . . . 0.0 108.976 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.98 -35.44 57.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.344 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -120.92 68.82 16.82 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.126 0.97 . . . . 0.0 111.313 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.59 -51.97 2.17 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.381 2.054 . . . . 0.0 112.335 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.0 -38.08 4.53 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.873 1.225 . . . . 0.0 114.305 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -31.8 71.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.954 -0.733 . . . . 0.0 112.341 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.86 -65.26 2.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.434 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 83.3 Cg_exo -49.52 -45.76 29.63 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.558 2.172 . . . . 0.0 112.438 174.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp . . . . . 0 C--N 1.344 0.362 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.433 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.6 pt . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.22 147.44 87.55 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.834 0.976 . . . . 0.0 110.435 -0.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 m -133.19 122.79 24.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.85 100.05 10.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.99 113.37 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -93.28 97.55 10.69 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.631 0.772 . . . . 0.0 109.646 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 N--CA 1.451 -0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 108.895 178.288 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 . . . . . 0 CA--C 1.53 0.182 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 106.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.52 -43.18 23.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.611 0.764 . . . . 0.0 109.887 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.99 156.51 31.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.706 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.9 p -127.8 99.93 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.226 1.41 . . . . 0.0 108.389 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.07 105.53 16.56 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.33 132.7 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.83 164.89 40.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.163 0.887 . . . . 0.0 112.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.4 171.14 13.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.143 0.577 . . . . 0.0 110.235 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.33 168.07 17.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.474 1.51 . . . . 0.0 107.774 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -77.94 164.57 24.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.918 0.389 . . . . 0.0 110.467 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.45 -46.85 80.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.54 -56.34 24.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.44 -39.73 80.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.617 0.708 . . . . 0.0 110.514 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.06 -48.61 80.94 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.147 0.431 . . . . 0.0 110.127 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -56.17 -47.96 77.26 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.595 0.634 . . . . 0.0 110.665 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -57.19 -52.01 67.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.649 0.379 . . . . 0.0 110.153 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -53.66 -53.26 54.43 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 110.154 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -56.6 -52.39 65.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.761 0.424 . . . . 0.0 110.303 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.19 -52.07 62.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.916 0.325 . . . . 0.0 110.615 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.7 75.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.871 0.868 . . . . 0.0 112.287 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -78.45 -46.05 20.68 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 117.899 0.318 . . . . 0.0 110.872 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -61.23 -47.28 86.81 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.407 0.683 . . . . 0.0 109.744 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 124.606 1.162 . . . . 0.0 111.492 179.391 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? . . . . . 0 CA--C 1.533 0.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.56 142.36 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.385 0.674 . . . . 0.0 110.874 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -91.86 116.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-O 121.473 0.654 . . . . 0.0 110.875 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.23 101.87 11.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.524 1.129 . . . . 0.0 108.921 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.1 164.71 20.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 112.933 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.5 p -132.49 160.65 35.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 170.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -55.71 -44.24 77.27 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.742 0.701 . . . . 0.0 109.475 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.21 -47.98 83.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.848 1.259 . . . . 0.0 111.549 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.8 p -78.64 -21.79 47.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.007 -0.433 . . . . 0.0 112.105 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.95 -51.89 1.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.161 1.784 . . . . 0.0 113.729 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -51.65 -61.51 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.468 0.652 . . . . 0.0 110.681 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -60.92 -46.86 88.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.716 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -69.88 -32.21 70.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.7 -64.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.267 1.027 . . . . 0.0 111.833 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.3 -37.45 77.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.46 -0.15 . . . . 0.0 111.358 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 mttm . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.967 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.75 138.26 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 C-N-CA 125.577 1.551 . . . . 0.0 108.622 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.2 tp -118.08 102.47 9.05 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -94.5 106.41 18.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.879 1.272 . . . . 0.0 107.923 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.22 123.94 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -138.09 177.62 7.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.606 0.762 . . . . 0.0 112.061 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.64 151.15 35.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.807 1.643 . . . . 0.0 108.126 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -54.69 -36.93 65.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.309 0.644 . . . . 0.0 111.897 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -85.12 -2.47 58.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.524 1.13 . . . . 0.0 112.745 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.2 t -79.58 80.3 5.97 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.9 -1.125 . . . . 0.0 111.411 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.61 -57.86 3.73 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 123.785 0.707 . . . . 0.0 112.001 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -53.1 -34.46 68.4 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.097 2.531 . . . . 0.0 113.484 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -64.01 -46.55 83.99 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -61.41 -41.86 97.81 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -57.43 -43.76 84.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.198 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -78.76 -26.25 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.822 0.737 . . . . 0.0 112.81 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.2 -55.09 3.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.37 -43.17 39.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.948 2.432 . . . . 0.0 112.904 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.8 -49.82 82.7 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 mt -55.74 -44.06 77.19 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -58.63 -57.68 11.89 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.524 0.73 . . . . 0.0 110.377 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -59.74 -43.08 94.38 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.773 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 mm -54.59 -44.66 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.912 0.485 . . . . 0.0 109.996 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -35.17 65.73 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.074 0.397 . . . . 0.0 111.126 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -76.48 -52.44 9.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.0 -45.12 64.42 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.953 0.901 . . . . 0.0 111.682 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -98.06 24.72 6.75 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.266 1.027 . . . . 0.0 111.522 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -54.04 129.73 35.4 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.462 1.028 . . . . 0.0 110.421 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.77 -17.47 15.6 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.305 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -99.38 -44.79 6.07 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.692 1.246 . . . . 0.0 109.56 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.4 tp -127.22 128.53 46.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.166 0.986 . . . . 0.0 109.724 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -94.94 96.03 9.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.21 136.1 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.67 150.31 49.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.17 0.988 . . . . 0.0 109.524 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -124.61 138.65 54.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.508 1.523 . . . . 0.0 107.38 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -131.06 120.4 23.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.49 110.77 18.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.9 -36.72 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.42 -46.63 89.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.0 0.818 . . . . 0.0 109.688 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.33 -30.05 65.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.244 1.017 . . . . 0.0 110.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -127.92 72.4 78.88 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.857 0.863 . . . . 0.0 111.341 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -52.79 -59.04 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.896 2.397 . . . . 0.0 113.192 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.68 -47.32 2.29 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.765 1.65 . . . . 0.0 115.171 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -28.63 68.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -65.03 -67.68 0.98 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.302 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 89.0 Cg_exo -49.22 -45.11 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.194 1.929 . . . . 0.0 112.558 175.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt . . . . . 0 C--N 1.345 0.379 0 CA-C-N 118.359 0.527 . . . . 0.0 112.2 179.042 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt . . . . . 0 CA--C 1.539 0.54 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.36 145.15 75.42 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 120.575 1.241 . . . . 0.0 109.624 -1.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.9 m -139.38 127.87 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.02 113.03 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.302 1.441 . . . . 0.0 109.233 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -105.87 120.18 41.09 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.66 103.83 15.82 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 . . . . . 0 N--CA 1.452 -0.332 0 C-N-CA 126.352 1.861 . . . . 0.0 109.538 -179.757 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 CA--C 1.53 0.197 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.41 105.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.73 -45.26 19.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.733 0.813 . . . . 0.0 109.949 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.66 158.56 35.67 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.525 HG22 ' HG ' ' A' ' 79' ' ' LEU . 53.3 p -134.26 124.99 26.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.531 1.133 . . . . 0.0 108.756 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -113.77 117.88 32.74 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -95.37 129.72 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.18 164.71 35.04 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.007 0.813 . . . . 0.0 111.554 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 164.51 25.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.948 0.499 . . . . 0.0 110.116 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.86 161.51 39.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.296 1.038 . . . . 0.0 108.81 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.4 p -72.84 162.26 29.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.316 0.579 . . . . 0.0 110.589 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -56.73 -40.12 75.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.6 -54.69 35.61 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -56.77 -43.53 80.9 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.201 0.501 . . . . 0.0 110.299 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.22 -53.63 56.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -53.82 -48.15 70.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.469 0.577 . . . . 0.0 110.731 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.76 -53.16 58.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.187 0.595 . . . . 0.0 110.04 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -55.17 -52.31 63.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.598 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -57.0 -54.01 51.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.847 0.459 . . . . 0.0 110.221 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.58 -50.55 67.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.923 0.489 . . . . 0.0 110.653 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.17 76.94 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.197 0.599 . . . . 0.0 111.691 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -77.96 -49.38 14.23 Favored 'General case' 0 N--CA 1.46 0.074 0 O-C-N 122.19 -0.319 . . . . 0.0 111.048 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.4 mt -60.07 -46.03 90.93 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.214 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 177.941 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.4 mttm . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.6 mt -86.44 136.11 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.898 0.479 . . . . 0.0 111.111 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -91.93 116.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.388 0.675 . . . . 0.0 110.6 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -86.29 99.95 11.94 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.291 1.037 . . . . 0.0 109.204 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.24 166.1 16.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.139 0.976 . . . . 0.0 112.24 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p -131.09 163.37 27.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -53.97 -49.78 68.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.92 -46.19 90.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.03 1.332 . . . . 0.0 111.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.9 p -78.46 -24.75 45.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -34.57 -61.3 0.4 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 126.034 1.734 . . . . 0.0 114.052 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.68 -59.32 4.75 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.714 -0.616 . . . . 0.0 110.916 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.36 -38.15 71.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.424 0.69 . . . . 0.0 112.698 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -81.86 -57.93 3.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.405 0.622 . . . . 0.0 112.086 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.39 -55.29 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.18 1.792 . . . . 0.0 113.075 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.13 -28.67 69.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.581 -0.699 . . . . 0.0 111.898 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 CA--C 1.54 0.582 0 O-C-N 122.079 -0.388 . . . . 0.0 111.468 174.824 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.196 0 CA-C-O 119.325 -0.369 . . . . 0.0 110.106 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.9 127.99 69.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.297 1.039 . . . . 0.0 108.931 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.32 101.86 11.31 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -89.86 112.14 24.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 118.099 0.409 . . . . 0.0 110.718 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.23 106.22 18.27 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.223 1.009 . . . . 0.0 108.659 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -79.69 121.56 25.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -139.24 -178.41 5.35 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.493 0.717 . . . . 0.0 111.169 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.8 151.86 34.24 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 108.495 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -53.69 -39.5 65.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.074 0.95 . . . . 0.0 111.876 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -82.23 -6.23 59.07 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.078 0.951 . . . . 0.0 112.573 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.3 t -79.43 80.61 5.78 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.059 -1.026 . . . . 0.0 111.115 -177.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.45 -58.48 2.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.29 0.948 . . . . 0.0 112.149 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.48 -38.66 89.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.331 2.687 . . . . 0.0 113.18 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -62.6 -47.58 83.18 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.83 -44.46 96.79 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.6 ttm -52.04 -41.56 62.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.919 0.888 . . . . 0.0 111.315 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -83.49 -8.71 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.57 -50.79 74.96 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.058 1.299 . . . . 0.0 113.032 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.68 -41.83 70.95 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.445 2.097 . . . . 0.0 111.516 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.96 -51.15 76.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -54.85 -43.85 73.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.112 0.414 . . . . 0.0 110.78 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.01 -53.15 60.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.272 0.558 . . . . 0.0 109.872 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.49 -47.04 73.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.895 0.478 . . . . 0.0 110.083 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.9 mm -59.12 -47.19 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.157 0.983 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.36 -42.43 66.82 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.753 0.421 . . . . 0.0 109.875 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.38 -56.64 8.86 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -50.67 -45.23 57.95 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.738 0.815 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -97.33 21.36 10.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.91 128.71 31.27 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.408 1.004 . . . . 0.0 110.109 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.55 -19.55 23.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.224 -0.765 . . . . 0.0 113.058 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -99.14 -44.29 6.33 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.658 1.229 . . . . 0.0 109.381 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -132.71 133.97 44.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.369 1.068 . . . . 0.0 108.796 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.4 m -101.44 105.74 16.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.04 139.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.99 154.89 50.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.897 0.879 . . . . 0.0 109.074 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.95 147.56 52.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.719 1.207 . . . . 0.0 108.433 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 tt -138.89 120.32 14.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -85.29 107.51 17.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.29 -24.19 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.651 0.781 . . . . 0.0 112.116 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -61.77 -46.56 89.06 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.122 0.874 . . . . 0.0 108.885 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -76.05 -35.44 59.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.277 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.42 70.13 11.87 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.377 1.071 . . . . 0.0 111.073 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.12 -54.36 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.385 2.057 . . . . 0.0 112.418 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.12 -41.42 3.75 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.941 1.258 . . . . 0.0 114.594 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.23 71.12 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.016 -0.696 . . . . 0.0 112.32 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.02 -66.81 1.33 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.641 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 81.0 Cg_exo -49.31 -48.49 18.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.166 1.911 . . . . 0.0 112.173 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp . . . . . 0 C--N 1.344 0.355 0 CA-C-N 118.079 0.399 . . . . 0.0 111.845 -179.736 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt . . . . . 0 CA--C 1.538 0.489 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.7 144.51 76.71 Favored 'Cis proline' 0 N--CA 1.456 -0.719 0 CA-C-N 120.543 1.23 . . . . 0.0 110.053 -0.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.5 m -136.81 123.4 20.97 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -107.21 104.27 13.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 109.704 -173.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.512 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.1 mp -94.09 115.77 28.12 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.5 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 . . . . . 0 N--CA 1.452 -0.362 0 C-N-CA 124.956 1.302 . . . . 0.0 109.306 178.504 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 . . . . . 0 CA--C 1.53 0.199 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.92 107.13 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.67 -43.96 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.62 0.768 . . . . 0.0 110.046 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.53 156.28 34.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.078 0.551 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.512 HG22 ' HG ' ' A' ' 79' ' ' LEU . 73.7 p -129.26 110.81 12.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.856 1.262 . . . . 0.0 109.348 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -98.49 110.46 23.05 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -91.29 129.68 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.34 163.9 34.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.191 0.901 . . . . 0.0 112.177 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 167.77 20.18 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 110.129 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.81 169.55 21.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.332 1.053 . . . . 0.0 109.258 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.6 p -77.54 160.16 28.8 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.782 0.433 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.11 -45.52 75.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.98 -54.05 38.04 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.02 -39.19 88.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.923 0.862 . . . . 0.0 111.148 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.98 -52.36 65.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -55.33 -45.51 76.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.898 -0.501 . . . . 0.0 111.283 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.48 -55.35 34.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 109.885 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -53.4 -51.88 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.041 0.936 . . . . 0.0 110.727 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.64 -51.73 68.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.811 0.444 . . . . 0.0 110.238 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -54.42 -51.68 64.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.807 0.443 . . . . 0.0 110.214 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.48 70.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.503 0.721 . . . . 0.0 111.843 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -78.06 -40.32 38.98 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.121 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.2 mt -62.01 -47.45 84.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.262 0 C-N-CA 123.17 0.588 . . . . 0.0 109.734 177.592 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -95.56 142.76 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.895 0.878 . . . . 0.0 110.611 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.97 115.35 29.97 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-O 121.572 0.701 . . . . 0.0 111.456 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -84.56 95.77 8.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.777 1.231 . . . . 0.0 109.408 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.44 163.24 16.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.072 0.949 . . . . 0.0 113.121 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.1 p -128.17 160.67 31.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.547 1.939 . . . . 0.0 107.701 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.1 -51.55 57.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.037 0.935 . . . . 0.0 109.197 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.23 -45.15 72.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.343 1.457 . . . . 0.0 111.836 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.61 -26.69 45.4 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -34.03 -69.43 0.09 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.608 1.563 . . . . 0.0 114.968 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.74 -59.75 3.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.58 0.752 . . . . 0.0 110.295 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -51.58 -42.53 61.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.96 1.304 . . . . 0.0 113.377 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.28 -53.15 5.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.747 0.419 . . . . 0.0 111.538 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -79.66 -58.78 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.791 1.236 . . . . 0.0 113.204 -173.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.34 -32.8 73.63 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.055 -0.403 . . . . 0.0 111.579 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp . . . . . 0 CA--C 1.538 0.498 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.727 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.7 mt -113.08 134.19 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.05 101.78 9.32 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.57 114.93 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.84 107.35 19.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.847 1.259 . . . . 0.0 108.294 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -79.8 126.11 30.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -136.12 178.26 7.19 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.654 0.781 . . . . 0.0 111.734 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.8 37.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.556 1.542 . . . . 0.0 108.245 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -53.15 -35.82 60.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.998 0.919 . . . . 0.0 112.121 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -89.2 -2.37 58.47 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.999 1.319 . . . . 0.0 112.79 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.4 t -79.52 78.04 6.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.948 -1.095 . . . . 0.0 111.711 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.88 -57.78 3.36 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.659 0.647 . . . . 0.0 112.341 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -52.51 -35.7 67.47 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.227 2.618 . . . . 0.0 113.241 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.39 -45.48 92.97 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -60.76 -42.74 98.06 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 93.5 mmm -59.02 -45.84 89.68 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.164 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -76.6 -26.23 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.612 0.642 . . . . 0.0 112.592 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.57 -57.69 0.91 Allowed Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.36 -40.09 87.45 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.298 1.998 . . . . 0.0 111.835 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.2 -49.14 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 mt -56.27 -42.85 78.14 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.88 -47.5 86.09 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.12 -48.47 80.11 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.833 -0.542 . . . . 0.0 109.73 177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.8 mm -55.66 -46.79 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.976 0.51 . . . . 0.0 109.9 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.06 -35.97 62.6 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.238 0.615 . . . . 0.0 110.768 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.4 -59.15 2.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -49.63 -44.19 47.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.53 1.132 . . . . 0.0 113.174 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -102.21 20.75 16.16 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.108 0.963 . . . . 0.0 111.502 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.41 125.71 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.386 0.994 . . . . 0.0 109.496 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.42 -20.09 39.81 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.58 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -99.2 -46.69 5.46 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.492 1.146 . . . . 0.0 109.362 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -127.11 124.17 38.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.715 1.206 . . . . 0.0 108.553 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.7 m -92.45 101.02 13.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -78.82 139.97 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.75 154.76 50.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.438 1.095 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -130.28 145.99 51.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.043 1.737 . . . . 0.0 107.35 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -143.94 126.79 16.27 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -86.7 106.72 17.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 109.256 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.15 -24.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.996 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -62.23 -44.41 96.62 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.419 1.009 . . . . 0.0 108.903 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -78.68 -34.47 46.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.425 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -123.4 66.37 33.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.678 1.191 . . . . 0.0 111.922 -173.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.15 -52.06 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.686 2.257 . . . . 0.0 112.94 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.07 -41.74 1.44 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.82 1.676 . . . . 0.0 114.268 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -37.21 54.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.195 0.998 . . . . 0.0 113.239 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.43 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.768 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 99.8 Cg_exo -44.9 -48.1 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.795 2.33 . . . . 0.0 113.131 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt . . . . . 0 C--N 1.346 0.442 0 CA-C-N 118.912 0.778 . . . . 0.0 112.572 -179.546 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.8 pt . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.4 141.94 71.51 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.936 1.013 . . . . 0.0 109.582 -2.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -139.32 130.38 26.5 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.45 103.64 12.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.047 1.339 . . . . 0.0 109.35 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.497 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.6 mp -91.83 115.53 28.14 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.57 12.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 N--CA 1.448 -0.536 0 C-N-CA 125.468 1.507 . . . . 0.0 108.205 178.415 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 . . . . . 0 CA--C 1.53 0.196 0 N-CA-C 110.7 -0.111 . . . . 0.0 110.7 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.77 105.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.92 -43.61 21.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.171 0.588 . . . . 0.0 110.462 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.11 154.35 32.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.087 0.555 . . . . 0.0 109.681 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.497 HG22 ' HG ' ' A' ' 79' ' ' LEU . 32.7 p -128.19 99.12 5.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.787 1.235 . . . . 0.0 107.776 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -86.0 110.12 19.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 130.18 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.53 163.39 38.43 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.83 0.729 . . . . 0.0 112.382 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 168.95 17.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.271 0.629 . . . . 0.0 110.309 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -163.64 164.22 24.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.088 1.355 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.1 p -72.32 161.95 30.13 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.37 -43.27 79.04 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.86 22.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -53.54 -44.86 69.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.269 0.534 . . . . 0.0 110.572 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.3 tp -58.74 -52.51 65.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -56.09 -46.77 78.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.571 0.623 . . . . 0.0 110.799 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.27 -52.89 62.83 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.501 0.32 . . . . 0.0 110.256 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -54.36 -53.19 57.34 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.859 0.864 . . . . 0.0 110.476 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.5 mt -56.69 -52.95 62.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.877 0.471 . . . . 0.0 110.29 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.35 -51.84 61.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.718 0.407 . . . . 0.0 110.318 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.38 74.75 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.313 0.645 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.02 -38.25 45.16 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.147 -0.346 . . . . 0.0 110.797 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -62.56 -48.54 79.05 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 123.156 0.582 . . . . 0.0 109.643 177.401 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.5 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -158.57 -137.21 0.05 OUTLIER 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.414 1.086 . . . . 0.0 108.877 178.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 62.1 mttp -95.27 53.75 1.55 Allowed 'General case' 0 C--O 1.232 0.152 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.5 mm -114.6 109.79 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 C-N-CA 128.004 2.522 . . . . 0.0 108.983 -172.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.2 mm -88.55 119.47 35.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 CA-C-O 121.916 0.865 . . . . 0.0 111.225 179.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -84.95 75.26 10.4 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -62.79 162.59 10.68 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.649 1.18 . . . . 0.0 112.667 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 69.1 p -131.88 162.77 29.83 Favored 'General case' 0 N--CA 1.446 -0.647 0 N-CA-C 106.842 -1.54 . . . . 0.0 106.842 173.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -52.96 -44.03 66.81 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 121.089 0.471 . . . . 0.0 110.025 178.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -61.31 -45.17 95.57 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.041 1.337 . . . . 0.0 112.057 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.44 -27.95 46.56 Favored 'General case' 0 CA--C 1.529 0.141 0 O-C-N 122.172 -0.33 . . . . 0.0 111.356 -177.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -36.22 -51.74 0.78 Allowed 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.653 1.581 . . . . 0.0 114.031 -179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -56.54 -64.86 0.73 Allowed 'General case' 0 CA--C 1.533 0.297 0 CA-C-O 121.651 0.738 . . . . 0.0 111.275 -178.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -60.38 -37.93 82.29 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.263 -176.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -79.83 -55.54 4.91 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 122.305 -0.247 . . . . 0.0 111.537 -177.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -87.26 -57.38 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 C-N-CA 123.76 0.824 . . . . 0.0 112.518 -174.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 70.6 mt -61.04 -36.75 80.41 Favored 'General case' 0 N--CA 1.46 0.074 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.384 -175.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -102.02 29.64 4.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 122.463 0.305 . . . . 0.0 111.19 175.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.56 121.71 9.68 Favored 'General case' 0 C--N 1.341 0.233 0 CA-C-N 118.778 0.717 . . . . 0.0 112.057 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.2 p-10 -80.27 53.36 1.76 Allowed 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.453 0.701 . . . . 0.0 109.236 175.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 154.06 -149.8 21.29 Favored Glycine 0 CA--C 1.529 0.921 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -107.63 122.63 47.09 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.264 1.026 . . . . 0.0 108.489 179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 7.0 mt -117.62 119.0 60.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.511 1.124 . . . . 0.0 108.734 -178.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 14.9 tp -93.0 102.98 15.33 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 176.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 32.1 t -87.29 113.84 25.37 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -93.54 117.68 30.39 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -90.36 121.68 32.56 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 106.229 -1.767 . . . . 0.0 106.229 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 19.1 p-90 -134.01 179.49 6.22 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.639 1.176 . . . . 0.0 110.752 -177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.35 154.4 39.91 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.459 1.104 . . . . 0.0 108.907 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -53.12 -36.29 60.62 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.129 0.972 . . . . 0.0 111.53 179.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -86.8 -4.68 59.2 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.857 1.263 . . . . 0.0 112.872 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.8 t -79.99 80.22 6.42 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 120.92 -1.113 . . . . 0.0 112.656 -176.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.51 -58.51 4.0 Favored Glycine 0 CA--C 1.541 1.667 0 C-N-CA 123.456 0.551 . . . . 0.0 112.344 176.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_exo -52.23 -37.01 69.54 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 123.219 2.613 . . . . 0.0 113.634 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 86.4 m -61.31 -44.21 97.6 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 52.9 mttm -63.99 -47.64 79.57 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 66.8 mtm -53.48 -39.52 64.58 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 118.852 -0.594 . . . . 0.0 112.166 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.2 pt -82.64 -13.21 12.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 119.227 0.921 . . . . 0.0 112.818 177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.34 -50.86 54.75 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 119.846 1.203 . . . . 0.0 113.405 -178.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -52.57 -44.52 46.8 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.357 2.038 . . . . 0.0 111.631 176.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.43 -51.24 75.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.138 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.6 mt -55.85 -43.2 76.83 Favored 'General case' 0 CA--C 1.535 0.372 0 O-C-N 122.227 -0.296 . . . . 0.0 110.93 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 60.7 m-20 -59.86 -52.83 63.77 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.307 0.643 . . . . 0.0 109.888 178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -55.59 -50.31 70.45 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.82 0.848 . . . . 0.0 109.938 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.0 mm -56.25 -50.88 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 123.711 0.805 . . . . 0.0 109.758 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.04 -43.41 66.58 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.206 0.603 . . . . 0.0 110.239 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -66.81 -57.63 6.66 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 120.935 -0.306 . . . . 0.0 110.588 176.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -47.19 -49.82 21.99 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 124.876 1.27 . . . . 0.0 112.973 -178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -91.28 14.16 15.21 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.253 0.621 . . . . 0.0 112.258 -177.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -50.43 134.18 23.81 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 119.865 1.211 . . . . 0.0 111.178 -179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.74 -29.26 6.95 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.494 -0.615 . . . . 0.0 111.797 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -98.98 -40.33 8.11 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 118.117 0.959 . . . . 0.0 109.013 178.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 20.0 tp -133.11 149.29 52.12 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.574 1.55 . . . . 0.0 109.072 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.6 m -124.17 147.24 48.14 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 103.915 -2.624 . . . . 0.0 103.915 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 41.7 t -121.73 152.34 25.47 Favored 'Isoleucine or valine' 0 C--O 1.231 0.09 0 CA-C-N 119.458 1.026 . . . . 0.0 108.534 -178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.81 151.02 45.41 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 178.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -128.79 100.45 5.71 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.578 -1.268 . . . . 0.0 107.578 179.111 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 tt -97.94 121.72 40.2 Favored 'General case' 0 C--O 1.231 0.121 0 O-C-N 121.376 -0.827 . . . . 0.0 110.682 -177.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 63.9 t-20 -82.68 108.45 16.06 Favored 'General case' 0 C--O 1.236 0.376 0 C-N-CA 123.488 0.715 . . . . 0.0 109.759 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt -65.1 -25.13 36.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.008 0.523 . . . . 0.0 112.288 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -64.42 -44.11 92.25 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 119.274 0.943 . . . . 0.0 108.896 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -74.88 -35.64 62.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.954 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.1 m-80 -120.74 68.14 15.31 Favored Pre-proline 0 CA--C 1.531 0.225 0 C-N-CA 124.089 0.956 . . . . 0.0 111.815 -175.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -61.29 -42.23 36.39 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 121.884 1.722 . . . . 0.0 110.22 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.23 -37.59 6.07 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 124.623 1.106 . . . . 0.0 114.184 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.63 -22.45 56.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 118.38 1.09 . . . . 0.0 112.965 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.467 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.64 -59.22 14.05 Favored Pre-proline 0 CA--C 1.54 0.586 0 CA-C-O 118.208 -0.901 . . . . 0.0 112.663 -178.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 75.4 Cg_exo -51.09 -46.6 30.07 Favored 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.584 2.189 . . . . 0.0 112.88 177.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -45.16 -46.44 12.03 Favored 'General case' 0 C--N 1.341 0.201 0 C-N-CA 123.987 0.915 . . . . 0.0 112.501 -178.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -108.1 25.26 11.82 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.001 0.521 . . . . 0.0 111.962 -178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.19 46.39 21.16 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.031 0.824 . . . . 0.0 112.37 178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 37.8 mm -75.62 77.84 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -90.13 -4.26 57.41 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.78 0.832 . . . . 0.0 110.504 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -160.48 146.76 12.98 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 108.724 -1.75 . . . . 0.0 108.724 179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 28.4 pt -133.48 154.71 80.96 Favored Pre-proline 0 CA--C 1.537 0.453 0 C-N-CA 125.611 1.565 . . . . 0.0 108.346 -179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -67.38 132.14 17.68 Favored 'Cis proline' 0 N--CA 1.457 -0.672 0 CA-C-N 120.659 1.271 . . . . 0.0 111.011 -0.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.67 145.89 31.44 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 103.888 -2.634 . . . . 0.0 103.888 175.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 78.9 mt -129.72 100.39 5.48 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 106.969 -1.493 . . . . 0.0 106.969 -179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 5.4 mp -106.87 119.87 40.51 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 44.3 tp -95.37 107.5 19.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.322 0.649 . . . . 0.0 109.936 -179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -97.59 103.96 15.94 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 124.832 1.253 . . . . 0.0 109.395 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -86.98 104.38 16.24 Favored 'General case' 0 N--CA 1.456 -0.143 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 174.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 48.07 50.94 15.37 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.662 0.744 . . . . 0.0 110.764 -176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.73 -19.98 6.82 Favored Glycine 0 CA--C 1.531 1.075 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.928 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -80.44 112.37 17.71 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 119.195 1.497 . . . . 0.0 109.627 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 81.1 t -62.94 102.55 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 176.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.01 -42.43 26.57 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 123.637 0.775 . . . . 0.0 110.387 -177.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.16 153.67 28.07 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 179.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.3 p -132.68 114.88 14.7 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 125.155 1.382 . . . . 0.0 109.176 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.7 tmtm? -110.0 144.0 39.17 Favored 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 16.1 t -121.34 127.63 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.26 167.36 35.61 Favored Glycine 0 CA--C 1.528 0.863 0 C-N-CA 123.972 0.796 . . . . 0.0 111.465 -179.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.38 166.43 21.69 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.118 0.567 . . . . 0.0 110.624 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.41 165.03 31.84 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 125.294 1.438 . . . . 0.0 107.787 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 99.9 p -72.38 159.24 34.34 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.006 0.431 . . . . 0.0 110.494 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -56.94 -42.5 80.17 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 175.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.25 -54.74 33.61 Favored Glycine 0 CA--C 1.53 1.015 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -55.36 -47.1 76.3 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.106 0.453 . . . . 0.0 110.36 178.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 30.6 tp -59.21 -50.56 73.54 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -55.21 -48.2 74.21 Favored 'General case' 0 C--O 1.234 0.26 0 O-C-N 121.971 -0.455 . . . . 0.0 110.737 178.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -58.82 -53.25 60.55 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 123.205 0.602 . . . . 0.0 109.84 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -51.6 -53.21 40.76 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.145 0.978 . . . . 0.0 110.127 178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -58.49 -51.87 68.04 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 122.521 0.328 . . . . 0.0 110.757 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -54.44 -51.9 63.5 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 117.78 0.264 . . . . 0.0 110.565 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.97 -38.42 72.97 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.381 1.072 . . . . 0.0 111.942 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -78.34 -43.95 26.44 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-N 117.987 0.358 . . . . 0.0 110.63 -178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -62.62 -47.17 84.94 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.905 0.482 . . . . 0.0 109.781 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.203 0 C-N-CA 124.564 1.146 . . . . 0.0 111.467 179.403 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.45 -0.473 0 CA-C-O 120.822 0.344 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -69.75 72.35 0.37 Allowed 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.137 0.975 . . . . 0.0 110.28 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 21.0 mtpp -103.43 50.28 0.81 Allowed 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 105.303 -2.11 . . . . 0.0 105.303 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.4 mt -112.3 143.28 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 125.476 1.51 . . . . 0.0 110.269 -173.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.7 mm -90.21 110.89 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.166 0 CA-C-O 121.452 0.644 . . . . 0.0 110.773 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -82.18 97.32 8.17 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 124.534 1.134 . . . . 0.0 108.519 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.7 mt -80.73 169.94 16.96 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.731 0.776 . . . . 0.0 111.676 -176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 47.3 p -137.62 161.51 36.27 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 105.707 -1.96 . . . . 0.0 105.707 175.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -53.45 -43.31 67.99 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -61.5 -46.61 89.27 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 125.265 1.426 . . . . 0.0 112.009 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.8 p -78.23 -27.45 47.71 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.086 -0.384 . . . . 0.0 111.736 -176.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -36.71 -54.74 0.89 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.425 1.49 . . . . 0.0 113.599 -179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -54.83 -63.57 1.11 Allowed 'General case' 0 CA--C 1.529 0.173 0 CA-C-O 121.424 0.63 . . . . 0.0 111.181 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.85 -37.97 69.44 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.965 0.906 . . . . 0.0 113.022 -178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.53 -61.2 1.82 Allowed 'General case' 0 N--CA 1.449 -0.486 0 CA-C-O 120.806 0.336 . . . . 0.0 111.485 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.72 -49.42 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.484 1.114 . . . . 0.0 112.538 -172.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.252 45.1 mt -65.18 -29.9 70.77 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 118.962 -1.095 . . . . 0.0 110.862 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 28.2 mmmt -100.18 35.3 2.11 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 122.578 0.351 . . . . 0.0 110.827 173.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.08 73.42 0.07 Allowed 'General case' 0 C--N 1.344 0.35 0 C-N-CA 123.727 0.811 . . . . 0.0 112.058 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -70.24 72.37 0.45 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.277 1.031 . . . . 0.0 109.802 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 156.96 -117.7 0.79 Allowed Glycine 0 CA--C 1.525 0.697 0 N-CA-C 106.362 -2.695 . . . . 0.0 106.362 -177.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -150.09 118.54 6.47 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 177.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 14.9 mt -115.11 124.56 71.85 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 C-N-CA 124.781 1.232 . . . . 0.0 108.523 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -102.78 104.3 14.58 Favored 'General case' 0 C--O 1.228 -0.077 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.9 t -90.33 113.49 26.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 C-N-CA 122.761 0.425 . . . . 0.0 110.076 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -94.56 107.86 19.84 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 124.446 1.098 . . . . 0.0 108.643 174.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -79.96 124.49 28.74 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 107.187 -1.412 . . . . 0.0 107.187 176.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 14.9 p-90 -143.14 -179.72 6.55 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.626 0.77 . . . . 0.0 111.452 -178.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.2 150.78 33.18 Favored 'General case' 0 C--N 1.337 0.051 0 C-N-CA 125.848 1.659 . . . . 0.0 108.54 178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 mp0 -52.81 -42.86 65.5 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.465 0.706 . . . . 0.0 111.471 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 47.4 p-90 -79.38 -6.53 57.01 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.292 1.037 . . . . 0.0 112.77 -179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.4 t -79.72 80.86 6.06 Favored 'General case' 0 N--CA 1.455 -0.209 0 O-C-N 120.918 -1.114 . . . . 0.0 111.158 -178.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.4 -59.08 3.7 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 176.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_exo -50.65 -33.31 39.13 Favored 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 123.422 2.748 . . . . 0.0 113.653 178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 64.2 m -69.92 -50.82 38.32 Favored 'General case' 0 N--CA 1.456 -0.148 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -55.34 -43.99 75.51 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 178.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.77 -30.85 57.78 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 118.495 -0.764 . . . . 0.0 112.242 177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 pt -92.97 -3.03 10.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 CA-C-N 119.604 1.093 . . . . 0.0 112.204 177.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -54.81 -50.0 88.49 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 119.785 1.175 . . . . 0.0 110.993 177.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.99 -47.35 28.04 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 111.352 175.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 59.4 mt -55.13 -52.87 40.31 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 178.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 65.4 mt -58.49 -40.81 83.81 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 122.642 0.377 . . . . 0.0 110.77 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.7 m-20 -60.55 -50.31 74.04 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.711 0.804 . . . . 0.0 109.719 178.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -56.63 -50.34 72.32 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.505 0.722 . . . . 0.0 109.289 178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 27.0 mm -55.21 -48.61 76.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.6 -47.24 70.36 Favored 'General case' 0 N--CA 1.458 -0.056 0 CA-C-N 118.152 0.433 . . . . 0.0 110.458 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -63.21 -49.11 75.5 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 120.824 0.345 . . . . 0.0 111.462 179.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -62.71 -49.19 76.04 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -177.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 61.6 m-85 -91.4 27.44 1.95 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.167 0.987 . . . . 0.0 113.259 -174.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 31.7 mm-40 -53.86 128.36 29.72 Favored 'General case' 0 CA--C 1.532 0.264 0 O-C-N 121.338 -0.851 . . . . 0.0 109.973 176.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.3 -17.05 14.31 Favored Glycine 0 CA--C 1.532 1.146 0 CA-C-O 119.274 -0.737 . . . . 0.0 113.195 -178.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.0 mtpp -99.7 -41.85 7.11 Favored 'General case' 0 CA--C 1.528 0.129 0 CA-C-N 118.648 1.224 . . . . 0.0 110.171 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -140.05 133.2 29.63 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.781 0.832 . . . . 0.0 109.251 -178.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 52.7 m -98.71 107.95 20.52 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 175.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.35 134.89 26.79 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.935 -1.506 . . . . 0.0 106.935 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.13 152.53 51.87 Favored 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 123.884 0.873 . . . . 0.0 108.776 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -127.55 145.13 50.96 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 124.974 1.31 . . . . 0.0 107.959 176.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -134.71 118.92 17.64 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.465 -1.679 . . . . 0.0 106.465 177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -89.41 101.51 14.19 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.239 -1.393 . . . . 0.0 107.239 -178.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -52.0 -37.65 22.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -61.29 -47.53 85.55 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 118.883 0.765 . . . . 0.0 110.423 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -81.92 -20.3 39.0 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.395 1.078 . . . . 0.0 111.561 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -129.25 63.76 68.6 Favored Pre-proline 0 CA--C 1.536 0.437 0 C-N-CA 125.424 1.49 . . . . 0.0 108.846 -175.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -65.56 -45.14 7.3 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 122.581 2.188 . . . . 0.0 113.746 -175.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.49 -45.67 1.94 Allowed Glycine 0 CA--C 1.532 1.111 0 C-N-CA 125.356 1.455 . . . . 0.0 115.581 -175.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 9.9 m -73.09 -28.13 62.11 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -52.82 -57.69 15.04 Favored Pre-proline 0 CA--C 1.539 0.549 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 -177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -63.76 -43.47 16.41 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 121.478 1.452 . . . . 0.0 111.048 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 58.3 mttp -48.44 -49.13 36.55 Favored 'General case' 0 C--N 1.342 0.243 0 C-N-CA 123.043 0.537 . . . . 0.0 111.503 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -99.15 24.09 8.32 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 43.49 48.95 7.11 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.57 1.081 . . . . 0.0 113.274 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.9 mm -76.32 74.04 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.7 mmm180 -79.97 -4.66 53.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.354 0.662 . . . . 0.0 111.798 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -159.33 165.41 34.36 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 108.409 -1.876 . . . . 0.0 108.409 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.1 pt -149.58 153.53 36.88 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 125.593 1.557 . . . . 0.0 107.286 -179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.67 143.55 71.7 Favored 'Cis proline' 0 N--CA 1.456 -0.71 0 CA-C-N 120.706 1.288 . . . . 0.0 109.854 -0.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.0 m -137.59 122.71 19.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 -179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 26.6 mt -108.43 115.96 31.09 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 125.058 1.343 . . . . 0.0 109.218 -173.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -110.54 121.73 46.03 Favored 'General case' 0 C--O 1.232 0.135 0 N-CA-C 107.675 -1.231 . . . . 0.0 107.675 177.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.4 tp -97.99 110.04 22.69 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -103.67 130.45 51.14 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.828 1.651 . . . . 0.0 111.329 -178.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -122.3 113.2 19.09 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 105.479 -2.045 . . . . 0.0 105.479 173.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 51.5 t30 51.99 42.1 30.13 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.915 0.779 . . . . 0.0 110.177 -178.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 73.62 -14.31 3.46 Favored Glycine 0 CA--C 1.531 1.093 0 O-C-N 121.561 -0.712 . . . . 0.0 114.095 -177.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -80.55 120.9 25.12 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 118.918 1.359 . . . . 0.0 107.342 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -69.9 115.42 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.3 -46.39 17.81 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.665 0.786 . . . . 0.0 109.212 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.74 163.3 26.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.567 0.747 . . . . 0.0 109.252 177.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.447 HG22 ' HG ' ' A' ' 79' ' ' LEU . 71.9 p -136.81 134.56 37.13 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.481 1.112 . . . . 0.0 109.125 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -124.6 117.59 24.64 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 177.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 71.6 t -95.59 133.11 37.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 107.847 -1.168 . . . . 0.0 107.847 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.2 161.5 37.5 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 123.986 0.803 . . . . 0.0 111.554 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.31 167.89 13.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.114 0.566 . . . . 0.0 110.549 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.57 163.6 27.2 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.807 1.243 . . . . 0.0 108.121 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.9 p -72.68 162.74 29.1 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-O 121.334 0.588 . . . . 0.0 111.282 -179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -54.16 -46.63 72.36 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.85 22.86 Favored Glycine 0 CA--C 1.527 0.798 0 N-CA-C 111.211 -0.755 . . . . 0.0 111.211 178.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -53.81 -45.45 70.78 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 117.455 0.627 . . . . 0.0 110.37 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 44.9 tp -59.16 -51.09 71.5 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 119.276 -0.392 . . . . 0.0 110.35 179.112 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -53.34 -49.78 66.38 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 118.559 0.618 . . . . 0.0 110.46 177.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -57.36 -50.63 72.35 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 117.772 0.26 . . . . 0.0 110.693 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -54.39 -53.21 57.11 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.449 0.699 . . . . 0.0 110.516 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.9 mt -58.04 -53.02 62.96 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 122.837 0.455 . . . . 0.0 110.328 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -53.35 -51.49 62.28 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.021 0.528 . . . . 0.0 110.493 179.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.8 -37.29 68.41 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.696 0.798 . . . . 0.0 111.863 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -78.04 -47.53 18.2 Favored 'General case' 0 CA--C 1.526 0.039 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 -178.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.29 -44.76 88.65 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.196 0.598 . . . . 0.0 109.805 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.29 0 C-N-CA 122.996 0.518 . . . . 0.0 109.612 177.647 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.4 m . . . . . 0 CA--C 1.532 0.278 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 30.8 t70 39.59 -100.75 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.984 1.714 . . . . 0.0 112.777 -177.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -133.84 37.3 3.26 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.424 1.089 . . . . 0.0 108.892 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.5 mt -91.85 140.08 16.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.951 0.9 . . . . 0.0 109.686 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.3 mm -90.38 122.48 41.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 122.019 0.914 . . . . 0.0 111.188 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 67.9 m80 -95.57 83.32 3.76 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 79.9 mt -68.17 166.01 17.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.007 1.323 . . . . 0.0 112.715 -176.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 63.0 p -128.41 161.2 30.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 171.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -55.85 -45.02 78.57 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.66 -47.23 86.42 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.883 1.273 . . . . 0.0 111.458 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 80.2 p -78.2 -24.78 46.96 Favored 'General case' 0 CA--C 1.531 0.244 0 O-C-N 122.126 -0.359 . . . . 0.0 111.846 -175.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 15.0 t80 -36.45 -50.24 0.76 Allowed 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 126.017 1.727 . . . . 0.0 113.548 179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -55.21 -63.76 1.06 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.327 0.584 . . . . 0.0 110.374 179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.9 m -59.47 -34.52 72.65 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.439 0.696 . . . . 0.0 112.072 -177.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -83.29 -65.9 0.95 Allowed 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 -176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 20.0 t -79.94 -45.49 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 C-N-CA 125.163 1.385 . . . . 0.0 112.603 -172.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . 0.261 46.9 mt -64.89 -30.26 71.24 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 118.253 -1.379 . . . . 0.0 110.245 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.5 mmtm -96.22 30.43 2.49 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 122.977 0.511 . . . . 0.0 110.726 172.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.21 74.78 0.05 Allowed 'General case' 0 C--N 1.343 0.3 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 -178.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -56.54 135.52 54.52 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 175.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 77.58 -95.68 1.23 Allowed Glycine 0 CA--C 1.528 0.868 0 N-CA-C 107.899 -2.081 . . . . 0.0 107.899 -175.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -167.19 136.32 2.75 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-N 117.954 0.877 . . . . 0.0 110.71 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.4 mt -119.78 128.48 75.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 124.957 1.303 . . . . 0.0 107.802 175.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.53 103.11 13.03 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 17.8 t -91.89 110.13 22.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 122.663 0.385 . . . . 0.0 110.454 -179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -89.69 108.31 19.6 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -79.59 118.0 21.03 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 176.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 21.3 p-90 -133.0 178.32 6.98 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.472 1.109 . . . . 0.0 112.184 -176.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -153.17 154.57 35.0 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.127 1.371 . . . . 0.0 108.57 178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -56.89 -26.04 58.18 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.0 p-90 -92.03 -4.32 54.63 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.468 1.107 . . . . 0.0 112.254 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.5 t -79.66 83.37 5.64 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 120.93 -1.106 . . . . 0.0 112.105 -176.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.03 -58.91 4.14 Favored Glycine 0 CA--C 1.538 1.526 0 C-N-CA 123.582 0.61 . . . . 0.0 112.518 177.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.06 -30.82 61.74 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.074 2.516 . . . . 0.0 113.347 179.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 81.2 m -65.47 -42.81 91.88 Favored 'General case' 0 N--CA 1.457 -0.102 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -63.49 -43.08 98.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 176.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 51.5 ttp -54.27 -47.96 71.74 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 122.636 0.374 . . . . 0.0 110.675 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.2 pt -77.54 -26.56 15.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 118.504 -0.76 . . . . 0.0 112.848 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.92 -57.08 1.06 Allowed Pre-proline 0 CA--C 1.543 0.696 0 N-CA-C 115.116 1.524 . . . . 0.0 115.116 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -58.94 -36.41 96.9 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 121.986 1.791 . . . . 0.0 112.003 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.8 mt -64.93 -49.63 78.89 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.247 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.9 mt -55.04 -42.82 73.14 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.77 0.428 . . . . 0.0 110.376 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 -59.87 -48.75 80.44 Favored 'General case' 0 CA--C 1.527 0.073 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.0 tt0 -56.87 -49.71 74.68 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.4 mm -54.39 -46.27 69.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.979 0.912 . . . . 0.0 109.79 177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.45 -31.37 55.41 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.965 0.506 . . . . 0.0 111.459 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -82.21 -58.84 2.77 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 109.704 -0.48 . . . . 0.0 109.704 176.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -48.51 -44.55 36.14 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.677 1.191 . . . . 0.0 113.232 -178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -104.92 23.09 14.1 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.468 1.107 . . . . 0.0 111.024 -178.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -55.32 130.1 41.07 Favored 'General case' 0 N--CA 1.452 -0.346 0 O-C-N 121.218 -0.926 . . . . 0.0 110.027 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.71 -19.15 21.84 Favored Glycine 0 CA--C 1.532 1.154 0 CA-C-O 119.25 -0.75 . . . . 0.0 112.887 -178.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -99.37 -45.22 5.92 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.606 1.203 . . . . 0.0 109.34 179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.2 tp -131.57 116.73 17.79 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.658 1.183 . . . . 0.0 108.64 -179.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 48.4 m -87.41 109.07 19.3 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.518 -1.29 . . . . 0.0 107.518 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 47.0 t -79.24 140.5 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.29 149.07 46.83 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 123.934 0.894 . . . . 0.0 109.767 179.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.8 mtpp -130.44 103.92 6.95 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -98.37 119.52 37.2 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 122.98 0.512 . . . . 0.0 109.836 -177.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -81.21 106.64 13.35 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.199 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pp -68.0 -32.32 55.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.15 0 C-N-CA 123.74 0.816 . . . . 0.0 112.992 -177.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.27 -44.62 95.16 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 119.183 0.901 . . . . 0.0 109.145 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 25.2 mm-40 -77.33 -35.05 55.11 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.261 0.624 . . . . 0.0 110.762 178.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.4 m-80 -118.3 67.78 7.01 Favored Pre-proline 0 CA--C 1.532 0.257 0 C-N-CA 124.13 0.972 . . . . 0.0 111.22 -177.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -64.14 -40.33 26.94 Favored 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 122.16 1.907 . . . . 0.0 110.964 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.06 -35.46 3.52 Favored Glycine 0 CA--C 1.528 0.876 0 C-N-CA 125.219 1.39 . . . . 0.0 114.459 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -73.41 -24.59 60.3 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 118.429 1.115 . . . . 0.0 112.971 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.45 -57.39 26.78 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -178.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -62.92 -35.72 65.15 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 122.24 1.96 . . . . 0.0 112.441 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -47.14 -44.37 21.63 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.898 0.772 . . . . 0.0 112.051 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -113.87 24.96 11.59 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.342 0.657 . . . . 0.0 110.693 178.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 36.97 50.96 1.54 Allowed Glycine 0 C--N 1.34 0.8 0 C-N-CA 126.627 2.061 . . . . 0.0 113.405 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.4 mp -45.02 118.21 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 C-N-CA 124.094 0.957 . . . . 0.0 110.919 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 2.5 mtm-85 -79.72 -45.33 19.14 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.03 0.932 . . . . 0.0 111.335 -176.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -172.19 142.62 6.97 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 32.9 pt -90.95 145.95 32.79 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 123.899 0.88 . . . . 0.0 110.37 -178.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.38 129.79 16.98 Favored 'Cis proline' 0 N--CA 1.456 -0.696 0 CA-C-N 120.189 1.103 . . . . 0.0 111.34 -0.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.3 112.16 23.73 Favored 'General case' 0 N--CA 1.455 -0.211 0 N-CA-C 104.405 -2.443 . . . . 0.0 104.405 177.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.4 mt -98.92 94.49 6.59 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.404 ' HG ' HG22 ' A' ' 89' ' ' THR . 9.1 mp -93.17 115.11 27.75 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 tp -93.04 105.99 18.01 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -101.88 122.87 44.82 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 125.351 1.46 . . . . 0.0 111.609 -177.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -105.47 102.88 12.32 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 171.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 40.74 58.8 2.33 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.937 1.295 . . . . 0.0 111.819 -176.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.13 -25.35 5.51 Favored Glycine 0 CA--C 1.527 0.843 0 CA-C-O 119.54 -0.589 . . . . 0.0 113.902 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -79.96 109.59 14.54 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.659 1.23 . . . . 0.0 110.186 -179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.25 109.24 1.12 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 176.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.23 -43.36 23.96 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.926 0.891 . . . . 0.0 110.314 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.87 160.08 35.75 Favored 'General case' 0 C--O 1.232 0.142 0 C-N-CA 123.176 0.59 . . . . 0.0 109.482 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.404 HG22 ' HG ' ' A' ' 79' ' ' LEU . 61.6 p -135.64 103.87 5.59 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.588 1.155 . . . . 0.0 109.152 -178.534 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 13.0 tptm -90.55 120.84 31.97 Favored 'General case' 0 N--CA 1.461 0.079 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.6 t -98.95 103.35 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 179.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 115.34 161.62 13.18 Favored Glycine 0 CA--C 1.526 0.764 0 C-N-CA 123.486 0.565 . . . . 0.0 112.015 179.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.63 166.0 23.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.852 0.861 . . . . 0.0 111.669 -179.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -163.84 164.35 23.53 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 126.262 1.825 . . . . 0.0 107.36 177.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 2.5 p -93.31 170.86 9.3 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 124.987 1.315 . . . . 0.0 113.051 -174.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -61.87 156.28 21.16 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 173.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 84.68 -62.64 4.53 Favored Glycine 0 CA--C 1.522 0.529 0 N-CA-C 107.27 -2.332 . . . . 0.0 107.27 -176.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -59.61 -54.69 43.55 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 38.1 tp -55.81 -48.99 74.44 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.141 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 55.9 mtpt -55.18 -47.08 75.73 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 122.558 0.343 . . . . 0.0 111.829 -179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -63.43 -47.84 80.26 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.059 0.544 . . . . 0.0 109.796 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -53.47 -52.49 59.33 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.9 mt -59.22 -51.16 71.18 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.586 0.355 . . . . 0.0 110.648 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.04 -50.91 65.63 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.704 0.401 . . . . 0.0 110.774 179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.91 -35.84 69.47 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.237 1.015 . . . . 0.0 111.434 179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m-80 -77.55 -48.15 17.69 Favored 'General case' 0 N--CA 1.457 -0.096 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 -179.335 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 46.0 mt -54.95 -48.4 73.23 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.307 0 C-N-CA 123.096 0.559 . . . . 0.0 109.51 176.905 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.226 -0.136 0 N-CA-C 113.072 0.767 . . . . 0.0 113.072 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 35.6 t70 34.55 -95.94 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 126.76 2.024 . . . . 0.0 114.553 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -132.37 25.94 4.47 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.673 1.189 . . . . 0.0 109.701 -178.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 20.9 mt -79.97 136.31 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 O-C-N 121.949 -0.469 . . . . 0.0 111.054 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.43 115.12 29.17 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.136 0 CA-C-O 121.545 0.688 . . . . 0.0 111.587 -179.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.2 m80 -82.69 96.69 8.22 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 124.018 0.927 . . . . 0.0 108.679 178.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.6 mt -84.35 158.86 21.01 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-O 122.125 0.964 . . . . 0.0 113.188 -175.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 51.0 p -125.1 160.46 29.02 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 126.904 2.082 . . . . 0.0 106.699 171.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -55.95 -44.31 78.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 176.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -54.44 -46.97 73.36 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.875 1.27 . . . . 0.0 111.019 178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 17.4 p -78.1 -28.04 48.55 Favored 'General case' 0 CA--C 1.531 0.247 0 O-C-N 122.229 -0.295 . . . . 0.0 111.681 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 14.9 t80 -38.08 -53.67 1.38 Allowed 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.51 1.524 . . . . 0.0 113.673 -177.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -54.93 -62.83 1.4 Allowed 'General case' 0 CA--C 1.53 0.187 0 CA-C-O 121.375 0.607 . . . . 0.0 110.929 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -57.17 -36.69 71.08 Favored 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 124.179 0.992 . . . . 0.0 113.319 -178.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.25 -62.04 1.59 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 120.771 0.32 . . . . 0.0 111.294 -175.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.5 t -79.65 -49.07 20.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.487 1.115 . . . . 0.0 112.636 -172.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.0 mt -65.67 -30.36 71.04 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 118.496 -1.282 . . . . 0.0 110.619 -177.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.1 mttm -96.48 32.48 2.01 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 119.443 -0.313 . . . . 0.0 110.848 173.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.4 66.86 0.19 Allowed 'General case' 0 C--N 1.345 0.383 0 C-N-CA 123.839 0.856 . . . . 0.0 111.629 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -72.75 70.58 0.97 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.728 1.211 . . . . 0.0 109.297 -179.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 165.07 -117.82 0.77 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 104.993 -3.243 . . . . 0.0 104.993 -177.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -149.79 115.21 5.5 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 118.13 0.965 . . . . 0.0 108.74 177.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 9.7 mt -112.67 125.91 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.168 0 C-N-CA 124.518 1.127 . . . . 0.0 108.652 178.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -104.35 104.2 14.05 Favored 'General case' 0 C--N 1.337 0.06 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 31.3 t -91.74 114.97 29.79 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 C-N-CA 122.756 0.422 . . . . 0.0 110.344 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -95.83 106.83 19.01 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.693 1.197 . . . . 0.0 107.91 174.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -79.35 121.82 25.6 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 106.85 -1.537 . . . . 0.0 106.85 177.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 18.1 p-90 -135.21 179.28 6.42 Favored 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 124.679 1.192 . . . . 0.0 110.852 -177.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -150.34 155.64 40.01 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.799 1.24 . . . . 0.0 108.727 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.4 mp0 -57.5 -27.9 62.95 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.589 0.632 . . . . 0.0 112.232 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.8 p-90 -90.07 -3.96 57.64 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.614 1.166 . . . . 0.0 112.452 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.2 t -79.67 80.11 6.1 Favored 'General case' 0 C--O 1.232 0.175 0 O-C-N 120.936 -1.102 . . . . 0.0 112.581 -176.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.62 -58.86 4.52 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 123.151 0.405 . . . . 0.0 112.156 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_exo -52.72 -32.52 55.61 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.369 2.713 . . . . 0.0 113.697 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.6 m -63.34 -44.36 95.09 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -62.97 -43.57 98.43 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 177.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.5 mtt -55.62 -42.51 75.02 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 119.095 -0.479 . . . . 0.0 111.149 178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.0 pt -80.68 -23.26 11.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 118.889 0.768 . . . . 0.0 112.89 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.49 -51.74 6.39 Favored Pre-proline 0 CA--C 1.544 0.735 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 -178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.57 -43.09 60.7 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.449 2.099 . . . . 0.0 111.964 175.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.3 mt -61.58 -48.65 87.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.185 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.8 mt -56.74 -41.62 77.86 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 122.419 -0.176 . . . . 0.0 110.551 178.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -62.41 -49.65 74.65 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 123.228 0.611 . . . . 0.0 110.094 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -55.43 -50.45 69.79 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 178.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.7 mm -56.22 -49.02 78.49 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 C-N-CA 123.411 0.684 . . . . 0.0 109.733 177.256 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.46 -43.2 67.92 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 123.126 0.57 . . . . 0.0 110.358 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -67.73 -57.19 6.77 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 120.968 -0.293 . . . . 0.0 110.289 177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -50.5 -44.07 55.92 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.649 1.18 . . . . 0.0 112.758 -177.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -100.17 21.53 12.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.385 1.074 . . . . 0.0 111.973 -178.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -54.67 128.14 31.25 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 119.566 1.075 . . . . 0.0 110.189 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.28 -19.18 28.58 Favored Glycine 0 CA--C 1.533 1.174 0 CA-C-O 119.213 -0.771 . . . . 0.0 113.049 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.2 mtpt -99.09 -45.39 5.94 Favored 'General case' 0 C--N 1.338 0.107 0 CA-C-N 118.668 1.234 . . . . 0.0 109.452 178.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -129.6 131.22 46.43 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.447 1.099 . . . . 0.0 108.46 -179.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.1 m -99.4 104.07 15.91 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 176.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.0 t -79.29 138.84 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.42 150.63 47.79 Favored 'General case' 0 N--CA 1.447 -0.615 0 C-N-CA 123.863 0.865 . . . . 0.0 109.241 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.5 mtpm? -125.81 135.31 51.85 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 176.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.3 tt -125.92 122.0 34.77 Favored 'General case' 0 CA--C 1.522 -0.121 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 178.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -86.71 110.97 20.25 Favored 'General case' 0 N--CA 1.453 -0.275 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 -179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 25.8 pt -67.32 -29.29 45.26 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.25 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -63.23 -47.66 81.57 Favored 'General case' 0 N--CA 1.462 0.164 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -70.34 -31.17 68.35 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.495 1.118 . . . . 0.0 110.253 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.8 m-80 -127.04 73.41 76.78 Favored Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 123.734 0.814 . . . . 0.0 111.834 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_exo -53.37 -56.05 3.06 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 C-N-CA 122.616 2.211 . . . . 0.0 112.688 -179.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.58 -48.26 1.25 Allowed Glycine 0 CA--C 1.529 0.921 0 C-N-CA 126.216 1.865 . . . . 0.0 115.57 -176.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.83 -28.52 69.54 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 121.756 -0.85 . . . . 0.0 113.023 -177.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -58.89 -64.41 2.96 Favored Pre-proline 0 CA--C 1.54 0.561 0 N-CA-C 113.364 0.875 . . . . 0.0 113.364 -178.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.49 -42.74 45.39 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 121.734 1.623 . . . . 0.0 111.22 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -49.24 -44.58 43.65 Favored 'General case' 0 C--N 1.341 0.21 0 CA-C-N 118.229 0.468 . . . . 0.0 111.765 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -104.07 25.9 9.42 Favored 'General case' 0 CA--C 1.534 0.33 0 N-CA-C 112.434 0.531 . . . . 0.0 112.434 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.3 44.97 10.71 Favored Glycine 0 CA--C 1.53 0.986 0 C-N-CA 124.537 1.065 . . . . 0.0 113.477 177.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.5 mm -75.71 75.77 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 121.606 0.717 . . . . 0.0 109.177 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -79.43 -4.93 53.43 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.013 0.925 . . . . 0.0 111.545 179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.25 170.74 40.34 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.384 -2.287 . . . . 0.0 107.384 179.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 14.5 pt -150.73 153.16 33.39 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 125.092 1.357 . . . . 0.0 107.711 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.46 142.19 61.77 Favored 'Cis proline' 0 N--CA 1.454 -0.799 0 CA-C-N 120.586 1.245 . . . . 0.0 110.154 -1.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 m -134.9 119.98 18.71 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 105.88 -1.896 . . . . 0.0 105.88 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.0 mt -105.19 116.16 31.48 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 125.543 1.537 . . . . 0.0 109.156 -173.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.472 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.7 mp -111.22 122.26 47.4 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 tp -98.17 104.88 16.95 Favored 'General case' 0 CA--C 1.529 0.142 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -95.0 122.56 37.77 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 125.276 1.43 . . . . 0.0 110.392 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -117.33 113.75 22.58 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.622 -1.622 . . . . 0.0 106.622 175.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 51.44 44.2 29.12 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.359 1.064 . . . . 0.0 110.056 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.96 -17.31 7.28 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.229 -0.761 . . . . 0.0 114.172 -179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -86.55 123.73 32.07 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 119.059 1.429 . . . . 0.0 109.938 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.45 110.13 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 175.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.02 -42.42 26.55 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.798 0.839 . . . . 0.0 109.836 -178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.68 162.6 35.11 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.472 HG22 ' HG ' ' A' ' 79' ' ' LEU . 62.1 p -137.36 138.81 40.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.446 1.098 . . . . 0.0 109.345 -178.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -130.47 122.26 27.35 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.5 t -99.73 131.14 47.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 93.34 165.46 37.7 Favored Glycine 0 CA--C 1.528 0.883 0 C-N-CA 124.066 0.841 . . . . 0.0 111.934 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.72 165.96 22.94 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.257 0.623 . . . . 0.0 110.443 178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -160.18 167.92 26.58 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.816 1.246 . . . . 0.0 108.55 179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.7 p -75.46 159.91 30.81 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-O 120.99 0.424 . . . . 0.0 110.55 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -55.61 -42.88 75.52 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 175.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.24 -56.53 24.72 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 177.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 18.0 mm-40 -56.41 -42.43 77.98 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.804 0.802 . . . . 0.0 110.721 179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 25.2 tp -59.6 -51.36 70.17 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -54.82 -47.69 73.75 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.726 0.694 . . . . 0.0 111.033 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -55.43 -53.33 57.64 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 118.041 0.382 . . . . 0.0 110.052 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -54.17 -53.01 59.26 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.797 0.839 . . . . 0.0 110.778 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.5 mt -58.05 -53.39 58.78 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 122.894 0.478 . . . . 0.0 110.526 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -53.37 -51.21 63.24 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.321 0.649 . . . . 0.0 110.29 179.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.73 -37.35 68.33 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.209 0.604 . . . . 0.0 111.693 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -78.13 -46.23 21.21 Favored 'General case' 0 C--N 1.337 0.042 0 O-C-N 122.134 -0.354 . . . . 0.0 110.665 -178.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.7 mt -58.46 -47.08 85.2 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 109.082 -0.711 . . . . 0.0 109.082 179.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 C-N-CA 123.005 0.522 . . . . 0.0 109.614 177.258 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 4.7 m . . . . . 0 N--CA 1.453 -0.289 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -163.4 173.92 12.6 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.898 1.279 . . . . 0.0 108.336 179.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -134.82 48.65 2.28 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 mt -102.38 139.28 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 123.876 0.87 . . . . 0.0 109.895 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.6 mm -88.68 114.25 26.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.244 1.021 . . . . 0.0 111.175 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.8 m80 -87.02 76.4 9.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.183 0.993 . . . . 0.0 108.95 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.2 mt -66.48 160.17 25.6 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.997 1.319 . . . . 0.0 113.632 -176.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.0 p -125.18 160.45 29.13 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 126.473 1.909 . . . . 0.0 107.638 172.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -53.61 -49.88 66.87 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -52.74 -45.87 67.2 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.993 1.317 . . . . 0.0 111.591 179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 27.9 p -78.33 -28.57 47.34 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -177.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -35.82 -55.23 0.73 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.64 1.576 . . . . 0.0 115.001 -175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -54.65 -62.29 1.75 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-O 121.715 0.769 . . . . 0.0 111.347 -178.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -61.99 -41.77 98.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 123.212 0.605 . . . . 0.0 112.193 -176.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -76.31 -40.47 51.41 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 38.8 t -101.15 -63.47 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 C-N-CA 123.841 0.856 . . . . 0.0 112.151 -175.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 63.3 mt -59.62 -33.48 71.55 Favored 'General case' 0 C--O 1.227 -0.131 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -90.78 4.98 50.16 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 177.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.37 105.71 11.84 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 120.384 1.447 . . . . 0.0 111.978 -179.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -77.26 67.25 3.18 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 173.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.69 -157.72 10.62 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 108.737 -1.745 . . . . 0.0 108.737 -178.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.88 110.53 19.15 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.778 1.231 . . . . 0.0 108.378 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 10.3 mt -114.45 123.05 69.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 C-N-CA 125.16 1.384 . . . . 0.0 108.649 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.4 tp -103.05 103.6 13.69 Favored 'General case' 0 C--O 1.231 0.093 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 38.7 t -90.46 113.13 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.293 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 178.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -92.79 109.27 20.7 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 172.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 56.9 m-85 -79.68 126.89 31.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 105.614 -1.995 . . . . 0.0 105.614 175.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.8 p-90 -134.72 177.14 8.02 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.392 1.077 . . . . 0.0 110.005 -178.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.45 156.45 43.75 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 -179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 45.1 mm-40 -59.51 -27.73 66.43 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.347 0.521 . . . . 0.0 110.723 179.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.436 ' CZ3' HD11 ' A' ' 75' ' ' ILE . 52.5 p-90 -91.22 -1.77 57.62 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.972 1.309 . . . . 0.0 112.369 178.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 42.6 t -79.85 79.03 6.41 Favored 'General case' 0 C--O 1.232 0.182 0 O-C-N 120.864 -1.147 . . . . 0.0 111.868 -178.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -45.8 -56.98 6.3 Favored Glycine 0 CA--C 1.539 1.587 0 CA-C-O 119.823 -0.432 . . . . 0.0 112.12 176.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_exo -52.89 -34.32 65.62 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.254 2.636 . . . . 0.0 113.722 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.2 m -62.78 -41.99 99.49 Favored 'General case' 0 C--N 1.338 0.095 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -67.86 -45.62 74.06 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.8 ttm -50.66 -44.03 57.45 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.837 0.455 . . . . 0.0 111.265 178.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.5 pt -86.02 -5.77 10.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 N-CA-C 113.018 0.747 . . . . 0.0 113.018 178.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.32 -50.67 78.29 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 119.98 1.264 . . . . 0.0 112.336 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_exo -51.55 -46.11 33.7 Favored 'Trans proline' 0 N--CA 1.457 -0.675 0 C-N-CA 122.364 2.043 . . . . 0.0 111.361 176.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 49.7 mt -58.05 -52.8 53.88 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 85.9 mt -56.44 -39.92 73.92 Favored 'General case' 0 CA--C 1.536 0.44 0 O-C-N 122.143 -0.348 . . . . 0.0 110.986 178.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -62.22 -50.99 69.56 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -55.91 -49.46 73.39 Favored 'General case' 0 CA--C 1.53 0.19 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.4 mm -55.16 -49.25 73.62 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.387 0.675 . . . . 0.0 109.821 177.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.92 -41.73 64.71 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-N 117.999 0.363 . . . . 0.0 110.595 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -69.74 -55.81 8.9 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 120.929 -0.308 . . . . 0.0 110.849 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -49.02 -49.15 42.42 Favored 'General case' 0 C--N 1.332 -0.152 0 C-N-CA 124.447 1.099 . . . . 0.0 112.329 -178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -97.45 23.59 7.47 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.927 0.891 . . . . 0.0 111.5 -177.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -51.95 130.0 28.39 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 119.35 0.977 . . . . 0.0 110.937 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.09 -17.61 9.34 Favored Glycine 0 CA--C 1.533 1.207 0 CA-C-O 119.214 -0.77 . . . . 0.0 113.435 -178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -99.18 -41.79 7.34 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.708 1.254 . . . . 0.0 109.107 179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.3 tp -131.63 134.88 46.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.216 1.407 . . . . 0.0 108.071 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.8 m -107.52 104.2 13.71 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 178.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 39.1 t -79.83 140.69 16.37 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 O-C-N 121.444 -0.785 . . . . 0.0 109.305 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.47 150.32 49.79 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.206 1.002 . . . . 0.0 109.203 178.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -132.91 99.31 4.55 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.709 1.204 . . . . 0.0 108.575 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.7 tt -98.22 127.01 43.94 Favored 'General case' 0 N--CA 1.461 0.121 0 O-C-N 121.836 -0.54 . . . . 0.0 110.559 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -87.72 112.56 22.52 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 122.78 0.432 . . . . 0.0 110.725 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 17.6 pt -67.18 -30.38 49.14 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.522 0.729 . . . . 0.0 112.832 -178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -65.98 -45.76 80.49 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 77.8 mt-30 -65.98 -36.51 83.51 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.76 176.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.5 m-80 -124.78 74.77 64.77 Favored Pre-proline 0 CA--C 1.535 0.368 0 C-N-CA 123.91 0.884 . . . . 0.0 112.612 -175.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.67 -61.23 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 123.389 2.726 . . . . 0.0 113.672 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.36 -48.94 1.66 Allowed Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.039 1.78 . . . . 0.0 114.684 -176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.05 -34.13 59.25 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -179.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.582 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.37 -68.88 0.68 Allowed Pre-proline 0 CA--C 1.536 0.441 0 CA-C-O 117.598 -1.192 . . . . 0.0 110.193 178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.582 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 84.8 Cg_exo -47.49 -48.18 16.05 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.107 1.871 . . . . 0.0 112.715 174.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 57.8 mttp -48.1 -47.65 34.15 Favored 'General case' 0 C--N 1.345 0.409 0 CA-C-N 118.653 0.66 . . . . 0.0 111.916 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -101.49 25.16 8.7 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.26 39.33 20.55 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 124.345 0.974 . . . . 0.0 113.095 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 26.0 mm -78.1 91.21 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.0 mmp_? -83.28 -8.5 59.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.402 0.281 . . . . 0.0 111.183 -178.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -173.69 167.93 40.67 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 107.149 -2.381 . . . . 0.0 107.149 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.436 HD11 ' CZ3' ' A' ' 31' ' ' TRP . 1.3 pp -132.77 157.94 77.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 125.349 1.46 . . . . 0.0 109.057 -179.347 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -70.06 143.89 75.71 Favored 'Cis proline' 0 N--CA 1.46 -0.476 0 CA-C-N 120.362 1.165 . . . . 0.0 110.8 -0.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 18.9 m -140.78 123.04 15.8 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.1 mt -104.12 126.19 51.04 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.64 1.576 . . . . 0.0 109.362 -177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.4 mp -119.61 119.25 33.2 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 19.2 tp -96.82 102.05 13.75 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -89.44 117.4 28.33 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 125.301 1.44 . . . . 0.0 108.998 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -111.91 124.87 53.29 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 106.454 -1.684 . . . . 0.0 106.454 175.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 51.99 42.91 30.63 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-O 121.461 0.648 . . . . 0.0 109.857 -177.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.44 -8.43 13.77 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-O 118.49 -1.172 . . . . 0.0 115.377 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 61.3 mm-40 -104.96 133.0 50.49 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-N 119.708 1.754 . . . . 0.0 110.878 -177.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 59.1 t -62.08 105.49 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 177.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -82.03 -43.73 17.57 Favored 'General case' 0 N--CA 1.456 -0.167 0 C-N-CA 123.455 0.702 . . . . 0.0 110.556 -179.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -152.9 166.04 33.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 42.9 p -145.21 169.1 18.87 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.16 0.584 . . . . 0.0 109.655 -179.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -150.03 151.34 33.11 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 174.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -129.4 140.29 49.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 80.35 169.86 40.74 Favored Glycine 0 CA--C 1.53 1.029 0 N-CA-C 110.492 -1.043 . . . . 0.0 110.492 -176.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.74 173.17 10.2 Favored 'General case' 0 CA--C 1.533 0.299 0 O-C-N 122.277 -0.543 . . . . 0.0 110.224 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -160.86 162.05 32.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.173 1.389 . . . . 0.0 107.366 177.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.31 151.64 29.41 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.428 0.691 . . . . 0.0 110.894 -178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -50.07 -47.54 53.57 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.463 1.105 . . . . 0.0 112.139 -177.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.55 -56.52 23.2 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -53.62 -45.08 69.98 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 123.796 0.838 . . . . 0.0 110.259 178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 46.8 tp -58.75 -53.25 60.47 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -54.52 -47.28 73.31 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 118.117 0.417 . . . . 0.0 111.345 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -58.68 -52.28 66.34 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 123.777 0.831 . . . . 0.0 109.927 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -54.07 -53.48 52.59 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 123.87 0.868 . . . . 0.0 110.076 178.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -57.57 -51.75 68.23 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 122.429 0.292 . . . . 0.0 110.558 -179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -54.56 -51.69 64.45 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 122.832 0.453 . . . . 0.0 110.493 179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.02 -39.06 71.37 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.916 0.887 . . . . 0.0 111.7 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 20.0 m-80 -77.87 -42.73 32.46 Favored 'General case' 0 CA--C 1.528 0.099 0 O-C-N 122.315 -0.24 . . . . 0.0 110.413 -178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 39.6 mt -60.35 -45.54 93.09 Favored 'General case' 0 CA--C 1.529 0.169 0 N-CA-C 109.325 -0.621 . . . . 0.0 109.325 178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.322 0 C-N-CA 123.152 0.581 . . . . 0.0 109.659 177.686 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 52.0 p . . . . . 0 N--CA 1.453 -0.281 0 N-CA-C 110.269 -0.271 . . . . 0.0 110.269 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -72.88 97.65 2.31 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.8 mtpt -122.75 40.86 3.59 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 175.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 18.1 mt -91.12 141.4 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 C-N-CA 124.004 0.922 . . . . 0.0 110.75 -176.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -90.91 113.53 26.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.465 0.65 . . . . 0.0 110.654 178.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -84.33 97.89 9.71 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.271 1.028 . . . . 0.0 109.261 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.7 mt -87.07 160.25 18.66 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.2 1.0 . . . . 0.0 112.837 -176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 43.8 p -127.31 160.31 31.73 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.399 1.88 . . . . 0.0 106.951 172.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -53.33 -48.74 68.2 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 177.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -53.99 -45.52 71.47 Favored 'General case' 0 CA--C 1.527 0.095 0 C-N-CA 124.926 1.29 . . . . 0.0 111.423 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 23.5 p -78.67 -28.78 45.36 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -177.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -33.35 -65.61 0.17 Allowed 'General case' 0 C--O 1.223 -0.293 0 C-N-CA 126.059 1.743 . . . . 0.0 115.268 -175.576 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -52.4 -56.49 14.63 Favored 'General case' 0 CA--C 1.53 0.183 0 O-C-N 121.607 -0.683 . . . . 0.0 111.43 -176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -59.95 -45.63 92.02 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.331 0.652 . . . . 0.0 112.758 -179.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.56 -39.64 52.13 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -174.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 43.8 t -97.35 -65.13 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.679 1.192 . . . . 0.0 112.116 -174.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 75.3 mt -60.39 -31.35 70.28 Favored 'General case' 0 N--CA 1.455 -0.182 0 N-CA-C 112.725 0.639 . . . . 0.0 112.725 -173.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 58.8 mttm -91.46 3.84 53.98 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.524 0.602 . . . . 0.0 112.567 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.413 ' CB ' HD12 ' A' ' 23' ' ' ILE . . . -77.57 106.3 9.27 Favored 'General case' 0 C--N 1.342 0.274 0 CA-C-N 120.106 1.321 . . . . 0.0 112.104 -178.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -77.37 67.31 3.29 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 173.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -170.27 -159.03 15.17 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 108.097 -2.001 . . . . 0.0 108.097 -178.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -114.82 111.85 21.87 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.917 0.887 . . . . 0.0 109.07 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.413 HD12 ' CB ' ' A' ' 19' ' ' ALA . 7.7 mt -113.8 129.2 70.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 C-N-CA 125.012 1.325 . . . . 0.0 108.843 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.4 tp -109.91 103.73 12.55 Favored 'General case' 0 N--CA 1.46 0.056 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.5 t -90.9 117.68 34.63 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 118.326 0.512 . . . . 0.0 110.468 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -96.78 110.91 23.29 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.849 1.259 . . . . 0.0 108.918 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -83.66 121.32 27.11 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 32.7 p-90 -137.34 176.57 8.59 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.15 149.17 31.51 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 125.842 1.657 . . . . 0.0 109.243 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -55.36 -34.8 64.6 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 123.532 0.733 . . . . 0.0 112.388 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.9 p-90 -84.6 -10.27 57.53 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.94 0.896 . . . . 0.0 112.084 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.4 t -79.75 79.99 6.19 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.076 -1.015 . . . . 0.0 110.906 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.78 -58.58 2.6 Favored Glycine 0 CA--C 1.537 1.427 0 C-N-CA 124.153 0.882 . . . . 0.0 112.074 177.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_exo -54.02 -36.51 84.58 Favored 'Trans proline' 0 N--CA 1.457 -0.623 0 C-N-CA 123.344 2.696 . . . . 0.0 113.598 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 74.7 m -63.59 -46.08 87.45 Favored 'General case' 0 C--N 1.337 0.045 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -64.65 -42.17 95.63 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 52.9 ttp -52.69 -44.35 66.2 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.394 0.678 . . . . 0.0 110.683 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.4 pt -78.78 -10.05 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.34 -57.21 12.44 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 120.052 1.297 . . . . 0.0 113.116 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -53.69 -41.06 77.08 Favored 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.056 1.837 . . . . 0.0 111.435 177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.9 mt -59.84 -51.93 67.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 177.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.4 mt -55.65 -41.22 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.833 0.453 . . . . 0.0 110.55 178.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.11 -52.69 63.84 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -53.45 -48.63 68.66 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.829 -0.545 . . . . 0.0 109.984 178.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 24.9 mm -56.56 -49.43 77.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 C-N-CA 122.997 0.519 . . . . 0.0 109.668 177.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.0 -45.94 68.1 Favored 'General case' 0 C--O 1.227 -0.124 0 C-N-CA 123.383 0.673 . . . . 0.0 110.253 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -65.39 -57.41 8.42 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 120.818 0.342 . . . . 0.0 110.476 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -49.21 -50.57 37.73 Favored 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 124.919 1.288 . . . . 0.0 112.548 -179.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -94.04 20.49 7.83 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 123.71 0.804 . . . . 0.0 111.995 -178.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -58.53 99.83 0.05 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.687 1.13 . . . . 0.0 110.788 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.7 -23.48 8.34 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 124.617 1.103 . . . . 0.0 111.284 -179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -99.43 -36.79 9.46 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.664 1.186 . . . . 0.0 109.706 179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -138.33 139.03 38.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.062 0.945 . . . . 0.0 108.522 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 75.6 m -106.89 102.38 11.74 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 177.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 64.9 t -79.21 138.31 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.21 154.12 51.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 124.086 0.955 . . . . 0.0 108.662 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.0 145.42 51.25 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 125.022 1.329 . . . . 0.0 108.208 177.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -137.6 121.32 17.45 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 177.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -84.35 110.34 18.53 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -66.89 -31.22 52.48 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 N-CA-C 113.342 0.867 . . . . 0.0 113.342 -176.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -62.88 -45.57 91.94 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 119.231 0.923 . . . . 0.0 109.058 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -71.93 -36.8 70.04 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.068 177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -122.63 69.9 35.24 Favored Pre-proline 0 CA--C 1.532 0.269 0 C-N-CA 124.246 1.018 . . . . 0.0 111.612 -175.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.05 -47.27 6.74 Favored 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 121.972 1.781 . . . . 0.0 111.083 -178.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.78 -37.85 2.15 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.529 1.538 . . . . 0.0 114.895 -178.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.4 -22.84 61.06 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 118.346 1.073 . . . . 0.0 113.677 -177.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.92 -55.74 5.12 Favored Pre-proline 0 CA--C 1.542 0.666 0 N-CA-C 113.344 0.868 . . . . 0.0 113.344 -177.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -49.62 -37.02 42.52 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.327 2.684 . . . . 0.0 113.577 177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -43.78 -43.25 6.01 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.103 0.961 . . . . 0.0 112.107 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 49.6 m-85 -117.82 29.93 7.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.403 0.681 . . . . 0.0 110.563 -179.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.89 40.77 27.38 Favored Glycine 0 CA--C 1.529 0.96 0 C-N-CA 124.693 1.14 . . . . 0.0 112.823 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 48.6 mt -78.99 79.07 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.8 mmp_? -88.68 -4.66 58.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.886 0.874 . . . . 0.0 111.541 -179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -142.27 160.91 27.28 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 108.438 -1.865 . . . . 0.0 108.438 178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.7 pt -147.59 156.35 45.27 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.586 1.554 . . . . 0.0 107.745 -179.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -68.19 145.15 75.07 Favored 'Cis proline' 0 N--CA 1.456 -0.733 0 CA-C-N 120.725 1.295 . . . . 0.0 110.006 -0.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.4 m -138.79 124.51 19.69 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 106.396 -1.705 . . . . 0.0 106.396 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 34.2 mt -108.06 115.74 30.68 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 125.616 1.566 . . . . 0.0 108.913 -175.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.2 mp -105.95 116.41 31.9 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 177.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 28.2 tp -96.72 104.1 16.06 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -94.94 118.81 32.43 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 125.576 1.55 . . . . 0.0 109.206 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 50.4 mtpt -111.46 122.48 47.96 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 106.629 -1.619 . . . . 0.0 106.629 174.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 52.39 42.69 31.19 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.253 0.621 . . . . 0.0 109.912 -178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 75.77 -14.73 5.52 Favored Glycine 0 CA--C 1.534 1.224 0 CA-C-O 119.041 -0.866 . . . . 0.0 114.71 -179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -94.19 134.77 36.29 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 119.215 1.508 . . . . 0.0 110.535 -177.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.3 t -65.2 107.98 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 N-CA-C 108.088 -1.079 . . . . 0.0 108.088 177.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -45.02 19.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.25 159.92 34.7 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 82.4 p -136.53 129.87 31.59 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.335 1.054 . . . . 0.0 108.53 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.4 tmtm? -119.31 119.22 33.38 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.52 132.32 43.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.51 163.89 34.37 Favored Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.147 0.879 . . . . 0.0 111.435 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.2 167.26 22.26 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.044 0.537 . . . . 0.0 110.221 178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -160.93 162.99 32.18 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.782 1.233 . . . . 0.0 108.147 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.88 162.91 28.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.206 0.527 . . . . 0.0 110.98 -179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -55.8 -45.07 78.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.65 -54.41 36.57 Favored Glycine 0 CA--C 1.529 0.944 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 178.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -56.43 -46.13 80.42 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.164 0.482 . . . . 0.0 110.447 178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 29.8 tp -59.29 -52.34 66.09 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 110.475 -0.194 . . . . 0.0 110.475 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -55.93 -48.11 76.31 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 118.163 0.438 . . . . 0.0 110.535 178.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -56.99 -53.41 58.36 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 122.777 0.431 . . . . 0.0 109.919 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.7 t80 -52.98 -54.09 40.25 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.093 0.957 . . . . 0.0 110.312 178.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 88.3 mt -57.54 -53.24 60.39 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 119.317 -0.373 . . . . 0.0 110.652 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -53.57 -52.31 60.15 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 117.918 0.327 . . . . 0.0 110.562 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.83 73.85 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.899 0.88 . . . . 0.0 112.004 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.6 m-80 -77.68 -42.61 33.96 Favored 'General case' 0 C--O 1.23 0.029 0 O-C-N 122.095 -0.378 . . . . 0.0 110.319 -177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 45.8 mt -59.49 -48.24 82.41 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.319 0 C-N-CA 123.139 0.576 . . . . 0.0 109.525 177.077 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 33.7 p . . . . . 0 N--CA 1.454 -0.241 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 37.6 t0 -73.67 70.94 1.39 Allowed 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 123.528 0.731 . . . . 0.0 109.894 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.9 mtpm? -103.82 47.74 0.87 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 179.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 6.0 mt -108.4 138.51 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.318 -173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.6 mm -86.5 110.91 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.255 0 CA-C-O 122.218 1.009 . . . . 0.0 111.01 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -82.41 76.11 9.29 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 123.771 0.828 . . . . 0.0 108.9 179.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.76 159.19 22.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.715 1.206 . . . . 0.0 113.659 -176.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 48.1 p -125.74 160.53 29.52 Favored 'General case' 0 N--CA 1.447 -0.613 0 C-N-CA 126.8 2.04 . . . . 0.0 106.755 171.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -54.68 -45.46 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 177.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -54.67 -46.13 74.01 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.3 1.44 . . . . 0.0 111.432 179.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 14.1 p -78.67 -27.45 45.18 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -37.8 -54.51 1.24 Allowed 'General case' 0 CA--C 1.529 0.16 0 C-N-CA 125.327 1.451 . . . . 0.0 114.113 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -57.09 -50.25 73.38 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.595 0.712 . . . . 0.0 111.664 -178.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.3 m -66.24 -40.94 90.58 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 124.237 1.015 . . . . 0.0 111.339 -176.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -84.01 -58.49 2.75 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -177.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.8 t -79.72 -51.52 16.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 124.038 0.935 . . . . 0.0 112.4 -172.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 59.2 mt -64.87 -32.78 74.64 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 119.05 -1.06 . . . . 0.0 111.299 -176.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 57.1 mttm -96.8 26.07 4.81 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 122.499 0.319 . . . . 0.0 111.201 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.32 72.93 0.32 Allowed 'General case' 0 C--N 1.343 0.299 0 O-C-N 121.338 -0.851 . . . . 0.0 111.664 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -67.56 73.58 0.15 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.706 1.203 . . . . 0.0 110.211 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 161.51 -112.75 0.53 Allowed Glycine 0 CA--C 1.525 0.718 0 N-CA-C 106.303 -2.719 . . . . 0.0 106.303 -177.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -155.63 122.69 5.41 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 117.813 0.807 . . . . 0.0 109.132 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.6 mt -120.25 119.44 59.96 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 125.179 1.392 . . . . 0.0 108.096 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.8 tp -94.61 104.8 16.73 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 176.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -89.68 109.66 20.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 122.829 0.452 . . . . 0.0 110.014 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -90.19 119.35 30.44 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 172.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -86.74 125.62 34.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 175.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 31.1 p-90 -138.43 176.31 8.81 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 123.486 0.715 . . . . 0.0 111.157 -177.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.45 151.77 32.11 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 125.056 1.342 . . . . 0.0 107.563 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -56.08 -36.87 68.59 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.615 0.766 . . . . 0.0 111.55 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.4 p-90 -79.71 -11.03 59.87 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.241 1.017 . . . . 0.0 112.813 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.1 t -79.56 81.3 5.84 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.046 -1.034 . . . . 0.0 111.855 -176.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.07 -57.62 3.51 Favored Glycine 0 CA--C 1.537 1.459 0 C-N-CA 124.013 0.816 . . . . 0.0 112.369 176.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -54.91 -33.58 82.72 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 122.862 2.375 . . . . 0.0 113.261 178.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 70.0 m -65.04 -43.55 91.98 Favored 'General case' 0 C--O 1.23 0.07 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 178.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -61.49 -47.6 84.88 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -50.38 -41.89 52.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.888 0.875 . . . . 0.0 111.953 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -83.69 -8.82 11.42 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.453 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.91 -51.17 73.32 Favored Pre-proline 0 CA--C 1.54 0.563 0 CA-C-N 119.9 1.227 . . . . 0.0 112.721 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -53.94 -40.96 78.8 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 122.508 2.139 . . . . 0.0 112.078 176.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 48.6 mt -62.08 -52.5 59.6 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 69.2 mt -56.24 -42.84 77.97 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.826 0.45 . . . . 0.0 110.656 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 78.4 m-20 -59.28 -53.43 58.28 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-O 121.827 0.822 . . . . 0.0 109.327 178.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 -55.87 -47.14 77.86 Favored 'General case' 0 N--CA 1.454 -0.275 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.007 179.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 16.2 mm -56.11 -50.4 70.52 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 C-N-CA 123.116 0.566 . . . . 0.0 109.806 176.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.85 -41.61 67.65 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 122.982 0.513 . . . . 0.0 110.646 179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -68.24 -50.3 54.89 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.299 -0.251 . . . . 0.0 110.966 178.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.62 -49.32 77.92 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 123.33 0.652 . . . . 0.0 112.731 -178.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -87.11 30.14 0.79 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.745 0.818 . . . . 0.0 112.592 -176.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -52.27 125.0 14.57 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.561 -0.712 . . . . 0.0 110.213 176.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.65 -15.35 14.36 Favored Glycine 0 CA--C 1.531 1.064 0 CA-C-O 119.38 -0.678 . . . . 0.0 113.484 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.9 mtpp -99.7 -36.23 9.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 CA-C-N 118.431 1.116 . . . . 0.0 110.568 -179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 22.5 tp -146.67 142.23 27.66 Favored 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 123.199 0.6 . . . . 0.0 109.479 -177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 50.8 m -108.36 139.79 42.57 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 172.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 25.4 t -111.96 143.19 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.83 151.08 51.44 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 123.943 0.897 . . . . 0.0 108.599 178.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 16.9 mtpp -133.27 101.93 5.37 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 -179.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -98.01 123.28 41.96 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 121.729 -0.607 . . . . 0.0 110.791 -177.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 62.8 t-20 -82.34 108.44 15.77 Favored 'General case' 0 C--O 1.235 0.332 0 C-N-CA 123.238 0.615 . . . . 0.0 110.077 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.6 pt -66.66 -23.9 32.01 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-O 119.185 -0.436 . . . . 0.0 111.744 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 68.2 m-20 -62.18 -46.17 90.15 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -76.3 -32.54 58.8 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.478 0.711 . . . . 0.0 110.558 178.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -128.53 70.19 79.73 Favored Pre-proline 0 CA--C 1.534 0.358 0 C-N-CA 123.574 0.75 . . . . 0.0 112.411 -175.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -53.64 -59.35 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.505 2.137 . . . . 0.0 112.923 -178.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.18 -42.22 1.62 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 126.345 1.926 . . . . 0.0 115.296 -176.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -58.77 -28.15 65.65 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.871 0.835 . . . . 0.0 112.854 -178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.587 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -70.01 -65.21 1.17 Allowed Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 118.177 -0.916 . . . . 0.0 110.196 177.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.587 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 94.4 Cg_exo -47.25 -40.18 27.52 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.247 2.631 . . . . 0.0 113.192 175.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -49.42 -38.3 28.72 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.937 0.789 . . . . 0.0 112.242 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -111.3 26.24 10.88 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.347 0.659 . . . . 0.0 110.68 177.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.4 37.65 25.75 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.14 1.352 . . . . 0.0 113.336 179.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 54.4 mt -78.84 99.71 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-N 117.808 0.804 . . . . 0.0 109.087 -178.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 28.1 mtm-85 -79.8 -19.16 49.22 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.837 1.255 . . . . 0.0 112.897 -177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.78 174.35 35.14 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -178.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.7 pt -143.31 157.5 59.73 Favored Pre-proline 0 CA--C 1.537 0.481 0 C-N-CA 125.474 1.51 . . . . 0.0 108.122 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -68.68 142.48 67.64 Favored 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 120.541 1.229 . . . . 0.0 110.523 -0.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 52.4 m -142.85 127.51 18.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.796 -1.928 . . . . 0.0 105.796 179.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.72 118.57 37.13 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.466 1.506 . . . . 0.0 109.234 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 11.3 mp -110.66 118.31 35.84 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.99 -1.485 . . . . 0.0 106.99 176.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 55.5 tp -93.44 107.36 19.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -102.17 126.95 49.27 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.765 1.226 . . . . 0.0 111.465 -178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -110.49 102.02 10.66 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 104.902 -2.258 . . . . 0.0 104.902 172.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.48 57.45 3.42 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.758 1.223 . . . . 0.0 111.712 -177.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.81 -23.65 4.93 Favored Glycine 0 CA--C 1.526 0.767 0 CA-C-O 119.44 -0.645 . . . . 0.0 113.836 179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -79.76 108.93 13.71 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 118.759 1.279 . . . . 0.0 109.005 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 94.7 t -65.67 111.79 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 176.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.98 -44.42 22.41 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 123.366 0.666 . . . . 0.0 109.639 -178.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.13 161.33 31.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 78.4 p -135.23 132.28 37.68 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.395 1.078 . . . . 0.0 109.166 -179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -120.54 117.99 29.04 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.3 t -93.71 132.75 36.96 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.09 163.64 39.39 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 123.635 0.636 . . . . 0.0 111.778 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.35 167.94 15.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.14 0.576 . . . . 0.0 110.416 179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.54 166.61 26.78 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.972 1.309 . . . . 0.0 107.723 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 76.8 p -82.42 161.49 22.45 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 121.225 0.536 . . . . 0.0 110.799 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 21.2 tptm -48.82 -51.88 27.11 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.249 1.019 . . . . 0.0 109.813 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -53.55 -54.78 28.38 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 111.526 -0.63 . . . . 0.0 111.526 179.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -55.28 -46.39 76.18 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 117.089 0.445 . . . . 0.0 110.337 179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.4 tp -60.06 -48.39 81.93 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.549 -0.262 . . . . 0.0 110.543 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -55.93 -50.13 71.58 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 118.319 0.509 . . . . 0.0 110.026 177.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 47.7 mm-40 -56.99 -50.79 71.62 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 117.836 0.289 . . . . 0.0 110.556 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.32 -53.79 45.9 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.507 0.723 . . . . 0.0 110.364 178.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 84.1 mt -58.85 -54.93 41.53 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 122.562 0.345 . . . . 0.0 110.791 -179.281 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -52.2 -51.7 56.6 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.262 0.625 . . . . 0.0 110.674 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.7 -38.04 69.18 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.669 0.788 . . . . 0.0 111.929 179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -78.07 -48.64 15.61 Favored 'General case' 0 C--O 1.227 -0.112 0 O-C-N 122.16 -0.338 . . . . 0.0 110.36 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 47.1 mt -58.55 -44.77 89.76 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.161 0.584 . . . . 0.0 109.911 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.259 0 C-N-CA 122.837 0.455 . . . . 0.0 109.775 177.768 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.1 t . . . . . 0 N--CA 1.452 -0.371 0 N-CA-C 109.925 -0.398 . . . . 0.0 109.925 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -74.02 74.07 1.69 Allowed 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 121.175 0.512 . . . . 0.0 111.236 -178.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 31.4 mtmm -108.64 39.53 1.98 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 106.241 -1.762 . . . . 0.0 106.241 175.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 19.4 mt -96.31 139.37 19.41 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.528 0 C-N-CA 123.652 0.781 . . . . 0.0 110.344 -174.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.0 mm -86.44 110.79 20.5 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.178 -178.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 61.1 m80 -81.12 94.04 6.55 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 124.106 0.962 . . . . 0.0 108.799 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 91.2 mt -81.78 163.82 22.11 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.986 0.914 . . . . 0.0 112.614 -175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 64.1 p -133.56 163.55 29.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 126.457 1.903 . . . . 0.0 106.226 173.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -55.07 -43.38 73.84 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 109.326 -0.62 . . . . 0.0 109.326 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -60.13 -46.31 90.09 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.962 1.305 . . . . 0.0 111.877 179.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.7 p -78.31 -27.54 47.24 Favored 'General case' 0 CA--C 1.529 0.164 0 O-C-N 122.096 -0.377 . . . . 0.0 111.385 -177.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -36.65 -54.62 0.88 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.549 1.54 . . . . 0.0 113.426 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -54.9 -63.73 1.06 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.379 0.609 . . . . 0.0 110.902 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -56.1 -41.74 75.68 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 123.845 0.858 . . . . 0.0 112.787 -176.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.07 -58.42 2.97 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 112.011 0.375 . . . . 0.0 112.011 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -81.11 -52.19 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.311 0 C-N-CA 123.881 0.872 . . . . 0.0 112.712 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 55.4 mt -64.24 -29.99 71.06 Favored 'General case' 0 C--O 1.228 -0.047 0 C-N-CA 119.639 -0.825 . . . . 0.0 111.556 -175.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 53.5 mtmt -105.52 40.54 1.53 Allowed 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.52 123.99 8.64 Favored 'General case' 0 C--N 1.343 0.286 0 C-N-CA 123.551 0.74 . . . . 0.0 112.425 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -76.9 61.43 1.93 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.632 1.173 . . . . 0.0 109.306 176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 115.19 -116.97 3.86 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.28 122.17 45.11 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.196 0.998 . . . . 0.0 109.052 -178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 12.9 mt -116.42 125.58 73.51 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.066 0 C-N-CA 124.619 1.168 . . . . 0.0 108.354 178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.0 tp -103.28 103.34 13.35 Favored 'General case' 0 CA--C 1.524 -0.051 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 177.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 36.5 t -89.8 114.22 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.179 0 C-N-CA 122.745 0.418 . . . . 0.0 110.103 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -95.36 114.3 26.07 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 174.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.5 m-85 -82.86 128.1 34.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 35.9 p-90 -142.43 174.61 10.47 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 123.446 0.698 . . . . 0.0 111.787 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -145.46 153.89 41.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.41 1.484 . . . . 0.0 107.789 177.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -52.32 -43.67 64.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.141 0.576 . . . . 0.0 111.663 -179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.6 p-90 -80.08 -2.45 44.4 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.952 1.301 . . . . 0.0 112.957 -179.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.3 t -79.4 78.76 5.9 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.896 -1.128 . . . . 0.0 111.004 -178.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.78 -57.36 3.43 Favored Glycine 0 CA--C 1.536 1.373 0 C-N-CA 123.74 0.686 . . . . 0.0 112.185 177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -54.81 -32.46 77.08 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.071 2.514 . . . . 0.0 113.413 178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 82.6 m -65.18 -47.64 76.27 Favored 'General case' 0 C--N 1.339 0.122 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -59.62 -40.4 87.44 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 44.1 ttm -58.59 -46.11 87.66 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 122.96 0.504 . . . . 0.0 110.876 178.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.9 pt -76.27 -26.82 17.3 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-N 118.746 0.703 . . . . 0.0 112.555 179.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.91 -56.66 1.11 Allowed Pre-proline 0 CA--C 1.545 0.759 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -55.97 -38.89 94.03 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.217 1.944 . . . . 0.0 112.09 177.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 36.7 mt -62.11 -48.51 88.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 176.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.5 mt -56.5 -42.55 78.54 Favored 'General case' 0 CA--C 1.536 0.433 0 O-C-N 122.24 -0.288 . . . . 0.0 110.261 177.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -59.05 -48.83 80.16 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 123.188 0.595 . . . . 0.0 109.703 178.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.3 mt-10 -59.35 -49.6 77.21 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.795 -0.565 . . . . 0.0 109.832 177.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 21.6 mm -52.04 -45.95 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 123.631 0.773 . . . . 0.0 110.047 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.82 -33.42 61.58 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.691 0.397 . . . . 0.0 111.38 178.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -78.47 -54.86 5.71 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 176.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -49.88 -44.53 49.98 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.974 0.909 . . . . 0.0 112.516 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 81.6 m-85 -103.77 22.1 15.07 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 123.962 0.905 . . . . 0.0 112.189 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -51.17 135.97 24.89 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 118.876 0.762 . . . . 0.0 111.17 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.76 -23.51 3.61 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.97 -0.906 . . . . 0.0 113.531 -179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -99.38 -45.3 5.89 Favored 'General case' 0 C--N 1.34 0.184 0 CA-C-N 119.015 1.408 . . . . 0.0 110.251 -179.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.2 tp -119.02 121.69 40.46 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.183 0.993 . . . . 0.0 108.944 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 80.7 m -93.54 103.67 15.84 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 177.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 30.8 t -78.94 137.96 20.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 -178.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.57 151.08 48.98 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.053 0.941 . . . . 0.0 109.434 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.1 mtpm? -128.92 136.48 50.45 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.4 tt -127.33 122.08 32.78 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 123.194 0.597 . . . . 0.0 110.19 179.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.1 t-20 -83.07 106.34 14.8 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.047 0.539 . . . . 0.0 110.077 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.84 -26.22 36.49 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.165 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -58.51 -51.02 71.62 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 119.327 0.967 . . . . 0.0 109.298 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 31.0 mm100 -78.83 -31.06 45.62 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 123.795 0.838 . . . . 0.0 111.089 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.9 m-80 -121.82 66.46 20.79 Favored Pre-proline 0 C--O 1.234 0.255 0 C-N-CA 123.446 0.698 . . . . 0.0 111.479 -176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -61.8 -54.24 1.69 Allowed 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.379 2.053 . . . . 0.0 112.156 -177.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -37.41 -46.44 1.45 Allowed Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.881 1.705 . . . . 0.0 114.3 -177.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -52.53 -38.86 60.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 124.272 1.029 . . . . 0.0 112.938 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.55 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.4 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.538 0.518 0 CA-C-O 117.759 -1.115 . . . . 0.0 110.691 179.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 78.5 Cg_exo -50.87 -45.32 36.65 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.167 1.911 . . . . 0.0 112.695 174.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -52.51 -46.49 66.69 Favored 'General case' 0 C--N 1.344 0.34 0 CA-C-N 119.095 0.861 . . . . 0.0 111.858 -179.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -95.03 19.15 10.82 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.316 0.507 . . . . 0.0 111.648 177.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 45.95 46.07 14.39 Favored Glycine 0 C--N 1.338 0.688 0 C-N-CA 125.741 1.639 . . . . 0.0 112.996 178.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -58.19 135.66 22.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 CA-C-N 117.999 0.899 . . . . 0.0 110.372 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -79.2 -37.77 37.41 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.952 0.901 . . . . 0.0 111.164 -177.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -178.9 -161.07 25.92 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 107.788 -2.125 . . . . 0.0 107.788 -179.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 27.3 pt -139.32 141.22 28.37 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 119.055 1.427 . . . . 0.0 108.943 177.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -72.1 147.6 89.03 Favored 'Cis proline' 0 N--CA 1.454 -0.795 0 CA-C-N 119.555 0.877 . . . . 0.0 110.296 -1.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 24.0 m -145.76 127.12 14.92 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.822 -1.918 . . . . 0.0 105.822 175.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 29.8 mt -102.51 126.0 49.42 Favored 'General case' 0 N--CA 1.448 -0.535 0 C-N-CA 125.669 1.588 . . . . 0.0 108.558 -177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -116.33 120.25 38.28 Favored 'General case' 0 N--CA 1.462 0.149 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 43.8 tp -96.64 102.06 13.78 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.363 0.665 . . . . 0.0 109.444 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 74.2 m-85 -92.86 112.04 23.86 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.704 1.602 . . . . 0.0 110.116 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -96.73 112.32 24.12 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 173.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 48.82 39.07 13.27 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.572 0.749 . . . . 0.0 111.462 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.05 -16.92 55.94 Favored Glycine 0 CA--C 1.53 0.975 0 CA-C-O 119.198 -0.779 . . . . 0.0 114.514 179.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -90.23 121.02 31.88 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 119.342 1.571 . . . . 0.0 109.631 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 98.3 t -62.87 106.29 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 175.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 -43.29 22.75 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 123.444 0.698 . . . . 0.0 110.297 -178.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -159.82 168.75 25.11 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.5 p -144.72 163.2 34.7 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 178.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -142.14 121.63 13.26 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 106.765 -1.569 . . . . 0.0 106.765 176.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.1 t -96.14 132.44 40.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.457 1.103 . . . . 0.0 108.783 179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.49 167.19 42.38 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 121.598 0.555 . . . . 0.0 111.963 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.48 169.07 14.87 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 123.15 0.58 . . . . 0.0 110.266 179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -161.69 165.64 27.86 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 125.037 1.335 . . . . 0.0 107.66 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 89.9 p -75.69 159.24 31.34 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-O 121.171 0.51 . . . . 0.0 110.417 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -52.77 -46.88 67.75 Favored 'General case' 0 N--CA 1.455 -0.214 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.578 177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.46 -57.01 19.09 Favored Glycine 0 CA--C 1.528 0.889 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -54.05 -46.06 71.83 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 117.311 0.555 . . . . 0.0 111.199 179.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 31.6 tp -60.39 -51.25 70.28 Favored 'General case' 0 CA--C 1.531 0.239 0 O-C-N 122.239 -0.288 . . . . 0.0 110.683 179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -55.46 -48.53 74.36 Favored 'General case' 0 CA--C 1.528 0.104 0 O-C-N 122.18 -0.325 . . . . 0.0 110.621 178.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -57.83 -51.71 68.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.938 0.895 . . . . 0.0 110.036 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -54.36 -54.02 46.06 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.872 0.869 . . . . 0.0 109.962 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 82.5 mt -57.86 -50.03 74.69 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.209 -0.307 . . . . 0.0 110.758 -179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -54.72 -52.23 63.13 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.543 0.337 . . . . 0.0 110.156 178.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.83 -36.06 71.76 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.047 0.939 . . . . 0.0 111.947 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -78.32 -50.88 10.98 Favored 'General case' 0 C--O 1.227 -0.111 0 CA-C-N 117.918 0.326 . . . . 0.0 110.46 -178.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 53.5 mt -64.05 -42.3 97.09 Favored 'General case' 0 CA--C 1.531 0.238 0 O-C-N 122.107 -0.371 . . . . 0.0 110.575 -178.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.14 0 C-N-CA 124.717 1.207 . . . . 0.0 111.727 179.292 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.1 p . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 119.218 -0.42 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.2 t70 5.21 -85.79 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.283 0 C-N-CA 129.158 2.983 . . . . 0.0 114.725 -178.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -133.5 44.62 2.77 Favored 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 124.803 1.241 . . . . 0.0 107.696 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 5.9 mt -103.47 134.83 43.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 C-N-CA 123.479 0.712 . . . . 0.0 110.94 -177.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.5 mm -89.12 117.36 32.31 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 CA-C-O 122.207 1.003 . . . . 0.0 110.6 177.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -89.07 78.26 7.45 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.9 mt -66.81 163.87 18.45 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.747 1.219 . . . . 0.0 112.937 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.1 p -132.67 163.56 28.68 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 126.259 1.824 . . . . 0.0 106.707 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -54.74 -42.7 71.92 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 118.267 0.485 . . . . 0.0 109.743 177.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.57 -45.69 92.98 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.898 1.279 . . . . 0.0 111.709 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.7 p -78.71 -26.24 44.82 Favored 'General case' 0 CA--C 1.529 0.148 0 O-C-N 122.161 -0.337 . . . . 0.0 111.321 -178.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -37.81 -57.06 1.04 Allowed 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 125.532 1.533 . . . . 0.0 113.581 -178.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -54.79 -61.69 2.15 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-O 121.703 0.763 . . . . 0.0 110.394 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.3 m -52.26 -42.58 63.78 Favored 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.201 1.4 . . . . 0.0 113.326 -177.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -87.34 -57.48 2.94 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.961 0.504 . . . . 0.0 112.068 -176.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 19.1 t -79.92 -51.01 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.061 0.944 . . . . 0.0 112.536 -173.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.6 mt -65.7 -36.11 82.69 Favored 'General case' 0 C--O 1.227 -0.113 0 C-N-CA 119.091 -1.043 . . . . 0.0 110.215 -176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -96.79 32.64 2.04 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 119.361 -0.352 . . . . 0.0 110.826 173.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.67 114.74 1.65 Allowed 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.178 0.899 . . . . 0.0 111.601 -179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -79.09 62.59 3.54 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 177.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 136.99 -136.43 8.32 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -113.68 120.25 40.23 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.647 1.179 . . . . 0.0 108.722 -178.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 8.4 mt -111.98 125.94 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 C-N-CA 124.444 1.097 . . . . 0.0 108.299 179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -104.16 100.48 10.22 Favored 'General case' 0 CA--C 1.521 -0.16 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 15.1 t -91.94 112.7 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 122.44 0.296 . . . . 0.0 110.424 -179.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -89.35 108.06 19.42 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 173.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -79.93 120.23 23.86 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.363 -2.088 . . . . 0.0 105.363 175.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.9 p-90 -137.25 173.19 11.95 Favored 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 123.942 0.897 . . . . 0.0 111.603 -175.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -135.38 151.27 50.3 Favored 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 124.675 1.19 . . . . 0.0 108.357 177.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 67.6 mm-40 -55.04 -38.39 67.92 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.281 0.491 . . . . 0.0 111.357 -179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -83.81 -2.48 56.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.679 1.192 . . . . 0.0 112.488 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 52.1 t -79.47 80.79 5.81 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 120.948 -1.095 . . . . 0.0 110.685 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.89 -58.51 2.65 Favored Glycine 0 CA--C 1.535 1.339 0 C-N-CA 124.184 0.897 . . . . 0.0 111.919 177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -54.0 -39.58 84.57 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.428 2.752 . . . . 0.0 113.543 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.1 m -62.28 -48.7 78.72 Favored 'General case' 0 C--O 1.23 0.056 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 -179.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -61.76 -44.24 97.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 177.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 46.4 ttm -52.53 -41.46 63.51 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.08 0.952 . . . . 0.0 111.135 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.3 pt -82.58 -11.97 12.18 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 CA-C-O 118.662 -0.685 . . . . 0.0 112.775 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.75 -49.85 54.99 Favored Pre-proline 0 CA--C 1.539 0.527 0 CA-C-N 120.321 1.419 . . . . 0.0 113.423 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -55.31 -37.96 94.14 Favored 'Trans proline' 0 N--CA 1.458 -0.582 0 C-N-CA 122.315 2.01 . . . . 0.0 111.764 175.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 44.9 mt -66.56 -48.98 78.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 107.815 -1.18 . . . . 0.0 107.815 177.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.0 mt -55.52 -41.78 73.61 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.271 0.487 . . . . 0.0 110.236 177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -61.47 -52.54 64.09 Favored 'General case' 0 CA--C 1.53 0.18 0 C-N-CA 123.158 0.583 . . . . 0.0 109.92 177.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -54.06 -47.68 71.38 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.951 0.5 . . . . 0.0 109.698 178.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 20.9 mm -57.1 -49.93 78.03 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 C-N-CA 123.73 0.812 . . . . 0.0 109.539 176.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.09 -43.7 67.0 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.073 0.397 . . . . 0.0 110.064 179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -65.3 -50.83 64.18 Favored 'General case' 0 CA--C 1.535 0.382 0 CA-C-N 116.931 -0.122 . . . . 0.0 111.197 177.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 54.5 mt-10 -60.39 -44.24 95.86 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.722 1.209 . . . . 0.0 113.62 -177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -97.52 29.19 3.38 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.713 1.205 . . . . 0.0 112.131 -176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.82 132.28 18.17 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.83 -0.543 . . . . 0.0 111.418 179.375 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.13 -19.04 2.34 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-O 118.741 -1.033 . . . . 0.0 114.123 -179.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.3 mtmt -98.84 -41.75 7.49 Favored 'General case' 0 C--N 1.339 0.131 0 CA-C-N 119.429 1.614 . . . . 0.0 109.859 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 11.0 tp -129.97 119.74 23.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.542 0.737 . . . . 0.0 109.415 -178.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 57.6 m -95.41 103.73 15.6 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 57.9 t -79.24 144.06 11.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.317 -0.864 . . . . 0.0 109.8 -176.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -140.12 151.75 45.56 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.113 0.965 . . . . 0.0 109.134 178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 24.8 mtpp -133.15 103.86 6.22 Favored 'General case' 0 C--N 1.333 -0.123 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -98.69 119.57 37.66 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 122.754 0.421 . . . . 0.0 110.606 -177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 12.4 t-20 -80.15 106.35 12.1 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.495 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.83 -27.46 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.753 0.821 . . . . 0.0 112.519 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -60.05 -51.3 70.24 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 119.215 0.916 . . . . 0.0 109.385 179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -74.63 -32.15 62.2 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.71 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 26.5 m-80 -118.85 67.49 7.99 Favored Pre-proline 0 CA--C 1.532 0.27 0 C-N-CA 123.718 0.807 . . . . 0.0 111.661 -176.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -64.92 -44.72 9.48 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 110.714 -178.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.18 -37.7 4.59 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.291 1.424 . . . . 0.0 114.325 -178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -69.22 -24.34 64.01 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-N 118.255 1.027 . . . . 0.0 113.087 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.28 -59.32 14.21 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 113.299 0.852 . . . . 0.0 113.299 -179.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -62.14 -33.8 81.02 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.216 1.944 . . . . 0.0 112.377 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -48.44 -42.87 33.66 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 119.082 0.856 . . . . 0.0 111.922 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -113.19 26.48 10.42 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.365 0.666 . . . . 0.0 110.715 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 36.82 52.64 1.49 Allowed Glycine 0 CA--C 1.526 0.765 0 C-N-CA 126.035 1.778 . . . . 0.0 112.9 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.5 mp -52.44 115.62 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 118.039 0.919 . . . . 0.0 109.297 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.58 -43.99 21.93 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 122.962 0.505 . . . . 0.0 111.027 -177.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.91 142.85 7.95 Favored Glycine 0 C--N 1.335 0.524 0 N-CA-C 108.968 -1.653 . . . . 0.0 108.968 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 39.4 pt -94.45 148.13 34.45 Favored Pre-proline 0 CA--C 1.538 0.511 0 C-N-CA 124.183 0.993 . . . . 0.0 110.288 -178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.97 134.43 31.75 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.991 1.033 . . . . 0.0 110.739 -0.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.79 115.76 28.28 Favored 'General case' 0 C--N 1.338 0.074 0 N-CA-C 105.029 -2.211 . . . . 0.0 105.029 177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 24.5 mt -98.51 94.06 6.49 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 -177.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 89' ' ' THR . 9.4 mp -91.91 114.92 27.59 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -179.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.0 tp -94.09 100.12 12.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.564 0.746 . . . . 0.0 109.511 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -94.22 111.0 22.7 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.231 1.412 . . . . 0.0 110.672 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 57.0 mttp -93.86 106.94 18.89 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 173.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 44.22 52.72 7.0 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.282 0.633 . . . . 0.0 111.875 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.94 -19.91 8.99 Favored Glycine 0 CA--C 1.53 0.986 0 CA-C-O 119.314 -0.714 . . . . 0.0 114.426 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.9 mm-40 -84.35 114.37 21.82 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 119.1 1.45 . . . . 0.0 110.022 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 71.7 t -65.0 107.71 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.1 -43.26 24.46 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.64 0.776 . . . . 0.0 109.959 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.27 159.92 31.97 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.458 0.703 . . . . 0.0 109.243 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.418 HG22 ' HG ' ' A' ' 79' ' ' LEU . 45.6 p -134.11 103.77 5.93 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.439 1.096 . . . . 0.0 108.461 -179.331 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.3 tmtm? -87.59 114.95 24.67 Favored 'General case' 0 C--N 1.338 0.087 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 38.6 t -90.84 119.22 37.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 102.05 166.38 26.92 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-O 121.579 0.544 . . . . 0.0 112.436 178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.64 165.19 25.1 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.463 0.705 . . . . 0.0 110.87 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -163.89 168.62 19.24 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 126.214 1.806 . . . . 0.0 106.994 178.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.3 p -97.1 178.44 5.26 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 122.11 0.957 . . . . 0.0 112.235 -177.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 60.1 tttm -64.67 161.77 17.1 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 81.4 -60.7 4.69 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 49.9 mt-30 -61.31 -56.23 22.85 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 22.6 tp -56.9 -46.02 82.21 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.056 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 52.4 mtpt -56.14 -49.76 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 O-C-N 122.335 -0.228 . . . . 0.0 111.072 178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -57.86 -50.31 73.73 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.269 0.628 . . . . 0.0 109.831 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -52.97 -52.24 58.8 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 121.117 0.484 . . . . 0.0 110.067 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 73.0 mt -58.96 -47.1 86.31 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 122.694 0.397 . . . . 0.0 110.957 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -55.9 -54.15 48.21 Favored 'General case' 0 C--N 1.333 -0.143 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.47 -37.91 68.4 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.075 0.95 . . . . 0.0 111.983 179.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -77.89 -50.86 11.39 Favored 'General case' 0 C--O 1.227 -0.119 0 O-C-N 122.209 -0.307 . . . . 0.0 110.739 -178.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 72.5 mt -59.73 -42.87 94.12 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.137 0.575 . . . . 0.0 109.956 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.158 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 177.525 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.659 0.266 . . . . 0.0 110.318 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 35.13 -92.28 0.01 OUTLIER 'General case' 0 CA--C 1.528 0.13 0 C-N-CA 127.682 2.393 . . . . 0.0 113.406 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 24.1 mtpp -139.71 33.37 2.01 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 123.632 0.773 . . . . 0.0 110.529 -178.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.7 mt -83.26 136.21 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 O-C-N 122.07 -0.394 . . . . 0.0 111.303 -178.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.2 mm -90.28 120.66 39.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.116 0 CA-C-O 121.958 0.885 . . . . 0.0 111.121 177.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -92.86 80.93 4.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.1 0.96 . . . . 0.0 108.871 -179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 82.2 mt -66.55 164.97 15.49 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.879 1.272 . . . . 0.0 112.784 -177.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 60.6 p -132.9 163.04 30.04 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.393 -1.706 . . . . 0.0 106.393 172.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -53.71 -44.24 69.65 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.157 0.503 . . . . 0.0 109.659 177.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.9 -45.85 92.97 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 124.997 1.319 . . . . 0.0 111.963 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 21.2 p -78.35 -26.76 46.86 Favored 'General case' 0 CA--C 1.53 0.187 0 O-C-N 122.109 -0.37 . . . . 0.0 111.487 -176.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -36.93 -54.76 0.93 Allowed 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 125.737 1.615 . . . . 0.0 113.391 -179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -54.7 -62.85 1.39 Allowed 'General case' 0 CA--C 1.531 0.244 0 CA-C-O 121.447 0.641 . . . . 0.0 110.999 -179.306 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -56.73 -38.85 72.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.685 0.794 . . . . 0.0 113.108 -178.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -84.63 -59.21 2.43 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 111.716 0.265 . . . . 0.0 111.716 -175.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.5 t -79.79 -52.89 14.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 C-N-CA 124.532 1.133 . . . . 0.0 112.439 -173.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 60.7 mt -64.31 -28.61 69.83 Favored 'General case' 0 C--O 1.226 -0.136 0 C-N-CA 119.57 -0.852 . . . . 0.0 111.329 -175.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.4 mttp -103.26 35.2 2.63 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 122.813 0.445 . . . . 0.0 110.112 174.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.84 115.63 1.34 Allowed 'General case' 0 C--N 1.344 0.326 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -178.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -75.83 69.79 2.52 Favored 'General case' 0 CA--C 1.531 0.224 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.63 -107.63 1.55 Allowed Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.902 1.239 . . . . 0.0 110.051 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.35 125.79 29.93 Favored 'General case' 0 C--O 1.232 0.163 0 C-N-CA 123.625 0.77 . . . . 0.0 110.079 -177.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 13.1 mt -117.51 127.31 74.96 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.145 0 C-N-CA 124.505 1.122 . . . . 0.0 108.792 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -104.83 102.83 12.36 Favored 'General case' 0 C--N 1.337 0.055 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 34.7 t -89.76 113.23 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 110.001 -0.37 . . . . 0.0 110.001 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -93.46 111.5 23.18 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.0 m-85 -80.91 124.9 29.5 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 175.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 16.7 p-90 -139.69 -179.57 6.0 Favored 'General case' 0 CA--C 1.527 0.094 0 C-N-CA 123.861 0.864 . . . . 0.0 111.191 -176.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.27 152.4 33.17 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 124.871 1.268 . . . . 0.0 108.935 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -58.43 -22.55 54.74 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.502 1.121 . . . . 0.0 113.226 -178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.1 p-90 -99.44 -2.04 37.06 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.712 1.205 . . . . 0.0 111.727 178.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.9 t -79.96 83.92 5.8 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.021 -1.049 . . . . 0.0 112.29 -176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.83 -59.88 3.12 Favored Glycine 0 CA--C 1.538 1.519 0 C-N-CA 123.828 0.728 . . . . 0.0 112.437 177.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -53.77 -32.79 67.64 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.994 2.463 . . . . 0.0 113.337 178.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.6 m -65.13 -45.88 83.24 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 178.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -60.57 -42.25 96.27 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 176.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 84.1 mtp -57.51 -44.79 85.3 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 119.225 -0.417 . . . . 0.0 110.964 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.9 pt -77.5 -21.19 14.06 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-N 118.922 0.783 . . . . 0.0 112.734 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.52 -57.31 2.48 Favored Pre-proline 0 CA--C 1.543 0.689 0 CA-C-N 119.702 1.137 . . . . 0.0 114.024 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -56.09 -40.08 87.16 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.161 1.907 . . . . 0.0 112.055 177.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 40.1 mt -59.73 -50.61 79.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 177.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -57.2 -44.13 83.36 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.132 0.573 . . . . 0.0 110.682 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 -59.94 -51.85 67.94 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 123.636 0.775 . . . . 0.0 110.002 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -54.56 -51.43 65.27 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 123.536 0.734 . . . . 0.0 109.221 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 19.4 mm -54.51 -47.67 70.9 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.07 -46.34 75.42 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.198 0.453 . . . . 0.0 110.946 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -67.61 -43.15 81.15 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -67.82 -54.89 15.49 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.342 1.057 . . . . 0.0 112.476 -177.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 -82.57 23.46 0.78 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.401 1.08 . . . . 0.0 111.038 -179.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -59.23 101.71 0.11 Allowed 'General case' 0 N--CA 1.449 -0.525 0 C-N-CA 125.823 1.649 . . . . 0.0 110.276 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 113.45 -21.53 16.87 Favored Glycine 0 CA--C 1.531 1.035 0 C-N-CA 124.629 1.109 . . . . 0.0 111.446 -178.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -99.6 -35.67 9.77 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.707 1.203 . . . . 0.0 110.236 179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.1 tp -142.09 139.43 32.22 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.22 1.008 . . . . 0.0 109.447 -177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 54.5 m -109.51 105.33 14.61 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 61.2 t -80.09 140.96 15.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 O-C-N 121.241 -0.912 . . . . 0.0 109.264 -179.125 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.6 150.35 49.64 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.69 0.796 . . . . 0.0 109.459 178.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp -131.19 103.06 6.27 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.884 1.274 . . . . 0.0 108.101 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -98.32 119.78 37.6 Favored 'General case' 0 C--O 1.231 0.114 0 O-C-N 121.815 -0.553 . . . . 0.0 110.407 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -81.89 108.82 15.71 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.028 0.531 . . . . 0.0 109.684 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 pp -66.04 -25.01 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 C-N-CA 123.32 0.648 . . . . 0.0 111.894 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 67.9 m-20 -63.1 -47.68 81.8 Favored 'General case' 0 C--N 1.341 0.204 0 CA-C-N 119.294 0.952 . . . . 0.0 108.542 177.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -71.99 -32.82 67.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.572 177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -124.32 69.52 51.64 Favored Pre-proline 0 CA--C 1.534 0.339 0 C-N-CA 123.506 0.722 . . . . 0.0 112.638 -176.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -53.21 -50.78 12.78 Favored 'Trans proline' 0 N--CA 1.455 -0.753 0 C-N-CA 122.332 2.021 . . . . 0.0 111.897 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.54 -42.45 3.55 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 125.705 1.621 . . . . 0.0 114.989 -177.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.08 -23.63 64.96 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 118.289 1.045 . . . . 0.0 112.85 -177.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.37 -62.37 6.07 Favored Pre-proline 0 CA--C 1.538 0.495 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -59.65 -42.34 47.8 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 121.799 1.666 . . . . 0.0 111.376 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -47.03 -44.74 20.82 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.276 0.63 . . . . 0.0 111.866 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 78.4 m-85 -106.52 24.86 11.92 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.96 47.04 26.14 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 123.892 0.758 . . . . 0.0 113.045 177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.1 mm -80.23 77.06 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 33.5 mtm180 -79.16 -5.29 53.86 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 123.543 0.737 . . . . 0.0 111.583 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -164.6 171.34 40.04 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 107.572 -2.211 . . . . 0.0 107.572 178.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 19.6 pt -148.83 152.69 37.69 Favored Pre-proline 0 CA--C 1.538 0.494 0 C-N-CA 125.235 1.414 . . . . 0.0 107.421 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -68.53 142.66 68.0 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 CA-C-N 120.651 1.268 . . . . 0.0 110.029 -0.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 20.5 m -137.31 114.96 11.23 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 31.9 mt -95.24 127.8 41.58 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 125.089 1.356 . . . . 0.0 108.941 -177.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 8.9 mp -119.73 119.02 32.42 Favored 'General case' 0 C--O 1.231 0.113 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 27.0 tp -97.16 104.02 16.0 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.037 0.535 . . . . 0.0 109.655 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -93.33 106.43 18.4 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.799 1.639 . . . . 0.0 109.823 -179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.9 mtpt -93.17 114.55 27.07 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 47.39 47.11 17.17 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.098 0.959 . . . . 0.0 110.972 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.64 -14.49 30.09 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.092 -0.838 . . . . 0.0 114.723 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.5 mm-40 -94.92 122.5 37.63 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 119.218 1.509 . . . . 0.0 110.157 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.3 t -62.78 106.3 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 176.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.29 -43.47 23.61 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.635 0.774 . . . . 0.0 109.755 -178.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.41 169.12 23.73 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.359 -0.978 . . . . 0.0 108.359 178.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 31.4 p -139.46 164.93 28.56 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.2 tmtt? -149.28 116.72 6.13 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 177.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.7 t -94.76 133.73 34.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.037 -1.097 . . . . 0.0 108.037 178.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.16 163.94 39.85 Favored Glycine 0 CA--C 1.527 0.816 0 C-N-CA 123.57 0.605 . . . . 0.0 111.674 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.62 167.57 16.64 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.277 0.631 . . . . 0.0 110.815 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -162.01 167.61 24.16 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.989 1.316 . . . . 0.0 108.074 179.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.4 p -79.5 165.97 22.45 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-O 121.318 0.58 . . . . 0.0 111.29 -178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -56.19 -45.24 79.88 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 174.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -58.46 -57.66 18.67 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.854 0.74 . . . . 0.0 111.432 178.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -57.68 -40.95 80.58 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-N 117.684 0.742 . . . . 0.0 110.701 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.64 -50.8 71.06 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-O 119.214 -0.422 . . . . 0.0 109.978 177.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 24.3 mtpp -53.16 -51.3 62.48 Favored 'General case' 0 C--N 1.339 0.146 0 CA-C-N 118.482 0.583 . . . . 0.0 110.19 176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -53.72 -53.28 54.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.572 0.749 . . . . 0.0 110.47 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -54.29 -52.48 61.31 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 123.711 0.804 . . . . 0.0 110.491 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.7 mt -58.12 -52.47 65.42 Favored 'General case' 0 C--O 1.224 -0.259 0 C-N-CA 122.61 0.364 . . . . 0.0 110.584 -179.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -54.12 -52.86 59.73 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.668 0.787 . . . . 0.0 109.68 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -54.54 -40.72 68.96 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.585 0.754 . . . . 0.0 111.916 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 25.5 m-80 -78.23 -48.12 16.47 Favored 'General case' 0 C--O 1.228 -0.064 0 O-C-N 122.326 -0.234 . . . . 0.0 111.168 -177.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 64.6 mt -57.22 -46.24 83.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.515 0.726 . . . . 0.0 109.3 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.192 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 177.123 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 CA--C 1.531 0.248 0 N-CA-C 111.3 0.111 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -67.13 103.62 1.24 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 122.625 0.37 . . . . 0.0 110.881 -178.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -122.78 35.43 4.88 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 173.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mt -84.58 138.32 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 C-N-CA 123.127 0.571 . . . . 0.0 111.088 -175.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.6 mm -91.79 113.6 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.378 0.671 . . . . 0.0 110.808 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.2 m80 -84.36 99.43 10.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 124.396 1.078 . . . . 0.0 109.28 -179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.1 mt -85.73 171.19 11.8 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 124.202 1.001 . . . . 0.0 111.481 -177.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 58.7 p -137.37 166.43 23.84 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 171.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -52.81 -41.95 64.65 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.287 171.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -63.63 -47.93 79.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.642 1.177 . . . . 0.0 111.904 -179.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 16.0 p -78.37 -26.41 46.62 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -35.14 -54.16 0.61 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 125.368 1.467 . . . . 0.0 113.898 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -55.02 -65.47 0.57 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.523 0.677 . . . . 0.0 111.013 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.1 m -56.46 -37.5 70.37 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.166 0.987 . . . . 0.0 112.746 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.39 -60.72 1.95 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 112.054 0.39 . . . . 0.0 112.054 -177.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.87 -50.14 18.23 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 C-N-CA 123.962 0.905 . . . . 0.0 112.479 -173.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.07 -32.5 74.0 Favored 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 119.194 -1.003 . . . . 0.0 111.078 -176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -98.8 27.59 4.83 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 122.512 0.325 . . . . 0.0 110.872 174.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.89 73.22 0.26 Allowed 'General case' 0 C--N 1.343 0.291 0 O-C-N 121.522 -0.736 . . . . 0.0 111.863 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -68.09 73.49 0.2 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.373 1.069 . . . . 0.0 109.991 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 162.24 -121.05 0.99 Allowed Glycine 0 CA--C 1.527 0.803 0 N-CA-C 106.105 -2.798 . . . . 0.0 106.105 -177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -148.66 120.0 7.87 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 177.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.7 mt -116.85 124.24 72.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 125.09 1.356 . . . . 0.0 108.14 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 13.1 tp -100.95 102.68 13.75 Favored 'General case' 0 C--O 1.228 -0.051 0 N-CA-C 108.072 -1.085 . . . . 0.0 108.072 177.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.4 t -86.57 113.68 24.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 122.657 0.383 . . . . 0.0 110.426 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -95.48 109.54 21.73 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.528 1.131 . . . . 0.0 108.634 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -79.97 122.04 26.22 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 106.901 -1.518 . . . . 0.0 106.901 176.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 26.4 p-90 -136.81 178.65 6.91 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.583 1.153 . . . . 0.0 111.063 -178.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.02 154.26 36.72 Favored 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 125.858 1.663 . . . . 0.0 108.004 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.1 mp0 -54.56 -40.51 68.8 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 119.295 0.952 . . . . 0.0 112.035 -179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.8 p-90 -79.34 -2.43 41.49 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.546 1.138 . . . . 0.0 112.968 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 47.5 t -79.41 78.58 5.91 Favored 'General case' 0 CA--C 1.53 0.193 0 O-C-N 120.901 -1.124 . . . . 0.0 111.55 -177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.26 -57.61 3.63 Favored Glycine 0 CA--C 1.537 1.456 0 C-N-CA 123.772 0.701 . . . . 0.0 112.206 177.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -54.26 -34.42 79.56 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.902 2.401 . . . . 0.0 113.239 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.2 m -63.67 -46.34 86.02 Favored 'General case' 0 C--N 1.341 0.196 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 178.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.1 mmtp -59.07 -46.75 87.47 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 176.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 81.8 mtp -55.07 -43.83 74.24 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 119.112 -0.47 . . . . 0.0 111.569 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.0 pt -80.37 -20.71 11.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-N 118.916 0.78 . . . . 0.0 112.97 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.15 -52.65 9.4 Favored Pre-proline 0 CA--C 1.543 0.678 0 CA-C-N 119.977 1.262 . . . . 0.0 114.238 -178.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_exo -52.9 -41.14 72.87 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 122.493 2.129 . . . . 0.0 112.143 175.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.6 mt -62.92 -49.58 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 178.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 81.3 mt -54.96 -42.28 72.16 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.136 -0.32 . . . . 0.0 110.136 177.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.8 m-20 -62.5 -45.82 91.25 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.925 0.49 . . . . 0.0 110.176 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -59.24 -46.92 87.19 Favored 'General case' 0 C--N 1.334 -0.094 0 O-C-N 121.717 -0.614 . . . . 0.0 109.775 178.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 34.9 mm -57.67 -48.4 83.44 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.38 -43.39 64.7 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 123.231 0.612 . . . . 0.0 110.381 179.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -68.82 -63.46 1.06 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.448 176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -45.41 -47.11 13.66 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.956 1.302 . . . . 0.0 113.618 -177.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -95.09 21.54 7.66 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.023 0.929 . . . . 0.0 112.295 -177.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.59 130.92 17.57 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.435 1.016 . . . . 0.0 110.302 176.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.09 -18.18 4.3 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 119.209 -0.773 . . . . 0.0 114.209 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.6 mtpt -99.29 -39.39 8.45 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.821 1.31 . . . . 0.0 109.768 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -140.74 136.62 32.73 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 124.232 1.013 . . . . 0.0 108.361 -179.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 55.4 m -102.23 107.46 18.52 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 106.781 -1.563 . . . . 0.0 106.781 175.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 92.0 t -79.0 135.89 24.87 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 106.286 -1.746 . . . . 0.0 106.286 178.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -134.23 154.3 51.35 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 123.534 0.733 . . . . 0.0 109.323 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -128.36 144.77 51.18 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.206 1.402 . . . . 0.0 108.707 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 7.9 tt -134.37 129.42 35.39 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -97.38 100.89 12.34 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 -175.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -57.09 -30.1 33.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.297 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 27.9 m-20 -61.77 -46.1 91.04 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 119.27 0.941 . . . . 0.0 109.966 179.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -88.58 -19.33 26.44 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 125.365 1.466 . . . . 0.0 111.771 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -127.24 55.52 15.61 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 125.413 1.485 . . . . 0.0 109.946 -176.393 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.25 -42.67 21.56 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.722 2.281 . . . . 0.0 112.295 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -45.47 -33.68 4.52 Favored Glycine 0 CA--C 1.53 0.997 0 C-N-CA 124.578 1.085 . . . . 0.0 113.827 -178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -76.2 -23.87 54.67 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.435 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -64.4 -55.66 28.76 Favored Pre-proline 0 CA--C 1.541 0.621 0 CA-C-N 119.286 0.948 . . . . 0.0 112.407 -179.072 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.435 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 72.2 Cg_exo -51.52 -41.83 58.57 Favored 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 123.281 2.654 . . . . 0.0 113.496 177.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -45.65 -46.55 14.68 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.511 0.724 . . . . 0.0 112.574 -178.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 76.0 m-85 -108.03 16.53 23.31 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.2 0.6 . . . . 0.0 111.197 179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 46.46 47.22 17.21 Favored Glycine 0 C--N 1.339 0.726 0 C-N-CA 125.195 1.379 . . . . 0.0 111.216 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.3 mm -51.61 115.78 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-N 117.5 0.65 . . . . 0.0 109.838 -177.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.02 -28.54 43.32 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.279 1.032 . . . . 0.0 112.07 -173.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -176.14 -167.78 35.42 Favored Glycine 0 CA--C 1.522 0.505 0 N-CA-C 107.661 -2.175 . . . . 0.0 107.661 -178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 17.7 pt -146.76 151.02 41.36 Favored Pre-proline 0 CA--C 1.535 0.38 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -69.95 143.36 74.0 Favored 'Cis proline' 0 N--CA 1.457 -0.657 0 CA-C-N 120.328 1.153 . . . . 0.0 110.204 -0.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 30.2 m -139.69 126.01 20.15 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.57 116.14 31.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.022 1.729 . . . . 0.0 108.948 -174.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.405 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.2 mp -110.13 119.33 38.93 Favored 'General case' 0 N--CA 1.463 0.203 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 176.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 32.3 tp -94.55 106.3 18.27 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -101.23 128.94 47.13 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 125.352 1.461 . . . . 0.0 111.707 -178.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -113.11 102.04 10.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 104.589 -2.375 . . . . 0.0 104.589 171.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 42.34 58.38 3.04 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.056 1.342 . . . . 0.0 111.738 -177.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 81.84 -24.13 4.69 Favored Glycine 0 CA--C 1.527 0.831 0 CA-C-O 119.504 -0.609 . . . . 0.0 113.784 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -79.78 109.12 13.89 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.664 1.232 . . . . 0.0 109.239 -179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.7 t -66.04 111.32 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.275 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.08 -43.71 23.61 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.429 0.692 . . . . 0.0 109.746 -179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.24 161.13 33.38 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.405 HG22 ' HG ' ' A' ' 79' ' ' LEU . 80.5 p -135.59 135.41 40.25 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.401 1.08 . . . . 0.0 109.157 -179.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.7 127.97 49.95 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 60.0 t -107.74 129.19 62.19 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 N-CA-C 107.962 -1.125 . . . . 0.0 107.962 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 90.17 173.72 44.98 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.053 0.835 . . . . 0.0 111.43 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.02 171.35 13.65 Favored 'General case' 0 CA--C 1.533 0.316 0 O-C-N 122.34 -0.506 . . . . 0.0 110.221 178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -164.3 164.46 22.33 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.528 1.531 . . . . 0.0 107.617 179.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.2 p -73.9 161.17 30.42 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-O 121.124 0.488 . . . . 0.0 110.764 179.638 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -56.43 -42.93 78.89 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.89 -58.65 13.08 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -53.33 -45.49 69.09 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 117.265 0.532 . . . . 0.0 110.872 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.5 tp -59.8 -52.06 67.08 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 110.471 -0.196 . . . . 0.0 110.471 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.8 mtpp -55.83 -46.94 78.02 Favored 'General case' 0 CA--C 1.529 0.173 0 O-C-N 122.111 -0.368 . . . . 0.0 110.893 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.95 -52.86 63.76 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.622 0.769 . . . . 0.0 109.901 179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -53.79 -53.14 56.48 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.223 1.009 . . . . 0.0 110.219 178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.3 mt -58.96 -50.32 74.51 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 122.402 0.281 . . . . 0.0 110.685 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.36 -49.83 71.26 Favored 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 122.603 0.361 . . . . 0.0 110.491 178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.62 -39.75 77.64 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.551 0.741 . . . . 0.0 111.521 179.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -77.65 -46.38 22.17 Favored 'General case' 0 C--O 1.227 -0.116 0 O-C-N 122.151 -0.343 . . . . 0.0 110.923 -177.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 56.6 mt -62.3 -43.77 98.06 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 C-N-CA 125.606 1.562 . . . . 0.0 108.501 178.089 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 50.7 m . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -73.88 90.33 1.91 Allowed 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 177.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -113.61 36.89 3.42 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 176.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 mt -100.82 138.19 25.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.985 0.914 . . . . 0.0 111.507 -175.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.3 mm -92.83 118.55 38.72 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.146 0 C-N-CA 123.48 0.712 . . . . 0.0 110.542 178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -87.74 101.3 13.55 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.24 1.016 . . . . 0.0 109.292 -179.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 72.6 mt -87.94 168.34 12.96 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.549 1.14 . . . . 0.0 112.593 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 53.6 p -135.43 162.12 33.52 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 172.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.83 -43.83 69.74 Favored 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -60.78 -46.24 91.25 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.968 1.307 . . . . 0.0 112.014 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.27 -26.46 47.17 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 122.028 -0.42 . . . . 0.0 111.467 -176.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -35.97 -54.12 0.76 Allowed 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 125.745 1.618 . . . . 0.0 113.633 -179.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -55.34 -62.3 1.76 Allowed 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 121.282 0.563 . . . . 0.0 110.939 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.4 m -59.03 -40.3 84.6 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 123.281 0.632 . . . . 0.0 112.44 -176.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.19 -58.38 3.09 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 112.409 0.522 . . . . 0.0 112.409 -176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 31.1 t -80.74 -52.35 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 C-N-CA 123.885 0.874 . . . . 0.0 112.349 -173.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 67.2 mt -63.36 -26.13 68.61 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 119.367 -0.933 . . . . 0.0 111.635 -176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -103.09 36.12 2.33 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.078 0.551 . . . . 0.0 109.859 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -44.4 136.36 4.17 Favored 'General case' 0 C--N 1.343 0.316 0 N-CA-C 115.88 1.807 . . . . 0.0 115.88 -175.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -72.74 75.62 1.12 Allowed 'General case' 0 N--CA 1.452 -0.325 0 C-N-CA 124.208 1.003 . . . . 0.0 108.74 175.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.89 -74.64 1.57 Allowed Glycine 0 CA--C 1.526 0.767 0 N-CA-C 110.909 -0.876 . . . . 0.0 110.909 -179.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -136.12 121.46 19.24 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 117.888 0.844 . . . . 0.0 109.857 -178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.1 mt -118.68 132.03 69.74 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.108 0 C-N-CA 124.316 1.046 . . . . 0.0 108.531 177.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -111.84 100.92 9.3 Favored 'General case' 0 C--O 1.229 -0.025 0 N-CA-C 107.562 -1.273 . . . . 0.0 107.562 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -90.16 117.64 33.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 C-N-CA 122.661 0.385 . . . . 0.0 110.75 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -97.43 109.39 22.15 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.882 1.273 . . . . 0.0 108.882 174.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.0 m-85 -82.43 124.18 29.81 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 176.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 24.9 p-90 -142.38 172.83 12.16 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -176.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 147.98 40.23 Favored 'General case' 0 C--N 1.339 0.134 0 C-N-CA 125.293 1.437 . . . . 0.0 110.195 178.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.5 mp0 -54.92 -35.87 64.64 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 123.177 0.591 . . . . 0.0 112.033 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 44.5 p-90 -84.81 -5.67 59.33 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.954 0.902 . . . . 0.0 112.358 179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.4 t -79.85 82.01 6.01 Favored 'General case' 0 N--CA 1.453 -0.283 0 O-C-N 121.063 -1.023 . . . . 0.0 110.728 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.76 -57.51 3.37 Favored Glycine 0 CA--C 1.536 1.406 0 C-N-CA 123.941 0.782 . . . . 0.0 111.983 177.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -54.51 -34.36 81.81 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.148 2.565 . . . . 0.0 113.435 178.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 73.4 m -65.76 -49.57 67.91 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 178.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.2 mtpt -58.98 -39.98 83.42 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.635 177.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 54.5 ttp -58.52 -47.69 83.33 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.203 0.601 . . . . 0.0 110.426 177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.2 pt -75.83 -25.01 17.0 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-O 118.626 -0.702 . . . . 0.0 112.659 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -58.02 1.16 Allowed Pre-proline 0 CA--C 1.544 0.737 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -56.13 -40.63 83.63 Favored 'Trans proline' 0 N--CA 1.458 -0.577 0 C-N-CA 122.192 1.928 . . . . 0.0 111.521 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.0 mt -58.97 -49.97 81.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 176.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 72.1 mt -55.77 -42.52 75.62 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 117.889 0.313 . . . . 0.0 110.46 177.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -59.9 -53.66 55.22 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 178.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.09 -45.89 75.47 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.62 -0.675 . . . . 0.0 110.392 178.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.6 mm -57.07 -48.62 81.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 123.017 0.527 . . . . 0.0 109.648 176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.84 -42.63 76.04 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.557 0.743 . . . . 0.0 110.27 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -63.52 -56.73 13.71 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 177.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -49.57 -51.0 40.02 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.992 1.317 . . . . 0.0 112.028 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -96.98 23.7 6.97 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.797 0.839 . . . . 0.0 112.525 -177.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -54.89 128.93 35.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.461 1.028 . . . . 0.0 110.461 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.51 -16.99 21.94 Favored Glycine 0 CA--C 1.532 1.141 0 CA-C-O 119.259 -0.745 . . . . 0.0 113.298 -178.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -99.52 -42.72 6.8 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 118.674 1.237 . . . . 0.0 109.365 179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 10.4 tp -134.11 119.25 18.67 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.807 1.243 . . . . 0.0 107.648 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 81.8 m -86.24 102.78 14.25 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 177.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 85.5 t -78.63 139.96 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 106.817 -1.549 . . . . 0.0 106.817 178.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.55 154.59 49.8 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.2 mttm -129.19 145.17 51.38 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 125.136 1.374 . . . . 0.0 108.489 177.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.6 tt -137.19 123.39 20.49 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 7.8 t-20 -84.53 109.38 17.89 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -62.8 -31.54 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -60.38 -52.72 64.02 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 118.998 0.817 . . . . 0.0 110.069 -179.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -71.82 -30.82 65.9 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.826 178.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -117.64 71.14 7.13 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 123.801 0.84 . . . . 0.0 110.935 -177.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -61.94 -53.98 1.79 Allowed 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.716 2.277 . . . . 0.0 112.597 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.71 -45.81 2.08 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 125.38 1.467 . . . . 0.0 114.358 -177.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -34.55 65.53 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 124.4 1.08 . . . . 0.0 113.356 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -55.41 -66.34 1.07 Allowed Pre-proline 0 CA--C 1.536 0.419 0 CA-C-O 118.212 -0.899 . . . . 0.0 112.842 -177.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -58.88 -42.9 48.01 Favored 'Trans proline' 0 N--CA 1.454 -0.85 0 CA-C-N 121.228 1.474 . . . . 0.0 111.106 178.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? -50.35 -46.09 55.5 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.452 0.569 . . . . 0.0 111.692 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -100.32 24.62 8.55 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 178.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.38 41.8 24.97 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 124.07 0.843 . . . . 0.0 113.584 177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 31.5 mm -76.82 76.36 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.18 -4.48 50.71 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.34 0.656 . . . . 0.0 111.451 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -165.45 171.44 40.72 Favored Glycine 0 CA--C 1.524 0.636 0 N-CA-C 107.383 -2.287 . . . . 0.0 107.383 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 18.0 pt -147.99 152.15 39.59 Favored Pre-proline 0 CA--C 1.538 0.513 0 C-N-CA 124.93 1.292 . . . . 0.0 107.54 179.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -69.19 146.27 80.5 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 CA-C-N 120.365 1.166 . . . . 0.0 110.042 -1.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.0 m -137.82 123.54 19.89 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 179.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 23.6 mt -108.58 112.64 25.11 Favored 'General case' 0 N--CA 1.449 -0.505 0 C-N-CA 125.727 1.611 . . . . 0.0 109.173 -174.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.418 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.1 mp -104.86 122.28 45.43 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 177.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.8 tp -96.55 99.75 11.37 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.787 0.835 . . . . 0.0 109.278 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -89.55 107.36 19.03 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.862 1.665 . . . . 0.0 109.708 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -92.49 112.2 24.07 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 105.983 -1.858 . . . . 0.0 105.983 174.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 45.23 45.7 9.65 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.297 1.039 . . . . 0.0 111.083 -177.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.2 -13.58 56.89 Favored Glycine 0 CA--C 1.531 1.048 0 CA-C-O 119.125 -0.82 . . . . 0.0 115.077 178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -95.44 121.38 37.06 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 119.151 1.476 . . . . 0.0 109.967 -179.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 80.1 t -62.89 102.47 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 176.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -80.0 -41.76 25.21 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 123.867 0.867 . . . . 0.0 110.976 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -153.11 159.16 42.72 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 -179.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.418 HG22 ' HG ' ' A' ' 79' ' ' LEU . 82.2 p -138.54 131.13 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.262 1.025 . . . . 0.0 109.299 -178.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.2 tmtt? -120.27 117.68 28.46 Favored 'General case' 0 CA--C 1.527 0.095 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 61.8 t -97.35 134.06 36.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.26 163.65 39.46 Favored Glycine 0 CA--C 1.527 0.84 0 C-N-CA 123.663 0.649 . . . . 0.0 111.864 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.34 169.12 14.52 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.395 0.678 . . . . 0.0 110.488 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.0 pt? -162.61 168.66 21.41 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.627 1.171 . . . . 0.0 108.531 179.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 149.47 33.88 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 124.747 1.219 . . . . 0.0 110.609 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -52.47 -49.18 65.18 Favored 'General case' 0 C--O 1.226 -0.167 0 C-N-CA 123.173 0.589 . . . . 0.0 111.252 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.77 42.14 Favored Glycine 0 CA--C 1.528 0.878 0 N-CA-C 110.887 -0.885 . . . . 0.0 110.887 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 2.9 mp0 -58.67 -43.17 89.8 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 122.97 0.508 . . . . 0.0 110.418 179.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 27.3 tp -60.3 -50.55 73.19 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.4 mtpt -54.63 -49.94 69.33 Favored 'General case' 0 C--N 1.338 0.074 0 O-C-N 122.045 -0.409 . . . . 0.0 110.503 177.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -56.46 -52.79 63.37 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 124.08 0.952 . . . . 0.0 110.095 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -54.27 -53.76 49.33 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.671 0.788 . . . . 0.0 110.19 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 85.4 mt -58.12 -49.95 75.19 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 119.355 -0.355 . . . . 0.0 110.624 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -53.97 -51.36 64.11 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-N 117.968 0.349 . . . . 0.0 110.138 177.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.31 -36.41 71.07 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.791 0.837 . . . . 0.0 111.894 179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -77.7 -46.01 23.16 Favored 'General case' 0 CA--C 1.528 0.103 0 O-C-N 121.988 -0.445 . . . . 0.0 109.855 -178.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 24.9 mt -59.26 -46.48 88.41 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.298 0 C-N-CA 123.062 0.545 . . . . 0.0 109.624 177.571 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 55.5 p . . . . . 0 CA--C 1.533 0.315 0 CA-C-O 120.763 0.316 . . . . 0.0 110.678 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -73.94 100.51 3.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 O-C-N 122.11 -0.369 . . . . 0.0 110.172 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 86.5 mttt -120.43 33.36 5.62 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.3 mt -85.58 138.31 19.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 123.136 0.574 . . . . 0.0 111.166 -175.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.5 mm -92.57 119.99 41.1 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.099 0 CA-C-O 121.283 0.563 . . . . 0.0 110.365 179.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 72.9 m80 -88.94 103.55 16.14 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.444 1.097 . . . . 0.0 109.34 -178.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 70.0 mt -90.22 164.99 14.19 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.612 1.165 . . . . 0.0 113.206 -175.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 62.4 p -136.07 162.21 33.53 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 105.846 -1.909 . . . . 0.0 105.846 172.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -53.65 -44.14 69.38 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 118.331 0.514 . . . . 0.0 109.939 178.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -60.23 -46.24 90.47 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.925 1.29 . . . . 0.0 112.096 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 24.6 p -78.56 -26.17 45.56 Favored 'General case' 0 C--O 1.234 0.277 0 O-C-N 122.085 -0.385 . . . . 0.0 111.482 -176.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -36.98 -54.43 0.95 Allowed 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 126.015 1.726 . . . . 0.0 114.125 -178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -52.69 -60.2 3.55 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.521 -0.737 . . . . 0.0 111.159 -177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.03 -44.53 97.26 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 123.592 0.757 . . . . 0.0 112.335 -178.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.8 -27.01 50.01 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 -173.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 59.0 t -117.8 -62.55 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 C-N-CA 124.017 0.927 . . . . 0.0 111.746 -175.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 74.2 mt -60.86 -35.81 77.56 Favored 'General case' 0 CA--C 1.527 0.084 0 O-C-N 121.949 -0.47 . . . . 0.0 111.444 -175.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.6 mtpm? -91.11 5.72 47.85 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 119.222 -0.418 . . . . 0.0 112.124 177.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -74.49 98.0 3.24 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 119.755 1.161 . . . . 0.0 111.13 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -73.6 69.48 1.26 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.13 -160.44 27.43 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 107.916 -2.074 . . . . 0.0 107.916 -178.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -105.15 119.16 38.35 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 117.805 0.802 . . . . 0.0 109.124 178.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -112.46 139.25 38.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 C-N-CA 126.147 1.779 . . . . 0.0 107.793 177.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -122.97 99.35 6.33 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 177.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 28.8 t -90.92 114.12 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 110.357 -0.238 . . . . 0.0 110.357 -178.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -91.59 107.58 19.3 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.159 0.983 . . . . 0.0 108.404 174.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -79.72 120.41 23.98 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 106.379 -1.711 . . . . 0.0 106.379 176.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.2 p-90 -136.49 179.46 6.35 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.968 0.907 . . . . 0.0 110.868 -178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -151.84 154.69 36.67 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.275 1.03 . . . . 0.0 109.652 178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -56.25 -26.33 51.14 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.775 1.23 . . . . 0.0 112.333 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 60.9 p-90 -93.75 -8.22 41.31 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.526 1.131 . . . . 0.0 112.483 178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 51.3 t -79.74 82.88 5.77 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 120.992 -1.067 . . . . 0.0 112.903 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.42 -58.23 4.69 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.571 0.605 . . . . 0.0 112.469 176.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_exo -53.16 -32.28 58.98 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.2 2.6 . . . . 0.0 113.236 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.7 m -65.45 -43.85 89.08 Favored 'General case' 0 N--CA 1.455 -0.183 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 50.7 mttp -63.24 -41.78 99.13 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 176.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 50.9 ttp -55.11 -47.73 74.58 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.618 0.367 . . . . 0.0 110.83 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.1 pt -76.54 -26.92 16.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.14 -56.66 1.18 Allowed Pre-proline 0 CA--C 1.543 0.701 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_endo -57.44 -35.94 98.81 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.183 1.922 . . . . 0.0 111.953 178.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 37.0 mt -64.73 -49.45 80.14 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.042 -1.466 . . . . 0.0 107.042 176.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 70.5 mt -54.51 -42.22 70.55 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.799 0.272 . . . . 0.0 110.473 177.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -61.83 -51.46 68.15 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 178.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.2 tm-20 -52.69 -47.96 66.88 Favored 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.934 -0.478 . . . . 0.0 109.863 178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 28.3 mm -59.12 -48.58 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 C-N-CA 123.39 0.676 . . . . 0.0 109.421 177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.69 -43.21 65.44 Favored 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 123.182 0.593 . . . . 0.0 110.05 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -67.12 -61.65 1.82 Allowed 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 116.588 -0.278 . . . . 0.0 110.751 178.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -53.14 -48.4 67.94 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.113 0.965 . . . . 0.0 112.397 -176.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -88.7 13.52 12.16 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.757 0.823 . . . . 0.0 112.248 -177.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -55.08 116.5 2.82 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 119.906 1.23 . . . . 0.0 109.729 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 106.66 -26.79 18.61 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 123.798 0.713 . . . . 0.0 111.585 -178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 31.6 mtmm -99.19 -42.15 7.17 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.681 0.793 . . . . 0.0 109.765 178.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.0 tp -129.08 141.34 51.24 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.296 1.038 . . . . 0.0 109.956 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 3.9 m -108.59 96.81 6.59 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 106.692 -1.595 . . . . 0.0 106.692 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 63.8 t -78.92 136.42 23.83 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 O-C-N 121.213 -0.929 . . . . 0.0 108.534 -177.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.66 157.44 46.48 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 123.937 0.895 . . . . 0.0 109.249 -179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.4 mttm -131.97 146.52 52.14 Favored 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 125.279 1.432 . . . . 0.0 108.789 178.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -138.45 124.98 20.68 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 45.8 t-20 -86.97 108.55 18.87 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 178.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 14.5 pt -65.43 -23.56 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 112.373 0.508 . . . . 0.0 112.373 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -62.16 -45.36 93.75 Favored 'General case' 0 N--CA 1.461 0.117 0 CA-C-N 119.132 0.878 . . . . 0.0 108.794 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -77.49 -35.18 53.87 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.371 178.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.0 m-80 -123.03 69.13 37.3 Favored Pre-proline 0 CA--C 1.533 0.318 0 C-N-CA 123.986 0.914 . . . . 0.0 111.51 -175.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.24 -55.86 1.09 Allowed 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.102 1.868 . . . . 0.0 112.19 -177.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -41.3 -40.65 2.68 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 125.782 1.658 . . . . 0.0 114.691 -176.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.55 -33.7 68.4 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 122.092 -0.652 . . . . 0.0 112.494 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.544 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -64.58 -65.07 2.17 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.113 -0.946 . . . . 0.0 110.581 178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.544 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 80.5 Cg_exo -48.21 -42.99 32.6 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 122.783 2.322 . . . . 0.0 112.786 174.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 10.6 mtpm? -49.84 -42.38 47.22 Favored 'General case' 0 C--N 1.343 0.325 0 CA-C-N 118.942 0.792 . . . . 0.0 112.027 179.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -103.82 25.3 10.01 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.043 0.383 . . . . 0.0 111.502 178.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.77 46.32 48.27 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.432 1.015 . . . . 0.0 113.172 178.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 58.8 mt -94.27 105.96 17.53 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.71 -30.04 40.84 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.659 0.784 . . . . 0.0 112.431 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.97 -179.14 26.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.617 -0.993 . . . . 0.0 110.617 -177.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 pt -143.02 159.31 56.68 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 125.63 1.572 . . . . 0.0 108.347 -178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -67.44 141.37 57.48 Favored 'Cis proline' 0 N--CA 1.459 -0.534 0 CA-C-N 120.727 1.295 . . . . 0.0 110.308 -0.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 54.7 m -141.07 125.72 17.88 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 106.649 -1.611 . . . . 0.0 106.649 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 21.8 mt -108.51 107.37 17.86 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.274 1.43 . . . . 0.0 109.516 -174.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.447 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -95.79 116.13 28.44 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 177.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -93.5 99.9 12.29 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 178.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -92.91 112.33 24.25 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.225 1.41 . . . . 0.0 108.949 179.069 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -102.29 118.2 36.37 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 175.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.3 43.38 31.53 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.607 0.763 . . . . 0.0 109.524 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.88 -0.98 33.95 Favored Glycine 0 CA--C 1.534 1.232 0 CA-C-O 118.665 -1.075 . . . . 0.0 114.816 -179.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -102.5 125.1 49.1 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.602 1.701 . . . . 0.0 109.492 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 82.0 t -61.34 104.64 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.99 -43.32 22.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.674 0.79 . . . . 0.0 110.067 179.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.67 156.45 34.97 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 123.09 0.556 . . . . 0.0 109.805 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.447 HG22 ' HG ' ' A' ' 79' ' ' LEU . 77.0 p -132.07 112.45 12.35 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 124.673 1.189 . . . . 0.0 109.025 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 7.5 tmtt? -98.73 110.85 23.39 Favored 'General case' 0 C--O 1.228 -0.073 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 178.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -90.59 131.96 36.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 177.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.29 162.69 38.46 Favored Glycine 0 CA--C 1.528 0.871 0 C-N-CA 123.744 0.688 . . . . 0.0 111.996 179.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.43 170.06 12.75 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.223 0.609 . . . . 0.0 110.442 179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -164.54 163.75 21.89 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 125.027 1.331 . . . . 0.0 108.002 -179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 94.9 p -73.79 163.08 28.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-O 121.124 0.487 . . . . 0.0 110.817 179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -55.41 -44.63 76.38 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 175.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.36 -54.52 36.49 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 178.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -56.65 -44.47 81.34 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 117.272 0.536 . . . . 0.0 110.404 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.2 tp -59.79 -53.87 52.85 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -54.82 -46.28 74.52 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.142 0.428 . . . . 0.0 110.835 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -57.03 -53.72 54.89 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.528 0.731 . . . . 0.0 110.057 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -54.64 -53.09 59.33 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.148 0.979 . . . . 0.0 110.421 179.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 90.4 mt -57.21 -50.62 72.28 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 122.674 0.389 . . . . 0.0 110.305 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -55.3 -51.71 65.8 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 122.612 0.365 . . . . 0.0 110.288 178.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.91 -37.79 69.39 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.658 0.783 . . . . 0.0 111.928 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.2 m-80 -77.88 -46.89 20.07 Favored 'General case' 0 CA--C 1.527 0.078 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 -178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 50.0 mt -58.77 -44.64 90.71 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.066 0.546 . . . . 0.0 109.719 179.187 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.314 0 C-N-CA 122.998 0.519 . . . . 0.0 109.636 177.556 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 CA--C 1.534 0.353 0 CA-C-O 119.248 -0.406 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.2 t70 3.54 -84.21 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 129.173 2.989 . . . . 0.0 114.501 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -135.8 45.12 2.44 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 177.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.3 mt -105.86 133.02 51.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 124.005 0.922 . . . . 0.0 110.023 -178.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.9 mt -86.94 146.03 6.85 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.183 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 176.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.5 m80 -115.52 100.1 7.83 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 -178.259 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.4 mt -91.1 163.98 14.1 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.636 1.174 . . . . 0.0 113.209 -173.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 66.2 p -135.57 163.89 29.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 126.512 1.925 . . . . 0.0 106.288 174.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -54.39 -45.91 72.97 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.178 0.513 . . . . 0.0 109.89 178.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.21 -44.56 92.26 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 125.184 1.394 . . . . 0.0 112.049 -179.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 22.0 p -78.61 -31.61 47.11 Favored 'General case' 0 CA--C 1.529 0.143 0 O-C-N 122.203 -0.311 . . . . 0.0 111.227 -177.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.3 t80 -32.66 -55.07 0.36 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 126.215 1.806 . . . . 0.0 115.048 -178.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -54.67 -62.55 1.58 Allowed 'General case' 0 CA--C 1.53 0.201 0 O-C-N 121.455 -0.778 . . . . 0.0 111.438 -177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.8 m -63.52 -42.48 98.45 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.969 -176.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.13 -37.85 66.5 Favored 'General case' 0 N--CA 1.452 -0.332 0 CA-C-O 118.736 -0.65 . . . . 0.0 112.505 -176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 44.5 t -107.46 -65.21 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.749 0.82 . . . . 0.0 112.382 -174.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 68.3 mt -58.09 -36.2 72.51 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -173.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -92.63 8.49 38.84 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 118.5 -0.762 . . . . 0.0 113.018 179.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.08 169.36 18.31 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 120.595 1.543 . . . . 0.0 112.08 179.596 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -119.02 166.45 12.86 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 173.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 75.49 -139.77 25.21 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -130.3 123.82 30.92 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 117.661 0.73 . . . . 0.0 110.208 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 5.8 mt -111.36 129.9 65.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 C-N-CA 124.99 1.316 . . . . 0.0 107.724 177.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -112.06 102.46 10.67 Favored 'General case' 0 C--O 1.228 -0.057 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 23.6 t -92.92 115.69 32.33 Favored 'Isoleucine or valine' 0 C--O 1.231 0.115 0 C-N-CA 122.521 0.329 . . . . 0.0 110.692 -178.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -93.45 110.55 22.11 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.527 1.131 . . . . 0.0 109.073 174.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -82.14 123.9 29.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 107.189 -1.411 . . . . 0.0 107.189 176.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.5 p-90 -138.07 173.8 11.24 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.421 0.688 . . . . 0.0 111.55 -177.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -144.96 151.42 38.59 Favored 'General case' 0 C--O 1.227 -0.112 0 C-N-CA 125.207 1.403 . . . . 0.0 107.734 177.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -54.75 -38.12 66.78 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 118.777 0.717 . . . . 0.0 112.354 -178.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 51.4 p-90 -80.05 -4.7 53.79 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.128 0.971 . . . . 0.0 112.911 178.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 48.0 t -79.46 82.03 5.65 Favored 'General case' 0 N--CA 1.455 -0.189 0 O-C-N 120.906 -1.121 . . . . 0.0 111.193 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -43.92 -57.95 4.5 Favored Glycine 0 CA--C 1.538 1.525 0 C-N-CA 123.429 0.538 . . . . 0.0 112.269 177.461 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_exo -52.21 -32.23 49.41 Favored 'Trans proline' 0 CA--C 1.534 0.523 0 C-N-CA 123.386 2.724 . . . . 0.0 113.481 178.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 76.0 m -63.39 -41.01 98.75 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 35.9 mmtm -63.61 -41.63 98.29 Favored 'General case' 0 C--O 1.226 -0.134 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 92.5 mmm -60.35 -45.06 94.83 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-O 119.535 -0.269 . . . . 0.0 110.981 179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.7 pt -76.21 -27.66 17.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 CA-C-O 118.77 -0.633 . . . . 0.0 112.605 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -57.38 1.26 Allowed Pre-proline 0 CA--C 1.545 0.767 0 N-CA-C 115.005 1.483 . . . . 0.0 115.005 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -58.26 -37.45 95.2 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.069 1.846 . . . . 0.0 111.66 177.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.9 mt -62.11 -48.95 86.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 176.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 89.3 mt -55.64 -43.92 76.68 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 178.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 -60.51 -51.91 67.43 Favored 'General case' 0 CA--C 1.531 0.248 0 O-C-N 122.113 -0.367 . . . . 0.0 110.732 178.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -54.45 -50.99 66.38 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 17.3 mm -55.92 -46.95 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.279 0 C-N-CA 123.747 0.819 . . . . 0.0 109.937 177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -43.44 71.61 Favored 'General case' 0 N--CA 1.456 -0.136 0 C-N-CA 122.81 0.444 . . . . 0.0 110.244 178.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.12 -55.95 12.03 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.378 176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -51.66 -45.45 63.4 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.285 1.034 . . . . 0.0 112.858 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -98.15 22.38 9.57 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.216 1.007 . . . . 0.0 111.426 -179.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -52.9 131.34 35.59 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 119.514 1.052 . . . . 0.0 110.512 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.13 -20.75 11.87 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 119.219 -0.767 . . . . 0.0 113.081 -178.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -99.18 -48.47 4.83 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-N 118.735 1.267 . . . . 0.0 109.268 179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.7 tp -121.59 122.51 39.82 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.495 1.118 . . . . 0.0 109.156 -179.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 70.9 m -92.78 101.58 13.97 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 176.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 99.4 t -78.91 139.57 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 108.037 -1.098 . . . . 0.0 108.037 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -139.97 157.94 44.87 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.867 0.867 . . . . 0.0 108.918 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.6 mttm -133.67 147.81 51.45 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 126.155 1.782 . . . . 0.0 108.085 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.4 tt -139.11 125.61 20.5 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.626 -0.879 . . . . 0.0 108.626 176.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 29.7 t-20 -87.37 109.04 19.27 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -68.2 -24.88 30.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -59.74 -50.22 74.7 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 119.452 1.024 . . . . 0.0 108.847 179.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 30.7 mm100 -75.53 -26.71 58.29 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.001 0.92 . . . . 0.0 111.185 178.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -127.47 69.35 75.02 Favored Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.405 0.682 . . . . 0.0 111.939 -177.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -55.55 -59.57 0.73 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.428 2.085 . . . . 0.0 112.94 -178.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.93 -41.0 2.46 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 126.064 1.792 . . . . 0.0 115.233 -176.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.93 -26.9 66.32 Favored 'General case' 0 N--CA 1.449 -0.484 0 O-C-N 122.026 -0.69 . . . . 0.0 112.717 -178.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.572 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -71.31 -64.94 1.02 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 119.083 0.856 . . . . 0.0 110.463 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.572 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 88.7 Cg_exo -47.44 -39.07 28.25 Favored 'Trans proline' 0 C--N 1.35 0.621 0 C-N-CA 123.283 2.656 . . . . 0.0 112.971 175.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 18.8 mtpp -47.7 -36.18 10.86 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 118.602 0.637 . . . . 0.0 112.59 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -117.42 28.66 8.33 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.073 0.549 . . . . 0.0 110.667 177.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 52.43 35.48 44.22 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 124.734 1.159 . . . . 0.0 113.467 179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 56.9 mt -79.51 82.45 1.11 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 O-C-N 121.655 -0.909 . . . . 0.0 109.265 -178.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 42.6 mtm105 -79.46 -5.57 55.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.6 0.76 . . . . 0.0 112.771 -179.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -153.05 166.4 31.48 Favored Glycine 0 CA--C 1.527 0.79 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 25.9 pt -144.83 156.61 55.6 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.507 1.523 . . . . 0.0 107.854 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -68.12 145.2 75.04 Favored 'Cis proline' 0 N--CA 1.456 -0.689 0 CA-C-N 120.573 1.24 . . . . 0.0 109.927 -1.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 47.3 m -139.96 127.58 21.69 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.533 -1.655 . . . . 0.0 106.533 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 20.9 mt -110.4 108.18 18.12 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 125.126 1.37 . . . . 0.0 109.686 -173.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.451 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -96.45 118.16 32.38 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tp -97.0 99.51 11.04 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.426 0.69 . . . . 0.0 109.379 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -91.23 105.34 17.72 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.734 1.613 . . . . 0.0 109.991 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -89.73 113.81 25.39 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 106.068 -1.827 . . . . 0.0 106.068 173.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 44.87 52.7 7.94 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.424 1.089 . . . . 0.0 110.864 -177.491 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 77.3 -12.75 12.35 Favored Glycine 0 CA--C 1.532 1.156 0 CA-C-O 118.915 -0.936 . . . . 0.0 115.035 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -94.73 121.74 36.62 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 119.571 1.685 . . . . 0.0 110.254 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.12 106.25 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.338 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 177.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.6 -43.64 22.55 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.632 0.773 . . . . 0.0 109.824 179.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.84 158.51 35.29 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.249 0.62 . . . . 0.0 109.657 179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.451 HG22 ' HG ' ' A' ' 79' ' ' LEU . 80.7 p -131.97 112.17 12.16 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.869 1.267 . . . . 0.0 108.653 -179.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.9 tmtm? -98.79 111.51 23.87 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 64.2 t -91.0 130.51 40.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 177.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.24 163.78 34.71 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.084 0.85 . . . . 0.0 111.896 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.62 167.22 22.2 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.08 0.552 . . . . 0.0 110.246 178.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.06 166.81 27.51 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.566 1.146 . . . . 0.0 108.544 179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 78.0 p -83.21 161.71 21.45 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-O 121.022 0.439 . . . . 0.0 110.526 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 84.0 tttt -52.98 -42.85 65.92 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 123.524 0.73 . . . . 0.0 110.519 178.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.79 -54.39 37.94 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -55.36 -46.05 76.48 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 122.348 -0.501 . . . . 0.0 109.979 178.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 24.5 tp -58.28 -50.73 72.56 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -53.63 -49.88 66.91 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.607 0.639 . . . . 0.0 111.107 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -57.76 -50.96 71.48 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.269 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -53.94 -52.6 60.13 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.385 0.674 . . . . 0.0 110.506 178.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 89.4 mt -57.69 -52.11 66.76 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.037 0.535 . . . . 0.0 110.227 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -54.11 -52.7 60.19 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 122.646 0.379 . . . . 0.0 110.292 179.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.74 -39.5 71.23 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 123.767 0.827 . . . . 0.0 112.003 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 13.9 m-80 -77.85 -47.08 19.66 Favored 'General case' 0 C--N 1.339 0.119 0 O-C-N 122.218 -0.301 . . . . 0.0 110.554 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 57.1 mt -57.98 -47.6 82.49 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 177.176 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.453 -0.291 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -63.74 104.84 0.72 Allowed 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.526 0.73 . . . . 0.0 111.108 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 93.4 mttt -124.56 36.11 4.67 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 173.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 16.9 mt -87.0 140.06 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 123.424 0.69 . . . . 0.0 111.215 -175.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.8 mm -90.97 114.53 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.123 0 C-N-CA 123.326 0.65 . . . . 0.0 110.422 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -85.59 102.4 13.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.229 1.012 . . . . 0.0 109.946 -178.654 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.96 163.16 14.1 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.035 1.334 . . . . 0.0 113.19 -176.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.0 p -130.74 159.74 36.38 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.189 2.196 . . . . 0.0 106.228 171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.24 -45.6 68.81 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 177.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -55.35 -47.46 75.7 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.92 1.288 . . . . 0.0 111.626 179.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 18.2 p -78.23 -26.07 47.18 Favored 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -177.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -37.24 -51.87 1.04 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.666 1.586 . . . . 0.0 114.092 -176.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -56.87 -62.95 1.38 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-O 121.574 0.702 . . . . 0.0 111.019 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.2 m -57.65 -39.21 76.47 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.918 0.887 . . . . 0.0 112.32 -176.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -80.68 -55.58 4.74 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 16.4 t -88.91 -53.73 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 124.235 1.014 . . . . 0.0 112.959 -172.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 82.4 mt -62.01 -37.74 86.02 Favored 'General case' 0 N--CA 1.46 0.057 0 C-N-CA 119.528 -0.869 . . . . 0.0 109.991 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -97.61 29.62 3.25 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 119.384 -0.341 . . . . 0.0 111.109 174.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -53.81 119.54 5.1 Favored 'General case' 0 C--N 1.343 0.301 0 CA-C-N 119.221 0.919 . . . . 0.0 111.985 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -79.85 60.18 3.38 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.55 -143.86 13.65 Favored Glycine 0 CA--C 1.529 0.952 0 N-CA-C 111.093 -0.803 . . . . 0.0 111.093 -178.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.24 117.24 33.51 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 125.349 1.46 . . . . 0.0 108.767 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 6.3 mt -113.87 125.33 71.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 C-N-CA 124.543 1.137 . . . . 0.0 108.219 179.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.2 tp -102.31 101.91 12.23 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 176.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 33.4 t -86.57 118.62 33.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -97.73 116.5 30.07 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 123.575 0.75 . . . . 0.0 109.053 174.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -90.81 121.35 32.6 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 45.7 p-90 -135.39 178.65 6.87 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 123.936 0.895 . . . . 0.0 111.584 -177.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -148.72 150.6 33.44 Favored 'General case' 0 N--CA 1.457 -0.083 0 C-N-CA 125.413 1.485 . . . . 0.0 108.327 177.417 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 18.3 mt-10 -55.75 -37.27 68.26 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.891 0.876 . . . . 0.0 112.386 -177.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.8 p-90 -83.33 -5.43 59.14 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.139 0.976 . . . . 0.0 112.54 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.9 t -79.59 81.69 5.81 Favored 'General case' 0 CA--C 1.53 0.185 0 O-C-N 120.958 -1.089 . . . . 0.0 111.684 -176.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.81 -57.49 3.41 Favored Glycine 0 CA--C 1.537 1.462 0 C-N-CA 123.811 0.72 . . . . 0.0 112.362 176.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_exo -52.59 -36.96 73.33 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 122.999 2.466 . . . . 0.0 113.31 177.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 65.0 m -64.01 -47.75 79.05 Favored 'General case' 0 N--CA 1.457 -0.11 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -57.85 -43.22 85.75 Favored 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 177.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 71.2 mtm -61.0 -44.89 96.76 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 118.985 -0.531 . . . . 0.0 111.598 178.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -74.67 -27.51 20.83 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-N 119.359 0.981 . . . . 0.0 112.507 179.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.43 -58.16 1.03 Allowed Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 114.763 1.394 . . . . 0.0 114.763 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -55.99 -37.42 96.14 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.495 2.13 . . . . 0.0 112.324 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.8 mt -62.4 -51.13 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.122 0 N-CA-C 107.294 -1.373 . . . . 0.0 107.294 176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 59.4 mt -55.09 -42.05 72.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.17 0.188 . . . . 0.0 110.598 178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.67 -51.74 68.08 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.178 0.513 . . . . 0.0 109.727 178.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 -57.22 -44.75 84.01 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.866 -0.521 . . . . 0.0 110.274 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.4 mm -58.33 -46.78 89.03 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 123.548 0.739 . . . . 0.0 109.287 176.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.7 -45.46 66.9 Favored 'General case' 0 C--N 1.339 0.12 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -62.79 -59.12 5.31 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 110.455 -0.202 . . . . 0.0 110.455 176.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -48.81 -48.04 41.82 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 113.408 0.892 . . . . 0.0 113.408 -178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 22.8 m-85 -94.02 15.09 17.81 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 118.654 -0.688 . . . . 0.0 112.243 -176.603 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.6 88.88 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.342 0 CA-C-N 119.47 1.032 . . . . 0.0 111.491 -179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 139.25 -28.47 2.58 Favored Glycine 0 CA--C 1.527 0.799 0 C-N-CA 124.819 1.199 . . . . 0.0 110.242 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -99.47 -38.2 8.89 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.28 1.032 . . . . 0.0 109.987 179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.8 tp -135.11 141.32 45.98 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.811 0.844 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 83.8 m -108.03 104.82 14.35 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 106.247 -1.761 . . . . 0.0 106.247 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 73.3 t -79.11 137.74 21.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 N-CA-C 107.603 -1.258 . . . . 0.0 107.603 -179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -133.7 156.17 48.41 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.863 0.865 . . . . 0.0 108.786 179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.4 mttm -132.64 146.21 51.7 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 125.476 1.51 . . . . 0.0 109.908 178.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.9 tt -140.42 126.17 19.29 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 123.421 0.688 . . . . 0.0 109.394 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -87.17 109.31 19.37 Favored 'General case' 0 C--O 1.235 0.327 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 178.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.88 -24.99 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 122.99 0.516 . . . . 0.0 111.719 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -60.51 -46.39 90.29 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 119.261 0.937 . . . . 0.0 108.898 178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -77.66 -35.72 52.14 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.489 179.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -121.79 69.15 25.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 124.28 1.032 . . . . 0.0 111.139 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -59.32 -56.33 1.38 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.473 2.115 . . . . 0.0 112.787 -177.046 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -36.62 -45.6 1.02 Allowed Glycine 0 CA--C 1.53 1.016 0 C-N-CA 126.092 1.806 . . . . 0.0 114.597 -176.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -49.98 -37.23 31.46 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.307 1.043 . . . . 0.0 113.078 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -60.04 -66.44 1.49 Allowed Pre-proline 0 CA--C 1.538 0.514 0 CA-C-O 118.309 -0.853 . . . . 0.0 112.396 179.781 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -59.63 -36.84 91.21 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 121.72 1.613 . . . . 0.0 111.22 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -51.56 -45.99 63.24 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.349 0.977 . . . . 0.0 110.71 177.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -98.68 28.65 4.12 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 122.35 0.26 . . . . 0.0 111.683 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 40.15 46.87 3.4 Favored Glycine 0 CA--C 1.528 0.848 0 C-N-CA 125.769 1.652 . . . . 0.0 114.052 177.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.2 mt -71.59 135.75 27.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 O-C-N 121.663 -0.904 . . . . 0.0 110.439 -178.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.05 -46.37 9.38 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.889 1.276 . . . . 0.0 109.818 178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -162.99 167.16 37.24 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 34.8 pt -112.55 152.64 44.8 Favored Pre-proline 0 CA--C 1.538 0.492 0 C-N-CA 125.376 1.47 . . . . 0.0 109.376 -179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -68.67 142.0 65.22 Favored 'Cis proline' 0 N--CA 1.454 -0.824 0 CA-C-N 120.219 1.114 . . . . 0.0 110.562 -0.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.44 144.46 47.94 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 72.0 mt -128.64 101.46 6.16 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.0 mp -104.97 120.71 42.12 Favored 'General case' 0 C--O 1.23 0.039 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 -179.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 54.0 tp -95.47 105.01 16.94 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.842 0.857 . . . . 0.0 109.495 -179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -97.62 110.54 23.08 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 125.835 1.654 . . . . 0.0 110.057 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -93.88 105.18 17.21 Favored 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 105.8 -1.926 . . . . 0.0 105.8 173.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 46.29 51.83 11.06 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.669 0.747 . . . . 0.0 111.272 -177.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.9 -19.96 7.03 Favored Glycine 0 CA--C 1.529 0.961 0 CA-C-O 119.365 -0.686 . . . . 0.0 114.247 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -80.59 111.22 16.81 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 119.061 1.43 . . . . 0.0 109.623 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 83.9 t -62.49 102.79 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.68 -43.28 23.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.047 0.939 . . . . 0.0 110.956 -178.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -154.57 154.36 32.93 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 123.142 0.577 . . . . 0.0 109.524 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 80.8 p -136.75 116.79 13.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.473 1.109 . . . . 0.0 109.453 -177.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.6 tmtm? -108.46 136.26 48.38 Favored 'General case' 0 CA--C 1.528 0.133 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 176.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.7 t -115.62 128.16 72.95 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.57 168.15 35.37 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 123.789 0.709 . . . . 0.0 111.394 -179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -75.39 168.05 20.74 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.198 0.599 . . . . 0.0 110.552 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -162.24 164.07 27.88 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.201 1.4 . . . . 0.0 107.779 179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 97.0 p -72.67 161.26 30.99 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.839 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -56.72 -43.67 80.85 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 175.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.1 -58.33 14.23 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 177.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -53.13 -45.93 68.55 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 117.248 0.524 . . . . 0.0 110.945 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 32.2 tp -59.75 -51.38 70.0 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 122.388 -0.195 . . . . 0.0 110.73 179.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -56.64 -47.66 79.24 Favored 'General case' 0 C--O 1.231 0.114 0 CA-C-N 118.132 0.424 . . . . 0.0 110.688 178.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.73 -52.37 65.24 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.661 0.784 . . . . 0.0 109.757 179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 65.4 t80 -54.87 -55.4 30.88 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.997 0.919 . . . . 0.0 110.319 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 93.6 mt -57.3 -48.61 78.49 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 122.136 -0.352 . . . . 0.0 110.792 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -56.57 -51.48 68.43 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 122.577 0.351 . . . . 0.0 110.243 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -58.41 -36.26 73.3 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.975 0.91 . . . . 0.0 111.972 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -78.17 -50.06 12.66 Favored 'General case' 0 C--O 1.228 -0.078 0 CA-C-N 117.847 0.294 . . . . 0.0 110.367 -178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 52.9 mt -63.38 -42.97 98.85 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.811 0.444 . . . . 0.0 110.514 -178.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.136 0 C-N-CA 124.703 1.201 . . . . 0.0 111.703 179.359 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 10.9 p . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.624 0.726 . . . . 0.0 109.326 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -73.85 68.68 1.32 Allowed 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 124.106 0.962 . . . . 0.0 109.354 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -123.6 50.42 1.6 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.656 -1.609 . . . . 0.0 106.656 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.1 mt -108.17 137.42 39.78 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 C-N-CA 124.922 1.289 . . . . 0.0 108.809 -178.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.3 mt -85.73 146.92 5.87 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.23 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.0 m80 -117.29 99.38 6.98 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -178.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.8 mt -89.81 164.36 14.67 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 124.476 1.111 . . . . 0.0 113.306 -173.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 55.1 p -134.98 162.69 31.74 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 126.228 1.811 . . . . 0.0 106.417 174.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -55.64 -44.59 77.3 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.403 0.547 . . . . 0.0 109.615 178.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.53 -44.71 89.66 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 124.976 1.31 . . . . 0.0 111.893 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.58 -32.71 47.82 Favored 'General case' 0 C--O 1.233 0.195 0 O-C-N 122.159 -0.338 . . . . 0.0 111.222 -177.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -32.15 -53.32 0.29 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.028 2.131 . . . . 0.0 115.315 -178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -54.99 -61.61 2.19 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.331 -0.855 . . . . 0.0 110.983 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -61.87 -43.54 98.64 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.736 0.815 . . . . 0.0 112.307 -179.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -77.39 -31.07 53.95 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 118.261 -0.876 . . . . 0.0 113.273 -173.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 42.1 t -114.35 -61.63 2.48 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 C-N-CA 123.975 0.91 . . . . 0.0 111.382 -176.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 56.9 mt -59.22 -36.13 74.87 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 111.949 0.351 . . . . 0.0 111.949 -174.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.7 mtpm? -92.54 6.17 48.17 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 112.869 0.692 . . . . 0.0 112.869 178.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.99 99.85 9.36 Favored 'General case' 0 N--CA 1.455 -0.222 0 CA-C-N 120.427 1.467 . . . . 0.0 111.618 -178.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -71.85 74.46 0.87 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 175.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -176.29 -165.5 32.11 Favored Glycine 0 CA--C 1.527 0.8 0 N-CA-C 107.808 -2.117 . . . . 0.0 107.808 -178.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.53 110.06 21.46 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 124.326 1.05 . . . . 0.0 108.325 178.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 4.6 mt -111.29 127.19 68.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.22 0 C-N-CA 124.926 1.29 . . . . 0.0 108.714 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.39 103.0 12.36 Favored 'General case' 0 C--N 1.333 -0.116 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 35.8 t -90.49 118.48 35.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -96.46 108.03 20.52 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.913 1.285 . . . . 0.0 108.442 174.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -79.72 121.81 25.8 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 106.989 -1.486 . . . . 0.0 106.989 177.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 23.0 p-90 -137.54 179.48 6.38 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.919 0.887 . . . . 0.0 111.696 -176.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -154.58 152.6 30.22 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 125.325 1.45 . . . . 0.0 109.55 -179.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.8 mp0 -51.74 -37.12 49.77 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 118.84 0.745 . . . . 0.0 112.203 178.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.6 p-90 -85.63 -4.56 59.2 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.053 0.941 . . . . 0.0 113.03 -178.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 43.0 t -79.42 79.86 5.83 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 120.934 -1.104 . . . . 0.0 111.111 -177.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -40.28 -59.91 2.1 Favored Glycine 0 CA--C 1.54 1.608 0 C-N-CA 123.904 0.764 . . . . 0.0 112.693 177.728 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -53.87 -29.07 51.52 Favored 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 123.402 2.735 . . . . 0.0 113.937 179.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 77.7 m -62.75 -42.47 99.69 Favored 'General case' 0 CA--C 1.53 0.19 0 O-C-N 121.408 -0.807 . . . . 0.0 109.227 179.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -66.12 -35.58 80.88 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 176.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 65.8 mtt -62.27 -44.64 96.08 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 34.4 pt -76.26 -25.54 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.379 0 CA-C-O 118.772 -0.632 . . . . 0.0 112.435 178.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -37.31 -57.88 1.31 Allowed Pre-proline 0 CA--C 1.545 0.781 0 N-CA-C 114.794 1.405 . . . . 0.0 114.794 179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -57.03 -38.17 96.58 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.812 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.8 mt -60.84 -50.32 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 176.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 90.8 mt -55.71 -43.95 76.99 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 122.808 0.443 . . . . 0.0 110.303 177.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -60.92 -51.58 68.67 Favored 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 121.477 0.656 . . . . 0.0 110.354 179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -54.73 -48.72 72.18 Favored 'General case' 0 CA--C 1.529 0.138 0 O-C-N 121.626 -0.671 . . . . 0.0 109.733 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 22.3 mm -56.68 -47.61 82.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 122.827 0.451 . . . . 0.0 109.824 176.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.71 -44.94 66.66 Favored 'General case' 0 C--N 1.338 0.081 0 CA-C-N 118.4 0.545 . . . . 0.0 110.495 179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -68.13 -57.77 5.54 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 120.2 -0.6 . . . . 0.0 110.755 177.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 77.9 mt-10 -52.19 -43.06 63.99 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.105 0.962 . . . . 0.0 113.515 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 14.1 m-85 -98.07 16.85 19.9 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.244 1.018 . . . . 0.0 111.674 -178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -52.26 134.33 33.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 119.353 0.979 . . . . 0.0 110.25 179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.9 -25.5 6.7 Favored Glycine 0 CA--C 1.531 1.033 0 CA-C-O 119.082 -0.843 . . . . 0.0 112.705 -178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -98.84 -41.1 7.79 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 118.782 1.291 . . . . 0.0 109.689 178.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.6 tp -131.19 140.03 49.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.541 1.137 . . . . 0.0 109.743 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 53.3 m -109.56 106.1 15.67 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 106.769 -1.567 . . . . 0.0 106.769 176.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 48.2 t -79.87 135.66 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -137.67 156.75 47.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 123.739 0.816 . . . . 0.0 109.115 179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mttm -130.29 148.07 52.08 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.897 1.679 . . . . 0.0 107.403 177.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.5 tt -138.6 123.83 19.23 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 176.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 54.4 t-20 -86.79 108.48 18.73 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -66.22 -25.81 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 C-N-CA 123.052 0.541 . . . . 0.0 111.933 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -62.41 -45.86 91.22 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 108.493 -0.928 . . . . 0.0 108.493 178.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -74.95 -32.64 61.79 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.584 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.4 m-80 -126.8 70.12 72.73 Favored Pre-proline 0 CA--C 1.535 0.373 0 C-N-CA 123.792 0.837 . . . . 0.0 112.921 -175.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.26 -56.22 2.94 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.425 2.083 . . . . 0.0 112.857 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -40.98 -40.85 2.44 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.059 1.79 . . . . 0.0 115.625 -176.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.2 -22.01 66.84 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 117.836 0.818 . . . . 0.0 112.98 -177.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.508 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -74.6 -61.98 1.03 Allowed Pre-proline 0 CA--C 1.541 0.629 0 CA-C-O 118.155 -0.926 . . . . 0.0 111.452 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.508 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 87.8 Cg_exo -48.42 -39.85 36.2 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.132 2.555 . . . . 0.0 112.274 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -45.78 -34.1 3.48 Favored 'General case' 0 C--N 1.344 0.336 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -124.28 29.71 6.28 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 122.883 0.473 . . . . 0.0 110.602 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.17 37.94 31.71 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.867 1.222 . . . . 0.0 113.26 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 55.9 mt -80.53 85.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -86.13 -4.91 59.27 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.517 0.727 . . . . 0.0 112.224 -178.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -150.26 166.74 30.09 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.969 -1.652 . . . . 0.0 108.969 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 pt -146.71 156.88 48.31 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.902 1.681 . . . . 0.0 107.285 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -67.03 141.11 54.59 Favored 'Cis proline' 0 N--CA 1.46 -0.493 0 CA-C-N 121.027 1.403 . . . . 0.0 109.99 -0.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.6 m -139.45 121.86 16.09 Favored 'General case' 0 N--CA 1.451 -0.425 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 33.9 mt -100.75 127.62 47.11 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.393 1.477 . . . . 0.0 108.943 -177.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 10.9 mp -118.2 119.36 34.46 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 26.3 tp -98.31 102.87 14.74 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -94.84 120.7 35.5 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 125.685 1.594 . . . . 0.0 110.018 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.3 mttp -106.33 116.03 31.22 Favored 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 173.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 50.0 47.54 23.18 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 121.519 0.676 . . . . 0.0 109.927 -177.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 72.24 -7.22 8.44 Favored Glycine 0 CA--C 1.532 1.119 0 CA-C-O 118.774 -1.014 . . . . 0.0 115.454 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 -96.17 126.83 41.66 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 119.592 1.696 . . . . 0.0 109.031 179.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 92.4 t -62.68 107.26 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.58 -44.14 21.64 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 123.366 0.667 . . . . 0.0 109.478 179.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -161.36 167.84 25.0 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 38.7 p -142.65 165.99 25.87 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.5 tmtm? -150.67 120.59 7.12 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.75 -1.204 . . . . 0.0 107.75 176.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 87.1 t -98.83 131.64 45.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 178.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.22 164.86 36.33 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 123.947 0.784 . . . . 0.0 111.598 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.96 167.11 22.54 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.157 0.583 . . . . 0.0 110.256 179.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -161.38 162.85 30.86 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.911 1.284 . . . . 0.0 108.254 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 95.8 p -73.95 164.14 27.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.363 0.601 . . . . 0.0 111.487 -179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -53.29 -49.28 67.31 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -56.17 -55.21 30.55 Favored Glycine 0 CA--C 1.529 0.927 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -54.69 -47.61 73.44 Favored 'General case' 0 CA--C 1.528 0.11 0 CA-C-N 117.542 0.671 . . . . 0.0 110.671 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 26.7 tp -59.8 -49.58 77.16 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 110.333 -0.247 . . . . 0.0 110.333 -179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.5 mtpm? -53.29 -50.85 64.04 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 122.64 0.376 . . . . 0.0 110.875 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -60.14 -50.19 74.66 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 122.798 0.439 . . . . 0.0 110.47 -179.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 58.4 t80 -53.37 -54.25 39.37 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.141 0.576 . . . . 0.0 109.946 178.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.6 mt -59.18 -49.91 76.06 Favored 'General case' 0 N--CA 1.451 -0.416 0 O-C-N 122.269 -0.269 . . . . 0.0 110.884 -179.063 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -54.86 -53.51 54.45 Favored 'General case' 0 N--CA 1.456 -0.146 0 CA-C-N 117.784 0.266 . . . . 0.0 110.306 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.47 -39.98 74.1 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.234 1.014 . . . . 0.0 111.916 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 -77.74 -42.53 33.9 Favored 'General case' 0 N--CA 1.457 -0.089 0 O-C-N 122.258 -0.276 . . . . 0.0 110.727 -177.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 51.9 mt -63.13 -44.87 94.38 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 178.193 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 177.559 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 78.8 p . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 22.2 t70 59.06 -91.69 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.476 1.111 . . . . 0.0 110.614 -177.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -139.57 20.03 2.54 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.647 1.179 . . . . 0.0 110.223 177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.5 mt -80.37 132.21 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.214 0 O-C-N 121.835 -0.541 . . . . 0.0 110.211 -179.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.1 mm -96.16 123.87 48.6 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.093 0 C-N-CA 123.502 0.721 . . . . 0.0 111.111 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 73.5 m80 -90.67 108.51 19.86 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.143 0.977 . . . . 0.0 109.469 -178.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.6 mt -94.04 166.36 12.18 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.072 0.949 . . . . 0.0 112.943 -175.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 71.0 p -132.5 162.24 31.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 172.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -55.14 -47.65 74.81 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -58.65 -47.62 83.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.095 1.358 . . . . 0.0 111.534 -179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 83.0 p -78.45 -25.25 45.84 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -176.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 7.2 t80 -35.9 -51.27 0.7 Allowed 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.443 1.897 . . . . 0.0 114.91 -178.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -55.53 -62.32 1.76 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 118.93 0.787 . . . . 0.0 110.739 -178.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.6 m -60.36 -42.36 95.6 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 123.529 0.731 . . . . 0.0 111.643 -177.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 66.5 m-20 -71.59 -41.41 69.0 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 -175.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 35.3 t -107.98 -63.01 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.273 0 C-N-CA 124.487 1.115 . . . . 0.0 113.133 -172.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 69.3 mt -58.11 -37.28 74.25 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 111.52 0.193 . . . . 0.0 111.52 -174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 46.7 mtpt -88.36 2.29 52.87 Favored 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -82.52 106.82 14.7 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 120.638 1.563 . . . . 0.0 110.723 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.5 p-10 -76.5 62.36 1.87 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.786 0.835 . . . . 0.0 109.345 175.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.75 -167.65 24.55 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -103.57 108.96 20.45 Favored 'General case' 0 N--CA 1.456 -0.159 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.5 mt -108.31 124.48 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 C-N-CA 124.066 0.946 . . . . 0.0 108.643 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 11.0 tp -105.39 99.48 9.09 Favored 'General case' 0 CA--C 1.52 -0.201 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 10.9 t -89.37 114.66 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 179.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -89.56 105.57 17.89 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -79.52 119.96 23.23 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.401 -1.703 . . . . 0.0 106.401 177.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 22.8 p-90 -134.33 -177.94 4.82 Favored 'General case' 0 CA--C 1.529 0.136 0 C-N-CA 124.563 1.145 . . . . 0.0 111.2 -177.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.87 152.59 35.33 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 124.737 1.215 . . . . 0.0 109.306 178.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.1 mt-10 -54.88 -28.53 51.06 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.519 1.128 . . . . 0.0 112.758 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.1 p-90 -94.96 -4.63 46.37 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.726 1.21 . . . . 0.0 112.387 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 54.1 t -79.99 83.7 5.85 Favored 'General case' 0 N--CA 1.457 -0.111 0 O-C-N 121.007 -1.058 . . . . 0.0 111.583 -177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -44.7 -61.38 3.37 Favored Glycine 0 CA--C 1.537 1.467 0 CA-C-O 119.673 -0.515 . . . . 0.0 112.24 177.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -48.38 -36.71 31.14 Favored 'Trans proline' 0 N--CA 1.459 -0.536 0 C-N-CA 123.7 2.933 . . . . 0.0 113.779 179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 84.5 m -61.5 -37.99 85.7 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -70.27 -46.5 64.24 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -51.58 -40.91 60.68 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-O 119.184 -0.436 . . . . 0.0 111.461 179.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.5 pt -81.82 -10.88 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 113.207 0.818 . . . . 0.0 113.207 178.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.5 -51.45 69.25 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-N 119.995 1.27 . . . . 0.0 113.295 -178.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.73 -41.7 72.13 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.314 2.01 . . . . 0.0 111.537 176.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 52.1 mt -61.11 -52.16 64.77 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 94.9 mt -54.31 -44.61 72.14 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 177.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -60.13 -57.27 13.54 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 123.007 0.523 . . . . 0.0 111.321 179.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -60.0 -40.81 90.5 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 121.627 -0.671 . . . . 0.0 110.719 -179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 10.0 mm -57.81 -46.5 87.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 175.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.4 -43.98 71.92 Favored 'General case' 0 N--CA 1.457 -0.119 0 C-N-CA 122.725 0.41 . . . . 0.0 110.259 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -65.09 -54.7 25.96 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.46 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -51.16 -46.71 62.12 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.391 1.076 . . . . 0.0 112.593 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.7 m-85 -96.07 18.84 12.66 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.642 0.777 . . . . 0.0 111.903 -178.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -50.67 137.02 20.64 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 119.335 0.971 . . . . 0.0 111.334 -179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.22 -26.23 5.11 Favored Glycine 0 CA--C 1.53 1.001 0 CA-C-O 119.068 -0.851 . . . . 0.0 112.554 -178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 55.0 mtpt -99.1 -51.27 3.88 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.772 1.286 . . . . 0.0 109.189 179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.9 tp -114.39 132.09 56.35 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.663 1.185 . . . . 0.0 108.995 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 99.2 m -106.65 102.47 11.85 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.923 -1.88 . . . . 0.0 105.923 177.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 60.5 t -79.13 142.68 13.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 -178.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -141.34 160.8 39.37 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.4 mttm -136.04 147.46 47.92 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.949 1.3 . . . . 0.0 108.351 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 8.5 tt -140.76 125.6 18.15 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 177.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 -87.97 108.58 19.27 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -63.88 -25.71 38.84 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.711 0.804 . . . . 0.0 112.178 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 71.4 m-20 -61.41 -46.48 89.95 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 119.105 0.866 . . . . 0.0 108.976 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -76.98 -35.44 57.18 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.718 -0.673 . . . . 0.0 110.344 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -120.92 68.82 16.82 Favored Pre-proline 0 CA--C 1.533 0.299 0 C-N-CA 124.126 0.97 . . . . 0.0 111.313 -174.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -63.59 -51.97 2.17 Favored 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.381 2.054 . . . . 0.0 112.335 -177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -44.0 -38.08 4.53 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 124.873 1.225 . . . . 0.0 114.305 -177.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -31.8 71.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 O-C-N 121.954 -0.733 . . . . 0.0 112.341 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.585 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.86 -65.26 2.27 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 118.144 -0.932 . . . . 0.0 110.434 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.585 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 83.3 Cg_exo -49.52 -45.76 29.63 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.558 2.172 . . . . 0.0 112.438 174.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -47.61 -42.48 24.18 Favored 'General case' 0 C--N 1.344 0.362 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -108.23 22.71 15.56 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 118.325 0.511 . . . . 0.0 111.673 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 50.44 46.19 45.42 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.366 0.984 . . . . 0.0 113.361 177.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 1.7 mp -65.06 132.4 30.88 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 177.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 53.0 mtm-85 -104.86 -10.89 17.03 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.523 1.129 . . . . 0.0 113.108 -175.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 178.47 -172.08 44.44 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.033 -2.027 . . . . 0.0 108.033 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 23.6 pt -144.24 144.91 27.5 Favored Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 118.604 1.202 . . . . 0.0 108.316 178.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.22 147.44 87.55 Favored 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.834 0.976 . . . . 0.0 110.435 -0.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 75.6 m -133.19 122.79 24.51 Favored 'General case' 0 CA--C 1.519 -0.24 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 173.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 14.1 mt -99.85 100.05 10.92 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 107.555 -1.276 . . . . 0.0 107.555 -177.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 4.1 mp -92.99 113.37 25.63 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 15.1 tp -93.28 97.55 10.69 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 123.631 0.772 . . . . 0.0 109.646 -178.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -86.35 106.12 17.17 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 125.316 1.446 . . . . 0.0 108.895 178.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -94.45 114.16 26.13 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 106.569 -1.641 . . . . 0.0 106.569 174.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 51.97 45.65 27.92 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.109 0.964 . . . . 0.0 109.935 -177.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 74.72 -3.19 44.76 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-O 118.68 -1.067 . . . . 0.0 114.629 -179.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -101.5 122.36 43.67 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 119.669 1.735 . . . . 0.0 109.796 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 57.8 t -62.63 106.25 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 178.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.52 -43.18 23.61 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 123.611 0.764 . . . . 0.0 109.887 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.99 156.51 31.32 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.243 0.617 . . . . 0.0 109.706 179.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 57.9 p -127.8 99.93 5.74 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.226 1.41 . . . . 0.0 108.389 -179.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -86.07 105.53 16.56 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 179.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 59.0 t -84.33 132.7 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.83 164.89 40.36 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 124.163 0.887 . . . . 0.0 112.081 179.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.4 171.14 13.66 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.143 0.577 . . . . 0.0 110.235 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -165.33 168.07 17.2 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.474 1.51 . . . . 0.0 107.774 179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 83.1 p -77.94 164.57 24.99 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 120.918 0.389 . . . . 0.0 110.467 -179.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -56.45 -46.85 80.11 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 108.574 -0.899 . . . . 0.0 108.574 174.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.54 -56.34 24.08 Favored Glycine 0 CA--C 1.527 0.787 0 N-CA-C 111.358 -0.697 . . . . 0.0 111.358 178.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -58.44 -39.73 80.62 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 117.617 0.708 . . . . 0.0 110.514 179.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 28.5 tp -61.06 -48.61 80.94 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.147 0.431 . . . . 0.0 110.127 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.6 mtpm? -56.17 -47.96 77.26 Favored 'General case' 0 CA--C 1.529 0.138 0 CA-C-N 118.595 0.634 . . . . 0.0 110.665 177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -57.19 -52.01 67.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 122.649 0.379 . . . . 0.0 110.153 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -53.66 -53.26 54.43 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.838 0.855 . . . . 0.0 110.154 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 81.9 mt -56.6 -52.39 65.03 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.761 0.424 . . . . 0.0 110.303 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -54.19 -52.07 62.38 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 117.916 0.325 . . . . 0.0 110.615 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -57.01 -39.7 75.24 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.871 0.868 . . . . 0.0 112.287 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -78.45 -46.05 20.68 Favored 'General case' 0 C--O 1.228 -0.072 0 CA-C-N 117.899 0.318 . . . . 0.0 110.872 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 69.5 mt -61.23 -47.28 86.81 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.407 0.683 . . . . 0.0 109.744 -179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.187 0 C-N-CA 124.606 1.162 . . . . 0.0 111.492 179.391 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.53 0.176 0 CA-C-O 120.637 0.256 . . . . 0.0 110.812 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -66.32 98.58 0.48 Allowed 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 122.298 -0.251 . . . . 0.0 110.532 -178.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 6.5 mtpm? -113.28 38.58 2.83 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 106.282 -1.747 . . . . 0.0 106.282 174.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.0 mt -97.56 142.36 14.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 123.385 0.674 . . . . 0.0 110.874 -174.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.3 mm -91.86 116.69 33.59 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.111 0 CA-C-O 121.473 0.654 . . . . 0.0 110.875 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.2 m80 -83.23 101.87 11.54 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.524 1.129 . . . . 0.0 108.921 -179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 27.5 mt -83.1 164.71 20.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.042 0.937 . . . . 0.0 112.933 -175.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 70.5 p -132.49 160.65 35.87 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 170.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -55.71 -44.24 77.27 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.742 0.701 . . . . 0.0 109.475 177.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -60.21 -47.98 83.69 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.848 1.259 . . . . 0.0 111.549 179.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 85.8 p -78.64 -21.79 47.85 Favored 'General case' 0 CA--C 1.531 0.231 0 O-C-N 122.007 -0.433 . . . . 0.0 112.105 -176.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -37.95 -51.89 1.35 Allowed 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 126.161 1.784 . . . . 0.0 113.729 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -51.65 -61.51 2.2 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 121.468 0.652 . . . . 0.0 110.681 -179.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -60.92 -46.86 88.99 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.716 -178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -69.88 -32.21 70.44 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 58.4 t -115.7 -64.73 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 C-N-CA 124.267 1.027 . . . . 0.0 111.833 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.3 -37.45 77.74 Favored 'General case' 0 N--CA 1.455 -0.206 0 O-C-N 122.46 -0.15 . . . . 0.0 111.358 -174.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -99.89 14.82 29.12 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.304 0.483 . . . . 0.0 112.304 178.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.62 120.97 14.35 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 119.417 1.008 . . . . 0.0 110.528 178.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -78.47 56.47 1.78 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 123.525 0.73 . . . . 0.0 110.241 178.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 169.22 -162.03 35.66 Favored Glycine 0 CA--C 1.526 0.781 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -179.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.67 129.98 38.43 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -116.75 138.26 47.95 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.173 0 C-N-CA 125.577 1.551 . . . . 0.0 108.622 178.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 12.2 tp -118.08 102.47 9.05 Favored 'General case' 0 C--N 1.334 -0.102 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 175.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.4 t -88.99 113.21 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.224 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -94.5 106.41 18.39 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 124.879 1.272 . . . . 0.0 107.923 174.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 62.5 m-85 -80.22 123.94 28.37 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 177.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 29.5 p-90 -138.09 177.62 7.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.606 0.762 . . . . 0.0 112.061 -177.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -147.64 151.15 35.72 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.807 1.643 . . . . 0.0 108.126 178.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 19.2 mp0 -54.69 -36.93 65.2 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.309 0.644 . . . . 0.0 111.897 -179.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -85.12 -2.47 58.05 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.524 1.13 . . . . 0.0 112.745 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 53.2 t -79.58 80.3 5.97 Favored 'General case' 0 CA--C 1.53 0.179 0 O-C-N 120.9 -1.125 . . . . 0.0 111.411 -177.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -42.61 -57.86 3.73 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 123.785 0.707 . . . . 0.0 112.001 177.028 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -53.1 -34.46 68.4 Favored 'Trans proline' 0 CA--C 1.538 0.704 0 C-N-CA 123.097 2.531 . . . . 0.0 113.484 178.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 85.9 m -64.01 -46.55 83.99 Favored 'General case' 0 C--N 1.338 0.105 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 178.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptm? -61.41 -41.86 97.81 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 176.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 64.3 mtt -57.43 -43.76 84.12 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 119.211 -0.424 . . . . 0.0 111.198 178.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 33.6 pt -78.76 -26.25 13.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.439 0 CA-C-N 118.822 0.737 . . . . 0.0 112.81 178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.2 -55.09 3.2 Favored Pre-proline 0 CA--C 1.543 0.704 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -49.37 -43.17 39.05 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 122.948 2.432 . . . . 0.0 112.904 175.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 53.4 mt -61.8 -49.82 82.7 Favored 'Isoleucine or valine' 0 C--N 1.339 0.119 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 58.3 mt -55.74 -44.06 77.19 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -58.63 -57.68 11.89 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.524 0.73 . . . . 0.0 110.377 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 19.0 pt-20 -59.74 -43.08 94.38 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 119.834 -0.747 . . . . 0.0 110.773 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 9.3 mm -54.59 -44.66 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 C-N-CA 122.912 0.485 . . . . 0.0 109.996 177.461 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.68 -35.17 65.73 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.074 0.397 . . . . 0.0 111.126 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -76.48 -52.44 9.79 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 177.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -52.0 -45.12 64.42 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 123.953 0.901 . . . . 0.0 111.682 -179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -98.06 24.72 6.75 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.266 1.027 . . . . 0.0 111.522 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 -54.04 129.73 35.4 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.462 1.028 . . . . 0.0 110.421 179.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.77 -17.47 15.6 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 119.232 -0.76 . . . . 0.0 113.305 -178.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -99.38 -44.79 6.07 Favored 'General case' 0 C--N 1.339 0.109 0 CA-C-N 118.692 1.246 . . . . 0.0 109.56 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.4 tp -127.22 128.53 46.22 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.166 0.986 . . . . 0.0 109.724 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 4.6 m -94.94 96.03 9.02 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 178.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 45.0 t -78.21 136.1 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 -178.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -135.67 150.31 49.55 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.17 0.988 . . . . 0.0 109.524 -178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.5 mttt -124.61 138.65 54.3 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 125.508 1.523 . . . . 0.0 107.38 178.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.0 tt -131.06 120.4 23.37 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 177.637 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -84.49 110.77 18.92 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -64.9 -36.72 78.42 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -177.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -60.42 -46.63 89.33 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 119.0 0.818 . . . . 0.0 109.688 -179.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 58.6 mt-30 -71.33 -30.05 65.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 124.244 1.017 . . . . 0.0 110.49 179.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 23.9 m-80 -127.92 72.4 78.88 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.857 0.863 . . . . 0.0 111.341 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_exo -52.79 -59.04 1.18 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 122.896 2.397 . . . . 0.0 113.192 -178.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -38.68 -47.32 2.29 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.765 1.65 . . . . 0.0 115.171 -176.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.2 -28.63 68.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 112.771 0.656 . . . . 0.0 112.771 -177.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.559 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -65.03 -67.68 0.98 Allowed Pre-proline 0 CA--C 1.539 0.556 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.302 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.559 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 89.0 Cg_exo -49.22 -45.11 31.2 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.194 1.929 . . . . 0.0 112.558 175.542 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -47.77 -40.86 21.86 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 118.359 0.527 . . . . 0.0 112.2 179.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -110.66 25.93 11.24 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.102 0.561 . . . . 0.0 111.847 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 48.82 38.78 23.74 Favored Glycine 0 CA--C 1.53 0.977 0 C-N-CA 124.237 0.922 . . . . 0.0 113.107 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 23.6 mm -78.35 79.86 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -179.723 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 5.1 mmp_? -85.6 -2.72 58.46 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.225 0.61 . . . . 0.0 111.099 -179.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -157.74 165.91 33.72 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 108.189 -1.964 . . . . 0.0 108.189 178.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt -147.86 154.21 43.39 Favored Pre-proline 0 CA--C 1.539 0.54 0 C-N-CA 125.514 1.525 . . . . 0.0 107.729 -179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -68.36 145.15 75.42 Favored 'Cis proline' 0 N--CA 1.454 -0.798 0 CA-C-N 120.575 1.241 . . . . 0.0 109.624 -1.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 44.9 m -139.38 127.87 22.97 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 179.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 37.9 mt -112.02 113.03 25.08 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.302 1.441 . . . . 0.0 109.233 -174.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 89' ' ' THR . 11.0 mp -105.87 120.18 41.09 Favored 'General case' 0 C--O 1.231 0.112 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.8 tp -98.66 103.83 15.82 Favored 'General case' 0 N--CA 1.456 -0.169 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -96.13 104.98 16.97 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.352 1.861 . . . . 0.0 109.538 -179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -83.71 102.48 12.29 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 173.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 9.8 t-20 47.9 54.49 9.93 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 121.805 0.812 . . . . 0.0 110.925 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.59 -18.61 8.43 Favored Glycine 0 CA--C 1.533 1.156 0 CA-C-O 119.19 -0.783 . . . . 0.0 113.804 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -84.97 109.93 18.53 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 119.443 1.621 . . . . 0.0 109.973 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 88.0 t -60.41 105.13 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 176.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.73 -45.26 19.23 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.733 0.813 . . . . 0.0 109.949 -179.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -157.66 158.56 35.67 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 109.441 -0.578 . . . . 0.0 109.441 178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.525 HG22 ' HG ' ' A' ' 79' ' ' LEU . 53.3 p -134.26 124.99 26.83 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.531 1.133 . . . . 0.0 108.756 -178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -113.77 117.88 32.74 Favored 'General case' 0 CA--C 1.527 0.082 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 66.5 t -95.37 129.72 45.11 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 N-CA-C 107.481 -1.303 . . . . 0.0 107.481 177.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.18 164.71 35.04 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 124.007 0.813 . . . . 0.0 111.554 -179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.43 164.51 25.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 122.948 0.499 . . . . 0.0 110.116 178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -156.86 161.51 39.69 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 124.296 1.038 . . . . 0.0 108.81 -179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 93.4 p -72.84 162.26 29.71 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.316 0.579 . . . . 0.0 110.589 179.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 61.5 tttp -56.73 -40.12 75.14 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 175.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -59.6 -54.69 35.61 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 110.601 -1.0 . . . . 0.0 110.601 177.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -56.77 -43.53 80.9 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 117.201 0.501 . . . . 0.0 110.299 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 39.9 tp -59.22 -53.63 56.13 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -53.82 -48.15 70.19 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-N 118.469 0.577 . . . . 0.0 110.731 177.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -54.76 -53.16 58.77 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.187 0.595 . . . . 0.0 110.04 178.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 57.5 t80 -55.17 -52.31 63.72 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.416 1.086 . . . . 0.0 110.598 179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.7 mt -57.0 -54.01 51.54 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 122.847 0.459 . . . . 0.0 110.221 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -54.58 -50.55 67.74 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 122.923 0.489 . . . . 0.0 110.653 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.17 76.94 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.197 0.599 . . . . 0.0 111.691 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -77.96 -49.38 14.23 Favored 'General case' 0 N--CA 1.46 0.074 0 O-C-N 122.19 -0.319 . . . . 0.0 111.048 -177.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 71.4 mt -60.07 -46.03 90.93 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.214 0 C-N-CA 125.444 1.498 . . . . 0.0 108.6 177.941 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.1 m . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -69.72 104.79 2.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.746 -0.464 . . . . 0.0 109.746 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 65.4 mttm -121.39 34.14 5.3 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 174.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 12.6 mt -86.44 136.11 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 C-N-CA 122.898 0.479 . . . . 0.0 111.111 -176.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 31.5 mm -91.93 116.26 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 C-N-CA 123.388 0.675 . . . . 0.0 110.6 179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -86.29 99.95 11.94 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.291 1.037 . . . . 0.0 109.204 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 85.4 mt -85.24 166.1 16.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.139 0.976 . . . . 0.0 112.24 -176.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 68.8 p -131.09 163.37 27.8 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 172.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -53.97 -49.78 68.01 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 109.176 -0.675 . . . . 0.0 109.176 176.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -59.92 -46.19 90.18 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 125.03 1.332 . . . . 0.0 111.855 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 59.9 p -78.46 -24.75 45.85 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -175.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -34.57 -61.3 0.4 Allowed 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 126.034 1.734 . . . . 0.0 114.052 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -53.68 -59.32 4.75 Favored 'General case' 0 CA--C 1.528 0.101 0 O-C-N 121.714 -0.616 . . . . 0.0 110.916 -177.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -56.36 -38.15 71.0 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.424 0.69 . . . . 0.0 112.698 -179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -81.86 -57.93 3.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 CA-C-O 121.405 0.622 . . . . 0.0 112.086 -176.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.0 t -80.39 -55.29 8.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.18 1.792 . . . . 0.0 113.075 -173.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 78.0 mt -65.13 -28.67 69.58 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.581 -0.699 . . . . 0.0 111.898 -174.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -88.84 8.64 28.09 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 122.079 -0.388 . . . . 0.0 111.468 174.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.1 81.69 0.69 Allowed 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.12 -0.987 . . . . 0.0 111.846 -178.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -71.6 70.15 0.66 Allowed 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 174.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 172.97 -134.35 2.93 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 106.953 -2.459 . . . . 0.0 106.953 -176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -133.61 114.66 13.76 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 117.92 0.86 . . . . 0.0 110.106 -179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.5 mt -112.9 127.99 69.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.297 1.039 . . . . 0.0 108.931 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -106.32 101.86 11.31 Favored 'General case' 0 C--O 1.226 -0.139 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 37.5 t -89.86 112.14 24.16 Favored 'Isoleucine or valine' 0 C--O 1.231 0.127 0 CA-C-N 118.099 0.409 . . . . 0.0 110.718 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -92.23 106.22 18.27 Favored 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 124.223 1.009 . . . . 0.0 108.659 174.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -79.69 121.56 25.47 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 176.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 13.5 p-90 -139.24 -178.41 5.35 Favored 'General case' 0 C--N 1.338 0.089 0 C-N-CA 123.493 0.717 . . . . 0.0 111.169 -177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.8 151.86 34.24 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 124.909 1.284 . . . . 0.0 108.495 178.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -53.69 -39.5 65.2 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.074 0.95 . . . . 0.0 111.876 -179.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.6 p-90 -82.23 -6.23 59.07 Favored 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.078 0.951 . . . . 0.0 112.573 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.3 t -79.43 80.61 5.78 Favored 'General case' 0 C--O 1.234 0.264 0 O-C-N 121.059 -1.026 . . . . 0.0 111.115 -177.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.45 -58.48 2.93 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.29 0.948 . . . . 0.0 112.149 177.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.48 -38.66 89.87 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 123.331 2.687 . . . . 0.0 113.18 178.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 63.6 m -62.6 -47.58 83.18 Favored 'General case' 0 CA--C 1.523 -0.072 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -61.83 -44.46 96.79 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.103 -0.702 . . . . 0.0 109.103 177.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 45.6 ttm -52.04 -41.56 62.38 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.919 0.888 . . . . 0.0 111.315 178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.9 pt -83.49 -8.71 11.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.57 -50.79 74.96 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-N 120.058 1.299 . . . . 0.0 113.032 -179.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.68 -41.83 70.95 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.445 2.097 . . . . 0.0 111.516 176.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 62.7 mt -61.96 -51.15 76.0 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.179 0 N-CA-C 107.966 -1.124 . . . . 0.0 107.966 178.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 83.7 mt -54.85 -43.85 73.46 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 118.112 0.414 . . . . 0.0 110.78 178.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -61.01 -53.15 60.76 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-O 121.272 0.558 . . . . 0.0 109.872 178.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -54.49 -47.04 73.49 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 122.895 0.478 . . . . 0.0 110.083 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 11.9 mm -59.12 -47.19 90.94 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.259 0 C-N-CA 124.157 0.983 . . . . 0.0 109.59 177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.36 -42.43 66.82 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 122.753 0.421 . . . . 0.0 109.875 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -67.38 -56.64 8.86 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 110.382 -0.229 . . . . 0.0 110.382 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -50.67 -45.23 57.95 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.738 0.815 . . . . 0.0 112.51 -178.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -97.33 21.36 10.16 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.153 0.981 . . . . 0.0 111.798 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -53.91 128.71 31.27 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 119.408 1.004 . . . . 0.0 110.109 179.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.55 -19.55 23.41 Favored Glycine 0 CA--C 1.533 1.214 0 CA-C-O 119.224 -0.765 . . . . 0.0 113.058 -178.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -99.14 -44.29 6.33 Favored 'General case' 0 CA--C 1.529 0.151 0 CA-C-N 118.658 1.229 . . . . 0.0 109.381 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -132.71 133.97 44.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.369 1.068 . . . . 0.0 108.796 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 66.4 m -101.44 105.74 16.79 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 176.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 98.3 t -79.04 139.5 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 107.051 -1.462 . . . . 0.0 107.051 179.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.99 154.89 50.29 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 123.897 0.879 . . . . 0.0 109.074 -178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -131.95 147.56 52.47 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 124.719 1.207 . . . . 0.0 108.433 178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.2 tt -138.89 120.32 14.95 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.233 -1.025 . . . . 0.0 108.233 175.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 40.6 t-20 -85.29 107.51 17.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 pp -64.29 -24.19 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.651 0.781 . . . . 0.0 112.116 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -61.77 -46.56 89.06 Favored 'General case' 0 C--N 1.341 0.215 0 CA-C-N 119.122 0.874 . . . . 0.0 108.885 177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 42.7 mt-30 -76.05 -35.44 59.46 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.277 178.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -119.42 70.13 11.87 Favored Pre-proline 0 CA--C 1.534 0.343 0 C-N-CA 124.377 1.071 . . . . 0.0 111.073 -175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -61.12 -54.36 1.88 Allowed 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.385 2.057 . . . . 0.0 112.418 -177.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -42.12 -41.42 3.75 Favored Glycine 0 CA--C 1.532 1.11 0 C-N-CA 124.941 1.258 . . . . 0.0 114.594 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.23 71.12 Favored 'General case' 0 N--CA 1.45 -0.425 0 O-C-N 122.016 -0.696 . . . . 0.0 112.32 -178.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.02 -66.81 1.33 Allowed Pre-proline 0 CA--C 1.537 0.452 0 CA-C-O 117.794 -1.098 . . . . 0.0 110.641 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.556 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 81.0 Cg_exo -49.31 -48.49 18.46 Favored 'Trans proline' 0 N--CA 1.457 -0.655 0 C-N-CA 122.166 1.911 . . . . 0.0 112.173 174.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 24.5 mtpp -48.67 -48.67 39.76 Favored 'General case' 0 C--N 1.344 0.355 0 CA-C-N 118.079 0.399 . . . . 0.0 111.845 -179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 73.3 m-85 -97.55 24.74 6.35 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 49.25 40.64 29.96 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.197 0.904 . . . . 0.0 113.184 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 36.3 mm -77.4 86.26 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 N-CA-C 108.482 -0.933 . . . . 0.0 108.482 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.9 mmm180 -78.89 -6.09 55.25 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 123.169 0.588 . . . . 0.0 112.386 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -168.64 175.01 43.32 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 107.839 -2.104 . . . . 0.0 107.839 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.8 pt -146.6 152.56 45.57 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.667 1.187 . . . . 0.0 107.997 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -69.7 144.51 76.71 Favored 'Cis proline' 0 N--CA 1.456 -0.719 0 CA-C-N 120.543 1.23 . . . . 0.0 110.053 -0.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.5 m -136.81 123.4 20.97 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 17.1 mt -107.21 104.27 13.86 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 124.96 1.304 . . . . 0.0 109.704 -173.275 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.512 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.1 mp -94.09 115.77 28.12 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.14 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.5 12.57 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 79.2 m-85 -87.18 109.28 19.35 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.956 1.302 . . . . 0.0 109.306 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.3 mmmm -100.61 120.45 40.06 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 175.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 49.61 47.44 22.72 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.242 0.617 . . . . 0.0 110.274 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 71.81 -5.61 11.76 Favored Glycine 0 CA--C 1.535 1.303 0 CA-C-O 118.528 -1.151 . . . . 0.0 115.225 -179.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -105.28 129.43 53.64 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.825 1.813 . . . . 0.0 110.481 -178.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.92 107.13 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.67 -43.96 21.77 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.62 0.768 . . . . 0.0 110.046 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.53 156.28 34.88 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.078 0.551 . . . . 0.0 109.757 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.512 HG22 ' HG ' ' A' ' 79' ' ' LEU . 73.7 p -129.26 110.81 12.27 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.856 1.262 . . . . 0.0 109.348 -178.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.6 tmtm? -98.49 110.46 23.05 Favored 'General case' 0 CA--C 1.523 -0.077 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 63.4 t -91.29 129.68 41.65 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 95.34 163.9 34.61 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.191 0.901 . . . . 0.0 112.177 179.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.77 167.77 20.18 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.155 0.582 . . . . 0.0 110.129 178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -161.81 169.55 21.13 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.332 1.053 . . . . 0.0 109.258 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 90.6 p -77.54 160.16 28.8 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.782 0.433 . . . . 0.0 110.205 179.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -55.11 -45.52 75.5 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 174.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -55.98 -54.05 38.04 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 111.431 -0.667 . . . . 0.0 111.431 178.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 20.3 mm100 -61.02 -39.19 88.82 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 117.923 0.862 . . . . 0.0 111.148 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 35.6 tp -59.98 -52.36 65.7 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 53.6 mtpt -55.33 -45.51 76.39 Favored 'General case' 0 N--CA 1.456 -0.151 0 O-C-N 121.898 -0.501 . . . . 0.0 111.283 178.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -56.48 -55.35 34.83 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.323 0.649 . . . . 0.0 109.885 177.733 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -53.4 -51.88 61.12 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.041 0.936 . . . . 0.0 110.727 178.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 97.5 mt -57.64 -51.73 68.3 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 122.811 0.444 . . . . 0.0 110.238 -179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -54.42 -51.68 64.16 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 122.807 0.443 . . . . 0.0 110.214 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -55.0 -40.48 70.18 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 123.503 0.721 . . . . 0.0 111.843 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 15.8 m-80 -78.06 -40.32 38.98 Favored 'General case' 0 N--CA 1.461 0.113 0 O-C-N 122.202 -0.311 . . . . 0.0 111.121 -178.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 42.2 mt -62.01 -47.45 84.7 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.262 0 C-N-CA 123.17 0.588 . . . . 0.0 109.734 177.592 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.451 -0.384 0 N-CA-C 112.357 0.502 . . . . 0.0 112.357 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 60.6 t0 -58.78 98.92 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.902 0.881 . . . . 0.0 112.397 -176.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -125.03 45.12 2.63 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.984 -1.858 . . . . 0.0 105.984 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 32.0 mt -95.56 142.76 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 123.895 0.878 . . . . 0.0 110.611 -176.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.5 mm -90.97 115.35 29.97 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 CA-C-O 121.572 0.701 . . . . 0.0 111.456 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 69.7 m80 -84.56 95.77 8.95 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 124.777 1.231 . . . . 0.0 109.408 -179.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.0 mt -87.44 163.24 16.84 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.072 0.949 . . . . 0.0 113.121 -176.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.1 p -128.17 160.67 31.33 Favored 'General case' 0 C--O 1.236 0.392 0 C-N-CA 126.547 1.939 . . . . 0.0 107.701 173.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -52.1 -51.55 57.01 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.037 0.935 . . . . 0.0 109.197 177.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -54.23 -45.15 72.24 Favored 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 125.343 1.457 . . . . 0.0 111.836 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.4 p -78.61 -26.69 45.4 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -177.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -34.03 -69.43 0.09 Allowed 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.608 1.563 . . . . 0.0 114.968 -174.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -51.74 -59.75 3.94 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 123.58 0.752 . . . . 0.0 110.295 -178.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 1.5 m -51.58 -42.53 61.97 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 124.96 1.304 . . . . 0.0 113.377 -178.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -83.28 -53.15 5.96 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 122.747 0.419 . . . . 0.0 111.538 -176.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 53.1 t -79.66 -58.78 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 C-N-CA 124.791 1.236 . . . . 0.0 113.204 -173.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.34 -32.8 73.63 Favored 'General case' 0 C--N 1.332 -0.167 0 O-C-N 122.055 -0.403 . . . . 0.0 111.579 -174.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -81.06 -5.52 57.73 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 177.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.415 ' CB ' HD12 ' A' ' 23' ' ' ILE . . . -73.77 95.0 2.32 Favored 'General case' 0 N--CA 1.454 -0.263 0 CA-C-N 119.725 1.148 . . . . 0.0 111.763 -177.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -76.02 64.87 1.97 Allowed 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 175.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -169.9 -154.35 9.25 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 107.67 -2.172 . . . . 0.0 107.67 -176.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -115.61 116.03 27.44 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 119.604 1.702 . . . . 0.0 109.137 179.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.415 HD12 ' CB ' ' A' ' 19' ' ' ALA . 2.7 mt -113.08 134.19 56.52 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -115.05 101.78 9.32 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.5 t -92.57 114.93 30.35 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.133 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.84 107.35 19.25 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.847 1.259 . . . . 0.0 108.294 175.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -79.8 126.11 30.55 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 178.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 42.0 p-90 -136.12 178.26 7.19 Favored 'General case' 0 C--O 1.231 0.088 0 C-N-CA 123.654 0.781 . . . . 0.0 111.734 -178.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -149.64 153.8 37.62 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.556 1.542 . . . . 0.0 108.245 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -53.15 -35.82 60.17 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.998 0.919 . . . . 0.0 112.121 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -89.2 -2.37 58.47 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.999 1.319 . . . . 0.0 112.79 -179.596 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 50.4 t -79.52 78.04 6.08 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.948 -1.095 . . . . 0.0 111.711 -177.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -41.88 -57.78 3.36 Favored Glycine 0 CA--C 1.539 1.593 0 C-N-CA 123.659 0.647 . . . . 0.0 112.341 177.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -52.51 -35.7 67.47 Favored 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.227 2.618 . . . . 0.0 113.241 178.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 83.3 m -62.39 -45.48 92.97 Favored 'General case' 0 C--N 1.338 0.085 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 mmtp -60.76 -42.74 98.06 Favored 'General case' 0 CA--C 1.528 0.121 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 93.5 mmm -59.02 -45.84 89.68 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 119.48 -0.295 . . . . 0.0 111.164 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.1 pt -76.6 -26.23 16.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-N 118.612 0.642 . . . . 0.0 112.592 179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.57 -57.69 0.91 Allowed Pre-proline 0 CA--C 1.543 0.682 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -55.36 -40.09 87.45 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.298 1.998 . . . . 0.0 111.835 177.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.5 mt -60.2 -49.14 85.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.186 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 176.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 51.4 mt -56.27 -42.85 78.14 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 110.302 -0.259 . . . . 0.0 110.302 178.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.6 m-20 -60.88 -47.5 86.09 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 178.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.12 -48.47 80.11 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.833 -0.542 . . . . 0.0 109.73 177.002 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 26.8 mm -55.66 -46.79 79.54 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.274 0 C-N-CA 122.976 0.51 . . . . 0.0 109.9 177.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.06 -35.97 62.6 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.238 0.615 . . . . 0.0 110.768 179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -75.4 -59.15 2.87 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 176.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -49.63 -44.19 47.23 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 124.53 1.132 . . . . 0.0 113.174 -177.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -102.21 20.75 16.16 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.108 0.963 . . . . 0.0 111.502 -178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -56.41 125.71 23.2 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 119.386 0.994 . . . . 0.0 109.496 179.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 90.42 -20.09 39.81 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 119.305 -0.719 . . . . 0.0 112.58 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -99.2 -46.69 5.46 Favored 'General case' 0 C--N 1.338 0.088 0 CA-C-N 118.492 1.146 . . . . 0.0 109.362 178.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -127.11 124.17 38.53 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.715 1.206 . . . . 0.0 108.553 -178.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 94.7 m -92.45 101.02 13.47 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 107.165 -1.42 . . . . 0.0 107.165 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 54.1 t -78.82 139.97 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 -179.173 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -136.75 154.76 50.49 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 124.438 1.095 . . . . 0.0 109.58 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 59.6 mttt -130.28 145.99 51.83 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.043 1.737 . . . . 0.0 107.35 178.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 tt -143.94 126.79 16.27 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 177.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ASN . . . . . . . . . . . . . 64.6 t-20 -86.7 106.72 17.84 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 123.326 0.65 . . . . 0.0 109.256 179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pp -65.15 -24.37 35.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 118.981 -0.533 . . . . 0.0 111.996 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -62.23 -44.41 96.62 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.419 1.009 . . . . 0.0 108.903 178.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -78.68 -34.47 46.19 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.425 179.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 29.5 m-80 -123.4 66.37 33.88 Favored Pre-proline 0 CA--C 1.535 0.367 0 C-N-CA 124.678 1.191 . . . . 0.0 111.922 -173.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -61.15 -52.06 3.83 Favored 'Trans proline' 0 N--CA 1.454 -0.794 0 C-N-CA 122.686 2.257 . . . . 0.0 112.94 -176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -39.07 -41.74 1.44 Allowed Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.82 1.676 . . . . 0.0 114.268 -177.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -52.27 -37.21 54.8 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.195 0.998 . . . . 0.0 113.239 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.542 ' HB3' ' HD3' ' A' ' 68' ' ' PRO . . . -61.43 -66.8 1.33 Allowed Pre-proline 0 CA--C 1.537 0.471 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.768 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 67' ' ' ALA . 99.8 Cg_exo -44.9 -48.1 11.16 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.795 2.33 . . . . 0.0 113.131 173.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.3 mtmt -48.16 -43.75 31.82 Favored 'General case' 0 C--N 1.346 0.442 0 CA-C-N 118.912 0.778 . . . . 0.0 112.572 -179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 96.8 m-85 -108.01 25.82 11.12 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 117.973 0.351 . . . . 0.0 111.521 178.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 41.75 47.71 5.0 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 125.239 1.399 . . . . 0.0 112.299 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.6 mt -74.81 130.15 36.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.05 -36.52 40.82 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 112.54 0.571 . . . . 0.0 112.54 -175.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -171.53 -156.74 12.25 Favored Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -178.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.8 pt -144.98 151.35 48.71 Favored Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 124.377 1.071 . . . . 0.0 108.343 179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.4 141.94 71.51 Favored 'Cis proline' 0 N--CA 1.456 -0.693 0 CA-C-N 119.936 1.013 . . . . 0.0 109.582 -2.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 90.1 m -139.32 130.38 26.5 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.031 -1.47 . . . . 0.0 107.031 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LEU . . . . . . . . . . . . . 15.8 mt -108.45 103.64 12.82 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.047 1.339 . . . . 0.0 109.35 -175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.497 ' HG ' HG22 ' A' ' 89' ' ' THR . 10.6 mp -91.83 115.53 28.14 Favored 'General case' 0 N--CA 1.463 0.196 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.2 tp -94.17 100.57 12.63 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -87.11 104.3 16.21 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.468 1.507 . . . . 0.0 108.205 178.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 12.8 mmmm -94.84 113.52 25.28 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 51.4 43.31 29.58 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.503 1.521 . . . . 0.0 111.335 -179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 84.06 -12.67 53.12 Favored Glycine 0 CA--C 1.532 1.11 0 CA-C-O 118.992 -0.893 . . . . 0.0 113.77 -179.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -99.46 128.73 45.59 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 119.459 1.629 . . . . 0.0 110.7 -178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 96.8 t -64.77 105.81 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.356 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 177.453 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.92 -43.61 21.86 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.171 0.588 . . . . 0.0 110.462 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -155.11 154.35 32.24 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.087 0.555 . . . . 0.0 109.681 -178.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.497 HG22 ' HG ' ' A' ' 79' ' ' LEU . 32.7 p -128.19 99.12 5.33 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.787 1.235 . . . . 0.0 107.776 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -86.0 110.12 19.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 -178.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 45.6 t -89.16 130.18 38.94 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 178.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 91.53 163.39 38.43 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.83 0.729 . . . . 0.0 112.382 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.91 168.95 17.89 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.271 0.629 . . . . 0.0 110.309 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -163.64 164.22 24.1 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 125.088 1.355 . . . . 0.0 108.073 -179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' SER . . . . . . . . . . . . . 96.1 p -72.32 161.95 30.13 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.995 0.426 . . . . 0.0 110.542 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -56.37 -43.27 79.04 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 175.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -57.17 -56.86 22.8 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 110.509 -1.037 . . . . 0.0 110.509 178.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -53.54 -44.86 69.55 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 117.269 0.534 . . . . 0.0 110.572 178.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 33.3 tp -58.74 -52.51 65.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 54.3 mtpt -56.09 -46.77 78.92 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 118.571 0.623 . . . . 0.0 110.799 178.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -56.27 -52.89 62.83 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 122.501 0.32 . . . . 0.0 110.256 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 53.2 t80 -54.36 -53.19 57.34 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 123.859 0.864 . . . . 0.0 110.476 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 92.5 mt -56.69 -52.95 62.96 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 122.877 0.471 . . . . 0.0 110.29 -179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -53.35 -51.84 61.15 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.718 0.407 . . . . 0.0 110.318 178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -56.46 -40.38 74.75 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.313 0.645 . . . . 0.0 112.034 179.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -78.02 -38.25 45.16 Favored 'General case' 0 CA--C 1.529 0.149 0 O-C-N 122.147 -0.346 . . . . 0.0 110.797 -177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LEU . . . . . . . . . . . . . 44.3 mt -62.56 -48.54 79.05 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 177.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.311 0 C-N-CA 123.156 0.582 . . . . 0.0 109.643 177.401 . . . . . . . . 0 0 . 1 stop_ save_